data_2bud_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2bud _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.56 HD13 ' CZ ' ' A' ' 429' ' ' ARG . 70.1 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.004 0.431 . . . . 1.9299999999999999 112.14 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -89.74 130.72 35.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.694 -0.685 . . . . 2.1699999999999999 110.689 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.5 mt -81.73 -43.63 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 1.4399999999999999 111.394 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 72.7 p -65.46 74.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.979 -0.555 . . . . 2.2000000000000002 111.211 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -173.83 -27.19 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.561 -0.745 . . . . 1.9199999999999999 109.964 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.49 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -165.67 57.7 0.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.372 -0.831 . . . . 2.8900000000000001 111.392 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 51.2 Cg_exo -53.67 -39.12 84.46 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.247 1.964 . . . . 0.97999999999999998 111.604 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.46 -32.4 73.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.751 -0.659 . . . . 1.21 110.943 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 84.6 tttt -50.4 127.06 16.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.241 -0.436 . . . . 2.27 111.117 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 47.4 mm -83.46 127.39 39.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 1.1299999999999999 110.743 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -102.32 143.34 32.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.313 . . . . 1.1000000000000001 110.694 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -92.25 140.01 30.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.272 -0.422 . . . . 1.3200000000000001 110.282 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.657 HD11 ' N ' ' A' ' 385' ' ' ILE . 1.0 OUTLIER -133.49 126.88 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 1.2 111.111 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 45.2 ttt85 -79.83 116.77 20.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.008 -0.542 . . . . 3.1699999999999999 110.431 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -69.98 155.55 40.42 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.677 -0.409 . . . . 2.9900000000000002 110.21 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -51.26 -45.24 61.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 2.8199999999999998 111.55 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -56.96 -34.61 68.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.086 -0.709 . . . . 1.23 109.086 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 132.57 -36.72 2.13 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.494 -0.775 . . . . 1.03 112.947 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 82.3 p -59.57 112.83 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.182 0.515 . . . . 1.46 112.163 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.613 HG23 ' HB3' ' A' ' 439' ' ' LEU . 61.6 t -73.5 142.38 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.707 -0.679 . . . . 1.24 110.696 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -147.94 143.94 27.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.38 . . . . 3.2400000000000002 111.254 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -55.84 154.64 6.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.906 -0.588 . . . . 3.5600000000000001 111.809 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.507 ' HA2' HD12 ' A' ' 385' ' ' ILE . . . -171.35 129.68 1.82 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.688 -0.687 . . . . 0.32000000000000001 112.316 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -84.89 128.5 34.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.75 0.309 . . . . 1.28 110.752 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.7 OUTLIER -97.2 134.5 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.507 -0.315 . . . . 1.5800000000000001 110.424 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 76.3 mt -120.57 -43.76 2.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.971 0.73 . . . . 2.04 112.971 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -122.75 174.78 6.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.117 0.484 . . . . 2.6400000000000001 112.228 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.4 p -166.3 144.92 5.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.513 -0.767 . . . . 1.1299999999999999 110.608 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.511 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 39.3 ptt180 -143.54 134.72 25.76 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.809 0.337 . . . . 1.8799999999999999 110.842 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.63 HG21 ' HB3' ' A' ' 410' ' ' ASP . 18.0 p -98.85 38.02 1.43 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.098 0.407 . . . . 1.79 112.098 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.534 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 3.0 m 47.52 -173.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.285 -0.416 . . . . 2.2999999999999998 111.249 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.534 ' H ' ' CG2' ' A' ' 403' ' ' THR . 94.4 mt-10 -68.68 -41.62 78.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.799 0.333 . . . . 3.8700000000000001 111.402 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.423 ' HB3' ' HG3' ' A' ' 409' ' ' PRO . 24.3 t-20 -54.57 -52.48 61.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.154 -0.476 . . . . 3.1600000000000001 111.311 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 55.55 59.67 3.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 2.1800000000000002 111.756 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.431 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -163.51 11.08 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.459 0.647 . . . . 2.77 110.024 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.627 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -177.57 -49.77 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 114.808 -1.087 . . . . 3.2799999999999998 110.23 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 30.8 Cg_endo -62.2 145.62 96.17 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.408 2.072 . . . . 2.8700000000000001 112.425 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.63 ' HB3' HG21 ' A' ' 402' ' ' THR . 12.5 p-10 -178.47 124.65 0.11 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.047 -0.524 . . . . 2.1400000000000001 110.763 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 400' ' ' SER . 10.8 mp0 -129.89 137.89 50.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.947 -0.57 . . . . 2.1000000000000001 110.127 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.617 ' HB2' HD13 ' A' ' 432' ' ' ILE . 1.4 m-85 -109.76 133.41 53.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.883 0.373 . . . . 1.0600000000000001 111.664 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 30.9 t80 -72.9 120.72 18.92 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.439 -0.578 . . . . 1.05 109.439 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.565 HG13 HG12 ' A' ' 427' ' ' VAL . 8.8 p -112.56 138.75 40.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.584 0.587 . . . . 1.8400000000000001 112.584 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . 0.505 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 83.8 t60 -120.81 88.95 3.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.218 -0.901 . . . . 0.70999999999999996 109.412 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -52.85 116.2 2.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 1.1299999999999999 111.318 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.3 t -62.11 128.89 24.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 1.7 111.371 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.39 -42.44 1.95 Allowed Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.776 -0.647 . . . . 1.1699999999999999 113.351 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 423' ' ' LEU . 7.8 mp -59.45 161.06 6.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.013 0.435 . . . . 2.1499999999999999 111.576 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.596 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 4.9 m120 -49.78 140.91 10.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.514 -0.766 . . . . 2.7599999999999998 111.925 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . 0.507 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 88.7 mtm180 -65.23 -36.45 84.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.867 -0.606 . . . . 4.6500000000000004 110.829 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . 0.442 ' HG2' ' HB3' ' A' ' 420' ' ' ASN . 3.7 ptm85 -55.65 -35.57 66.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.281 -0.418 . . . . 4.3200000000000003 110.643 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.596 ' HG ' ' HB2' ' A' ' 420' ' ' ASN . 76.7 mt -59.02 -35.17 72.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 2.04 111.394 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.507 ' OD2' ' HA ' ' A' ' 421' ' ' ARG . 48.9 m-20 -54.69 139.7 38.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 1.2 111.901 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 179.45 -153.35 12.11 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.472 -0.785 . . . . 0.69999999999999996 111.852 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . 0.511 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 77.0 m95 -94.93 140.48 29.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.833 0.349 . . . . 0.76000000000000001 111.082 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.565 HG12 HG13 ' A' ' 414' ' ' VAL . 16.1 m -138.76 137.5 42.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.032 -0.531 . . . . 1.4399999999999999 111.399 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.49 ' HA2' ' CE1' ' A' ' 430' ' ' HIS . . . -62.22 150.13 47.03 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.819 -0.628 . . . . 1.72 112.591 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.56 ' CZ ' HD13 ' A' ' 373' ' ' ILE . 41.0 tpt85 -53.61 -38.17 63.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 2.3199999999999998 111.302 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.49 ' CE1' ' HA2' ' A' ' 428' ' ' GLY . 19.5 p-80 -58.08 -29.86 65.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.952 0.352 . . . . 2.23 111.952 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.05 -36.13 48.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.578 -0.283 . . . . 3.4199999999999999 111.215 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.617 HD13 ' HB2' ' A' ' 412' ' ' TYR . 54.1 mt -89.28 139.7 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.945 0.402 . . . . 1.1399999999999999 111.366 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.6 m -160.97 139.51 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.95999999999999996 110.651 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -63.78 -26.46 68.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 1.3500000000000001 111.281 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.609 ' ND2' ' HB2' ' A' ' 437' ' ' ASP . 45.8 t30 -109.62 134.06 52.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.92 0.39 . . . . 2.5299999999999998 110.691 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -73.37 -39.85 64.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.007 -0.542 . . . . 1.3300000000000001 112.275 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . 0.609 ' HB2' ' ND2' ' A' ' 435' ' ' ASN . 57.0 m-20 -49.69 -40.87 41.66 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.787 0.291 . . . . 1.3400000000000001 111.787 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.4 -40.96 94.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.348 . . . . 1.5600000000000001 110.97 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.613 ' HB3' HG23 ' A' ' 392' ' ' VAL . 88.5 mt -64.88 -83.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 1.76 111.558 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -138.59 34.36 2.12 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.492 -0.861 . . . . 1.3600000000000001 113.077 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 437' ' ' ASP . . . 43.63 44.17 6.67 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.365 -0.445 . . . . 1.8300000000000001 113.732 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' A' ' 441' ' ' GLY . 48.0 mm . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.534 0.683 . . . . 1.9199999999999999 111.476 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.495 HG22 HD11 ' A' ' 373' ' ' ILE . 31.4 mm . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 121.315 0.579 . . . . 1.9299999999999999 112.448 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -106.19 69.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.711 -0.677 . . . . 2.1699999999999999 110.489 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.586 HG21 ' N ' ' A' ' 376' ' ' SER . 73.5 mt -60.67 -82.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.036 0.754 . . . . 1.4399999999999999 113.036 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' SER . . . . . 0.586 ' N ' HG21 ' A' ' 375' ' ' ILE . 52.0 m -49.93 -28.73 7.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.121 -0.49 . . . . 2.2000000000000002 111.814 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -70.44 -38.25 74.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.698 -0.683 . . . . 1.9199999999999999 111.144 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 3.9 m120 -146.04 66.17 11.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 2.8900000000000001 111.68 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.13 -40.65 76.33 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.691 2.261 . . . . 0.97999999999999998 112.227 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.05 -37.13 85.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.887 -0.597 . . . . 1.21 111.327 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.3 tttp -51.17 125.63 14.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.399 . . . . 2.27 111.124 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.648 HG22 HG22 ' A' ' 417' ' ' VAL . 42.5 mm -87.04 132.87 31.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.973 -0.558 . . . . 1.1299999999999999 111.47 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -107.25 143.69 35.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.371 -0.377 . . . . 1.1000000000000001 110.361 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -92.64 138.35 31.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.667 0.27 . . . . 1.3200000000000001 110.641 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.562 HG13 HG12 ' A' ' 432' ' ' ILE . 3.0 mp -123.01 135.45 63.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.893 0.378 . . . . 1.2 111.267 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.659 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 56.3 ttt-85 -92.44 121.73 34.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 3.1699999999999999 111.204 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -79.52 156.64 27.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.546 -0.297 . . . . 2.9900000000000002 110.412 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -51.54 -45.45 62.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 2.8199999999999998 111.036 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.45 ' OD1' HG22 ' A' ' 391' ' ' THR . 2.2 p30 -59.44 -32.53 70.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 1.23 110.295 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 112.33 37.75 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.894 -0.593 . . . . 1.03 112.828 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' THR . . . . . 0.45 HG22 ' OD1' ' A' ' 389' ' ' ASP . 62.9 p -120.84 112.34 18.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.863 0.363 . . . . 1.46 111.342 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.64 HG12 HD11 ' A' ' 439' ' ' LEU . 87.0 t -69.6 138.92 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 1.24 111.21 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . 0.481 ' HB3' HD12 ' A' ' 419' ' ' LEU . 91.0 m-70 -149.37 138.81 21.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.11 -0.496 . . . . 3.2400000000000002 110.978 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 73.8 mtm-85 -57.41 150.28 18.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.545 . . . . 3.5600000000000001 111.802 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.549 ' HA2' HD12 ' A' ' 385' ' ' ILE . . . -175.7 132.98 2.26 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.586 -0.734 . . . . 0.32000000000000001 111.856 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 82.8 mt-30 -95.2 129.99 42.1 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.851 0.315 . . . . 1.28 111.851 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.768 HG23 HD12 ' A' ' 432' ' ' ILE . 21.5 t -85.9 132.38 32.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.94 -0.393 . . . . 1.5800000000000001 109.94 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . 0.401 ' C ' HD12 ' A' ' 375' ' ' ILE . 91.9 mt -121.02 -40.82 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.575 0.583 . . . . 2.04 112.575 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . 0.414 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 97.9 mm-40 -136.86 176.46 8.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.231 0.538 . . . . 2.6400000000000001 112.25 -178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.7 p -158.0 140.13 14.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.369 -0.832 . . . . 1.1299999999999999 109.947 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.45 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 38.0 ptt180 -142.31 137.05 30.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.066 0.46 . . . . 1.8799999999999999 112.035 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 42.1 p -77.42 137.46 38.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 1.79 110.312 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.474 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.7 m -62.4 -174.29 0.06 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.03 -0.359 . . . . 2.2999999999999998 110.03 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.474 ' H ' ' CG2' ' A' ' 403' ' ' THR . 55.5 mt-10 -48.21 -40.69 25.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.8 0.333 . . . . 3.8700000000000001 110.695 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.503 ' O ' ' HD2' ' A' ' 409' ' ' PRO . 50.1 t30 -80.5 54.19 2.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.979 -0.555 . . . . 3.1600000000000001 110.664 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.438 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . -51.43 98.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.131 0.491 . . . . 2.1800000000000002 110.995 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -177.28 -29.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.378 -0.828 . . . . 2.77 109.978 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.569 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -145.57 -51.21 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.106 -0.952 . . . . 3.2799999999999998 111.259 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 51.0 Cg_exo -55.46 145.71 66.97 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.457 2.105 . . . . 2.8700000000000001 112.354 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.401 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 12.8 p-10 -173.01 128.62 0.47 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.153 0.502 . . . . 2.1400000000000001 111.326 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 400' ' ' SER . 52.2 mp0 -108.73 144.25 36.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.643 -0.708 . . . . 2.1000000000000001 109.98 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.559 ' HB3' HG12 ' A' ' 397' ' ' VAL . 0.8 OUTLIER -109.15 124.18 50.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.079 0.466 . . . . 1.0600000000000001 111.841 -178.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 11.9 t80 -63.96 149.9 46.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.567 -0.742 . . . . 1.05 109.341 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 12.3 p -153.78 137.52 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.199 0.523 . . . . 1.8400000000000001 112.356 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -118.46 107.46 13.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.415 -0.811 . . . . 0.70999999999999996 109.553 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -62.13 127.82 33.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.081 0.467 . . . . 1.1299999999999999 111.218 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.648 HG22 HG22 ' A' ' 382' ' ' ILE . 2.4 t -82.49 34.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.518 -0.764 . . . . 1.7 111.223 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -176.81 -48.39 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.769 -0.729 . . . . 1.1699999999999999 112.783 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.481 HD12 ' HB3' ' A' ' 393' ' ' HIS . 7.0 mp -62.75 150.37 41.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 2.1499999999999999 110.916 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.495 ' O ' HD21 ' A' ' 423' ' ' LEU . 48.5 t30 -53.09 165.91 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.943 -0.571 . . . . 2.7599999999999998 111.157 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -64.22 -27.56 69.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 4.6500000000000004 110.543 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -53.44 -39.75 64.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.802 -0.635 . . . . 4.3200000000000003 111.047 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.495 HD21 ' O ' ' A' ' 420' ' ' ASN . 1.6 mm? -70.9 -34.82 71.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.178 -0.465 . . . . 2.04 110.502 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -53.76 131.56 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.798 -0.637 . . . . 1.2 111.25 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 169.72 -146.39 10.01 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.867 -0.606 . . . . 0.69999999999999996 112.209 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . 0.45 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 57.0 m95 -103.75 140.09 38.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.801 0.334 . . . . 0.76000000000000001 110.722 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 432' ' ' ILE . 32.0 m -141.04 144.7 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 1.4399999999999999 111.097 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -59.0 148.69 39.43 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.961 -0.638 . . . . 1.72 112.835 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -52.3 -39.81 61.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.765 0.317 . . . . 2.3199999999999998 111.316 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.517 ' ND1' ' HG3' ' A' ' 431' ' ' ARG . 6.1 p80 -57.09 -27.5 61.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 2.23 111.973 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.517 ' HG3' ' ND1' ' A' ' 430' ' ' HIS . 67.9 mtt-85 -78.51 -38.84 39.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.637 0.236 . . . . 3.4199999999999999 111.637 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.768 HD12 HG23 ' A' ' 397' ' ' VAL . 51.9 mt -87.91 131.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 1.1399999999999999 110.836 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 71.4 m -161.15 140.18 10.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.591 . . . . 0.95999999999999996 111.089 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -60.19 -24.47 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.035 -0.53 . . . . 1.3500000000000001 111.211 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.425 ' O ' ' HG ' ' A' ' 439' ' ' LEU . 24.0 t-20 -108.4 128.8 55.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.407 -0.36 . . . . 2.5299999999999998 110.944 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -83.3 -40.12 19.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 1.3300000000000001 112.058 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -47.96 -40.59 22.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.43 -0.35 . . . . 1.3400000000000001 111.386 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -70.64 -37.12 73.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 1.5600000000000001 110.902 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 386' ' ' ARG . 84.1 mt -57.32 -84.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.942 -0.572 . . . . 1.76 111.778 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -172.07 40.6 0.17 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.527 -0.844 . . . . 1.3600000000000001 112.885 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 392' ' ' VAL . . . 66.93 143.54 0.06 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.802 -0.713 . . . . 1.8300000000000001 112.861 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 442' ' ' ILE . 50.4 mm . . . . . 0 C--N 1.332 -0.162 0 CA-C-O 120.756 0.312 . . . . 1.9199999999999999 110.204 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 432' ' ' ILE . 68.0 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.733 0.301 . . . . 1.9299999999999999 111.184 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -89.36 129.65 35.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.389 -0.369 . . . . 2.1699999999999999 110.938 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 88.8 mt -95.56 -45.96 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 1.4399999999999999 111.531 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 64.7 m -65.08 72.69 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.397 -0.82 . . . . 2.2000000000000002 111.643 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . 0.549 ' HG3' ' ND2' ' A' ' 378' ' ' ASN . 11.9 pt-20 -175.11 -33.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 1.9199999999999999 110.781 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.549 ' ND2' ' HG3' ' A' ' 377' ' ' GLU . 0.1 OUTLIER -168.53 60.16 0.44 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.532 . . . . 2.8900000000000001 111.582 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.06 -37.78 79.54 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.289 1.993 . . . . 0.97999999999999998 111.543 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.8 -33.45 75.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.646 . . . . 1.21 110.881 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 86.0 tttt -51.44 134.52 28.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.104 -0.498 . . . . 2.27 111.294 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 38.3 mm -82.95 136.26 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.025 -0.534 . . . . 1.1299999999999999 111.268 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -114.41 143.94 44.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.554 -0.293 . . . . 1.1000000000000001 110.452 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 5.3 m-85 -90.07 135.48 33.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.391 -0.368 . . . . 1.3200000000000001 110.718 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.838 HG22 HG13 ' A' ' 427' ' ' VAL . 2.5 mp -118.7 130.47 73.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.4 -0.364 . . . . 1.2 110.984 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.593 ' HD2' ' O ' ' A' ' 439' ' ' LEU . 30.1 ttt85 -90.46 121.77 32.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.465 -0.334 . . . . 3.1699999999999999 110.777 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -79.08 163.03 25.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.331 -0.395 . . . . 2.9900000000000002 110.356 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -57.34 -42.62 82.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.628 0.251 . . . . 2.8199999999999998 110.85 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -60.47 -16.84 40.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.186 0.517 . . . . 1.23 110.05 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.401 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . 91.47 40.84 5.28 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.417 -0.81 . . . . 1.03 112.52 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 60.9 p -120.99 111.31 17.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 1.46 111.437 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.73 135.77 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 1.24 111.0 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -150.0 139.01 21.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 3.2400000000000002 110.81 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -56.47 148.4 19.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.133 0.492 . . . . 3.5600000000000001 111.788 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.444 ' HA2' HD12 ' A' ' 385' ' ' ILE . . . -171.48 128.01 1.52 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.461 -0.791 . . . . 0.32000000000000001 111.769 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -81.63 128.62 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.849 0.357 . . . . 1.28 111.195 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.84 HG22 HG21 ' A' ' 414' ' ' VAL . 1.0 OUTLIER -101.32 126.0 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.772 -0.455 . . . . 1.5800000000000001 109.772 178.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 50.7 mt -120.71 -34.46 3.57 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.674 0.62 . . . . 2.04 112.674 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . 0.413 ' HB2' ' CB ' ' A' ' 413' ' ' TYR . 70.4 mt-30 -118.97 166.97 12.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.038 0.447 . . . . 2.6400000000000001 111.807 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.7 p -165.93 151.62 8.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.679 -0.691 . . . . 1.1299999999999999 110.729 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -161.24 134.69 6.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.906 0.384 . . . . 1.8799999999999999 111.314 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.565 ' O ' ' HG2' ' A' ' 409' ' ' PRO . 20.4 p -101.0 39.22 1.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 1.79 110.617 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.494 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.5 m 47.31 -174.32 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.618 -0.719 . . . . 2.2999999999999998 111.004 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.494 ' H ' ' CG2' ' A' ' 403' ' ' THR . 0.4 OUTLIER -77.77 -40.54 40.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 3.8700000000000001 110.992 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.32 -51.31 70.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.513 . . . . 3.1600000000000001 111.276 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.462 ' C ' ' HD2' ' A' ' 409' ' ' PRO . . . 65.83 -175.08 0.18 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.993 0.425 . . . . 2.1800000000000002 110.366 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . 62.35 11.35 4.49 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.605 -0.725 . . . . 2.77 112.05 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.502 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -168.74 -54.78 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.466 -0.334 . . . . 3.2799999999999998 111.264 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.565 ' HG2' ' O ' ' A' ' 402' ' ' THR . 47.6 Cg_endo -68.02 148.55 75.98 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.478 2.119 . . . . 2.8700000000000001 112.386 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.511 ' HB3' HG21 ' A' ' 402' ' ' THR . 40.0 p-10 -175.51 132.54 0.28 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.901 -0.59 . . . . 2.1400000000000001 110.662 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 96.7 mt-10 -151.32 137.16 18.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 2.1000000000000001 111.202 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.608 ' CE1' ' HG2' ' A' ' 429' ' ' ARG . 3.9 m-85 -117.09 128.73 55.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 1.0600000000000001 111.727 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 20.0 t80 -64.05 135.82 56.75 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.953 -0.567 . . . . 1.05 109.986 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.84 HG21 HG22 ' A' ' 397' ' ' VAL . 60.4 t -129.28 139.5 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.813 0.671 . . . . 1.8400000000000001 112.813 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -120.31 89.32 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.059 -0.973 . . . . 0.70999999999999996 109.142 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.457 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 7.3 m-85 -54.45 116.0 2.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.88 -0.6 . . . . 1.1299999999999999 111.349 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 65.2 t -61.6 125.83 18.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.791 -0.641 . . . . 1.7 111.245 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.56 -43.44 1.85 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.745 -0.661 . . . . 1.1699999999999999 113.101 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 7.6 mp -59.74 152.11 23.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.982 0.42 . . . . 2.1499999999999999 111.389 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -50.36 144.13 7.9 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.659 -0.7 . . . . 2.7599999999999998 111.837 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -58.6 -34.87 71.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.603 -0.726 . . . . 4.6500000000000004 111.45 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . 0.435 ' HG3' HD13 ' A' ' 423' ' ' LEU . 14.8 ptp180 -51.35 -37.07 45.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 4.3200000000000003 111.635 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.444 ' CD2' HD22 ' A' ' 419' ' ' LEU . 10.6 mp -61.1 -33.95 74.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.5 -0.318 . . . . 2.04 111.106 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -48.87 138.25 11.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.241 -0.436 . . . . 1.2 111.068 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -176.17 -137.79 2.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.647 -0.787 . . . . 0.69999999999999996 112.7 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . 0.485 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 38.4 m95 -130.46 141.35 50.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.063 0.458 . . . . 0.76000000000000001 110.905 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.838 HG13 HG22 ' A' ' 385' ' ' ILE . 4.6 m -108.2 156.77 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.683 -0.689 . . . . 1.4399999999999999 110.888 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -79.06 35.34 1.92 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.394 -0.908 . . . . 1.72 111.503 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.608 ' HG2' ' CE1' ' A' ' 412' ' ' TYR . 0.6 OUTLIER 66.0 -73.24 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.003 0.521 . . . . 2.3199999999999998 110.651 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.43 ' C ' ' H ' ' A' ' 432' ' ' ILE . 13.5 p80 -52.51 -18.33 1.65 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.514 -0.312 . . . . 2.23 111.664 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.429 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 64.5 mtt85 -78.73 28.57 0.21 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.6 0.238 . . . . 3.4199999999999999 111.039 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.564 HG12 HG13 ' A' ' 385' ' ' ILE . 42.4 mt -150.27 138.8 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.82 0.343 . . . . 1.1399999999999999 111.036 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 68.1 m -163.96 140.62 6.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.493 . . . . 0.95999999999999996 110.785 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -55.59 -24.29 32.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 1.3500000000000001 111.278 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -108.73 129.81 55.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.113 0.482 . . . . 2.5299999999999998 111.034 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -74.24 -31.93 62.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.768 -0.651 . . . . 1.3300000000000001 111.648 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -44.64 -77.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 1.3400000000000001 111.735 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -47.37 -38.52 13.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 1.5600000000000001 111.81 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.593 ' O ' ' HD2' ' A' ' 386' ' ' ARG . 96.4 mt -61.27 -42.45 98.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.882 0.327 . . . . 1.76 111.882 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 165.01 21.58 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.354 -0.927 . . . . 1.3600000000000001 112.881 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 64.06 153.73 0.09 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.661 -0.78 . . . . 1.8300000000000001 112.472 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 45.9 mm . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.646 0.26 . . . . 1.9199999999999999 110.451 179.743 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 75.9 mt . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 113.343 0.868 . . . . 1.9299999999999999 113.343 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.78 129.76 36.13 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.329 -0.619 . . . . 2.1699999999999999 109.329 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.6 mt -84.56 -40.87 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.62 0.6 . . . . 1.4399999999999999 112.62 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.6 t -49.54 -17.76 0.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.016 0.436 . . . . 2.2000000000000002 111.22 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -56.39 -43.73 79.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.516 -0.766 . . . . 1.9199999999999999 111.495 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.438 ' N ' ' ND2' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -171.11 69.1 0.49 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 2.8900000000000001 111.392 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.13 -40.05 60.37 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.418 2.079 . . . . 0.97999999999999998 112.047 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -60.55 -36.33 78.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.511 . . . . 1.21 110.844 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 58.9 tttm -52.15 132.81 33.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.18 -0.464 . . . . 2.27 111.431 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.463 HD11 ' HG2' ' A' ' 396' ' ' GLN . 43.2 mm -86.47 131.55 34.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.011 -0.541 . . . . 1.1299999999999999 111.029 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.508 ' O ' HD13 ' A' ' 385' ' ' ILE . 7.3 m-85 -105.47 143.29 33.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.547 -0.297 . . . . 1.1000000000000001 110.58 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.59 140.39 29.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.347 -0.388 . . . . 1.3200000000000001 110.474 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.683 HD12 HG22 ' A' ' 414' ' ' VAL . 0.9 OUTLIER -132.96 128.21 56.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.754 0.311 . . . . 1.2 111.026 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.685 ' NH1' ' HA2' ' A' ' 440' ' ' GLY . 36.7 ttt85 -86.01 121.57 28.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 3.1699999999999999 110.797 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.404 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 61.7 mtp85 -72.93 159.14 34.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 2.9900000000000002 110.659 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -55.03 -45.52 75.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.513 -0.312 . . . . 2.8199999999999998 111.339 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.462 ' OD2' HG22 ' A' ' 391' ' ' THR . 12.0 p-10 -57.98 -29.08 64.96 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.262 -0.644 . . . . 1.23 109.262 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 111.03 37.26 1.7 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.3 -0.864 . . . . 1.03 113.267 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' THR . . . . . 0.462 HG22 ' OD2' ' A' ' 389' ' ' ASP . 29.9 p -121.24 111.15 17.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.878 0.37 . . . . 1.46 111.562 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.443 HG12 HD11 ' A' ' 439' ' ' LEU . 59.6 t -71.13 137.89 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.027 -0.533 . . . . 1.24 111.011 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -150.57 139.64 21.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 3.2400000000000002 110.957 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -56.63 147.56 22.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.815 -0.63 . . . . 3.5600000000000001 111.474 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.615 ' HA2' HD12 ' A' ' 385' ' ' ILE . . . -164.98 128.43 1.79 Allowed Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.824 -0.626 . . . . 0.32000000000000001 112.238 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . 0.463 ' HG2' HD11 ' A' ' 382' ' ' ILE . 88.5 mt-30 -83.32 110.18 17.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.686 0.279 . . . . 1.28 111.503 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.6 OUTLIER -79.09 135.04 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 1.5800000000000001 109.976 178.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 94.1 mt -120.24 -31.91 4.27 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.789 0.663 . . . . 2.04 112.789 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -140.19 175.3 9.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.071 0.462 . . . . 2.6400000000000001 111.931 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.6 p -165.5 149.23 8.21 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.616 -0.72 . . . . 1.1299999999999999 110.576 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 401' ' ' ARG . 14.5 ptt-85 -158.11 138.43 12.6 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.073 0.463 . . . . 1.8799999999999999 111.923 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.561 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 47.2 p -75.29 139.44 42.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.948 -0.569 . . . . 1.79 110.276 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.624 ' HG1' ' HB2' ' A' ' 409' ' ' PRO . 3.5 m -61.76 -174.39 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.504 -0.316 . . . . 2.2999999999999998 110.263 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.524 ' H ' ' CG2' ' A' ' 403' ' ' THR . 50.2 mt-10 -54.6 -45.76 73.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.666 0.269 . . . . 3.8700000000000001 111.573 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -59.84 -47.39 85.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 3.1600000000000001 110.864 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.561 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 64.11 -177.07 0.16 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.024 -0.534 . . . . 2.1800000000000002 110.858 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . 63.22 11.2 5.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.395 -0.82 . . . . 2.77 112.134 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.503 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -170.84 -53.1 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.558 -0.292 . . . . 3.2799999999999998 111.68 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.624 ' HB2' ' HG1' ' A' ' 403' ' ' THR . 65.4 Cg_endo -72.07 149.83 53.15 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.281 1.987 . . . . 2.8700000000000001 112.036 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.462 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 5.1 p-10 -170.32 126.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.11 0.481 . . . . 2.1400000000000001 111.493 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.588 ' O ' ' HA ' ' A' ' 400' ' ' SER . 64.8 mm-40 -109.81 134.68 51.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.496 -0.775 . . . . 2.1000000000000001 110.319 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.506 ' HB2' HD13 ' A' ' 432' ' ' ILE . 2.6 m-85 -112.81 129.26 56.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.87 0.367 . . . . 1.0600000000000001 111.872 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 26.0 t80 -69.19 129.74 40.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.899 -0.778 . . . . 1.05 108.899 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.683 HG22 HD12 ' A' ' 385' ' ' ILE . 10.3 p -131.17 136.8 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.801 0.667 . . . . 1.8400000000000001 112.801 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -114.75 89.8 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.019 -0.992 . . . . 0.70999999999999996 109.582 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.533 ' HA ' ' HA3' ' A' ' 395' ' ' GLY . 35.2 m-85 -54.02 128.1 29.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 1.1299999999999999 111.231 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 67.0 t -71.89 127.92 34.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.996 -0.547 . . . . 1.7 111.278 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.35 -37.14 1.56 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.841 -0.695 . . . . 1.1699999999999999 113.261 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.486 ' HB3' HD11 ' A' ' 423' ' ' LEU . 7.9 mp -59.34 159.7 7.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.237 0.542 . . . . 2.1499999999999999 111.809 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.755 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 5.6 m120 -51.07 140.55 15.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.179 -0.918 . . . . 2.7599999999999998 111.821 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -60.36 -38.36 83.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 4.6500000000000004 110.733 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -60.19 -38.44 83.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 4.3200000000000003 110.991 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.755 ' HG ' ' HB2' ' A' ' 420' ' ' ASN . 90.0 mt -56.65 -31.17 64.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 2.04 110.978 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -52.13 134.5 32.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 1.2 111.182 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 177.04 176.52 45.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.042 -0.599 . . . . 0.69999999999999996 112.369 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -75.2 140.44 43.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.005 0.431 . . . . 0.76000000000000001 110.997 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.508 ' CG2' HD12 ' A' ' 432' ' ' ILE . 25.4 m -133.37 138.82 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 1.4399999999999999 111.354 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -61.73 147.63 48.11 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.859 -0.686 . . . . 1.72 112.394 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.416 ' O ' ' HD2' ' A' ' 429' ' ' ARG . 23.2 tpt180 -51.49 -39.97 58.62 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.758 0.281 . . . . 2.3199999999999998 111.758 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -53.31 -30.78 40.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.757 0.313 . . . . 2.23 111.466 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 431' ' ' ARG . 68.0 mtt-85 -79.47 -35.05 40.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.154 -0.475 . . . . 3.4199999999999999 111.569 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.537 HG12 HG13 ' A' ' 385' ' ' ILE . 53.6 mt -88.89 140.47 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 1.1399999999999999 112.013 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.507 ' N ' HG21 ' A' ' 432' ' ' ILE . 66.8 m -159.89 139.9 11.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.675 -0.693 . . . . 0.95999999999999996 110.413 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.76 16.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 1.3500000000000001 111.773 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.486 ' H ' ' C ' ' A' ' 433' ' ' SER . 22.2 p30 -162.63 135.65 5.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.978 0.418 . . . . 2.5299999999999998 111.055 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.07 73.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 1.3300000000000001 111.639 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -49.73 -40.85 42.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 1.3400000000000001 111.419 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -97.17 49.55 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.44 -0.346 . . . . 1.5600000000000001 111.173 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.443 HD11 HG12 ' A' ' 392' ' ' VAL . 95.6 mt -148.55 -84.53 0.1 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.38 -0.373 . . . . 1.76 111.286 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . 0.685 ' HA2' ' NH1' ' A' ' 386' ' ' ARG . . . -171.02 30.72 0.13 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.577 -0.821 . . . . 1.3600000000000001 112.647 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 63.99 151.35 0.06 OUTLIER Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.743 -0.742 . . . . 1.8300000000000001 112.543 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 44.8 mm . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.665 0.269 . . . . 1.9199999999999999 110.464 179.575 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 70.5 mt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.805 0.336 . . . . 1.9299999999999999 111.564 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 0.3 OUTLIER -93.95 130.58 39.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 2.1699999999999999 110.503 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.29 -41.25 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.125 0.417 . . . . 1.4399999999999999 112.125 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 82.1 p -47.46 -26.4 1.36 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.018 -0.537 . . . . 2.2000000000000002 112.021 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.6 pt-20 -67.5 -39.23 85.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.197 -0.456 . . . . 1.9199999999999999 111.898 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 5.6 m120 -151.87 67.31 7.11 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 112.095 0.406 . . . . 2.8900000000000001 112.095 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.7 -41.1 63.48 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.734 2.289 . . . . 0.97999999999999998 112.419 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.94 -38.28 85.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.973 -0.558 . . . . 1.21 111.324 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 87.4 tttt -48.91 127.12 13.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 2.27 111.075 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.434 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 44.3 mm -86.32 126.68 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.989 -0.55 . . . . 1.1299999999999999 111.165 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.417 ' O ' HD13 ' A' ' 385' ' ' ILE . 2.6 m-85 -105.13 144.16 32.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.311 -0.404 . . . . 1.1000000000000001 110.151 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.435 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 1.9 m-85 -89.88 137.32 32.44 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.929 -0.308 . . . . 1.3200000000000001 110.543 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.53 HG13 HG12 ' A' ' 432' ' ' ILE . 2.7 mp -122.89 125.57 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.329 -0.396 . . . . 1.2 111.218 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.469 ' HE ' ' HA3' ' A' ' 390' ' ' GLY . 78.1 ttt180 -83.86 116.82 22.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 3.1699999999999999 110.261 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.434 ' HB2' ' OD1' ' A' ' 389' ' ' ASP . 51.9 mtp85 -71.53 163.98 26.71 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.941 -0.304 . . . . 2.9900000000000002 110.703 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 389' ' ' ASP . 11.5 pm0 -49.72 -39.76 38.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.309 -0.405 . . . . 2.8199999999999998 111.214 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.45 ' N ' ' HG2' ' A' ' 388' ' ' GLU . 43.1 p-10 -65.87 -35.04 79.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 1.23 111.215 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.469 ' HA3' ' HE ' ' A' ' 386' ' ' ARG . . . 129.32 -31.31 3.47 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.718 -0.753 . . . . 1.03 112.539 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 71.3 p -59.36 113.09 2.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.096 0.474 . . . . 1.46 112.144 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.689 HG12 HD11 ' A' ' 439' ' ' LEU . 59.8 t -71.15 141.31 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.562 -0.745 . . . . 1.24 110.902 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -148.9 134.77 18.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.484 -0.325 . . . . 3.2400000000000002 110.803 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.434 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 88.2 mtm180 -54.22 152.97 5.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.232 -0.44 . . . . 3.5600000000000001 111.498 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 416' ' ' TYR . . . -168.83 135.66 3.71 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.657 -0.701 . . . . 0.32000000000000001 112.089 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -87.04 110.37 20.03 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.724 0.268 . . . . 1.28 111.724 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.565 HG23 HD12 ' A' ' 432' ' ' ILE . 11.6 t -77.94 128.01 38.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.765 -0.828 . . . . 1.5800000000000001 108.765 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . 0.408 ' HA ' HD21 ' A' ' 398' ' ' LEU . 58.2 mt -121.0 -38.27 2.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.011 0.745 . . . . 2.04 113.011 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . 0.448 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 26.0 mt-30 -133.95 176.53 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 2.6400000000000001 112.049 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.3 p -162.16 148.03 13.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.676 -0.693 . . . . 1.1299999999999999 110.349 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.401 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 39.4 ptt180 -161.45 139.19 9.1 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.887 0.375 . . . . 1.8799999999999999 111.536 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 67.3 p -73.4 -125.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 1.79 109.884 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.44 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.23 -173.52 3.16 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.77 -0.456 . . . . 2.2999999999999998 109.77 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.44 ' H ' ' CG2' ' A' ' 403' ' ' THR . 55.6 mt-10 -46.11 -43.77 15.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.678 0.275 . . . . 3.8700000000000001 111.275 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -67.72 -52.62 35.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 3.1600000000000001 110.798 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 53.81 54.33 10.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.003 -0.544 . . . . 2.1800000000000002 111.658 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.456 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -149.09 10.65 0.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.517 0.675 . . . . 2.77 109.755 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.475 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . -179.46 -47.71 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.628 -1.169 . . . . 3.2799999999999998 110.077 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 408' ' ' ALA . 39.5 Cg_exo -57.53 146.79 82.36 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.509 2.139 . . . . 2.8700000000000001 112.585 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.6 p30 -174.38 138.07 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 2.1400000000000001 110.568 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.4 mt-10 -137.14 134.4 36.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 2.1000000000000001 110.375 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 0.8 OUTLIER -109.93 125.7 53.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.855 0.359 . . . . 1.0600000000000001 111.49 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 14.0 t80 -59.49 147.13 37.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.974 -0.557 . . . . 1.05 109.516 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.66 134.55 4.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.237 0.541 . . . . 1.8400000000000001 112.055 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -120.24 101.85 8.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.455 -0.793 . . . . 0.70999999999999996 109.902 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.471 ' HA ' ' HA3' ' A' ' 395' ' ' GLY . 50.1 m-85 -59.82 129.49 42.1 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.899 0.381 . . . . 1.1299999999999999 110.681 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.83 37.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.887 -0.597 . . . . 1.7 111.109 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -175.47 -36.1 0.05 OUTLIER Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.254 -0.974 . . . . 1.1699999999999999 113.851 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.714 HD11 HD21 ' A' ' 423' ' ' LEU . 13.0 mt -62.8 -167.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.729 0.776 . . . . 2.1499999999999999 112.48 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.526 ' OD1' ' HG2' ' A' ' 422' ' ' ARG . 16.5 t-20 -81.29 149.85 28.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.55 -1.204 . . . . 2.7599999999999998 111.025 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -59.47 -40.89 88.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.91 0.386 . . . . 4.6500000000000004 110.779 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . 0.526 ' HG2' ' OD1' ' A' ' 420' ' ' ASN . 16.2 ptm180 -69.19 -34.9 75.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.048 -0.524 . . . . 4.3200000000000003 110.851 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.714 HD21 HD11 ' A' ' 419' ' ' LEU . 1.3 mp -56.48 -34.94 67.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.875 -0.602 . . . . 2.04 111.201 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -59.09 137.6 57.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.077 -0.51 . . . . 1.2 110.757 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -170.52 -140.51 3.03 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.619 -0.8 . . . . 0.69999999999999996 112.646 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . 0.401 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 16.8 m95 -119.7 134.76 55.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.906 0.384 . . . . 0.76000000000000001 110.81 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.482 HG22 HG13 ' A' ' 432' ' ' ILE . 31.5 m -109.47 155.27 10.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.987 -0.551 . . . . 1.4399999999999999 111.758 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -74.11 25.27 1.04 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.918 -0.583 . . . . 1.72 113.951 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.541 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 36.2 tpt85 71.26 -46.32 0.64 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.68 0.622 . . . . 2.3199999999999998 112.68 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -58.77 -19.86 44.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.944 0.402 . . . . 2.23 110.911 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.4 mtt180 -78.66 -30.32 46.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.813 -0.63 . . . . 3.4199999999999999 111.464 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.565 HD12 HG23 ' A' ' 397' ' ' VAL . 66.8 mt -88.02 137.29 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 120.766 0.317 . . . . 1.1399999999999999 110.728 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.505 ' HG ' HD22 ' A' ' 439' ' ' LEU . 57.9 m -160.18 139.73 11.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 0.95999999999999996 111.075 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -69.26 -23.48 63.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 1.3500000000000001 111.472 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -108.23 133.54 52.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.891 0.377 . . . . 2.5299999999999998 111.129 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -67.85 -43.9 78.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 1.3300000000000001 111.366 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -54.92 -39.82 69.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 1.3400000000000001 111.014 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.06 51.0 1.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 1.5600000000000001 110.948 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.689 HD11 HG12 ' A' ' 392' ' ' VAL . 82.3 mt -150.13 -93.51 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 1.76 111.106 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -177.02 48.05 0.1 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.609 -0.805 . . . . 1.3600000000000001 112.746 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.28 132.07 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.83 -0.7 . . . . 1.8300000000000001 112.848 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 442' ' ' ILE . 47.9 mm . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 110.247 -0.279 . . . . 1.9199999999999999 110.247 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 373' ' ' ILE . 66.8 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.845 0.355 . . . . 1.9299999999999999 111.633 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.05 129.71 35.63 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.19 -0.459 . . . . 2.1699999999999999 109.989 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.93 -43.19 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.079 0.4 . . . . 1.4399999999999999 112.079 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.0 t -48.86 -30.35 5.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.044 0.449 . . . . 2.2000000000000002 111.151 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.76 -36.61 36.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.752 -0.658 . . . . 1.9199999999999999 111.8 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.483 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -146.46 72.17 12.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.004 0.43 . . . . 2.8900000000000001 111.439 -179.428 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -63.62 -36.42 53.13 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.105 1.87 . . . . 0.97999999999999998 111.286 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -64.37 -31.29 72.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 1.21 110.823 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 62.5 tttm -49.31 130.77 19.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.074 -0.512 . . . . 2.27 111.424 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.463 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 33.2 mm -88.68 135.46 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.773 -0.649 . . . . 1.1299999999999999 111.109 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -117.43 143.83 45.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.537 -0.301 . . . . 1.1000000000000001 110.711 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.434 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 1.8 m-85 -89.14 147.03 24.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.841 0.353 . . . . 1.3200000000000001 111.136 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.643 HD11 ' N ' ' A' ' 385' ' ' ILE . 2.8 mp -132.22 131.68 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 1.2 110.741 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 42.2 ttt-85 -84.8 123.55 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.251 -0.431 . . . . 3.1699999999999999 111.198 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -83.75 167.24 17.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.29 -0.414 . . . . 2.9900000000000002 110.461 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.457 ' C ' ' H ' ' A' ' 390' ' ' GLY . 0.5 OUTLIER -58.36 -42.7 87.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.506 -0.315 . . . . 2.8199999999999998 111.082 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -69.86 5.13 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.403 . . . . 1.23 110.581 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 388' ' ' GLU . . . 70.76 42.71 61.06 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.902 -0.59 . . . . 1.03 112.955 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 82.5 p -120.62 111.47 17.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.958 0.408 . . . . 1.46 111.151 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.623 HG12 HD11 ' A' ' 439' ' ' LEU . 22.6 t -69.94 135.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 1.24 111.308 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -149.28 139.85 22.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 3.2400000000000002 110.742 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.463 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 54.9 mtm-85 -56.03 157.8 4.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.318 0.58 . . . . 3.5600000000000001 112.048 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.443 ' HA2' HD12 ' A' ' 385' ' ' ILE . . . -178.56 126.56 1.08 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.125 -0.943 . . . . 0.32000000000000001 111.442 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . 0.425 ' HG2' HD11 ' A' ' 382' ' ' ILE . 89.1 mt-30 -83.42 129.38 34.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.823 0.344 . . . . 1.28 111.791 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.867 HG23 HD12 ' A' ' 432' ' ' ILE . 8.5 t -88.9 134.69 27.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.51 -0.552 . . . . 1.5800000000000001 109.51 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 78.0 mt -120.18 -38.51 2.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.568 0.581 . . . . 2.04 112.568 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -141.65 176.12 9.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.051 0.453 . . . . 2.6400000000000001 111.809 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 97.4 p -155.62 149.66 25.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.604 -0.725 . . . . 1.1299999999999999 110.176 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 18.4 ptt-85 -149.26 134.78 18.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.229 0.538 . . . . 1.8799999999999999 112.246 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 409' ' ' PRO . 46.2 p -93.65 138.1 32.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.819 -0.628 . . . . 1.79 110.065 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.525 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 3.5 m -61.5 -174.65 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.655 -0.248 . . . . 2.2999999999999998 110.47 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.525 ' H ' ' CG2' ' A' ' 403' ' ' THR . 55.9 mt-10 -53.72 -39.02 64.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.571 0.224 . . . . 3.8700000000000001 111.565 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.413 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 50.2 t30 -56.86 -49.66 74.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.423 -0.353 . . . . 3.1600000000000001 110.988 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 54.12 52.9 11.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.221 -0.445 . . . . 2.1800000000000002 111.494 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -156.5 10.83 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.844 -0.616 . . . . 2.77 110.141 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.59 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.19 -48.28 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.15 -0.932 . . . . 3.2799999999999998 110.561 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 24.0 Cg_exo -63.75 140.02 71.97 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.589 2.192 . . . . 2.8700000000000001 112.4 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.468 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 13.2 p-10 -173.82 122.63 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 2.1400000000000001 110.988 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 400' ' ' SER . 9.1 mp0 -113.94 134.24 54.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 2.1000000000000001 110.504 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.494 ' HB2' HD11 ' A' ' 432' ' ' ILE . 6.5 m-85 -109.57 125.15 52.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 1.0600000000000001 111.575 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.741 ' HA ' ' HA ' ' A' ' 426' ' ' TRP . 14.0 t80 -60.9 139.74 57.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 1.05 110.234 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.499 HG13 HG12 ' A' ' 427' ' ' VAL . 13.0 p -133.96 137.73 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.218 0.532 . . . . 1.8400000000000001 111.928 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -119.54 96.6 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.48 -0.782 . . . . 0.70999999999999996 109.889 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -58.99 124.6 20.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 1.1299999999999999 111.024 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.79 128.54 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.911 -0.586 . . . . 1.7 111.396 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 78.17 -40.64 1.94 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.896 -0.668 . . . . 1.1699999999999999 113.072 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.491 ' HB3' HD21 ' A' ' 423' ' ' LEU . 7.5 mp -59.34 153.87 17.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.982 0.42 . . . . 2.1499999999999999 111.28 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.623 HD22 HD11 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -49.31 142.22 7.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.722 -0.672 . . . . 2.7599999999999998 112.143 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -60.81 -36.7 79.7 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.463 -0.79 . . . . 4.6500000000000004 111.96 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . 0.568 HH11 HD13 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -53.64 -29.0 36.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.907 0.385 . . . . 4.3200000000000003 110.761 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.623 HD11 HD22 ' A' ' 420' ' ' ASN . 1.1 tp -63.2 -33.32 75.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 2.04 111.303 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -44.94 133.61 6.23 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.181 -0.463 . . . . 1.2 111.4 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . 0.456 ' O ' HG11 ' A' ' 414' ' ' VAL . . . 174.36 154.59 11.05 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.793 -0.64 . . . . 0.69999999999999996 112.053 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . 0.741 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 11.4 m95 -68.75 134.03 49.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.76000000000000001 110.296 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.499 HG12 HG13 ' A' ' 414' ' ' VAL . 35.6 m -127.05 142.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 1.4399999999999999 111.245 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.423 ' HA2' ' CE1' ' A' ' 430' ' ' HIS . . . -52.24 147.42 13.15 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.026 -0.607 . . . . 1.72 112.912 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.455 ' O ' ' HD2' ' A' ' 429' ' ' ARG . 14.6 tpt180 -52.01 -42.03 62.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.633 0.254 . . . . 2.3199999999999998 111.429 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.423 ' CE1' ' HA2' ' A' ' 428' ' ' GLY . 13.4 p-80 -56.58 -25.88 53.83 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.968 0.359 . . . . 2.23 111.968 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 56.4 mtt85 -77.89 -40.59 39.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.692 -0.231 . . . . 3.4199999999999999 111.532 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.867 HD12 HG23 ' A' ' 397' ' ' VAL . 59.7 mt -88.79 136.54 23.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.914 0.388 . . . . 1.1399999999999999 110.948 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 435' ' ' ASN . 67.3 m -161.4 139.7 9.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.953 -0.567 . . . . 0.95999999999999996 110.743 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -76.73 16.13 0.55 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 1.3500000000000001 111.181 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.436 ' O ' HD13 ' A' ' 439' ' ' LEU . 6.1 m120 -134.59 116.01 14.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.409 -0.359 . . . . 2.5299999999999998 110.734 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.33 98.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.031 -0.531 . . . . 1.3300000000000001 111.595 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -57.04 -40.87 77.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 1.3400000000000001 111.13 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' A' ' 439' ' ' LEU . 59.0 m-20 -83.16 45.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 1.5600000000000001 111.011 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.623 HD11 HG12 ' A' ' 392' ' ' VAL . 47.6 mt -154.58 -41.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.22 -0.446 . . . . 1.76 111.011 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 157.81 40.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.701 -0.761 . . . . 1.3600000000000001 112.132 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.58 -128.89 41.68 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.629 -0.796 . . . . 1.8300000000000001 112.103 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 44.8 mm . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 121.106 0.479 . . . . 1.9199999999999999 110.447 179.751 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.561 HG21 ' N ' ' A' ' 374' ' ' ASP . 72.5 mt . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 113.069 0.766 . . . . 1.9299999999999999 113.069 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.561 ' N ' HG21 ' A' ' 373' ' ' ILE . 1.6 m-20 -138.99 132.73 30.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.491 -0.777 . . . . 2.1699999999999999 109.852 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 82.7 mt -78.2 -40.9 26.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.089 0.403 . . . . 1.4399999999999999 112.089 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 88.1 p -47.91 -21.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.278 0.561 . . . . 2.2000000000000002 110.851 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -58.11 -47.63 82.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.192 -0.913 . . . . 1.9199999999999999 110.949 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 7.5 m120 -165.25 111.26 0.81 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.799 -0.637 . . . . 2.8900000000000001 111.29 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.3 -41.04 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.932 2.422 . . . . 0.97999999999999998 112.22 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.99 -32.37 61.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.993 -0.548 . . . . 1.21 111.666 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.579 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.2 tttp -46.35 129.31 10.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.973 0.416 . . . . 2.27 111.556 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 50.0 mm -87.75 126.13 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.894 -0.594 . . . . 1.1299999999999999 111.276 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -99.58 143.1 30.21 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.098 -0.334 . . . . 1.1000000000000001 110.098 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -92.73 136.25 33.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 1.3200000000000001 111.292 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.496 HD12 HG22 ' A' ' 414' ' ' VAL . 2.5 mp -116.21 129.58 72.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.078 -0.51 . . . . 1.2 110.757 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.56 ' CZ ' ' HA3' ' A' ' 390' ' ' GLY . 0.0 OUTLIER -97.48 110.26 22.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 3.1699999999999999 110.232 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.424 ' O ' ' HD3' ' A' ' 386' ' ' ARG . 76.6 mtp180 -77.74 158.82 29.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.501 -0.318 . . . . 2.9900000000000002 110.983 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -54.15 -41.52 68.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.485 -0.325 . . . . 2.8199999999999998 111.449 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -60.46 -10.12 4.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.938 0.399 . . . . 1.23 110.788 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.56 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . 83.88 36.04 14.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.931 -0.577 . . . . 1.03 112.424 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 73.1 p -121.07 111.72 17.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.31 . . . . 1.46 111.146 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 439' ' ' LEU . 54.6 t -73.53 134.24 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 1.24 110.537 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -142.63 135.93 28.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.941 0.401 . . . . 3.2400000000000002 110.751 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.439 HH11 ' HG3' ' A' ' 394' ' ' ARG . 54.4 mtm-85 -56.64 146.48 25.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 3.5600000000000001 111.293 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 416' ' ' TYR . . . -164.12 129.88 2.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.615 -0.72 . . . . 0.32000000000000001 112.065 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -88.36 105.07 17.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.739 0.304 . . . . 1.28 111.379 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.693 HG23 ' HB3' ' A' ' 412' ' ' TYR . 0.5 OUTLIER -71.09 129.78 34.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.964 -0.384 . . . . 1.5800000000000001 109.964 178.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 81.3 mt -121.0 -34.32 3.55 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 112.686 0.624 . . . . 2.04 112.686 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . 0.447 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 74.2 mt-30 -129.18 175.46 8.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.036 0.446 . . . . 2.6400000000000001 111.918 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 99.4 p -166.53 148.56 6.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.612 -0.722 . . . . 1.1299999999999999 110.63 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 37.9 ptt180 -155.76 134.57 11.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.769 0.319 . . . . 1.8799999999999999 110.941 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 65.2 p -72.38 -132.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.575 -0.284 . . . . 1.79 110.533 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.45 HG21 ' H ' ' A' ' 404' ' ' GLU . 1.2 m -162.84 -173.6 3.56 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.854 -0.424 . . . . 2.2999999999999998 109.854 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.45 ' H ' HG21 ' A' ' 403' ' ' THR . 67.2 mm-40 -44.55 -38.83 4.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.759 0.314 . . . . 3.8700000000000001 111.172 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 407' ' ' ALA . 25.1 t-20 -65.66 -53.08 46.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 3.1600000000000001 110.73 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 54.85 61.99 2.72 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.184 -0.462 . . . . 2.1800000000000002 111.895 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -165.07 2.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 2.77 110.708 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.404 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . -175.71 -49.97 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.529 -0.76 . . . . 3.2799999999999998 110.853 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.486 ' O ' ' HA ' ' A' ' 402' ' ' THR . 27.3 Cg_exo -61.72 143.0 95.95 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.332 2.022 . . . . 2.8700000000000001 112.056 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.598 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.6 p30 -179.84 131.92 0.1 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.234 0.54 . . . . 2.1400000000000001 112.054 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 400' ' ' SER . 49.8 mp0 -109.47 135.82 49.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.516 -0.765 . . . . 2.1000000000000001 109.297 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.693 ' HB3' HG23 ' A' ' 397' ' ' VAL . 0.4 OUTLIER -109.33 126.35 53.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.942 0.401 . . . . 1.0600000000000001 111.61 -178.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.615 ' O ' HG21 ' A' ' 397' ' ' VAL . 19.8 t80 -62.42 135.83 57.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 1.05 109.673 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.496 HG22 HD12 ' A' ' 385' ' ' ILE . 14.6 p -139.93 137.71 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.333 0.587 . . . . 1.8400000000000001 112.563 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -112.23 97.4 6.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.197 -0.91 . . . . 0.70999999999999996 109.762 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.491 ' HA ' ' HA3' ' A' ' 395' ' ' GLY . 7.8 m-85 -57.09 127.13 30.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 1.1299999999999999 111.133 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.98 129.4 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.037 -0.529 . . . . 1.7 111.042 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.53 -43.28 2.08 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.828 -0.701 . . . . 1.1699999999999999 112.897 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.91 155.47 16.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.887 0.375 . . . . 2.1499999999999999 111.196 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -51.21 140.57 16.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 2.7599999999999998 110.727 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 22.8 ptt-85 -62.31 -37.43 85.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.443 . . . . 4.6500000000000004 110.362 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -55.66 -40.37 72.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.519 -0.764 . . . . 4.3200000000000003 110.704 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . . . . . . . . . 48.4 mt -62.57 -35.53 79.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.914 -0.584 . . . . 2.04 110.575 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' A' ' 416' ' ' TYR . 9.1 m-20 -64.94 138.17 58.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.58 -0.736 . . . . 1.2 111.623 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . 0.416 ' O ' HG11 ' A' ' 414' ' ' VAL . . . -177.89 -151.26 9.16 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.702 -0.681 . . . . 0.69999999999999996 111.909 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -83.29 137.27 34.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.76000000000000001 110.76 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.575 ' CG2' ' HB2' ' A' ' 431' ' ' ARG . 1.9 p -127.23 139.8 50.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 1.4399999999999999 111.724 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -64.87 147.4 50.98 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.688 -0.687 . . . . 1.72 112.578 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 45.3 tpt85 -52.7 -39.24 61.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 2.3199999999999998 111.355 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.463 ' HD1' ' H ' ' A' ' 430' ' ' HIS . 19.6 p-80 -64.47 -27.97 69.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.453 0.538 . . . . 2.23 112.453 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.575 ' HB2' ' CG2' ' A' ' 427' ' ' VAL . 61.3 mtt-85 -78.56 -30.02 46.6 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.176 0.436 . . . . 3.4199999999999999 112.176 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.429 HG23 HD11 ' A' ' 432' ' ' ILE . 65.1 mt -87.8 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.043 0.449 . . . . 1.1399999999999999 111.795 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.406 ' C ' ' H ' ' A' ' 435' ' ' ASN . 56.7 m -161.57 139.41 9.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.531 -0.759 . . . . 0.95999999999999996 110.27 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -74.67 16.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 1.3500000000000001 111.927 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.518 HD21 ' HB2' ' A' ' 437' ' ' ASP . 16.3 p-10 -159.61 136.33 9.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.049 0.452 . . . . 2.5299999999999998 111.321 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -65.52 -31.88 73.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.707 -0.679 . . . . 1.3300000000000001 111.586 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . 0.518 ' HB2' HD21 ' A' ' 435' ' ' ASN . 31.6 m-20 -49.37 -41.06 38.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.296 -0.411 . . . . 1.3400000000000001 111.256 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -97.98 43.01 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 1.5600000000000001 110.649 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.482 HD11 HG12 ' A' ' 392' ' ' VAL . 96.7 mt -150.52 -84.02 0.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.113 -0.494 . . . . 1.76 110.993 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -173.89 41.23 0.14 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.087 -0.578 . . . . 1.3600000000000001 112.065 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 61.26 -138.71 47.48 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.881 -0.676 . . . . 1.8300000000000001 112.459 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 36.3 mm . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 121.227 0.537 . . . . 1.9199999999999999 110.354 179.702 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.492 HG22 HD11 ' A' ' 373' ' ' ILE . 42.0 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.225 0.536 . . . . 1.9299999999999999 111.635 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.695 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 57.5 m-20 -150.08 69.0 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.393 -0.821 . . . . 2.1699999999999999 109.91 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.53 HD12 ' C ' ' A' ' 397' ' ' VAL . 60.7 mt -45.48 -35.84 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.542 -0.754 . . . . 1.4399999999999999 112.431 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 41.9 t -45.84 -35.87 4.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.433 0.531 . . . . 2.2000000000000002 112.433 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 16.9 pt-20 -79.13 -36.99 39.68 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.11 0.411 . . . . 1.9199999999999999 112.11 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.652 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 6.8 m120 -145.58 83.49 8.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 112.353 0.501 . . . . 2.8900000000000001 112.353 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -63.95 -41.21 24.12 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.022 2.481 . . . . 0.97999999999999998 112.875 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.77 -31.97 61.92 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.162 0.431 . . . . 1.21 112.162 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.652 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 87.9 tttt -41.1 129.73 2.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.014 0.435 . . . . 2.27 111.213 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 48.9 mm -83.09 132.69 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.686 -0.688 . . . . 1.1299999999999999 111.96 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -113.21 143.42 44.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.036 -0.529 . . . . 1.1000000000000001 109.72 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.573 ' HB3' HG13 ' A' ' 392' ' ' VAL . 27.1 m-85 -93.7 130.51 39.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.673 0.273 . . . . 1.3200000000000001 111.029 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.636 HG23 ' HH ' ' A' ' 416' ' ' TYR . 2.1 mp -117.5 131.03 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.361 -0.382 . . . . 1.2 110.945 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.547 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 55.4 ttp180 -84.7 124.02 31.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.582 -0.281 . . . . 3.1699999999999999 110.997 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -73.17 -174.97 1.7 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.799 0.333 . . . . 2.9900000000000002 110.654 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -67.31 -45.3 76.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 2.8199999999999998 111.177 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -70.73 -36.1 73.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 1.23 111.8 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 141.35 -33.09 2.02 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.436 -0.888 . . . . 1.03 112.764 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 41.4 p -59.05 112.82 1.82 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.302 0.572 . . . . 1.46 111.611 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' A' ' 384' ' ' PHE . 46.6 t -78.98 131.03 35.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.328 -0.851 . . . . 1.24 111.853 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . 0.496 ' ND1' HD13 ' A' ' 419' ' ' LEU . 45.2 m170 -122.79 138.33 54.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.99 -0.55 . . . . 3.2400000000000002 110.401 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 416' ' ' TYR . 64.9 mtt85 -58.73 153.62 16.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.144 0.497 . . . . 3.5600000000000001 111.988 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -174.37 132.39 2.23 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.501 -0.772 . . . . 0.32000000000000001 111.828 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -91.35 129.97 37.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.92 0.36 . . . . 1.28 111.752 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.846 HG23 HD12 ' A' ' 432' ' ' ILE . 16.0 t -84.64 136.08 23.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.821 -0.437 . . . . 1.5800000000000001 109.821 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.24 -46.58 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.116 0.413 . . . . 2.04 112.116 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -125.58 175.71 7.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 2.6400000000000001 111.82 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 81.0 p -165.47 145.33 6.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.457 -0.792 . . . . 1.1299999999999999 110.304 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 20.3 ptt-85 -145.64 136.66 24.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.052 0.453 . . . . 1.8799999999999999 111.528 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.686 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 17.9 p -102.06 37.41 1.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.821 -0.627 . . . . 1.79 111.044 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.524 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 3.2 m 49.29 -173.33 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.178 -0.465 . . . . 2.2999999999999998 110.659 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.524 ' H ' ' CG2' ' A' ' 403' ' ' THR . 59.1 mm-40 -65.08 -40.97 95.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 3.8700000000000001 111.164 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.414 ' HB2' ' HG3' ' A' ' 409' ' ' PRO . 19.9 m-20 -57.08 -55.16 38.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 3.1600000000000001 112.053 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.686 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 55.92 41.51 29.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.369 0.604 . . . . 2.1800000000000002 109.813 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -139.54 10.14 2.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.041 -0.981 . . . . 2.77 110.03 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.63 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -179.9 -50.05 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.005 -0.998 . . . . 3.2799999999999998 110.16 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 20.4 Cg_endo -59.9 147.57 92.12 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.451 2.1 . . . . 2.8700000000000001 112.138 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.532 ' HB3' HG21 ' A' ' 402' ' ' THR . 12.1 p-10 -176.85 134.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.424 . . . . 2.1400000000000001 110.982 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 400' ' ' SER . 51.4 mt-10 -145.93 134.2 21.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 2.1000000000000001 110.006 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.671 ' HB3' HG12 ' A' ' 397' ' ' VAL . 3.5 m-85 -112.52 128.88 56.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.969 0.414 . . . . 1.0600000000000001 111.739 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 24.5 t80 -67.78 150.37 48.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.93 -0.577 . . . . 1.05 109.769 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.435 ' CG1' HG23 ' A' ' 427' ' ' VAL . 8.9 p -148.03 137.72 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.175 0.512 . . . . 1.8400000000000001 112.081 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -115.67 101.14 8.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.70999999999999996 110.312 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.636 ' HH ' HG23 ' A' ' 385' ' ' ILE . 2.4 m-85 -63.44 124.41 21.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.437 -0.347 . . . . 1.1299999999999999 110.62 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 91.5 t -74.98 128.36 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 1.7 110.985 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.88 -40.92 1.67 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.895 -0.669 . . . . 1.1699999999999999 112.905 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 2.8 mm? -59.27 157.53 10.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.229 0.538 . . . . 2.1499999999999999 111.987 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -52.45 147.19 8.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.129 -0.941 . . . . 2.7599999999999998 111.795 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -61.54 -38.18 86.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.944 -0.571 . . . . 4.6500000000000004 110.56 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 64.0 mtt-85 -54.51 -39.51 67.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.943 -0.571 . . . . 4.3200000000000003 109.94 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.61 HD11 ' N ' ' A' ' 423' ' ' LEU . 5.3 mp -63.56 -35.66 81.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.18 -0.918 . . . . 2.04 110.321 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 416' ' ' TYR . 15.2 m-20 -65.88 133.31 50.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.54 -0.755 . . . . 1.2 111.269 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 173.98 -152.92 15.82 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.915 -0.66 . . . . 0.69999999999999996 112.178 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . 0.415 ' O ' HG11 ' A' ' 427' ' ' VAL . 57.0 m95 -96.32 139.81 31.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.854 0.359 . . . . 0.76000000000000001 110.964 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.462 ' O ' HG21 ' A' ' 427' ' ' VAL . 17.8 m -143.15 144.67 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 1.4399999999999999 110.991 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -58.89 151.09 34.64 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.832 -0.699 . . . . 1.72 112.425 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -51.45 -40.16 58.86 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.769 0.285 . . . . 2.3199999999999998 111.769 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -51.62 -30.95 23.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.644 0.259 . . . . 2.23 111.426 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.632 ' O ' HD22 ' A' ' 439' ' ' LEU . 99.0 mtt180 -80.16 -38.66 30.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 3.4199999999999999 111.969 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.846 HD12 HG23 ' A' ' 397' ' ' VAL . 77.5 mt -88.1 132.15 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.648 -0.421 . . . . 1.1399999999999999 110.749 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 435' ' ' ASN . 75.7 m -163.42 143.43 8.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.797 -0.638 . . . . 0.95999999999999996 111.157 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.06 16.46 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 1.3500000000000001 111.224 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.779 HD22 ' HB2' ' A' ' 437' ' ' ASP . 52.6 t30 -152.12 132.49 13.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.969 0.414 . . . . 2.5299999999999998 110.651 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -79.21 -34.99 42.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.913 -0.585 . . . . 1.3300000000000001 112.546 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . 0.779 ' HB2' HD22 ' A' ' 435' ' ' ASN . 1.5 m-20 -48.96 -40.45 30.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.67 0.271 . . . . 1.3400000000000001 111.499 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.96 -33.69 75.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 1.5600000000000001 111.084 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.632 HD22 ' O ' ' A' ' 431' ' ' ARG . 7.3 mp -85.34 -86.37 0.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.85 -0.614 . . . . 1.76 112.554 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -167.51 52.92 0.23 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.482 -0.866 . . . . 1.3600000000000001 113.045 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 71.53 -148.35 43.55 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.831 -0.7 . . . . 1.8300000000000001 112.748 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 49.2 mm . . . . . 0 C--N 1.328 -0.334 0 N-CA-C 110.427 -0.212 . . . . 1.9199999999999999 110.427 179.582 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.595 HG12 ' CZ ' ' A' ' 429' ' ' ARG . 47.9 mm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.974 0.416 . . . . 1.9299999999999999 111.892 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.66 ' HB3' ' HG3' ' A' ' 377' ' ' GLU . 1.5 m-20 -90.07 140.95 29.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.833 -0.621 . . . . 2.1699999999999999 110.44 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.557 HG21 ' N ' ' A' ' 376' ' ' SER . 68.8 mt -111.65 -80.29 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.481 0.549 . . . . 1.4399999999999999 112.481 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' SER . . . . . 0.557 ' N ' HG21 ' A' ' 375' ' ' ILE . 45.4 t -52.42 -22.48 4.76 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.438 0.637 . . . . 2.2000000000000002 110.818 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . 0.66 ' HG3' ' HB3' ' A' ' 374' ' ' ASP . 21.8 mm-40 -62.48 -39.54 93.76 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.901 -1.045 . . . . 1.9199999999999999 111.138 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.419 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -155.5 64.13 3.91 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.529 . . . . 2.8900000000000001 111.109 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -51.31 -40.26 61.74 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.48 2.12 . . . . 0.97999999999999998 112.273 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -60.02 -36.69 77.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.084 -0.507 . . . . 1.21 110.933 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -54.57 130.09 38.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.064 -0.517 . . . . 2.27 111.358 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 46.6 mm -87.54 136.58 22.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.116 -0.493 . . . . 1.1299999999999999 110.664 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -110.72 144.0 40.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.738 0.304 . . . . 1.1000000000000001 110.784 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.427 ' C ' HD13 ' A' ' 385' ' ' ILE . 3.3 m-85 -92.62 132.78 36.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 1.3200000000000001 110.884 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.503 HG12 HG13 ' A' ' 414' ' ' VAL . 2.3 mp -114.06 123.38 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.29 -0.414 . . . . 1.2 111.023 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 387' ' ' ARG . 4.8 tmm_? -92.34 110.27 21.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 3.1699999999999999 110.273 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.597 ' HG2' ' NH2' ' A' ' 431' ' ' ARG . 70.7 mtp180 -73.81 153.55 39.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.288 -0.414 . . . . 2.9900000000000002 110.857 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 390' ' ' GLY . 49.5 mt-10 -54.15 -41.31 68.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 2.8199999999999998 111.685 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -66.7 5.21 0.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.093 0.473 . . . . 1.23 110.633 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 388' ' ' GLU . . . 74.94 35.4 50.23 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.494 -0.775 . . . . 1.03 113.707 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 49.2 p -121.44 110.73 16.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 1.46 111.19 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.445 HG12 HD13 ' A' ' 439' ' ' LEU . 51.6 t -73.86 140.69 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 1.24 111.384 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . 0.434 ' N ' HG11 ' A' ' 392' ' ' VAL . 92.5 m-70 -150.6 136.59 18.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.936 -0.574 . . . . 3.2400000000000002 110.43 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 69.9 mtm-85 -56.77 152.88 11.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.058 0.456 . . . . 3.5600000000000001 112.019 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -173.39 134.97 3.08 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.572 -0.74 . . . . 0.32000000000000001 112.096 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -95.37 129.56 42.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.726 0.298 . . . . 1.28 111.476 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' A' ' 412' ' ' TYR . 13.2 t -89.09 128.69 41.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.363 -0.381 . . . . 1.5800000000000001 110.323 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 89.6 mt -121.29 -40.03 2.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.096 0.406 . . . . 2.04 112.096 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . 0.49 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 66.1 mt-30 -127.38 175.74 7.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.073 0.463 . . . . 2.6400000000000001 111.936 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 95.7 p -165.51 148.74 7.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.592 -0.731 . . . . 1.1299999999999999 110.152 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -163.45 135.69 5.16 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.036 0.446 . . . . 1.8799999999999999 112.065 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 41.1 p -74.78 139.76 43.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 1.79 109.786 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.489 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.6 m -61.21 -174.84 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.281 -0.266 . . . . 2.2999999999999998 110.281 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.489 ' H ' ' CG2' ' A' ' 403' ' ' THR . 7.5 mp0 -50.3 -40.31 48.16 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.744 0.276 . . . . 3.8700000000000001 111.744 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.538 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 49.3 t30 -56.91 -49.39 75.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 3.1600000000000001 110.8 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.584 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.28 55.18 8.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 2.1800000000000002 111.466 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -158.7 9.77 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 2.77 110.16 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.541 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.38 -48.66 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.039 -0.982 . . . . 3.2799999999999998 110.209 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 20.2 Cg_exo -65.26 144.69 81.75 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.579 2.186 . . . . 2.8700000000000001 112.512 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.591 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.1 p30 -169.48 129.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 2.1400000000000001 110.542 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.9 mt-10 -115.87 134.65 54.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.971 -0.559 . . . . 2.1000000000000001 110.797 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.582 ' HB3' HG12 ' A' ' 397' ' ' VAL . 1.6 m-85 -109.24 123.55 49.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 1.0600000000000001 110.626 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 17.1 t80 -56.16 143.09 34.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.502 . . . . 1.05 110.206 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.503 HG13 HG12 ' A' ' 385' ' ' ILE . 28.6 t -136.41 136.91 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.152 0.501 . . . . 1.8400000000000001 111.823 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -117.25 90.57 3.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.641 -0.709 . . . . 0.70999999999999996 110.083 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.409 ' H ' ' HD1' ' A' ' 416' ' ' TYR . 4.1 m-85 -59.76 115.63 3.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 1.1299999999999999 110.724 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.74 130.99 29.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.0 -0.545 . . . . 1.7 111.008 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.13 -45.71 2.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.894 -0.67 . . . . 1.1699999999999999 112.574 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.43 143.56 55.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.957 0.408 . . . . 2.1499999999999999 111.121 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.52 HD21 ' HB3' ' A' ' 422' ' ' ARG . 53.1 t30 -56.25 161.49 2.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.862 -0.608 . . . . 2.7599999999999998 111.327 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -59.96 -29.03 68.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.035 -0.53 . . . . 4.6500000000000004 110.803 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . 0.52 ' HB3' HD21 ' A' ' 420' ' ' ASN . 12.5 tpt180 -53.43 -39.39 64.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.72 -0.673 . . . . 4.3200000000000003 111.305 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' ' 420' ' ' ASN . 2.2 mm? -69.75 -35.63 75.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.232 -0.44 . . . . 2.04 110.529 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -60.51 138.41 58.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.85 -0.614 . . . . 1.2 111.089 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -173.3 -137.94 2.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.861 -0.685 . . . . 0.69999999999999996 112.475 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 37.9 m95 -128.93 132.88 47.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.76000000000000001 110.916 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 411' ' ' GLU . 34.0 m -115.64 150.34 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 1.4399999999999999 111.011 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -74.3 32.7 0.96 Allowed Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.807 -0.711 . . . . 1.72 113.681 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.595 ' CZ ' HG12 ' A' ' 373' ' ' ILE . 42.2 tpt85 71.55 -45.65 0.62 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.705 0.632 . . . . 2.3199999999999998 112.705 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.508 ' CE1' ' HG3' ' A' ' 431' ' ' ARG . 8.7 p80 -54.62 -22.79 14.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.823 0.305 . . . . 2.23 111.823 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.597 ' NH2' ' HG2' ' A' ' 387' ' ' ARG . 75.2 mtp180 -79.44 -31.7 42.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.256 0.465 . . . . 3.4199999999999999 112.256 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.517 HD11 HG23 ' A' ' 397' ' ' VAL . 57.6 mt -87.49 136.85 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.849 0.357 . . . . 1.1399999999999999 111.333 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 63.7 m -158.7 140.65 13.77 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.98 -0.554 . . . . 0.95999999999999996 110.938 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -74.75 16.85 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.002 -0.544 . . . . 1.3500000000000001 112.084 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.739 HD22 ' HB2' ' A' ' 437' ' ' ASP . 53.5 t30 -155.64 132.05 10.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 2.5299999999999998 111.203 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -73.55 -41.19 63.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.854 -0.612 . . . . 1.3300000000000001 112.178 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . 0.739 ' HB2' HD22 ' A' ' 435' ' ' ASN . 54.0 m-20 -49.03 -40.5 31.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.503 -0.317 . . . . 1.3400000000000001 111.391 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -65.37 -44.36 87.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 1.5600000000000001 110.946 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 386' ' ' ARG . 68.0 mt -62.97 -83.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.227 -0.442 . . . . 1.76 111.179 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -157.98 32.03 0.51 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.489 -0.862 . . . . 1.3600000000000001 112.825 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 48.98 40.99 28.45 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.924 -0.655 . . . . 1.8300000000000001 112.515 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . 0.44 ' HA ' ' HB ' ' A' ' 392' ' ' VAL . 45.6 mm . . . . . 0 C--N 1.325 -0.464 0 N-CA-C 110.178 -0.305 . . . . 1.9199999999999999 110.178 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.547 ' H ' HH22 ' A' ' 429' ' ' ARG . 86.4 mt . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 120.93 0.395 . . . . 1.9299999999999999 111.836 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.06 129.72 44.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.87 -0.605 . . . . 2.1699999999999999 110.041 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.519 HD12 HG11 ' A' ' 397' ' ' VAL . 82.9 mt -68.32 -45.24 82.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.493 -0.321 . . . . 1.4399999999999999 111.842 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 69.0 m -70.15 62.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.692 -0.685 . . . . 2.2000000000000002 110.848 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -147.52 -33.71 0.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.737 -0.665 . . . . 1.9199999999999999 110.0 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -173.0 65.7 0.34 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.132 -0.94 . . . . 2.8900000000000001 110.959 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.6 -38.44 55.04 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.457 2.104 . . . . 0.97999999999999998 111.859 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.04 -36.99 83.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 1.21 110.593 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -51.64 140.45 18.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.016 -0.538 . . . . 2.27 110.844 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 382' ' ' ILE . 49.8 mm -86.23 128.89 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 1.1299999999999999 111.537 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -105.28 144.76 31.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 1.1000000000000001 110.378 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.477 ' N ' ' HD1' ' A' ' 384' ' ' PHE . 1.8 m-30 -90.5 133.5 35.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.446 -0.343 . . . . 1.3200000000000001 110.633 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.622 HD11 ' N ' ' A' ' 385' ' ' ILE . 3.0 mp -128.94 128.98 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.799 0.333 . . . . 1.2 111.145 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.619 ' N ' HD22 ' A' ' 439' ' ' LEU . 58.1 ttt-85 -92.73 123.24 35.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 3.1699999999999999 111.193 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -71.05 158.16 36.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.367 -0.379 . . . . 2.9900000000000002 110.162 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -49.53 -35.59 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 2.8199999999999998 110.828 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.97 -36.24 69.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 1.23 111.666 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.525 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . 135.99 -35.17 2.17 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.378 -0.915 . . . . 1.03 113.126 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 68.7 p -58.67 112.36 1.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 1.46 112.207 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.411 HG23 HD21 ' A' ' 439' ' ' LEU . 97.1 t -72.39 144.92 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.186 -0.916 . . . . 1.24 111.225 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -150.48 139.74 21.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.161 -0.472 . . . . 3.2400000000000002 110.959 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -60.07 151.29 27.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.87 -0.605 . . . . 3.5600000000000001 112.168 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.584 ' HA2' HD12 ' A' ' 385' ' ' ILE . . . -169.62 135.13 3.43 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.434 -0.803 . . . . 0.32000000000000001 111.823 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -91.97 111.57 23.16 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.304 0.483 . . . . 1.28 112.304 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.733 HG21 HD12 ' A' ' 432' ' ' ILE . 24.4 t -76.43 132.87 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.483 -0.326 . . . . 1.5800000000000001 110.383 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.33 -42.92 2.43 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.735 0.643 . . . . 2.04 112.735 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . 0.475 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 97.5 mm-40 -129.18 177.46 7.14 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.212 0.53 . . . . 2.6400000000000001 112.208 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.0 p -153.35 157.3 39.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.454 -0.794 . . . . 1.1299999999999999 110.043 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 33.2 ptt180 -154.09 137.09 15.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.08 0.467 . . . . 1.8799999999999999 112.258 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 409' ' ' PRO . 36.4 p -96.31 136.07 37.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 1.79 110.036 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.502 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.6 m -62.75 -174.52 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.469 -0.332 . . . . 2.2999999999999998 110.622 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.502 ' H ' ' CG2' ' A' ' 403' ' ' THR . 64.9 mm-40 -53.13 -40.07 63.95 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.721 0.267 . . . . 3.8700000000000001 111.721 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.691 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 26.0 t-20 -55.95 -51.01 69.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 3.1600000000000001 110.994 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 53.49 55.96 7.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.079 0.466 . . . . 2.1800000000000002 111.89 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.498 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -160.55 10.86 0.1 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.727 -0.669 . . . . 2.77 109.456 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.536 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.64 -48.06 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.611 -1.177 . . . . 3.2799999999999998 110.213 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.691 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 38.2 Cg_exo -61.04 138.14 76.5 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.736 2.291 . . . . 2.8700000000000001 112.701 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 13.6 p-10 -173.39 123.31 0.38 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.909 -0.587 . . . . 2.1400000000000001 111.09 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 400' ' ' SER . 58.3 mp0 -112.51 142.34 45.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.774 -0.648 . . . . 2.1000000000000001 110.284 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.628 ' HB2' HD11 ' A' ' 432' ' ' ILE . 1.2 m-85 -109.03 124.17 50.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.019 0.438 . . . . 1.0600000000000001 111.804 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.475 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 18.8 t80 -62.19 150.16 39.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.722 -0.672 . . . . 1.05 109.409 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.506 HG13 HG12 ' A' ' 427' ' ' VAL . 7.3 p -150.92 132.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.286 0.565 . . . . 1.8400000000000001 112.193 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -110.74 90.98 3.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.268 -0.878 . . . . 0.70999999999999996 109.596 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.492 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 14.3 m-85 -53.03 135.68 36.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.094 0.473 . . . . 1.1299999999999999 111.25 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.472 ' CG1' ' H ' ' A' ' 418' ' ' GLY . 17.6 t -63.67 -124.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.454 -0.794 . . . . 1.7 111.417 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.472 ' H ' ' CG1' ' A' ' 417' ' ' VAL . . . -39.7 -29.41 0.16 Allowed Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.248 0.459 . . . . 1.1699999999999999 114.248 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 7.1 mp -58.79 141.31 53.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.244 0.522 . . . . 2.1499999999999999 110.955 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.603 ' O ' HD21 ' A' ' 423' ' ' LEU . 49.2 t30 -55.42 154.89 5.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.966 -0.561 . . . . 2.7599999999999998 111.286 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 68.5 mtt-85 -53.35 -29.81 36.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.663 -0.699 . . . . 4.6500000000000004 112.152 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . 0.419 ' HG2' ' HB3' ' A' ' 420' ' ' ASN . 16.8 ptm180 -52.65 -40.7 63.08 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.956 0.354 . . . . 4.3200000000000003 111.956 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.603 HD21 ' O ' ' A' ' 420' ' ' ASN . 1.1 mm? -71.05 -35.09 71.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.713 0.292 . . . . 2.04 111.028 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.27 130.51 46.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 1.2 111.427 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.67 -145.67 9.19 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.69999999999999996 112.012 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -100.36 140.22 34.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.76000000000000001 110.946 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.506 HG12 HG13 ' A' ' 414' ' ' VAL . 28.5 m -140.26 145.72 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 1.4399999999999999 110.971 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 430' ' ' HIS . . . -59.83 147.55 43.54 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.914 -0.584 . . . . 1.72 113.361 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.547 HH22 ' H ' ' A' ' 373' ' ' ILE . 15.4 tpt180 -50.93 -38.92 53.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.654 0.381 . . . . 2.3199999999999998 111.72 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.434 ' CE1' ' HA2' ' A' ' 428' ' ' GLY . 24.8 p-80 -57.87 -28.83 64.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.092 0.404 . . . . 2.23 112.092 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.556 ' HB3' HG21 ' A' ' 385' ' ' ILE . 98.8 mtt180 -78.35 -38.62 41.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.993 0.368 . . . . 3.4199999999999999 111.993 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.733 HD12 HG21 ' A' ' 397' ' ' VAL . 60.1 mt -88.01 133.27 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.898 0.38 . . . . 1.1399999999999999 110.893 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 435' ' ' ASN . 58.0 m -165.11 145.71 7.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.736 -0.665 . . . . 0.95999999999999996 110.806 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . 0.526 ' H ' HD12 ' A' ' 373' ' ' ILE . 52.0 p-10 -71.28 16.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 1.3500000000000001 111.911 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.46 ' H ' ' C ' ' A' ' 433' ' ' SER . 20.7 p30 -165.8 133.93 3.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 2.5299999999999998 111.095 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -68.66 -13.27 62.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 1.3300000000000001 111.949 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.41 -41.08 72.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.686 0.279 . . . . 1.3400000000000001 111.363 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.47 -6.46 58.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 1.5600000000000001 111.48 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.619 HD22 ' N ' ' A' ' 386' ' ' ARG . 8.5 mp -96.68 -93.28 0.22 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.245 -0.434 . . . . 1.76 111.598 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -171.56 38.27 0.17 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.776 -0.726 . . . . 1.3600000000000001 112.485 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.98 138.84 0.05 OUTLIER Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.865 -0.683 . . . . 1.8300000000000001 112.812 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 43.2 mm . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 109.126 -0.694 . . . . 1.9199999999999999 109.126 178.721 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 373' ' ' ILE . 68.1 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.814 0.34 . . . . 1.9299999999999999 110.767 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.544 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 0.9 OUTLIER -88.21 69.86 9.2 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.152 -0.476 . . . . 2.1699999999999999 110.859 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 377' ' ' GLU . 61.7 mt -45.86 -44.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 1.4399999999999999 111.709 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 73.1 m -63.1 73.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 2.2000000000000002 111.559 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.4 pt-20 -173.97 -31.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 1.9199999999999999 110.482 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.492 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -152.99 58.16 2.3 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.53 . . . . 2.8900000000000001 111.606 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 50.3 Cg_exo -53.03 -37.6 79.1 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.283 1.989 . . . . 0.97999999999999998 111.504 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.1 -34.19 75.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.7 -0.682 . . . . 1.21 110.695 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -53.38 123.22 11.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.191 -0.458 . . . . 2.27 110.784 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 45.8 mm -84.91 128.92 38.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 1.1299999999999999 111.38 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -106.93 143.38 35.11 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.069 -0.345 . . . . 1.1000000000000001 110.069 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.489 ' HB2' HD13 ' A' ' 439' ' ' LEU . 5.2 m-85 -89.78 139.35 30.66 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.807 -0.357 . . . . 1.3200000000000001 110.192 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.537 HG13 HG12 ' A' ' 432' ' ' ILE . 2.6 mp -115.25 129.51 71.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.255 -0.429 . . . . 1.2 111.829 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.642 HH21 ' N ' ' A' ' 392' ' ' VAL . 5.2 tpm_? -88.25 90.14 8.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.865 -0.607 . . . . 3.1699999999999999 110.176 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.663 ' HD3' ' HG1' ' A' ' 391' ' ' THR . 58.1 mtp85 -55.88 153.6 8.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.725 0.297 . . . . 2.9900000000000002 110.816 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.76 -44.76 77.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.212 -0.449 . . . . 2.8199999999999998 111.318 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -58.27 -14.86 8.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.263 0.554 . . . . 1.23 109.749 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 91.66 39.77 5.49 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.176 -0.92 . . . . 1.03 112.561 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' THR . . . . . 0.663 ' HG1' ' HD3' ' A' ' 387' ' ' ARG . 70.8 p -121.91 110.19 15.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.591 0.234 . . . . 1.46 110.917 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.642 ' N ' HH21 ' A' ' 386' ' ' ARG . 63.4 t -70.97 132.71 32.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.628 0.252 . . . . 1.24 110.348 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . 0.413 ' N ' HG11 ' A' ' 392' ' ' VAL . 83.6 m-70 -151.31 135.35 16.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.893 0.378 . . . . 3.2400000000000002 110.582 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.441 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 71.2 mtt-85 -52.85 151.8 4.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.862 -0.608 . . . . 3.5600000000000001 112.135 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 416' ' ' TYR . . . -170.16 131.51 2.26 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.204 -0.907 . . . . 0.32000000000000001 111.411 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -87.14 128.97 35.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.769 0.318 . . . . 1.28 111.734 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 8.7 t -89.71 132.95 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.462 -0.57 . . . . 1.5800000000000001 109.462 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 68.2 mt -120.34 -37.32 3.06 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.51 0.559 . . . . 2.04 112.51 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -139.46 175.96 9.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.479 . . . . 2.6400000000000001 112.13 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.5 p -163.85 149.44 10.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.577 -0.738 . . . . 1.1299999999999999 110.344 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -158.05 136.85 11.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.869 0.366 . . . . 1.8799999999999999 111.5 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 63.1 p -77.65 -128.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.356 -0.384 . . . . 1.79 109.969 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -164.84 -173.41 2.96 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 110.214 -0.291 . . . . 2.2999999999999998 110.214 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -44.9 -45.21 10.22 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.659 0.266 . . . . 3.8700000000000001 111.588 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -66.75 -51.45 55.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.529 -0.305 . . . . 3.1600000000000001 110.953 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 52.97 52.92 12.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.131 0.491 . . . . 2.1800000000000002 111.469 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.444 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -150.66 10.75 0.65 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.694 -0.684 . . . . 2.77 109.688 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.502 ' HB2' ' HD3' ' A' ' 409' ' ' PRO . . . -178.48 -47.6 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 114.585 -1.189 . . . . 3.2799999999999998 110.055 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 408' ' ' ALA . 31.9 Cg_exo -58.8 143.59 99.0 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.463 2.108 . . . . 2.8700000000000001 112.447 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 42.5 p-10 -176.26 136.07 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.796 -0.638 . . . . 2.1400000000000001 110.804 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.5 mt-10 -130.96 134.18 46.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 2.1000000000000001 110.342 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 2.4 m-85 -112.32 127.48 56.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.377 . . . . 1.0600000000000001 111.671 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -64.76 144.78 57.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.437 -0.579 . . . . 1.05 109.437 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.414 HG13 HG12 ' A' ' 427' ' ' VAL . 6.4 p -143.99 129.83 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.43 0.633 . . . . 1.8400000000000001 112.625 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -111.86 89.22 3.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.929 -1.032 . . . . 0.70999999999999996 109.123 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.524 ' HA ' ' HA3' ' A' ' 395' ' ' GLY . 30.0 m-85 -52.49 115.6 1.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 1.1299999999999999 110.941 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.47 130.13 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.853 -0.612 . . . . 1.7 110.875 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.81 -42.6 2.5 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.98 -0.628 . . . . 1.1699999999999999 112.798 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.461 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 2.7 mm? -59.6 159.43 8.45 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.92 0.39 . . . . 2.1499999999999999 111.668 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 69.1 m-20 -53.83 142.86 22.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.79 -0.641 . . . . 2.7599999999999998 111.383 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -60.73 -36.65 79.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 4.6500000000000004 111.196 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -56.37 -32.15 64.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.355 -0.384 . . . . 4.3200000000000003 111.0 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 420' ' ' ASN . 1.1 tp -56.4 -29.78 61.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 2.04 111.351 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.57 140.23 11.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.085 0.469 . . . . 1.2 111.824 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -174.82 -149.83 7.43 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.681 -0.691 . . . . 0.69999999999999996 112.097 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -127.46 133.08 49.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.76000000000000001 110.808 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 411' ' ' GLU . 5.1 m -109.43 153.17 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.955 -0.566 . . . . 1.4399999999999999 111.049 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -76.97 29.98 1.57 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.434 -0.888 . . . . 1.72 112.455 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.545 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 39.2 tpt85 71.88 -37.41 0.39 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.181 0.437 . . . . 2.3199999999999998 112.181 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.412 ' H ' ' C ' ' A' ' 428' ' ' GLY . 22.1 p-80 -58.83 -27.36 65.04 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.712 0.264 . . . . 2.23 111.712 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.605 ' NH2' ' HA ' ' A' ' 387' ' ' ARG . 81.2 mtp180 -78.56 -38.37 40.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.958 0.355 . . . . 3.4199999999999999 111.958 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.537 HG12 HG13 ' A' ' 385' ' ' ILE . 73.2 mt -88.44 131.41 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 1.1399999999999999 110.37 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 49.0 m -154.87 139.6 17.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.006 0.432 . . . . 0.95999999999999996 111.631 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.41 -25.4 67.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.615 . . . . 1.3500000000000001 110.349 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.689 HD22 ' HB2' ' A' ' 437' ' ' ASP . 48.4 t30 -108.56 134.13 51.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.837 -0.619 . . . . 2.5299999999999998 110.286 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . 0.458 ' CB ' HD12 ' A' ' 442' ' ' ILE . . . -69.26 -42.91 74.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.023 -0.535 . . . . 1.3300000000000001 112.298 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . 0.689 ' HB2' HD22 ' A' ' 435' ' ' ASN . 54.4 m-20 -57.63 -40.54 79.45 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.584 0.216 . . . . 1.3400000000000001 111.584 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -56.3 -35.06 67.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 1.5600000000000001 110.471 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 386' ' ' ARG . 86.4 mt -57.29 -82.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.775 -0.648 . . . . 1.76 111.184 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . 0.524 ' HA2' HH11 ' A' ' 386' ' ' ARG . . . -168.35 -27.98 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.05 -0.595 . . . . 1.3600000000000001 112.138 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 154.44 143.08 3.59 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.104 -0.57 . . . . 1.8300000000000001 112.117 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . 0.458 HD12 ' CB ' ' A' ' 436' ' ' ALA . 44.7 mm . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.989 0.423 . . . . 1.9199999999999999 110.884 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.695 0.283 . . . . 1.9299999999999999 110.76 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.75 128.94 35.64 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 116.265 -0.425 . . . . 2.1699999999999999 110.727 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.477 ' O ' HG21 ' A' ' 375' ' ' ILE . 95.7 mt -91.74 -33.83 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.145 -0.48 . . . . 1.4399999999999999 110.901 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.4 t -72.05 62.36 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.042 -0.526 . . . . 2.2000000000000002 111.057 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -168.24 -26.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.695 -0.684 . . . . 1.9199999999999999 109.874 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.615 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 3.5 m120 -156.63 62.41 2.86 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.347 -0.842 . . . . 2.8900000000000001 111.517 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 79.0 Cg_exo -52.68 -41.21 70.69 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.998 2.465 . . . . 0.97999999999999998 112.8 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -70.01 -32.85 71.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.226 -0.443 . . . . 1.21 111.78 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.0 tttm -44.52 127.09 5.8 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.931 0.396 . . . . 2.27 110.967 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.487 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 41.0 mm -86.91 127.07 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 1.1299999999999999 111.406 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -107.72 144.0 35.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 1.1000000000000001 110.004 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.431 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 3.9 m-85 -91.29 138.27 31.72 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.081 -0.247 . . . . 1.3200000000000001 110.833 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 431' ' ' ARG . 2.8 mp -121.37 126.99 75.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.449 -0.341 . . . . 1.2 110.87 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.581 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 38.4 ttt85 -91.57 122.53 34.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 3.1699999999999999 111.032 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -83.23 172.19 12.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.744 0.307 . . . . 2.9900000000000002 110.695 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -53.05 -71.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 2.8199999999999998 111.045 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -40.99 -31.64 0.19 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.068 0.461 . . . . 1.23 110.565 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 111.14 39.48 1.38 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.795 -0.639 . . . . 1.03 112.986 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 39.7 p -114.02 111.04 21.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.95 0.405 . . . . 1.46 110.976 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 46.1 t -72.53 140.74 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 1.24 111.39 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -148.14 134.34 19.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.582 . . . . 3.2400000000000002 110.42 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.487 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 83.0 mtm180 -58.43 150.37 22.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.074 0.464 . . . . 3.5600000000000001 111.94 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -172.73 132.05 2.27 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.638 -0.71 . . . . 0.32000000000000001 112.254 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -91.72 111.61 23.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.577 0.227 . . . . 1.28 111.607 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.636 HG12 ' HB3' ' A' ' 412' ' ' TYR . 8.7 t -66.49 134.12 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.927 -0.397 . . . . 1.5800000000000001 109.927 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 91.6 mt -119.07 -44.49 2.6 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.907 0.336 . . . . 2.04 111.907 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . 0.479 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 84.0 mt-30 -124.5 174.33 7.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.991 0.424 . . . . 2.6400000000000001 111.645 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 87.7 p -165.88 144.95 6.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.78 -0.645 . . . . 1.1299999999999999 110.351 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.51 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 41.2 ptt180 -156.97 134.89 10.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.003 0.43 . . . . 1.8799999999999999 111.448 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 14.1 p -85.99 38.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.942 -0.572 . . . . 1.79 111.041 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.483 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.8 m 51.75 -173.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.545 -0.298 . . . . 2.2999999999999998 110.272 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.483 ' H ' ' CG2' ' A' ' 403' ' ' THR . 8.4 mp0 -54.87 -49.52 70.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.721 0.296 . . . . 3.8700000000000001 110.631 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -87.21 115.09 24.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.302 -0.408 . . . . 3.1600000000000001 110.727 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -94.91 51.84 1.41 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.832 0.349 . . . . 2.1800000000000002 111.293 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -124.98 -11.52 7.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 2.77 111.215 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.531 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -161.84 -50.48 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.868 -0.606 . . . . 3.2799999999999998 111.107 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' A' ' 408' ' ' ALA . 72.1 Cg_exo -50.17 152.06 8.43 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.498 2.132 . . . . 2.8700000000000001 112.621 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.658 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 44.0 p-10 -175.74 137.22 0.34 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.093 -0.503 . . . . 2.1400000000000001 111.134 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -150.16 135.9 18.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 2.1000000000000001 110.497 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.636 ' HB3' HG12 ' A' ' 397' ' ' VAL . 2.1 m-85 -115.66 126.48 54.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.45 -0.341 . . . . 1.0600000000000001 111.358 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 426' ' ' TRP . 12.8 t80 -65.78 142.78 57.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.195 -0.457 . . . . 1.05 110.32 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.522 HG22 HG12 ' A' ' 427' ' ' VAL . 20.1 t -128.33 136.87 58.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 112.546 0.573 . . . . 1.8400000000000001 112.546 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -120.88 89.87 3.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.70999999999999996 109.943 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.61 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 50.0 m-85 -56.5 129.25 39.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 1.1299999999999999 111.19 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.415 HG22 HD13 ' A' ' 382' ' ' ILE . 2.8 t -82.98 34.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.782 -0.644 . . . . 1.7 111.259 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -178.4 -41.44 0.07 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.455 -0.879 . . . . 1.1699999999999999 113.103 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.61 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 2.2 mm? -59.77 156.77 13.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.84 0.352 . . . . 2.1499999999999999 111.081 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -49.72 144.55 6.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.021 -0.536 . . . . 2.7599999999999998 111.77 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -56.83 -39.4 74.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.88 -0.6 . . . . 4.6500000000000004 111.092 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 41.4 ptt85 -62.26 -32.15 72.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.895 0.378 . . . . 4.3200000000000003 110.702 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' A' ' 419' ' ' LEU . 1.1 tp -61.67 -32.38 72.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.974 -0.557 . . . . 2.04 111.056 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -48.16 129.1 14.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.301 -0.409 . . . . 1.2 110.448 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.95 165.59 35.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.53 -0.843 . . . . 0.69999999999999996 112.487 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . 0.56 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 8.3 m95 -74.42 128.49 35.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.739 0.304 . . . . 0.76000000000000001 110.496 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.522 HG12 HG22 ' A' ' 414' ' ' VAL . 4.4 m -119.89 152.68 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 1.4399999999999999 110.819 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.44 ' HA2' ' CE1' ' A' ' 430' ' ' HIS . . . -56.87 148.59 31.55 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.954 -0.641 . . . . 1.72 112.825 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -50.2 -42.16 50.97 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.567 0.347 . . . . 2.3199999999999998 111.844 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.44 ' CE1' ' HA2' ' A' ' 428' ' ' GLY . 22.2 p-80 -54.81 -28.54 50.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.289 0.477 . . . . 2.23 112.289 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.3 mtt180 -78.59 -38.3 40.36 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.601 0.593 . . . . 3.4199999999999999 112.601 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.592 HD12 HG23 ' A' ' 397' ' ' VAL . 68.8 mt -88.6 130.65 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 120.601 -0.44 . . . . 1.1399999999999999 111.009 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.436 ' HB2' ' CD1' ' A' ' 439' ' ' LEU . 44.6 m -168.11 140.42 3.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.837 -0.62 . . . . 0.95999999999999996 110.949 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -66.02 -15.53 63.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.015 -0.539 . . . . 1.3500000000000001 111.278 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.432 ' HB2' ' OD2' ' A' ' 438' ' ' ASP . 5.8 m120 -108.48 130.9 55.25 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.841 0.353 . . . . 2.5299999999999998 110.851 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 441' ' ' GLY . . . -74.74 -34.75 62.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 1.3300000000000001 112.03 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.03 -40.56 67.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.425 -0.352 . . . . 1.3400000000000001 111.641 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' ' 435' ' ' ASN . 61.9 m-20 -64.11 -21.21 66.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 1.5600000000000001 111.369 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.581 ' HB3' ' HB2' ' A' ' 386' ' ' ARG . 8.7 mp -93.94 -88.65 0.23 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.097 -0.501 . . . . 1.76 111.917 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . 0.505 ' HA2' ' NH1' ' A' ' 386' ' ' ARG . . . -164.43 49.92 0.29 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.021 -0.609 . . . . 1.3600000000000001 112.157 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 436' ' ' ALA . . . 69.19 -129.61 23.49 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.59 -0.814 . . . . 1.8300000000000001 112.375 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 43.3 mm . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 120.829 0.347 . . . . 1.9199999999999999 110.651 179.896 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.668 HG12 ' CZ ' ' A' ' 429' ' ' ARG . 49.5 mm . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.888 0.375 . . . . 1.9299999999999999 111.939 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -102.59 130.87 49.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.902 -0.59 . . . . 2.1699999999999999 109.996 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 77.5 mt -81.22 -42.28 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.42 0.526 . . . . 1.4399999999999999 112.42 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 41.5 t -47.93 -22.75 0.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.137 0.494 . . . . 2.2000000000000002 111.308 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -54.77 -47.67 73.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.408 -0.815 . . . . 1.9199999999999999 111.118 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 379' ' ' PRO . 8.2 m120 -167.06 112.9 0.67 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.833 -0.621 . . . . 2.8900000000000001 110.979 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 378' ' ' ASN . 12.2 Cg_exo -71.5 -41.05 2.56 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.826 2.35 . . . . 0.97999999999999998 112.699 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -80.94 -34.24 33.39 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.125 0.417 . . . . 1.21 112.125 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -44.82 124.98 4.69 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.765 0.317 . . . . 2.27 111.413 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.881 HD13 HG23 ' A' ' 417' ' ' VAL . 11.4 mm -77.99 131.05 35.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.132 -0.486 . . . . 1.1299999999999999 111.854 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -111.35 144.15 41.0 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.781 -0.452 . . . . 1.1000000000000001 109.781 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.414 ' C ' HD13 ' A' ' 385' ' ' ILE . 46.9 m-85 -89.69 134.74 34.0 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.852 -0.339 . . . . 1.3200000000000001 110.899 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.618 HG22 HG13 ' A' ' 427' ' ' VAL . 2.6 mp -119.47 132.86 68.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.262 -0.426 . . . . 1.2 110.899 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.629 ' N ' HD22 ' A' ' 439' ' ' LEU . 50.3 ttt-85 -93.92 115.78 28.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.672 0.272 . . . . 3.1699999999999999 110.819 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -76.56 157.04 32.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.524 -0.307 . . . . 2.9900000000000002 110.554 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -53.9 -44.95 70.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.581 -0.281 . . . . 2.8199999999999998 111.086 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -54.9 -27.35 42.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.253 0.549 . . . . 1.23 109.597 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 103.13 38.5 2.86 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.34 -0.845 . . . . 1.03 113.183 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 69.1 p -121.07 112.15 18.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 1.46 111.455 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.33 132.28 33.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 1.24 110.351 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -146.5 135.89 22.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.021 0.439 . . . . 3.2400000000000002 111.22 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.517 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 74.0 mtt-85 -53.84 153.67 4.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.722 -0.672 . . . . 3.5600000000000001 111.875 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 415' ' ' HIS . . . -179.59 130.74 1.55 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.763 -0.653 . . . . 0.32000000000000001 112.192 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 75.5 mt-30 -91.82 134.11 35.04 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.99 0.395 . . . . 1.28 111.885 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.625 ' CG2' HD11 ' A' ' 432' ' ' ILE . 5.2 t -87.4 133.28 30.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.23 -0.441 . . . . 1.5800000000000001 110.722 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 85.0 mt -121.16 -46.75 2.29 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.075 0.398 . . . . 2.04 112.075 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . 0.481 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 13.5 mm100 -127.07 176.84 7.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.916 0.389 . . . . 2.6400000000000001 111.647 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 87.9 p -162.42 139.56 8.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.79 -0.641 . . . . 1.1299999999999999 110.92 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.667 ' HD3' ' O ' ' A' ' 401' ' ' ARG . 0.1 OUTLIER -148.39 138.64 22.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 1.8799999999999999 110.906 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 13.9 m -103.33 42.25 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 1.79 110.096 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.534 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 3.5 m 51.27 -173.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.736 -0.665 . . . . 2.2999999999999998 110.648 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.534 ' H ' ' CG2' ' A' ' 403' ' ' THR . 95.6 mt-10 -63.98 -37.16 86.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 3.8700000000000001 110.69 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.667 ' HB2' ' HG2' ' A' ' 409' ' ' PRO . 5.1 m120 -56.25 -51.99 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.598 . . . . 3.1600000000000001 111.442 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.622 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.33 56.43 5.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 2.1800000000000002 110.863 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -161.9 -3.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 2.77 111.04 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.481 ' H ' ' CD ' ' A' ' 409' ' ' PRO . . . -169.54 -44.54 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.71 -0.677 . . . . 3.2799999999999998 111.649 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.667 ' HG2' ' HB2' ' A' ' 405' ' ' ASN . 15.7 Cg_exo -69.79 47.85 0.59 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.825 2.35 . . . . 2.8700000000000001 113.87 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.728 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 47.2 p-10 -68.59 143.84 54.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.908 0.385 . . . . 2.1400000000000001 110.893 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 50.6 mt-10 -148.72 146.69 28.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.016 -0.538 . . . . 2.1000000000000001 110.423 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -127.06 125.28 41.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.913 0.387 . . . . 1.0600000000000001 111.688 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.481 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 20.2 t80 -63.47 149.99 44.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.045 -0.724 . . . . 1.05 109.045 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.444 HG13 HG12 ' A' ' 427' ' ' VAL . 7.8 p -158.83 133.32 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.016 0.747 . . . . 1.8400000000000001 113.016 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . 0.563 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 76.2 t60 -105.06 106.24 16.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.03 -0.987 . . . . 0.70999999999999996 109.167 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 2.1 m-85 -62.19 100.63 0.18 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.55 0.691 . . . . 1.1299999999999999 109.939 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.881 HG23 HD13 ' A' ' 382' ' ' ILE . 44.2 t -48.63 123.74 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.555 -1.202 . . . . 1.7 111.75 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 83.07 -33.37 2.91 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.183 -0.917 . . . . 1.1699999999999999 113.409 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 423' ' ' LEU . 8.9 mt -68.23 -173.6 0.42 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.42 0.629 . . . . 2.1499999999999999 112.456 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.727 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 5.2 m120 -74.3 145.85 43.62 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 114.961 -1.018 . . . . 2.7599999999999998 111.053 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . 0.455 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 45.1 mtp85 -65.21 -39.24 92.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.22 -0.446 . . . . 4.6500000000000004 111.348 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -57.44 -35.71 70.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.742 0.306 . . . . 4.3200000000000003 111.122 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.727 ' HG ' ' HB2' ' A' ' 420' ' ' ASN . 85.4 mt -56.94 -33.94 67.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 2.04 111.191 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' A' ' 415' ' ' HIS . 39.8 m-20 -52.94 141.87 20.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.521 . . . . 1.2 111.759 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -171.85 -142.06 3.59 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.644 -0.707 . . . . 0.69999999999999996 111.954 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -124.29 138.07 54.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.018 0.437 . . . . 0.76000000000000001 110.715 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.618 HG13 HG22 ' A' ' 385' ' ' ILE . 15.7 m -109.08 158.58 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.925 -0.58 . . . . 1.4399999999999999 111.844 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -81.61 39.98 2.57 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.882 -0.675 . . . . 1.72 113.009 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.668 ' CZ ' HG12 ' A' ' 373' ' ' ILE . 38.4 tpt85 68.56 -72.4 0.1 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.492 0.553 . . . . 2.3199999999999998 112.492 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -47.2 -15.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 2.23 113.053 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.543 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 99.5 mtt180 -78.29 -35.55 47.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.723 0.268 . . . . 3.4199999999999999 111.723 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.625 HD11 ' CG2' ' A' ' 397' ' ' VAL . 97.4 mt -88.45 132.23 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 1.1399999999999999 111.16 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.415 ' HB2' ' CD1' ' A' ' 439' ' ' LEU . 75.0 m -166.06 139.29 4.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.855 -0.611 . . . . 0.95999999999999996 110.779 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -61.86 -23.15 66.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 1.3500000000000001 111.095 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.428 ' HB2' ' OD2' ' A' ' 438' ' ' ASP . 80.3 m-20 -108.44 131.69 54.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.916 0.389 . . . . 2.5299999999999998 110.909 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 441' ' ' GLY . . . -75.82 -31.96 59.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 1.3300000000000001 111.915 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.66 -40.55 62.95 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.453 -0.34 . . . . 1.3400000000000001 111.462 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 435' ' ' ASN . 57.6 m-20 -61.96 -23.6 66.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 1.5600000000000001 111.091 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.703 ' N ' HD11 ' A' ' 439' ' ' LEU . 8.5 mp -91.61 -84.63 0.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.82 -0.627 . . . . 1.76 112.313 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -158.81 57.02 0.34 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.462 -0.875 . . . . 1.3600000000000001 112.995 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 436' ' ' ALA . . . 66.68 -129.03 30.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.636 -0.793 . . . . 1.8300000000000001 112.841 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 46.2 mm . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.395 0.14 . . . . 1.9199999999999999 110.912 -179.529 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.435 HD13 ' NE ' ' A' ' 429' ' ' ARG . 76.4 mt . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 121.17 0.51 . . . . 1.9299999999999999 111.905 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 42.7 m-20 -89.47 77.36 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.833 -0.621 . . . . 2.1699999999999999 110.923 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.4 mt -48.36 -41.2 10.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 1.4399999999999999 111.648 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 77.9 p -64.94 76.14 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.545 . . . . 2.2000000000000002 111.687 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 16.2 pt-20 -174.69 -27.62 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.862 -0.608 . . . . 1.9199999999999999 110.242 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.574 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 3.5 m120 -156.14 62.3 2.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.691 -0.686 . . . . 2.8900000000000001 112.235 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.14 -40.97 75.36 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.778 2.319 . . . . 0.97999999999999998 112.542 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -70.86 -34.41 71.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.041 -0.527 . . . . 1.21 111.722 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.574 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 86.2 tttt -43.03 129.73 4.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.981 0.42 . . . . 2.27 111.028 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.407 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 46.8 mm -81.64 123.26 37.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.854 -0.612 . . . . 1.1299999999999999 111.448 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -102.02 143.41 31.9 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.922 -0.399 . . . . 1.1000000000000001 109.922 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.84 139.2 30.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.587 -0.279 . . . . 1.3200000000000001 110.798 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.573 HD13 ' N ' ' A' ' 385' ' ' ILE . 1.7 mp -131.94 133.45 60.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.69 0.281 . . . . 1.2 111.168 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.615 ' CZ ' ' HA2' ' A' ' 440' ' ' GLY . 8.1 tpt180 -90.41 121.71 32.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 3.1699999999999999 110.585 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -74.53 164.22 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 2.9900000000000002 110.556 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -61.3 -45.32 94.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.335 -0.393 . . . . 2.8199999999999998 110.825 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -61.47 -12.88 16.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.133 0.492 . . . . 1.23 110.058 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.416 ' C ' ' HE ' ' A' ' 386' ' ' ARG . . . 90.78 41.78 5.26 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.409 -0.814 . . . . 1.03 112.53 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 82.8 p -121.35 112.64 18.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.679 0.276 . . . . 1.46 111.352 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 59.4 t -68.43 134.2 30.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 1.24 110.711 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -149.65 137.63 20.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 3.2400000000000002 110.989 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.407 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 77.9 mtm180 -60.79 152.53 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 3.5600000000000001 111.531 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -171.01 126.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.771 -0.65 . . . . 0.32000000000000001 112.295 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 57.0 mt-30 -78.8 130.15 35.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.724 0.297 . . . . 1.28 111.514 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.552 HG23 ' HB3' ' A' ' 412' ' ' TYR . 0.7 OUTLIER -98.85 126.87 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.61 -0.515 . . . . 1.5800000000000001 109.61 178.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . 0.472 ' N ' ' CD2' ' A' ' 398' ' ' LEU . 0.4 OUTLIER -115.05 -47.21 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.534 0.568 . . . . 2.04 112.534 -177.215 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -127.71 176.41 7.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 2.6400000000000001 111.726 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 84.7 p -165.47 141.93 5.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.784 -0.644 . . . . 1.1299999999999999 110.967 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.49 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 41.0 ptt180 -142.88 135.23 27.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.346 -0.388 . . . . 1.8799999999999999 110.772 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 24.9 p -81.92 40.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 1.79 112.159 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.504 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.8 m 50.58 -173.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.506 -0.183 . . . . 2.2999999999999998 110.506 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.504 ' H ' ' CG2' ' A' ' 403' ' ' THR . 48.6 mt-10 -56.73 -50.02 73.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.321 . . . . 3.8700000000000001 110.446 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -83.73 117.85 23.51 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.296 -0.411 . . . . 3.1600000000000001 110.613 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -101.43 76.68 1.71 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.964 0.411 . . . . 2.1800000000000002 111.326 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -160.68 10.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 2.77 110.65 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.62 ' HB2' ' HD3' ' A' ' 409' ' ' PRO . . . -178.52 -51.61 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.609 -0.723 . . . . 3.2799999999999998 110.903 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 408' ' ' ALA . 49.9 Cg_exo -57.07 154.11 35.16 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.689 2.259 . . . . 2.8700000000000001 113.028 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.664 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 44.2 p-10 -178.62 130.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.852 -0.613 . . . . 2.1400000000000001 111.081 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 400' ' ' SER . 58.9 mp0 -136.85 135.28 37.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.85 -0.614 . . . . 2.1000000000000001 109.933 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.552 ' HB3' HG23 ' A' ' 397' ' ' VAL . 0.4 OUTLIER -110.91 130.17 55.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 1.0600000000000001 111.897 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 14.6 t80 -65.03 141.62 58.7 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.516 -0.92 . . . . 1.05 108.516 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 6.4 p -147.72 110.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.608 0.966 . . . . 1.8400000000000001 113.608 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -86.44 90.94 8.37 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.531 -0.759 . . . . 0.70999999999999996 109.344 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.429 ' CD1' ' HA ' ' A' ' 424' ' ' ASP . 35.6 m-85 -52.84 128.71 27.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.055 0.455 . . . . 1.1299999999999999 111.394 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 86.2 t -73.2 127.81 35.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.748 -0.66 . . . . 1.7 111.166 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.34 -44.91 2.25 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.985 -0.626 . . . . 1.1699999999999999 113.022 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.42 ' HB3' HD11 ' A' ' 423' ' ' LEU . 7.7 mp -59.7 148.98 32.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.861 0.362 . . . . 2.1499999999999999 111.204 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -54.47 137.72 42.01 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.948 -0.569 . . . . 2.7599999999999998 111.798 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -32.31 50.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.655 -0.702 . . . . 4.6500000000000004 111.368 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . 0.749 HH11 HD22 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -54.79 -38.85 67.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 4.3200000000000003 110.52 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.749 HD22 HH11 ' A' ' 422' ' ' ARG . 96.5 mt -65.55 -35.44 80.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.019 0.438 . . . . 2.04 110.54 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' A' ' 416' ' ' TYR . 16.8 m-20 -54.84 138.32 43.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.654 -0.703 . . . . 1.2 111.602 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -179.46 -141.68 4.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.715 -0.675 . . . . 0.69999999999999996 111.938 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . 0.49 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 53.4 m95 -106.2 140.28 39.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.76000000000000001 110.695 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.485 HG23 HG13 ' A' ' 414' ' ' VAL . 17.1 m -132.88 141.73 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 1.4399999999999999 111.953 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -64.99 150.96 51.66 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.855 -0.611 . . . . 1.72 112.525 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.435 ' NE ' HD13 ' A' ' 373' ' ' ILE . 41.0 tpt85 -51.74 -38.28 54.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.771 0.319 . . . . 2.3199999999999998 111.269 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.552 ' ND1' ' HG3' ' A' ' 431' ' ' ARG . 6.4 p80 -60.19 -28.96 68.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.44 0.533 . . . . 2.23 112.44 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.552 ' HG3' ' ND1' ' A' ' 430' ' ' HIS . 72.1 mtt-85 -78.23 -35.62 48.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.52 0.2 . . . . 3.4199999999999999 111.537 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 397' ' ' VAL . 66.3 mt -88.67 139.7 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.138 0.494 . . . . 1.1399999999999999 111.869 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 435' ' ' ASN . 69.9 m -163.39 139.17 6.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.5 -0.773 . . . . 0.95999999999999996 110.327 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -75.83 16.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 1.3500000000000001 111.359 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 433' ' ' SER . 75.9 m-80 -147.88 130.76 16.15 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.879 0.371 . . . . 2.5299999999999998 110.699 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -69.87 -37.85 76.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.53 . . . . 1.3300000000000001 111.898 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -50.39 -40.87 51.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 1.3400000000000001 111.214 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.14 49.39 1.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 1.5600000000000001 110.999 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . . . . . . . . . 88.7 mt -145.7 -84.87 0.12 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.521 -0.309 . . . . 1.76 111.539 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . 0.615 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . -167.66 40.5 0.24 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.416 -0.897 . . . . 1.3600000000000001 113.014 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.46 144.2 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.765 -0.731 . . . . 1.8300000000000001 112.88 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 48.8 mm . . . . . 0 C--N 1.33 -0.281 0 N-CA-C 110.461 -0.2 . . . . 1.9199999999999999 110.461 179.462 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.506 HG13 ' HE ' ' A' ' 429' ' ' ARG . 70.4 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.672 0.273 . . . . 1.9299999999999999 110.335 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.5 129.36 36.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.877 0.37 . . . . 2.1699999999999999 111.288 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.435 HD12 ' C ' ' A' ' 397' ' ' VAL . 82.5 mt -84.79 -39.43 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 1.4399999999999999 110.816 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.4 t -66.55 72.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.751 -0.659 . . . . 2.2000000000000002 111.022 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . 0.455 ' HG3' ' ND2' ' A' ' 378' ' ' ASN . 12.2 pt-20 -174.45 -28.64 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.536 -0.757 . . . . 1.9199999999999999 109.644 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.485 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -172.2 57.69 0.24 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.206 -0.906 . . . . 2.8900000000000001 111.052 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 52.2 Cg_exo -52.86 -39.86 76.82 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.297 1.998 . . . . 0.97999999999999998 111.893 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.474 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 54.0 m-20 -62.57 -33.84 75.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.93 -0.577 . . . . 1.21 110.877 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 86.1 tttt -49.1 121.29 4.67 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.205 -0.452 . . . . 2.27 110.799 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.791 HD11 HG23 ' A' ' 417' ' ' VAL . 18.6 mm -69.97 129.43 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 1.1299999999999999 112.0 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 395' ' ' GLY . 82.0 m-85 -109.75 144.69 37.79 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.283 -0.417 . . . . 1.1000000000000001 110.234 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -85.6 128.5 34.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.731 0.301 . . . . 1.3200000000000001 110.884 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.488 ' C ' HD22 ' A' ' 439' ' ' LEU . 1.8 mp -113.22 128.17 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.238 -0.437 . . . . 1.2 110.66 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.681 ' N ' HD22 ' A' ' 439' ' ' LEU . 25.4 tpt180 -98.27 120.62 39.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.373 -0.376 . . . . 3.1699999999999999 111.267 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.449 ' HD3' ' HG1' ' A' ' 391' ' ' THR . 77.6 mtp180 -83.18 157.33 22.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 2.9900000000000002 110.556 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -55.71 -39.7 71.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 2.8199999999999998 111.301 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.416 ' OD2' HG22 ' A' ' 391' ' ' THR . 11.6 p-10 -71.44 5.5 2.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.442 -0.344 . . . . 1.23 111.684 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 74.08 44.14 30.72 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.018 -0.61 . . . . 1.03 113.776 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' THR . . . . . 0.449 ' HG1' ' HD3' ' A' ' 387' ' ' ARG . 25.3 p -122.38 111.65 17.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.828 0.314 . . . . 1.46 111.625 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.419 ' N ' HH11 ' A' ' 386' ' ' ARG . 72.4 t -69.36 135.61 27.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.649 -0.25 . . . . 1.24 110.416 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -151.41 133.08 14.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.426 -0.352 . . . . 3.2400000000000002 111.046 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.459 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 88.9 mtm180 -59.07 153.34 18.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 3.5600000000000001 112.036 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.602 ' HA3' ' HA ' ' A' ' 416' ' ' TYR . . . -175.44 132.45 2.16 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.798 -0.637 . . . . 0.32000000000000001 112.516 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . 0.479 ' HG3' HG21 ' A' ' 417' ' ' VAL . 75.3 mt-30 -96.15 112.03 23.89 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 111.773 0.286 . . . . 1.28 111.773 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.725 HG21 HD12 ' A' ' 432' ' ' ILE . 2.6 t -63.49 136.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.218 -0.29 . . . . 1.5800000000000001 110.218 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 98.8 mt -120.36 -38.92 2.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.16 0.43 . . . . 2.04 112.16 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . 0.412 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 85.7 mt-30 -139.96 176.45 8.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.066 0.46 . . . . 2.6400000000000001 111.588 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.1 p -163.7 150.94 12.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.692 -0.686 . . . . 1.1299999999999999 110.24 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 39.2 ptt180 -156.17 134.58 11.54 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.862 0.363 . . . . 1.8799999999999999 111.86 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 32.7 p -78.25 136.93 37.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 1.79 110.293 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 409' ' ' PRO . 1.7 m -63.74 -174.49 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.285 -0.416 . . . . 2.2999999999999998 110.777 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.461 ' H ' ' CG2' ' A' ' 403' ' ' THR . 49.1 mt-10 -48.76 -43.1 37.47 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.386 0.513 . . . . 3.8700000000000001 112.386 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.545 ' HB3' ' HG3' ' A' ' 409' ' ' PRO . 50.9 t30 -55.9 -49.67 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.585 0.231 . . . . 3.1600000000000001 111.457 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.435 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 57.32 59.11 3.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.947 0.403 . . . . 2.1800000000000002 111.537 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -154.75 -2.27 0.16 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.602 . . . . 2.77 110.143 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.664 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -178.46 -49.35 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 114.848 -1.069 . . . . 3.2799999999999998 110.181 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 11.7 Cg_endo -54.62 141.39 74.84 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.44 2.093 . . . . 2.8700000000000001 112.298 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 36.6 p-10 -177.09 132.06 0.18 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.799 -0.637 . . . . 2.1400000000000001 111.077 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.4 mt-10 -108.55 135.45 49.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.595 . . . . 2.1000000000000001 109.549 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.525 ' HB3' HG12 ' A' ' 397' ' ' VAL . 1.0 OUTLIER -108.83 120.61 43.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.894 0.378 . . . . 1.0600000000000001 111.73 -178.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 11.9 t80 -60.89 137.47 58.21 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.914 -0.773 . . . . 1.05 108.914 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.411 HG22 HD12 ' A' ' 385' ' ' ILE . 7.3 p -136.87 130.52 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.904 0.705 . . . . 1.8400000000000001 112.904 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . 0.474 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 81.5 t60 -102.1 89.49 3.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.87 -1.059 . . . . 0.70999999999999996 109.018 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.602 ' HA ' ' HA3' ' A' ' 395' ' ' GLY . 22.6 m-85 -46.55 123.95 5.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.373 0.606 . . . . 1.1299999999999999 111.019 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.791 HG23 HD11 ' A' ' 382' ' ' ILE . 43.5 t -74.7 125.48 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.133 -0.94 . . . . 1.7 111.022 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.84 -42.98 2.55 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.585 -0.734 . . . . 1.1699999999999999 112.279 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 7.1 mp -65.03 151.95 44.69 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.928 0.394 . . . . 2.1499999999999999 111.44 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.537 ' O ' HD21 ' A' ' 423' ' ' LEU . 55.9 t30 -57.84 160.14 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 2.7599999999999998 111.226 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . 0.441 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 68.2 mtt-85 -62.47 -26.56 68.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.257 0.551 . . . . 4.6500000000000004 110.453 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . 0.501 ' HB3' HD21 ' A' ' 420' ' ' ASN . 68.2 ttt180 -52.31 -36.35 52.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.282 -0.872 . . . . 4.3200000000000003 111.829 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.537 HD21 ' O ' ' A' ' 420' ' ' ASN . 2.8 mm? -68.91 -34.6 75.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.451 . . . . 2.04 111.584 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 415' ' ' HIS . 1.2 m-20 -45.84 140.52 3.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.15 0.5 . . . . 1.2 112.149 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -178.18 -142.41 4.68 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.584 -0.735 . . . . 0.69999999999999996 112.176 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 42.4 m95 -129.7 138.31 51.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.945 0.403 . . . . 0.76000000000000001 110.815 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.447 HG22 HG13 ' A' ' 432' ' ' ILE . 22.2 m -125.82 149.55 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 1.4399999999999999 111.196 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -77.01 29.49 1.59 Allowed Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.904 -0.665 . . . . 1.72 114.475 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.57 ' HB3' ' O ' ' A' ' 428' ' ' GLY . 37.4 tpt85 75.25 -43.96 0.52 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.171 0.804 . . . . 2.3199999999999998 113.171 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.462 ' H ' ' CD2' ' A' ' 430' ' ' HIS . 2.0 m170 -52.25 -30.47 27.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.736 0.779 . . . . 2.23 110.269 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.496 HH11 ' HG3' ' A' ' 431' ' ' ARG . 28.8 mtt85 -78.48 -32.31 48.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.311 -1.313 . . . . 3.4199999999999999 112.595 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.725 HD12 HG21 ' A' ' 397' ' ' VAL . 77.0 mt -88.46 129.72 39.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.799 -0.36 . . . . 1.1399999999999999 110.375 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.466 ' HB2' HD12 ' A' ' 439' ' ' LEU . 63.3 m -164.92 143.67 6.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.152 -0.476 . . . . 0.95999999999999996 111.149 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -73.61 16.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 1.3500000000000001 111.721 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 433' ' ' SER . 21.6 p30 -159.17 135.71 9.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.94 0.4 . . . . 2.5299999999999998 111.124 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -69.37 -26.41 64.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.79 -0.641 . . . . 1.3300000000000001 112.21 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -46.67 -40.76 13.75 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.49 -0.323 . . . . 1.3400000000000001 111.794 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -72.94 -33.01 65.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.004 0.43 . . . . 1.5600000000000001 111.012 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.681 HD22 ' N ' ' A' ' 386' ' ' ARG . 6.7 mp -77.99 -84.39 0.08 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.706 -0.679 . . . . 1.76 111.866 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . 0.475 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . -148.39 28.59 1.35 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.671 -0.776 . . . . 1.3600000000000001 112.535 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 48.46 55.11 11.27 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.945 -0.645 . . . . 1.8300000000000001 112.65 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 31.4 mm . . . . . 0 C--N 1.326 -0.439 0 N-CA-C 110.285 -0.265 . . . . 1.9199999999999999 110.285 -179.58 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.52 ' HB ' HH12 ' A' ' 429' ' ' ARG . 68.8 mt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.089 0.471 . . . . 1.9299999999999999 111.587 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.51 142.7 27.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 2.1699999999999999 110.354 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 397' ' ' VAL . 4.6 mp -71.4 -43.31 73.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.742 0.275 . . . . 1.4399999999999999 111.742 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 49.2 m -49.11 -20.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.982 0.42 . . . . 2.2000000000000002 111.52 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -58.39 -48.28 81.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.701 -0.681 . . . . 1.9199999999999999 111.773 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.44 ' N ' ' ND2' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -174.98 73.61 0.3 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.12 -0.491 . . . . 2.8900000000000001 110.911 -179.105 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . 0.401 ' HG3' HG21 ' A' ' 375' ' ' ILE . 78.2 Cg_exo -51.36 -40.17 62.32 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.521 2.147 . . . . 0.97999999999999998 112.477 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.526 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 1.5 m-20 -62.39 -37.29 85.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 1.21 111.199 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 79.1 tttt -50.54 127.48 17.89 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.972 0.415 . . . . 2.27 111.006 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.806 HD13 HG12 ' A' ' 417' ' ' VAL . 20.8 mm -73.22 132.6 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.817 -0.629 . . . . 1.1299999999999999 111.859 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -118.68 144.19 46.37 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.091 -0.504 . . . . 1.1000000000000001 110.256 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.488 ' CD2' ' HB1' ' A' ' 436' ' ' ALA . 3.0 m-85 -85.58 138.57 32.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.841 0.353 . . . . 1.3200000000000001 111.183 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.708 HD11 ' N ' ' A' ' 385' ' ' ILE . 2.5 mp -116.3 126.36 73.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.129 -0.487 . . . . 1.2 110.852 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 36.7 ttt85 -90.57 111.44 22.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 3.1699999999999999 110.839 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.436 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 76.8 mtp180 -71.89 157.8 37.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.41 -0.359 . . . . 2.9900000000000002 110.263 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.441 ' HG2' HH22 ' A' ' 431' ' ' ARG . 48.9 mt-10 -49.32 -41.0 37.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 2.8199999999999998 111.331 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -71.33 -36.13 71.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 1.23 111.572 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 137.19 -28.15 2.82 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.427 -0.892 . . . . 1.03 112.811 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' THR . . . . . 0.436 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 47.5 p -58.81 112.09 1.52 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 1.46 111.718 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.62 HG12 HD11 ' A' ' 439' ' ' LEU . 73.1 t -84.92 141.14 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.625 -0.716 . . . . 1.24 110.88 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . 0.431 ' HB3' HD12 ' A' ' 419' ' ' LEU . 93.7 m-70 -145.45 139.92 27.21 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.987 0.422 . . . . 3.2400000000000002 111.243 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.493 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 88.0 mtm180 -55.17 152.24 8.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.793 -0.64 . . . . 3.5600000000000001 112.064 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.565 ' HA2' HD12 ' A' ' 385' ' ' ILE . . . -178.74 128.16 1.23 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.481 -0.781 . . . . 0.32000000000000001 111.861 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . 0.526 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 78.4 mt-30 -84.47 130.74 34.73 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.338 0.496 . . . . 1.28 112.338 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.652 HG21 HD12 ' A' ' 432' ' ' ILE . 9.8 t -81.99 134.56 26.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.547 -0.538 . . . . 1.5800000000000001 109.547 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 90.2 mt -120.78 -43.19 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.475 0.546 . . . . 2.04 112.475 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . 0.475 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 97.6 mm-40 -134.91 175.94 9.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.076 0.465 . . . . 2.6400000000000001 111.816 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.5 p -165.54 143.43 5.91 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.687 -0.688 . . . . 1.1299999999999999 110.633 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.469 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 40.6 ptt180 -151.08 135.05 16.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.952 0.406 . . . . 1.8799999999999999 111.346 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 23.3 p -82.91 43.29 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 1.79 111.648 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.513 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 3.0 m 50.91 -174.08 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.201 -0.454 . . . . 2.2999999999999998 110.869 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.513 ' H ' ' CG2' ' A' ' 403' ' ' THR . 93.3 mt-10 -65.38 -42.94 92.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.717 0.294 . . . . 3.8700000000000001 111.225 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -57.34 -51.31 69.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 3.1600000000000001 111.18 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.481 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 55.61 63.52 2.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.985 0.421 . . . . 2.1800000000000002 111.831 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -160.63 7.76 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.404 0.621 . . . . 2.77 110.039 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.461 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . 179.81 -48.96 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.779 -1.1 . . . . 3.2799999999999998 109.99 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 408' ' ' ALA . 31.4 Cg_exo -59.34 160.92 18.16 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.621 2.214 . . . . 2.8700000000000001 112.251 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.646 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.1 p30 178.43 141.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.128 -0.487 . . . . 2.1400000000000001 111.049 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.6 mt-10 -142.25 134.74 28.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.97 -0.559 . . . . 2.1000000000000001 110.285 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 0.6 OUTLIER -109.5 124.27 50.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 1.0600000000000001 111.469 -179.208 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 8.8 t80 -66.41 137.32 56.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 1.05 109.652 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.589 HG13 HG12 ' A' ' 427' ' ' VAL . 8.0 p -135.61 137.62 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.18 0.514 . . . . 1.8400000000000001 112.248 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . 0.483 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 73.0 t60 -118.46 108.81 15.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.852 . . . . 0.70999999999999996 109.585 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.451 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 97.9 m-85 -55.99 126.44 25.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.225 0.536 . . . . 1.1299999999999999 110.727 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.806 HG12 HD13 ' A' ' 382' ' ' ILE . 2.1 t -78.67 28.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.366 -0.834 . . . . 1.7 111.81 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 416' ' ' TYR . . . 173.1 -37.45 0.14 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.107 -1.045 . . . . 1.1699999999999999 113.773 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.451 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 7.0 mp -61.79 -166.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.371 0.605 . . . . 2.1499999999999999 112.432 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.712 ' HB3' ' HD2' ' A' ' 422' ' ' ARG . 5.0 m120 -63.65 146.73 53.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.244 -0.889 . . . . 2.7599999999999998 111.915 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -72.8 -42.24 64.12 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.165 -0.47 . . . . 4.6500000000000004 110.94 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . 0.712 ' HD2' ' HB3' ' A' ' 420' ' ' ASN . 0.1 OUTLIER -64.22 -24.77 67.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 4.3200000000000003 109.713 179.255 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 420' ' ' ASN . 1.2 tp -58.04 -33.1 68.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.351 -0.84 . . . . 2.04 111.048 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.483 ' OD1' ' HA ' ' A' ' 415' ' ' HIS . 65.8 m-20 -50.5 137.13 19.72 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.897 -0.592 . . . . 1.2 111.534 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -179.18 174.09 46.1 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.782 -0.645 . . . . 0.69999999999999996 112.086 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . 0.469 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 15.7 m95 -81.49 140.35 34.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.38 . . . . 0.76000000000000001 110.851 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.589 HG12 HG13 ' A' ' 414' ' ' VAL . 21.8 m -108.85 160.26 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.508 . . . . 1.4399999999999999 111.527 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -75.86 24.91 1.53 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.757 -0.735 . . . . 1.72 113.045 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.574 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 8.2 tpt180 71.93 -45.83 0.63 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.851 0.686 . . . . 2.3199999999999998 112.851 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -65.61 -14.98 62.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.71 0.291 . . . . 2.23 111.494 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.441 HH22 ' HG2' ' A' ' 388' ' ' GLU . 66.2 mtt-85 -79.38 -36.31 39.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.43 -0.35 . . . . 3.4199999999999999 111.852 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.652 HD12 HG21 ' A' ' 397' ' ' VAL . 75.2 mt -87.73 132.31 33.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.031 0.444 . . . . 1.1399999999999999 111.587 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 59.1 m -163.91 139.37 6.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.595 -0.73 . . . . 0.95999999999999996 110.377 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.27 -22.57 66.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.359 -0.382 . . . . 1.3500000000000001 111.029 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.68 130.17 55.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.763 0.316 . . . . 2.5299999999999998 110.8 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . 0.488 ' HB1' ' CD2' ' A' ' 384' ' ' PHE . . . -80.88 -40.51 24.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 1.3300000000000001 111.673 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -51.81 -40.79 61.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.391 -0.368 . . . . 1.3400000000000001 110.744 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -64.08 -38.1 89.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.102 0.477 . . . . 1.5600000000000001 109.894 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.62 HD11 HG12 ' A' ' 392' ' ' VAL . 76.8 mt -60.47 -83.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.56 -0.745 . . . . 1.76 110.725 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 139.28 52.19 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.99 -0.624 . . . . 1.3600000000000001 112.029 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -161.83 -70.75 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 119.565 -1.302 . . . . 1.8300000000000001 114.122 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . 0.493 ' H ' HG22 ' A' ' 392' ' ' VAL . 1.6 mp . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 109.126 -0.694 . . . . 1.9199999999999999 109.126 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.062 0.458 . . . . 1.9299999999999999 111.761 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.554 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 54.8 m-20 -89.71 77.2 7.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.957 -0.565 . . . . 2.1699999999999999 110.3 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 80.0 mt -42.51 -36.67 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.305 -0.407 . . . . 1.4399999999999999 111.964 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.8 t -69.17 68.86 0.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.46 . . . . 2.2000000000000002 111.486 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.0 pt-20 -173.55 -26.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.009 -0.541 . . . . 1.9199999999999999 110.062 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 0.1 OUTLIER -162.73 57.85 0.73 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.642 -0.708 . . . . 2.8900000000000001 111.931 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . 0.426 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 53.0 Cg_exo -54.21 -35.59 83.29 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.071 1.847 . . . . 0.97999999999999998 111.179 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -66.04 -33.38 75.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.446 -0.797 . . . . 1.21 110.936 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 63.7 tttp -46.75 131.6 11.57 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.216 -0.447 . . . . 2.27 111.379 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.49 HD11 ' HG2' ' A' ' 396' ' ' GLN . 41.5 mm -85.92 126.13 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 1.1299999999999999 111.273 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -103.7 144.26 31.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.467 -0.333 . . . . 1.1000000000000001 110.3 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 2.0 m-85 -85.54 132.51 34.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 1.3200000000000001 111.688 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.58 HD12 HG22 ' A' ' 414' ' ' VAL . 2.0 mp -114.05 118.48 58.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.083 -0.508 . . . . 1.2 110.202 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.494 ' HD3' ' O ' ' A' ' 387' ' ' ARG . 0.0 OUTLIER -85.85 114.76 23.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.287 -0.415 . . . . 3.1699999999999999 110.969 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.494 ' O ' ' HD3' ' A' ' 386' ' ' ARG . 25.3 mmm180 -67.02 153.59 43.29 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.442 -0.344 . . . . 2.9900000000000002 110.146 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -53.17 -39.13 63.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.228 -0.442 . . . . 2.8199999999999998 110.706 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -64.66 -35.52 81.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 1.23 110.856 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 135.27 -35.56 2.16 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.584 -0.817 . . . . 1.03 113.043 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 80.8 p -58.85 112.54 1.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.043 0.449 . . . . 1.46 112.004 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 56.5 t -74.53 143.15 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.925 -0.58 . . . . 1.24 110.721 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -147.52 133.42 19.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 3.2400000000000002 111.113 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -56.21 155.57 6.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.903 -0.589 . . . . 3.5600000000000001 111.921 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -172.04 130.67 1.98 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.532 -0.758 . . . . 0.32000000000000001 112.088 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . 0.49 ' HG2' HD11 ' A' ' 382' ' ' ILE . 86.9 mt-30 -81.74 110.62 17.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.938 0.347 . . . . 1.28 111.938 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 1.0 OUTLIER -82.02 132.28 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 1.5800000000000001 109.897 178.393 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 45.1 mt -120.95 -32.51 3.95 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.35 0.5 . . . . 2.04 112.35 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -140.27 176.31 8.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 2.6400000000000001 111.919 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.3 p -165.07 149.93 9.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.739 -0.664 . . . . 1.1299999999999999 110.723 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 38.2 ptt180 -154.55 138.42 16.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.863 0.364 . . . . 1.8799999999999999 111.089 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 77.5 p -70.01 -132.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.437 -0.347 . . . . 1.79 110.988 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.539 ' HG1' ' HB2' ' A' ' 409' ' ' PRO . 1.3 m -162.43 -172.76 3.29 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.023 -0.362 . . . . 2.2999999999999998 110.023 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.437 ' H ' ' CG2' ' A' ' 403' ' ' THR . 48.4 mt-10 -41.65 -45.77 3.5 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.668 0.271 . . . . 3.8700000000000001 111.47 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -67.31 -50.58 59.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.806 0.336 . . . . 3.1600000000000001 110.633 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.458 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.17 56.32 7.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.965 -0.561 . . . . 2.1800000000000002 111.591 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -151.98 9.36 0.51 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.156 0.503 . . . . 2.77 110.421 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.517 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.69 -49.0 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.262 -0.881 . . . . 3.2799999999999998 110.625 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.539 ' HB2' ' HG1' ' A' ' 403' ' ' THR . 32.0 Cg_exo -58.29 147.26 85.58 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.321 2.014 . . . . 2.8700000000000001 112.179 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.9 p30 -177.95 131.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 2.1400000000000001 111.438 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 400' ' ' SER . 50.2 mt-10 -115.25 136.83 52.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.693 -0.685 . . . . 2.1000000000000001 109.707 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.445 ' N ' ' CD1' ' A' ' 412' ' ' TYR . 0.6 OUTLIER -109.74 130.08 55.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.909 0.385 . . . . 1.0600000000000001 111.903 -178.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 31.3 t80 -60.56 146.64 44.38 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.627 -0.879 . . . . 1.05 108.627 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.58 HG22 HD12 ' A' ' 385' ' ' ILE . 7.2 p -151.13 133.65 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 119.662 -0.815 . . . . 1.8400000000000001 113.181 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -116.2 107.76 15.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.996 -1.002 . . . . 0.70999999999999996 109.439 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.451 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 63.0 m-85 -61.43 125.37 23.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.028 0.442 . . . . 1.1299999999999999 111.279 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.62 32.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.685 -0.688 . . . . 1.7 111.239 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -175.63 -44.2 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.436 -0.888 . . . . 1.1699999999999999 112.89 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.451 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 7.2 mp -64.88 -166.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.199 0.523 . . . . 2.1499999999999999 111.701 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 4.4 m120 -74.1 145.09 44.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.446 -0.797 . . . . 2.7599999999999998 111.796 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 62.2 mtm-85 -65.33 -38.58 90.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.959 -0.564 . . . . 4.6500000000000004 110.71 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . 0.52 ' HG3' HD11 ' A' ' 423' ' ' LEU . 14.0 ptm180 -55.39 -36.13 66.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.057 0.456 . . . . 4.3200000000000003 110.967 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.52 HD11 ' HG3' ' A' ' 422' ' ' ARG . 4.5 mp -52.75 -25.87 12.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.468 -0.787 . . . . 2.04 111.787 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.16 135.44 21.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.989 0.423 . . . . 1.2 111.299 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 413' ' ' TYR . . . 177.24 -140.29 4.79 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.953 -0.641 . . . . 0.69999999999999996 112.302 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 42.7 m95 -122.27 138.19 54.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.793 0.33 . . . . 0.76000000000000001 110.709 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.463 ' CG2' HD13 ' A' ' 432' ' ' ILE . 30.8 m -134.05 142.64 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.4399999999999999 111.765 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.408 ' HA2' ' NH1' ' A' ' 431' ' ' ARG . . . -63.47 144.92 49.65 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.831 -0.7 . . . . 1.72 111.994 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -55.58 -28.4 54.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.036 0.446 . . . . 2.3199999999999998 111.49 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.604 ' H ' ' CD2' ' A' ' 430' ' ' HIS . 0.9 OUTLIER -56.58 -31.27 64.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.811 0.815 . . . . 2.23 109.572 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.461 ' O ' HD23 ' A' ' 439' ' ' LEU . 33.0 mtt85 -83.14 -36.23 24.93 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.117 -1.401 . . . . 3.4199999999999999 111.418 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.541 HG12 HG13 ' A' ' 385' ' ' ILE . 65.9 mt -88.83 135.31 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.021 0.439 . . . . 1.1399999999999999 111.766 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 435' ' ' ASN . 55.8 m -161.76 140.12 9.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.843 -0.617 . . . . 0.95999999999999996 110.619 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -72.67 16.19 0.16 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.243 -0.435 . . . . 1.3500000000000001 111.612 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 433' ' ' SER . 75.0 m-80 -146.53 131.92 18.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.938 0.399 . . . . 2.5299999999999998 110.97 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -68.17 -42.32 80.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.983 -0.553 . . . . 1.3300000000000001 111.441 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -54.66 -40.74 69.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.282 -0.417 . . . . 1.3400000000000001 111.038 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.59 42.91 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 1.5600000000000001 110.848 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 431' ' ' ARG . 97.5 mt -151.82 -83.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 1.76 111.104 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -166.39 44.31 0.27 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.994 -0.622 . . . . 1.3600000000000001 112.141 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.13 -136.03 45.77 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 1.8300000000000001 112.298 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.586 0.232 . . . . 1.9199999999999999 110.648 179.608 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.816 0.341 . . . . 1.9299999999999999 111.046 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -88.14 110.61 20.81 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.155 -0.475 . . . . 2.1699999999999999 110.556 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 397' ' ' VAL . 93.0 mt -66.82 -43.44 89.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.866 -0.606 . . . . 1.4399999999999999 111.972 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 75.9 p -69.84 64.84 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.101 0.477 . . . . 2.2000000000000002 110.842 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -149.46 -27.99 0.27 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.9199999999999999 109.685 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.443 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -172.28 60.72 0.29 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.282 -0.872 . . . . 2.8900000000000001 111.239 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -51.32 -37.3 60.04 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.311 2.008 . . . . 0.97999999999999998 111.676 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -62.96 -34.22 77.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.762 -0.654 . . . . 1.21 110.866 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -53.86 124.68 16.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 2.27 111.199 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.693 HD13 HG12 ' A' ' 417' ' ' VAL . 16.2 mm -79.88 124.4 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.074 -0.512 . . . . 1.1299999999999999 111.755 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.508 ' HB2' ' O ' ' A' ' 395' ' ' GLY . 4.2 m-85 -104.07 144.21 31.86 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.235 -0.283 . . . . 1.1000000000000001 110.235 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -94.65 135.91 35.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.012 0.434 . . . . 1.3200000000000001 110.867 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.596 HD13 ' N ' ' A' ' 385' ' ' ILE . 2.8 mp -119.24 126.07 75.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 1.2 110.063 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.772 ' HE ' ' HA2' ' A' ' 440' ' ' GLY . 55.7 ttt-85 -89.19 121.65 31.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 3.1699999999999999 111.048 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.479 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 59.8 mtp85 -79.63 168.3 19.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 2.9900000000000002 110.602 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -56.1 -42.87 77.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 2.8199999999999998 111.233 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.435 ' CG ' HG22 ' A' ' 391' ' ' THR . 48.2 p-10 -72.3 5.7 2.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 1.23 111.954 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.603 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . 73.07 48.81 18.65 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.52 -0.848 . . . . 1.03 113.077 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' THR . . . . . 0.479 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 81.9 p -120.69 110.54 16.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.687 0.279 . . . . 1.46 111.561 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 441' ' ' GLY . 58.6 t -70.52 127.56 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.082 -0.34 . . . . 1.24 110.082 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -145.02 135.99 24.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.112 0.482 . . . . 3.2400000000000002 111.482 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.499 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 59.6 mtt85 -55.56 155.29 5.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.802 -0.635 . . . . 3.5600000000000001 112.057 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 383' ' ' TYR . . . 178.02 126.64 1.0 Allowed Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.396 -0.82 . . . . 0.32000000000000001 111.371 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 85.4 mt-30 -91.74 129.22 37.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.972 0.386 . . . . 1.28 111.739 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.639 HG23 HD12 ' A' ' 432' ' ' ILE . 4.2 t -82.95 126.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.134 -0.691 . . . . 1.5800000000000001 109.134 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 66.8 mt -120.71 -46.85 2.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.251 0.463 . . . . 2.04 112.251 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . 0.516 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 12.0 mm-40 -123.73 176.51 6.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.107 0.48 . . . . 2.6400000000000001 111.6 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 97.0 p -163.57 146.06 9.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.634 -0.712 . . . . 1.1299999999999999 110.109 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -162.57 139.03 7.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.879 0.371 . . . . 1.8799999999999999 111.332 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.715 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 72.2 p -70.59 -125.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 1.79 110.033 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.424 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.76 -173.41 2.97 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.662 -0.495 . . . . 2.2999999999999998 109.662 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.424 ' H ' ' CG2' ' A' ' 403' ' ' THR . 64.2 mm-40 -44.86 -40.39 6.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.802 0.334 . . . . 3.8700000000000001 110.856 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.612 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 0.7 OUTLIER -68.13 -53.66 23.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.193 -0.458 . . . . 3.1600000000000001 110.563 179.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.408 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 51.29 51.69 16.38 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.192 0.52 . . . . 2.1800000000000002 111.358 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.453 ' HB3' ' ND2' ' A' ' 405' ' ' ASN . . . -152.83 10.73 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.484 -0.78 . . . . 2.77 109.46 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.453 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . -177.82 -48.25 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 114.465 -1.243 . . . . 3.2799999999999998 110.034 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.612 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 36.1 Cg_exo -60.89 149.24 89.47 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.524 2.15 . . . . 2.8700000000000001 112.383 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.715 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 12.1 p-10 -174.07 137.51 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 2.1400000000000001 110.348 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.9 mt-10 -134.83 134.68 41.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 2.1000000000000001 110.902 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 1.2 m-85 -109.76 125.66 52.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.058 0.456 . . . . 1.0600000000000001 111.175 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 14.3 t80 -62.22 144.0 56.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.71 -0.677 . . . . 1.05 110.189 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.508 HG23 HG12 ' A' ' 427' ' ' VAL . 0.0 OUTLIER -144.56 129.66 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.624 0.602 . . . . 1.8400000000000001 112.624 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . 0.415 ' O ' ' HA3' ' A' ' 395' ' ' GLY . 38.4 t60 -103.38 97.15 7.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.153 -0.93 . . . . 0.70999999999999996 109.169 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 36.7 m-85 -53.2 106.41 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.391 0.615 . . . . 1.1299999999999999 111.22 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.693 HG12 HD13 ' A' ' 382' ' ' ILE . 58.3 t -67.16 130.01 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.905 -1.043 . . . . 1.7 111.143 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 81.4 -45.55 3.26 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.747 -0.661 . . . . 1.1699999999999999 112.608 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 6.9 mp -65.6 166.57 10.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.997 0.427 . . . . 2.1499999999999999 111.427 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -53.86 143.37 21.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.831 -0.622 . . . . 2.7599999999999998 111.544 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 53.9 mtt85 -61.75 -38.52 88.27 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.854 -0.612 . . . . 4.6500000000000004 111.286 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -56.25 -32.58 64.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 4.3200000000000003 111.439 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . . . . . . . . . 1.9 mp -58.21 -27.95 64.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.226 -0.443 . . . . 2.04 111.822 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -48.39 139.77 8.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 1.2 111.325 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -171.66 -147.83 5.86 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.76 -0.734 . . . . 0.69999999999999996 112.466 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -128.65 138.37 52.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.021 0.439 . . . . 0.76000000000000001 111.18 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.508 HG12 HG23 ' A' ' 414' ' ' VAL . 23.0 m -115.04 155.57 16.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.692 -0.686 . . . . 1.4399999999999999 111.494 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -78.04 30.94 1.8 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.913 -0.66 . . . . 1.72 114.075 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.551 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 9.7 tpt180 72.09 -45.63 0.62 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.688 0.625 . . . . 2.3199999999999998 112.688 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -62.41 -21.53 65.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.706 0.289 . . . . 2.23 111.592 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.446 ' HD2' ' HB ' ' A' ' 427' ' ' VAL . 90.7 mtt180 -79.11 -26.95 42.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.188 0.44 . . . . 3.4199999999999999 112.188 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.639 HD12 HG23 ' A' ' 397' ' ' VAL . 71.4 mt -88.11 136.8 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.965 0.412 . . . . 1.1399999999999999 111.243 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.439 ' N ' HG21 ' A' ' 432' ' ' ILE . 56.4 m -159.69 138.69 10.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.95999999999999996 110.612 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.29 -26.51 62.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 1.3500000000000001 111.138 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -112.85 130.62 56.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 2.5299999999999998 110.729 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . 0.621 ' HB2' HD13 ' A' ' 442' ' ' ILE . . . -66.91 -32.52 73.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 1.3300000000000001 111.176 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -51.54 -40.88 60.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.232 -0.44 . . . . 1.3400000000000001 110.783 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.85 -38.46 83.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.171 0.51 . . . . 1.5600000000000001 110.118 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.547 ' C ' ' HD2' ' A' ' 386' ' ' ARG . 69.3 mt -61.89 -93.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.525 -0.761 . . . . 1.76 111.238 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . 0.772 ' HA2' ' HE ' ' A' ' 386' ' ' ARG . . . -166.29 39.87 0.26 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.116 -0.564 . . . . 1.3600000000000001 111.931 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 392' ' ' VAL . . . 67.62 131.19 0.03 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.018 -0.61 . . . . 1.8300000000000001 112.162 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . 0.621 HD13 ' HB2' ' A' ' 436' ' ' ALA . 5.3 mp . . . . . 0 C--N 1.332 -0.167 0 CA-C-O 120.67 0.271 . . . . 1.9199999999999999 110.322 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 373' ' ' ILE . 68.1 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.772 0.32 . . . . 1.9299999999999999 110.711 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -88.92 129.45 35.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 2.1699999999999999 111.228 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 78.7 mt -84.27 -45.18 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 1.4399999999999999 111.16 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 48.0 t -64.11 78.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 2.2000000000000002 110.859 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . 0.532 ' HG3' ' ND2' ' A' ' 378' ' ' ASN . 12.1 pt-20 -173.71 -28.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.528 -0.76 . . . . 1.9199999999999999 110.074 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.622 HD22 ' HH ' ' A' ' 383' ' ' TYR . 0.1 OUTLIER -173.07 61.54 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.536 -0.757 . . . . 2.8900000000000001 111.509 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.99 -38.67 86.7 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.318 2.012 . . . . 0.97999999999999998 111.877 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.506 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 28.3 m-20 -65.34 -33.51 76.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.996 -0.547 . . . . 1.21 111.073 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 85.2 tttt -48.02 126.58 10.96 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.942 0.401 . . . . 2.27 111.076 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.9 HD13 HG12 ' A' ' 417' ' ' VAL . 36.5 mm -71.79 120.71 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.89 -0.596 . . . . 1.1299999999999999 111.724 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.622 ' HH ' HD22 ' A' ' 378' ' ' ASN . 5.2 m-85 -99.57 144.4 28.7 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.587 -0.523 . . . . 1.1000000000000001 109.587 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 45.1 m-85 -88.88 133.08 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.895 -0.322 . . . . 1.3200000000000001 110.795 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.601 HG22 HG13 ' A' ' 427' ' ' VAL . 2.1 mp -116.33 144.67 23.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.819 0.342 . . . . 1.2 111.539 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.643 ' NH1' ' HA2' ' A' ' 440' ' ' GLY . 39.1 ttt85 -124.48 104.25 8.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 3.1699999999999999 110.525 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.478 ' HG3' ' CE1' ' A' ' 393' ' ' HIS . 10.0 mtp-105 -65.04 161.6 18.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.831 0.348 . . . . 2.9900000000000002 110.944 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.573 ' HG3' HH21 ' A' ' 431' ' ' ARG . 50.5 mp0 -48.76 -45.05 39.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.054 0.761 . . . . 2.8199999999999998 113.054 -177.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' A' ' 391' ' ' THR . 8.0 p-10 -60.16 -35.26 74.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.595 0.236 . . . . 1.23 111.59 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 118.45 44.3 0.52 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.605 -0.807 . . . . 1.03 112.413 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' THR . . . . . 0.447 HG22 ' OD2' ' A' ' 389' ' ' ASP . 21.5 p -116.64 112.49 21.34 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.789 0.292 . . . . 1.46 111.789 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 86.4 t -79.56 134.23 28.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.604 -0.517 . . . . 1.24 109.604 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . 0.497 ' HE1' HG23 ' A' ' 385' ' ' ILE . 0.6 OUTLIER -156.47 133.98 10.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.939 0.4 . . . . 3.2400000000000002 111.03 -178.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.498 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 99.6 mtt180 -60.07 145.18 47.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.931 -0.577 . . . . 3.5600000000000001 111.75 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -174.21 128.85 1.52 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.532 -0.758 . . . . 0.32000000000000001 111.976 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . 0.506 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 68.6 mt-30 -78.31 129.68 35.31 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.689 -0.3 . . . . 1.28 111.597 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.561 HG22 HD11 ' A' ' 432' ' ' ILE . 0.5 OUTLIER -88.28 132.08 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.547 -0.538 . . . . 1.5800000000000001 109.547 177.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . 0.623 HD11 ' N ' ' A' ' 398' ' ' LEU . 4.9 mp -106.14 -49.44 3.37 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.791 0.663 . . . . 2.04 112.791 -177.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' A' ' 412' ' ' TYR . 98.1 mm-40 -142.94 178.02 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.004 0.431 . . . . 2.6400000000000001 111.869 -178.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.7 p -148.83 149.39 31.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.683 -0.69 . . . . 1.1299999999999999 109.987 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -158.49 139.08 12.69 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.169 0.509 . . . . 1.8799999999999999 112.356 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.572 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 50.6 p -87.6 139.1 30.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.671 -0.695 . . . . 1.79 109.557 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.5 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.9 m -60.53 -174.57 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.58 0.229 . . . . 2.2999999999999998 110.579 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.5 ' H ' ' CG2' ' A' ' 403' ' ' THR . 59.1 mm-40 -50.73 -41.74 56.6 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.798 0.295 . . . . 3.8700000000000001 111.798 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.51 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 50.8 t30 -59.19 -49.57 77.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.569 -0.287 . . . . 3.1600000000000001 111.076 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.572 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 52.71 48.25 22.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.154 0.502 . . . . 2.1800000000000002 111.483 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.447 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -145.75 10.79 1.22 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.603 -0.726 . . . . 2.77 109.478 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.48 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . 179.78 -47.81 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.472 -1.24 . . . . 3.2799999999999998 110.0 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.51 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 36.3 Cg_exo -57.9 143.46 95.86 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.561 2.174 . . . . 2.8700000000000001 112.513 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -170.48 136.31 1.29 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.69 -0.687 . . . . 2.1400000000000001 110.326 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 400' ' ' SER . 64.8 mm-40 -140.89 135.12 30.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.193 -0.458 . . . . 2.1000000000000001 110.886 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.535 ' HB3' HG23 ' A' ' 397' ' ' VAL . 1.2 m-85 -109.21 119.19 38.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.145 -0.48 . . . . 1.0600000000000001 111.213 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.404 ' HD2' ' HB2' ' A' ' 398' ' ' LEU . 10.5 t80 -57.41 145.99 30.84 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.278 -0.638 . . . . 1.05 109.278 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 14.4 p -154.82 129.52 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.201 0.815 . . . . 1.8400000000000001 113.201 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -101.85 113.09 25.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.344 -0.844 . . . . 0.70999999999999996 109.084 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.479 ' HE2' ' ND1' ' A' ' 393' ' ' HIS . 65.1 m-85 -61.42 132.69 54.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.356 0.598 . . . . 1.1299999999999999 111.125 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.9 HG12 HD13 ' A' ' 382' ' ' ILE . 1.3 t -78.82 27.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.212 -0.904 . . . . 1.7 111.406 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 416' ' ' TYR . . . 172.74 -43.04 0.17 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.407 -0.901 . . . . 1.1699999999999999 113.289 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.56 HD22 HD21 ' A' ' 423' ' ' LEU . 7.3 mp -59.75 151.88 24.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 2.1499999999999999 111.604 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -50.36 147.13 4.6 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.494 -0.776 . . . . 2.7599999999999998 112.203 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . 0.423 ' HA ' ' CG ' ' A' ' 424' ' ' ASP . 87.1 mtm180 -59.24 -28.88 67.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.706 -0.679 . . . . 4.6500000000000004 110.927 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -53.61 -41.2 66.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.285 0.564 . . . . 4.3200000000000003 110.059 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.561 HD11 ' N ' ' A' ' 423' ' ' LEU . 6.4 mp -71.56 -33.12 68.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.142 -0.935 . . . . 2.04 110.999 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.423 ' CG ' ' HA ' ' A' ' 421' ' ' ARG . 10.6 m-20 -53.11 131.44 36.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 1.2 110.783 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 176.43 -142.03 5.77 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.702 -0.761 . . . . 0.69999999999999996 112.51 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -105.19 135.83 45.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.76000000000000001 110.933 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.601 HG13 HG22 ' A' ' 385' ' ' ILE . 3.4 m -128.81 134.56 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.534 . . . . 1.4399999999999999 111.634 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.42 ' HA2' ' CE1' ' A' ' 430' ' ' HIS . . . -57.7 150.06 31.98 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.722 -0.752 . . . . 1.72 111.99 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -47.92 -39.77 19.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.615 0.245 . . . . 2.3199999999999998 111.331 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.497 ' HD1' ' H ' ' A' ' 430' ' ' HIS . 9.1 p-80 -61.77 -32.26 72.51 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.866 0.321 . . . . 2.23 111.866 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.573 HH21 ' HG3' ' A' ' 388' ' ' GLU . 57.0 mtt85 -82.21 26.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.108 -0.237 . . . . 3.4199999999999999 111.191 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.561 HD11 HG22 ' A' ' 397' ' ' VAL . 66.0 mt -149.58 135.63 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 1.1399999999999999 110.868 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.625 ' HG ' HD22 ' A' ' 439' ' ' LEU . 70.5 m -166.25 139.23 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 0.95999999999999996 110.866 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.65 16.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 1.3500000000000001 110.507 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 433' ' ' SER . 74.9 m-20 -138.79 128.26 24.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.902 -0.59 . . . . 2.5299999999999998 110.328 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . 0.521 ' HB2' HD13 ' A' ' 442' ' ' ILE . . . -65.17 -43.1 92.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 1.3300000000000001 111.754 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -56.24 -40.36 74.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 1.3400000000000001 111.333 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.77 42.44 0.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 1.5600000000000001 111.601 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.625 HD22 ' HG ' ' A' ' 433' ' ' SER . 85.9 mt -150.2 -88.41 0.07 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.72 -0.218 . . . . 1.76 111.438 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . 0.643 ' HA2' ' NH1' ' A' ' 386' ' ' ARG . . . -171.45 38.12 0.17 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.542 -0.837 . . . . 1.3600000000000001 112.859 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.83 141.02 0.04 OUTLIER Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.736 -0.745 . . . . 1.8300000000000001 112.869 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . 0.521 HD13 ' HB2' ' A' ' 436' ' ' ALA . 42.3 mm . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.985 0.421 . . . . 1.9199999999999999 110.689 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.455 HG13 ' HE ' ' A' ' 429' ' ' ARG . 70.6 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.752 0.311 . . . . 1.9299999999999999 111.337 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.677 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 23.6 m-20 -88.87 111.58 22.24 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 116.09 -0.505 . . . . 2.1699999999999999 110.902 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.405 ' O ' HG21 ' A' ' 375' ' ' ILE . 86.4 mt -73.17 -39.68 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.709 0.29 . . . . 1.4399999999999999 111.781 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 40.1 t -46.72 -28.74 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.011 -0.54 . . . . 2.2000000000000002 112.422 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . 0.677 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 15.5 pt-20 -69.43 -38.47 77.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.508 -0.315 . . . . 1.9199999999999999 111.772 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.663 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 5.5 m120 -153.06 69.16 6.85 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 112.322 0.49 . . . . 2.8900000000000001 112.322 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.38 -40.68 77.37 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.684 2.256 . . . . 0.97999999999999998 112.577 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -70.3 -34.09 72.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.536 . . . . 1.21 111.774 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.663 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 63.0 tttp -46.38 136.36 7.36 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.983 0.421 . . . . 2.27 111.021 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.483 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 46.4 mm -84.86 130.47 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.782 -0.644 . . . . 1.1299999999999999 111.834 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -118.93 143.6 46.92 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.496 -0.557 . . . . 1.1000000000000001 109.496 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.51 ' CE1' ' HG2' ' A' ' 394' ' ' ARG . 1.3 m-85 -84.83 143.74 28.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.783 0.325 . . . . 1.3200000000000001 111.351 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 431' ' ' ARG . 2.8 mp -119.85 133.83 65.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 116.228 -0.442 . . . . 1.2 111.492 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.554 ' NH1' ' HA2' ' A' ' 440' ' ' GLY . 28.3 tpt180 -87.0 106.01 17.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 3.1699999999999999 110.418 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.647 ' HB2' ' HG1' ' A' ' 391' ' ' THR . 62.5 mtp85 -66.69 160.52 25.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 2.9900000000000002 111.067 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.7 -71.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.865 -0.607 . . . . 2.8199999999999998 111.048 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.408 ' OD1' HG22 ' A' ' 391' ' ' THR . 2.4 p30 -41.7 -28.9 0.16 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.052 0.453 . . . . 1.23 110.28 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 110.16 44.3 1.02 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.737 -0.665 . . . . 1.03 113.459 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' THR . . . . . 0.647 ' HG1' ' HB2' ' A' ' 387' ' ' ARG . 37.0 p -121.2 110.37 16.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.967 0.413 . . . . 1.46 111.062 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.665 HG12 HD11 ' A' ' 439' ' ' LEU . 90.2 t -71.6 133.13 32.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 1.24 111.352 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -151.93 138.46 18.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.111 -0.495 . . . . 3.2400000000000002 110.537 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.51 ' HG2' ' CE1' ' A' ' 384' ' ' PHE . 60.6 mtt85 -51.6 155.65 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.392 0.615 . . . . 3.5600000000000001 112.601 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -178.61 133.37 2.1 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.103 -0.953 . . . . 0.32000000000000001 111.84 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . 0.617 ' O ' HD23 ' A' ' 398' ' ' LEU . 55.1 mt-30 -80.95 130.68 35.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.771 0.285 . . . . 1.28 111.771 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.837 HG23 HD12 ' A' ' 432' ' ' ILE . 14.5 t -91.43 126.61 44.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.81 -0.811 . . . . 1.5800000000000001 108.81 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 396' ' ' GLN . 0.3 OUTLIER -108.83 -40.08 5.15 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.023 0.749 . . . . 2.04 113.023 -177.029 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -139.95 176.02 9.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.95 0.405 . . . . 2.6400000000000001 111.901 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.577 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.2 p -163.56 150.96 12.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.829 -0.623 . . . . 1.1299999999999999 110.611 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 39.9 ptt180 -153.14 134.33 14.15 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.492 -0.322 . . . . 1.8799999999999999 111.163 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 47.7 p -71.93 135.71 46.6 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.96 0.41 . . . . 1.79 110.69 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.473 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.1 m -62.51 -174.1 0.06 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.837 -0.62 . . . . 2.2999999999999998 110.372 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.473 ' H ' ' CG2' ' A' ' 403' ' ' THR . 60.3 mm-40 -44.94 -37.04 3.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.86 0.319 . . . . 3.8700000000000001 111.86 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.514 HD21 ' HD2' ' A' ' 409' ' ' PRO . 45.4 t30 -57.52 -49.76 75.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.747 0.308 . . . . 3.1600000000000001 110.873 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.599 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.78 66.03 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.183 -0.462 . . . . 2.1800000000000002 111.603 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -162.65 -23.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 2.77 110.518 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.642 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -159.99 -52.33 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.683 -0.69 . . . . 3.2799999999999998 110.7 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.668 ' O ' ' HA ' ' A' ' 402' ' ' THR . 52.1 Cg_exo -54.96 149.2 43.66 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.196 1.93 . . . . 2.8700000000000001 111.341 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 34.4 p-10 -179.08 143.71 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.091 0.472 . . . . 2.1400000000000001 111.58 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 400' ' ' SER . 0.5 OUTLIER -106.82 135.25 48.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.756 -0.656 . . . . 2.1000000000000001 109.859 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.593 ' HB3' ' CG1' ' A' ' 397' ' ' VAL . 0.4 OUTLIER -109.75 128.11 55.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.345 -0.389 . . . . 1.0600000000000001 111.958 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 9.4 t80 -64.54 141.56 58.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 1.05 109.833 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.51 132.99 60.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.153 0.797 . . . . 1.8400000000000001 113.153 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -116.13 89.9 3.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.036 -0.984 . . . . 0.70999999999999996 109.304 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.419 ' H ' ' HD1' ' A' ' 416' ' ' TYR . 6.2 m-85 -55.89 127.2 29.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.953 0.406 . . . . 1.1299999999999999 111.161 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.46 HG22 HD13 ' A' ' 382' ' ' ILE . 61.9 t -70.38 127.23 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.01 -0.541 . . . . 1.7 111.375 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.53 -41.93 1.69 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.966 -0.635 . . . . 1.1699999999999999 113.182 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.43 156.92 12.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.947 0.403 . . . . 2.1499999999999999 111.375 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.593 ' OD1' HD11 ' A' ' 423' ' ' LEU . 22.5 p30 -49.58 143.38 7.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.786 -0.643 . . . . 2.7599999999999998 111.65 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 421' ' ' ARG . 57.0 mtt85 -62.77 -36.16 82.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.636 -0.711 . . . . 4.6500000000000004 111.898 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -54.09 -30.04 46.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.341 . . . . 4.3200000000000003 111.029 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.593 HD11 ' OD1' ' A' ' 420' ' ' ASN . 1.1 tp -59.41 -31.69 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 2.04 111.365 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.449 ' HB3' ' HH ' ' A' ' 413' ' ' TYR . 1.1 m-20 -46.5 134.83 8.95 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.946 0.403 . . . . 1.2 111.155 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.88 155.08 12.27 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.827 -0.701 . . . . 0.69999999999999996 112.268 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 12.2 m95 -71.05 137.64 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.679 0.276 . . . . 0.76000000000000001 110.38 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.426 ' HB ' ' HD3' ' A' ' 431' ' ' ARG . 11.4 m -138.0 141.23 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.438 -0.346 . . . . 1.4399999999999999 110.843 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -50.01 150.7 4.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.668 -0.777 . . . . 1.72 112.442 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.455 ' HE ' HG13 ' A' ' 373' ' ' ILE . 32.6 tpt85 -48.7 -42.03 33.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.479 0.18 . . . . 2.3199999999999998 111.477 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -55.43 -31.71 62.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.541 -0.3 . . . . 2.23 111.469 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 73.5 mtp180 -81.61 20.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.611 -0.268 . . . . 3.4199999999999999 111.228 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.837 HD12 HG23 ' A' ' 397' ' ' VAL . 83.5 mt -150.33 126.04 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.826 0.346 . . . . 1.1399999999999999 110.914 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 435' ' ' ASN . 65.5 m -165.67 143.4 5.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.863 -0.608 . . . . 0.95999999999999996 110.65 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . 0.484 ' OD1' ' HE3' ' A' ' 381' ' ' LYS . 27.5 m-20 -70.62 16.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 1.3500000000000001 111.293 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.511 ' H ' ' C ' ' A' ' 433' ' ' SER . 16.1 p-10 -158.9 128.14 5.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.926 0.393 . . . . 2.5299999999999998 110.585 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . 0.6 ' HB2' HD12 ' A' ' 442' ' ' ILE . . . -68.09 -25.08 65.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.97 -0.559 . . . . 1.3300000000000001 111.896 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.34 -41.19 18.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.405 -0.361 . . . . 1.3400000000000001 111.631 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -82.63 -41.68 19.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.927 0.394 . . . . 1.5600000000000001 110.948 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.665 HD11 HG12 ' A' ' 392' ' ' VAL . 49.0 mt -54.63 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 1.76 111.565 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . 0.554 ' HA2' ' NH1' ' A' ' 386' ' ' ARG . . . -157.29 38.66 0.55 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.851 -0.69 . . . . 1.3600000000000001 112.186 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.12 146.0 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.686 -0.768 . . . . 1.8300000000000001 112.199 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 436' ' ' ALA . 48.8 mm . . . . . 0 C--N 1.331 -0.22 0 N-CA-C 109.975 -0.38 . . . . 1.9199999999999999 109.975 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.461 HG21 ' N ' ' A' ' 374' ' ' ASP . 69.3 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.798 0.333 . . . . 1.9299999999999999 111.057 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.461 ' N ' HG21 ' A' ' 373' ' ' ILE . 30.4 m-20 -88.22 110.47 20.74 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.23 -0.441 . . . . 2.1699999999999999 110.854 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.431 HD12 ' C ' ' A' ' 398' ' ' LEU . 82.0 mt -76.48 -34.75 25.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 1.4399999999999999 111.623 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 80.4 p -70.17 64.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 2.2000000000000002 111.643 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -174.66 -27.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.904 -0.589 . . . . 1.9199999999999999 110.073 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.596 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 2.7 m120 -149.49 60.26 4.45 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.77 . . . . 2.8900000000000001 112.413 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 73.3 Cg_exo -55.69 -40.92 82.46 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.713 2.276 . . . . 0.97999999999999998 112.341 179.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -69.4 -30.05 67.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 1.21 111.94 -179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 88.1 tttt -44.92 130.03 7.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.001 0.429 . . . . 2.27 111.005 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 38.4 mm -91.99 135.01 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 1.1299999999999999 111.5 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 383' ' ' TYR . 1.6 m-85 -119.95 143.13 48.17 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.961 -0.385 . . . . 1.1000000000000001 109.961 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -92.65 136.18 33.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.777 -0.369 . . . . 1.3200000000000001 110.597 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 431' ' ' ARG . 3.1 mp -125.61 128.37 72.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.868 0.366 . . . . 1.2 110.935 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.633 ' N ' HD21 ' A' ' 439' ' ' LEU . 78.8 ttt180 -81.8 120.65 25.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.994 -0.548 . . . . 3.1699999999999999 110.801 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.452 ' HE ' ' HG1' ' A' ' 391' ' ' THR . 59.0 mtm180 -74.63 166.59 23.31 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.759 -0.377 . . . . 2.9900000000000002 110.623 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 388' ' ' GLU . 9.0 mp0 -49.66 -44.67 47.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.29 -0.414 . . . . 2.8199999999999998 111.398 -179.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -65.72 -35.11 79.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.429 -0.351 . . . . 1.23 111.353 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.473 ' HA3' ' HE ' ' A' ' 386' ' ' ARG . . . 130.2 -29.21 3.72 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.76 -0.734 . . . . 1.03 112.293 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 391' ' ' THR . . . . . 0.452 ' HG1' ' HE ' ' A' ' 387' ' ' ARG . 51.3 p -59.48 113.63 2.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.241 0.544 . . . . 1.46 111.843 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.461 HG12 HD23 ' A' ' 439' ' ' LEU . 49.1 t -72.62 143.09 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.399 -0.818 . . . . 1.24 111.49 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -146.56 145.09 30.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.707 -0.679 . . . . 3.2400000000000002 109.35 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.531 ' HB2' ' CG1' ' A' ' 417' ' ' VAL . 55.0 mtt85 -74.07 145.93 44.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.482 0.658 . . . . 3.5600000000000001 111.604 -178.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 416' ' ' TYR . . . -146.42 125.05 2.14 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 114.891 -1.05 . . . . 0.32000000000000001 110.996 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -81.84 84.07 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.783 0.325 . . . . 1.28 111.132 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.692 HG22 HG21 ' A' ' 414' ' ' VAL . 0.6 OUTLIER -59.0 132.31 23.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.144 -0.48 . . . . 1.5800000000000001 110.457 179.9 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 375' ' ' ILE . 59.4 mt -120.64 -38.8 2.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.157 -0.474 . . . . 2.04 112.128 -178.401 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -119.8 170.51 9.16 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.177 0.513 . . . . 2.6400000000000001 112.076 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.1 p -165.69 151.22 9.05 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.437 -0.801 . . . . 1.1299999999999999 109.9 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -162.3 137.43 7.07 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.388 0.514 . . . . 1.8799999999999999 112.388 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 35.9 p -86.34 135.61 33.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.86 -0.609 . . . . 1.79 109.429 177.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.496 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.3 m -60.29 -174.7 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.67 0.272 . . . . 2.2999999999999998 110.917 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.496 ' H ' ' CG2' ' A' ' 403' ' ' THR . 4.8 mm-40 -50.66 -42.61 56.75 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.992 0.367 . . . . 3.8700000000000001 111.992 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.551 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 50.8 t30 -56.65 -48.87 76.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.719 0.295 . . . . 3.1600000000000001 110.837 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.509 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 53.19 52.16 14.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 2.1800000000000002 111.529 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.411 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -153.53 10.23 0.42 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.44 0.638 . . . . 2.77 109.642 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.471 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . 179.81 -48.32 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.688 -1.142 . . . . 3.2799999999999998 110.122 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.551 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 36.3 Cg_exo -60.57 141.64 95.81 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.677 2.252 . . . . 2.8700000000000001 112.745 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -173.16 127.73 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.652 -0.704 . . . . 2.1400000000000001 110.784 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 400' ' ' SER . 9.2 mp0 -120.42 134.59 55.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.782 -0.645 . . . . 2.1000000000000001 109.675 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.596 ' HB3' HG23 ' A' ' 397' ' ' VAL . 1.2 m-85 -110.03 123.45 49.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.806 0.336 . . . . 1.0600000000000001 111.649 -178.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.666 ' O ' HG21 ' A' ' 397' ' ' VAL . 19.7 t80 -63.86 119.3 9.74 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.317 -0.624 . . . . 1.05 109.317 178.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.692 HG21 HG22 ' A' ' 397' ' ' VAL . 22.6 t -112.36 135.77 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.461 0.912 . . . . 1.8400000000000001 113.461 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -111.14 89.38 3.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.996 -1.002 . . . . 0.70999999999999996 108.543 177.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.406 ' HA ' ' HA3' ' A' ' 395' ' ' GLY . 62.5 m-85 -52.18 103.16 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.281 0.563 . . . . 1.1299999999999999 110.904 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 394' ' ' ARG . 11.3 p -62.44 136.46 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.147 -0.933 . . . . 1.7 110.932 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 80.43 -47.97 3.54 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.235 -0.746 . . . . 1.1699999999999999 111.235 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.507 ' N ' HD21 ' A' ' 419' ' ' LEU . 2.0 mm? -65.68 159.77 24.22 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.74 0.305 . . . . 2.1499999999999999 110.634 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.612 ' OD1' HD11 ' A' ' 423' ' ' LEU . 21.3 p30 -51.62 141.67 15.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 2.7599999999999998 111.082 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 31.9 ptt85 -60.55 -33.05 72.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.233 -0.44 . . . . 4.6500000000000004 111.918 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -56.4 -29.61 61.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 4.3200000000000003 111.1 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.612 HD11 ' OD1' ' A' ' 420' ' ' ASN . 1.2 tp -58.1 -26.7 62.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 2.04 111.661 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -44.79 135.17 5.21 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.948 0.404 . . . . 1.2 111.174 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -178.82 145.98 7.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.01 -0.614 . . . . 0.69999999999999996 112.189 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -67.49 121.3 15.51 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.99 -0.374 . . . . 0.76000000000000001 109.99 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 6.4 m -118.79 149.59 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 1.4399999999999999 111.537 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.419 ' HA2' ' CE1' ' A' ' 430' ' ' HIS . . . -63.27 146.97 50.61 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.625 -0.798 . . . . 1.72 111.674 178.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 37.1 tpt85 -51.34 -29.73 16.21 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.684 0.253 . . . . 2.3199999999999998 111.684 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.419 ' CE1' ' HA2' ' A' ' 428' ' ' GLY . 22.7 p-80 -60.37 -31.94 70.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.955 0.354 . . . . 2.23 111.955 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 99.4 mtt180 -79.03 -30.94 44.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.355 -0.384 . . . . 3.4199999999999999 110.93 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 412' ' ' TYR . 95.7 mt -89.03 129.93 39.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 1.1399999999999999 111.603 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.457 ' HB2' ' CD1' ' A' ' 439' ' ' LEU . 69.6 m -169.09 140.05 2.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.803 -0.635 . . . . 0.95999999999999996 110.5 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -75.82 16.21 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.415 -0.357 . . . . 1.3500000000000001 111.269 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.755 HD22 ' HB2' ' A' ' 437' ' ' ASP . 51.9 t30 -139.45 131.39 27.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.891 0.377 . . . . 2.5299999999999998 110.652 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . 0.439 ' HB1' HD12 ' A' ' 442' ' ' ILE . . . -71.72 -37.17 70.65 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.627 0.603 . . . . 1.3300000000000001 112.627 -178.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . 0.755 ' HB2' HD22 ' A' ' 435' ' ' ASN . 55.5 m-20 -52.51 -40.72 62.75 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.727 0.299 . . . . 1.3400000000000001 111.597 -178.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . 0.409 ' OD2' ' HB3' ' A' ' 435' ' ' ASN . 61.5 m-20 -64.19 -24.58 67.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.391 -0.368 . . . . 1.5600000000000001 111.335 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.678 ' N ' HD11 ' A' ' 439' ' ' LEU . 8.4 mp -94.81 -85.46 0.31 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.159 -0.473 . . . . 1.76 112.191 -179.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -179.65 51.85 0.09 OUTLIER Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.097 -1.049 . . . . 1.3600000000000001 113.661 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 68.31 143.97 0.11 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.724 -0.751 . . . . 1.8300000000000001 113.363 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . 0.439 HD12 ' HB1' ' A' ' 436' ' ' ALA . 46.8 mm . . . . . 0 C--N 1.33 -0.27 0 N-CA-C 110.485 -0.191 . . . . 1.9199999999999999 110.485 179.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 21.9 mm . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.923 0.392 . . . . 1.9299999999999999 110.254 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -87.09 110.49 20.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.125 0.488 . . . . 2.1699999999999999 111.084 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 397' ' ' VAL . 72.0 mt -79.89 -39.01 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.678 -0.692 . . . . 1.4399999999999999 111.248 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 58.1 m -70.71 58.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.597 -0.729 . . . . 2.2000000000000002 111.983 -179.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -174.47 -30.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 1.9199999999999999 110.47 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.492 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -156.12 58.41 1.74 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.796 -0.638 . . . . 2.8900000000000001 111.172 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 51.3 Cg_exo -53.72 -39.33 84.0 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.198 1.932 . . . . 0.97999999999999998 111.461 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.32 -31.59 72.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.67 -0.696 . . . . 1.21 111.175 179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 83.7 tttt -45.83 125.45 6.17 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.016 0.436 . . . . 2.27 110.805 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.874 HD13 HG12 ' A' ' 417' ' ' VAL . 21.4 mm -79.71 123.75 36.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.91 -0.586 . . . . 1.1299999999999999 111.902 -179.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -110.08 143.86 39.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.627 -0.508 . . . . 1.1000000000000001 109.627 178.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.512 ' HB2' ' CD1' ' A' ' 439' ' ' LEU . 19.6 m-85 -91.47 138.83 31.27 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.822 -0.351 . . . . 1.3200000000000001 110.617 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.526 HD13 ' N ' ' A' ' 385' ' ' ILE . 2.7 mp -124.33 130.35 73.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.313 -0.403 . . . . 1.2 111.439 -179.045 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 439' ' ' LEU . 57.4 ttt-85 -99.05 122.23 42.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 3.1699999999999999 110.926 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -82.7 -173.25 4.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.506 -0.316 . . . . 2.9900000000000002 110.74 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.444 ' N ' ' OE1' ' A' ' 388' ' ' GLU . 0.4 OUTLIER -63.71 -44.62 93.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.835 0.35 . . . . 2.8199999999999998 110.828 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -71.17 5.57 2.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.115 -0.493 . . . . 1.23 111.249 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 388' ' ' GLU . . . 71.35 28.89 69.05 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.021 -0.609 . . . . 1.03 113.074 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 42.3 p -93.9 110.33 22.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.668 0.27 . . . . 1.46 111.04 179.274 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.618 HG13 HD11 ' A' ' 442' ' ' ILE . 42.1 t -74.59 131.57 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.852 -0.425 . . . . 1.24 109.852 179.13 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . 0.508 ' HB3' HD12 ' A' ' 419' ' ' LEU . 76.6 m-70 -145.39 135.52 23.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.454 -0.339 . . . . 3.2400000000000002 111.038 -179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.503 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 58.9 mtt85 -58.9 150.59 23.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.967 0.413 . . . . 3.5600000000000001 111.576 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 416' ' ' TYR . . . -177.05 132.84 2.11 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.755 -0.657 . . . . 0.32000000000000001 112.097 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -90.51 129.72 36.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.64 0.257 . . . . 1.28 111.535 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' A' ' 412' ' ' TYR . 5.8 t -85.4 126.85 40.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 109.613 -0.514 . . . . 1.5800000000000001 109.613 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 70.5 mt -121.12 -40.14 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.214 0.45 . . . . 2.04 112.214 -178.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . 0.487 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 98.3 mm-40 -128.6 176.45 7.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.987 0.422 . . . . 2.6400000000000001 112.04 -178.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 87.7 p -161.83 149.4 14.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.684 -0.689 . . . . 1.1299999999999999 110.594 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -162.49 143.8 10.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.107 0.479 . . . . 1.8799999999999999 111.33 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 30.2 p -115.13 134.03 55.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.741 -0.663 . . . . 1.79 109.489 178.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 404' ' ' GLU . 1.9 m -58.42 -174.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.889 -0.411 . . . . 2.2999999999999998 109.889 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.424 ' H ' HG23 ' A' ' 403' ' ' THR . 4.8 mm-40 -39.64 -44.78 1.55 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 3.8700000000000001 110.207 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -94.09 129.29 40.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.712 -0.676 . . . . 3.1600000000000001 109.345 178.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -113.89 57.6 0.69 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.164 0.506 . . . . 2.1800000000000002 111.489 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -138.71 11.35 2.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.623 -0.717 . . . . 2.77 110.028 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.473 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . -173.8 -46.01 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.077 -0.965 . . . . 3.2799999999999998 110.951 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 402' ' ' THR . 19.8 Cg_exo -68.62 38.85 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 123.162 2.574 . . . . 2.8700000000000001 113.897 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.28 131.78 35.31 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.417 -0.586 . . . . 2.1400000000000001 109.417 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 50.1 mt-10 -136.79 134.97 37.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.731 0.3 . . . . 2.1000000000000001 111.265 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 429' ' ' ARG . 1.4 m-85 -119.21 127.62 53.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.482 -0.326 . . . . 1.0600000000000001 111.113 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.487 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 15.0 t80 -57.82 143.5 42.08 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.483 -0.562 . . . . 1.05 109.483 178.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.8 110.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.688 0.625 . . . . 1.8400000000000001 112.688 -179.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -90.58 96.49 10.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.483 -0.78 . . . . 0.70999999999999996 109.254 178.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.52 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 54.4 m-85 -51.83 125.88 16.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.248 0.547 . . . . 1.1299999999999999 111.067 -178.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.874 HG12 HD13 ' A' ' 382' ' ' ILE . 2.5 t -79.32 34.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.256 -0.884 . . . . 1.7 111.105 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 416' ' ' TYR . . . -179.53 -45.88 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.564 -0.744 . . . . 1.1699999999999999 112.679 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.853 HD21 HD21 ' A' ' 423' ' ' LEU . 7.0 mp -63.98 155.55 30.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.137 0.494 . . . . 2.1499999999999999 111.458 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 1.8 m120 -50.43 142.31 10.68 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.45 -0.796 . . . . 2.7599999999999998 111.693 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . 0.723 ' HD2' ' N ' ' A' ' 422' ' ' ARG . 7.1 ppt_? -58.4 -29.88 66.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.176 -0.466 . . . . 4.6500000000000004 110.822 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . 0.723 ' N ' ' HD2' ' A' ' 421' ' ' ARG . 38.0 ptt180 -63.98 -37.15 86.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 4.3200000000000003 110.321 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.853 HD21 HD21 ' A' ' 419' ' ' LEU . 7.0 mp -61.92 -33.35 74.08 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.877 -0.601 . . . . 2.04 110.755 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -50.63 138.19 18.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.681 -0.69 . . . . 1.2 111.141 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -170.99 -141.18 3.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.824 -0.703 . . . . 0.69999999999999996 112.506 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -122.26 132.58 54.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.859 0.361 . . . . 0.76000000000000001 110.873 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 411' ' ' GLU . 20.3 m -110.81 155.64 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 1.4399999999999999 111.693 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -71.35 21.32 0.69 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.065 -0.588 . . . . 1.72 113.935 -179.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.51 ' HB2' ' CD1' ' A' ' 412' ' ' TYR . 37.7 tpt85 70.64 -46.17 0.62 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.138 0.792 . . . . 2.3199999999999998 113.138 178.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -59.89 -14.69 16.58 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.67 0.748 . . . . 2.23 109.33 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.435 ' HD2' ' HB ' ' A' ' 427' ' ' VAL . 58.0 mtt85 -79.06 -34.89 43.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.571 -1.195 . . . . 3.4199999999999999 111.221 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.444 HD13 ' HB2' ' A' ' 412' ' ' TYR . 65.8 mt -87.63 137.34 21.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.857 0.36 . . . . 1.1399999999999999 110.869 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.0 m -159.69 138.8 11.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.95999999999999996 110.721 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.17 -18.89 60.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 1.3500000000000001 110.811 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -108.59 132.93 53.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.105 -0.498 . . . . 2.5299999999999998 111.017 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . 0.559 ' HB3' HG12 ' A' ' 442' ' ' ILE . . . -66.23 -38.73 88.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.987 -0.551 . . . . 1.3300000000000001 111.519 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -51.87 -40.73 61.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.308 -0.406 . . . . 1.3400000000000001 111.257 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -81.69 41.1 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 1.5600000000000001 110.624 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.546 ' O ' ' HD2' ' A' ' 386' ' ' ARG . 54.7 mt -152.62 -85.88 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.42 . . . . 1.76 111.34 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.01 32.91 0.25 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.444 -0.884 . . . . 1.3600000000000001 112.857 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 54.25 36.94 58.28 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 121.144 -0.55 . . . . 1.8300000000000001 113.604 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . 0.618 HD11 HG13 ' A' ' 392' ' ' VAL . 48.0 mm . . . . . 0 C--N 1.327 -0.388 0 N-CA-C 111.76 0.281 . . . . 1.9199999999999999 111.76 178.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 67.5 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.873 0.368 . . . . 1.9299999999999999 111.782 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 3.6 m-20 -91.68 68.53 5.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.026 -0.534 . . . . 2.1699999999999999 110.372 178.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.441 ' O ' HG21 ' A' ' 375' ' ' ILE . 75.3 mt -51.86 -34.74 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 1.4399999999999999 112.073 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 37.6 t -47.8 -24.8 1.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.192 -0.458 . . . . 2.2000000000000002 112.201 -178.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 11.9 pt-20 -69.22 -37.82 78.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.321 -0.4 . . . . 1.9199999999999999 111.848 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.455 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -154.17 65.0 4.89 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 111.695 0.257 . . . . 2.8900000000000001 111.695 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.85 -37.66 85.24 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.396 2.064 . . . . 0.97999999999999998 111.673 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -64.29 -33.67 76.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.684 -0.689 . . . . 1.21 111.168 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -52.19 127.96 23.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.944 0.402 . . . . 2.27 110.935 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.569 HG23 HH11 ' A' ' 394' ' ' ARG . 45.1 mm -87.36 131.42 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.971 -0.559 . . . . 1.1299999999999999 111.604 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -111.24 144.29 40.66 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.255 -0.429 . . . . 1.1000000000000001 110.026 179.104 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.515 ' C ' HD13 ' A' ' 385' ' ' ILE . 18.2 m-85 -88.92 142.43 27.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.979 -0.288 . . . . 1.3200000000000001 110.673 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.577 HD13 ' N ' ' A' ' 385' ' ' ILE . 3.4 mp -123.96 133.53 69.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.981 0.42 . . . . 1.2 111.92 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.592 ' N ' HD22 ' A' ' 439' ' ' LEU . 42.7 ttt85 -87.14 117.0 25.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 3.1699999999999999 110.455 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.446 ' HD3' ' HG1' ' A' ' 391' ' ' THR . 58.3 mtp85 -70.12 169.52 13.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.754 0.311 . . . . 2.9900000000000002 111.142 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -51.72 -45.52 63.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.191 -0.459 . . . . 2.8199999999999998 111.339 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.457 ' OD1' HG22 ' A' ' 391' ' ' THR . 2.3 p30 -69.53 -36.05 76.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.316 -0.402 . . . . 1.23 111.021 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 120.29 36.14 0.82 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.966 -0.635 . . . . 1.03 112.5 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 391' ' ' THR . . . . . 0.457 HG22 ' OD1' ' A' ' 389' ' ' ASP . 17.5 p -110.71 114.48 27.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.188 0.518 . . . . 1.46 111.289 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.45 HG12 HD21 ' A' ' 439' ' ' LEU . 91.9 t -66.66 135.02 29.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.456 -0.793 . . . . 1.24 111.842 -178.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -153.77 132.26 12.11 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.411 -0.813 . . . . 3.2400000000000002 110.38 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.569 HH11 HG23 ' A' ' 382' ' ' ILE . 73.6 mtt-85 -54.56 154.07 5.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.355 0.598 . . . . 3.5600000000000001 112.354 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -169.59 135.14 3.44 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.145 -0.934 . . . . 0.32000000000000001 111.499 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -91.61 111.21 22.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.807 0.303 . . . . 1.28 111.76 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.639 HG23 HD11 ' A' ' 432' ' ' ILE . 4.1 t -74.87 129.09 36.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 109.942 -0.392 . . . . 1.5800000000000001 109.942 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 77.0 mt -121.2 -41.28 2.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.362 0.504 . . . . 2.04 112.362 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . 0.444 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 72.5 mt-30 -135.47 177.03 8.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.963 0.411 . . . . 2.6400000000000001 111.577 -178.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 412' ' ' TYR . 80.8 p -151.53 139.39 19.91 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.901 -0.59 . . . . 1.1299999999999999 110.72 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -154.69 144.08 21.3 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.334 -0.394 . . . . 1.8799999999999999 111.136 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.406 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 41.6 p -94.47 -121.72 0.1 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.713 -0.477 . . . . 1.79 109.713 178.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.426 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.71 -173.38 2.98 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.607 -0.516 . . . . 2.2999999999999998 109.607 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.426 ' H ' ' CG2' ' A' ' 403' ' ' THR . 48.9 mt-10 -43.67 -43.42 5.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.758 0.313 . . . . 3.8700000000000001 111.389 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -70.28 -51.88 27.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 3.1600000000000001 111.308 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.406 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.08 53.06 11.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.328 0.585 . . . . 2.1800000000000002 110.864 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -162.35 12.38 0.07 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.172 -0.922 . . . . 2.77 109.273 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.61 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -161.04 -41.52 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.448 -1.251 . . . . 3.2799999999999998 111.716 -178.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.61 ' HD2' ' H ' ' A' ' 408' ' ' ALA . 75.5 Cg_exo -52.21 -62.27 0.39 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.234 1.956 . . . . 2.8700000000000001 113.708 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 36.02 74.39 0.07 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.228 0.537 . . . . 2.1400000000000001 111.231 -179.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.41 147.72 30.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 2.1000000000000001 110.779 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 6.0 m-85 -127.21 125.15 40.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.374 . . . . 1.0600000000000001 111.203 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.444 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 15.5 t80 -57.84 149.89 21.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.923 -0.58 . . . . 1.05 110.414 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.517 HG23 HG12 ' A' ' 385' ' ' ILE . 11.2 p -155.82 138.05 6.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.143 0.497 . . . . 1.8400000000000001 112.212 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -115.02 101.49 9.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.68 -0.691 . . . . 0.70999999999999996 110.386 179.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.453 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 8.6 m-85 -62.1 116.1 4.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.193 -0.458 . . . . 1.1299999999999999 111.298 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.58 130.42 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 1.7 111.054 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.77 -42.8 1.83 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.859 -0.686 . . . . 1.1699999999999999 112.761 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.502 ' N ' HD21 ' A' ' 419' ' ' LEU . 2.0 mm? -59.33 152.85 20.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.862 0.363 . . . . 2.1499999999999999 111.209 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 11.8 p-10 -49.73 136.53 17.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 2.7599999999999998 111.349 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . 0.425 HH11 ' HG3' ' A' ' 421' ' ' ARG . 60.9 mtt85 -57.35 -40.47 78.13 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.84 0.682 . . . . 4.6500000000000004 112.84 -178.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -53.84 -29.15 39.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.777 0.323 . . . . 4.3200000000000003 110.864 -179.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 420' ' ' ASN . 1.2 tp -59.26 -34.13 71.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 2.04 110.858 179.056 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -48.21 138.14 9.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.945 -0.57 . . . . 1.2 111.311 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.87 -142.91 4.82 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.001 -0.618 . . . . 0.69999999999999996 112.121 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -128.6 134.59 48.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.376 . . . . 0.76000000000000001 110.639 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 431' ' ' ARG . 29.3 m -109.38 158.76 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.944 -0.571 . . . . 1.4399999999999999 111.887 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -77.46 35.01 1.56 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.834 -0.621 . . . . 1.72 114.441 -179.135 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 23.6 tpt180 70.69 -70.37 0.15 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.248 0.833 . . . . 2.3199999999999998 113.248 178.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -45.39 -16.12 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.947 0.403 . . . . 2.23 111.707 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 53.4 mtt85 -77.47 -39.06 47.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.956 -0.565 . . . . 3.4199999999999999 111.333 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.639 HD11 HG23 ' A' ' 397' ' ' VAL . 86.7 mt -87.04 132.07 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.155 -0.313 . . . . 1.1399999999999999 110.155 179.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 61.0 m -164.0 142.13 7.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.95999999999999996 111.136 -179.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -58.72 -26.09 63.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.076 -0.511 . . . . 1.3500000000000001 110.793 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -121.78 135.15 54.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.161 -0.472 . . . . 2.5299999999999998 110.851 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -70.75 -10.96 60.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 1.3300000000000001 111.635 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.07 -40.99 77.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 1.3400000000000001 111.716 -179.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -83.03 18.23 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.826 0.346 . . . . 1.5600000000000001 111.337 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 386' ' ' ARG . 8.4 mp -118.02 -96.54 0.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.76 111.216 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . 0.568 ' HA2' ' NH1' ' A' ' 386' ' ' ARG . . . -173.9 41.61 0.14 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.323 -0.942 . . . . 1.3600000000000001 113.431 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.9 149.76 0.09 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.662 -0.78 . . . . 1.8300000000000001 113.28 179.074 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 442' ' ' ILE . 1.5 mp . . . . . 0 CA--C 1.518 -0.28 0 N-CA-C 109.128 -0.693 . . . . 1.9199999999999999 109.128 178.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.681 HG13 ' HE ' ' A' ' 429' ' ' ARG . 85.7 mt . . . . . 0 N--CA 1.462 0.13 0 CA-C-O 120.763 0.316 . . . . 1.9299999999999999 111.622 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 377' ' ' GLU . 31.6 m-20 -89.56 129.52 36.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 2.1699999999999999 109.914 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 397' ' ' VAL . 95.5 mt -88.26 -41.51 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.409 0.522 . . . . 1.4399999999999999 112.409 -179.176 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.7 t -46.74 -21.13 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.284 -0.417 . . . . 2.2000000000000002 111.865 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 374' ' ' ASP . 6.7 mt-10 -61.77 -42.39 98.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.855 -0.611 . . . . 1.9199999999999999 111.369 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.415 ' N ' ' ND2' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -167.64 69.79 0.91 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 2.8900000000000001 111.188 -179.21 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.47 -39.66 54.52 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.57 2.18 . . . . 0.97999999999999998 112.158 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.79 -39.29 84.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 1.21 110.69 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -54.66 130.83 41.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.144 -0.48 . . . . 2.27 111.048 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 28.7 mm -84.72 135.68 24.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.072 -0.513 . . . . 1.1299999999999999 111.442 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -108.17 143.8 36.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.374 -0.375 . . . . 1.1000000000000001 110.388 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.419 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 7.1 m-85 -88.22 133.64 33.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.603 0.24 . . . . 1.3200000000000001 110.659 179.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.511 HD13 ' N ' ' A' ' 385' ' ' ILE . 1.9 mp -121.77 130.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.75 0.31 . . . . 1.2 110.699 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.475 ' CZ ' ' HA3' ' A' ' 390' ' ' GLY . 60.7 ttt-85 -80.71 117.15 21.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.373 -0.376 . . . . 3.1699999999999999 110.648 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.72 ' HE ' ' HA ' ' A' ' 387' ' ' ARG . 2.0 mmp_? -68.17 164.81 19.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 2.9900000000000002 110.571 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 389' ' ' ASP . 0.5 OUTLIER -51.71 -45.02 63.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 2.8199999999999998 111.615 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.419 ' N ' ' HG2' ' A' ' 388' ' ' GLU . 40.8 p-10 -69.63 -35.72 75.48 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.679 0.252 . . . . 1.23 111.679 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.475 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . 138.8 -32.45 2.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.583 -0.818 . . . . 1.03 112.561 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 72.4 p -59.1 112.24 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.082 0.468 . . . . 1.46 111.657 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.657 HG12 HD11 ' A' ' 439' ' ' LEU . 57.1 t -72.88 140.92 17.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.738 -0.665 . . . . 1.24 111.274 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . 0.451 ' N ' HG11 ' A' ' 392' ' ' VAL . 36.4 m-70 -139.7 137.57 35.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 3.2400000000000002 110.718 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 55.5 mtt85 -62.38 145.04 55.01 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.914 0.388 . . . . 3.5600000000000001 110.923 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 416' ' ' TYR . . . -164.14 134.4 3.35 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.022 -0.608 . . . . 0.32000000000000001 112.397 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . 0.533 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 90.0 mt-30 -82.19 132.28 35.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.531 0.205 . . . . 1.28 111.506 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.734 HG23 HD12 ' A' ' 432' ' ' ILE . 11.7 t -99.82 122.19 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.067 -0.716 . . . . 1.5800000000000001 109.067 178.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . 0.472 ' N ' ' CD2' ' A' ' 398' ' ' LEU . 0.7 OUTLIER -111.64 -41.91 3.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.703 0.631 . . . . 2.04 112.703 -177.026 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -132.95 176.45 8.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.993 0.425 . . . . 2.6400000000000001 111.77 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.2 p -164.27 147.45 9.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.753 -0.658 . . . . 1.1299999999999999 110.863 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.4 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 38.6 ptt180 -160.66 134.2 6.8 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.002 0.43 . . . . 1.8799999999999999 111.41 -179.521 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.737 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 35.5 p -81.42 137.44 35.66 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.246 -0.434 . . . . 1.79 110.004 178.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.484 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.1 m -62.13 -174.03 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 2.2999999999999998 110.761 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.484 ' H ' ' CG2' ' A' ' 403' ' ' THR . 50.6 mt-10 -42.28 -41.84 2.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.977 0.362 . . . . 3.8700000000000001 111.977 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.705 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 24.0 t-20 -57.43 -48.48 79.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 3.1600000000000001 110.673 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.737 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.63 57.23 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 2.1800000000000002 111.997 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.406 ' O ' ' HB1' ' A' ' 408' ' ' ALA . . . -168.95 10.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 2.77 110.629 179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.474 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . 179.85 -43.8 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.729 -0.669 . . . . 3.2799999999999998 111.918 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.705 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 11.7 Cg_exo -71.73 49.56 1.23 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.77 2.314 . . . . 2.8700000000000001 114.193 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.8 p30 -78.17 126.73 31.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.847 0.356 . . . . 2.1400000000000001 110.504 178.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 400' ' ' SER . 47.4 mt-10 -114.05 134.63 54.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 2.1000000000000001 110.482 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.641 ' HB3' HG12 ' A' ' 397' ' ' VAL . 1.6 m-85 -111.91 134.05 53.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.973 0.416 . . . . 1.0600000000000001 111.941 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 17.8 t80 -66.57 138.41 57.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.691 -0.855 . . . . 1.05 108.691 177.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 21.7 t -140.78 110.08 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 113.202 0.815 . . . . 1.8400000000000001 113.202 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . 0.48 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 86.4 t60 -90.1 88.5 7.29 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.661 -0.866 . . . . 0.70999999999999996 108.661 177.176 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . 0.508 ' HB2' ' CD1' ' A' ' 419' ' ' LEU . 4.7 m-85 -57.95 116.01 3.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.807 0.813 . . . . 1.1299999999999999 111.482 -178.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 5.5 m -53.87 129.56 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 CA-C-N 114.027 -1.442 . . . . 1.7 112.818 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 81.88 -52.1 4.55 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 115.415 0.926 . . . . 1.1699999999999999 115.415 177.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.868 HD12 ' HB2' ' A' ' 423' ' ' LEU . 0.5 OUTLIER -62.18 162.52 9.48 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.901 0.851 . . . . 2.1499999999999999 112.561 -177.706 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.603 ' O ' HD11 ' A' ' 419' ' ' LEU . 56.0 t30 -59.68 143.51 50.5 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.507 -0.77 . . . . 2.7599999999999998 111.877 -179.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . 0.651 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 99.3 mtt180 -53.39 -20.21 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 4.6500000000000004 111.716 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . 0.555 ' HB3' HD21 ' A' ' 420' ' ' ASN . 2.6 tpm_? -55.32 -40.34 71.04 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.854 -0.612 . . . . 4.3200000000000003 112.157 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.868 ' HB2' HD12 ' A' ' 419' ' ' LEU . 2.1 mm? -70.62 -35.13 72.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.87 0.322 . . . . 2.04 111.87 -179.249 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.651 ' OD2' ' HA ' ' A' ' 421' ' ' ARG . 62.3 m-20 -48.71 132.38 17.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.97 0.415 . . . . 1.2 111.407 -178.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.28 179.99 46.17 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.856 -0.687 . . . . 0.69999999999999996 112.33 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 36.2 m95 -76.8 139.21 40.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.605 0.24 . . . . 0.76000000000000001 110.45 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.425 HG11 ' C ' ' A' ' 426' ' ' TRP . 12.3 m -140.39 146.75 24.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.966 0.412 . . . . 1.4399999999999999 111.492 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.448 ' HA2' ' CE1' ' A' ' 430' ' ' HIS . . . -59.21 149.16 39.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.873 -0.68 . . . . 1.72 112.407 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.681 ' HE ' HG13 ' A' ' 373' ' ' ILE . 37.9 tpt85 -52.09 -39.62 60.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.727 0.269 . . . . 2.3199999999999998 111.727 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.448 ' CE1' ' HA2' ' A' ' 428' ' ' GLY . 19.5 p-80 -55.97 -26.7 49.33 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.143 0.423 . . . . 2.23 112.143 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.473 ' HB3' HG21 ' A' ' 385' ' ' ILE . 57.3 mtt85 -78.09 -38.58 43.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.845 0.313 . . . . 3.4199999999999999 111.845 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.734 HD12 HG23 ' A' ' 397' ' ' VAL . 59.6 mt -88.75 134.78 27.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.88 0.371 . . . . 1.1399999999999999 111.154 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 435' ' ' ASN . 71.1 m -160.64 139.74 10.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.95999999999999996 110.928 -179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -74.37 16.75 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 1.3500000000000001 111.719 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 433' ' ' SER . 6.1 m120 -138.47 131.31 29.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.986 0.422 . . . . 2.5299999999999998 111.133 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -67.33 -72.77 0.16 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.892 -0.594 . . . . 1.3300000000000001 111.62 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -40.71 -39.3 1.05 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.927 -0.579 . . . . 1.3400000000000001 111.715 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.87 47.37 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.301 -0.409 . . . . 1.5600000000000001 111.298 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.657 HD11 HG12 ' A' ' 392' ' ' VAL . 94.7 mt -149.87 -84.81 0.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.644 -0.253 . . . . 1.76 111.405 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -163.3 40.91 0.33 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.508 -0.853 . . . . 1.3600000000000001 113.089 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.21 146.83 0.32 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 1.8300000000000001 113.237 179.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.671 0.272 . . . . 1.9199999999999999 110.99 179.843 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 77.5 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.922 0.391 . . . . 1.9299999999999999 111.977 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.407 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 21.8 m-20 -88.95 137.7 32.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 2.1699999999999999 110.673 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 79.4 mt -96.48 -46.62 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.206 0.527 . . . . 1.4399999999999999 111.464 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 56.8 m -53.9 -18.15 3.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.297 -0.865 . . . . 2.2000000000000002 111.613 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 24.1 pt-20 -74.97 -40.47 60.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.134 -0.485 . . . . 1.9199999999999999 111.917 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 378' ' ' ASN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 6.0 m120 -154.86 74.57 5.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 2.8900000000000001 112.029 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.44 -40.74 81.91 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.68 2.254 . . . . 0.97999999999999998 112.172 179.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -67.58 -37.56 82.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.848 -0.614 . . . . 1.21 111.36 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.586 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 63.9 tttp -50.35 129.44 21.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 2.27 111.261 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.452 HD11 ' HG2' ' A' ' 396' ' ' GLN . 40.2 mm -88.62 132.82 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.037 -0.529 . . . . 1.1299999999999999 111.189 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.88 143.62 34.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.931 -0.396 . . . . 1.1000000000000001 109.931 179.018 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -89.72 122.9 33.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 1.3200000000000001 110.779 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.488 HD12 HG12 ' A' ' 414' ' ' VAL . 2.1 mp -106.09 123.09 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 1.2 111.328 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.531 ' NH1' ' HA2' ' A' ' 440' ' ' GLY . 38.4 ttt85 -84.08 118.53 24.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 3.1699999999999999 110.534 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -71.45 157.28 38.31 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.887 -0.325 . . . . 2.9900000000000002 110.566 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.593 ' HA ' HH12 ' A' ' 431' ' ' ARG . 16.3 pt-20 -49.66 -41.2 42.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 2.8199999999999998 111.74 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -67.01 -36.24 81.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.683 -0.235 . . . . 1.23 111.138 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 136.44 -33.68 2.33 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.448 -0.882 . . . . 1.03 112.842 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 57.6 p -59.17 113.87 2.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.317 0.579 . . . . 1.46 112.149 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.63 HG12 HD11 ' A' ' 439' ' ' LEU . 60.7 t -69.17 144.6 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.321 -0.854 . . . . 1.24 111.351 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -151.59 129.75 11.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.006 -0.543 . . . . 3.2400000000000002 110.684 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 394' ' ' ARG . 61.3 mtt85 -55.4 153.85 6.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.878 -0.601 . . . . 3.5600000000000001 112.137 -179.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -175.75 135.24 2.91 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.416 -0.811 . . . . 0.32000000000000001 112.114 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 74.7 mt-30 -91.5 138.06 31.87 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.944 -0.151 . . . . 1.28 111.007 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 397' ' ' VAL . . . . . 0.432 ' CG2' HD11 ' A' ' 432' ' ' ILE . 14.5 t -92.09 102.19 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.211 -0.662 . . . . 1.5800000000000001 109.211 178.27 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . 0.55 HD11 ' N ' ' A' ' 398' ' ' LEU . 6.2 mp -84.95 -36.81 21.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.594 -0.73 . . . . 2.04 112.473 -177.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 399' ' ' GLN . . . . . 0.479 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 66.0 mt-30 -141.0 175.66 9.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.976 0.417 . . . . 2.6400000000000001 111.333 -178.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 93.2 p -165.63 144.22 6.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.689 -0.687 . . . . 1.1299999999999999 110.589 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . 0.571 ' HG3' ' HB3' ' A' ' 410' ' ' ASP . 36.1 ptt180 -118.74 175.4 5.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 1.8799999999999999 109.989 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.541 ' HA ' ' HB2' ' A' ' 410' ' ' ASP . 26.6 p -127.82 133.38 49.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.128 0.489 . . . . 1.79 111.956 -179.161 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 403' ' ' THR . . . . . 0.47 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 1.4 m -63.19 -170.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.488 -0.778 . . . . 2.2999999999999998 110.363 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.47 ' H ' ' CG2' ' A' ' 403' ' ' THR . 49.9 mt-10 -42.44 -35.61 1.08 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.667 0.27 . . . . 3.8700000000000001 110.566 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.428 ' OD1' ' HB3' ' A' ' 407' ' ' ALA . 30.6 t-20 -54.17 -46.42 72.32 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.697 -0.483 . . . . 3.1600000000000001 109.697 178.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.501 ' HA ' ' CB ' ' A' ' 402' ' ' THR . . . 62.07 64.33 1.0 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.38 -0.827 . . . . 2.1800000000000002 111.409 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.428 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -166.91 -25.1 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.416 0.524 . . . . 2.77 112.416 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 408' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -165.46 -47.26 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 114.101 1.148 . . . . 3.2799999999999998 114.101 -179.045 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 55.7 Cg_exo -55.51 -155.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.676 2.25 . . . . 2.8700000000000001 114.868 -177.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 410' ' ' ASP . . . . . 0.571 ' HB3' ' HG3' ' A' ' 401' ' ' ARG . 0.1 OUTLIER 80.38 -160.1 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.794 -1.094 . . . . 2.1400000000000001 113.056 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 426' ' ' TRP . 95.1 mt-10 -106.48 149.02 27.5 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.067 -0.515 . . . . 2.1000000000000001 111.554 -177.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.542 ' N ' ' HD1' ' A' ' 412' ' ' TYR . 0.4 OUTLIER -112.0 134.93 53.25 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.652 -0.704 . . . . 1.0600000000000001 112.176 -177.952 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.479 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 14.8 t80 -67.05 145.43 55.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.75 -0.659 . . . . 1.05 110.419 179.318 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 13.7 t -148.57 129.48 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.127 0.788 . . . . 1.8400000000000001 113.127 -179.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 415' ' ' HIS . . . . . 0.441 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 56.0 t60 -105.32 104.03 13.68 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.87 -0.605 . . . . 0.70999999999999996 109.539 177.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 416' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -66.22 128.84 37.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.933 0.397 . . . . 1.1299999999999999 111.162 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.24 128.91 36.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.86 -0.609 . . . . 1.7 111.823 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 75.29 -47.17 1.97 Allowed Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.781 -0.645 . . . . 1.1699999999999999 113.363 179.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.408 ' HB3' ' CD1' ' A' ' 423' ' ' LEU . 7.6 mp -59.74 161.95 5.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.418 . . . . 2.1499999999999999 111.62 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 420' ' ' ASN . . . . . 0.436 ' HB3' ' HG2' ' A' ' 422' ' ' ARG . 75.8 m-20 -50.11 139.73 13.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.634 -0.712 . . . . 2.7599999999999998 111.82 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -63.59 -31.21 72.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.659 -0.701 . . . . 4.6500000000000004 111.199 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . 0.436 ' HG2' ' HB3' ' A' ' 420' ' ' ASN . 14.6 ptp180 -52.77 -35.02 55.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 4.3200000000000003 111.196 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 423' ' ' LEU . . . . . 0.45 ' HA ' HD21 ' A' ' 423' ' ' LEU . 50.8 mt -56.09 -32.13 63.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 2.04 111.357 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.441 ' OD2' ' HA ' ' A' ' 415' ' ' HIS . 1.1 m-20 -47.73 134.1 13.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.906 0.384 . . . . 1.2 111.327 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 413' ' ' TYR . . . -179.84 -142.62 5.16 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.749 . . . . 0.69999999999999996 112.242 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 426' ' ' TRP . . . . . 0.513 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 37.3 m95 -122.49 138.56 54.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.937 0.399 . . . . 0.76000000000000001 110.574 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 431' ' ' ARG . 10.3 m -109.37 158.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 1.4399999999999999 111.652 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -75.31 27.17 1.23 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.651 -0.785 . . . . 1.72 113.391 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.47 ' HB3' ' O ' ' A' ' 428' ' ' GLY . 40.8 tpt85 70.9 -47.0 0.65 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.869 0.468 . . . . 2.3199999999999998 112.144 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . 0.415 ' HE1' ' NE ' ' A' ' 431' ' ' ARG . 10.6 p80 -69.95 -7.09 37.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 2.23 110.801 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.608 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 39.2 mmt180 -79.2 -37.3 38.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 3.4199999999999999 110.817 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.432 HD11 ' CG2' ' A' ' 397' ' ' VAL . 56.4 mt -87.88 135.8 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 1.1399999999999999 110.784 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 54.0 m -157.65 139.51 14.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.255 -0.43 . . . . 0.95999999999999996 111.015 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -79.21 16.31 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 1.3500000000000001 111.902 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -145.64 132.82 20.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.958 0.408 . . . . 2.5299999999999998 111.096 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 436' ' ' ALA . . . . . 0.433 ' HB2' HD12 ' A' ' 442' ' ' ILE . . . -70.52 -43.72 69.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 1.3300000000000001 111.434 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -55.09 -40.37 70.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.225 -0.443 . . . . 1.3400000000000001 111.2 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -79.26 46.38 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 1.5600000000000001 111.164 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.63 HD11 HG12 ' A' ' 392' ' ' VAL . 98.3 mt -151.08 -84.04 0.09 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.502 -0.317 . . . . 1.76 111.133 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . 0.531 ' HA2' ' NH1' ' A' ' 386' ' ' ARG . . . -175.0 52.3 0.13 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.927 -0.654 . . . . 1.3600000000000001 112.402 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 72.36 -139.51 28.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.839 -0.696 . . . . 1.8300000000000001 112.407 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 442' ' ' ILE . . . . . 0.433 HD12 ' HB2' ' A' ' 436' ' ' ALA . 33.9 mm . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 109.95 -0.389 . . . . 1.9199999999999999 109.95 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 112.534 -0.227 . . . . 11.91 112.534 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 79.8 p -172.57 130.8 0.56 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.683 0.277 . . . . 10.130000000000001 110.726 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 70.0 t60 59.35 109.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.947 -0.57 . . . . 8.6699999999999999 111.084 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 26.5 mmt -71.87 130.44 41.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 5.7000000000000002 110.793 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 369' ' ' LEU . 58.9 m-20 -59.87 150.98 66.35 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 6.0599999999999996 110.58 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.87 38.39 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.603 2.202 . . . . 6.5899999999999999 112.809 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 371' ' ' GLN . 2.8 tm? -170.24 -40.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 7.21 110.461 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.428 ' O ' ' HG3' ' A' ' 370' ' ' MET . 13.9 tpt -77.67 34.42 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 5.6699999999999999 110.565 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.452 ' H ' ' C ' ' A' ' 369' ' ' LEU . 25.8 mt-30 -80.97 63.03 5.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 5.6100000000000003 110.643 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.599 ' HB2' ' OH ' ' A' ' 412' ' ' TYR . 63.5 pttt 53.04 138.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.04 0.837 . . . . 5.7800000000000002 112.298 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.56 HD13 ' CZ ' ' A' ' 429' ' ' ARG . 70.1 mt -48.68 129.15 5.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.61 -0.723 . . . . 1.9299999999999999 112.14 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -89.74 130.72 35.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.694 -0.685 . . . . 2.1699999999999999 110.689 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.5 mt -81.73 -43.63 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 1.4399999999999999 111.394 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 72.7 p -65.46 74.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.979 -0.555 . . . . 2.2000000000000002 111.211 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -173.83 -27.19 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.561 -0.745 . . . . 1.9199999999999999 109.964 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.49 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -165.67 57.7 0.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.372 -0.831 . . . . 2.8900000000000001 111.392 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 51.2 Cg_exo -53.67 -39.12 84.46 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.247 1.964 . . . . 0.97999999999999998 111.604 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.46 -32.4 73.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.751 -0.659 . . . . 1.21 110.943 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 84.6 tttt -50.4 127.06 16.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.241 -0.436 . . . . 2.27 111.117 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 47.4 mm -83.46 127.39 39.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 1.1299999999999999 110.743 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -102.32 143.34 32.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.313 . . . . 1.1000000000000001 110.694 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -92.25 140.01 30.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.272 -0.422 . . . . 1.3200000000000001 110.282 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.657 HD11 ' N ' ' A' ' 385' ' ' ILE . 1.0 OUTLIER -133.49 126.88 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 1.2 111.111 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.453 HH22 HD21 ' A' ' 445' ' ' LEU . 45.2 ttt85 -79.83 116.77 20.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.008 -0.542 . . . . 3.1699999999999999 110.431 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -69.98 155.55 40.42 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.677 -0.409 . . . . 2.9900000000000002 110.21 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -51.26 -45.24 61.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 2.8199999999999998 111.55 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -56.96 -34.61 68.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.086 -0.709 . . . . 1.23 109.086 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 132.57 -36.72 2.13 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.494 -0.775 . . . . 1.03 112.947 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 82.3 p -59.57 112.83 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.182 0.515 . . . . 1.46 112.163 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.613 HG23 ' HB3' ' A' ' 439' ' ' LEU . 61.6 t -73.5 142.38 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.707 -0.679 . . . . 1.24 110.696 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -147.94 143.94 27.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.38 . . . . 3.2400000000000002 111.254 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -55.84 154.64 6.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.906 -0.588 . . . . 3.5600000000000001 111.809 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.507 ' HA2' HD12 ' A' ' 385' ' ' ILE . . . -171.35 129.68 1.82 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.688 -0.687 . . . . 0.32000000000000001 112.316 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -84.89 128.5 34.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.75 0.309 . . . . 1.28 110.752 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.7 OUTLIER -97.2 134.5 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.507 -0.315 . . . . 1.5800000000000001 110.424 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 76.3 mt -120.57 -43.76 2.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.971 0.73 . . . . 2.04 112.971 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -122.75 174.78 6.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.117 0.484 . . . . 2.6400000000000001 112.228 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.4 p -166.3 144.92 5.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.513 -0.767 . . . . 1.1299999999999999 110.608 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.511 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 39.3 ptt180 -143.54 134.72 25.76 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.809 0.337 . . . . 1.8799999999999999 110.842 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.63 HG21 ' HB3' ' A' ' 410' ' ' ASP . 18.0 p -98.85 38.02 1.43 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.098 0.407 . . . . 1.79 112.098 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.534 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 3.0 m 47.52 -173.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.285 -0.416 . . . . 2.2999999999999998 111.249 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.534 ' H ' ' CG2' ' A' ' 403' ' ' THR . 94.4 mt-10 -68.68 -41.62 78.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.799 0.333 . . . . 3.8700000000000001 111.402 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.423 ' HB3' ' HG3' ' A' ' 409' ' ' PRO . 24.3 t-20 -54.57 -52.48 61.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.154 -0.476 . . . . 3.1600000000000001 111.311 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 55.55 59.67 3.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 2.1800000000000002 111.756 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.431 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -163.51 11.08 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.459 0.647 . . . . 2.77 110.024 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.627 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -177.57 -49.77 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 114.808 -1.087 . . . . 3.2799999999999998 110.23 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 30.8 Cg_endo -62.2 145.62 96.17 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.408 2.072 . . . . 2.8700000000000001 112.425 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.63 ' HB3' HG21 ' A' ' 402' ' ' THR . 12.5 p-10 -178.47 124.65 0.11 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.047 -0.524 . . . . 2.1400000000000001 110.763 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 400' ' ' SER . 10.8 mp0 -129.89 137.89 50.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.947 -0.57 . . . . 2.1000000000000001 110.127 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.617 ' HB2' HD13 ' A' ' 432' ' ' ILE . 1.4 m-85 -109.76 133.41 53.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.883 0.373 . . . . 1.0600000000000001 111.664 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 30.9 t80 -72.9 120.72 18.92 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.439 -0.578 . . . . 1.05 109.439 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.565 HG13 HG12 ' A' ' 427' ' ' VAL . 8.8 p -112.56 138.75 40.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.584 0.587 . . . . 1.8400000000000001 112.584 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . 0.505 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 83.8 t60 -120.81 88.95 3.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.218 -0.901 . . . . 0.70999999999999996 109.412 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -52.85 116.2 2.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 1.1299999999999999 111.318 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.3 t -62.11 128.89 24.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 1.7 111.371 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.39 -42.44 1.95 Allowed Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.776 -0.647 . . . . 1.1699999999999999 113.351 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 423' ' ' LEU . 7.8 mp -59.45 161.06 6.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.013 0.435 . . . . 2.1499999999999999 111.576 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.596 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 4.9 m120 -49.78 140.91 10.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.514 -0.766 . . . . 2.7599999999999998 111.925 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . 0.507 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 88.7 mtm180 -65.23 -36.45 84.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.867 -0.606 . . . . 4.6500000000000004 110.829 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . 0.442 ' HG2' ' HB3' ' A' ' 420' ' ' ASN . 3.7 ptm85 -55.65 -35.57 66.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.281 -0.418 . . . . 4.3200000000000003 110.643 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.596 ' HG ' ' HB2' ' A' ' 420' ' ' ASN . 76.7 mt -59.02 -35.17 72.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 2.04 111.394 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.507 ' OD2' ' HA ' ' A' ' 421' ' ' ARG . 48.9 m-20 -54.69 139.7 38.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 1.2 111.901 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 179.45 -153.35 12.11 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.472 -0.785 . . . . 0.69999999999999996 111.852 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . 0.511 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 77.0 m95 -94.93 140.48 29.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.833 0.349 . . . . 0.76000000000000001 111.082 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.565 HG12 HG13 ' A' ' 414' ' ' VAL . 16.1 m -138.76 137.5 42.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.032 -0.531 . . . . 1.4399999999999999 111.399 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.49 ' HA2' ' CE1' ' A' ' 430' ' ' HIS . . . -62.22 150.13 47.03 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.819 -0.628 . . . . 1.72 112.591 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.56 ' CZ ' HD13 ' A' ' 373' ' ' ILE . 41.0 tpt85 -53.61 -38.17 63.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 2.3199999999999998 111.302 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.49 ' CE1' ' HA2' ' A' ' 428' ' ' GLY . 19.5 p-80 -58.08 -29.86 65.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.952 0.352 . . . . 2.23 111.952 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.05 -36.13 48.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.578 -0.283 . . . . 3.4199999999999999 111.215 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.617 HD13 ' HB2' ' A' ' 412' ' ' TYR . 54.1 mt -89.28 139.7 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.945 0.402 . . . . 1.1399999999999999 111.366 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.6 m -160.97 139.51 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.95999999999999996 110.651 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -63.78 -26.46 68.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 1.3500000000000001 111.281 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.609 ' ND2' ' HB2' ' A' ' 437' ' ' ASP . 45.8 t30 -109.62 134.06 52.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.92 0.39 . . . . 2.5299999999999998 110.691 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -73.37 -39.85 64.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.007 -0.542 . . . . 1.3300000000000001 112.275 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . 0.609 ' HB2' ' ND2' ' A' ' 435' ' ' ASN . 57.0 m-20 -49.69 -40.87 41.66 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.787 0.291 . . . . 1.3400000000000001 111.787 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.4 -40.96 94.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.348 . . . . 1.5600000000000001 110.97 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.613 ' HB3' HG23 ' A' ' 392' ' ' VAL . 88.5 mt -64.88 -83.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 1.76 111.558 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . 0.508 ' O ' HG21 ' A' ' 444' ' ' VAL . . . -138.59 34.36 2.12 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.492 -0.861 . . . . 1.3600000000000001 113.077 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 437' ' ' ASP . . . 43.63 44.17 6.67 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.365 -0.445 . . . . 1.8300000000000001 113.732 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' A' ' 441' ' ' GLY . 48.0 mm 70.99 73.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.534 0.683 . . . . 1.9199999999999999 111.476 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 36.4 m 45.45 59.13 3.74 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.579 0.955 . . . . 3.4199999999999999 113.579 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 440' ' ' GLY . 16.1 m -151.72 127.43 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 115.756 -0.656 . . . . 4.6399999999999997 110.123 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.453 HD21 HH22 ' A' ' 386' ' ' ARG . 82.7 mt -76.34 126.05 86.9 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.409 -0.359 . . . . 4.9900000000000002 111.31 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.76 140.28 35.24 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.62 2.214 . . . . 8.0099999999999998 112.055 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -54.66 128.08 61.16 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.339 -0.391 . . . . 9.0600000000000005 110.966 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.44 131.36 37.94 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.535 2.157 . . . . 11.42 112.436 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.68 133.19 35.63 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.623 2.215 . . . . 13.529999999999999 112.161 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 94.3 mt -80.99 46.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 16.010000000000002 110.986 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . 57.72 62.92 5.01 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.313 -0.403 . . . . 16.739999999999998 110.932 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.65 135.27 41.27 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.519 2.146 . . . . 18.530000000000001 112.648 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -171.8 128.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.892 -0.594 . . . . 20.550000000000001 110.513 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.207 -0.902 . . . . 21.41 110.915 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 112.452 -0.259 . . . . 11.91 112.452 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.5 t 64.25 131.41 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.953 0.406 . . . . 10.130000000000001 111.278 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -174.37 58.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.097 -0.502 . . . . 8.6699999999999999 110.502 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 67.9 mtm -58.54 140.52 54.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 5.7000000000000002 110.826 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.492 ' HB2' ' HG2' ' A' ' 370' ' ' MET . 55.3 m-20 61.03 120.22 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.005 -0.543 . . . . 6.0599999999999996 111.563 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.67 49.17 3.09 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.657 2.238 . . . . 6.5899999999999999 112.861 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.579 HD13 ' N ' ' A' ' 370' ' ' MET . 4.5 pp -155.42 -33.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.709 -0.223 . . . . 7.21 111.586 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.579 ' N ' HD13 ' A' ' 369' ' ' LEU . 22.4 ptm -78.53 42.9 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.599 -0.273 . . . . 5.6699999999999999 111.449 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -56.25 134.12 53.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.653 0.263 . . . . 5.6100000000000003 110.473 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.403 ' HD2' ' CZ ' ' A' ' 429' ' ' ARG . 48.3 mmtm -145.74 135.27 23.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.464 -0.335 . . . . 5.7800000000000002 111.374 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.495 HG22 HD11 ' A' ' 373' ' ' ILE . 31.4 mm 57.04 127.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.793 -0.64 . . . . 1.9299999999999999 112.448 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -106.19 69.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.711 -0.677 . . . . 2.1699999999999999 110.489 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.586 HG21 ' N ' ' A' ' 376' ' ' SER . 73.5 mt -60.67 -82.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.036 0.754 . . . . 1.4399999999999999 113.036 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.586 ' N ' HG21 ' A' ' 375' ' ' ILE . 52.0 m -49.93 -28.73 7.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.121 -0.49 . . . . 2.2000000000000002 111.814 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -70.44 -38.25 74.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.698 -0.683 . . . . 1.9199999999999999 111.144 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 3.9 m120 -146.04 66.17 11.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 2.8900000000000001 111.68 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.13 -40.65 76.33 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.691 2.261 . . . . 0.97999999999999998 112.227 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.05 -37.13 85.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.887 -0.597 . . . . 1.21 111.327 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.3 tttp -51.17 125.63 14.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.399 . . . . 2.27 111.124 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.648 HG22 HG22 ' A' ' 417' ' ' VAL . 42.5 mm -87.04 132.87 31.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.973 -0.558 . . . . 1.1299999999999999 111.47 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -107.25 143.69 35.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.371 -0.377 . . . . 1.1000000000000001 110.361 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -92.64 138.35 31.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.667 0.27 . . . . 1.3200000000000001 110.641 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.562 HG13 HG12 ' A' ' 432' ' ' ILE . 3.0 mp -123.01 135.45 63.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.893 0.378 . . . . 1.2 111.267 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.659 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 56.3 ttt-85 -92.44 121.73 34.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 3.1699999999999999 111.204 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -79.52 156.64 27.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.546 -0.297 . . . . 2.9900000000000002 110.412 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -51.54 -45.45 62.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 2.8199999999999998 111.036 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.45 ' OD1' HG22 ' A' ' 391' ' ' THR . 2.2 p30 -59.44 -32.53 70.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 1.23 110.295 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 112.33 37.75 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.894 -0.593 . . . . 1.03 112.828 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' THR . . . . . 0.45 HG22 ' OD1' ' A' ' 389' ' ' ASP . 62.9 p -120.84 112.34 18.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.863 0.363 . . . . 1.46 111.342 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.64 HG12 HD11 ' A' ' 439' ' ' LEU . 87.0 t -69.6 138.92 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 1.24 111.21 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.481 ' HB3' HD12 ' A' ' 419' ' ' LEU . 91.0 m-70 -149.37 138.81 21.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.11 -0.496 . . . . 3.2400000000000002 110.978 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 73.8 mtm-85 -57.41 150.28 18.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.545 . . . . 3.5600000000000001 111.802 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.549 ' HA2' HD12 ' A' ' 385' ' ' ILE . . . -175.7 132.98 2.26 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.586 -0.734 . . . . 0.32000000000000001 111.856 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 82.8 mt-30 -95.2 129.99 42.1 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.851 0.315 . . . . 1.28 111.851 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.768 HG23 HD12 ' A' ' 432' ' ' ILE . 21.5 t -85.9 132.38 32.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.94 -0.393 . . . . 1.5800000000000001 109.94 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . 0.401 ' C ' HD12 ' A' ' 375' ' ' ILE . 91.9 mt -121.02 -40.82 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.575 0.583 . . . . 2.04 112.575 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . 0.414 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 97.9 mm-40 -136.86 176.46 8.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.231 0.538 . . . . 2.6400000000000001 112.25 -178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.7 p -158.0 140.13 14.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.369 -0.832 . . . . 1.1299999999999999 109.947 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.45 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 38.0 ptt180 -142.31 137.05 30.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.066 0.46 . . . . 1.8799999999999999 112.035 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 42.1 p -77.42 137.46 38.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 1.79 110.312 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.474 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.7 m -62.4 -174.29 0.06 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.03 -0.359 . . . . 2.2999999999999998 110.03 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.474 ' H ' ' CG2' ' A' ' 403' ' ' THR . 55.5 mt-10 -48.21 -40.69 25.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.8 0.333 . . . . 3.8700000000000001 110.695 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.503 ' O ' ' HD2' ' A' ' 409' ' ' PRO . 50.1 t30 -80.5 54.19 2.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.979 -0.555 . . . . 3.1600000000000001 110.664 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.438 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . -51.43 98.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.131 0.491 . . . . 2.1800000000000002 110.995 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -177.28 -29.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.378 -0.828 . . . . 2.77 109.978 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.569 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -145.57 -51.21 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.106 -0.952 . . . . 3.2799999999999998 111.259 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 51.0 Cg_exo -55.46 145.71 66.97 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.457 2.105 . . . . 2.8700000000000001 112.354 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.401 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 12.8 p-10 -173.01 128.62 0.47 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.153 0.502 . . . . 2.1400000000000001 111.326 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 400' ' ' SER . 52.2 mp0 -108.73 144.25 36.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.643 -0.708 . . . . 2.1000000000000001 109.98 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.559 ' HB3' HG12 ' A' ' 397' ' ' VAL . 0.8 OUTLIER -109.15 124.18 50.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.079 0.466 . . . . 1.0600000000000001 111.841 -178.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 11.9 t80 -63.96 149.9 46.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.567 -0.742 . . . . 1.05 109.341 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 12.3 p -153.78 137.52 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.199 0.523 . . . . 1.8400000000000001 112.356 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -118.46 107.46 13.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.415 -0.811 . . . . 0.70999999999999996 109.553 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -62.13 127.82 33.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.081 0.467 . . . . 1.1299999999999999 111.218 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.648 HG22 HG22 ' A' ' 382' ' ' ILE . 2.4 t -82.49 34.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.518 -0.764 . . . . 1.7 111.223 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -176.81 -48.39 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.769 -0.729 . . . . 1.1699999999999999 112.783 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.481 HD12 ' HB3' ' A' ' 393' ' ' HIS . 7.0 mp -62.75 150.37 41.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 2.1499999999999999 110.916 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.495 ' O ' HD21 ' A' ' 423' ' ' LEU . 48.5 t30 -53.09 165.91 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.943 -0.571 . . . . 2.7599999999999998 111.157 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -64.22 -27.56 69.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 4.6500000000000004 110.543 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -53.44 -39.75 64.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.802 -0.635 . . . . 4.3200000000000003 111.047 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.495 HD21 ' O ' ' A' ' 420' ' ' ASN . 1.6 mm? -70.9 -34.82 71.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.178 -0.465 . . . . 2.04 110.502 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -53.76 131.56 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.798 -0.637 . . . . 1.2 111.25 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 169.72 -146.39 10.01 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.867 -0.606 . . . . 0.69999999999999996 112.209 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . 0.45 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 57.0 m95 -103.75 140.09 38.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.801 0.334 . . . . 0.76000000000000001 110.722 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 432' ' ' ILE . 32.0 m -141.04 144.7 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 1.4399999999999999 111.097 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -59.0 148.69 39.43 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.961 -0.638 . . . . 1.72 112.835 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.403 ' CZ ' ' HD2' ' A' ' 372' ' ' LYS . 18.3 tpt180 -52.3 -39.81 61.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.765 0.317 . . . . 2.3199999999999998 111.316 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.517 ' ND1' ' HG3' ' A' ' 431' ' ' ARG . 6.1 p80 -57.09 -27.5 61.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 2.23 111.973 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.517 ' HG3' ' ND1' ' A' ' 430' ' ' HIS . 67.9 mtt-85 -78.51 -38.84 39.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.637 0.236 . . . . 3.4199999999999999 111.637 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.768 HD12 HG23 ' A' ' 397' ' ' VAL . 51.9 mt -87.91 131.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 1.1399999999999999 110.836 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 71.4 m -161.15 140.18 10.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.591 . . . . 0.95999999999999996 111.089 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -60.19 -24.47 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.035 -0.53 . . . . 1.3500000000000001 111.211 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.425 ' O ' ' HG ' ' A' ' 439' ' ' LEU . 24.0 t-20 -108.4 128.8 55.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.407 -0.36 . . . . 2.5299999999999998 110.944 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -83.3 -40.12 19.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 1.3300000000000001 112.058 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -47.96 -40.59 22.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.43 -0.35 . . . . 1.3400000000000001 111.386 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -70.64 -37.12 73.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 1.5600000000000001 110.902 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 386' ' ' ARG . 84.1 mt -57.32 -84.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.942 -0.572 . . . . 1.76 111.778 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -172.07 40.6 0.17 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.527 -0.844 . . . . 1.3600000000000001 112.885 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 392' ' ' VAL . . . 66.93 143.54 0.06 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.802 -0.713 . . . . 1.8300000000000001 112.861 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 442' ' ' ILE . 50.4 mm -66.8 82.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.756 0.312 . . . . 1.9199999999999999 110.204 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.614 ' O ' HG11 ' A' ' 444' ' ' VAL . 21.5 m 62.69 133.22 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.94 -0.573 . . . . 3.4199999999999999 110.767 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.614 HG11 ' O ' ' A' ' 443' ' ' THR . 0.8 OUTLIER 57.76 132.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.368 -0.833 . . . . 4.6399999999999997 111.707 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.598 ' N ' HD21 ' A' ' 445' ' ' LEU . 2.3 pt? -152.84 139.29 12.33 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.693 -0.685 . . . . 4.9900000000000002 110.944 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.04 144.5 58.1 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.742 2.295 . . . . 8.0099999999999998 112.778 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -169.24 139.34 1.79 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.851 -0.613 . . . . 9.0600000000000005 110.787 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.58 135.98 63.1 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.512 2.141 . . . . 11.42 112.056 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.8 119.12 6.08 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.251 1.967 . . . . 13.529999999999999 112.201 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 450' ' ' LEU . 39.6 tp 179.22 44.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.855 -0.611 . . . . 16.010000000000002 109.948 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.45 ' C ' ' H ' ' A' ' 453' ' ' ASP . . . -173.95 150.61 1.67 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.861 -0.608 . . . . 16.739999999999998 110.769 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.24 30.18 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.43 2.087 . . . . 18.530000000000001 112.802 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 451' ' ' ALA . 50.6 p-10 -76.04 148.28 38.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.49 -0.323 . . . . 20.550000000000001 110.625 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.237 -0.887 . . . . 21.41 110.936 -179.857 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.454 -0.259 . . . . 11.91 112.454 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 51.4 m -80.15 45.94 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.735 0.302 . . . . 10.130000000000001 110.99 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -63.08 141.03 58.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 8.6699999999999999 111.098 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 408' ' ' ALA . 18.0 ptp -67.85 135.97 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.357 -0.383 . . . . 5.7000000000000002 110.426 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 371' ' ' GLN . 55.9 m-20 -62.31 122.14 71.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.424 -0.353 . . . . 6.0599999999999996 110.969 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.05 36.33 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.369 2.046 . . . . 6.5899999999999999 112.223 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.618 HD11 ' N ' ' A' ' 370' ' ' MET . 2.2 pp -153.19 -31.69 0.13 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.01 -0.541 . . . . 7.21 111.113 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.618 ' N ' HD11 ' A' ' 369' ' ' LEU . 69.0 mtm -154.19 55.54 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 5.6699999999999999 110.209 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.555 ' O ' ' HG3' ' A' ' 372' ' ' LYS . 17.2 pt20 -75.38 30.34 0.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.023 -0.535 . . . . 5.6100000000000003 111.823 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.643 ' HZ3' ' HB2' ' A' ' 372' ' ' LYS . 9.8 mtmp? -164.87 134.0 3.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.682 -0.69 . . . . 5.7800000000000002 110.435 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 432' ' ' ILE . 68.0 mt -78.2 136.56 23.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.199 -0.455 . . . . 1.9299999999999999 111.184 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -89.36 129.65 35.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.389 -0.369 . . . . 2.1699999999999999 110.938 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 88.8 mt -95.56 -45.96 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 1.4399999999999999 111.531 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 64.7 m -65.08 72.69 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.397 -0.82 . . . . 2.2000000000000002 111.643 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . 0.549 ' HG3' ' ND2' ' A' ' 378' ' ' ASN . 11.9 pt-20 -175.11 -33.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 1.9199999999999999 110.781 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.549 ' ND2' ' HG3' ' A' ' 377' ' ' GLU . 0.1 OUTLIER -168.53 60.16 0.44 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.532 . . . . 2.8900000000000001 111.582 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.06 -37.78 79.54 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.289 1.993 . . . . 0.97999999999999998 111.543 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.8 -33.45 75.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.646 . . . . 1.21 110.881 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 86.0 tttt -51.44 134.52 28.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.104 -0.498 . . . . 2.27 111.294 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 38.3 mm -82.95 136.26 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.025 -0.534 . . . . 1.1299999999999999 111.268 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -114.41 143.94 44.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.554 -0.293 . . . . 1.1000000000000001 110.452 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 5.3 m-85 -90.07 135.48 33.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.391 -0.368 . . . . 1.3200000000000001 110.718 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.838 HG22 HG13 ' A' ' 427' ' ' VAL . 2.5 mp -118.7 130.47 73.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.4 -0.364 . . . . 1.2 110.984 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.593 ' HD2' ' O ' ' A' ' 439' ' ' LEU . 30.1 ttt85 -90.46 121.77 32.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.465 -0.334 . . . . 3.1699999999999999 110.777 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -79.08 163.03 25.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.331 -0.395 . . . . 2.9900000000000002 110.356 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -57.34 -42.62 82.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.628 0.251 . . . . 2.8199999999999998 110.85 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -60.47 -16.84 40.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.186 0.517 . . . . 1.23 110.05 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.401 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . 91.47 40.84 5.28 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.417 -0.81 . . . . 1.03 112.52 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' THR . . . . . 0.425 ' CG2' HD12 ' A' ' 445' ' ' LEU . 60.9 p -120.99 111.31 17.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 1.46 111.437 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.73 135.77 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 1.24 111.0 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -150.0 139.01 21.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 3.2400000000000002 110.81 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -56.47 148.4 19.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.133 0.492 . . . . 3.5600000000000001 111.788 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.444 ' HA2' HD12 ' A' ' 385' ' ' ILE . . . -171.48 128.01 1.52 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.461 -0.791 . . . . 0.32000000000000001 111.769 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -81.63 128.62 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.849 0.357 . . . . 1.28 111.195 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.84 HG22 HG21 ' A' ' 414' ' ' VAL . 1.0 OUTLIER -101.32 126.0 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.772 -0.455 . . . . 1.5800000000000001 109.772 178.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 50.7 mt -120.71 -34.46 3.57 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.674 0.62 . . . . 2.04 112.674 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . 0.413 ' HB2' ' CB ' ' A' ' 413' ' ' TYR . 70.4 mt-30 -118.97 166.97 12.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.038 0.447 . . . . 2.6400000000000001 111.807 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.7 p -165.93 151.62 8.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.679 -0.691 . . . . 1.1299999999999999 110.729 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -161.24 134.69 6.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.906 0.384 . . . . 1.8799999999999999 111.314 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.565 ' O ' ' HG2' ' A' ' 409' ' ' PRO . 20.4 p -101.0 39.22 1.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 1.79 110.617 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.494 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.5 m 47.31 -174.32 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.618 -0.719 . . . . 2.2999999999999998 111.004 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.494 ' H ' ' CG2' ' A' ' 403' ' ' THR . 0.4 OUTLIER -77.77 -40.54 40.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 3.8700000000000001 110.992 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.32 -51.31 70.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.513 . . . . 3.1600000000000001 111.276 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.462 ' C ' ' HD2' ' A' ' 409' ' ' PRO . . . 65.83 -175.08 0.18 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.993 0.425 . . . . 2.1800000000000002 110.366 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . 62.35 11.35 4.49 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.605 -0.725 . . . . 2.77 112.05 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.561 ' HA ' ' HE3' ' A' ' 366' ' ' MET . . . -168.74 -54.78 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.466 -0.334 . . . . 3.2799999999999998 111.264 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.565 ' HG2' ' O ' ' A' ' 402' ' ' THR . 47.6 Cg_endo -68.02 148.55 75.98 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.478 2.119 . . . . 2.8700000000000001 112.386 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.511 ' HB3' HG21 ' A' ' 402' ' ' THR . 40.0 p-10 -175.51 132.54 0.28 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.901 -0.59 . . . . 2.1400000000000001 110.662 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 96.7 mt-10 -151.32 137.16 18.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 2.1000000000000001 111.202 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.608 ' CE1' ' HG2' ' A' ' 429' ' ' ARG . 3.9 m-85 -117.09 128.73 55.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 1.0600000000000001 111.727 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 20.0 t80 -64.05 135.82 56.75 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.953 -0.567 . . . . 1.05 109.986 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.84 HG21 HG22 ' A' ' 397' ' ' VAL . 60.4 t -129.28 139.5 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.813 0.671 . . . . 1.8400000000000001 112.813 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -120.31 89.32 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.059 -0.973 . . . . 0.70999999999999996 109.142 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.457 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 7.3 m-85 -54.45 116.0 2.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.88 -0.6 . . . . 1.1299999999999999 111.349 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 65.2 t -61.6 125.83 18.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.791 -0.641 . . . . 1.7 111.245 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.56 -43.44 1.85 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.745 -0.661 . . . . 1.1699999999999999 113.101 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 7.6 mp -59.74 152.11 23.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.982 0.42 . . . . 2.1499999999999999 111.389 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -50.36 144.13 7.9 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.659 -0.7 . . . . 2.7599999999999998 111.837 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -58.6 -34.87 71.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.603 -0.726 . . . . 4.6500000000000004 111.45 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . 0.435 ' HG3' HD13 ' A' ' 423' ' ' LEU . 14.8 ptp180 -51.35 -37.07 45.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 4.3200000000000003 111.635 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.444 ' CD2' HD22 ' A' ' 419' ' ' LEU . 10.6 mp -61.1 -33.95 74.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.5 -0.318 . . . . 2.04 111.106 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -48.87 138.25 11.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.241 -0.436 . . . . 1.2 111.068 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -176.17 -137.79 2.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.647 -0.787 . . . . 0.69999999999999996 112.7 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . 0.485 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 38.4 m95 -130.46 141.35 50.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.063 0.458 . . . . 0.76000000000000001 110.905 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.838 HG13 HG22 ' A' ' 385' ' ' ILE . 4.6 m -108.2 156.77 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.683 -0.689 . . . . 1.4399999999999999 110.888 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -79.06 35.34 1.92 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.394 -0.908 . . . . 1.72 111.503 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.608 ' HG2' ' CE1' ' A' ' 412' ' ' TYR . 0.6 OUTLIER 66.0 -73.24 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.003 0.521 . . . . 2.3199999999999998 110.651 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.43 ' C ' ' H ' ' A' ' 432' ' ' ILE . 13.5 p80 -52.51 -18.33 1.65 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.514 -0.312 . . . . 2.23 111.664 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.429 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 64.5 mtt85 -78.73 28.57 0.21 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.6 0.238 . . . . 3.4199999999999999 111.039 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.564 HG12 HG13 ' A' ' 385' ' ' ILE . 42.4 mt -150.27 138.8 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.82 0.343 . . . . 1.1399999999999999 111.036 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 68.1 m -163.96 140.62 6.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.493 . . . . 0.95999999999999996 110.785 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -55.59 -24.29 32.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 1.3500000000000001 111.278 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -108.73 129.81 55.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.113 0.482 . . . . 2.5299999999999998 111.034 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -74.24 -31.93 62.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.768 -0.651 . . . . 1.3300000000000001 111.648 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -44.64 -77.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 1.3400000000000001 111.735 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -47.37 -38.52 13.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 1.5600000000000001 111.81 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.593 ' O ' ' HD2' ' A' ' 386' ' ' ARG . 96.4 mt -61.27 -42.45 98.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.882 0.327 . . . . 1.76 111.882 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 165.01 21.58 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.354 -0.927 . . . . 1.3600000000000001 112.881 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 443' ' ' THR . . . 64.06 153.73 0.09 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.661 -0.78 . . . . 1.8300000000000001 112.472 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.538 ' O ' HG21 ' A' ' 444' ' ' VAL . 45.9 mm -58.26 84.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.646 0.26 . . . . 1.9199999999999999 110.451 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 442' ' ' ILE . 14.8 t 44.38 35.79 1.42 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.789 0.804 . . . . 3.4199999999999999 111.398 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 442' ' ' ILE . 40.7 t -99.31 65.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.566 -1.197 . . . . 4.6399999999999997 110.958 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.425 HD12 ' CG2' ' A' ' 391' ' ' THR . 7.0 mp -64.98 135.81 96.55 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.504 -0.317 . . . . 4.9900000000000002 110.87 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.36 138.05 78.41 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.745 2.297 . . . . 8.0099999999999998 112.69 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -172.24 132.13 0.71 Allowed Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.946 -0.57 . . . . 9.0600000000000005 110.815 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.75 133.15 24.9 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.465 2.11 . . . . 11.42 112.577 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.09 140.26 83.12 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.766 2.311 . . . . 13.529999999999999 112.277 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 92.1 mt 60.74 61.65 1.64 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.235 -0.439 . . . . 16.010000000000002 110.931 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -148.34 135.52 10.54 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 16.739999999999998 111.076 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.0 134.85 44.86 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.627 2.218 . . . . 18.530000000000001 112.356 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 36.2 t70 64.37 135.89 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.952 -0.567 . . . . 20.550000000000001 111.365 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.151 -0.928 . . . . 21.41 110.91 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.485 -0.246 . . . . 11.91 112.485 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 50.6 m 58.03 -142.04 0.71 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.692 -0.114 . . . . 10.130000000000001 110.692 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . 0.418 ' HE2' ' HD3' ' A' ' 368' ' ' PRO . 18.4 t-160 64.66 139.59 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.882 0.373 . . . . 8.6699999999999999 110.848 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.403 ' H ' ' HD2' ' A' ' 365' ' ' HIS . 21.1 ptt? -146.55 56.65 1.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.947 0.403 . . . . 5.7000000000000002 111.338 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 62.29 122.88 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.631 -0.713 . . . . 6.0599999999999996 112.298 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . 0.418 ' HD3' ' HE2' ' A' ' 365' ' ' HIS . 97.3 Cg_endo -85.1 49.56 2.59 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.953 2.436 . . . . 6.5899999999999999 112.276 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -158.7 -54.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 7.21 110.728 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' MET . . . . . . . . . . . . . 54.4 ttp -82.66 56.94 3.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.226 -0.443 . . . . 5.6699999999999999 110.28 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -49.65 120.25 4.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.901 -0.591 . . . . 5.6100000000000003 111.249 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 373' ' ' ILE . 21.7 pttp 34.52 56.98 0.69 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.365 -0.834 . . . . 5.7800000000000002 112.66 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 372' ' ' LYS . 75.9 mt 52.14 126.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.343 0.868 . . . . 1.9299999999999999 113.343 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.78 129.76 36.13 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.329 -0.619 . . . . 2.1699999999999999 109.329 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.6 mt -84.56 -40.87 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.62 0.6 . . . . 1.4399999999999999 112.62 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.6 t -49.54 -17.76 0.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.016 0.436 . . . . 2.2000000000000002 111.22 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -56.39 -43.73 79.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.516 -0.766 . . . . 1.9199999999999999 111.495 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.438 ' N ' ' ND2' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -171.11 69.1 0.49 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 2.8900000000000001 111.392 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.13 -40.05 60.37 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.418 2.079 . . . . 0.97999999999999998 112.047 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -60.55 -36.33 78.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.511 . . . . 1.21 110.844 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 58.9 tttm -52.15 132.81 33.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.18 -0.464 . . . . 2.27 111.431 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.463 HD11 ' HG2' ' A' ' 396' ' ' GLN . 43.2 mm -86.47 131.55 34.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.011 -0.541 . . . . 1.1299999999999999 111.029 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.508 ' O ' HD13 ' A' ' 385' ' ' ILE . 7.3 m-85 -105.47 143.29 33.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.547 -0.297 . . . . 1.1000000000000001 110.58 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.59 140.39 29.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.347 -0.388 . . . . 1.3200000000000001 110.474 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.683 HD12 HG22 ' A' ' 414' ' ' VAL . 0.9 OUTLIER -132.96 128.21 56.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.754 0.311 . . . . 1.2 111.026 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.685 ' NH1' ' HA2' ' A' ' 440' ' ' GLY . 36.7 ttt85 -86.01 121.57 28.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 3.1699999999999999 110.797 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.404 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 61.7 mtp85 -72.93 159.14 34.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 2.9900000000000002 110.659 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -55.03 -45.52 75.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.513 -0.312 . . . . 2.8199999999999998 111.339 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.462 ' OD2' HG22 ' A' ' 391' ' ' THR . 12.0 p-10 -57.98 -29.08 64.96 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.262 -0.644 . . . . 1.23 109.262 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 111.03 37.26 1.7 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.3 -0.864 . . . . 1.03 113.267 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' THR . . . . . 0.462 HG22 ' OD2' ' A' ' 389' ' ' ASP . 29.9 p -121.24 111.15 17.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.878 0.37 . . . . 1.46 111.562 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.443 HG12 HD11 ' A' ' 439' ' ' LEU . 59.6 t -71.13 137.89 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.027 -0.533 . . . . 1.24 111.011 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -150.57 139.64 21.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 3.2400000000000002 110.957 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -56.63 147.56 22.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.815 -0.63 . . . . 3.5600000000000001 111.474 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.615 ' HA2' HD12 ' A' ' 385' ' ' ILE . . . -164.98 128.43 1.79 Allowed Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.824 -0.626 . . . . 0.32000000000000001 112.238 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . 0.463 ' HG2' HD11 ' A' ' 382' ' ' ILE . 88.5 mt-30 -83.32 110.18 17.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.686 0.279 . . . . 1.28 111.503 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.6 OUTLIER -79.09 135.04 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 1.5800000000000001 109.976 178.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 94.1 mt -120.24 -31.91 4.27 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.789 0.663 . . . . 2.04 112.789 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -140.19 175.3 9.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.071 0.462 . . . . 2.6400000000000001 111.931 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.6 p -165.5 149.23 8.21 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.616 -0.72 . . . . 1.1299999999999999 110.576 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 401' ' ' ARG . 14.5 ptt-85 -158.11 138.43 12.6 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.073 0.463 . . . . 1.8799999999999999 111.923 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.561 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 47.2 p -75.29 139.44 42.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.948 -0.569 . . . . 1.79 110.276 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.624 ' HG1' ' HB2' ' A' ' 409' ' ' PRO . 3.5 m -61.76 -174.39 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.504 -0.316 . . . . 2.2999999999999998 110.263 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.524 ' H ' ' CG2' ' A' ' 403' ' ' THR . 50.2 mt-10 -54.6 -45.76 73.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.666 0.269 . . . . 3.8700000000000001 111.573 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -59.84 -47.39 85.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 3.1600000000000001 110.864 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.561 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 64.11 -177.07 0.16 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.024 -0.534 . . . . 2.1800000000000002 110.858 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . 63.22 11.2 5.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.395 -0.82 . . . . 2.77 112.134 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.503 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -170.84 -53.1 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.558 -0.292 . . . . 3.2799999999999998 111.68 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.624 ' HB2' ' HG1' ' A' ' 403' ' ' THR . 65.4 Cg_endo -72.07 149.83 53.15 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.281 1.987 . . . . 2.8700000000000001 112.036 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.462 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 5.1 p-10 -170.32 126.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.11 0.481 . . . . 2.1400000000000001 111.493 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.588 ' O ' ' HA ' ' A' ' 400' ' ' SER . 64.8 mm-40 -109.81 134.68 51.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.496 -0.775 . . . . 2.1000000000000001 110.319 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.506 ' HB2' HD13 ' A' ' 432' ' ' ILE . 2.6 m-85 -112.81 129.26 56.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.87 0.367 . . . . 1.0600000000000001 111.872 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 26.0 t80 -69.19 129.74 40.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.899 -0.778 . . . . 1.05 108.899 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.683 HG22 HD12 ' A' ' 385' ' ' ILE . 10.3 p -131.17 136.8 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.801 0.667 . . . . 1.8400000000000001 112.801 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -114.75 89.8 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.019 -0.992 . . . . 0.70999999999999996 109.582 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.533 ' HA ' ' HA3' ' A' ' 395' ' ' GLY . 35.2 m-85 -54.02 128.1 29.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 1.1299999999999999 111.231 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 67.0 t -71.89 127.92 34.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.996 -0.547 . . . . 1.7 111.278 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.35 -37.14 1.56 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.841 -0.695 . . . . 1.1699999999999999 113.261 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.486 ' HB3' HD11 ' A' ' 423' ' ' LEU . 7.9 mp -59.34 159.7 7.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.237 0.542 . . . . 2.1499999999999999 111.809 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.755 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 5.6 m120 -51.07 140.55 15.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.179 -0.918 . . . . 2.7599999999999998 111.821 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -60.36 -38.36 83.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 4.6500000000000004 110.733 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -60.19 -38.44 83.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 4.3200000000000003 110.991 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.755 ' HG ' ' HB2' ' A' ' 420' ' ' ASN . 90.0 mt -56.65 -31.17 64.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 2.04 110.978 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -52.13 134.5 32.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 1.2 111.182 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 177.04 176.52 45.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.042 -0.599 . . . . 0.69999999999999996 112.369 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -75.2 140.44 43.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.005 0.431 . . . . 0.76000000000000001 110.997 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.508 ' CG2' HD12 ' A' ' 432' ' ' ILE . 25.4 m -133.37 138.82 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 1.4399999999999999 111.354 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -61.73 147.63 48.11 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.859 -0.686 . . . . 1.72 112.394 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.416 ' O ' ' HD2' ' A' ' 429' ' ' ARG . 23.2 tpt180 -51.49 -39.97 58.62 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.758 0.281 . . . . 2.3199999999999998 111.758 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -53.31 -30.78 40.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.757 0.313 . . . . 2.23 111.466 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 431' ' ' ARG . 68.0 mtt-85 -79.47 -35.05 40.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.154 -0.475 . . . . 3.4199999999999999 111.569 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.537 HG12 HG13 ' A' ' 385' ' ' ILE . 53.6 mt -88.89 140.47 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 1.1399999999999999 112.013 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.507 ' N ' HG21 ' A' ' 432' ' ' ILE . 66.8 m -159.89 139.9 11.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.675 -0.693 . . . . 0.95999999999999996 110.413 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.76 16.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 1.3500000000000001 111.773 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.486 ' H ' ' C ' ' A' ' 433' ' ' SER . 22.2 p30 -162.63 135.65 5.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.978 0.418 . . . . 2.5299999999999998 111.055 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.07 73.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 1.3300000000000001 111.639 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -49.73 -40.85 42.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 1.3400000000000001 111.419 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -97.17 49.55 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.44 -0.346 . . . . 1.5600000000000001 111.173 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.443 HD11 HG12 ' A' ' 392' ' ' VAL . 95.6 mt -148.55 -84.53 0.1 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.38 -0.373 . . . . 1.76 111.286 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . 0.685 ' HA2' ' NH1' ' A' ' 386' ' ' ARG . . . -171.02 30.72 0.13 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.577 -0.821 . . . . 1.3600000000000001 112.647 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 63.99 151.35 0.06 OUTLIER Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.743 -0.742 . . . . 1.8300000000000001 112.543 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.41 ' O ' HG11 ' A' ' 444' ' ' VAL . 44.8 mm -64.18 79.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.665 0.269 . . . . 1.9199999999999999 110.464 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 9.7 t 40.74 44.39 1.86 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.005 0.907 . . . . 3.4199999999999999 111.71 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 442' ' ' ILE . 15.6 m -94.64 49.14 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.029 -1.441 . . . . 4.6399999999999997 111.221 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.611 ' O ' HD11 ' A' ' 445' ' ' LEU . 0.4 OUTLIER -96.77 143.77 26.7 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.46 -0.791 . . . . 4.9900000000000002 111.861 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.87 148.05 89.71 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.617 2.211 . . . . 8.0099999999999998 111.862 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . -49.17 133.0 16.34 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.288 -0.414 . . . . 9.0600000000000005 111.143 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 447' ' ' ALA . 35.3 Cg_exo -57.84 135.64 70.32 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.624 2.216 . . . . 11.42 112.478 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 32.4 Cg_exo -58.59 137.59 81.05 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.72 2.28 . . . . 13.529999999999999 112.295 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 6.6 mp 64.83 143.41 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.031 -0.532 . . . . 16.010000000000002 111.502 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -163.84 127.19 1.75 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.915 -0.584 . . . . 16.739999999999998 110.926 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.06 137.77 53.9 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.701 2.268 . . . . 18.530000000000001 112.63 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 65.11 135.65 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.003 -0.544 . . . . 20.550000000000001 111.497 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.22 -0.895 . . . . 21.41 111.036 179.912 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.495 -0.242 . . . . 11.91 112.495 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' SER . . . . . 0.55 ' HB3' ' NZ ' ' A' ' 372' ' ' LYS . 45.0 t -61.61 -41.06 96.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.707 0.289 . . . . 10.130000000000001 110.889 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 74.5 t60 65.68 139.12 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.017 -0.538 . . . . 8.6699999999999999 111.295 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 27.9 ttt -166.41 128.08 1.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.895 -0.593 . . . . 5.7000000000000002 110.593 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.45 ' HB3' HD22 ' A' ' 369' ' ' LEU . 62.2 m-20 59.75 119.34 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 115.997 -0.547 . . . . 6.0599999999999996 111.56 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.56 42.17 1.25 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.553 2.169 . . . . 6.5899999999999999 112.762 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.597 ' N ' HD21 ' A' ' 369' ' ' LEU . 1.9 pt? -170.01 -25.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.713 0.292 . . . . 7.21 111.218 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' MET . . . . . . . . . . . . . 44.2 ttp -135.01 62.88 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 5.6699999999999999 111.307 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -59.68 137.31 58.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.368 -0.378 . . . . 5.6100000000000003 110.454 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.55 ' NZ ' ' HB3' ' A' ' 364' ' ' SER . 23.7 pttm -49.85 130.23 21.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 5.7800000000000002 111.455 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.05 128.45 31.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.929 -0.578 . . . . 1.9299999999999999 111.564 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 0.3 OUTLIER -93.95 130.58 39.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 2.1699999999999999 110.503 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.29 -41.25 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.125 0.417 . . . . 1.4399999999999999 112.125 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 82.1 p -47.46 -26.4 1.36 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.018 -0.537 . . . . 2.2000000000000002 112.021 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.6 pt-20 -67.5 -39.23 85.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.197 -0.456 . . . . 1.9199999999999999 111.898 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 5.6 m120 -151.87 67.31 7.11 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 112.095 0.406 . . . . 2.8900000000000001 112.095 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.7 -41.1 63.48 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.734 2.289 . . . . 0.97999999999999998 112.419 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.94 -38.28 85.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.973 -0.558 . . . . 1.21 111.324 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 87.4 tttt -48.91 127.12 13.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 2.27 111.075 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.434 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 44.3 mm -86.32 126.68 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.989 -0.55 . . . . 1.1299999999999999 111.165 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.417 ' O ' HD13 ' A' ' 385' ' ' ILE . 2.6 m-85 -105.13 144.16 32.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.311 -0.404 . . . . 1.1000000000000001 110.151 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.435 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 1.9 m-85 -89.88 137.32 32.44 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.929 -0.308 . . . . 1.3200000000000001 110.543 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.53 HG13 HG12 ' A' ' 432' ' ' ILE . 2.7 mp -122.89 125.57 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.329 -0.396 . . . . 1.2 111.218 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.469 ' HE ' ' HA3' ' A' ' 390' ' ' GLY . 78.1 ttt180 -83.86 116.82 22.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 3.1699999999999999 110.261 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.434 ' HB2' ' OD1' ' A' ' 389' ' ' ASP . 51.9 mtp85 -71.53 163.98 26.71 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.941 -0.304 . . . . 2.9900000000000002 110.703 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 389' ' ' ASP . 11.5 pm0 -49.72 -39.76 38.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.309 -0.405 . . . . 2.8199999999999998 111.214 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.45 ' N ' ' HG2' ' A' ' 388' ' ' GLU . 43.1 p-10 -65.87 -35.04 79.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 1.23 111.215 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.469 ' HA3' ' HE ' ' A' ' 386' ' ' ARG . . . 129.32 -31.31 3.47 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.718 -0.753 . . . . 1.03 112.539 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 71.3 p -59.36 113.09 2.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.096 0.474 . . . . 1.46 112.144 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.689 HG12 HD11 ' A' ' 439' ' ' LEU . 59.8 t -71.15 141.31 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.562 -0.745 . . . . 1.24 110.902 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -148.9 134.77 18.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.484 -0.325 . . . . 3.2400000000000002 110.803 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.434 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 88.2 mtm180 -54.22 152.97 5.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.232 -0.44 . . . . 3.5600000000000001 111.498 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 416' ' ' TYR . . . -168.83 135.66 3.71 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.657 -0.701 . . . . 0.32000000000000001 112.089 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -87.04 110.37 20.03 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.724 0.268 . . . . 1.28 111.724 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.565 HG23 HD12 ' A' ' 432' ' ' ILE . 11.6 t -77.94 128.01 38.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.765 -0.828 . . . . 1.5800000000000001 108.765 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . 0.408 ' HA ' HD21 ' A' ' 398' ' ' LEU . 58.2 mt -121.0 -38.27 2.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.011 0.745 . . . . 2.04 113.011 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . 0.448 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 26.0 mt-30 -133.95 176.53 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 2.6400000000000001 112.049 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.3 p -162.16 148.03 13.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.676 -0.693 . . . . 1.1299999999999999 110.349 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.401 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 39.4 ptt180 -161.45 139.19 9.1 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.887 0.375 . . . . 1.8799999999999999 111.536 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 67.3 p -73.4 -125.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 1.79 109.884 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.44 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.23 -173.52 3.16 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.77 -0.456 . . . . 2.2999999999999998 109.77 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.44 ' H ' ' CG2' ' A' ' 403' ' ' THR . 55.6 mt-10 -46.11 -43.77 15.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.678 0.275 . . . . 3.8700000000000001 111.275 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -67.72 -52.62 35.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 3.1600000000000001 110.798 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 53.81 54.33 10.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.003 -0.544 . . . . 2.1800000000000002 111.658 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.456 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -149.09 10.65 0.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.517 0.675 . . . . 2.77 109.755 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.475 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . -179.46 -47.71 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.628 -1.169 . . . . 3.2799999999999998 110.077 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 408' ' ' ALA . 39.5 Cg_exo -57.53 146.79 82.36 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.509 2.139 . . . . 2.8700000000000001 112.585 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.6 p30 -174.38 138.07 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 2.1400000000000001 110.568 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.4 mt-10 -137.14 134.4 36.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 2.1000000000000001 110.375 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 0.8 OUTLIER -109.93 125.7 53.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.855 0.359 . . . . 1.0600000000000001 111.49 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 14.0 t80 -59.49 147.13 37.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.974 -0.557 . . . . 1.05 109.516 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.66 134.55 4.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.237 0.541 . . . . 1.8400000000000001 112.055 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -120.24 101.85 8.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.455 -0.793 . . . . 0.70999999999999996 109.902 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.471 ' HA ' ' HA3' ' A' ' 395' ' ' GLY . 50.1 m-85 -59.82 129.49 42.1 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.899 0.381 . . . . 1.1299999999999999 110.681 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.83 37.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.887 -0.597 . . . . 1.7 111.109 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -175.47 -36.1 0.05 OUTLIER Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.254 -0.974 . . . . 1.1699999999999999 113.851 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.714 HD11 HD21 ' A' ' 423' ' ' LEU . 13.0 mt -62.8 -167.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.729 0.776 . . . . 2.1499999999999999 112.48 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.526 ' OD1' ' HG2' ' A' ' 422' ' ' ARG . 16.5 t-20 -81.29 149.85 28.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.55 -1.204 . . . . 2.7599999999999998 111.025 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -59.47 -40.89 88.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.91 0.386 . . . . 4.6500000000000004 110.779 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . 0.526 ' HG2' ' OD1' ' A' ' 420' ' ' ASN . 16.2 ptm180 -69.19 -34.9 75.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.048 -0.524 . . . . 4.3200000000000003 110.851 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.714 HD21 HD11 ' A' ' 419' ' ' LEU . 1.3 mp -56.48 -34.94 67.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.875 -0.602 . . . . 2.04 111.201 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -59.09 137.6 57.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.077 -0.51 . . . . 1.2 110.757 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -170.52 -140.51 3.03 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.619 -0.8 . . . . 0.69999999999999996 112.646 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . 0.401 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 16.8 m95 -119.7 134.76 55.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.906 0.384 . . . . 0.76000000000000001 110.81 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.482 HG22 HG13 ' A' ' 432' ' ' ILE . 31.5 m -109.47 155.27 10.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.987 -0.551 . . . . 1.4399999999999999 111.758 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -74.11 25.27 1.04 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.918 -0.583 . . . . 1.72 113.951 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.541 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 36.2 tpt85 71.26 -46.32 0.64 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.68 0.622 . . . . 2.3199999999999998 112.68 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -58.77 -19.86 44.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.944 0.402 . . . . 2.23 110.911 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.4 mtt180 -78.66 -30.32 46.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.813 -0.63 . . . . 3.4199999999999999 111.464 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.565 HD12 HG23 ' A' ' 397' ' ' VAL . 66.8 mt -88.02 137.29 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 120.766 0.317 . . . . 1.1399999999999999 110.728 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.505 ' HG ' HD22 ' A' ' 439' ' ' LEU . 57.9 m -160.18 139.73 11.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 0.95999999999999996 111.075 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -69.26 -23.48 63.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 1.3500000000000001 111.472 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -108.23 133.54 52.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.891 0.377 . . . . 2.5299999999999998 111.129 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -67.85 -43.9 78.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 1.3300000000000001 111.366 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -54.92 -39.82 69.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 1.3400000000000001 111.014 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.06 51.0 1.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 1.5600000000000001 110.948 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.689 HD11 HG12 ' A' ' 392' ' ' VAL . 82.3 mt -150.13 -93.51 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 1.76 111.106 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -177.02 48.05 0.1 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.609 -0.805 . . . . 1.3600000000000001 112.746 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.28 132.07 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.83 -0.7 . . . . 1.8300000000000001 112.848 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.513 HG21 HG23 ' A' ' 443' ' ' THR . 47.9 mm -67.51 107.96 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 110.247 -0.279 . . . . 1.9199999999999999 110.247 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.513 HG23 HG21 ' A' ' 442' ' ' ILE . 11.8 t 40.23 41.21 0.94 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.644 0.735 . . . . 3.4199999999999999 111.757 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 442' ' ' ILE . 77.7 t -145.69 131.93 14.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.866 -1.061 . . . . 4.6399999999999997 111.1 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.453 HD12 ' HA2' ' A' ' 390' ' ' GLY . 96.1 mt -146.09 139.14 14.29 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.726 -0.67 . . . . 4.9900000000000002 110.465 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.53 131.31 43.07 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.543 2.162 . . . . 8.0099999999999998 112.651 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -67.97 144.48 97.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 9.0600000000000005 111.118 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.75 133.58 54.89 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.448 2.098 . . . . 11.42 112.189 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.33 130.8 23.31 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.437 2.091 . . . . 13.529999999999999 112.56 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 73.1 mt 62.53 127.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.863 -0.608 . . . . 16.010000000000002 111.621 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . 53.38 88.25 0.12 Allowed Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.88 -0.6 . . . . 16.739999999999998 111.802 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.54 130.39 18.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.494 2.129 . . . . 18.530000000000001 112.276 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -175.52 139.84 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 20.550000000000001 110.888 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . 0.445 ' N ' ' OE1' ' A' ' 454' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.281 -0.866 . . . . 21.41 110.894 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.467 -0.253 . . . . 11.91 112.467 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.9 t -64.45 126.66 28.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.86 0.362 . . . . 10.130000000000001 110.877 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -73.07 139.97 46.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 8.6699999999999999 110.78 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 62.3 mtt -63.43 118.57 8.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.404 -0.362 . . . . 5.7000000000000002 110.534 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.1 138.58 68.66 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 6.0599999999999996 111.169 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.09 38.1 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.561 2.174 . . . . 6.5899999999999999 112.317 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.418 ' C ' HD13 ' A' ' 369' ' ' LEU . 1.9 pp -152.3 27.68 0.58 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.079 0.466 . . . . 7.21 111.042 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.407 ' HB3' ' HE1' ' A' ' 370' ' ' MET . 44.2 ttp -170.81 49.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.768 -0.651 . . . . 5.6699999999999999 110.284 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.436 ' OE1' ' N ' ' A' ' 371' ' ' GLN . 0.5 OUTLIER -54.47 133.02 45.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.051 -0.522 . . . . 5.6100000000000003 110.7 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.508 ' HB2' ' OH ' ' A' ' 412' ' ' TYR . 48.0 mmtm -56.72 132.87 53.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 5.7800000000000002 111.004 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 373' ' ' ILE . 66.8 mt 58.15 101.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.837 -0.62 . . . . 1.9299999999999999 111.633 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.05 129.71 35.63 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.19 -0.459 . . . . 2.1699999999999999 109.989 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.93 -43.19 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.079 0.4 . . . . 1.4399999999999999 112.079 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.0 t -48.86 -30.35 5.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.044 0.449 . . . . 2.2000000000000002 111.151 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.76 -36.61 36.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.752 -0.658 . . . . 1.9199999999999999 111.8 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.483 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -146.46 72.17 12.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.004 0.43 . . . . 2.8900000000000001 111.439 -179.428 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -63.62 -36.42 53.13 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.105 1.87 . . . . 0.97999999999999998 111.286 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -64.37 -31.29 72.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 1.21 110.823 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 62.5 tttm -49.31 130.77 19.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.074 -0.512 . . . . 2.27 111.424 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.463 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 33.2 mm -88.68 135.46 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.773 -0.649 . . . . 1.1299999999999999 111.109 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -117.43 143.83 45.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.537 -0.301 . . . . 1.1000000000000001 110.711 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.434 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 1.8 m-85 -89.14 147.03 24.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.841 0.353 . . . . 1.3200000000000001 111.136 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.643 HD11 ' N ' ' A' ' 385' ' ' ILE . 2.8 mp -132.22 131.68 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 1.2 110.741 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 42.2 ttt-85 -84.8 123.55 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.251 -0.431 . . . . 3.1699999999999999 111.198 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -83.75 167.24 17.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.29 -0.414 . . . . 2.9900000000000002 110.461 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.457 ' C ' ' H ' ' A' ' 390' ' ' GLY . 0.5 OUTLIER -58.36 -42.7 87.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.506 -0.315 . . . . 2.8199999999999998 111.082 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -69.86 5.13 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.403 . . . . 1.23 110.581 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 388' ' ' GLU . . . 70.76 42.71 61.06 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.902 -0.59 . . . . 1.03 112.955 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 82.5 p -120.62 111.47 17.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.958 0.408 . . . . 1.46 111.151 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.623 HG12 HD11 ' A' ' 439' ' ' LEU . 22.6 t -69.94 135.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 1.24 111.308 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -149.28 139.85 22.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 3.2400000000000002 110.742 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.463 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 54.9 mtm-85 -56.03 157.8 4.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.318 0.58 . . . . 3.5600000000000001 112.048 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.443 ' HA2' HD12 ' A' ' 385' ' ' ILE . . . -178.56 126.56 1.08 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.125 -0.943 . . . . 0.32000000000000001 111.442 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . 0.425 ' HG2' HD11 ' A' ' 382' ' ' ILE . 89.1 mt-30 -83.42 129.38 34.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.823 0.344 . . . . 1.28 111.791 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.867 HG23 HD12 ' A' ' 432' ' ' ILE . 8.5 t -88.9 134.69 27.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.51 -0.552 . . . . 1.5800000000000001 109.51 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 78.0 mt -120.18 -38.51 2.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.568 0.581 . . . . 2.04 112.568 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -141.65 176.12 9.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.051 0.453 . . . . 2.6400000000000001 111.809 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 97.4 p -155.62 149.66 25.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.604 -0.725 . . . . 1.1299999999999999 110.176 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 18.4 ptt-85 -149.26 134.78 18.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.229 0.538 . . . . 1.8799999999999999 112.246 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 409' ' ' PRO . 46.2 p -93.65 138.1 32.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.819 -0.628 . . . . 1.79 110.065 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.525 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 3.5 m -61.5 -174.65 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.655 -0.248 . . . . 2.2999999999999998 110.47 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.525 ' H ' ' CG2' ' A' ' 403' ' ' THR . 55.9 mt-10 -53.72 -39.02 64.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.571 0.224 . . . . 3.8700000000000001 111.565 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.413 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 50.2 t30 -56.86 -49.66 74.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.423 -0.353 . . . . 3.1600000000000001 110.988 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 54.12 52.9 11.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.221 -0.445 . . . . 2.1800000000000002 111.494 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -156.5 10.83 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.844 -0.616 . . . . 2.77 110.141 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.59 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.19 -48.28 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.15 -0.932 . . . . 3.2799999999999998 110.561 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 24.0 Cg_exo -63.75 140.02 71.97 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.589 2.192 . . . . 2.8700000000000001 112.4 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.468 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 13.2 p-10 -173.82 122.63 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 2.1400000000000001 110.988 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 400' ' ' SER . 9.1 mp0 -113.94 134.24 54.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 2.1000000000000001 110.504 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.508 ' OH ' ' HB2' ' A' ' 372' ' ' LYS . 6.5 m-85 -109.57 125.15 52.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 1.0600000000000001 111.575 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.741 ' HA ' ' HA ' ' A' ' 426' ' ' TRP . 14.0 t80 -60.9 139.74 57.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 1.05 110.234 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.499 HG13 HG12 ' A' ' 427' ' ' VAL . 13.0 p -133.96 137.73 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.218 0.532 . . . . 1.8400000000000001 111.928 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -119.54 96.6 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.48 -0.782 . . . . 0.70999999999999996 109.889 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -58.99 124.6 20.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 1.1299999999999999 111.024 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.79 128.54 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.911 -0.586 . . . . 1.7 111.396 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 78.17 -40.64 1.94 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.896 -0.668 . . . . 1.1699999999999999 113.072 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.491 ' HB3' HD21 ' A' ' 423' ' ' LEU . 7.5 mp -59.34 153.87 17.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.982 0.42 . . . . 2.1499999999999999 111.28 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.623 HD22 HD11 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -49.31 142.22 7.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.722 -0.672 . . . . 2.7599999999999998 112.143 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -60.81 -36.7 79.7 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.463 -0.79 . . . . 4.6500000000000004 111.96 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . 0.568 HH11 HD13 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -53.64 -29.0 36.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.907 0.385 . . . . 4.3200000000000003 110.761 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.623 HD11 HD22 ' A' ' 420' ' ' ASN . 1.1 tp -63.2 -33.32 75.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 2.04 111.303 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -44.94 133.61 6.23 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.181 -0.463 . . . . 1.2 111.4 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . 0.456 ' O ' HG11 ' A' ' 414' ' ' VAL . . . 174.36 154.59 11.05 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.793 -0.64 . . . . 0.69999999999999996 112.053 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . 0.741 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 11.4 m95 -68.75 134.03 49.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.76000000000000001 110.296 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.499 HG12 HG13 ' A' ' 414' ' ' VAL . 35.6 m -127.05 142.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 1.4399999999999999 111.245 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.423 ' HA2' ' CE1' ' A' ' 430' ' ' HIS . . . -52.24 147.42 13.15 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.026 -0.607 . . . . 1.72 112.912 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.455 ' O ' ' HD2' ' A' ' 429' ' ' ARG . 14.6 tpt180 -52.01 -42.03 62.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.633 0.254 . . . . 2.3199999999999998 111.429 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.423 ' CE1' ' HA2' ' A' ' 428' ' ' GLY . 13.4 p-80 -56.58 -25.88 53.83 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.968 0.359 . . . . 2.23 111.968 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 56.4 mtt85 -77.89 -40.59 39.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.692 -0.231 . . . . 3.4199999999999999 111.532 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.867 HD12 HG23 ' A' ' 397' ' ' VAL . 59.7 mt -88.79 136.54 23.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.914 0.388 . . . . 1.1399999999999999 110.948 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 435' ' ' ASN . 67.3 m -161.4 139.7 9.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.953 -0.567 . . . . 0.95999999999999996 110.743 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -76.73 16.13 0.55 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 1.3500000000000001 111.181 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.436 ' O ' HD13 ' A' ' 439' ' ' LEU . 6.1 m120 -134.59 116.01 14.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.409 -0.359 . . . . 2.5299999999999998 110.734 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.33 98.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.031 -0.531 . . . . 1.3300000000000001 111.595 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -57.04 -40.87 77.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 1.3400000000000001 111.13 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' A' ' 439' ' ' LEU . 59.0 m-20 -83.16 45.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 1.5600000000000001 111.011 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.623 HD11 HG12 ' A' ' 392' ' ' VAL . 47.6 mt -154.58 -41.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.22 -0.446 . . . . 1.76 111.011 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 157.81 40.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.701 -0.761 . . . . 1.3600000000000001 112.132 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.58 -128.89 41.68 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.629 -0.796 . . . . 1.8300000000000001 112.103 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 44.8 mm -126.04 71.69 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.106 0.479 . . . . 1.9199999999999999 110.447 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.416 ' C ' HG21 ' A' ' 444' ' ' VAL . 56.2 m 52.36 45.84 27.76 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.593 -0.73 . . . . 3.4199999999999999 110.719 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.416 HG21 ' C ' ' A' ' 443' ' ' THR . 87.7 t -150.9 121.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.725 -0.67 . . . . 4.6399999999999997 111.017 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.605 ' N ' HD21 ' A' ' 445' ' ' LEU . 4.0 mm? -91.56 130.55 38.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 4.9900000000000002 110.564 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.54 127.06 15.77 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.438 2.092 . . . . 8.0099999999999998 112.335 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . 53.87 64.38 6.65 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 9.0600000000000005 111.459 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.7 130.41 18.15 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.315 2.01 . . . . 11.42 112.243 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.88 53.82 4.58 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.788 2.325 . . . . 13.529999999999999 112.69 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 451' ' ' ALA . 8.6 tt -165.23 124.51 1.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.917 0.389 . . . . 16.010000000000002 110.878 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.501 ' O ' HD22 ' A' ' 450' ' ' LEU . . . -76.66 142.21 69.94 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.982 -0.554 . . . . 16.739999999999998 111.08 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.25 -146.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.684 2.256 . . . . 18.530000000000001 112.646 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -59.06 -48.51 81.34 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.285 -0.416 . . . . 20.550000000000001 111.066 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.155 -0.926 . . . . 21.41 111.019 -179.911 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.441 -0.264 . . . . 11.91 112.441 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 49.9 m -61.59 130.41 45.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.77 0.319 . . . . 10.130000000000001 110.945 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -81.26 37.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 8.6699999999999999 111.307 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 23.6 ttt 63.23 146.34 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.244 -0.435 . . . . 5.7000000000000002 111.005 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.14 126.03 25.62 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 6.0599999999999996 111.301 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.29 37.7 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.676 2.251 . . . . 6.5899999999999999 112.81 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 371' ' ' GLN . 23.2 tp -178.29 -51.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.214 -0.448 . . . . 7.21 110.407 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.415 ' O ' ' HG3' ' A' ' 370' ' ' MET . 14.3 tpt -82.6 33.9 0.43 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.207 0.527 . . . . 5.6699999999999999 109.861 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.424 ' H ' ' C ' ' A' ' 369' ' ' LEU . 18.4 pt20 -80.64 48.8 1.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.8 -0.636 . . . . 5.6100000000000003 111.077 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 373' ' ' ILE . 62.7 mttp 60.3 116.01 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.758 -0.655 . . . . 5.7800000000000002 111.952 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.561 HG21 ' N ' ' A' ' 374' ' ' ASP . 72.5 mt 55.38 140.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 113.069 0.766 . . . . 1.9299999999999999 113.069 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.561 ' N ' HG21 ' A' ' 373' ' ' ILE . 1.6 m-20 -138.99 132.73 30.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.491 -0.777 . . . . 2.1699999999999999 109.852 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 82.7 mt -78.2 -40.9 26.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.089 0.403 . . . . 1.4399999999999999 112.089 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 88.1 p -47.91 -21.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.278 0.561 . . . . 2.2000000000000002 110.851 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -58.11 -47.63 82.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.192 -0.913 . . . . 1.9199999999999999 110.949 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 7.5 m120 -165.25 111.26 0.81 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.799 -0.637 . . . . 2.8900000000000001 111.29 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.3 -41.04 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.932 2.422 . . . . 0.97999999999999998 112.22 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.99 -32.37 61.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.993 -0.548 . . . . 1.21 111.666 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.579 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.2 tttp -46.35 129.31 10.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.973 0.416 . . . . 2.27 111.556 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 50.0 mm -87.75 126.13 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.894 -0.594 . . . . 1.1299999999999999 111.276 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -99.58 143.1 30.21 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.098 -0.334 . . . . 1.1000000000000001 110.098 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -92.73 136.25 33.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 1.3200000000000001 111.292 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.496 HD12 HG22 ' A' ' 414' ' ' VAL . 2.5 mp -116.21 129.58 72.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.078 -0.51 . . . . 1.2 110.757 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.56 ' CZ ' ' HA3' ' A' ' 390' ' ' GLY . 0.0 OUTLIER -97.48 110.26 22.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 3.1699999999999999 110.232 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.424 ' O ' ' HD3' ' A' ' 386' ' ' ARG . 76.6 mtp180 -77.74 158.82 29.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.501 -0.318 . . . . 2.9900000000000002 110.983 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -54.15 -41.52 68.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.485 -0.325 . . . . 2.8199999999999998 111.449 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -60.46 -10.12 4.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.938 0.399 . . . . 1.23 110.788 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.56 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . 83.88 36.04 14.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.931 -0.577 . . . . 1.03 112.424 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 73.1 p -121.07 111.72 17.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.31 . . . . 1.46 111.146 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 439' ' ' LEU . 54.6 t -73.53 134.24 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 1.24 110.537 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -142.63 135.93 28.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.941 0.401 . . . . 3.2400000000000002 110.751 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.439 HH11 ' HG3' ' A' ' 394' ' ' ARG . 54.4 mtm-85 -56.64 146.48 25.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 3.5600000000000001 111.293 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 416' ' ' TYR . . . -164.12 129.88 2.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.615 -0.72 . . . . 0.32000000000000001 112.065 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -88.36 105.07 17.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.739 0.304 . . . . 1.28 111.379 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.693 HG23 ' HB3' ' A' ' 412' ' ' TYR . 0.5 OUTLIER -71.09 129.78 34.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.964 -0.384 . . . . 1.5800000000000001 109.964 178.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 81.3 mt -121.0 -34.32 3.55 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 112.686 0.624 . . . . 2.04 112.686 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . 0.447 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 74.2 mt-30 -129.18 175.46 8.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.036 0.446 . . . . 2.6400000000000001 111.918 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 99.4 p -166.53 148.56 6.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.612 -0.722 . . . . 1.1299999999999999 110.63 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 37.9 ptt180 -155.76 134.57 11.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.769 0.319 . . . . 1.8799999999999999 110.941 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 65.2 p -72.38 -132.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.575 -0.284 . . . . 1.79 110.533 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.45 HG21 ' H ' ' A' ' 404' ' ' GLU . 1.2 m -162.84 -173.6 3.56 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.854 -0.424 . . . . 2.2999999999999998 109.854 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.45 ' H ' HG21 ' A' ' 403' ' ' THR . 67.2 mm-40 -44.55 -38.83 4.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.759 0.314 . . . . 3.8700000000000001 111.172 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 407' ' ' ALA . 25.1 t-20 -65.66 -53.08 46.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 3.1600000000000001 110.73 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 54.85 61.99 2.72 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.184 -0.462 . . . . 2.1800000000000002 111.895 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -165.07 2.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 2.77 110.708 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.404 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . -175.71 -49.97 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.529 -0.76 . . . . 3.2799999999999998 110.853 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.486 ' O ' ' HA ' ' A' ' 402' ' ' THR . 27.3 Cg_exo -61.72 143.0 95.95 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.332 2.022 . . . . 2.8700000000000001 112.056 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.598 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.6 p30 -179.84 131.92 0.1 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.234 0.54 . . . . 2.1400000000000001 112.054 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 400' ' ' SER . 49.8 mp0 -109.47 135.82 49.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.516 -0.765 . . . . 2.1000000000000001 109.297 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.693 ' HB3' HG23 ' A' ' 397' ' ' VAL . 0.4 OUTLIER -109.33 126.35 53.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.942 0.401 . . . . 1.0600000000000001 111.61 -178.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.615 ' O ' HG21 ' A' ' 397' ' ' VAL . 19.8 t80 -62.42 135.83 57.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 1.05 109.673 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.496 HG22 HD12 ' A' ' 385' ' ' ILE . 14.6 p -139.93 137.71 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.333 0.587 . . . . 1.8400000000000001 112.563 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -112.23 97.4 6.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.197 -0.91 . . . . 0.70999999999999996 109.762 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.491 ' HA ' ' HA3' ' A' ' 395' ' ' GLY . 7.8 m-85 -57.09 127.13 30.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 1.1299999999999999 111.133 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.98 129.4 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.037 -0.529 . . . . 1.7 111.042 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.53 -43.28 2.08 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.828 -0.701 . . . . 1.1699999999999999 112.897 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.91 155.47 16.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.887 0.375 . . . . 2.1499999999999999 111.196 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -51.21 140.57 16.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 2.7599999999999998 110.727 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 22.8 ptt-85 -62.31 -37.43 85.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.443 . . . . 4.6500000000000004 110.362 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -55.66 -40.37 72.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.519 -0.764 . . . . 4.3200000000000003 110.704 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . . . . . . . . . 48.4 mt -62.57 -35.53 79.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.914 -0.584 . . . . 2.04 110.575 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' A' ' 416' ' ' TYR . 9.1 m-20 -64.94 138.17 58.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.58 -0.736 . . . . 1.2 111.623 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . 0.416 ' O ' HG11 ' A' ' 414' ' ' VAL . . . -177.89 -151.26 9.16 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.702 -0.681 . . . . 0.69999999999999996 111.909 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -83.29 137.27 34.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.76000000000000001 110.76 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.575 ' CG2' ' HB2' ' A' ' 431' ' ' ARG . 1.9 p -127.23 139.8 50.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 1.4399999999999999 111.724 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -64.87 147.4 50.98 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.688 -0.687 . . . . 1.72 112.578 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 45.3 tpt85 -52.7 -39.24 61.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 2.3199999999999998 111.355 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.463 ' HD1' ' H ' ' A' ' 430' ' ' HIS . 19.6 p-80 -64.47 -27.97 69.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.453 0.538 . . . . 2.23 112.453 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.575 ' HB2' ' CG2' ' A' ' 427' ' ' VAL . 61.3 mtt-85 -78.56 -30.02 46.6 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.176 0.436 . . . . 3.4199999999999999 112.176 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.429 HG23 HD11 ' A' ' 432' ' ' ILE . 65.1 mt -87.8 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.043 0.449 . . . . 1.1399999999999999 111.795 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.406 ' C ' ' H ' ' A' ' 435' ' ' ASN . 56.7 m -161.57 139.41 9.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.531 -0.759 . . . . 0.95999999999999996 110.27 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -74.67 16.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 1.3500000000000001 111.927 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.518 HD21 ' HB2' ' A' ' 437' ' ' ASP . 16.3 p-10 -159.61 136.33 9.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.049 0.452 . . . . 2.5299999999999998 111.321 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -65.52 -31.88 73.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.707 -0.679 . . . . 1.3300000000000001 111.586 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . 0.518 ' HB2' HD21 ' A' ' 435' ' ' ASN . 31.6 m-20 -49.37 -41.06 38.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.296 -0.411 . . . . 1.3400000000000001 111.256 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -97.98 43.01 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 1.5600000000000001 110.649 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.482 HD11 HG12 ' A' ' 392' ' ' VAL . 96.7 mt -150.52 -84.02 0.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.113 -0.494 . . . . 1.76 110.993 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -173.89 41.23 0.14 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.087 -0.578 . . . . 1.3600000000000001 112.065 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 61.26 -138.71 47.48 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.881 -0.676 . . . . 1.8300000000000001 112.459 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 36.3 mm -119.83 61.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.227 0.537 . . . . 1.9199999999999999 110.354 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 59.2 m 48.46 45.62 20.78 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.442 -0.799 . . . . 3.4199999999999999 110.902 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 18.4 t -96.18 51.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.361 0.6 . . . . 4.6399999999999997 110.761 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.13 135.22 44.88 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.48 -0.782 . . . . 4.9900000000000002 111.218 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.2 137.35 28.54 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.572 2.181 . . . . 8.0099999999999998 112.397 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . -170.08 123.97 0.65 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.252 -0.431 . . . . 9.0600000000000005 111.022 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 447' ' ' ALA . 16.7 Cg_exo -67.58 129.1 19.31 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.605 2.203 . . . . 11.42 112.251 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.54 50.18 3.42 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.683 2.255 . . . . 13.529999999999999 112.503 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -170.92 137.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 16.010000000000002 111.115 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -64.33 137.9 97.27 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 16.739999999999998 111.009 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.85 139.42 74.24 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.653 2.235 . . . . 18.530000000000001 112.378 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -170.7 137.28 1.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 20.550000000000001 111.077 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . 0.604 ' NE2' ' H ' ' A' ' 454' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.275 -0.869 . . . . 21.41 110.773 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.407 -0.277 . . . . 11.91 112.407 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 46.9 t -61.61 -49.7 75.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.727 0.299 . . . . 10.130000000000001 110.953 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -176.29 37.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 8.6699999999999999 110.944 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.695 ' HE2' ' HB3' ' A' ' 370' ' ' MET . 0.0 OUTLIER 65.38 141.53 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.083 -0.508 . . . . 5.7000000000000002 110.694 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.741 ' HB3' HD22 ' A' ' 369' ' ' LEU . 1.4 m-20 -47.52 128.89 10.54 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.177 -0.465 . . . . 6.0599999999999996 111.293 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.5 46.12 2.1 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.892 2.395 . . . . 6.5899999999999999 113.575 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.741 HD22 ' HB3' ' A' ' 367' ' ' ASP . 2.5 pt? -161.15 -27.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.652 0.263 . . . . 7.21 111.138 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.695 ' HB3' ' HE2' ' A' ' 366' ' ' MET . 43.6 tpp -75.3 32.33 0.1 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.056 0.455 . . . . 5.6699999999999999 111.084 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.479 ' H ' ' C ' ' A' ' 369' ' ' LEU . 73.6 mt-30 -111.27 41.16 1.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.365 0.602 . . . . 5.6100000000000003 109.932 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.415 ' HE3' ' HE ' ' A' ' 429' ' ' ARG . 50.1 mtmt -78.18 167.08 21.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.249 -0.887 . . . . 5.7800000000000002 111.935 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.492 HG22 HD11 ' A' ' 373' ' ' ILE . 42.0 mt 68.56 136.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 115.518 -0.765 . . . . 1.9299999999999999 111.635 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.695 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 57.5 m-20 -150.08 69.0 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.393 -0.821 . . . . 2.1699999999999999 109.91 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.53 HD12 ' C ' ' A' ' 397' ' ' VAL . 60.7 mt -45.48 -35.84 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.542 -0.754 . . . . 1.4399999999999999 112.431 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 41.9 t -45.84 -35.87 4.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.433 0.531 . . . . 2.2000000000000002 112.433 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 16.9 pt-20 -79.13 -36.99 39.68 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.11 0.411 . . . . 1.9199999999999999 112.11 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.652 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 6.8 m120 -145.58 83.49 8.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 112.353 0.501 . . . . 2.8900000000000001 112.353 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -63.95 -41.21 24.12 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.022 2.481 . . . . 0.97999999999999998 112.875 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.77 -31.97 61.92 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.162 0.431 . . . . 1.21 112.162 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.652 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 87.9 tttt -41.1 129.73 2.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.014 0.435 . . . . 2.27 111.213 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 48.9 mm -83.09 132.69 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.686 -0.688 . . . . 1.1299999999999999 111.96 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -113.21 143.42 44.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.036 -0.529 . . . . 1.1000000000000001 109.72 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.573 ' HB3' HG13 ' A' ' 392' ' ' VAL . 27.1 m-85 -93.7 130.51 39.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.673 0.273 . . . . 1.3200000000000001 111.029 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.636 HG23 ' HH ' ' A' ' 416' ' ' TYR . 2.1 mp -117.5 131.03 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.361 -0.382 . . . . 1.2 110.945 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.547 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 55.4 ttp180 -84.7 124.02 31.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.582 -0.281 . . . . 3.1699999999999999 110.997 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -73.17 -174.97 1.7 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.799 0.333 . . . . 2.9900000000000002 110.654 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -67.31 -45.3 76.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 2.8199999999999998 111.177 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -70.73 -36.1 73.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 1.23 111.8 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 141.35 -33.09 2.02 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.436 -0.888 . . . . 1.03 112.764 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 443' ' ' THR . 41.4 p -59.05 112.82 1.82 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.302 0.572 . . . . 1.46 111.611 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' A' ' 384' ' ' PHE . 46.6 t -78.98 131.03 35.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.328 -0.851 . . . . 1.24 111.853 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.496 ' ND1' HD13 ' A' ' 419' ' ' LEU . 45.2 m170 -122.79 138.33 54.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.99 -0.55 . . . . 3.2400000000000002 110.401 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 416' ' ' TYR . 64.9 mtt85 -58.73 153.62 16.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.144 0.497 . . . . 3.5600000000000001 111.988 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -174.37 132.39 2.23 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.501 -0.772 . . . . 0.32000000000000001 111.828 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -91.35 129.97 37.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.92 0.36 . . . . 1.28 111.752 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.846 HG23 HD12 ' A' ' 432' ' ' ILE . 16.0 t -84.64 136.08 23.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.821 -0.437 . . . . 1.5800000000000001 109.821 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.24 -46.58 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.116 0.413 . . . . 2.04 112.116 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -125.58 175.71 7.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 2.6400000000000001 111.82 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 81.0 p -165.47 145.33 6.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.457 -0.792 . . . . 1.1299999999999999 110.304 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 20.3 ptt-85 -145.64 136.66 24.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.052 0.453 . . . . 1.8799999999999999 111.528 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.686 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 17.9 p -102.06 37.41 1.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.821 -0.627 . . . . 1.79 111.044 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.524 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 3.2 m 49.29 -173.33 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.178 -0.465 . . . . 2.2999999999999998 110.659 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.524 ' H ' ' CG2' ' A' ' 403' ' ' THR . 59.1 mm-40 -65.08 -40.97 95.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 3.8700000000000001 111.164 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.414 ' HB2' ' HG3' ' A' ' 409' ' ' PRO . 19.9 m-20 -57.08 -55.16 38.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 3.1600000000000001 112.053 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.686 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 55.92 41.51 29.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.369 0.604 . . . . 2.1800000000000002 109.813 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.63 ' HA ' ' HG2' ' A' ' 366' ' ' MET . . . -139.54 10.14 2.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.041 -0.981 . . . . 2.77 110.03 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.63 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -179.9 -50.05 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.005 -0.998 . . . . 3.2799999999999998 110.16 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 20.4 Cg_endo -59.9 147.57 92.12 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.451 2.1 . . . . 2.8700000000000001 112.138 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.532 ' HB3' HG21 ' A' ' 402' ' ' THR . 12.1 p-10 -176.85 134.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.424 . . . . 2.1400000000000001 110.982 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 400' ' ' SER . 51.4 mt-10 -145.93 134.2 21.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 2.1000000000000001 110.006 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.671 ' HB3' HG12 ' A' ' 397' ' ' VAL . 3.5 m-85 -112.52 128.88 56.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.969 0.414 . . . . 1.0600000000000001 111.739 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 24.5 t80 -67.78 150.37 48.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.93 -0.577 . . . . 1.05 109.769 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.435 ' CG1' HG23 ' A' ' 427' ' ' VAL . 8.9 p -148.03 137.72 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.175 0.512 . . . . 1.8400000000000001 112.081 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -115.67 101.14 8.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.70999999999999996 110.312 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.636 ' HH ' HG23 ' A' ' 385' ' ' ILE . 2.4 m-85 -63.44 124.41 21.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.437 -0.347 . . . . 1.1299999999999999 110.62 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 91.5 t -74.98 128.36 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 1.7 110.985 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.88 -40.92 1.67 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.895 -0.669 . . . . 1.1699999999999999 112.905 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 2.8 mm? -59.27 157.53 10.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.229 0.538 . . . . 2.1499999999999999 111.987 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -52.45 147.19 8.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.129 -0.941 . . . . 2.7599999999999998 111.795 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -61.54 -38.18 86.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.944 -0.571 . . . . 4.6500000000000004 110.56 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 64.0 mtt-85 -54.51 -39.51 67.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.943 -0.571 . . . . 4.3200000000000003 109.94 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.61 HD11 ' N ' ' A' ' 423' ' ' LEU . 5.3 mp -63.56 -35.66 81.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.18 -0.918 . . . . 2.04 110.321 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 416' ' ' TYR . 15.2 m-20 -65.88 133.31 50.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.54 -0.755 . . . . 1.2 111.269 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 173.98 -152.92 15.82 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.915 -0.66 . . . . 0.69999999999999996 112.178 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . 0.415 ' O ' HG11 ' A' ' 427' ' ' VAL . 57.0 m95 -96.32 139.81 31.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.854 0.359 . . . . 0.76000000000000001 110.964 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.462 ' O ' HG21 ' A' ' 427' ' ' VAL . 17.8 m -143.15 144.67 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 1.4399999999999999 110.991 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -58.89 151.09 34.64 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.832 -0.699 . . . . 1.72 112.425 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.415 ' HE ' ' HE3' ' A' ' 372' ' ' LYS . 21.5 tpt180 -51.45 -40.16 58.86 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.769 0.285 . . . . 2.3199999999999998 111.769 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -51.62 -30.95 23.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.644 0.259 . . . . 2.23 111.426 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.632 ' O ' HD22 ' A' ' 439' ' ' LEU . 99.0 mtt180 -80.16 -38.66 30.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 3.4199999999999999 111.969 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.846 HD12 HG23 ' A' ' 397' ' ' VAL . 77.5 mt -88.1 132.15 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.648 -0.421 . . . . 1.1399999999999999 110.749 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 435' ' ' ASN . 75.7 m -163.42 143.43 8.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.797 -0.638 . . . . 0.95999999999999996 111.157 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.06 16.46 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 1.3500000000000001 111.224 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.779 HD22 ' HB2' ' A' ' 437' ' ' ASP . 52.6 t30 -152.12 132.49 13.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.969 0.414 . . . . 2.5299999999999998 110.651 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -79.21 -34.99 42.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.913 -0.585 . . . . 1.3300000000000001 112.546 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . 0.779 ' HB2' HD22 ' A' ' 435' ' ' ASN . 1.5 m-20 -48.96 -40.45 30.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.67 0.271 . . . . 1.3400000000000001 111.499 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.96 -33.69 75.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 1.5600000000000001 111.084 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.632 HD22 ' O ' ' A' ' 431' ' ' ARG . 7.3 mp -85.34 -86.37 0.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.85 -0.614 . . . . 1.76 112.554 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -167.51 52.92 0.23 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.482 -0.866 . . . . 1.3600000000000001 113.045 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 71.53 -148.35 43.55 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.831 -0.7 . . . . 1.8300000000000001 112.748 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.515 ' O ' HG21 ' A' ' 443' ' ' THR . 49.2 mm -118.28 108.86 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.427 -0.212 . . . . 1.9199999999999999 110.427 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.522 ' O ' HG21 ' A' ' 444' ' ' VAL . 10.0 t 38.18 39.14 0.25 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.4 0.619 . . . . 3.4199999999999999 112.074 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 443' ' ' THR . 81.7 t -149.49 122.23 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.102 -0.954 . . . . 4.6399999999999997 111.302 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 444' ' ' VAL . 36.8 tp 175.26 68.2 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.219 0 CA-C-N 115.821 -0.627 . . . . 4.9900000000000002 110.265 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -52.49 135.58 55.24 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.791 2.328 . . . . 8.0099999999999998 112.902 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -173.24 135.48 0.7 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.705 -0.68 . . . . 9.0600000000000005 110.589 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.85 136.32 71.6 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.42 2.08 . . . . 11.42 112.2 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.38 132.04 36.69 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.514 2.143 . . . . 13.529999999999999 112.232 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -62.01 131.16 48.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 16.010000000000002 110.856 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . -70.64 131.41 87.95 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.037 -0.529 . . . . 16.739999999999998 110.968 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.421 ' O ' ' HB3' ' A' ' 453' ' ' ASP . 32.0 Cg_exo -58.58 130.75 38.71 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.378 2.052 . . . . 18.530000000000001 112.032 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 452' ' ' PRO . 63.7 t0 74.09 -46.24 0.61 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.007 -0.542 . . . . 20.550000000000001 111.496 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.251 -0.88 . . . . 21.41 110.264 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.4 -0.28 . . . . 11.91 112.4 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 59.1 m -160.38 41.71 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.819 0.342 . . . . 10.130000000000001 110.88 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -67.66 -27.04 66.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 8.6699999999999999 110.575 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 95.4 mmm 65.99 51.36 1.34 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.38 -0.827 . . . . 5.7000000000000002 111.33 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.403 ' OD2' ' HE2' ' A' ' 372' ' ' LYS . 57.9 m-20 61.92 154.02 0.11 Allowed Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.119 -0.491 . . . . 6.0599999999999996 111.8 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . 0.533 ' HG2' ' HG3' ' A' ' 371' ' ' GLN . 77.2 Cg_exo -50.75 -20.46 6.7 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.605 2.203 . . . . 6.5899999999999999 112.41 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 369' ' ' LEU . 1.1 tm? 178.75 -52.47 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.313 -1.312 . . . . 7.21 109.939 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.468 ' O ' ' HG3' ' A' ' 370' ' ' MET . 4.2 tpt -170.6 33.24 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.776 -0.647 . . . . 5.6699999999999999 109.62 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.533 ' HG3' ' HG2' ' A' ' 368' ' ' PRO . 8.3 mm100 -70.98 106.13 3.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.611 -0.722 . . . . 5.6100000000000003 111.012 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.523 ' HD2' ' NE ' ' A' ' 429' ' ' ARG . 67.4 mmtt -160.0 -179.52 7.86 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.235 -0.439 . . . . 5.7800000000000002 110.988 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.595 HG12 ' CZ ' ' A' ' 429' ' ' ARG . 47.9 mm -59.85 131.43 24.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.008 -0.542 . . . . 1.9299999999999999 111.892 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.66 ' HB3' ' HG3' ' A' ' 377' ' ' GLU . 1.5 m-20 -90.07 140.95 29.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.833 -0.621 . . . . 2.1699999999999999 110.44 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.557 HG21 ' N ' ' A' ' 376' ' ' SER . 68.8 mt -111.65 -80.29 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.481 0.549 . . . . 1.4399999999999999 112.481 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.557 ' N ' HG21 ' A' ' 375' ' ' ILE . 45.4 t -52.42 -22.48 4.76 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.438 0.637 . . . . 2.2000000000000002 110.818 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . 0.66 ' HG3' ' HB3' ' A' ' 374' ' ' ASP . 21.8 mm-40 -62.48 -39.54 93.76 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.901 -1.045 . . . . 1.9199999999999999 111.138 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.419 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -155.5 64.13 3.91 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.529 . . . . 2.8900000000000001 111.109 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -51.31 -40.26 61.74 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.48 2.12 . . . . 0.97999999999999998 112.273 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -60.02 -36.69 77.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.084 -0.507 . . . . 1.21 110.933 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -54.57 130.09 38.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.064 -0.517 . . . . 2.27 111.358 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 46.6 mm -87.54 136.58 22.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.116 -0.493 . . . . 1.1299999999999999 110.664 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -110.72 144.0 40.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.738 0.304 . . . . 1.1000000000000001 110.784 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.427 ' C ' HD13 ' A' ' 385' ' ' ILE . 3.3 m-85 -92.62 132.78 36.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 1.3200000000000001 110.884 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.503 HG12 HG13 ' A' ' 414' ' ' VAL . 2.3 mp -114.06 123.38 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.29 -0.414 . . . . 1.2 111.023 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 387' ' ' ARG . 4.8 tmm_? -92.34 110.27 21.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 3.1699999999999999 110.273 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.597 ' HG2' ' NH2' ' A' ' 431' ' ' ARG . 70.7 mtp180 -73.81 153.55 39.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.288 -0.414 . . . . 2.9900000000000002 110.857 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 390' ' ' GLY . 49.5 mt-10 -54.15 -41.31 68.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 2.8199999999999998 111.685 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -66.7 5.21 0.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.093 0.473 . . . . 1.23 110.633 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.546 ' O ' HD13 ' A' ' 445' ' ' LEU . . . 74.94 35.4 50.23 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.494 -0.775 . . . . 1.03 113.707 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 49.2 p -121.44 110.73 16.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 1.46 111.19 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.445 HG12 HD13 ' A' ' 439' ' ' LEU . 51.6 t -73.86 140.69 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 1.24 111.384 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.434 ' N ' HG11 ' A' ' 392' ' ' VAL . 92.5 m-70 -150.6 136.59 18.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.936 -0.574 . . . . 3.2400000000000002 110.43 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 69.9 mtm-85 -56.77 152.88 11.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.058 0.456 . . . . 3.5600000000000001 112.019 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -173.39 134.97 3.08 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.572 -0.74 . . . . 0.32000000000000001 112.096 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -95.37 129.56 42.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.726 0.298 . . . . 1.28 111.476 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' A' ' 412' ' ' TYR . 13.2 t -89.09 128.69 41.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.363 -0.381 . . . . 1.5800000000000001 110.323 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 89.6 mt -121.29 -40.03 2.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.096 0.406 . . . . 2.04 112.096 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . 0.49 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 66.1 mt-30 -127.38 175.74 7.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.073 0.463 . . . . 2.6400000000000001 111.936 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 95.7 p -165.51 148.74 7.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.592 -0.731 . . . . 1.1299999999999999 110.152 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -163.45 135.69 5.16 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.036 0.446 . . . . 1.8799999999999999 112.065 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 41.1 p -74.78 139.76 43.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 1.79 109.786 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.489 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.6 m -61.21 -174.84 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.281 -0.266 . . . . 2.2999999999999998 110.281 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.489 ' H ' ' CG2' ' A' ' 403' ' ' THR . 7.5 mp0 -50.3 -40.31 48.16 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.744 0.276 . . . . 3.8700000000000001 111.744 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.538 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 49.3 t30 -56.91 -49.39 75.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 3.1600000000000001 110.8 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.584 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.28 55.18 8.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 2.1800000000000002 111.466 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -158.7 9.77 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 2.77 110.16 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.541 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.38 -48.66 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.039 -0.982 . . . . 3.2799999999999998 110.209 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 20.2 Cg_exo -65.26 144.69 81.75 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.579 2.186 . . . . 2.8700000000000001 112.512 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.591 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.1 p30 -169.48 129.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 2.1400000000000001 110.542 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.9 mt-10 -115.87 134.65 54.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.971 -0.559 . . . . 2.1000000000000001 110.797 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.582 ' HB3' HG12 ' A' ' 397' ' ' VAL . 1.6 m-85 -109.24 123.55 49.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 1.0600000000000001 110.626 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 17.1 t80 -56.16 143.09 34.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.502 . . . . 1.05 110.206 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.503 HG13 HG12 ' A' ' 385' ' ' ILE . 28.6 t -136.41 136.91 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.152 0.501 . . . . 1.8400000000000001 111.823 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -117.25 90.57 3.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.641 -0.709 . . . . 0.70999999999999996 110.083 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.409 ' H ' ' HD1' ' A' ' 416' ' ' TYR . 4.1 m-85 -59.76 115.63 3.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 1.1299999999999999 110.724 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.74 130.99 29.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.0 -0.545 . . . . 1.7 111.008 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.13 -45.71 2.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.894 -0.67 . . . . 1.1699999999999999 112.574 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.43 143.56 55.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.957 0.408 . . . . 2.1499999999999999 111.121 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.52 HD21 ' HB3' ' A' ' 422' ' ' ARG . 53.1 t30 -56.25 161.49 2.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.862 -0.608 . . . . 2.7599999999999998 111.327 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -59.96 -29.03 68.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.035 -0.53 . . . . 4.6500000000000004 110.803 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . 0.52 ' HB3' HD21 ' A' ' 420' ' ' ASN . 12.5 tpt180 -53.43 -39.39 64.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.72 -0.673 . . . . 4.3200000000000003 111.305 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' ' 420' ' ' ASN . 2.2 mm? -69.75 -35.63 75.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.232 -0.44 . . . . 2.04 110.529 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -60.51 138.41 58.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.85 -0.614 . . . . 1.2 111.089 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -173.3 -137.94 2.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.861 -0.685 . . . . 0.69999999999999996 112.475 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 37.9 m95 -128.93 132.88 47.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.76000000000000001 110.916 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 411' ' ' GLU . 34.0 m -115.64 150.34 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 1.4399999999999999 111.011 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -74.3 32.7 0.96 Allowed Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.807 -0.711 . . . . 1.72 113.681 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.595 ' CZ ' HG12 ' A' ' 373' ' ' ILE . 42.2 tpt85 71.55 -45.65 0.62 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.705 0.632 . . . . 2.3199999999999998 112.705 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.508 ' CE1' ' HG3' ' A' ' 431' ' ' ARG . 8.7 p80 -54.62 -22.79 14.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.823 0.305 . . . . 2.23 111.823 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.597 ' NH2' ' HG2' ' A' ' 387' ' ' ARG . 75.2 mtp180 -79.44 -31.7 42.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.256 0.465 . . . . 3.4199999999999999 112.256 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.517 HD11 HG23 ' A' ' 397' ' ' VAL . 57.6 mt -87.49 136.85 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.849 0.357 . . . . 1.1399999999999999 111.333 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 63.7 m -158.7 140.65 13.77 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.98 -0.554 . . . . 0.95999999999999996 110.938 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -74.75 16.85 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.002 -0.544 . . . . 1.3500000000000001 112.084 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.739 HD22 ' HB2' ' A' ' 437' ' ' ASP . 53.5 t30 -155.64 132.05 10.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 2.5299999999999998 111.203 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -73.55 -41.19 63.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.854 -0.612 . . . . 1.3300000000000001 112.178 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . 0.739 ' HB2' HD22 ' A' ' 435' ' ' ASN . 54.0 m-20 -49.03 -40.5 31.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.503 -0.317 . . . . 1.3400000000000001 111.391 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -65.37 -44.36 87.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 1.5600000000000001 110.946 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 386' ' ' ARG . 68.0 mt -62.97 -83.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.227 -0.442 . . . . 1.76 111.179 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -157.98 32.03 0.51 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.489 -0.862 . . . . 1.3600000000000001 112.825 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 48.98 40.99 28.45 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.924 -0.655 . . . . 1.8300000000000001 112.515 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 444' ' ' VAL . 45.6 mm 57.27 102.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.178 -0.305 . . . . 1.9199999999999999 110.178 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.717 HG21 HG21 ' A' ' 444' ' ' VAL . 15.2 t 41.5 -145.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.322 0.389 . . . . 3.4199999999999999 110.621 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.717 HG21 HG21 ' A' ' 443' ' ' THR . 3.1 t 58.78 63.85 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.369 -0.378 . . . . 4.6399999999999997 111.88 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 390' ' ' GLY . 83.4 mt -136.89 130.77 17.76 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.753 0.311 . . . . 4.9900000000000002 111.172 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 145.92 52.78 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.788 2.325 . . . . 8.0099999999999998 112.621 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -54.3 143.97 43.1 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.017 -0.538 . . . . 9.0600000000000005 111.171 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.18 136.87 62.92 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.582 2.188 . . . . 11.42 112.377 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 451' ' ' ALA . 21.4 Cg_endo -60.63 135.91 63.58 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.579 2.186 . . . . 13.529999999999999 112.276 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 1.3 pp -78.24 33.65 0.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 16.010000000000002 111.603 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 449' ' ' PRO . . . -63.24 137.58 97.11 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 16.739999999999998 111.122 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.62 139.03 73.34 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.555 2.17 . . . . 18.530000000000001 112.213 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 34.3 t70 66.2 134.08 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.961 -0.563 . . . . 20.550000000000001 111.175 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . 0.433 ' N ' ' OE1' ' A' ' 454' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.293 -0.86 . . . . 21.41 110.883 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.418 ' HA2' ' OG ' ' A' ' 376' ' ' SER . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.464 -0.254 . . . . 11.91 112.464 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 75.7 p -67.23 -124.82 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.518 0.199 . . . . 10.130000000000001 110.902 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . 0.537 ' HD1' ' N ' ' A' ' 366' ' ' MET . 8.4 p80 -161.19 -152.67 0.27 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 110.332 -0.247 . . . . 8.6699999999999999 110.332 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.537 ' N ' ' HD1' ' A' ' 365' ' ' HIS . 26.5 ptt? -78.1 46.67 0.61 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.881 0.372 . . . . 5.7000000000000002 111.217 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -62.97 116.26 23.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 6.0599999999999996 111.469 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . 0.737 ' HD2' ' HG3' ' A' ' 371' ' ' GLN . 74.3 Cg_exo -50.52 -21.29 7.38 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.968 2.446 . . . . 6.5899999999999999 113.104 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.649 ' N ' HD21 ' A' ' 369' ' ' LEU . 2.3 pt? -171.92 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.898 -1.046 . . . . 7.21 110.307 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' MET . . . . . . . . . . . . . 4.6 tmm? 178.73 38.14 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.51 -0.768 . . . . 5.6699999999999999 109.503 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.737 ' HG3' ' HD2' ' A' ' 368' ' ' PRO . 22.5 mt-30 -77.95 141.95 38.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.571 . . . . 5.6100000000000003 111.015 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.495 ' HB2' ' HE2' ' A' ' 365' ' ' HIS . 67.8 mttm 63.14 144.45 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.074 -0.512 . . . . 5.7800000000000002 111.602 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.547 ' H ' HH22 ' A' ' 429' ' ' ARG . 86.4 mt -50.4 129.39 8.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.932 -0.576 . . . . 1.9299999999999999 111.836 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.06 129.72 44.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.87 -0.605 . . . . 2.1699999999999999 110.041 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.519 HD12 HG11 ' A' ' 397' ' ' VAL . 82.9 mt -68.32 -45.24 82.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.493 -0.321 . . . . 1.4399999999999999 111.842 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.418 ' OG ' ' HA2' ' A' ' 363' ' ' GLY . 69.0 m -70.15 62.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.692 -0.685 . . . . 2.2000000000000002 110.848 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -147.52 -33.71 0.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.737 -0.665 . . . . 1.9199999999999999 110.0 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -173.0 65.7 0.34 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.132 -0.94 . . . . 2.8900000000000001 110.959 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.6 -38.44 55.04 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.457 2.104 . . . . 0.97999999999999998 111.859 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.04 -36.99 83.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 1.21 110.593 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -51.64 140.45 18.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.016 -0.538 . . . . 2.27 110.844 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 382' ' ' ILE . 49.8 mm -86.23 128.89 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 1.1299999999999999 111.537 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -105.28 144.76 31.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 1.1000000000000001 110.378 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.477 ' N ' ' HD1' ' A' ' 384' ' ' PHE . 1.8 m-30 -90.5 133.5 35.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.446 -0.343 . . . . 1.3200000000000001 110.633 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.622 HD11 ' N ' ' A' ' 385' ' ' ILE . 3.0 mp -128.94 128.98 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.799 0.333 . . . . 1.2 111.145 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.619 ' N ' HD22 ' A' ' 439' ' ' LEU . 58.1 ttt-85 -92.73 123.24 35.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 3.1699999999999999 111.193 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -71.05 158.16 36.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.367 -0.379 . . . . 2.9900000000000002 110.162 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -49.53 -35.59 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 2.8199999999999998 110.828 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.97 -36.24 69.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 1.23 111.666 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.525 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . 135.99 -35.17 2.17 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.378 -0.915 . . . . 1.03 113.126 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 68.7 p -58.67 112.36 1.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 1.46 112.207 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.411 HG23 HD21 ' A' ' 439' ' ' LEU . 97.1 t -72.39 144.92 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.186 -0.916 . . . . 1.24 111.225 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -150.48 139.74 21.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.161 -0.472 . . . . 3.2400000000000002 110.959 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -60.07 151.29 27.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.87 -0.605 . . . . 3.5600000000000001 112.168 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.584 ' HA2' HD12 ' A' ' 385' ' ' ILE . . . -169.62 135.13 3.43 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.434 -0.803 . . . . 0.32000000000000001 111.823 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -91.97 111.57 23.16 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.304 0.483 . . . . 1.28 112.304 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.733 HG21 HD12 ' A' ' 432' ' ' ILE . 24.4 t -76.43 132.87 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.483 -0.326 . . . . 1.5800000000000001 110.383 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.33 -42.92 2.43 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.735 0.643 . . . . 2.04 112.735 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . 0.475 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 97.5 mm-40 -129.18 177.46 7.14 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.212 0.53 . . . . 2.6400000000000001 112.208 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.0 p -153.35 157.3 39.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.454 -0.794 . . . . 1.1299999999999999 110.043 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 33.2 ptt180 -154.09 137.09 15.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.08 0.467 . . . . 1.8799999999999999 112.258 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 409' ' ' PRO . 36.4 p -96.31 136.07 37.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 1.79 110.036 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.502 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.6 m -62.75 -174.52 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.469 -0.332 . . . . 2.2999999999999998 110.622 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.502 ' H ' ' CG2' ' A' ' 403' ' ' THR . 64.9 mm-40 -53.13 -40.07 63.95 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.721 0.267 . . . . 3.8700000000000001 111.721 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.691 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 26.0 t-20 -55.95 -51.01 69.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 3.1600000000000001 110.994 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 53.49 55.96 7.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.079 0.466 . . . . 2.1800000000000002 111.89 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.498 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -160.55 10.86 0.1 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.727 -0.669 . . . . 2.77 109.456 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.536 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.64 -48.06 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.611 -1.177 . . . . 3.2799999999999998 110.213 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.691 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 38.2 Cg_exo -61.04 138.14 76.5 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.736 2.291 . . . . 2.8700000000000001 112.701 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 13.6 p-10 -173.39 123.31 0.38 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.909 -0.587 . . . . 2.1400000000000001 111.09 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 400' ' ' SER . 58.3 mp0 -112.51 142.34 45.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.774 -0.648 . . . . 2.1000000000000001 110.284 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.628 ' HB2' HD11 ' A' ' 432' ' ' ILE . 1.2 m-85 -109.03 124.17 50.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.019 0.438 . . . . 1.0600000000000001 111.804 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.475 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 18.8 t80 -62.19 150.16 39.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.722 -0.672 . . . . 1.05 109.409 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.506 HG13 HG12 ' A' ' 427' ' ' VAL . 7.3 p -150.92 132.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.286 0.565 . . . . 1.8400000000000001 112.193 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -110.74 90.98 3.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.268 -0.878 . . . . 0.70999999999999996 109.596 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.492 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 14.3 m-85 -53.03 135.68 36.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.094 0.473 . . . . 1.1299999999999999 111.25 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.472 ' CG1' ' H ' ' A' ' 418' ' ' GLY . 17.6 t -63.67 -124.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.454 -0.794 . . . . 1.7 111.417 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.472 ' H ' ' CG1' ' A' ' 417' ' ' VAL . . . -39.7 -29.41 0.16 Allowed Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.248 0.459 . . . . 1.1699999999999999 114.248 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 7.1 mp -58.79 141.31 53.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.244 0.522 . . . . 2.1499999999999999 110.955 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.603 ' O ' HD21 ' A' ' 423' ' ' LEU . 49.2 t30 -55.42 154.89 5.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.966 -0.561 . . . . 2.7599999999999998 111.286 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 68.5 mtt-85 -53.35 -29.81 36.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.663 -0.699 . . . . 4.6500000000000004 112.152 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . 0.419 ' HG2' ' HB3' ' A' ' 420' ' ' ASN . 16.8 ptm180 -52.65 -40.7 63.08 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.956 0.354 . . . . 4.3200000000000003 111.956 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.603 HD21 ' O ' ' A' ' 420' ' ' ASN . 1.1 mm? -71.05 -35.09 71.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.713 0.292 . . . . 2.04 111.028 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.27 130.51 46.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 1.2 111.427 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.67 -145.67 9.19 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.69999999999999996 112.012 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -100.36 140.22 34.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.76000000000000001 110.946 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.506 HG12 HG13 ' A' ' 414' ' ' VAL . 28.5 m -140.26 145.72 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 1.4399999999999999 110.971 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 430' ' ' HIS . . . -59.83 147.55 43.54 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.914 -0.584 . . . . 1.72 113.361 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.547 HH22 ' H ' ' A' ' 373' ' ' ILE . 15.4 tpt180 -50.93 -38.92 53.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.654 0.381 . . . . 2.3199999999999998 111.72 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.434 ' CE1' ' HA2' ' A' ' 428' ' ' GLY . 24.8 p-80 -57.87 -28.83 64.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.092 0.404 . . . . 2.23 112.092 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.556 ' HB3' HG21 ' A' ' 385' ' ' ILE . 98.8 mtt180 -78.35 -38.62 41.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.993 0.368 . . . . 3.4199999999999999 111.993 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.733 HD12 HG21 ' A' ' 397' ' ' VAL . 60.1 mt -88.01 133.27 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.898 0.38 . . . . 1.1399999999999999 110.893 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 435' ' ' ASN . 58.0 m -165.11 145.71 7.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.736 -0.665 . . . . 0.95999999999999996 110.806 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . 0.526 ' H ' HD12 ' A' ' 373' ' ' ILE . 52.0 p-10 -71.28 16.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 1.3500000000000001 111.911 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.46 ' H ' ' C ' ' A' ' 433' ' ' SER . 20.7 p30 -165.8 133.93 3.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 2.5299999999999998 111.095 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -68.66 -13.27 62.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 1.3300000000000001 111.949 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.41 -41.08 72.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.686 0.279 . . . . 1.3400000000000001 111.363 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.47 -6.46 58.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 1.5600000000000001 111.48 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.619 HD22 ' N ' ' A' ' 386' ' ' ARG . 8.5 mp -96.68 -93.28 0.22 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.245 -0.434 . . . . 1.76 111.598 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -171.56 38.27 0.17 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.776 -0.726 . . . . 1.3600000000000001 112.485 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.98 138.84 0.05 OUTLIER Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.865 -0.683 . . . . 1.8300000000000001 112.812 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.726 ' O ' HG21 ' A' ' 443' ' ' THR . 43.2 mm -63.84 125.9 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 109.126 -0.694 . . . . 1.9199999999999999 109.126 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.726 HG21 ' O ' ' A' ' 442' ' ' ILE . 13.1 t 41.8 -152.23 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.857 0.723 . . . . 3.4199999999999999 111.776 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.534 HG11 ' O ' ' A' ' 444' ' ' VAL . 7.4 p 45.04 57.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.627 0.727 . . . . 4.6399999999999997 112.333 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 443' ' ' THR . 96.4 mt -134.0 141.55 40.06 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.54 -0.755 . . . . 4.9900000000000002 110.567 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.66 45.97 1.57 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.726 2.284 . . . . 8.0099999999999998 112.868 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -61.95 135.64 94.74 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.392 -0.367 . . . . 9.0600000000000005 110.738 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.13 130.0 25.98 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.352 2.035 . . . . 11.42 111.999 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.04 124.7 12.1 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.361 2.041 . . . . 13.529999999999999 112.332 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 57.6 tp -88.29 136.61 32.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 16.010000000000002 111.03 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -60.96 137.37 93.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 16.739999999999998 110.824 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.33 130.99 34.17 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.425 2.083 . . . . 18.530000000000001 112.237 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -176.06 44.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.136 -0.483 . . . . 20.550000000000001 110.993 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.247 -0.882 . . . . 21.41 110.896 179.813 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.523 -0.231 . . . . 11.91 112.523 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 69.1 m -164.09 -45.49 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.81 0.338 . . . . 10.130000000000001 110.834 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -62.26 139.65 58.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 8.6699999999999999 110.785 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.559 ' HB3' ' HG2' ' A' ' 371' ' ' GLN . 65.8 mtt -67.27 128.11 35.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.387 -0.37 . . . . 5.7000000000000002 110.405 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 369' ' ' LEU . 32.0 m-20 -66.14 136.2 95.3 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.366 -0.379 . . . . 6.0599999999999996 110.768 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.3 37.26 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.476 2.117 . . . . 6.5899999999999999 112.389 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.402 ' H ' ' C ' ' A' ' 367' ' ' ASP . 2.4 pp -163.42 0.87 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.149 -0.478 . . . . 7.21 111.199 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.448 ' C ' ' H ' ' A' ' 372' ' ' LYS . 55.5 ttp -174.44 66.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.127 -0.488 . . . . 5.6699999999999999 110.741 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.559 ' HG2' ' HB3' ' A' ' 366' ' ' MET . 65.9 mt-30 -77.83 35.64 0.2 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.979 0.419 . . . . 5.6100000000000003 111.172 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.49 ' HD2' ' O ' ' A' ' 372' ' ' LYS . 0.0 OUTLIER 177.3 141.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.623 -0.717 . . . . 5.7800000000000002 110.263 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 373' ' ' ILE . 68.1 mt -61.56 130.18 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.814 0.34 . . . . 1.9299999999999999 110.767 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.544 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 0.9 OUTLIER -88.21 69.86 9.2 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.152 -0.476 . . . . 2.1699999999999999 110.859 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 377' ' ' GLU . 61.7 mt -45.86 -44.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 1.4399999999999999 111.709 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 73.1 m -63.1 73.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 2.2000000000000002 111.559 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.4 pt-20 -173.97 -31.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 1.9199999999999999 110.482 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.492 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -152.99 58.16 2.3 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.53 . . . . 2.8900000000000001 111.606 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 50.3 Cg_exo -53.03 -37.6 79.1 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.283 1.989 . . . . 0.97999999999999998 111.504 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.1 -34.19 75.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.7 -0.682 . . . . 1.21 110.695 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -53.38 123.22 11.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.191 -0.458 . . . . 2.27 110.784 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 45.8 mm -84.91 128.92 38.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 1.1299999999999999 111.38 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -106.93 143.38 35.11 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.069 -0.345 . . . . 1.1000000000000001 110.069 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.489 ' HB2' HD13 ' A' ' 439' ' ' LEU . 5.2 m-85 -89.78 139.35 30.66 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.807 -0.357 . . . . 1.3200000000000001 110.192 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.537 HG13 HG12 ' A' ' 432' ' ' ILE . 2.6 mp -115.25 129.51 71.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.255 -0.429 . . . . 1.2 111.829 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.642 HH21 ' N ' ' A' ' 392' ' ' VAL . 5.2 tpm_? -88.25 90.14 8.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.865 -0.607 . . . . 3.1699999999999999 110.176 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.663 ' HD3' ' HG1' ' A' ' 391' ' ' THR . 58.1 mtp85 -55.88 153.6 8.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.725 0.297 . . . . 2.9900000000000002 110.816 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.76 -44.76 77.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.212 -0.449 . . . . 2.8199999999999998 111.318 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -58.27 -14.86 8.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.263 0.554 . . . . 1.23 109.749 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 91.66 39.77 5.49 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.176 -0.92 . . . . 1.03 112.561 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' THR . . . . . 0.663 ' HG1' ' HD3' ' A' ' 387' ' ' ARG . 70.8 p -121.91 110.19 15.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.591 0.234 . . . . 1.46 110.917 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.642 ' N ' HH21 ' A' ' 386' ' ' ARG . 63.4 t -70.97 132.71 32.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.628 0.252 . . . . 1.24 110.348 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.413 ' N ' HG11 ' A' ' 392' ' ' VAL . 83.6 m-70 -151.31 135.35 16.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.893 0.378 . . . . 3.2400000000000002 110.582 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.441 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 71.2 mtt-85 -52.85 151.8 4.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.862 -0.608 . . . . 3.5600000000000001 112.135 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 416' ' ' TYR . . . -170.16 131.51 2.26 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.204 -0.907 . . . . 0.32000000000000001 111.411 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -87.14 128.97 35.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.769 0.318 . . . . 1.28 111.734 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 8.7 t -89.71 132.95 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.462 -0.57 . . . . 1.5800000000000001 109.462 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 68.2 mt -120.34 -37.32 3.06 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.51 0.559 . . . . 2.04 112.51 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -139.46 175.96 9.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.479 . . . . 2.6400000000000001 112.13 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.5 p -163.85 149.44 10.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.577 -0.738 . . . . 1.1299999999999999 110.344 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -158.05 136.85 11.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.869 0.366 . . . . 1.8799999999999999 111.5 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 63.1 p -77.65 -128.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.356 -0.384 . . . . 1.79 109.969 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -164.84 -173.41 2.96 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 110.214 -0.291 . . . . 2.2999999999999998 110.214 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -44.9 -45.21 10.22 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.659 0.266 . . . . 3.8700000000000001 111.588 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -66.75 -51.45 55.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.529 -0.305 . . . . 3.1600000000000001 110.953 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 52.97 52.92 12.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.131 0.491 . . . . 2.1800000000000002 111.469 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.444 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -150.66 10.75 0.65 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.694 -0.684 . . . . 2.77 109.688 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.543 ' HA ' ' HE2' ' A' ' 366' ' ' MET . . . -178.48 -47.6 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 114.585 -1.189 . . . . 3.2799999999999998 110.055 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 408' ' ' ALA . 31.9 Cg_exo -58.8 143.59 99.0 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.463 2.108 . . . . 2.8700000000000001 112.447 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 42.5 p-10 -176.26 136.07 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.796 -0.638 . . . . 2.1400000000000001 110.804 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.5 mt-10 -130.96 134.18 46.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 2.1000000000000001 110.342 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 2.4 m-85 -112.32 127.48 56.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.377 . . . . 1.0600000000000001 111.671 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -64.76 144.78 57.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.437 -0.579 . . . . 1.05 109.437 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.414 HG13 HG12 ' A' ' 427' ' ' VAL . 6.4 p -143.99 129.83 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.43 0.633 . . . . 1.8400000000000001 112.625 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -111.86 89.22 3.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.929 -1.032 . . . . 0.70999999999999996 109.123 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.524 ' HA ' ' HA3' ' A' ' 395' ' ' GLY . 30.0 m-85 -52.49 115.6 1.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 1.1299999999999999 110.941 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.47 130.13 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.853 -0.612 . . . . 1.7 110.875 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.81 -42.6 2.5 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.98 -0.628 . . . . 1.1699999999999999 112.798 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.461 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 2.7 mm? -59.6 159.43 8.45 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.92 0.39 . . . . 2.1499999999999999 111.668 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 69.1 m-20 -53.83 142.86 22.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.79 -0.641 . . . . 2.7599999999999998 111.383 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -60.73 -36.65 79.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 4.6500000000000004 111.196 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -56.37 -32.15 64.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.355 -0.384 . . . . 4.3200000000000003 111.0 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 420' ' ' ASN . 1.1 tp -56.4 -29.78 61.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 2.04 111.351 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.57 140.23 11.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.085 0.469 . . . . 1.2 111.824 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -174.82 -149.83 7.43 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.681 -0.691 . . . . 0.69999999999999996 112.097 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -127.46 133.08 49.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.76000000000000001 110.808 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 411' ' ' GLU . 5.1 m -109.43 153.17 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.955 -0.566 . . . . 1.4399999999999999 111.049 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -76.97 29.98 1.57 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.434 -0.888 . . . . 1.72 112.455 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.545 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 39.2 tpt85 71.88 -37.41 0.39 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.181 0.437 . . . . 2.3199999999999998 112.181 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.412 ' H ' ' C ' ' A' ' 428' ' ' GLY . 22.1 p-80 -58.83 -27.36 65.04 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.712 0.264 . . . . 2.23 111.712 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.605 ' NH2' ' HA ' ' A' ' 387' ' ' ARG . 81.2 mtp180 -78.56 -38.37 40.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.958 0.355 . . . . 3.4199999999999999 111.958 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.537 HG12 HG13 ' A' ' 385' ' ' ILE . 73.2 mt -88.44 131.41 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 1.1399999999999999 110.37 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 49.0 m -154.87 139.6 17.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.006 0.432 . . . . 0.95999999999999996 111.631 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.41 -25.4 67.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.615 . . . . 1.3500000000000001 110.349 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.689 HD22 ' HB2' ' A' ' 437' ' ' ASP . 48.4 t30 -108.56 134.13 51.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.837 -0.619 . . . . 2.5299999999999998 110.286 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . 0.458 ' CB ' HD12 ' A' ' 442' ' ' ILE . . . -69.26 -42.91 74.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.023 -0.535 . . . . 1.3300000000000001 112.298 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . 0.689 ' HB2' HD22 ' A' ' 435' ' ' ASN . 54.4 m-20 -57.63 -40.54 79.45 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.584 0.216 . . . . 1.3400000000000001 111.584 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -56.3 -35.06 67.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 1.5600000000000001 110.471 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 386' ' ' ARG . 86.4 mt -57.29 -82.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.775 -0.648 . . . . 1.76 111.184 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . 0.524 ' HA2' HH11 ' A' ' 386' ' ' ARG . . . -168.35 -27.98 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.05 -0.595 . . . . 1.3600000000000001 112.138 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 443' ' ' THR . . . 154.44 143.08 3.59 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.104 -0.57 . . . . 1.8300000000000001 112.117 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.543 HG21 HG22 ' A' ' 444' ' ' VAL . 44.7 mm -62.56 78.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 120.989 0.423 . . . . 1.9199999999999999 110.884 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.627 HG21 HD12 ' A' ' 445' ' ' LEU . 21.8 m -95.84 55.32 1.6 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.363 0.602 . . . . 3.4199999999999999 110.359 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.543 HG22 HG21 ' A' ' 442' ' ' ILE . 30.1 t -89.75 119.05 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.574 -0.739 . . . . 4.6399999999999997 111.383 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.627 HD12 HG21 ' A' ' 443' ' ' THR . 0.0 OUTLIER -151.31 57.93 2.58 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.311 -0.404 . . . . 4.9900000000000002 111.629 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 445' ' ' LEU . 15.5 Cg_exo -68.23 151.56 76.63 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.924 2.416 . . . . 8.0099999999999998 112.024 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -49.59 138.49 16.43 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.319 -0.401 . . . . 9.0600000000000005 110.878 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.34 116.64 3.36 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.433 2.089 . . . . 11.42 112.606 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -86.72 -159.91 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.155 2.57 . . . . 13.529999999999999 112.274 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 451' ' ' ALA . 83.0 mt -85.23 48.95 1.65 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.954 -0.566 . . . . 16.010000000000002 110.652 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 450' ' ' LEU . . . 67.13 129.66 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.99 -0.55 . . . . 16.739999999999998 111.2 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.77 138.18 37.2 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.637 2.224 . . . . 18.530000000000001 112.884 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 64.17 136.38 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.965 -0.561 . . . . 20.550000000000001 111.57 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.246 -0.883 . . . . 21.41 111.027 179.771 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.46 -0.256 . . . . 11.91 112.46 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 82.9 p -174.55 130.08 0.34 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 10.130000000000001 110.686 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . 0.445 ' HE1' ' HB3' ' A' ' 368' ' ' PRO . 78.8 t60 -71.44 132.85 45.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 8.6699999999999999 110.815 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 27.8 ttt -174.62 126.02 0.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 5.7000000000000002 110.523 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 49.88 78.18 0.42 Allowed Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 116.251 -0.431 . . . . 6.0599999999999996 111.04 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . 0.445 ' HB3' ' HE1' ' A' ' 365' ' ' HIS . 61.5 Cg_endo -73.57 40.15 0.53 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.727 2.285 . . . . 6.5899999999999999 112.921 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.635 ' N ' HD21 ' A' ' 369' ' ' LEU . 2.4 pt? -168.6 -41.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 7.21 110.42 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.473 ' O ' ' HG3' ' A' ' 370' ' ' MET . 3.9 tpt -90.96 45.84 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.263 0.554 . . . . 5.6699999999999999 110.217 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -62.59 141.63 58.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.001 -0.545 . . . . 5.6100000000000003 111.252 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.509 ' NZ ' ' HB2' ' A' ' 372' ' ' LYS . 0.0 OUTLIER -55.6 141.15 38.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.534 -0.757 . . . . 5.7800000000000002 111.468 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.65 133.07 25.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.255 -0.43 . . . . 1.9299999999999999 110.76 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.75 128.94 35.64 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 116.265 -0.425 . . . . 2.1699999999999999 110.727 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.477 ' O ' HG21 ' A' ' 375' ' ' ILE . 95.7 mt -91.74 -33.83 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.145 -0.48 . . . . 1.4399999999999999 110.901 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.4 t -72.05 62.36 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.042 -0.526 . . . . 2.2000000000000002 111.057 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -168.24 -26.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.695 -0.684 . . . . 1.9199999999999999 109.874 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.615 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 3.5 m120 -156.63 62.41 2.86 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.347 -0.842 . . . . 2.8900000000000001 111.517 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 79.0 Cg_exo -52.68 -41.21 70.69 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.998 2.465 . . . . 0.97999999999999998 112.8 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -70.01 -32.85 71.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.226 -0.443 . . . . 1.21 111.78 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.0 tttm -44.52 127.09 5.8 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.931 0.396 . . . . 2.27 110.967 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.487 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 41.0 mm -86.91 127.07 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 1.1299999999999999 111.406 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -107.72 144.0 35.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 1.1000000000000001 110.004 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.431 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 3.9 m-85 -91.29 138.27 31.72 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.081 -0.247 . . . . 1.3200000000000001 110.833 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 431' ' ' ARG . 2.8 mp -121.37 126.99 75.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.449 -0.341 . . . . 1.2 110.87 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.581 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 38.4 ttt85 -91.57 122.53 34.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 3.1699999999999999 111.032 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -83.23 172.19 12.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.744 0.307 . . . . 2.9900000000000002 110.695 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -53.05 -71.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 2.8199999999999998 111.045 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -40.99 -31.64 0.19 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.068 0.461 . . . . 1.23 110.565 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 111.14 39.48 1.38 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.795 -0.639 . . . . 1.03 112.986 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 39.7 p -114.02 111.04 21.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.95 0.405 . . . . 1.46 110.976 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.444 ' O ' ' HB ' ' A' ' 443' ' ' THR . 46.1 t -72.53 140.74 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 1.24 111.39 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -148.14 134.34 19.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.582 . . . . 3.2400000000000002 110.42 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.487 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 83.0 mtm180 -58.43 150.37 22.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.074 0.464 . . . . 3.5600000000000001 111.94 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -172.73 132.05 2.27 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.638 -0.71 . . . . 0.32000000000000001 112.254 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -91.72 111.61 23.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.577 0.227 . . . . 1.28 111.607 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.636 HG12 ' HB3' ' A' ' 412' ' ' TYR . 8.7 t -66.49 134.12 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.927 -0.397 . . . . 1.5800000000000001 109.927 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 91.6 mt -119.07 -44.49 2.6 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.907 0.336 . . . . 2.04 111.907 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . 0.479 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 84.0 mt-30 -124.5 174.33 7.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.991 0.424 . . . . 2.6400000000000001 111.645 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 87.7 p -165.88 144.95 6.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.78 -0.645 . . . . 1.1299999999999999 110.351 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.51 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 41.2 ptt180 -156.97 134.89 10.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.003 0.43 . . . . 1.8799999999999999 111.448 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 14.1 p -85.99 38.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.942 -0.572 . . . . 1.79 111.041 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.483 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.8 m 51.75 -173.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.545 -0.298 . . . . 2.2999999999999998 110.272 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.483 ' H ' ' CG2' ' A' ' 403' ' ' THR . 8.4 mp0 -54.87 -49.52 70.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.721 0.296 . . . . 3.8700000000000001 110.631 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -87.21 115.09 24.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.302 -0.408 . . . . 3.1600000000000001 110.727 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -94.91 51.84 1.41 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.832 0.349 . . . . 2.1800000000000002 111.293 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -124.98 -11.52 7.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 2.77 111.215 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.531 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -161.84 -50.48 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.868 -0.606 . . . . 3.2799999999999998 111.107 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' A' ' 408' ' ' ALA . 72.1 Cg_exo -50.17 152.06 8.43 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.498 2.132 . . . . 2.8700000000000001 112.621 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.658 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 44.0 p-10 -175.74 137.22 0.34 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.093 -0.503 . . . . 2.1400000000000001 111.134 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -150.16 135.9 18.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 2.1000000000000001 110.497 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.636 ' HB3' HG12 ' A' ' 397' ' ' VAL . 2.1 m-85 -115.66 126.48 54.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.45 -0.341 . . . . 1.0600000000000001 111.358 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 426' ' ' TRP . 12.8 t80 -65.78 142.78 57.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.195 -0.457 . . . . 1.05 110.32 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.522 HG22 HG12 ' A' ' 427' ' ' VAL . 20.1 t -128.33 136.87 58.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 112.546 0.573 . . . . 1.8400000000000001 112.546 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -120.88 89.87 3.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.70999999999999996 109.943 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.61 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 50.0 m-85 -56.5 129.25 39.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 1.1299999999999999 111.19 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.415 HG22 HD13 ' A' ' 382' ' ' ILE . 2.8 t -82.98 34.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.782 -0.644 . . . . 1.7 111.259 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -178.4 -41.44 0.07 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.455 -0.879 . . . . 1.1699999999999999 113.103 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.61 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 2.2 mm? -59.77 156.77 13.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.84 0.352 . . . . 2.1499999999999999 111.081 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -49.72 144.55 6.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.021 -0.536 . . . . 2.7599999999999998 111.77 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -56.83 -39.4 74.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.88 -0.6 . . . . 4.6500000000000004 111.092 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 41.4 ptt85 -62.26 -32.15 72.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.895 0.378 . . . . 4.3200000000000003 110.702 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' A' ' 419' ' ' LEU . 1.1 tp -61.67 -32.38 72.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.974 -0.557 . . . . 2.04 111.056 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -48.16 129.1 14.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.301 -0.409 . . . . 1.2 110.448 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.95 165.59 35.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.53 -0.843 . . . . 0.69999999999999996 112.487 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . 0.56 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 8.3 m95 -74.42 128.49 35.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.739 0.304 . . . . 0.76000000000000001 110.496 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.522 HG12 HG22 ' A' ' 414' ' ' VAL . 4.4 m -119.89 152.68 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 1.4399999999999999 110.819 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.44 ' HA2' ' CE1' ' A' ' 430' ' ' HIS . . . -56.87 148.59 31.55 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.954 -0.641 . . . . 1.72 112.825 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.448 ' NH2' ' HE3' ' A' ' 370' ' ' MET . 9.5 tpt180 -50.2 -42.16 50.97 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.567 0.347 . . . . 2.3199999999999998 111.844 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.44 ' CE1' ' HA2' ' A' ' 428' ' ' GLY . 22.2 p-80 -54.81 -28.54 50.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.289 0.477 . . . . 2.23 112.289 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.3 mtt180 -78.59 -38.3 40.36 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.601 0.593 . . . . 3.4199999999999999 112.601 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.592 HD12 HG23 ' A' ' 397' ' ' VAL . 68.8 mt -88.6 130.65 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 120.601 -0.44 . . . . 1.1399999999999999 111.009 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.436 ' HB2' ' CD1' ' A' ' 439' ' ' LEU . 44.6 m -168.11 140.42 3.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.837 -0.62 . . . . 0.95999999999999996 110.949 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -66.02 -15.53 63.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.015 -0.539 . . . . 1.3500000000000001 111.278 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.432 ' HB2' ' OD2' ' A' ' 438' ' ' ASP . 5.8 m120 -108.48 130.9 55.25 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.841 0.353 . . . . 2.5299999999999998 110.851 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 441' ' ' GLY . . . -74.74 -34.75 62.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 1.3300000000000001 112.03 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.03 -40.56 67.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.425 -0.352 . . . . 1.3400000000000001 111.641 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' ' 435' ' ' ASN . 61.9 m-20 -64.11 -21.21 66.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 1.5600000000000001 111.369 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.581 ' HB3' ' HB2' ' A' ' 386' ' ' ARG . 8.7 mp -93.94 -88.65 0.23 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.097 -0.501 . . . . 1.76 111.917 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . 0.505 ' HA2' ' NH1' ' A' ' 386' ' ' ARG . . . -164.43 49.92 0.29 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.021 -0.609 . . . . 1.3600000000000001 112.157 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 436' ' ' ALA . . . 69.19 -129.61 23.49 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.59 -0.814 . . . . 1.8300000000000001 112.375 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 43.3 mm -128.54 65.8 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.829 0.347 . . . . 1.9199999999999999 110.651 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 392' ' ' VAL . 9.9 t 39.64 51.47 2.33 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.756 0.789 . . . . 3.4199999999999999 111.55 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 8.4 p -146.05 60.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.671 -1.15 . . . . 4.6399999999999997 110.868 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 94.7 mt -50.71 146.31 9.99 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.443 -0.799 . . . . 4.9900000000000002 111.075 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -47.82 142.62 14.38 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.756 2.304 . . . . 8.0099999999999998 112.551 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . -157.66 138.56 9.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.531 . . . . 9.0600000000000005 110.94 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 447' ' ' ALA . 31.9 Cg_exo -58.58 131.73 44.17 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.612 2.208 . . . . 11.42 112.684 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.32 144.8 75.6 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.784 2.323 . . . . 13.529999999999999 112.224 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 450' ' ' LEU . 3.6 pp -53.79 147.15 12.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 16.010000000000002 111.212 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . 64.93 129.63 0.03 OUTLIER Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 115.872 -0.604 . . . . 16.739999999999998 111.301 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.87 133.26 28.75 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.489 2.126 . . . . 18.530000000000001 112.507 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -174.53 126.33 0.31 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.07 -0.513 . . . . 20.550000000000001 110.573 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.247 -0.882 . . . . 21.41 110.854 179.998 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.111 0 N-CA-C 112.456 -0.258 . . . . 11.91 112.456 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 67.6 m -159.65 44.73 0.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.967 0.413 . . . . 10.130000000000001 110.783 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . 0.582 ' HE1' ' HA ' ' A' ' 368' ' ' PRO . 15.0 p80 -169.84 138.62 1.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.984 -0.553 . . . . 8.6699999999999999 110.542 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' A' ' 366' ' ' MET . 1.6 mpt? -64.59 129.83 41.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 5.7000000000000002 111.49 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 58.64 126.44 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.696 -0.684 . . . . 6.0599999999999996 112.229 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . 0.582 ' HA ' ' HE1' ' A' ' 365' ' ' HIS . 72.4 Cg_endo -78.63 40.35 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.596 2.197 . . . . 6.5899999999999999 112.436 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.84 26.23 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.977 0.417 . . . . 7.21 111.247 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.414 ' O ' ' HG3' ' A' ' 370' ' ' MET . 12.2 tpt -172.8 66.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.873 -0.603 . . . . 5.6699999999999999 110.468 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -58.82 126.31 27.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.804 -0.635 . . . . 5.6100000000000003 111.093 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 365' ' ' HIS . 54.6 mtmt -59.58 151.39 24.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.863 -0.608 . . . . 5.7800000000000002 110.924 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.668 HG12 ' CZ ' ' A' ' 429' ' ' ARG . 49.5 mm -46.09 128.7 2.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.139 -0.482 . . . . 1.9299999999999999 111.939 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -102.59 130.87 49.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.902 -0.59 . . . . 2.1699999999999999 109.996 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 77.5 mt -81.22 -42.28 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.42 0.526 . . . . 1.4399999999999999 112.42 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 41.5 t -47.93 -22.75 0.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.137 0.494 . . . . 2.2000000000000002 111.308 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -54.77 -47.67 73.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.408 -0.815 . . . . 1.9199999999999999 111.118 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 379' ' ' PRO . 8.2 m120 -167.06 112.9 0.67 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.833 -0.621 . . . . 2.8900000000000001 110.979 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 378' ' ' ASN . 12.2 Cg_exo -71.5 -41.05 2.56 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.826 2.35 . . . . 0.97999999999999998 112.699 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -80.94 -34.24 33.39 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.125 0.417 . . . . 1.21 112.125 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -44.82 124.98 4.69 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.765 0.317 . . . . 2.27 111.413 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.881 HD13 HG23 ' A' ' 417' ' ' VAL . 11.4 mm -77.99 131.05 35.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.132 -0.486 . . . . 1.1299999999999999 111.854 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -111.35 144.15 41.0 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.781 -0.452 . . . . 1.1000000000000001 109.781 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.414 ' C ' HD13 ' A' ' 385' ' ' ILE . 46.9 m-85 -89.69 134.74 34.0 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.852 -0.339 . . . . 1.3200000000000001 110.899 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.618 HG22 HG13 ' A' ' 427' ' ' VAL . 2.6 mp -119.47 132.86 68.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.262 -0.426 . . . . 1.2 110.899 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.629 ' N ' HD22 ' A' ' 439' ' ' LEU . 50.3 ttt-85 -93.92 115.78 28.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.672 0.272 . . . . 3.1699999999999999 110.819 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -76.56 157.04 32.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.524 -0.307 . . . . 2.9900000000000002 110.554 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -53.9 -44.95 70.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.581 -0.281 . . . . 2.8199999999999998 111.086 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -54.9 -27.35 42.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.253 0.549 . . . . 1.23 109.597 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.496 ' O ' HD22 ' A' ' 445' ' ' LEU . . . 103.13 38.5 2.86 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.34 -0.845 . . . . 1.03 113.183 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' THR . . . . . 0.62 HG23 HG13 ' A' ' 444' ' ' VAL . 69.1 p -121.07 112.15 18.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 1.46 111.455 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.33 132.28 33.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 1.24 110.351 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -146.5 135.89 22.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.021 0.439 . . . . 3.2400000000000002 111.22 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.517 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 74.0 mtt-85 -53.84 153.67 4.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.722 -0.672 . . . . 3.5600000000000001 111.875 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 415' ' ' HIS . . . -179.59 130.74 1.55 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.763 -0.653 . . . . 0.32000000000000001 112.192 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 75.5 mt-30 -91.82 134.11 35.04 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.99 0.395 . . . . 1.28 111.885 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.625 ' CG2' HD11 ' A' ' 432' ' ' ILE . 5.2 t -87.4 133.28 30.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.23 -0.441 . . . . 1.5800000000000001 110.722 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 85.0 mt -121.16 -46.75 2.29 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.075 0.398 . . . . 2.04 112.075 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . 0.481 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 13.5 mm100 -127.07 176.84 7.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.916 0.389 . . . . 2.6400000000000001 111.647 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 87.9 p -162.42 139.56 8.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.79 -0.641 . . . . 1.1299999999999999 110.92 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.667 ' HD3' ' O ' ' A' ' 401' ' ' ARG . 0.1 OUTLIER -148.39 138.64 22.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 1.8799999999999999 110.906 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 13.9 m -103.33 42.25 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 1.79 110.096 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.534 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 3.5 m 51.27 -173.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.736 -0.665 . . . . 2.2999999999999998 110.648 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.534 ' H ' ' CG2' ' A' ' 403' ' ' THR . 95.6 mt-10 -63.98 -37.16 86.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 3.8700000000000001 110.69 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.667 ' HB2' ' HG2' ' A' ' 409' ' ' PRO . 5.1 m120 -56.25 -51.99 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.598 . . . . 3.1600000000000001 111.442 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.622 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.33 56.43 5.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 2.1800000000000002 110.863 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -161.9 -3.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 2.77 111.04 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.481 ' H ' ' CD ' ' A' ' 409' ' ' PRO . . . -169.54 -44.54 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.71 -0.677 . . . . 3.2799999999999998 111.649 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.667 ' HG2' ' HB2' ' A' ' 405' ' ' ASN . 15.7 Cg_exo -69.79 47.85 0.59 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.825 2.35 . . . . 2.8700000000000001 113.87 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.728 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 47.2 p-10 -68.59 143.84 54.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.908 0.385 . . . . 2.1400000000000001 110.893 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 50.6 mt-10 -148.72 146.69 28.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.016 -0.538 . . . . 2.1000000000000001 110.423 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -127.06 125.28 41.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.913 0.387 . . . . 1.0600000000000001 111.688 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.481 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 20.2 t80 -63.47 149.99 44.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.045 -0.724 . . . . 1.05 109.045 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.444 HG13 HG12 ' A' ' 427' ' ' VAL . 7.8 p -158.83 133.32 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.016 0.747 . . . . 1.8400000000000001 113.016 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . 0.563 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 76.2 t60 -105.06 106.24 16.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.03 -0.987 . . . . 0.70999999999999996 109.167 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 2.1 m-85 -62.19 100.63 0.18 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.55 0.691 . . . . 1.1299999999999999 109.939 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.881 HG23 HD13 ' A' ' 382' ' ' ILE . 44.2 t -48.63 123.74 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.555 -1.202 . . . . 1.7 111.75 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 83.07 -33.37 2.91 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.183 -0.917 . . . . 1.1699999999999999 113.409 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 423' ' ' LEU . 8.9 mt -68.23 -173.6 0.42 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.42 0.629 . . . . 2.1499999999999999 112.456 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.727 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 5.2 m120 -74.3 145.85 43.62 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 114.961 -1.018 . . . . 2.7599999999999998 111.053 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . 0.455 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 45.1 mtp85 -65.21 -39.24 92.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.22 -0.446 . . . . 4.6500000000000004 111.348 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -57.44 -35.71 70.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.742 0.306 . . . . 4.3200000000000003 111.122 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.727 ' HG ' ' HB2' ' A' ' 420' ' ' ASN . 85.4 mt -56.94 -33.94 67.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 2.04 111.191 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' A' ' 415' ' ' HIS . 39.8 m-20 -52.94 141.87 20.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.521 . . . . 1.2 111.759 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -171.85 -142.06 3.59 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.644 -0.707 . . . . 0.69999999999999996 111.954 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -124.29 138.07 54.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.018 0.437 . . . . 0.76000000000000001 110.715 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.618 HG13 HG22 ' A' ' 385' ' ' ILE . 15.7 m -109.08 158.58 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.925 -0.58 . . . . 1.4399999999999999 111.844 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -81.61 39.98 2.57 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.882 -0.675 . . . . 1.72 113.009 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.668 ' CZ ' HG12 ' A' ' 373' ' ' ILE . 38.4 tpt85 68.56 -72.4 0.1 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.492 0.553 . . . . 2.3199999999999998 112.492 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -47.2 -15.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 2.23 113.053 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.543 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 99.5 mtt180 -78.29 -35.55 47.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.723 0.268 . . . . 3.4199999999999999 111.723 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.625 HD11 ' CG2' ' A' ' 397' ' ' VAL . 97.4 mt -88.45 132.23 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 1.1399999999999999 111.16 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.415 ' HB2' ' CD1' ' A' ' 439' ' ' LEU . 75.0 m -166.06 139.29 4.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.855 -0.611 . . . . 0.95999999999999996 110.779 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -61.86 -23.15 66.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 1.3500000000000001 111.095 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.428 ' HB2' ' OD2' ' A' ' 438' ' ' ASP . 80.3 m-20 -108.44 131.69 54.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.916 0.389 . . . . 2.5299999999999998 110.909 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 441' ' ' GLY . . . -75.82 -31.96 59.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 1.3300000000000001 111.915 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.66 -40.55 62.95 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.453 -0.34 . . . . 1.3400000000000001 111.462 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 435' ' ' ASN . 57.6 m-20 -61.96 -23.6 66.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 1.5600000000000001 111.091 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.703 ' N ' HD11 ' A' ' 439' ' ' LEU . 8.5 mp -91.61 -84.63 0.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.82 -0.627 . . . . 1.76 112.313 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . 0.43 ' O ' HD23 ' A' ' 445' ' ' LEU . . . -158.81 57.02 0.34 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.462 -0.875 . . . . 1.3600000000000001 112.995 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 436' ' ' ALA . . . 66.68 -129.03 30.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.636 -0.793 . . . . 1.8300000000000001 112.841 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 443' ' ' THR . 46.2 mm -136.41 144.46 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.395 0.14 . . . . 1.9199999999999999 110.912 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 442' ' ' ILE . 8.3 t 49.91 179.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.835 0.709 . . . . 3.4199999999999999 112.585 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.62 HG13 HG23 ' A' ' 391' ' ' THR . 35.3 m -57.31 131.57 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.134 -0.939 . . . . 4.6399999999999997 112.216 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.562 ' N ' HD21 ' A' ' 445' ' ' LEU . 2.1 pt? -147.99 60.57 5.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.355 -0.839 . . . . 4.9900000000000002 110.422 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.99 134.1 8.1 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.737 2.291 . . . . 8.0099999999999998 113.021 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . 63.28 130.16 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.81 -0.632 . . . . 9.0600000000000005 111.868 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.43 146.23 49.65 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.716 2.277 . . . . 11.42 112.119 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.8 134.97 49.57 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.482 2.121 . . . . 13.529999999999999 112.203 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 451' ' ' ALA . 6.6 tt -173.65 143.54 1.02 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.046 -0.524 . . . . 16.010000000000002 110.216 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.577 ' HB2' ' OD1' ' A' ' 453' ' ' ASP . . . -46.42 143.75 3.7 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.136 -0.484 . . . . 16.739999999999998 111.569 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.668 ' HA ' HE22 ' A' ' 454' ' ' GLN . 72.5 Cg_endo -74.5 43.04 0.85 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.967 2.445 . . . . 18.530000000000001 113.071 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.577 ' OD1' ' HB2' ' A' ' 451' ' ' ALA . 1.2 m-20 -88.85 -41.53 12.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.673 -0.24 . . . . 20.550000000000001 111.27 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . 0.668 HE22 ' HA ' ' A' ' 452' ' ' PRO . 14.7 mp0 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.207 -0.902 . . . . 21.41 110.852 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.434 -0.267 . . . . 11.91 112.434 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 52.2 m 56.6 45.15 22.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.799 0.333 . . . . 10.130000000000001 110.943 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -59.12 136.61 58.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 8.6699999999999999 110.503 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.775 ' HE1' ' HZ3' ' A' ' 372' ' ' LYS . 1.2 mpt? -59.1 121.9 12.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.081 0.467 . . . . 5.7000000000000002 111.282 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -79.01 139.17 56.92 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.801 -0.636 . . . . 6.0599999999999996 111.217 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.72 42.46 1.31 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.68 2.253 . . . . 6.5899999999999999 112.603 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 6.8 tt -171.68 -49.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 7.21 109.904 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.419 ' HA ' ' OD1' ' A' ' 374' ' ' ASP . 53.2 ttp -102.74 61.04 0.8 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 5.6699999999999999 110.314 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.99 103.79 0.07 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.275 -0.421 . . . . 5.6100000000000003 111.078 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.775 ' HZ3' ' HE1' ' A' ' 366' ' ' MET . 63.1 mttp 44.42 59.14 3.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.779 -0.646 . . . . 5.7800000000000002 111.804 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.435 HD13 ' NE ' ' A' ' 429' ' ' ARG . 76.4 mt 62.96 131.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.988 -0.551 . . . . 1.9299999999999999 111.905 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 42.7 m-20 -89.47 77.36 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.833 -0.621 . . . . 2.1699999999999999 110.923 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.4 mt -48.36 -41.2 10.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 1.4399999999999999 111.648 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 77.9 p -64.94 76.14 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.545 . . . . 2.2000000000000002 111.687 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 16.2 pt-20 -174.69 -27.62 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.862 -0.608 . . . . 1.9199999999999999 110.242 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.574 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 3.5 m120 -156.14 62.3 2.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.691 -0.686 . . . . 2.8900000000000001 112.235 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.14 -40.97 75.36 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.778 2.319 . . . . 0.97999999999999998 112.542 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -70.86 -34.41 71.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.041 -0.527 . . . . 1.21 111.722 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.574 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 86.2 tttt -43.03 129.73 4.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.981 0.42 . . . . 2.27 111.028 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.407 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 46.8 mm -81.64 123.26 37.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.854 -0.612 . . . . 1.1299999999999999 111.448 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -102.02 143.41 31.9 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.922 -0.399 . . . . 1.1000000000000001 109.922 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.84 139.2 30.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.587 -0.279 . . . . 1.3200000000000001 110.798 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.573 HD13 ' N ' ' A' ' 385' ' ' ILE . 1.7 mp -131.94 133.45 60.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.69 0.281 . . . . 1.2 111.168 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.615 ' CZ ' ' HA2' ' A' ' 440' ' ' GLY . 8.1 tpt180 -90.41 121.71 32.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 3.1699999999999999 110.585 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -74.53 164.22 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 2.9900000000000002 110.556 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -61.3 -45.32 94.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.335 -0.393 . . . . 2.8199999999999998 110.825 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -61.47 -12.88 16.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.133 0.492 . . . . 1.23 110.058 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.416 ' C ' ' HE ' ' A' ' 386' ' ' ARG . . . 90.78 41.78 5.26 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.409 -0.814 . . . . 1.03 112.53 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 82.8 p -121.35 112.64 18.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.679 0.276 . . . . 1.46 111.352 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 59.4 t -68.43 134.2 30.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 1.24 110.711 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -149.65 137.63 20.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 3.2400000000000002 110.989 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.407 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 77.9 mtm180 -60.79 152.53 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 3.5600000000000001 111.531 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -171.01 126.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.771 -0.65 . . . . 0.32000000000000001 112.295 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 57.0 mt-30 -78.8 130.15 35.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.724 0.297 . . . . 1.28 111.514 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.552 HG23 ' HB3' ' A' ' 412' ' ' TYR . 0.7 OUTLIER -98.85 126.87 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.61 -0.515 . . . . 1.5800000000000001 109.61 178.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . 0.472 ' N ' ' CD2' ' A' ' 398' ' ' LEU . 0.4 OUTLIER -115.05 -47.21 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.534 0.568 . . . . 2.04 112.534 -177.215 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -127.71 176.41 7.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 2.6400000000000001 111.726 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 84.7 p -165.47 141.93 5.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.784 -0.644 . . . . 1.1299999999999999 110.967 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.49 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 41.0 ptt180 -142.88 135.23 27.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.346 -0.388 . . . . 1.8799999999999999 110.772 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 24.9 p -81.92 40.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 1.79 112.159 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.504 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.8 m 50.58 -173.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.506 -0.183 . . . . 2.2999999999999998 110.506 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.504 ' H ' ' CG2' ' A' ' 403' ' ' THR . 48.6 mt-10 -56.73 -50.02 73.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.321 . . . . 3.8700000000000001 110.446 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -83.73 117.85 23.51 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.296 -0.411 . . . . 3.1600000000000001 110.613 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -101.43 76.68 1.71 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.964 0.411 . . . . 2.1800000000000002 111.326 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -160.68 10.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 2.77 110.65 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.62 ' HB2' ' HD3' ' A' ' 409' ' ' PRO . . . -178.52 -51.61 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.609 -0.723 . . . . 3.2799999999999998 110.903 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 408' ' ' ALA . 49.9 Cg_exo -57.07 154.11 35.16 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.689 2.259 . . . . 2.8700000000000001 113.028 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.664 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 44.2 p-10 -178.62 130.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.852 -0.613 . . . . 2.1400000000000001 111.081 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 400' ' ' SER . 58.9 mp0 -136.85 135.28 37.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.85 -0.614 . . . . 2.1000000000000001 109.933 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.644 ' OH ' ' HB3' ' A' ' 372' ' ' LYS . 0.4 OUTLIER -110.91 130.17 55.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 1.0600000000000001 111.897 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 14.6 t80 -65.03 141.62 58.7 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.516 -0.92 . . . . 1.05 108.516 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 6.4 p -147.72 110.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.608 0.966 . . . . 1.8400000000000001 113.608 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -86.44 90.94 8.37 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.531 -0.759 . . . . 0.70999999999999996 109.344 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.429 ' CD1' ' HA ' ' A' ' 424' ' ' ASP . 35.6 m-85 -52.84 128.71 27.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.055 0.455 . . . . 1.1299999999999999 111.394 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 86.2 t -73.2 127.81 35.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.748 -0.66 . . . . 1.7 111.166 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.34 -44.91 2.25 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.985 -0.626 . . . . 1.1699999999999999 113.022 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.42 ' HB3' HD11 ' A' ' 423' ' ' LEU . 7.7 mp -59.7 148.98 32.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.861 0.362 . . . . 2.1499999999999999 111.204 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -54.47 137.72 42.01 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.948 -0.569 . . . . 2.7599999999999998 111.798 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -32.31 50.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.655 -0.702 . . . . 4.6500000000000004 111.368 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . 0.749 HH11 HD22 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -54.79 -38.85 67.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 4.3200000000000003 110.52 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.749 HD22 HH11 ' A' ' 422' ' ' ARG . 96.5 mt -65.55 -35.44 80.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.019 0.438 . . . . 2.04 110.54 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' A' ' 416' ' ' TYR . 16.8 m-20 -54.84 138.32 43.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.654 -0.703 . . . . 1.2 111.602 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -179.46 -141.68 4.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.715 -0.675 . . . . 0.69999999999999996 111.938 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . 0.49 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 53.4 m95 -106.2 140.28 39.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.76000000000000001 110.695 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.485 HG23 HG13 ' A' ' 414' ' ' VAL . 17.1 m -132.88 141.73 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 1.4399999999999999 111.953 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -64.99 150.96 51.66 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.855 -0.611 . . . . 1.72 112.525 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.435 ' NE ' HD13 ' A' ' 373' ' ' ILE . 41.0 tpt85 -51.74 -38.28 54.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.771 0.319 . . . . 2.3199999999999998 111.269 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.552 ' ND1' ' HG3' ' A' ' 431' ' ' ARG . 6.4 p80 -60.19 -28.96 68.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.44 0.533 . . . . 2.23 112.44 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.552 ' HG3' ' ND1' ' A' ' 430' ' ' HIS . 72.1 mtt-85 -78.23 -35.62 48.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.52 0.2 . . . . 3.4199999999999999 111.537 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 397' ' ' VAL . 66.3 mt -88.67 139.7 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.138 0.494 . . . . 1.1399999999999999 111.869 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 435' ' ' ASN . 69.9 m -163.39 139.17 6.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.5 -0.773 . . . . 0.95999999999999996 110.327 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -75.83 16.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 1.3500000000000001 111.359 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 433' ' ' SER . 75.9 m-80 -147.88 130.76 16.15 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.879 0.371 . . . . 2.5299999999999998 110.699 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -69.87 -37.85 76.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.53 . . . . 1.3300000000000001 111.898 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -50.39 -40.87 51.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 1.3400000000000001 111.214 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.14 49.39 1.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 1.5600000000000001 110.999 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . . . . . . . . . 88.7 mt -145.7 -84.87 0.12 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.521 -0.309 . . . . 1.76 111.539 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . 0.615 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . -167.66 40.5 0.24 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.416 -0.897 . . . . 1.3600000000000001 113.014 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.46 144.2 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.765 -0.731 . . . . 1.8300000000000001 112.88 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.489 ' O ' HG21 ' A' ' 443' ' ' THR . 48.8 mm -59.19 90.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 110.461 -0.2 . . . . 1.9199999999999999 110.461 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.637 ' HA ' HD12 ' A' ' 445' ' ' LEU . 8.9 t 39.53 42.39 0.89 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.614 0.721 . . . . 3.4199999999999999 111.634 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 444' ' ' VAL . 12.8 t -89.82 50.77 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.934 -1.03 . . . . 4.6399999999999997 111.854 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.637 HD12 ' HA ' ' A' ' 443' ' ' THR . 0.0 OUTLIER -109.34 146.79 34.67 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 4.9900000000000002 111.165 179.372 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -51.85 148.3 22.96 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.901 2.401 . . . . 8.0099999999999998 112.707 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -157.64 142.48 12.03 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.022 -0.535 . . . . 9.0600000000000005 110.912 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.52 129.38 19.8 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.78 2.32 . . . . 11.42 112.91 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.11 151.43 34.64 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.931 2.421 . . . . 13.529999999999999 112.578 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 65.74 148.12 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.093 -0.503 . . . . 16.010000000000002 111.513 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -157.77 138.28 9.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.64 . . . . 16.739999999999998 110.743 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.78 41.51 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.568 2.179 . . . . 18.530000000000001 112.88 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -73.37 -137.62 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.501 -0.318 . . . . 20.550000000000001 110.559 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.178 -0.915 . . . . 21.41 110.927 179.716 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 112.479 -0.249 . . . . 11.91 112.479 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.0 t -60.56 -47.02 88.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.796 0.331 . . . . 10.130000000000001 110.844 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . 0.618 ' HD1' ' N ' ' A' ' 366' ' ' MET . 26.6 t-80 -70.33 -129.03 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.138 -0.483 . . . . 8.6699999999999999 109.915 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.618 ' N ' ' HD1' ' A' ' 365' ' ' HIS . 0.0 OUTLIER -172.17 46.55 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.829 -0.434 . . . . 5.7000000000000002 109.829 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.459 ' HB3' HD22 ' A' ' 369' ' ' LEU . 55.1 m-20 48.36 85.13 0.19 Allowed Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.703 -0.681 . . . . 6.0599999999999996 111.344 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.57 49.54 2.44 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.627 2.218 . . . . 6.5899999999999999 112.304 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.584 ' HG ' ' HG2' ' A' ' 370' ' ' MET . 2.0 pt? -162.11 -22.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 7.21 110.47 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.584 ' HG2' ' HG ' ' A' ' 369' ' ' LEU . 19.1 ptp -158.17 13.88 0.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.178 -0.465 . . . . 5.6699999999999999 111.37 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.662 ' O ' ' HB3' ' A' ' 372' ' ' LYS . 98.4 mm-40 36.11 32.8 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.261 -0.881 . . . . 5.6100000000000003 112.477 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HB3' ' O ' ' A' ' 371' ' ' GLN . 24.1 pttm 139.16 144.9 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.614 1.196 . . . . 5.7800000000000002 110.488 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.506 HG13 ' HE ' ' A' ' 429' ' ' ARG . 70.4 mt -59.92 128.24 20.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.672 0.273 . . . . 1.9299999999999999 110.335 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 370' ' ' MET . 1.4 m-20 -89.5 129.36 36.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.877 0.37 . . . . 2.1699999999999999 111.288 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.435 HD12 ' C ' ' A' ' 397' ' ' VAL . 82.5 mt -84.79 -39.43 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 1.4399999999999999 110.816 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.4 t -66.55 72.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.751 -0.659 . . . . 2.2000000000000002 111.022 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . 0.455 ' HG3' ' ND2' ' A' ' 378' ' ' ASN . 12.2 pt-20 -174.45 -28.64 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.536 -0.757 . . . . 1.9199999999999999 109.644 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.485 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -172.2 57.69 0.24 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.206 -0.906 . . . . 2.8900000000000001 111.052 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 52.2 Cg_exo -52.86 -39.86 76.82 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.297 1.998 . . . . 0.97999999999999998 111.893 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.474 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 54.0 m-20 -62.57 -33.84 75.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.93 -0.577 . . . . 1.21 110.877 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 86.1 tttt -49.1 121.29 4.67 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.205 -0.452 . . . . 2.27 110.799 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.791 HD11 HG23 ' A' ' 417' ' ' VAL . 18.6 mm -69.97 129.43 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 1.1299999999999999 112.0 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 395' ' ' GLY . 82.0 m-85 -109.75 144.69 37.79 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.283 -0.417 . . . . 1.1000000000000001 110.234 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -85.6 128.5 34.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.731 0.301 . . . . 1.3200000000000001 110.884 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.488 ' C ' HD22 ' A' ' 439' ' ' LEU . 1.8 mp -113.22 128.17 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.238 -0.437 . . . . 1.2 110.66 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.681 ' N ' HD22 ' A' ' 439' ' ' LEU . 25.4 tpt180 -98.27 120.62 39.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.373 -0.376 . . . . 3.1699999999999999 111.267 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.449 ' HD3' ' HG1' ' A' ' 391' ' ' THR . 77.6 mtp180 -83.18 157.33 22.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 2.9900000000000002 110.556 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -55.71 -39.7 71.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 2.8199999999999998 111.301 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.416 ' OD2' HG22 ' A' ' 391' ' ' THR . 11.6 p-10 -71.44 5.5 2.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.442 -0.344 . . . . 1.23 111.684 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 74.08 44.14 30.72 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.018 -0.61 . . . . 1.03 113.776 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' THR . . . . . 0.488 HG23 HG22 ' A' ' 444' ' ' VAL . 25.3 p -122.38 111.65 17.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.828 0.314 . . . . 1.46 111.625 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.419 ' N ' HH11 ' A' ' 386' ' ' ARG . 72.4 t -69.36 135.61 27.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.649 -0.25 . . . . 1.24 110.416 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -151.41 133.08 14.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.426 -0.352 . . . . 3.2400000000000002 111.046 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.459 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 88.9 mtm180 -59.07 153.34 18.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 3.5600000000000001 112.036 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.602 ' HA3' ' HA ' ' A' ' 416' ' ' TYR . . . -175.44 132.45 2.16 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.798 -0.637 . . . . 0.32000000000000001 112.516 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . 0.479 ' HG3' HG21 ' A' ' 417' ' ' VAL . 75.3 mt-30 -96.15 112.03 23.89 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 111.773 0.286 . . . . 1.28 111.773 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.725 HG21 HD12 ' A' ' 432' ' ' ILE . 2.6 t -63.49 136.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.218 -0.29 . . . . 1.5800000000000001 110.218 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 98.8 mt -120.36 -38.92 2.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.16 0.43 . . . . 2.04 112.16 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . 0.412 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 85.7 mt-30 -139.96 176.45 8.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.066 0.46 . . . . 2.6400000000000001 111.588 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.1 p -163.7 150.94 12.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.692 -0.686 . . . . 1.1299999999999999 110.24 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 39.2 ptt180 -156.17 134.58 11.54 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.862 0.363 . . . . 1.8799999999999999 111.86 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 32.7 p -78.25 136.93 37.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 1.79 110.293 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 409' ' ' PRO . 1.7 m -63.74 -174.49 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.285 -0.416 . . . . 2.2999999999999998 110.777 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.461 ' H ' ' CG2' ' A' ' 403' ' ' THR . 49.1 mt-10 -48.76 -43.1 37.47 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.386 0.513 . . . . 3.8700000000000001 112.386 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.545 ' HB3' ' HG3' ' A' ' 409' ' ' PRO . 50.9 t30 -55.9 -49.67 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.585 0.231 . . . . 3.1600000000000001 111.457 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.435 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 57.32 59.11 3.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.947 0.403 . . . . 2.1800000000000002 111.537 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -154.75 -2.27 0.16 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.602 . . . . 2.77 110.143 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.664 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -178.46 -49.35 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 114.848 -1.069 . . . . 3.2799999999999998 110.181 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 11.7 Cg_endo -54.62 141.39 74.84 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.44 2.093 . . . . 2.8700000000000001 112.298 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 36.6 p-10 -177.09 132.06 0.18 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.799 -0.637 . . . . 2.1400000000000001 111.077 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.4 mt-10 -108.55 135.45 49.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.595 . . . . 2.1000000000000001 109.549 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.525 ' HB3' HG12 ' A' ' 397' ' ' VAL . 1.0 OUTLIER -108.83 120.61 43.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.894 0.378 . . . . 1.0600000000000001 111.73 -178.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 11.9 t80 -60.89 137.47 58.21 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.914 -0.773 . . . . 1.05 108.914 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.411 HG22 HD12 ' A' ' 385' ' ' ILE . 7.3 p -136.87 130.52 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.904 0.705 . . . . 1.8400000000000001 112.904 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . 0.474 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 81.5 t60 -102.1 89.49 3.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.87 -1.059 . . . . 0.70999999999999996 109.018 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.602 ' HA ' ' HA3' ' A' ' 395' ' ' GLY . 22.6 m-85 -46.55 123.95 5.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.373 0.606 . . . . 1.1299999999999999 111.019 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.791 HG23 HD11 ' A' ' 382' ' ' ILE . 43.5 t -74.7 125.48 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.133 -0.94 . . . . 1.7 111.022 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.84 -42.98 2.55 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.585 -0.734 . . . . 1.1699999999999999 112.279 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.66 HD12 ' HG2' ' A' ' 446' ' ' PRO . 7.1 mp -65.03 151.95 44.69 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.928 0.394 . . . . 2.1499999999999999 111.44 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.537 ' O ' HD21 ' A' ' 423' ' ' LEU . 55.9 t30 -57.84 160.14 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 2.7599999999999998 111.226 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . 0.441 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 68.2 mtt-85 -62.47 -26.56 68.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.257 0.551 . . . . 4.6500000000000004 110.453 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . 0.501 ' HB3' HD21 ' A' ' 420' ' ' ASN . 68.2 ttt180 -52.31 -36.35 52.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.282 -0.872 . . . . 4.3200000000000003 111.829 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.537 HD21 ' O ' ' A' ' 420' ' ' ASN . 2.8 mm? -68.91 -34.6 75.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.451 . . . . 2.04 111.584 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 415' ' ' HIS . 1.2 m-20 -45.84 140.52 3.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.15 0.5 . . . . 1.2 112.149 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -178.18 -142.41 4.68 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.584 -0.735 . . . . 0.69999999999999996 112.176 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 42.4 m95 -129.7 138.31 51.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.945 0.403 . . . . 0.76000000000000001 110.815 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.447 HG22 HG13 ' A' ' 432' ' ' ILE . 22.2 m -125.82 149.55 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 1.4399999999999999 111.196 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -77.01 29.49 1.59 Allowed Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.904 -0.665 . . . . 1.72 114.475 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.57 ' HB3' ' O ' ' A' ' 428' ' ' GLY . 37.4 tpt85 75.25 -43.96 0.52 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.171 0.804 . . . . 2.3199999999999998 113.171 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.462 ' H ' ' CD2' ' A' ' 430' ' ' HIS . 2.0 m170 -52.25 -30.47 27.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.736 0.779 . . . . 2.23 110.269 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.496 HH11 ' HG3' ' A' ' 431' ' ' ARG . 28.8 mtt85 -78.48 -32.31 48.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.311 -1.313 . . . . 3.4199999999999999 112.595 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.725 HD12 HG21 ' A' ' 397' ' ' VAL . 77.0 mt -88.46 129.72 39.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.799 -0.36 . . . . 1.1399999999999999 110.375 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.466 ' HB2' HD12 ' A' ' 439' ' ' LEU . 63.3 m -164.92 143.67 6.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.152 -0.476 . . . . 0.95999999999999996 111.149 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -73.61 16.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 1.3500000000000001 111.721 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 433' ' ' SER . 21.6 p30 -159.17 135.71 9.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.94 0.4 . . . . 2.5299999999999998 111.124 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -69.37 -26.41 64.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.79 -0.641 . . . . 1.3300000000000001 112.21 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -46.67 -40.76 13.75 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.49 -0.323 . . . . 1.3400000000000001 111.794 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -72.94 -33.01 65.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.004 0.43 . . . . 1.5600000000000001 111.012 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.681 HD22 ' N ' ' A' ' 386' ' ' ARG . 6.7 mp -77.99 -84.39 0.08 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.706 -0.679 . . . . 1.76 111.866 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . 0.475 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . -148.39 28.59 1.35 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.671 -0.776 . . . . 1.3600000000000001 112.535 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 48.46 55.11 11.27 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.945 -0.645 . . . . 1.8300000000000001 112.65 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.488 HG21 HD22 ' A' ' 445' ' ' LEU . 31.4 mm 62.83 113.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 110.285 -0.265 . . . . 1.9199999999999999 110.285 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.635 ' HB ' HH12 ' A' ' 386' ' ' ARG . 86.8 m -160.94 131.16 5.1 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.866 0.365 . . . . 3.4199999999999999 111.97 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.496 HG21 HG21 ' A' ' 443' ' ' THR . 33.0 t 48.5 61.69 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 CA-C-N 115.785 -0.643 . . . . 4.6399999999999997 111.25 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 442' ' ' ILE . 2.4 mm? -89.48 133.64 34.2 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.176 -0.466 . . . . 4.9900000000000002 111.155 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.66 ' HG2' HD12 ' A' ' 419' ' ' LEU . 32.5 Cg_exo -57.5 141.81 95.2 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.835 2.357 . . . . 8.0099999999999998 112.531 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -167.99 127.09 1.02 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.041 -0.527 . . . . 9.0600000000000005 110.792 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.33 133.28 24.16 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.535 2.157 . . . . 11.42 112.424 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.65 129.94 29.68 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.416 2.077 . . . . 13.529999999999999 111.818 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 99.1 mt 64.06 132.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.26 -0.427 . . . . 16.010000000000002 111.04 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . -61.47 124.22 79.95 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 16.739999999999998 111.281 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 451' ' ' ALA . 5.8 Cg_exo -78.93 41.93 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.028 2.485 . . . . 18.530000000000001 112.273 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -153.25 135.62 15.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 20.550000000000001 110.884 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.259 -0.877 . . . . 21.41 110.864 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.427 -0.269 . . . . 11.91 112.427 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 80.2 p -172.71 44.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 10.130000000000001 110.698 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 57.31 52.72 8.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 8.6699999999999999 110.352 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.55 ' HE3' ' OE1' ' A' ' 371' ' ' GLN . 27.7 ttt -57.19 128.13 35.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.885 -0.598 . . . . 5.7000000000000002 110.633 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.422 ' HB2' HD22 ' A' ' 369' ' ' LEU . 1.7 p30 -67.01 121.16 76.86 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 6.0599999999999996 111.272 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.3 44.06 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.828 2.352 . . . . 6.5899999999999999 112.681 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.641 ' N ' HD21 ' A' ' 369' ' ' LEU . 2.2 pt? -164.23 -41.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.567 -0.288 . . . . 7.21 111.24 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.411 ' O ' ' SD ' ' A' ' 370' ' ' MET . 0.0 OUTLIER -82.54 46.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.078 0.466 . . . . 5.6699999999999999 110.482 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.55 ' OE1' ' HE3' ' A' ' 366' ' ' MET . 3.4 mm100 -83.18 43.37 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 5.6100000000000003 111.144 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 371' ' ' GLN . 47.7 mmtm 67.01 139.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.101 0.477 . . . . 5.7800000000000002 111.561 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.52 ' HB ' HH12 ' A' ' 429' ' ' ARG . 68.8 mt 55.56 90.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.695 -0.684 . . . . 1.9299999999999999 111.587 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.51 142.7 27.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 2.1699999999999999 110.354 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 397' ' ' VAL . 4.6 mp -71.4 -43.31 73.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.742 0.275 . . . . 1.4399999999999999 111.742 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 49.2 m -49.11 -20.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.982 0.42 . . . . 2.2000000000000002 111.52 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -58.39 -48.28 81.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.701 -0.681 . . . . 1.9199999999999999 111.773 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.44 ' N ' ' ND2' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -174.98 73.61 0.3 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.12 -0.491 . . . . 2.8900000000000001 110.911 -179.105 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . 0.401 ' HG3' HG21 ' A' ' 375' ' ' ILE . 78.2 Cg_exo -51.36 -40.17 62.32 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.521 2.147 . . . . 0.97999999999999998 112.477 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.526 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 1.5 m-20 -62.39 -37.29 85.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 1.21 111.199 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 79.1 tttt -50.54 127.48 17.89 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.972 0.415 . . . . 2.27 111.006 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.806 HD13 HG12 ' A' ' 417' ' ' VAL . 20.8 mm -73.22 132.6 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.817 -0.629 . . . . 1.1299999999999999 111.859 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -118.68 144.19 46.37 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.091 -0.504 . . . . 1.1000000000000001 110.256 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.488 ' CD2' ' HB1' ' A' ' 436' ' ' ALA . 3.0 m-85 -85.58 138.57 32.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.841 0.353 . . . . 1.3200000000000001 111.183 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.708 HD11 ' N ' ' A' ' 385' ' ' ILE . 2.5 mp -116.3 126.36 73.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.129 -0.487 . . . . 1.2 110.852 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 36.7 ttt85 -90.57 111.44 22.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 3.1699999999999999 110.839 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.436 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 76.8 mtp180 -71.89 157.8 37.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.41 -0.359 . . . . 2.9900000000000002 110.263 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.441 ' HG2' HH22 ' A' ' 431' ' ' ARG . 48.9 mt-10 -49.32 -41.0 37.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 2.8199999999999998 111.331 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -71.33 -36.13 71.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 1.23 111.572 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 137.19 -28.15 2.82 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.427 -0.892 . . . . 1.03 112.811 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' THR . . . . . 0.436 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 47.5 p -58.81 112.09 1.52 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 1.46 111.718 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.62 HG12 HD11 ' A' ' 439' ' ' LEU . 73.1 t -84.92 141.14 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.625 -0.716 . . . . 1.24 110.88 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.431 ' HB3' HD12 ' A' ' 419' ' ' LEU . 93.7 m-70 -145.45 139.92 27.21 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.987 0.422 . . . . 3.2400000000000002 111.243 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.493 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 88.0 mtm180 -55.17 152.24 8.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.793 -0.64 . . . . 3.5600000000000001 112.064 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.565 ' HA2' HD12 ' A' ' 385' ' ' ILE . . . -178.74 128.16 1.23 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.481 -0.781 . . . . 0.32000000000000001 111.861 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . 0.526 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 78.4 mt-30 -84.47 130.74 34.73 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.338 0.496 . . . . 1.28 112.338 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.652 HG21 HD12 ' A' ' 432' ' ' ILE . 9.8 t -81.99 134.56 26.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.547 -0.538 . . . . 1.5800000000000001 109.547 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 90.2 mt -120.78 -43.19 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.475 0.546 . . . . 2.04 112.475 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . 0.475 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 97.6 mm-40 -134.91 175.94 9.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.076 0.465 . . . . 2.6400000000000001 111.816 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.5 p -165.54 143.43 5.91 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.687 -0.688 . . . . 1.1299999999999999 110.633 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.469 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 40.6 ptt180 -151.08 135.05 16.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.952 0.406 . . . . 1.8799999999999999 111.346 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 23.3 p -82.91 43.29 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 1.79 111.648 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.513 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 3.0 m 50.91 -174.08 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.201 -0.454 . . . . 2.2999999999999998 110.869 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.513 ' H ' ' CG2' ' A' ' 403' ' ' THR . 93.3 mt-10 -65.38 -42.94 92.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.717 0.294 . . . . 3.8700000000000001 111.225 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -57.34 -51.31 69.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 3.1600000000000001 111.18 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.481 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 55.61 63.52 2.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.985 0.421 . . . . 2.1800000000000002 111.831 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -160.63 7.76 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.404 0.621 . . . . 2.77 110.039 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.461 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . 179.81 -48.96 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.779 -1.1 . . . . 3.2799999999999998 109.99 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 408' ' ' ALA . 31.4 Cg_exo -59.34 160.92 18.16 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.621 2.214 . . . . 2.8700000000000001 112.251 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.646 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.1 p30 178.43 141.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.128 -0.487 . . . . 2.1400000000000001 111.049 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.6 mt-10 -142.25 134.74 28.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.97 -0.559 . . . . 2.1000000000000001 110.285 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 0.6 OUTLIER -109.5 124.27 50.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 1.0600000000000001 111.469 -179.208 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 8.8 t80 -66.41 137.32 56.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 1.05 109.652 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.589 HG13 HG12 ' A' ' 427' ' ' VAL . 8.0 p -135.61 137.62 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.18 0.514 . . . . 1.8400000000000001 112.248 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . 0.483 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 73.0 t60 -118.46 108.81 15.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.852 . . . . 0.70999999999999996 109.585 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.451 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 97.9 m-85 -55.99 126.44 25.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.225 0.536 . . . . 1.1299999999999999 110.727 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.806 HG12 HD13 ' A' ' 382' ' ' ILE . 2.1 t -78.67 28.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.366 -0.834 . . . . 1.7 111.81 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 416' ' ' TYR . . . 173.1 -37.45 0.14 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.107 -1.045 . . . . 1.1699999999999999 113.773 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.451 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 7.0 mp -61.79 -166.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.371 0.605 . . . . 2.1499999999999999 112.432 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.712 ' HB3' ' HD2' ' A' ' 422' ' ' ARG . 5.0 m120 -63.65 146.73 53.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.244 -0.889 . . . . 2.7599999999999998 111.915 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -72.8 -42.24 64.12 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.165 -0.47 . . . . 4.6500000000000004 110.94 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . 0.712 ' HD2' ' HB3' ' A' ' 420' ' ' ASN . 0.1 OUTLIER -64.22 -24.77 67.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 4.3200000000000003 109.713 179.255 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 420' ' ' ASN . 1.2 tp -58.04 -33.1 68.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.351 -0.84 . . . . 2.04 111.048 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.483 ' OD1' ' HA ' ' A' ' 415' ' ' HIS . 65.8 m-20 -50.5 137.13 19.72 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.897 -0.592 . . . . 1.2 111.534 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -179.18 174.09 46.1 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.782 -0.645 . . . . 0.69999999999999996 112.086 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . 0.469 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 15.7 m95 -81.49 140.35 34.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.38 . . . . 0.76000000000000001 110.851 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.589 HG12 HG13 ' A' ' 414' ' ' VAL . 21.8 m -108.85 160.26 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.508 . . . . 1.4399999999999999 111.527 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -75.86 24.91 1.53 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.757 -0.735 . . . . 1.72 113.045 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.574 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 8.2 tpt180 71.93 -45.83 0.63 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.851 0.686 . . . . 2.3199999999999998 112.851 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -65.61 -14.98 62.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.71 0.291 . . . . 2.23 111.494 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.441 HH22 ' HG2' ' A' ' 388' ' ' GLU . 66.2 mtt-85 -79.38 -36.31 39.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.43 -0.35 . . . . 3.4199999999999999 111.852 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.652 HD12 HG21 ' A' ' 397' ' ' VAL . 75.2 mt -87.73 132.31 33.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.031 0.444 . . . . 1.1399999999999999 111.587 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 59.1 m -163.91 139.37 6.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.595 -0.73 . . . . 0.95999999999999996 110.377 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.27 -22.57 66.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.359 -0.382 . . . . 1.3500000000000001 111.029 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.68 130.17 55.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.763 0.316 . . . . 2.5299999999999998 110.8 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . 0.488 ' HB1' ' CD2' ' A' ' 384' ' ' PHE . . . -80.88 -40.51 24.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 1.3300000000000001 111.673 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -51.81 -40.79 61.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.391 -0.368 . . . . 1.3400000000000001 110.744 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -64.08 -38.1 89.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.102 0.477 . . . . 1.5600000000000001 109.894 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.62 HD11 HG12 ' A' ' 392' ' ' VAL . 76.8 mt -60.47 -83.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.56 -0.745 . . . . 1.76 110.725 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 139.28 52.19 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.99 -0.624 . . . . 1.3600000000000001 112.029 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.539 ' HA3' HD23 ' A' ' 445' ' ' LEU . . . -161.83 -70.75 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 119.565 -1.302 . . . . 1.8300000000000001 114.122 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.493 ' H ' HG22 ' A' ' 392' ' ' VAL . 1.6 mp 61.99 151.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.126 -0.694 . . . . 1.9199999999999999 109.126 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 57.6 m -46.63 110.57 0.29 Allowed 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.256 -0.577 . . . . 3.4199999999999999 110.361 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 91.1 t 63.55 117.65 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.631 -0.713 . . . . 4.6399999999999997 111.28 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.539 HD23 ' HA3' ' A' ' 441' ' ' GLY . 43.8 mt -71.76 139.63 83.33 Favored Pre-proline 0 N--CA 1.463 0.18 0 CA-C-N 116.027 -0.533 . . . . 4.9900000000000002 111.372 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.02 -148.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.98 2.453 . . . . 8.0099999999999998 112.53 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -156.52 75.79 4.53 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 9.0600000000000005 110.962 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 27.8 Cg_endo -62.11 133.25 43.0 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.727 2.285 . . . . 11.42 112.778 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 24.3 Cg_exo -63.33 139.77 73.28 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.71 2.273 . . . . 13.529999999999999 112.244 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . 0.485 HD11 ' N ' ' A' ' 450' ' ' LEU . 6.6 mp -65.31 127.69 32.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.412 . . . . 16.010000000000002 111.084 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . 61.19 122.0 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 115.9 -0.591 . . . . 16.739999999999998 111.756 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.14 125.89 6.73 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.47 2.113 . . . . 18.530000000000001 112.392 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 8.9 t70 50.3 51.15 17.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.214 -0.448 . . . . 20.550000000000001 110.623 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.309 -0.853 . . . . 21.41 110.918 -179.807 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.432 -0.267 . . . . 11.91 112.432 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 57.0 m -161.51 132.97 5.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.769 0.319 . . . . 10.130000000000001 110.767 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -65.82 133.72 51.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 8.6699999999999999 110.773 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 88.0 mmm -65.72 127.24 31.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 5.7000000000000002 110.954 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' A' ' 368' ' ' PRO . 9.2 t70 -63.31 130.68 94.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.429 -0.351 . . . . 6.0599999999999996 110.861 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 367' ' ' ASP . 12.3 Cg_exo -69.74 -44.44 2.1 Favored 'Trans proline' 0 CA--C 1.514 -0.504 0 C-N-CA 122.805 2.337 . . . . 6.5899999999999999 112.953 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.466 ' O ' ' HG2' ' A' ' 370' ' ' MET . 7.1 tt -53.41 -48.58 68.57 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.696 -1.138 . . . . 7.21 110.249 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 369' ' ' LEU . 63.7 mmm -161.15 119.8 2.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.956 -0.565 . . . . 5.6699999999999999 110.888 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.646 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.0 OUTLIER -71.76 95.35 1.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 5.6100000000000003 109.972 179.152 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.51 ' HB2' ' OH ' ' A' ' 412' ' ' TYR . 68.1 mttm 64.29 136.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.912 -0.586 . . . . 5.7800000000000002 111.354 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.5 mt 61.21 116.83 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.652 -0.704 . . . . 1.9299999999999999 111.761 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.554 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 54.8 m-20 -89.71 77.2 7.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.957 -0.565 . . . . 2.1699999999999999 110.3 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 80.0 mt -42.51 -36.67 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.305 -0.407 . . . . 1.4399999999999999 111.964 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.8 t -69.17 68.86 0.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.46 . . . . 2.2000000000000002 111.486 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.0 pt-20 -173.55 -26.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.009 -0.541 . . . . 1.9199999999999999 110.062 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 0.1 OUTLIER -162.73 57.85 0.73 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.642 -0.708 . . . . 2.8900000000000001 111.931 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . 0.426 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 53.0 Cg_exo -54.21 -35.59 83.29 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.071 1.847 . . . . 0.97999999999999998 111.179 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -66.04 -33.38 75.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.446 -0.797 . . . . 1.21 110.936 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 63.7 tttp -46.75 131.6 11.57 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.216 -0.447 . . . . 2.27 111.379 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.49 HD11 ' HG2' ' A' ' 396' ' ' GLN . 41.5 mm -85.92 126.13 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 1.1299999999999999 111.273 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -103.7 144.26 31.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.467 -0.333 . . . . 1.1000000000000001 110.3 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 2.0 m-85 -85.54 132.51 34.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 1.3200000000000001 111.688 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.58 HD12 HG22 ' A' ' 414' ' ' VAL . 2.0 mp -114.05 118.48 58.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.083 -0.508 . . . . 1.2 110.202 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.494 ' HD3' ' O ' ' A' ' 387' ' ' ARG . 0.0 OUTLIER -85.85 114.76 23.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.287 -0.415 . . . . 3.1699999999999999 110.969 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.494 ' O ' ' HD3' ' A' ' 386' ' ' ARG . 25.3 mmm180 -67.02 153.59 43.29 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.442 -0.344 . . . . 2.9900000000000002 110.146 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -53.17 -39.13 63.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.228 -0.442 . . . . 2.8199999999999998 110.706 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -64.66 -35.52 81.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 1.23 110.856 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 135.27 -35.56 2.16 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.584 -0.817 . . . . 1.03 113.043 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 80.8 p -58.85 112.54 1.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.043 0.449 . . . . 1.46 112.004 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 56.5 t -74.53 143.15 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.925 -0.58 . . . . 1.24 110.721 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -147.52 133.42 19.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 3.2400000000000002 111.113 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -56.21 155.57 6.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.903 -0.589 . . . . 3.5600000000000001 111.921 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -172.04 130.67 1.98 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.532 -0.758 . . . . 0.32000000000000001 112.088 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . 0.49 ' HG2' HD11 ' A' ' 382' ' ' ILE . 86.9 mt-30 -81.74 110.62 17.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.938 0.347 . . . . 1.28 111.938 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 1.0 OUTLIER -82.02 132.28 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 1.5800000000000001 109.897 178.393 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 45.1 mt -120.95 -32.51 3.95 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.35 0.5 . . . . 2.04 112.35 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -140.27 176.31 8.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 2.6400000000000001 111.919 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.3 p -165.07 149.93 9.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.739 -0.664 . . . . 1.1299999999999999 110.723 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 38.2 ptt180 -154.55 138.42 16.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.863 0.364 . . . . 1.8799999999999999 111.089 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 77.5 p -70.01 -132.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.437 -0.347 . . . . 1.79 110.988 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.539 ' HG1' ' HB2' ' A' ' 409' ' ' PRO . 1.3 m -162.43 -172.76 3.29 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.023 -0.362 . . . . 2.2999999999999998 110.023 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.437 ' H ' ' CG2' ' A' ' 403' ' ' THR . 48.4 mt-10 -41.65 -45.77 3.5 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.668 0.271 . . . . 3.8700000000000001 111.47 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -67.31 -50.58 59.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.806 0.336 . . . . 3.1600000000000001 110.633 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.458 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.17 56.32 7.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.965 -0.561 . . . . 2.1800000000000002 111.591 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -151.98 9.36 0.51 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.156 0.503 . . . . 2.77 110.421 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.517 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.69 -49.0 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.262 -0.881 . . . . 3.2799999999999998 110.625 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.539 ' HB2' ' HG1' ' A' ' 403' ' ' THR . 32.0 Cg_exo -58.29 147.26 85.58 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.321 2.014 . . . . 2.8700000000000001 112.179 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.9 p30 -177.95 131.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 2.1400000000000001 111.438 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 400' ' ' SER . 50.2 mt-10 -115.25 136.83 52.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.693 -0.685 . . . . 2.1000000000000001 109.707 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.51 ' OH ' ' HB2' ' A' ' 372' ' ' LYS . 0.6 OUTLIER -109.74 130.08 55.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.909 0.385 . . . . 1.0600000000000001 111.903 -178.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 31.3 t80 -60.56 146.64 44.38 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.627 -0.879 . . . . 1.05 108.627 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.58 HG22 HD12 ' A' ' 385' ' ' ILE . 7.2 p -151.13 133.65 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 119.662 -0.815 . . . . 1.8400000000000001 113.181 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -116.2 107.76 15.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.996 -1.002 . . . . 0.70999999999999996 109.439 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.451 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 63.0 m-85 -61.43 125.37 23.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.028 0.442 . . . . 1.1299999999999999 111.279 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.62 32.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.685 -0.688 . . . . 1.7 111.239 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -175.63 -44.2 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.436 -0.888 . . . . 1.1699999999999999 112.89 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.451 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 7.2 mp -64.88 -166.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.199 0.523 . . . . 2.1499999999999999 111.701 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 4.4 m120 -74.1 145.09 44.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.446 -0.797 . . . . 2.7599999999999998 111.796 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 62.2 mtm-85 -65.33 -38.58 90.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.959 -0.564 . . . . 4.6500000000000004 110.71 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . 0.52 ' HG3' HD11 ' A' ' 423' ' ' LEU . 14.0 ptm180 -55.39 -36.13 66.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.057 0.456 . . . . 4.3200000000000003 110.967 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.52 HD11 ' HG3' ' A' ' 422' ' ' ARG . 4.5 mp -52.75 -25.87 12.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.468 -0.787 . . . . 2.04 111.787 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.16 135.44 21.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.989 0.423 . . . . 1.2 111.299 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 413' ' ' TYR . . . 177.24 -140.29 4.79 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.953 -0.641 . . . . 0.69999999999999996 112.302 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 42.7 m95 -122.27 138.19 54.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.793 0.33 . . . . 0.76000000000000001 110.709 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.463 ' CG2' HD13 ' A' ' 432' ' ' ILE . 30.8 m -134.05 142.64 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.4399999999999999 111.765 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.408 ' HA2' ' NH1' ' A' ' 431' ' ' ARG . . . -63.47 144.92 49.65 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.831 -0.7 . . . . 1.72 111.994 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.453 HH12 ' HB3' ' A' ' 372' ' ' LYS . 12.4 tpt180 -55.58 -28.4 54.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.036 0.446 . . . . 2.3199999999999998 111.49 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.604 ' H ' ' CD2' ' A' ' 430' ' ' HIS . 0.9 OUTLIER -56.58 -31.27 64.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.811 0.815 . . . . 2.23 109.572 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.461 ' O ' HD23 ' A' ' 439' ' ' LEU . 33.0 mtt85 -83.14 -36.23 24.93 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.117 -1.401 . . . . 3.4199999999999999 111.418 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.541 HG12 HG13 ' A' ' 385' ' ' ILE . 65.9 mt -88.83 135.31 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.021 0.439 . . . . 1.1399999999999999 111.766 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 435' ' ' ASN . 55.8 m -161.76 140.12 9.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.843 -0.617 . . . . 0.95999999999999996 110.619 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -72.67 16.19 0.16 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.243 -0.435 . . . . 1.3500000000000001 111.612 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 433' ' ' SER . 75.0 m-80 -146.53 131.92 18.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.938 0.399 . . . . 2.5299999999999998 110.97 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -68.17 -42.32 80.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.983 -0.553 . . . . 1.3300000000000001 111.441 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -54.66 -40.74 69.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.282 -0.417 . . . . 1.3400000000000001 111.038 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.59 42.91 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 1.5600000000000001 110.848 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 431' ' ' ARG . 97.5 mt -151.82 -83.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 1.76 111.104 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -166.39 44.31 0.27 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.994 -0.622 . . . . 1.3600000000000001 112.141 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.13 -136.03 45.77 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 1.8300000000000001 112.298 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.472 ' O ' HG21 ' A' ' 443' ' ' THR . 50.1 mm -126.64 105.48 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.586 0.232 . . . . 1.9199999999999999 110.648 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.472 HG21 ' O ' ' A' ' 442' ' ' ILE . 13.4 t 39.1 35.76 0.15 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.581 0.705 . . . . 3.4199999999999999 111.758 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 442' ' ' ILE . 96.3 t -153.25 127.57 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.655 -1.157 . . . . 4.6399999999999997 110.725 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 3.0 tp -97.55 123.47 52.08 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 116.293 -0.412 . . . . 4.9900000000000002 110.723 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.64 59.65 6.34 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.113 2.542 . . . . 8.0099999999999998 112.656 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.487 ' N ' ' HD3' ' A' ' 448' ' ' PRO . . . -164.19 58.07 0.63 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 111.849 0.314 . . . . 9.0600000000000005 111.849 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 447' ' ' ALA . 28.5 Cg_exo -61.37 134.3 51.07 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.398 2.065 . . . . 11.42 111.859 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.48 43.77 1.49 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.457 2.105 . . . . 13.529999999999999 112.782 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 6.2 mp 46.32 39.7 6.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.825 -0.625 . . . . 16.010000000000002 111.383 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -174.68 133.63 0.51 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.438 -0.346 . . . . 16.739999999999998 111.363 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.36 137.45 36.64 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.585 2.19 . . . . 18.530000000000001 112.197 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -170.68 55.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.175 0.512 . . . . 20.550000000000001 110.381 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.287 -0.863 . . . . 21.41 110.827 -179.82 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.477 -0.249 . . . . 11.91 112.477 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 79.7 p -172.58 46.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.769 0.319 . . . . 10.130000000000001 110.791 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . 0.603 ' HE1' ' HA ' ' A' ' 368' ' ' PRO . 31.2 t-80 -60.35 -35.59 76.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.243 0.544 . . . . 8.6699999999999999 110.392 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' A' ' 366' ' ' MET . 15.3 tpt 60.13 53.72 4.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.217 -0.901 . . . . 5.7000000000000002 111.698 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 368' ' ' PRO . 10.1 t70 63.91 139.46 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.23 -0.441 . . . . 6.0599999999999996 111.548 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . 0.603 ' HA ' ' HE1' ' A' ' 365' ' ' HIS . 14.7 Cg_exo -70.42 -155.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.178 1.918 . . . . 6.5899999999999999 110.308 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.485 HD11 ' C ' ' A' ' 369' ' ' LEU . 3.3 pp 37.82 21.39 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.615 0.572 . . . . 7.21 112.301 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.517 ' N ' ' O ' ' A' ' 368' ' ' PRO . 42.6 ttp -169.94 48.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 5.6699999999999999 110.41 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.81 124.35 18.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 5.6100000000000003 111.225 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.555 ' HB3' ' HH ' ' A' ' 412' ' ' TYR . 51.6 mtmt -68.45 139.87 55.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.05 -0.523 . . . . 5.7800000000000002 110.788 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 63.8 mt -56.23 134.7 20.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.318 -0.401 . . . . 1.9299999999999999 111.046 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -88.14 110.61 20.81 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.155 -0.475 . . . . 2.1699999999999999 110.556 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 397' ' ' VAL . 93.0 mt -66.82 -43.44 89.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.866 -0.606 . . . . 1.4399999999999999 111.972 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 75.9 p -69.84 64.84 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.101 0.477 . . . . 2.2000000000000002 110.842 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -149.46 -27.99 0.27 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.9199999999999999 109.685 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.443 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -172.28 60.72 0.29 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.282 -0.872 . . . . 2.8900000000000001 111.239 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -51.32 -37.3 60.04 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.311 2.008 . . . . 0.97999999999999998 111.676 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -62.96 -34.22 77.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.762 -0.654 . . . . 1.21 110.866 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -53.86 124.68 16.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 2.27 111.199 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.693 HD13 HG12 ' A' ' 417' ' ' VAL . 16.2 mm -79.88 124.4 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.074 -0.512 . . . . 1.1299999999999999 111.755 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.508 ' HB2' ' O ' ' A' ' 395' ' ' GLY . 4.2 m-85 -104.07 144.21 31.86 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.235 -0.283 . . . . 1.1000000000000001 110.235 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -94.65 135.91 35.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.012 0.434 . . . . 1.3200000000000001 110.867 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.596 HD13 ' N ' ' A' ' 385' ' ' ILE . 2.8 mp -119.24 126.07 75.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 1.2 110.063 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.772 ' HE ' ' HA2' ' A' ' 440' ' ' GLY . 55.7 ttt-85 -89.19 121.65 31.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 3.1699999999999999 111.048 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.479 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 59.8 mtp85 -79.63 168.3 19.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 2.9900000000000002 110.602 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -56.1 -42.87 77.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 2.8199999999999998 111.233 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.435 ' CG ' HG22 ' A' ' 391' ' ' THR . 48.2 p-10 -72.3 5.7 2.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 1.23 111.954 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.603 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . 73.07 48.81 18.65 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.52 -0.848 . . . . 1.03 113.077 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' THR . . . . . 0.479 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 81.9 p -120.69 110.54 16.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.687 0.279 . . . . 1.46 111.561 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 441' ' ' GLY . 58.6 t -70.52 127.56 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.082 -0.34 . . . . 1.24 110.082 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.467 ' HE1' HG12 ' A' ' 444' ' ' VAL . 89.8 m-70 -145.02 135.99 24.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.112 0.482 . . . . 3.2400000000000002 111.482 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.499 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 59.6 mtt85 -55.56 155.29 5.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.802 -0.635 . . . . 3.5600000000000001 112.057 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 383' ' ' TYR . . . 178.02 126.64 1.0 Allowed Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.396 -0.82 . . . . 0.32000000000000001 111.371 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 85.4 mt-30 -91.74 129.22 37.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.972 0.386 . . . . 1.28 111.739 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.639 HG23 HD12 ' A' ' 432' ' ' ILE . 4.2 t -82.95 126.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.134 -0.691 . . . . 1.5800000000000001 109.134 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 66.8 mt -120.71 -46.85 2.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.251 0.463 . . . . 2.04 112.251 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . 0.516 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 12.0 mm-40 -123.73 176.51 6.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.107 0.48 . . . . 2.6400000000000001 111.6 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 97.0 p -163.57 146.06 9.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.634 -0.712 . . . . 1.1299999999999999 110.109 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -162.57 139.03 7.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.879 0.371 . . . . 1.8799999999999999 111.332 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.715 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 72.2 p -70.59 -125.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 1.79 110.033 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.424 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.76 -173.41 2.97 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.662 -0.495 . . . . 2.2999999999999998 109.662 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.424 ' H ' ' CG2' ' A' ' 403' ' ' THR . 64.2 mm-40 -44.86 -40.39 6.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.802 0.334 . . . . 3.8700000000000001 110.856 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.612 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 0.7 OUTLIER -68.13 -53.66 23.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.193 -0.458 . . . . 3.1600000000000001 110.563 179.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.408 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 51.29 51.69 16.38 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.192 0.52 . . . . 2.1800000000000002 111.358 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.453 ' HB3' ' ND2' ' A' ' 405' ' ' ASN . . . -152.83 10.73 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.484 -0.78 . . . . 2.77 109.46 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.453 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . -177.82 -48.25 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 114.465 -1.243 . . . . 3.2799999999999998 110.034 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.612 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 36.1 Cg_exo -60.89 149.24 89.47 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.524 2.15 . . . . 2.8700000000000001 112.383 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.715 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 12.1 p-10 -174.07 137.51 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 2.1400000000000001 110.348 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.9 mt-10 -134.83 134.68 41.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 2.1000000000000001 110.902 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.555 ' HH ' ' HB3' ' A' ' 372' ' ' LYS . 1.2 m-85 -109.76 125.66 52.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.058 0.456 . . . . 1.0600000000000001 111.175 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 14.3 t80 -62.22 144.0 56.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.71 -0.677 . . . . 1.05 110.189 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.508 HG23 HG12 ' A' ' 427' ' ' VAL . 0.0 OUTLIER -144.56 129.66 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.624 0.602 . . . . 1.8400000000000001 112.624 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . 0.415 ' O ' ' HA3' ' A' ' 395' ' ' GLY . 38.4 t60 -103.38 97.15 7.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.153 -0.93 . . . . 0.70999999999999996 109.169 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 36.7 m-85 -53.2 106.41 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.391 0.615 . . . . 1.1299999999999999 111.22 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.693 HG12 HD13 ' A' ' 382' ' ' ILE . 58.3 t -67.16 130.01 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.905 -1.043 . . . . 1.7 111.143 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 81.4 -45.55 3.26 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.747 -0.661 . . . . 1.1699999999999999 112.608 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 6.9 mp -65.6 166.57 10.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.997 0.427 . . . . 2.1499999999999999 111.427 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -53.86 143.37 21.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.831 -0.622 . . . . 2.7599999999999998 111.544 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 53.9 mtt85 -61.75 -38.52 88.27 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.854 -0.612 . . . . 4.6500000000000004 111.286 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -56.25 -32.58 64.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 4.3200000000000003 111.439 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . . . . . . . . . 1.9 mp -58.21 -27.95 64.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.226 -0.443 . . . . 2.04 111.822 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -48.39 139.77 8.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 1.2 111.325 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -171.66 -147.83 5.86 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.76 -0.734 . . . . 0.69999999999999996 112.466 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -128.65 138.37 52.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.021 0.439 . . . . 0.76000000000000001 111.18 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.508 HG12 HG23 ' A' ' 414' ' ' VAL . 23.0 m -115.04 155.57 16.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.692 -0.686 . . . . 1.4399999999999999 111.494 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -78.04 30.94 1.8 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.913 -0.66 . . . . 1.72 114.075 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.551 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 9.7 tpt180 72.09 -45.63 0.62 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.688 0.625 . . . . 2.3199999999999998 112.688 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -62.41 -21.53 65.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.706 0.289 . . . . 2.23 111.592 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.446 ' HD2' ' HB ' ' A' ' 427' ' ' VAL . 90.7 mtt180 -79.11 -26.95 42.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.188 0.44 . . . . 3.4199999999999999 112.188 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.639 HD12 HG23 ' A' ' 397' ' ' VAL . 71.4 mt -88.11 136.8 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.965 0.412 . . . . 1.1399999999999999 111.243 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.439 ' N ' HG21 ' A' ' 432' ' ' ILE . 56.4 m -159.69 138.69 10.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.95999999999999996 110.612 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.29 -26.51 62.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 1.3500000000000001 111.138 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -112.85 130.62 56.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 2.5299999999999998 110.729 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . 0.621 ' HB2' HD13 ' A' ' 442' ' ' ILE . . . -66.91 -32.52 73.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 1.3300000000000001 111.176 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -51.54 -40.88 60.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.232 -0.44 . . . . 1.3400000000000001 110.783 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.85 -38.46 83.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.171 0.51 . . . . 1.5600000000000001 110.118 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.547 ' C ' ' HD2' ' A' ' 386' ' ' ARG . 69.3 mt -61.89 -93.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.525 -0.761 . . . . 1.76 111.238 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . 0.772 ' HA2' ' HE ' ' A' ' 386' ' ' ARG . . . -166.29 39.87 0.26 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.116 -0.564 . . . . 1.3600000000000001 111.931 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 392' ' ' VAL . . . 67.62 131.19 0.03 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.018 -0.61 . . . . 1.8300000000000001 112.162 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.621 HD13 ' HB2' ' A' ' 436' ' ' ALA . 5.3 mp -58.48 113.9 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.67 0.271 . . . . 1.9199999999999999 110.322 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 11.5 t -167.6 130.2 1.62 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.309 0.576 . . . . 3.4199999999999999 112.307 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.532 ' C ' ' HD3' ' A' ' 446' ' ' PRO . 67.9 t -100.57 124.47 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 115.405 -0.816 . . . . 4.6399999999999997 110.135 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 34.0 mt -115.45 69.83 2.97 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.162 -0.472 . . . . 4.9900000000000002 111.006 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.532 ' HD3' ' C ' ' A' ' 444' ' ' VAL . 36.8 Cg_exo -60.28 119.4 6.57 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.473 2.115 . . . . 8.0099999999999998 112.394 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . 59.45 122.97 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 115.943 -0.571 . . . . 9.0600000000000005 111.752 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 447' ' ' ALA . 19.9 Cg_exo -65.59 128.62 20.49 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.404 2.07 . . . . 11.42 111.771 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.18 123.0 10.9 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.218 1.945 . . . . 13.529999999999999 112.15 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . 0.418 ' H ' ' CD2' ' A' ' 450' ' ' LEU . 2.3 pt? -72.32 135.62 45.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 16.010000000000002 110.923 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 453' ' ' ASP . . . 55.46 75.7 0.57 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 16.739999999999998 111.115 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.73 16.37 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.333 2.022 . . . . 18.530000000000001 112.606 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 451' ' ' ALA . 7.8 t70 -84.91 128.44 34.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.461 . . . . 20.550000000000001 110.223 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.195 -0.907 . . . . 21.41 110.438 -179.877 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.488 -0.245 . . . . 11.91 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 32.1 t 56.87 -128.7 1.82 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 110.616 -0.142 . . . . 10.130000000000001 110.616 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -168.48 119.25 0.77 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.878 0.37 . . . . 8.6699999999999999 110.957 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.467 ' HG3' ' HE3' ' A' ' 372' ' ' LYS . 1.5 mpt? -94.93 125.57 39.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 5.7000000000000002 110.342 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -72.2 110.85 8.84 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.425 -0.352 . . . . 6.0599999999999996 111.103 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 366' ' ' MET . 91.9 Cg_endo -85.07 34.26 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.545 2.163 . . . . 6.5899999999999999 112.252 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.583 HD11 ' HG2' ' A' ' 370' ' ' MET . 0.9 OUTLIER -151.76 9.17 0.52 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 112.305 0.483 . . . . 7.21 112.305 -179.121 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.583 ' HG2' HD11 ' A' ' 369' ' ' LEU . 27.5 ptt? -173.57 9.17 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.894 0.378 . . . . 5.6699999999999999 111.135 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 41.97 -163.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.274 -0.875 . . . . 5.6100000000000003 111.815 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.481 ' HB3' ' HH ' ' A' ' 412' ' ' TYR . 42.7 mmtm -73.41 150.35 41.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.166 -0.47 . . . . 5.7800000000000002 110.698 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 373' ' ' ILE . 68.1 mt -52.22 135.61 13.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.437 -0.347 . . . . 1.9299999999999999 110.711 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -88.92 129.45 35.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 2.1699999999999999 111.228 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 78.7 mt -84.27 -45.18 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 1.4399999999999999 111.16 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 48.0 t -64.11 78.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 2.2000000000000002 110.859 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . 0.532 ' HG3' ' ND2' ' A' ' 378' ' ' ASN . 12.1 pt-20 -173.71 -28.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.528 -0.76 . . . . 1.9199999999999999 110.074 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.622 HD22 ' HH ' ' A' ' 383' ' ' TYR . 0.1 OUTLIER -173.07 61.54 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.536 -0.757 . . . . 2.8900000000000001 111.509 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.99 -38.67 86.7 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.318 2.012 . . . . 0.97999999999999998 111.877 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.506 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 28.3 m-20 -65.34 -33.51 76.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.996 -0.547 . . . . 1.21 111.073 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 85.2 tttt -48.02 126.58 10.96 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.942 0.401 . . . . 2.27 111.076 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.9 HD13 HG12 ' A' ' 417' ' ' VAL . 36.5 mm -71.79 120.71 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.89 -0.596 . . . . 1.1299999999999999 111.724 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.622 ' HH ' HD22 ' A' ' 378' ' ' ASN . 5.2 m-85 -99.57 144.4 28.7 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.587 -0.523 . . . . 1.1000000000000001 109.587 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 45.1 m-85 -88.88 133.08 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.895 -0.322 . . . . 1.3200000000000001 110.795 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.601 HG22 HG13 ' A' ' 427' ' ' VAL . 2.1 mp -116.33 144.67 23.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.819 0.342 . . . . 1.2 111.539 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.643 ' NH1' ' HA2' ' A' ' 440' ' ' GLY . 39.1 ttt85 -124.48 104.25 8.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 3.1699999999999999 110.525 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.478 ' HG3' ' CE1' ' A' ' 393' ' ' HIS . 10.0 mtp-105 -65.04 161.6 18.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.831 0.348 . . . . 2.9900000000000002 110.944 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.573 ' HG3' HH21 ' A' ' 431' ' ' ARG . 50.5 mp0 -48.76 -45.05 39.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.054 0.761 . . . . 2.8199999999999998 113.054 -177.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' A' ' 391' ' ' THR . 8.0 p-10 -60.16 -35.26 74.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.595 0.236 . . . . 1.23 111.59 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 118.45 44.3 0.52 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.605 -0.807 . . . . 1.03 112.413 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' THR . . . . . 0.604 HG23 ' HB ' ' A' ' 444' ' ' VAL . 21.5 p -116.64 112.49 21.34 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.789 0.292 . . . . 1.46 111.789 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 86.4 t -79.56 134.23 28.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.604 -0.517 . . . . 1.24 109.604 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.497 ' HE1' HG23 ' A' ' 385' ' ' ILE . 0.6 OUTLIER -156.47 133.98 10.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.939 0.4 . . . . 3.2400000000000002 111.03 -178.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.498 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 99.6 mtt180 -60.07 145.18 47.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.931 -0.577 . . . . 3.5600000000000001 111.75 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -174.21 128.85 1.52 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.532 -0.758 . . . . 0.32000000000000001 111.976 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . 0.506 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 68.6 mt-30 -78.31 129.68 35.31 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.689 -0.3 . . . . 1.28 111.597 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.561 HG22 HD11 ' A' ' 432' ' ' ILE . 0.5 OUTLIER -88.28 132.08 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.547 -0.538 . . . . 1.5800000000000001 109.547 177.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . 0.623 HD11 ' N ' ' A' ' 398' ' ' LEU . 4.9 mp -106.14 -49.44 3.37 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.791 0.663 . . . . 2.04 112.791 -177.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' A' ' 412' ' ' TYR . 98.1 mm-40 -142.94 178.02 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.004 0.431 . . . . 2.6400000000000001 111.869 -178.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.7 p -148.83 149.39 31.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.683 -0.69 . . . . 1.1299999999999999 109.987 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -158.49 139.08 12.69 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.169 0.509 . . . . 1.8799999999999999 112.356 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.572 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 50.6 p -87.6 139.1 30.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.671 -0.695 . . . . 1.79 109.557 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.5 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.9 m -60.53 -174.57 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.58 0.229 . . . . 2.2999999999999998 110.579 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.5 ' H ' ' CG2' ' A' ' 403' ' ' THR . 59.1 mm-40 -50.73 -41.74 56.6 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.798 0.295 . . . . 3.8700000000000001 111.798 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.51 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 50.8 t30 -59.19 -49.57 77.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.569 -0.287 . . . . 3.1600000000000001 111.076 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.572 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 52.71 48.25 22.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.154 0.502 . . . . 2.1800000000000002 111.483 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.447 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -145.75 10.79 1.22 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.603 -0.726 . . . . 2.77 109.478 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.48 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . 179.78 -47.81 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.472 -1.24 . . . . 3.2799999999999998 110.0 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.51 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 36.3 Cg_exo -57.9 143.46 95.86 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.561 2.174 . . . . 2.8700000000000001 112.513 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -170.48 136.31 1.29 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.69 -0.687 . . . . 2.1400000000000001 110.326 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 400' ' ' SER . 64.8 mm-40 -140.89 135.12 30.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.193 -0.458 . . . . 2.1000000000000001 110.886 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.535 ' HB3' HG23 ' A' ' 397' ' ' VAL . 1.2 m-85 -109.21 119.19 38.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.145 -0.48 . . . . 1.0600000000000001 111.213 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.404 ' HD2' ' HB2' ' A' ' 398' ' ' LEU . 10.5 t80 -57.41 145.99 30.84 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.278 -0.638 . . . . 1.05 109.278 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 14.4 p -154.82 129.52 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.201 0.815 . . . . 1.8400000000000001 113.201 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -101.85 113.09 25.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.344 -0.844 . . . . 0.70999999999999996 109.084 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.479 ' HE2' ' ND1' ' A' ' 393' ' ' HIS . 65.1 m-85 -61.42 132.69 54.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.356 0.598 . . . . 1.1299999999999999 111.125 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.9 HG12 HD13 ' A' ' 382' ' ' ILE . 1.3 t -78.82 27.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.212 -0.904 . . . . 1.7 111.406 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 416' ' ' TYR . . . 172.74 -43.04 0.17 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.407 -0.901 . . . . 1.1699999999999999 113.289 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.56 HD22 HD21 ' A' ' 423' ' ' LEU . 7.3 mp -59.75 151.88 24.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 2.1499999999999999 111.604 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -50.36 147.13 4.6 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.494 -0.776 . . . . 2.7599999999999998 112.203 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . 0.423 ' HA ' ' CG ' ' A' ' 424' ' ' ASP . 87.1 mtm180 -59.24 -28.88 67.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.706 -0.679 . . . . 4.6500000000000004 110.927 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -53.61 -41.2 66.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.285 0.564 . . . . 4.3200000000000003 110.059 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.561 HD11 ' N ' ' A' ' 423' ' ' LEU . 6.4 mp -71.56 -33.12 68.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.142 -0.935 . . . . 2.04 110.999 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.423 ' CG ' ' HA ' ' A' ' 421' ' ' ARG . 10.6 m-20 -53.11 131.44 36.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 1.2 110.783 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 176.43 -142.03 5.77 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.702 -0.761 . . . . 0.69999999999999996 112.51 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -105.19 135.83 45.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.76000000000000001 110.933 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.601 HG13 HG22 ' A' ' 385' ' ' ILE . 3.4 m -128.81 134.56 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.534 . . . . 1.4399999999999999 111.634 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.42 ' HA2' ' CE1' ' A' ' 430' ' ' HIS . . . -57.7 150.06 31.98 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.722 -0.752 . . . . 1.72 111.99 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -47.92 -39.77 19.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.615 0.245 . . . . 2.3199999999999998 111.331 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.497 ' HD1' ' H ' ' A' ' 430' ' ' HIS . 9.1 p-80 -61.77 -32.26 72.51 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.866 0.321 . . . . 2.23 111.866 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.573 HH21 ' HG3' ' A' ' 388' ' ' GLU . 57.0 mtt85 -82.21 26.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.108 -0.237 . . . . 3.4199999999999999 111.191 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.561 HD11 HG22 ' A' ' 397' ' ' VAL . 66.0 mt -149.58 135.63 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 1.1399999999999999 110.868 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.625 ' HG ' HD22 ' A' ' 439' ' ' LEU . 70.5 m -166.25 139.23 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 0.95999999999999996 110.866 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.65 16.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 1.3500000000000001 110.507 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 433' ' ' SER . 74.9 m-20 -138.79 128.26 24.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.902 -0.59 . . . . 2.5299999999999998 110.328 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . 0.521 ' HB2' HD13 ' A' ' 442' ' ' ILE . . . -65.17 -43.1 92.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 1.3300000000000001 111.754 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -56.24 -40.36 74.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 1.3400000000000001 111.333 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.77 42.44 0.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 1.5600000000000001 111.601 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.625 HD22 ' HG ' ' A' ' 433' ' ' SER . 85.9 mt -150.2 -88.41 0.07 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.72 -0.218 . . . . 1.76 111.438 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . 0.643 ' HA2' ' NH1' ' A' ' 386' ' ' ARG . . . -171.45 38.12 0.17 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.542 -0.837 . . . . 1.3600000000000001 112.859 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.83 141.02 0.04 OUTLIER Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.736 -0.745 . . . . 1.8300000000000001 112.869 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.521 HD13 ' HB2' ' A' ' 436' ' ' ALA . 42.3 mm -70.06 67.65 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.985 0.421 . . . . 1.9199999999999999 110.689 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.428 HG21 ' N ' ' A' ' 444' ' ' VAL . 67.9 m -164.85 136.43 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 3.4199999999999999 110.991 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.604 ' HB ' HG23 ' A' ' 391' ' ' THR . 23.9 m -79.58 54.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 4.6399999999999997 111.568 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.69 137.47 96.29 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.74 -0.664 . . . . 4.9900000000000002 111.101 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.69 142.05 17.75 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.702 2.268 . . . . 8.0099999999999998 112.601 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -171.43 134.59 0.92 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 9.0600000000000005 111.034 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.37 133.77 51.25 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.468 2.112 . . . . 11.42 112.01 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.76 127.5 19.78 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.459 2.106 . . . . 13.529999999999999 112.331 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 92.4 mt -74.78 137.65 42.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 16.010000000000002 110.701 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . -59.08 124.87 76.35 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 16.739999999999998 111.229 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 451' ' ' ALA . 21.1 Cg_exo -66.63 -149.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.794 2.329 . . . . 18.530000000000001 112.467 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -66.76 -45.74 77.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.367 -0.379 . . . . 20.550000000000001 110.775 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.205 -0.902 . . . . 21.41 111.007 -179.877 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.526 -0.23 . . . . 11.91 112.526 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.9 t -174.46 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.876 0.37 . . . . 10.130000000000001 110.853 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -58.45 138.17 56.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 8.6699999999999999 111.207 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.528 ' CE ' ' HB2' ' A' ' 407' ' ' ALA . 64.7 mtt -126.52 122.26 34.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 5.7000000000000002 110.408 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.759 ' HB3' HD12 ' A' ' 369' ' ' LEU . 30.1 m-20 -73.45 125.82 90.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.159 -0.473 . . . . 6.0599999999999996 111.559 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -84.27 40.4 0.87 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.698 2.265 . . . . 6.5899999999999999 112.644 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.759 HD12 ' HB3' ' A' ' 367' ' ' ASP . 0.0 OUTLIER -160.25 -30.99 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.739 -0.664 . . . . 7.21 109.634 179.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.491 ' HE2' HH21 ' A' ' 429' ' ' ARG . 0.0 OUTLIER -94.63 58.08 2.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.583 -0.735 . . . . 5.6699999999999999 109.031 178.63 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -71.31 51.51 0.17 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.718 -0.674 . . . . 5.6100000000000003 112.338 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.491 ' HB3' ' OH ' ' A' ' 412' ' ' TYR . 74.9 mmtt 62.15 147.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.277 0.56 . . . . 5.7800000000000002 112.461 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.455 HG13 ' HE ' ' A' ' 429' ' ' ARG . 70.6 mt -55.94 131.62 19.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.527 -0.76 . . . . 1.9299999999999999 111.337 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.677 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 23.6 m-20 -88.87 111.58 22.24 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 116.09 -0.505 . . . . 2.1699999999999999 110.902 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.405 ' O ' HG21 ' A' ' 375' ' ' ILE . 86.4 mt -73.17 -39.68 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.709 0.29 . . . . 1.4399999999999999 111.781 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 40.1 t -46.72 -28.74 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.011 -0.54 . . . . 2.2000000000000002 112.422 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . 0.677 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 15.5 pt-20 -69.43 -38.47 77.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.508 -0.315 . . . . 1.9199999999999999 111.772 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.663 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 5.5 m120 -153.06 69.16 6.85 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 112.322 0.49 . . . . 2.8900000000000001 112.322 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.38 -40.68 77.37 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.684 2.256 . . . . 0.97999999999999998 112.577 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -70.3 -34.09 72.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.536 . . . . 1.21 111.774 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.663 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 63.0 tttp -46.38 136.36 7.36 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.983 0.421 . . . . 2.27 111.021 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.483 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 46.4 mm -84.86 130.47 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.782 -0.644 . . . . 1.1299999999999999 111.834 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -118.93 143.6 46.92 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.496 -0.557 . . . . 1.1000000000000001 109.496 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.51 ' CE1' ' HG2' ' A' ' 394' ' ' ARG . 1.3 m-85 -84.83 143.74 28.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.783 0.325 . . . . 1.3200000000000001 111.351 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 431' ' ' ARG . 2.8 mp -119.85 133.83 65.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 116.228 -0.442 . . . . 1.2 111.492 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.554 ' NH1' ' HA2' ' A' ' 440' ' ' GLY . 28.3 tpt180 -87.0 106.01 17.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 3.1699999999999999 110.418 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.647 ' HB2' ' HG1' ' A' ' 391' ' ' THR . 62.5 mtp85 -66.69 160.52 25.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 2.9900000000000002 111.067 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.7 -71.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.865 -0.607 . . . . 2.8199999999999998 111.048 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.408 ' OD1' HG22 ' A' ' 391' ' ' THR . 2.4 p30 -41.7 -28.9 0.16 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.052 0.453 . . . . 1.23 110.28 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 110.16 44.3 1.02 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.737 -0.665 . . . . 1.03 113.459 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' THR . . . . . 0.647 ' HG1' ' HB2' ' A' ' 387' ' ' ARG . 37.0 p -121.2 110.37 16.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.967 0.413 . . . . 1.46 111.062 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.665 HG12 HD11 ' A' ' 439' ' ' LEU . 90.2 t -71.6 133.13 32.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 1.24 111.352 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -151.93 138.46 18.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.111 -0.495 . . . . 3.2400000000000002 110.537 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.51 ' HG2' ' CE1' ' A' ' 384' ' ' PHE . 60.6 mtt85 -51.6 155.65 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.392 0.615 . . . . 3.5600000000000001 112.601 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -178.61 133.37 2.1 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.103 -0.953 . . . . 0.32000000000000001 111.84 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . 0.617 ' O ' HD23 ' A' ' 398' ' ' LEU . 55.1 mt-30 -80.95 130.68 35.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.771 0.285 . . . . 1.28 111.771 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.837 HG23 HD12 ' A' ' 432' ' ' ILE . 14.5 t -91.43 126.61 44.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.81 -0.811 . . . . 1.5800000000000001 108.81 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 396' ' ' GLN . 0.3 OUTLIER -108.83 -40.08 5.15 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.023 0.749 . . . . 2.04 113.023 -177.029 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -139.95 176.02 9.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.95 0.405 . . . . 2.6400000000000001 111.901 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.577 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.2 p -163.56 150.96 12.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.829 -0.623 . . . . 1.1299999999999999 110.611 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 39.9 ptt180 -153.14 134.33 14.15 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.492 -0.322 . . . . 1.8799999999999999 111.163 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 47.7 p -71.93 135.71 46.6 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.96 0.41 . . . . 1.79 110.69 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.473 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.1 m -62.51 -174.1 0.06 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.837 -0.62 . . . . 2.2999999999999998 110.372 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.473 ' H ' ' CG2' ' A' ' 403' ' ' THR . 60.3 mm-40 -44.94 -37.04 3.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.86 0.319 . . . . 3.8700000000000001 111.86 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.514 HD21 ' HD2' ' A' ' 409' ' ' PRO . 45.4 t30 -57.52 -49.76 75.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.747 0.308 . . . . 3.1600000000000001 110.873 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.599 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.78 66.03 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.183 -0.462 . . . . 2.1800000000000002 111.603 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.528 ' HB2' ' CE ' ' A' ' 366' ' ' MET . . . -162.65 -23.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 2.77 110.518 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.642 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -159.99 -52.33 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.683 -0.69 . . . . 3.2799999999999998 110.7 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.668 ' O ' ' HA ' ' A' ' 402' ' ' THR . 52.1 Cg_exo -54.96 149.2 43.66 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.196 1.93 . . . . 2.8700000000000001 111.341 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 34.4 p-10 -179.08 143.71 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.091 0.472 . . . . 2.1400000000000001 111.58 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 400' ' ' SER . 0.5 OUTLIER -106.82 135.25 48.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.756 -0.656 . . . . 2.1000000000000001 109.859 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.593 ' HB3' ' CG1' ' A' ' 397' ' ' VAL . 0.4 OUTLIER -109.75 128.11 55.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.345 -0.389 . . . . 1.0600000000000001 111.958 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 9.4 t80 -64.54 141.56 58.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 1.05 109.833 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.51 132.99 60.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.153 0.797 . . . . 1.8400000000000001 113.153 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -116.13 89.9 3.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.036 -0.984 . . . . 0.70999999999999996 109.304 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.419 ' H ' ' HD1' ' A' ' 416' ' ' TYR . 6.2 m-85 -55.89 127.2 29.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.953 0.406 . . . . 1.1299999999999999 111.161 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.46 HG22 HD13 ' A' ' 382' ' ' ILE . 61.9 t -70.38 127.23 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.01 -0.541 . . . . 1.7 111.375 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.53 -41.93 1.69 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.966 -0.635 . . . . 1.1699999999999999 113.182 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.43 156.92 12.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.947 0.403 . . . . 2.1499999999999999 111.375 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.593 ' OD1' HD11 ' A' ' 423' ' ' LEU . 22.5 p30 -49.58 143.38 7.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.786 -0.643 . . . . 2.7599999999999998 111.65 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 421' ' ' ARG . 57.0 mtt85 -62.77 -36.16 82.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.636 -0.711 . . . . 4.6500000000000004 111.898 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -54.09 -30.04 46.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.341 . . . . 4.3200000000000003 111.029 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.593 HD11 ' OD1' ' A' ' 420' ' ' ASN . 1.1 tp -59.41 -31.69 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 2.04 111.365 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.449 ' HB3' ' HH ' ' A' ' 413' ' ' TYR . 1.1 m-20 -46.5 134.83 8.95 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.946 0.403 . . . . 1.2 111.155 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.88 155.08 12.27 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.827 -0.701 . . . . 0.69999999999999996 112.268 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 12.2 m95 -71.05 137.64 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.679 0.276 . . . . 0.76000000000000001 110.38 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.426 ' HB ' ' HD3' ' A' ' 431' ' ' ARG . 11.4 m -138.0 141.23 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.438 -0.346 . . . . 1.4399999999999999 110.843 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -50.01 150.7 4.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.668 -0.777 . . . . 1.72 112.442 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.491 HH21 ' HE2' ' A' ' 370' ' ' MET . 32.6 tpt85 -48.7 -42.03 33.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.479 0.18 . . . . 2.3199999999999998 111.477 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -55.43 -31.71 62.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.541 -0.3 . . . . 2.23 111.469 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 73.5 mtp180 -81.61 20.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.611 -0.268 . . . . 3.4199999999999999 111.228 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.837 HD12 HG23 ' A' ' 397' ' ' VAL . 83.5 mt -150.33 126.04 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.826 0.346 . . . . 1.1399999999999999 110.914 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 435' ' ' ASN . 65.5 m -165.67 143.4 5.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.863 -0.608 . . . . 0.95999999999999996 110.65 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . 0.484 ' OD1' ' HE3' ' A' ' 381' ' ' LYS . 27.5 m-20 -70.62 16.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 1.3500000000000001 111.293 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.511 ' H ' ' C ' ' A' ' 433' ' ' SER . 16.1 p-10 -158.9 128.14 5.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.926 0.393 . . . . 2.5299999999999998 110.585 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . 0.6 ' HB2' HD12 ' A' ' 442' ' ' ILE . . . -68.09 -25.08 65.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.97 -0.559 . . . . 1.3300000000000001 111.896 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.34 -41.19 18.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.405 -0.361 . . . . 1.3400000000000001 111.631 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -82.63 -41.68 19.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.927 0.394 . . . . 1.5600000000000001 110.948 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.665 HD11 HG12 ' A' ' 392' ' ' VAL . 49.0 mt -54.63 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 1.76 111.565 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . 0.554 ' HA2' ' NH1' ' A' ' 386' ' ' ARG . . . -157.29 38.66 0.55 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.851 -0.69 . . . . 1.3600000000000001 112.186 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.12 146.0 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.686 -0.768 . . . . 1.8300000000000001 112.199 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 436' ' ' ALA . 48.8 mm -48.51 115.65 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.975 -0.38 . . . . 1.9199999999999999 109.975 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.717 HG21 HD22 ' A' ' 445' ' ' LEU . 3.2 m -60.31 117.35 5.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.259 -0.428 . . . . 3.4199999999999999 110.976 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 443' ' ' THR . 60.9 t -142.97 63.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.204 0.526 . . . . 4.6399999999999997 110.733 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.717 HD22 HG21 ' A' ' 443' ' ' THR . 1.8 pt? -155.01 52.67 0.74 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 4.9900000000000002 111.344 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.653 ' HD3' ' N ' ' A' ' 445' ' ' LEU . 10.2 Cg_exo -65.61 148.37 87.17 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.958 2.439 . . . . 8.0099999999999998 111.968 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -55.58 129.67 70.25 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 110.315 -0.254 . . . . 9.0600000000000005 110.315 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.52 111.06 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.392 2.061 . . . . 11.42 112.663 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -82.47 -162.72 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.711 2.274 . . . . 13.529999999999999 112.068 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 93.8 mt -81.93 31.03 0.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.386 -0.37 . . . . 16.010000000000002 110.89 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -84.12 132.67 47.26 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 16.739999999999998 111.241 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.46 29.61 0.43 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.417 2.078 . . . . 18.530000000000001 112.595 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.17 136.1 41.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.914 0.388 . . . . 20.550000000000001 110.945 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.231 -0.89 . . . . 21.41 110.946 179.904 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.539 -0.224 . . . . 11.91 112.539 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 22.7 t 57.68 -137.62 0.93 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 110.481 -0.192 . . . . 10.130000000000001 110.481 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . 0.503 ' HE1' ' HA ' ' A' ' 368' ' ' PRO . 28.8 t-80 56.03 58.39 4.41 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.89 0.376 . . . . 8.6699999999999999 110.393 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.43 ' HB2' ' HE1' ' A' ' 366' ' ' MET . 24.2 ptm -55.6 125.34 20.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.173 -0.467 . . . . 5.7000000000000002 111.117 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 369' ' ' LEU . 1.4 m-20 54.97 113.23 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.823 -0.626 . . . . 6.0599999999999996 111.713 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . 0.503 ' HA ' ' HE1' ' A' ' 365' ' ' HIS . 60.6 Cg_endo -75.59 34.08 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.464 2.109 . . . . 6.5899999999999999 112.71 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.423 ' C ' ' H ' ' A' ' 371' ' ' GLN . 27.6 tp -178.88 -48.4 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.268 -0.424 . . . . 7.21 110.684 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 370' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.7 31.47 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.134 0.492 . . . . 5.6699999999999999 109.999 179.378 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' A' ' 369' ' ' LEU . 16.6 pt20 -79.55 158.58 27.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.953 -0.567 . . . . 5.6100000000000003 110.956 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -46.07 146.0 1.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.064 -0.517 . . . . 5.7800000000000002 111.648 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.461 HG21 ' N ' ' A' ' 374' ' ' ASP . 69.3 mt -51.12 135.17 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.756 -0.656 . . . . 1.9299999999999999 111.057 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.461 ' N ' HG21 ' A' ' 373' ' ' ILE . 30.4 m-20 -88.22 110.47 20.74 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.23 -0.441 . . . . 2.1699999999999999 110.854 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.431 HD12 ' C ' ' A' ' 398' ' ' LEU . 82.0 mt -76.48 -34.75 25.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 1.4399999999999999 111.623 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 80.4 p -70.17 64.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 2.2000000000000002 111.643 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -174.66 -27.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.904 -0.589 . . . . 1.9199999999999999 110.073 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.596 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 2.7 m120 -149.49 60.26 4.45 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.77 . . . . 2.8900000000000001 112.413 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 73.3 Cg_exo -55.69 -40.92 82.46 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.713 2.276 . . . . 0.97999999999999998 112.341 179.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -69.4 -30.05 67.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 1.21 111.94 -179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 88.1 tttt -44.92 130.03 7.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.001 0.429 . . . . 2.27 111.005 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 38.4 mm -91.99 135.01 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 1.1299999999999999 111.5 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 383' ' ' TYR . 1.6 m-85 -119.95 143.13 48.17 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.961 -0.385 . . . . 1.1000000000000001 109.961 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -92.65 136.18 33.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.777 -0.369 . . . . 1.3200000000000001 110.597 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 431' ' ' ARG . 3.1 mp -125.61 128.37 72.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.868 0.366 . . . . 1.2 110.935 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.633 ' N ' HD21 ' A' ' 439' ' ' LEU . 78.8 ttt180 -81.8 120.65 25.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.994 -0.548 . . . . 3.1699999999999999 110.801 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.452 ' HE ' ' HG1' ' A' ' 391' ' ' THR . 59.0 mtm180 -74.63 166.59 23.31 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.759 -0.377 . . . . 2.9900000000000002 110.623 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 388' ' ' GLU . 9.0 mp0 -49.66 -44.67 47.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.29 -0.414 . . . . 2.8199999999999998 111.398 -179.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -65.72 -35.11 79.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.429 -0.351 . . . . 1.23 111.353 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.473 ' HA3' ' HE ' ' A' ' 386' ' ' ARG . . . 130.2 -29.21 3.72 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.76 -0.734 . . . . 1.03 112.293 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 391' ' ' THR . . . . . 0.452 ' HG1' ' HE ' ' A' ' 387' ' ' ARG . 51.3 p -59.48 113.63 2.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.241 0.544 . . . . 1.46 111.843 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.461 HG12 HD23 ' A' ' 439' ' ' LEU . 49.1 t -72.62 143.09 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.399 -0.818 . . . . 1.24 111.49 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -146.56 145.09 30.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.707 -0.679 . . . . 3.2400000000000002 109.35 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.531 ' HB2' ' CG1' ' A' ' 417' ' ' VAL . 55.0 mtt85 -74.07 145.93 44.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.482 0.658 . . . . 3.5600000000000001 111.604 -178.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 416' ' ' TYR . . . -146.42 125.05 2.14 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 114.891 -1.05 . . . . 0.32000000000000001 110.996 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -81.84 84.07 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.783 0.325 . . . . 1.28 111.132 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.692 HG22 HG21 ' A' ' 414' ' ' VAL . 0.6 OUTLIER -59.0 132.31 23.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.144 -0.48 . . . . 1.5800000000000001 110.457 179.9 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 375' ' ' ILE . 59.4 mt -120.64 -38.8 2.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.157 -0.474 . . . . 2.04 112.128 -178.401 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -119.8 170.51 9.16 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.177 0.513 . . . . 2.6400000000000001 112.076 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.1 p -165.69 151.22 9.05 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.437 -0.801 . . . . 1.1299999999999999 109.9 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -162.3 137.43 7.07 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.388 0.514 . . . . 1.8799999999999999 112.388 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 35.9 p -86.34 135.61 33.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.86 -0.609 . . . . 1.79 109.429 177.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.496 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.3 m -60.29 -174.7 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.67 0.272 . . . . 2.2999999999999998 110.917 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.496 ' H ' ' CG2' ' A' ' 403' ' ' THR . 4.8 mm-40 -50.66 -42.61 56.75 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.992 0.367 . . . . 3.8700000000000001 111.992 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.551 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 50.8 t30 -56.65 -48.87 76.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.719 0.295 . . . . 3.1600000000000001 110.837 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.509 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 53.19 52.16 14.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 2.1800000000000002 111.529 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.411 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -153.53 10.23 0.42 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.44 0.638 . . . . 2.77 109.642 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.471 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . 179.81 -48.32 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.688 -1.142 . . . . 3.2799999999999998 110.122 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.551 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 36.3 Cg_exo -60.57 141.64 95.81 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.677 2.252 . . . . 2.8700000000000001 112.745 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -173.16 127.73 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.652 -0.704 . . . . 2.1400000000000001 110.784 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 400' ' ' SER . 9.2 mp0 -120.42 134.59 55.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.782 -0.645 . . . . 2.1000000000000001 109.675 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.596 ' HB3' HG23 ' A' ' 397' ' ' VAL . 1.2 m-85 -110.03 123.45 49.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.806 0.336 . . . . 1.0600000000000001 111.649 -178.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.666 ' O ' HG21 ' A' ' 397' ' ' VAL . 19.7 t80 -63.86 119.3 9.74 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.317 -0.624 . . . . 1.05 109.317 178.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.692 HG21 HG22 ' A' ' 397' ' ' VAL . 22.6 t -112.36 135.77 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.461 0.912 . . . . 1.8400000000000001 113.461 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -111.14 89.38 3.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.996 -1.002 . . . . 0.70999999999999996 108.543 177.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.406 ' HA ' ' HA3' ' A' ' 395' ' ' GLY . 62.5 m-85 -52.18 103.16 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.281 0.563 . . . . 1.1299999999999999 110.904 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 394' ' ' ARG . 11.3 p -62.44 136.46 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.147 -0.933 . . . . 1.7 110.932 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 80.43 -47.97 3.54 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.235 -0.746 . . . . 1.1699999999999999 111.235 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.507 ' N ' HD21 ' A' ' 419' ' ' LEU . 2.0 mm? -65.68 159.77 24.22 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.74 0.305 . . . . 2.1499999999999999 110.634 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.612 ' OD1' HD11 ' A' ' 423' ' ' LEU . 21.3 p30 -51.62 141.67 15.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 2.7599999999999998 111.082 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 31.9 ptt85 -60.55 -33.05 72.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.233 -0.44 . . . . 4.6500000000000004 111.918 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -56.4 -29.61 61.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 4.3200000000000003 111.1 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.612 HD11 ' OD1' ' A' ' 420' ' ' ASN . 1.2 tp -58.1 -26.7 62.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 2.04 111.661 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -44.79 135.17 5.21 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.948 0.404 . . . . 1.2 111.174 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -178.82 145.98 7.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.01 -0.614 . . . . 0.69999999999999996 112.189 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -67.49 121.3 15.51 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.99 -0.374 . . . . 0.76000000000000001 109.99 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 6.4 m -118.79 149.59 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 1.4399999999999999 111.537 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.419 ' HA2' ' CE1' ' A' ' 430' ' ' HIS . . . -63.27 146.97 50.61 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.625 -0.798 . . . . 1.72 111.674 178.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 37.1 tpt85 -51.34 -29.73 16.21 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.684 0.253 . . . . 2.3199999999999998 111.684 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.419 ' CE1' ' HA2' ' A' ' 428' ' ' GLY . 22.7 p-80 -60.37 -31.94 70.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.955 0.354 . . . . 2.23 111.955 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 99.4 mtt180 -79.03 -30.94 44.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.355 -0.384 . . . . 3.4199999999999999 110.93 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 412' ' ' TYR . 95.7 mt -89.03 129.93 39.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 1.1399999999999999 111.603 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.457 ' HB2' ' CD1' ' A' ' 439' ' ' LEU . 69.6 m -169.09 140.05 2.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.803 -0.635 . . . . 0.95999999999999996 110.5 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -75.82 16.21 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.415 -0.357 . . . . 1.3500000000000001 111.269 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.755 HD22 ' HB2' ' A' ' 437' ' ' ASP . 51.9 t30 -139.45 131.39 27.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.891 0.377 . . . . 2.5299999999999998 110.652 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . 0.439 ' HB1' HD12 ' A' ' 442' ' ' ILE . . . -71.72 -37.17 70.65 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.627 0.603 . . . . 1.3300000000000001 112.627 -178.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . 0.755 ' HB2' HD22 ' A' ' 435' ' ' ASN . 55.5 m-20 -52.51 -40.72 62.75 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.727 0.299 . . . . 1.3400000000000001 111.597 -178.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . 0.409 ' OD2' ' HB3' ' A' ' 435' ' ' ASN . 61.5 m-20 -64.19 -24.58 67.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.391 -0.368 . . . . 1.5600000000000001 111.335 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.678 ' N ' HD11 ' A' ' 439' ' ' LEU . 8.4 mp -94.81 -85.46 0.31 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.159 -0.473 . . . . 1.76 112.191 -179.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -179.65 51.85 0.09 OUTLIER Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.097 -1.049 . . . . 1.3600000000000001 113.661 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 68.31 143.97 0.11 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.724 -0.751 . . . . 1.8300000000000001 113.363 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.571 ' O ' HG21 ' A' ' 443' ' ' THR . 46.8 mm -65.59 95.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.485 -0.191 . . . . 1.9199999999999999 110.485 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.571 HG21 ' O ' ' A' ' 442' ' ' ILE . 8.1 t 37.35 53.29 1.3 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.855 0.836 . . . . 3.4199999999999999 111.385 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 6.4 p -148.12 132.07 9.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.627 -1.17 . . . . 4.6399999999999997 111.431 -179.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 446' ' ' PRO . 95.8 mt -151.61 131.68 7.07 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.777 -0.647 . . . . 4.9900000000000002 110.573 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 445' ' ' LEU . 23.9 Cg_exo -64.81 -154.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.694 2.263 . . . . 8.0099999999999998 112.702 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.92 137.6 69.5 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.894 -0.594 . . . . 9.0600000000000005 111.583 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.85 140.32 72.85 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.673 2.248 . . . . 11.42 112.068 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.74 131.12 31.95 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.524 2.149 . . . . 13.529999999999999 112.288 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 79.4 mt -66.34 129.68 40.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 16.010000000000002 110.819 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.411 ' HB1' ' HG3' ' A' ' 454' ' ' GLN . . . -175.55 130.83 0.41 Allowed Pre-proline 0 C--N 1.333 -0.13 0 CA-C-N 116.36 -0.382 . . . . 16.739999999999998 111.279 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.23 143.4 48.47 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.878 2.385 . . . . 18.530000000000001 112.114 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 38.7 t70 59.81 49.16 8.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.217 -0.447 . . . . 20.550000000000001 110.919 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . 0.411 ' HG3' ' HB1' ' A' ' 451' ' ' ALA . 97.9 mm-40 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.237 -0.887 . . . . 21.41 110.669 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.472 -0.251 . . . . 11.91 112.472 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 79.5 p -61.6 -45.33 94.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.783 0.325 . . . . 10.130000000000001 110.828 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -159.4 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.196 -0.457 . . . . 8.6699999999999999 110.48 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.545 ' HG3' ' HA ' ' A' ' 408' ' ' ALA . 94.7 mmm -63.36 147.81 50.12 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.678 0.275 . . . . 5.7000000000000002 110.675 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -118.56 61.23 4.6 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 112.036 0.384 . . . . 6.0599999999999996 112.036 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . 0.463 ' HD3' ' C ' ' A' ' 366' ' ' MET . 89.0 Cg_endo -83.94 34.98 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.534 2.156 . . . . 6.5899999999999999 111.593 179.179 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.77 -32.15 0.1 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.542 -0.754 . . . . 7.21 110.142 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.488 ' O ' ' HG2' ' A' ' 370' ' ' MET . 41.4 ttp -107.55 31.48 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.838 -0.619 . . . . 5.6699999999999999 110.091 179.213 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -64.04 139.8 58.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.526 . . . . 5.6100000000000003 111.067 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -147.78 57.92 1.11 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.879 0.371 . . . . 5.7800000000000002 111.44 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 21.9 mm -137.72 74.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 1.9299999999999999 110.254 179.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -87.09 110.49 20.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.125 0.488 . . . . 2.1699999999999999 111.084 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 397' ' ' VAL . 72.0 mt -79.89 -39.01 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.678 -0.692 . . . . 1.4399999999999999 111.248 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 58.1 m -70.71 58.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.597 -0.729 . . . . 2.2000000000000002 111.983 -179.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -174.47 -30.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 1.9199999999999999 110.47 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.492 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -156.12 58.41 1.74 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.796 -0.638 . . . . 2.8900000000000001 111.172 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 51.3 Cg_exo -53.72 -39.33 84.0 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.198 1.932 . . . . 0.97999999999999998 111.461 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.32 -31.59 72.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.67 -0.696 . . . . 1.21 111.175 179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 83.7 tttt -45.83 125.45 6.17 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.016 0.436 . . . . 2.27 110.805 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.874 HD13 HG12 ' A' ' 417' ' ' VAL . 21.4 mm -79.71 123.75 36.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.91 -0.586 . . . . 1.1299999999999999 111.902 -179.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -110.08 143.86 39.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.627 -0.508 . . . . 1.1000000000000001 109.627 178.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.512 ' HB2' ' CD1' ' A' ' 439' ' ' LEU . 19.6 m-85 -91.47 138.83 31.27 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.822 -0.351 . . . . 1.3200000000000001 110.617 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.526 HD13 ' N ' ' A' ' 385' ' ' ILE . 2.7 mp -124.33 130.35 73.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.313 -0.403 . . . . 1.2 111.439 -179.045 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 439' ' ' LEU . 57.4 ttt-85 -99.05 122.23 42.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 3.1699999999999999 110.926 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -82.7 -173.25 4.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.506 -0.316 . . . . 2.9900000000000002 110.74 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.444 ' N ' ' OE1' ' A' ' 388' ' ' GLU . 0.4 OUTLIER -63.71 -44.62 93.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.835 0.35 . . . . 2.8199999999999998 110.828 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -71.17 5.57 2.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.115 -0.493 . . . . 1.23 111.249 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 388' ' ' GLU . . . 71.35 28.89 69.05 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.021 -0.609 . . . . 1.03 113.074 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 391' ' ' THR . . . . . 0.418 HG23 ' HA ' ' A' ' 444' ' ' VAL . 42.3 p -93.9 110.33 22.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.668 0.27 . . . . 1.46 111.04 179.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.618 HG13 HD11 ' A' ' 442' ' ' ILE . 42.1 t -74.59 131.57 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.852 -0.425 . . . . 1.24 109.852 179.13 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.508 ' HB3' HD12 ' A' ' 419' ' ' LEU . 76.6 m-70 -145.39 135.52 23.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.454 -0.339 . . . . 3.2400000000000002 111.038 -179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.503 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 58.9 mtt85 -58.9 150.59 23.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.967 0.413 . . . . 3.5600000000000001 111.576 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 416' ' ' TYR . . . -177.05 132.84 2.11 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.755 -0.657 . . . . 0.32000000000000001 112.097 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -90.51 129.72 36.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.64 0.257 . . . . 1.28 111.535 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' A' ' 412' ' ' TYR . 5.8 t -85.4 126.85 40.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 109.613 -0.514 . . . . 1.5800000000000001 109.613 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 70.5 mt -121.12 -40.14 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.214 0.45 . . . . 2.04 112.214 -178.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . 0.487 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 98.3 mm-40 -128.6 176.45 7.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.987 0.422 . . . . 2.6400000000000001 112.04 -178.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 87.7 p -161.83 149.4 14.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.684 -0.689 . . . . 1.1299999999999999 110.594 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -162.49 143.8 10.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.107 0.479 . . . . 1.8799999999999999 111.33 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 30.2 p -115.13 134.03 55.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.741 -0.663 . . . . 1.79 109.489 178.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 404' ' ' GLU . 1.9 m -58.42 -174.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.889 -0.411 . . . . 2.2999999999999998 109.889 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.424 ' H ' HG23 ' A' ' 403' ' ' THR . 4.8 mm-40 -39.64 -44.78 1.55 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 3.8700000000000001 110.207 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -94.09 129.29 40.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.712 -0.676 . . . . 3.1600000000000001 109.345 178.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -113.89 57.6 0.69 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.164 0.506 . . . . 2.1800000000000002 111.489 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -138.71 11.35 2.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.623 -0.717 . . . . 2.77 110.028 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.545 ' HA ' ' HG3' ' A' ' 366' ' ' MET . . . -173.8 -46.01 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.077 -0.965 . . . . 3.2799999999999998 110.951 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 402' ' ' THR . 19.8 Cg_exo -68.62 38.85 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 123.162 2.574 . . . . 2.8700000000000001 113.897 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.28 131.78 35.31 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.417 -0.586 . . . . 2.1400000000000001 109.417 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 50.1 mt-10 -136.79 134.97 37.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.731 0.3 . . . . 2.1000000000000001 111.265 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 429' ' ' ARG . 1.4 m-85 -119.21 127.62 53.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.482 -0.326 . . . . 1.0600000000000001 111.113 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.487 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 15.0 t80 -57.82 143.5 42.08 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.483 -0.562 . . . . 1.05 109.483 178.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.8 110.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.688 0.625 . . . . 1.8400000000000001 112.688 -179.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -90.58 96.49 10.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.483 -0.78 . . . . 0.70999999999999996 109.254 178.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.52 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 54.4 m-85 -51.83 125.88 16.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.248 0.547 . . . . 1.1299999999999999 111.067 -178.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.874 HG12 HD13 ' A' ' 382' ' ' ILE . 2.5 t -79.32 34.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.256 -0.884 . . . . 1.7 111.105 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 416' ' ' TYR . . . -179.53 -45.88 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.564 -0.744 . . . . 1.1699999999999999 112.679 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.853 HD21 HD21 ' A' ' 423' ' ' LEU . 7.0 mp -63.98 155.55 30.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.137 0.494 . . . . 2.1499999999999999 111.458 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 1.8 m120 -50.43 142.31 10.68 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.45 -0.796 . . . . 2.7599999999999998 111.693 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . 0.723 ' HD2' ' N ' ' A' ' 422' ' ' ARG . 7.1 ppt_? -58.4 -29.88 66.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.176 -0.466 . . . . 4.6500000000000004 110.822 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . 0.723 ' N ' ' HD2' ' A' ' 421' ' ' ARG . 38.0 ptt180 -63.98 -37.15 86.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 4.3200000000000003 110.321 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.853 HD21 HD21 ' A' ' 419' ' ' LEU . 7.0 mp -61.92 -33.35 74.08 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.877 -0.601 . . . . 2.04 110.755 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -50.63 138.19 18.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.681 -0.69 . . . . 1.2 111.141 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -170.99 -141.18 3.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.824 -0.703 . . . . 0.69999999999999996 112.506 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -122.26 132.58 54.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.859 0.361 . . . . 0.76000000000000001 110.873 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 411' ' ' GLU . 20.3 m -110.81 155.64 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 1.4399999999999999 111.693 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -71.35 21.32 0.69 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.065 -0.588 . . . . 1.72 113.935 -179.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.51 ' HB2' ' CD1' ' A' ' 412' ' ' TYR . 37.7 tpt85 70.64 -46.17 0.62 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.138 0.792 . . . . 2.3199999999999998 113.138 178.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -59.89 -14.69 16.58 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.67 0.748 . . . . 2.23 109.33 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.435 ' HD2' ' HB ' ' A' ' 427' ' ' VAL . 58.0 mtt85 -79.06 -34.89 43.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.571 -1.195 . . . . 3.4199999999999999 111.221 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.444 HD13 ' HB2' ' A' ' 412' ' ' TYR . 65.8 mt -87.63 137.34 21.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.857 0.36 . . . . 1.1399999999999999 110.869 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.0 m -159.69 138.8 11.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.95999999999999996 110.721 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.17 -18.89 60.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 1.3500000000000001 110.811 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -108.59 132.93 53.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.105 -0.498 . . . . 2.5299999999999998 111.017 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . 0.559 ' HB3' HG12 ' A' ' 442' ' ' ILE . . . -66.23 -38.73 88.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.987 -0.551 . . . . 1.3300000000000001 111.519 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -51.87 -40.73 61.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.308 -0.406 . . . . 1.3400000000000001 111.257 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -81.69 41.1 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 1.5600000000000001 110.624 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.546 ' O ' ' HD2' ' A' ' 386' ' ' ARG . 54.7 mt -152.62 -85.88 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.42 . . . . 1.76 111.34 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.01 32.91 0.25 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.444 -0.884 . . . . 1.3600000000000001 112.857 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 54.25 36.94 58.28 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 121.144 -0.55 . . . . 1.8300000000000001 113.604 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.618 HD11 HG13 ' A' ' 392' ' ' VAL . 48.0 mm 47.05 80.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 111.76 0.281 . . . . 1.9199999999999999 111.76 178.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 15.1 t -172.81 133.37 0.57 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.202 0.525 . . . . 3.4199999999999999 112.043 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.469 ' O ' HG21 ' A' ' 444' ' ' VAL . 28.8 m -87.66 121.56 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.604 -0.725 . . . . 4.6399999999999997 111.18 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.487 HD11 ' N ' ' A' ' 445' ' ' LEU . 7.2 mp -76.64 120.29 81.03 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.486 . . . . 4.9900000000000002 110.973 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.57 146.21 60.66 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.968 2.445 . . . . 8.0099999999999998 112.592 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . 62.85 71.83 0.64 Allowed Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.03 -0.532 . . . . 9.0600000000000005 111.841 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.26 133.64 35.96 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.545 2.163 . . . . 11.42 112.182 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -77.15 50.22 3.06 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.634 2.222 . . . . 13.529999999999999 112.847 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 59.7 tp -174.49 136.86 0.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.241 -0.436 . . . . 16.010000000000002 110.955 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . 64.92 128.36 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 115.958 -0.564 . . . . 16.739999999999998 111.404 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 451' ' ' ALA . 24.7 Cg_exo -63.23 135.41 50.35 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.759 2.306 . . . . 18.530000000000001 112.262 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -79.29 43.0 0.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 20.550000000000001 111.172 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.166 -0.921 . . . . 21.41 110.85 179.797 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.534 -0.226 . . . . 11.91 112.534 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 49.6 m -60.17 -48.21 82.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.347 . . . . 10.130000000000001 110.75 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -65.53 132.88 50.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 8.6699999999999999 110.694 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 51.0 ttm -114.88 133.74 55.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 5.7000000000000002 111.072 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.48 ' OD2' ' HE1' ' A' ' 370' ' ' MET . 2.0 p30 -61.65 131.23 92.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.068 -0.515 . . . . 6.0599999999999996 110.594 179.567 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -87.05 44.25 1.1 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.639 2.226 . . . . 6.5899999999999999 113.557 -179.113 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.64 ' N ' HD21 ' A' ' 369' ' ' LEU . 2.5 pt? -164.69 -42.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.744 -0.382 . . . . 7.21 111.652 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.48 ' HE1' ' OD2' ' A' ' 367' ' ' ASP . 36.6 ttp -86.82 46.87 1.41 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.926 0.393 . . . . 5.6699999999999999 111.148 -179.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.456 ' HG2' ' OD1' ' A' ' 367' ' ' ASP . 3.4 mm100 -134.75 41.3 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.12 0.486 . . . . 5.6100000000000003 110.516 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -155.43 142.64 19.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.333 -0.849 . . . . 5.7800000000000002 110.169 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 67.5 mt -141.34 121.24 11.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.873 0.368 . . . . 1.9299999999999999 111.782 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 3.6 m-20 -91.68 68.53 5.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.026 -0.534 . . . . 2.1699999999999999 110.372 178.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.441 ' O ' HG21 ' A' ' 375' ' ' ILE . 75.3 mt -51.86 -34.74 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 1.4399999999999999 112.073 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 37.6 t -47.8 -24.8 1.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.192 -0.458 . . . . 2.2000000000000002 112.201 -178.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 11.9 pt-20 -69.22 -37.82 78.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.321 -0.4 . . . . 1.9199999999999999 111.848 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.455 ' C ' HD21 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -154.17 65.0 4.89 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 111.695 0.257 . . . . 2.8900000000000001 111.695 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.85 -37.66 85.24 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.396 2.064 . . . . 0.97999999999999998 111.673 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -64.29 -33.67 76.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.684 -0.689 . . . . 1.21 111.168 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -52.19 127.96 23.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.944 0.402 . . . . 2.27 110.935 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.569 HG23 HH11 ' A' ' 394' ' ' ARG . 45.1 mm -87.36 131.42 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.971 -0.559 . . . . 1.1299999999999999 111.604 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -111.24 144.29 40.66 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.255 -0.429 . . . . 1.1000000000000001 110.026 179.104 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.515 ' C ' HD13 ' A' ' 385' ' ' ILE . 18.2 m-85 -88.92 142.43 27.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.979 -0.288 . . . . 1.3200000000000001 110.673 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.577 HD13 ' N ' ' A' ' 385' ' ' ILE . 3.4 mp -123.96 133.53 69.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.981 0.42 . . . . 1.2 111.92 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.592 ' N ' HD22 ' A' ' 439' ' ' LEU . 42.7 ttt85 -87.14 117.0 25.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 3.1699999999999999 110.455 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.446 ' HD3' ' HG1' ' A' ' 391' ' ' THR . 58.3 mtp85 -70.12 169.52 13.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.754 0.311 . . . . 2.9900000000000002 111.142 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -51.72 -45.52 63.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.191 -0.459 . . . . 2.8199999999999998 111.339 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.457 ' OD1' HG22 ' A' ' 391' ' ' THR . 2.3 p30 -69.53 -36.05 76.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.316 -0.402 . . . . 1.23 111.021 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 120.29 36.14 0.82 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.966 -0.635 . . . . 1.03 112.5 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 391' ' ' THR . . . . . 0.457 HG22 ' OD1' ' A' ' 389' ' ' ASP . 17.5 p -110.71 114.48 27.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.188 0.518 . . . . 1.46 111.289 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.45 HG12 HD21 ' A' ' 439' ' ' LEU . 91.9 t -66.66 135.02 29.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.456 -0.793 . . . . 1.24 111.842 -178.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -153.77 132.26 12.11 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.411 -0.813 . . . . 3.2400000000000002 110.38 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.569 HH11 HG23 ' A' ' 382' ' ' ILE . 73.6 mtt-85 -54.56 154.07 5.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.355 0.598 . . . . 3.5600000000000001 112.354 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -169.59 135.14 3.44 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.145 -0.934 . . . . 0.32000000000000001 111.499 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -91.61 111.21 22.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.807 0.303 . . . . 1.28 111.76 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.639 HG23 HD11 ' A' ' 432' ' ' ILE . 4.1 t -74.87 129.09 36.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 109.942 -0.392 . . . . 1.5800000000000001 109.942 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 77.0 mt -121.2 -41.28 2.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.362 0.504 . . . . 2.04 112.362 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . 0.444 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 72.5 mt-30 -135.47 177.03 8.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.963 0.411 . . . . 2.6400000000000001 111.577 -178.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 412' ' ' TYR . 80.8 p -151.53 139.39 19.91 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.901 -0.59 . . . . 1.1299999999999999 110.72 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -154.69 144.08 21.3 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.334 -0.394 . . . . 1.8799999999999999 111.136 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.406 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 41.6 p -94.47 -121.72 0.1 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.713 -0.477 . . . . 1.79 109.713 178.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.426 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.71 -173.38 2.98 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.607 -0.516 . . . . 2.2999999999999998 109.607 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.426 ' H ' ' CG2' ' A' ' 403' ' ' THR . 48.9 mt-10 -43.67 -43.42 5.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.758 0.313 . . . . 3.8700000000000001 111.389 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -70.28 -51.88 27.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 3.1600000000000001 111.308 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.406 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.08 53.06 11.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.328 0.585 . . . . 2.1800000000000002 110.864 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -162.35 12.38 0.07 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.172 -0.922 . . . . 2.77 109.273 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.61 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -161.04 -41.52 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.448 -1.251 . . . . 3.2799999999999998 111.716 -178.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.61 ' HD2' ' H ' ' A' ' 408' ' ' ALA . 75.5 Cg_exo -52.21 -62.27 0.39 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.234 1.956 . . . . 2.8700000000000001 113.708 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 36.02 74.39 0.07 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.228 0.537 . . . . 2.1400000000000001 111.231 -179.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.41 147.72 30.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 2.1000000000000001 110.779 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 6.0 m-85 -127.21 125.15 40.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.374 . . . . 1.0600000000000001 111.203 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.444 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 15.5 t80 -57.84 149.89 21.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.923 -0.58 . . . . 1.05 110.414 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.517 HG23 HG12 ' A' ' 385' ' ' ILE . 11.2 p -155.82 138.05 6.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.143 0.497 . . . . 1.8400000000000001 112.212 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -115.02 101.49 9.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.68 -0.691 . . . . 0.70999999999999996 110.386 179.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.453 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 8.6 m-85 -62.1 116.1 4.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.193 -0.458 . . . . 1.1299999999999999 111.298 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.58 130.42 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 1.7 111.054 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.77 -42.8 1.83 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.859 -0.686 . . . . 1.1699999999999999 112.761 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.502 ' N ' HD21 ' A' ' 419' ' ' LEU . 2.0 mm? -59.33 152.85 20.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.862 0.363 . . . . 2.1499999999999999 111.209 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 11.8 p-10 -49.73 136.53 17.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 2.7599999999999998 111.349 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . 0.425 HH11 ' HG3' ' A' ' 421' ' ' ARG . 60.9 mtt85 -57.35 -40.47 78.13 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.84 0.682 . . . . 4.6500000000000004 112.84 -178.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -53.84 -29.15 39.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.777 0.323 . . . . 4.3200000000000003 110.864 -179.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 420' ' ' ASN . 1.2 tp -59.26 -34.13 71.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 2.04 110.858 179.056 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -48.21 138.14 9.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.945 -0.57 . . . . 1.2 111.311 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.87 -142.91 4.82 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.001 -0.618 . . . . 0.69999999999999996 112.121 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -128.6 134.59 48.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.376 . . . . 0.76000000000000001 110.639 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 431' ' ' ARG . 29.3 m -109.38 158.76 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.944 -0.571 . . . . 1.4399999999999999 111.887 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -77.46 35.01 1.56 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.834 -0.621 . . . . 1.72 114.441 -179.135 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 23.6 tpt180 70.69 -70.37 0.15 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.248 0.833 . . . . 2.3199999999999998 113.248 178.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -45.39 -16.12 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.947 0.403 . . . . 2.23 111.707 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 53.4 mtt85 -77.47 -39.06 47.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.956 -0.565 . . . . 3.4199999999999999 111.333 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.639 HD11 HG23 ' A' ' 397' ' ' VAL . 86.7 mt -87.04 132.07 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.155 -0.313 . . . . 1.1399999999999999 110.155 179.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 61.0 m -164.0 142.13 7.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.95999999999999996 111.136 -179.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -58.72 -26.09 63.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.076 -0.511 . . . . 1.3500000000000001 110.793 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -121.78 135.15 54.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.161 -0.472 . . . . 2.5299999999999998 110.851 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -70.75 -10.96 60.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 1.3300000000000001 111.635 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.07 -40.99 77.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 1.3400000000000001 111.716 -179.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -83.03 18.23 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.826 0.346 . . . . 1.5600000000000001 111.337 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 386' ' ' ARG . 8.4 mp -118.02 -96.54 0.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.76 111.216 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . 0.568 ' HA2' ' NH1' ' A' ' 386' ' ' ARG . . . -173.9 41.61 0.14 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.323 -0.942 . . . . 1.3600000000000001 113.431 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 444' ' ' VAL . . . 65.9 149.76 0.09 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.662 -0.78 . . . . 1.8300000000000001 113.28 179.074 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 442' ' ' ILE . 1.5 mp -61.97 89.42 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 109.128 -0.693 . . . . 1.9199999999999999 109.128 178.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.445 ' O ' HG21 ' A' ' 443' ' ' THR . 57.9 m 48.71 38.46 11.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.894 -1.048 . . . . 3.4199999999999999 110.681 -178.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.472 ' O ' ' HA2' ' A' ' 441' ' ' GLY . 70.2 t -155.95 127.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.995 -1.002 . . . . 4.6399999999999997 110.308 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 446' ' ' PRO . 3.6 mm? -70.88 125.45 92.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.502 -0.317 . . . . 4.9900000000000002 111.064 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 445' ' ' LEU . 25.3 Cg_exo -62.81 137.84 65.46 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.602 2.201 . . . . 8.0099999999999998 112.075 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -169.15 60.21 0.4 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 9.0600000000000005 111.263 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . 0.773 ' HB2' HD11 ' A' ' 450' ' ' LEU . 71.0 Cg_endo -76.08 131.93 13.54 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.525 2.15 . . . . 11.42 112.377 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.08 49.66 3.06 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.682 2.254 . . . . 13.529999999999999 112.595 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . 0.773 HD11 ' HB2' ' A' ' 448' ' ' PRO . 5.8 mp -117.2 139.38 50.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 16.010000000000002 110.952 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . -168.96 133.32 1.29 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 16.739999999999998 110.99 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.432 ' O ' ' HB3' ' A' ' 453' ' ' ASP . 27.9 Cg_exo -61.34 132.5 41.43 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.532 2.155 . . . . 18.530000000000001 112.19 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 452' ' ' PRO . 30.2 t70 70.22 -64.66 0.35 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.938 -0.574 . . . . 20.550000000000001 111.619 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.3 -0.857 . . . . 21.41 110.767 179.981 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.629 -0.188 . . . . 11.91 112.629 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 52.5 m -72.57 133.82 44.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.767 0.318 . . . . 10.130000000000001 111.103 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . 0.466 ' HD2' ' H ' ' A' ' 366' ' ' MET . 0.4 OUTLIER -174.87 -29.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 8.6699999999999999 111.068 179.604 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.466 ' H ' ' HD2' ' A' ' 365' ' ' HIS . 49.8 tpp -178.33 131.91 0.14 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.68 -0.691 . . . . 5.7000000000000002 110.442 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.464 ' OD2' ' HG ' ' A' ' 369' ' ' LEU . 37.4 t70 -63.8 121.88 73.55 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.447 -0.342 . . . . 6.0599999999999996 110.612 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 367' ' ' ASP . 6.3 Cg_exo -74.08 -48.01 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.911 2.407 . . . . 6.5899999999999999 113.786 -178.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.464 ' HG ' ' OD2' ' A' ' 367' ' ' ASP . 4.3 pp -53.88 -30.82 47.53 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.063 -0.971 . . . . 7.21 110.579 -179.391 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.541 ' HE2' ' HA ' ' A' ' 373' ' ' ILE . 54.4 ttp -168.24 116.78 0.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.807 -0.633 . . . . 5.6699999999999999 109.921 179.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -62.25 108.25 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.828 0.347 . . . . 5.6100000000000003 110.634 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.44 ' HB3' ' OH ' ' A' ' 412' ' ' TYR . 93.6 mttt 60.65 129.06 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.604 -0.725 . . . . 5.7800000000000002 111.401 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.681 HG13 ' HE ' ' A' ' 429' ' ' ARG . 85.7 mt -65.5 133.25 30.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.295 -0.411 . . . . 1.9299999999999999 111.622 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 377' ' ' GLU . 31.6 m-20 -89.56 129.52 36.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 2.1699999999999999 109.914 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 397' ' ' VAL . 95.5 mt -88.26 -41.51 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.409 0.522 . . . . 1.4399999999999999 112.409 -179.176 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.7 t -46.74 -21.13 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.284 -0.417 . . . . 2.2000000000000002 111.865 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 374' ' ' ASP . 6.7 mt-10 -61.77 -42.39 98.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.855 -0.611 . . . . 1.9199999999999999 111.369 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.415 ' N ' ' ND2' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -167.64 69.79 0.91 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 2.8900000000000001 111.188 -179.21 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.47 -39.66 54.52 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.57 2.18 . . . . 0.97999999999999998 112.158 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.79 -39.29 84.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 1.21 110.69 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -54.66 130.83 41.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.144 -0.48 . . . . 2.27 111.048 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 28.7 mm -84.72 135.68 24.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.072 -0.513 . . . . 1.1299999999999999 111.442 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -108.17 143.8 36.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.374 -0.375 . . . . 1.1000000000000001 110.388 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.419 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 7.1 m-85 -88.22 133.64 33.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.603 0.24 . . . . 1.3200000000000001 110.659 179.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.511 HD13 ' N ' ' A' ' 385' ' ' ILE . 1.9 mp -121.77 130.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.75 0.31 . . . . 1.2 110.699 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.475 ' CZ ' ' HA3' ' A' ' 390' ' ' GLY . 60.7 ttt-85 -80.71 117.15 21.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.373 -0.376 . . . . 3.1699999999999999 110.648 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.72 ' HE ' ' HA ' ' A' ' 387' ' ' ARG . 2.0 mmp_? -68.17 164.81 19.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 2.9900000000000002 110.571 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 389' ' ' ASP . 0.5 OUTLIER -51.71 -45.02 63.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 2.8199999999999998 111.615 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.419 ' N ' ' HG2' ' A' ' 388' ' ' GLU . 40.8 p-10 -69.63 -35.72 75.48 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.679 0.252 . . . . 1.23 111.679 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.475 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . 138.8 -32.45 2.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.583 -0.818 . . . . 1.03 112.561 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 72.4 p -59.1 112.24 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.082 0.468 . . . . 1.46 111.657 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.657 HG12 HD11 ' A' ' 439' ' ' LEU . 57.1 t -72.88 140.92 17.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.738 -0.665 . . . . 1.24 111.274 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.451 ' N ' HG11 ' A' ' 392' ' ' VAL . 36.4 m-70 -139.7 137.57 35.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 3.2400000000000002 110.718 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 55.5 mtt85 -62.38 145.04 55.01 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.914 0.388 . . . . 3.5600000000000001 110.923 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 416' ' ' TYR . . . -164.14 134.4 3.35 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.022 -0.608 . . . . 0.32000000000000001 112.397 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . 0.533 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 90.0 mt-30 -82.19 132.28 35.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.531 0.205 . . . . 1.28 111.506 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.734 HG23 HD12 ' A' ' 432' ' ' ILE . 11.7 t -99.82 122.19 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.067 -0.716 . . . . 1.5800000000000001 109.067 178.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . 0.472 ' N ' ' CD2' ' A' ' 398' ' ' LEU . 0.7 OUTLIER -111.64 -41.91 3.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.703 0.631 . . . . 2.04 112.703 -177.026 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -132.95 176.45 8.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.993 0.425 . . . . 2.6400000000000001 111.77 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.2 p -164.27 147.45 9.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.753 -0.658 . . . . 1.1299999999999999 110.863 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.4 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 38.6 ptt180 -160.66 134.2 6.8 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.002 0.43 . . . . 1.8799999999999999 111.41 -179.521 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.737 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 35.5 p -81.42 137.44 35.66 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.246 -0.434 . . . . 1.79 110.004 178.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.484 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 2.1 m -62.13 -174.03 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 2.2999999999999998 110.761 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.484 ' H ' ' CG2' ' A' ' 403' ' ' THR . 50.6 mt-10 -42.28 -41.84 2.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.977 0.362 . . . . 3.8700000000000001 111.977 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.705 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 24.0 t-20 -57.43 -48.48 79.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 3.1600000000000001 110.673 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.737 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.63 57.23 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 2.1800000000000002 111.997 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.406 ' O ' ' HB1' ' A' ' 408' ' ' ALA . . . -168.95 10.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 2.77 110.629 179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.474 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . 179.85 -43.8 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.729 -0.669 . . . . 3.2799999999999998 111.918 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.705 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 11.7 Cg_exo -71.73 49.56 1.23 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.77 2.314 . . . . 2.8700000000000001 114.193 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.8 p30 -78.17 126.73 31.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.847 0.356 . . . . 2.1400000000000001 110.504 178.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 400' ' ' SER . 47.4 mt-10 -114.05 134.63 54.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 2.1000000000000001 110.482 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.641 ' HB3' HG12 ' A' ' 397' ' ' VAL . 1.6 m-85 -111.91 134.05 53.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.973 0.416 . . . . 1.0600000000000001 111.941 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 17.8 t80 -66.57 138.41 57.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.691 -0.855 . . . . 1.05 108.691 177.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 21.7 t -140.78 110.08 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 113.202 0.815 . . . . 1.8400000000000001 113.202 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . 0.48 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 86.4 t60 -90.1 88.5 7.29 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.661 -0.866 . . . . 0.70999999999999996 108.661 177.176 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . 0.508 ' HB2' ' CD1' ' A' ' 419' ' ' LEU . 4.7 m-85 -57.95 116.01 3.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.807 0.813 . . . . 1.1299999999999999 111.482 -178.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 5.5 m -53.87 129.56 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 CA-C-N 114.027 -1.442 . . . . 1.7 112.818 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 81.88 -52.1 4.55 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 115.415 0.926 . . . . 1.1699999999999999 115.415 177.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.868 HD12 ' HB2' ' A' ' 423' ' ' LEU . 0.5 OUTLIER -62.18 162.52 9.48 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.901 0.851 . . . . 2.1499999999999999 112.561 -177.706 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.603 ' O ' HD11 ' A' ' 419' ' ' LEU . 56.0 t30 -59.68 143.51 50.5 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.507 -0.77 . . . . 2.7599999999999998 111.877 -179.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . 0.651 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 99.3 mtt180 -53.39 -20.21 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 4.6500000000000004 111.716 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . 0.555 ' HB3' HD21 ' A' ' 420' ' ' ASN . 2.6 tpm_? -55.32 -40.34 71.04 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.854 -0.612 . . . . 4.3200000000000003 112.157 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.868 ' HB2' HD12 ' A' ' 419' ' ' LEU . 2.1 mm? -70.62 -35.13 72.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.87 0.322 . . . . 2.04 111.87 -179.249 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.651 ' OD2' ' HA ' ' A' ' 421' ' ' ARG . 62.3 m-20 -48.71 132.38 17.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.97 0.415 . . . . 1.2 111.407 -178.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.28 179.99 46.17 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.856 -0.687 . . . . 0.69999999999999996 112.33 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 36.2 m95 -76.8 139.21 40.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.605 0.24 . . . . 0.76000000000000001 110.45 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.425 HG11 ' C ' ' A' ' 426' ' ' TRP . 12.3 m -140.39 146.75 24.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.966 0.412 . . . . 1.4399999999999999 111.492 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.448 ' HA2' ' CE1' ' A' ' 430' ' ' HIS . . . -59.21 149.16 39.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.873 -0.68 . . . . 1.72 112.407 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.681 ' HE ' HG13 ' A' ' 373' ' ' ILE . 37.9 tpt85 -52.09 -39.62 60.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.727 0.269 . . . . 2.3199999999999998 111.727 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.448 ' CE1' ' HA2' ' A' ' 428' ' ' GLY . 19.5 p-80 -55.97 -26.7 49.33 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.143 0.423 . . . . 2.23 112.143 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.473 ' HB3' HG21 ' A' ' 385' ' ' ILE . 57.3 mtt85 -78.09 -38.58 43.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.845 0.313 . . . . 3.4199999999999999 111.845 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.734 HD12 HG23 ' A' ' 397' ' ' VAL . 59.6 mt -88.75 134.78 27.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.88 0.371 . . . . 1.1399999999999999 111.154 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 435' ' ' ASN . 71.1 m -160.64 139.74 10.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.95999999999999996 110.928 -179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -74.37 16.75 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 1.3500000000000001 111.719 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 433' ' ' SER . 6.1 m120 -138.47 131.31 29.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.986 0.422 . . . . 2.5299999999999998 111.133 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -67.33 -72.77 0.16 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.892 -0.594 . . . . 1.3300000000000001 111.62 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -40.71 -39.3 1.05 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.927 -0.579 . . . . 1.3400000000000001 111.715 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.87 47.37 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.301 -0.409 . . . . 1.5600000000000001 111.298 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.657 HD11 HG12 ' A' ' 392' ' ' VAL . 94.7 mt -149.87 -84.81 0.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.644 -0.253 . . . . 1.76 111.405 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -163.3 40.91 0.33 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.508 -0.853 . . . . 1.3600000000000001 113.089 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.21 146.83 0.32 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 1.8300000000000001 113.237 179.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 47.2 mm -57.0 145.92 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.671 0.272 . . . . 1.9199999999999999 110.99 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 8.1 t -48.1 156.75 0.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 3.4199999999999999 111.757 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 45.9 t 65.93 59.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.382 0.61 . . . . 4.6399999999999997 111.009 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 91.0 mt -67.82 139.46 93.48 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.613 -0.722 . . . . 4.9900000000000002 110.658 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.61 127.62 26.12 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.383 2.055 . . . . 8.0099999999999998 112.305 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -73.6 130.35 83.91 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 9.0600000000000005 111.453 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . 0.545 ' HG2' ' HB2' ' A' ' 451' ' ' ALA . 31.9 Cg_endo -64.81 141.92 73.85 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.428 2.085 . . . . 11.42 112.034 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.82 133.88 53.64 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.637 2.225 . . . . 13.529999999999999 112.637 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 18.4 tp 52.9 42.12 32.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.879 -0.6 . . . . 16.010000000000002 110.992 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.545 ' HB2' ' HG2' ' A' ' 448' ' ' PRO . . . -73.51 133.69 80.04 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 16.739999999999998 111.232 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 453' ' ' ASP . 41.0 Cg_endo -67.21 129.39 20.35 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.322 2.015 . . . . 18.530000000000001 111.901 179.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 452' ' ' PRO . 2.5 p30 54.48 135.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.822 0.701 . . . . 20.550000000000001 112.191 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.239 -0.886 . . . . 21.41 111.059 -179.883 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.572 -0.211 . . . . 11.91 112.572 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.4 t -60.97 -42.1 97.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.638 0.256 . . . . 10.130000000000001 110.889 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 75.6 t60 65.01 133.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.009 -0.541 . . . . 8.6699999999999999 111.155 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 14.1 tpt -174.66 143.62 0.79 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 5.7000000000000002 110.287 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.484 ' HA ' ' CG ' ' A' ' 371' ' ' GLN . 12.0 p-10 -53.09 112.3 3.45 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.398 -0.365 . . . . 6.0599999999999996 111.069 -179.613 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . 0.844 ' HD2' ' HG2' ' A' ' 371' ' ' GLN . 87.9 Cg_endo -80.42 42.58 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.891 1.727 . . . . 6.5899999999999999 113.914 -178.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 370' ' ' MET . 2.0 tm? 166.75 -60.94 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.03 -0.73 . . . . 7.21 109.03 179.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 370' ' ' MET . . . . . 0.689 ' HG3' ' HE3' ' A' ' 372' ' ' LYS . 24.7 ttt 165.9 43.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.022 -1.444 . . . . 5.6699999999999999 107.883 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.844 ' HG2' ' HD2' ' A' ' 368' ' ' PRO . 1.4 pt20 -75.56 50.03 0.52 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.103 -0.953 . . . . 5.6100000000000003 112.298 -178.3 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.835 ' HG2' ' HB2' ' A' ' 408' ' ' ALA . 0.0 OUTLIER -139.8 57.98 1.61 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.571 0.7 . . . . 5.7800000000000002 110.841 178.936 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 77.5 mt 59.15 97.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.136 -0.938 . . . . 1.9299999999999999 111.977 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.407 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 21.8 m-20 -88.95 137.7 32.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 2.1699999999999999 110.673 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 79.4 mt -96.48 -46.62 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.206 0.527 . . . . 1.4399999999999999 111.464 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 56.8 m -53.9 -18.15 3.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.297 -0.865 . . . . 2.2000000000000002 111.613 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 24.1 pt-20 -74.97 -40.47 60.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.134 -0.485 . . . . 1.9199999999999999 111.917 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 378' ' ' ASN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 6.0 m120 -154.86 74.57 5.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 2.8900000000000001 112.029 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.44 -40.74 81.91 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.68 2.254 . . . . 0.97999999999999998 112.172 179.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -67.58 -37.56 82.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.848 -0.614 . . . . 1.21 111.36 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.586 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 63.9 tttp -50.35 129.44 21.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 2.27 111.261 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.452 HD11 ' HG2' ' A' ' 396' ' ' GLN . 40.2 mm -88.62 132.82 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.037 -0.529 . . . . 1.1299999999999999 111.189 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.88 143.62 34.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.931 -0.396 . . . . 1.1000000000000001 109.931 179.018 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -89.72 122.9 33.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 1.3200000000000001 110.779 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.488 HD12 HG12 ' A' ' 414' ' ' VAL . 2.1 mp -106.09 123.09 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 1.2 111.328 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.531 ' NH1' ' HA2' ' A' ' 440' ' ' GLY . 38.4 ttt85 -84.08 118.53 24.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 3.1699999999999999 110.534 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -71.45 157.28 38.31 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.887 -0.325 . . . . 2.9900000000000002 110.566 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.593 ' HA ' HH12 ' A' ' 431' ' ' ARG . 16.3 pt-20 -49.66 -41.2 42.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 2.8199999999999998 111.74 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -67.01 -36.24 81.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.683 -0.235 . . . . 1.23 111.138 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 136.44 -33.68 2.33 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.448 -0.882 . . . . 1.03 112.842 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 57.6 p -59.17 113.87 2.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.317 0.579 . . . . 1.46 112.149 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.63 HG12 HD11 ' A' ' 439' ' ' LEU . 60.7 t -69.17 144.6 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.321 -0.854 . . . . 1.24 111.351 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -151.59 129.75 11.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.006 -0.543 . . . . 3.2400000000000002 110.684 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 394' ' ' ARG . 61.3 mtt85 -55.4 153.85 6.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.878 -0.601 . . . . 3.5600000000000001 112.137 -179.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -175.75 135.24 2.91 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.416 -0.811 . . . . 0.32000000000000001 112.114 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 74.7 mt-30 -91.5 138.06 31.87 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.944 -0.151 . . . . 1.28 111.007 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . 0.432 ' CG2' HD11 ' A' ' 432' ' ' ILE . 14.5 t -92.09 102.19 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.211 -0.662 . . . . 1.5800000000000001 109.211 178.27 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . 0.55 HD11 ' N ' ' A' ' 398' ' ' LEU . 6.2 mp -84.95 -36.81 21.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.594 -0.73 . . . . 2.04 112.473 -177.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 399' ' ' GLN . . . . . 0.479 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 66.0 mt-30 -141.0 175.66 9.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.976 0.417 . . . . 2.6400000000000001 111.333 -178.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 93.2 p -165.63 144.22 6.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.689 -0.687 . . . . 1.1299999999999999 110.589 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . 0.571 ' HG3' ' HB3' ' A' ' 410' ' ' ASP . 36.1 ptt180 -118.74 175.4 5.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 1.8799999999999999 109.989 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.541 ' HA ' ' HB2' ' A' ' 410' ' ' ASP . 26.6 p -127.82 133.38 49.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.128 0.489 . . . . 1.79 111.956 -179.161 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 403' ' ' THR . . . . . 0.47 ' CG2' ' H ' ' A' ' 404' ' ' GLU . 1.4 m -63.19 -170.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.488 -0.778 . . . . 2.2999999999999998 110.363 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.47 ' H ' ' CG2' ' A' ' 403' ' ' THR . 49.9 mt-10 -42.44 -35.61 1.08 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.667 0.27 . . . . 3.8700000000000001 110.566 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.428 ' OD1' ' HB3' ' A' ' 407' ' ' ALA . 30.6 t-20 -54.17 -46.42 72.32 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.697 -0.483 . . . . 3.1600000000000001 109.697 178.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.501 ' HA ' ' CB ' ' A' ' 402' ' ' THR . . . 62.07 64.33 1.0 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.38 -0.827 . . . . 2.1800000000000002 111.409 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.428 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -166.91 -25.1 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.416 0.524 . . . . 2.77 112.416 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 408' ' ' ALA . . . . . 0.835 ' HB2' ' HG2' ' A' ' 372' ' ' LYS . . . -165.46 -47.26 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 114.101 1.148 . . . . 3.2799999999999998 114.101 -179.045 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 55.7 Cg_exo -55.51 -155.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.676 2.25 . . . . 2.8700000000000001 114.868 -177.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . 0.571 ' HB3' ' HG3' ' A' ' 401' ' ' ARG . 0.1 OUTLIER 80.38 -160.1 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.794 -1.094 . . . . 2.1400000000000001 113.056 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 426' ' ' TRP . 95.1 mt-10 -106.48 149.02 27.5 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.067 -0.515 . . . . 2.1000000000000001 111.554 -177.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.542 ' N ' ' HD1' ' A' ' 412' ' ' TYR . 0.4 OUTLIER -112.0 134.93 53.25 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.652 -0.704 . . . . 1.0600000000000001 112.176 -177.952 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.479 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 14.8 t80 -67.05 145.43 55.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.75 -0.659 . . . . 1.05 110.419 179.318 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 13.7 t -148.57 129.48 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.127 0.788 . . . . 1.8400000000000001 113.127 -179.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 415' ' ' HIS . . . . . 0.441 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 56.0 t60 -105.32 104.03 13.68 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.87 -0.605 . . . . 0.70999999999999996 109.539 177.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 416' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -66.22 128.84 37.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.933 0.397 . . . . 1.1299999999999999 111.162 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.24 128.91 36.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.86 -0.609 . . . . 1.7 111.823 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 75.29 -47.17 1.97 Allowed Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.781 -0.645 . . . . 1.1699999999999999 113.363 179.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.408 ' HB3' ' CD1' ' A' ' 423' ' ' LEU . 7.6 mp -59.74 161.95 5.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.418 . . . . 2.1499999999999999 111.62 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 420' ' ' ASN . . . . . 0.436 ' HB3' ' HG2' ' A' ' 422' ' ' ARG . 75.8 m-20 -50.11 139.73 13.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.634 -0.712 . . . . 2.7599999999999998 111.82 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -63.59 -31.21 72.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.659 -0.701 . . . . 4.6500000000000004 111.199 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . 0.436 ' HG2' ' HB3' ' A' ' 420' ' ' ASN . 14.6 ptp180 -52.77 -35.02 55.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 4.3200000000000003 111.196 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 423' ' ' LEU . . . . . 0.45 ' HA ' HD21 ' A' ' 423' ' ' LEU . 50.8 mt -56.09 -32.13 63.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 2.04 111.357 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.441 ' OD2' ' HA ' ' A' ' 415' ' ' HIS . 1.1 m-20 -47.73 134.1 13.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.906 0.384 . . . . 1.2 111.327 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 413' ' ' TYR . . . -179.84 -142.62 5.16 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.749 . . . . 0.69999999999999996 112.242 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 426' ' ' TRP . . . . . 0.513 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 37.3 m95 -122.49 138.56 54.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.937 0.399 . . . . 0.76000000000000001 110.574 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 431' ' ' ARG . 10.3 m -109.37 158.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 1.4399999999999999 111.652 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -75.31 27.17 1.23 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.651 -0.785 . . . . 1.72 113.391 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.47 ' HB3' ' O ' ' A' ' 428' ' ' GLY . 40.8 tpt85 70.9 -47.0 0.65 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.869 0.468 . . . . 2.3199999999999998 112.144 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . 0.415 ' HE1' ' NE ' ' A' ' 431' ' ' ARG . 10.6 p80 -69.95 -7.09 37.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 2.23 110.801 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.608 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 39.2 mmt180 -79.2 -37.3 38.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 3.4199999999999999 110.817 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.432 HD11 ' CG2' ' A' ' 397' ' ' VAL . 56.4 mt -87.88 135.8 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 1.1399999999999999 110.784 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 54.0 m -157.65 139.51 14.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.255 -0.43 . . . . 0.95999999999999996 111.015 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -79.21 16.31 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 1.3500000000000001 111.902 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -145.64 132.82 20.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.958 0.408 . . . . 2.5299999999999998 111.096 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 436' ' ' ALA . . . . . 0.433 ' HB2' HD12 ' A' ' 442' ' ' ILE . . . -70.52 -43.72 69.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 1.3300000000000001 111.434 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -55.09 -40.37 70.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.225 -0.443 . . . . 1.3400000000000001 111.2 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -79.26 46.38 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 1.5600000000000001 111.164 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.63 HD11 HG12 ' A' ' 392' ' ' VAL . 98.3 mt -151.08 -84.04 0.09 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.502 -0.317 . . . . 1.76 111.133 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . 0.531 ' HA2' ' NH1' ' A' ' 386' ' ' ARG . . . -175.0 52.3 0.13 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.927 -0.654 . . . . 1.3600000000000001 112.402 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 72.36 -139.51 28.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.839 -0.696 . . . . 1.8300000000000001 112.407 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 442' ' ' ILE . . . . . 0.541 ' O ' HG21 ' A' ' 443' ' ' THR . 33.9 mm -148.52 120.6 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.95 -0.389 . . . . 1.9199999999999999 109.95 179.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.59 ' O ' HG11 ' A' ' 444' ' ' VAL . 8.9 t 46.47 126.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 124.099 0.875 . . . . 3.4199999999999999 112.834 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.59 HG11 ' O ' ' A' ' 443' ' ' THR . 1.6 p 55.12 128.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.358 -0.837 . . . . 4.6399999999999997 112.058 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.21 119.46 70.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.703 -0.68 . . . . 4.9900000000000002 111.256 -179.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -78.42 137.28 14.7 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.627 2.218 . . . . 8.0099999999999998 112.201 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -171.51 132.13 0.8 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.507 -0.315 . . . . 9.0600000000000005 111.471 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.68 142.17 69.3 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.671 2.247 . . . . 11.42 112.114 179.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.38 116.65 3.48 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.348 2.032 . . . . 13.529999999999999 112.132 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -82.64 131.72 35.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 16.010000000000002 110.206 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -172.88 131.51 0.62 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.361 -0.381 . . . . 16.739999999999998 111.191 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.22 39.9 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.588 2.192 . . . . 18.530000000000001 112.441 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -174.67 52.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.065 0.46 . . . . 20.550000000000001 110.474 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.217 -0.897 . . . . 21.41 110.759 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.417 HD11 ' NH2' ' A' ' 429' ' ' ARG . 70.1 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.004 0.431 . . . . 1.48 112.14 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -89.74 130.72 35.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.694 -0.685 . . . . 2.1699999999999999 110.689 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.5 mt -81.73 -43.63 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.92000000000000004 111.394 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 72.7 p -65.46 74.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.979 -0.555 . . . . 1.71 111.211 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -173.83 -27.19 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.561 -0.745 . . . . 1.9199999999999999 109.964 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 34.9 p30 -165.67 57.7 0.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.372 -0.831 . . . . 2.1400000000000001 111.392 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 379' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 51.2 Cg_exo -53.67 -39.12 84.46 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.247 1.964 . . . . 0.84999999999999998 111.604 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.46 -32.4 73.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.751 -0.659 . . . . 1.21 110.943 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 84.6 tttt -50.4 127.06 16.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.241 -0.436 . . . . 1.6599999999999999 111.117 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 47.4 mm -83.46 127.39 39.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.40999999999999998 110.743 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -102.32 143.34 32.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.313 . . . . 0.63 110.694 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -92.25 140.01 30.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.272 -0.422 . . . . 0.95999999999999996 110.282 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 385' ' ' ILE . 1.0 OUTLIER -133.49 126.88 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.48999999999999999 111.111 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 45.2 ttt85 -79.83 116.77 20.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.008 -0.542 . . . . 2.4199999999999999 110.431 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -69.98 155.55 40.42 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.677 -0.409 . . . . 2.2999999999999998 110.21 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -51.26 -45.24 61.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 2.8199999999999998 111.55 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -56.96 -34.61 68.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.086 -0.709 . . . . 1.23 109.086 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 132.57 -36.72 2.13 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.494 -0.775 . . . . 1.03 112.947 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 82.3 p -59.57 112.83 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.182 0.515 . . . . 0.97999999999999998 112.163 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.5 142.38 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.707 -0.679 . . . . 0.55000000000000004 110.696 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -147.94 143.94 27.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.38 . . . . 2.4300000000000002 111.254 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -55.84 154.64 6.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.906 -0.588 . . . . 2.96 111.809 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -171.35 129.68 1.82 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.688 -0.687 . . . . 0.26000000000000001 112.316 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -84.89 128.5 34.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.75 0.309 . . . . 1.28 110.752 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.7 OUTLIER -97.2 134.5 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.507 -0.315 . . . . 0.82999999999999996 110.424 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 76.3 mt -120.57 -43.76 2.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.971 0.73 . . . . 1.45 112.971 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.413 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 80.5 mt-30 -122.75 174.78 6.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.117 0.484 . . . . 2.0800000000000001 112.228 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.4 p -166.3 144.92 5.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.513 -0.767 . . . . 0.56000000000000005 110.608 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.51 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 39.3 ptt180 -143.54 134.72 25.76 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.809 0.337 . . . . 1.55 110.842 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.633 HG22 ' HB3' ' A' ' 410' ' ' ASP . 18.0 p -98.85 38.02 1.43 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.098 0.407 . . . . 1.79 112.098 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.907 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.0 m 47.52 -173.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.285 -0.416 . . . . 1.95 111.249 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.907 ' H ' HG22 ' A' ' 403' ' ' THR . 94.4 mt-10 -68.68 -41.62 78.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.799 0.333 . . . . 3.8700000000000001 111.402 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.558 ' OD1' ' HB3' ' A' ' 407' ' ' ALA . 24.3 t-20 -54.57 -52.48 61.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.154 -0.476 . . . . 3.1600000000000001 111.311 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 55.55 59.67 3.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 2.1800000000000002 111.756 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.558 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -163.51 11.08 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.459 0.647 . . . . 2.77 110.024 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.638 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -177.57 -49.77 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 114.808 -1.087 . . . . 2.7599999999999998 110.23 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 30.8 Cg_endo -62.2 145.62 96.17 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.408 2.072 . . . . 2.4900000000000002 112.425 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.633 ' HB3' HG22 ' A' ' 402' ' ' THR . 12.5 p-10 -178.47 124.65 0.11 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.047 -0.524 . . . . 2.1400000000000001 110.763 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 400' ' ' SER . 10.8 mp0 -129.89 137.89 50.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.947 -0.57 . . . . 2.1000000000000001 110.127 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.606 ' HB2' HD12 ' A' ' 432' ' ' ILE . 1.4 m-85 -109.76 133.41 53.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.883 0.373 . . . . 0.71999999999999997 111.664 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 30.9 t80 -72.9 120.72 18.92 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.439 -0.578 . . . . 0.51000000000000001 109.439 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.483 HG21 HG12 ' A' ' 385' ' ' ILE . 8.8 p -112.56 138.75 40.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.584 0.587 . . . . 1.1499999999999999 112.584 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' HIS . . . . . 0.513 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 83.8 t60 -120.81 88.95 3.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.218 -0.901 . . . . 0.62 109.412 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.413 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 59.9 m-85 -52.85 116.2 2.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.65000000000000002 111.318 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.3 t -62.11 128.89 24.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 1.3400000000000001 111.371 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.39 -42.44 1.95 Allowed Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.776 -0.647 . . . . 0.81999999999999995 113.351 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.675 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.8 mp -59.45 161.06 6.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.013 0.435 . . . . 1.6000000000000001 111.576 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.616 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 4.9 m120 -49.78 140.91 10.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.514 -0.766 . . . . 2.5299999999999998 111.925 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' ARG . . . . . 0.522 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 88.7 mtm180 -65.23 -36.45 84.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.867 -0.606 . . . . 3.98 110.829 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 420' ' ' ASN . 3.7 ptm85 -55.65 -35.57 66.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.281 -0.418 . . . . 3.71 110.643 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 419' ' ' LEU . 76.7 mt -59.02 -35.17 72.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 1.49 111.394 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.522 ' OD2' ' HA ' ' A' ' 421' ' ' ARG . 48.9 m-20 -54.69 139.7 38.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 1.2 111.901 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 179.45 -153.35 12.11 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.472 -0.785 . . . . 0.69999999999999996 111.852 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' TRP . . . . . 0.51 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 77.0 m95 -94.93 140.48 29.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.833 0.349 . . . . 0.60999999999999999 111.082 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.53 ' CG2' HD11 ' A' ' 432' ' ' ILE . 16.1 m -138.76 137.5 42.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.032 -0.531 . . . . 0.89000000000000001 111.399 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.495 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -62.22 150.13 47.03 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.819 -0.628 . . . . 1.72 112.591 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.417 ' NH2' HD11 ' A' ' 373' ' ' ILE . 41.0 tpt85 -53.61 -38.17 63.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 1.73 111.302 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.495 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 19.5 p-80 -58.08 -29.86 65.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.952 0.352 . . . . 1.47 111.952 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.05 -36.13 48.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.578 -0.283 . . . . 2.8399999999999999 111.215 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 412' ' ' TYR . 54.1 mt -89.28 139.7 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.945 0.402 . . . . 0.46000000000000002 111.366 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.6 m -160.97 139.51 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.53000000000000003 110.651 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -63.78 -26.46 68.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 1.3500000000000001 111.281 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.455 ' OD1' ' HB2' ' A' ' 437' ' ' ASP . 12.0 t-20 -109.62 134.06 52.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.92 0.39 . . . . 2.1600000000000001 110.691 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -73.37 -39.85 64.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.75 112.275 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' ASP . . . . . 0.534 ' HA ' ' HA2' ' A' ' 441' ' ' GLY . 57.0 m-20 -49.69 -40.87 41.66 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.787 0.291 . . . . 1.3400000000000001 111.787 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.4 -40.96 94.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.348 . . . . 1.5600000000000001 110.97 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.88 -83.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 1.1200000000000001 111.558 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -138.59 34.36 2.12 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.492 -0.861 . . . . 1.3600000000000001 113.077 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 437' ' ' ASP . . . 43.63 44.17 6.67 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.365 -0.445 . . . . 1.8300000000000001 113.732 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 442' ' ' ILE . 48.0 mm . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.534 0.683 . . . . 1.48 111.476 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.659 HG22 HG13 ' A' ' 375' ' ' ILE . 31.4 mm . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 121.315 0.579 . . . . 1.48 112.448 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 377' ' ' GLU . 45.5 m-20 -106.19 69.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.711 -0.677 . . . . 2.1699999999999999 110.489 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.844 HD11 HG12 ' A' ' 397' ' ' VAL . 73.5 mt -60.67 -82.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.036 0.754 . . . . 0.92000000000000004 113.036 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 375' ' ' ILE . 52.0 m -49.93 -28.73 7.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.121 -0.49 . . . . 1.71 111.814 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 374' ' ' ASP . 8.5 mt-10 -70.44 -38.25 74.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.698 -0.683 . . . . 1.9199999999999999 111.144 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.527 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 51.1 m-20 -146.04 66.17 11.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 2.1400000000000001 111.68 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.13 -40.65 76.33 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.691 2.261 . . . . 0.84999999999999998 112.227 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.05 -37.13 85.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.887 -0.597 . . . . 1.21 111.327 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.3 tttp -51.17 125.63 14.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.399 . . . . 1.6599999999999999 111.124 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.936 HD12 HG21 ' A' ' 417' ' ' VAL . 42.5 mm -87.04 132.87 31.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.973 -0.558 . . . . 0.40999999999999998 111.47 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -107.25 143.69 35.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.371 -0.377 . . . . 0.63 110.361 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 436' ' ' ALA . 2.7 m-85 -92.64 138.35 31.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.667 0.27 . . . . 0.95999999999999996 110.641 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 385' ' ' ILE . 3.0 mp -123.01 135.45 63.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.893 0.378 . . . . 0.48999999999999999 111.267 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.662 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 56.3 ttt-85 -92.44 121.73 34.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 2.4199999999999999 111.204 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -79.52 156.64 27.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.546 -0.297 . . . . 2.2999999999999998 110.412 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -51.54 -45.45 62.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 2.8199999999999998 111.036 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -59.44 -32.53 70.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 1.23 110.295 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 112.33 37.75 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.894 -0.593 . . . . 1.03 112.828 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 62.9 p -120.84 112.34 18.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.863 0.363 . . . . 0.97999999999999998 111.342 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 87.0 t -69.6 138.92 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.55000000000000004 111.21 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -149.37 138.81 21.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.11 -0.496 . . . . 2.4300000000000002 110.978 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.495 ' HD2' HG21 ' A' ' 382' ' ' ILE . 73.8 mtm-85 -57.41 150.28 18.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.545 . . . . 2.96 111.802 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -175.7 132.98 2.26 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.586 -0.734 . . . . 0.26000000000000001 111.856 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 26.1 mt-30 -95.2 129.99 42.1 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.851 0.315 . . . . 1.28 111.851 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.844 HG12 HD11 ' A' ' 375' ' ' ILE . 21.5 t -85.9 132.38 32.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.94 -0.393 . . . . 0.82999999999999996 109.94 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.429 ' C ' HD13 ' A' ' 375' ' ' ILE . 91.9 mt -121.02 -40.82 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.575 0.583 . . . . 1.45 112.575 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.48 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 30.4 mm100 -136.86 176.46 8.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.231 0.538 . . . . 2.0800000000000001 112.25 -178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.7 p -158.0 140.13 14.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.369 -0.832 . . . . 0.56000000000000005 109.947 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.447 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 38.0 ptt180 -142.31 137.05 30.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.066 0.46 . . . . 1.55 112.035 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 409' ' ' PRO . 42.1 p -77.42 137.46 38.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 1.79 110.312 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.808 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.7 m -62.4 -174.29 0.06 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.03 -0.359 . . . . 1.95 110.03 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.808 ' H ' HG22 ' A' ' 403' ' ' THR . 55.5 mt-10 -48.21 -40.69 25.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.8 0.333 . . . . 3.8700000000000001 110.695 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.517 ' O ' ' HD2' ' A' ' 409' ' ' PRO . 50.1 t30 -80.5 54.19 2.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.979 -0.555 . . . . 3.1600000000000001 110.664 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . -51.43 98.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.131 0.491 . . . . 2.1800000000000002 110.995 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -177.28 -29.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.378 -0.828 . . . . 2.77 109.978 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.666 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -145.57 -51.21 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.106 -0.952 . . . . 2.7599999999999998 111.259 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.666 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 51.0 Cg_exo -55.46 145.71 66.97 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.457 2.105 . . . . 2.4900000000000002 112.354 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.402 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 12.8 p-10 -173.01 128.62 0.47 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.153 0.502 . . . . 2.1400000000000001 111.326 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 400' ' ' SER . 52.2 mp0 -108.73 144.25 36.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.643 -0.708 . . . . 2.1000000000000001 109.98 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.433 ' N ' ' HD1' ' A' ' 412' ' ' TYR . 0.8 OUTLIER -109.15 124.18 50.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.079 0.466 . . . . 0.71999999999999997 111.841 -178.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 11.9 t80 -63.96 149.9 46.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.567 -0.742 . . . . 0.51000000000000001 109.341 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 12.3 p -153.78 137.52 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.199 0.523 . . . . 1.1499999999999999 112.356 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -118.46 107.46 13.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.415 -0.811 . . . . 0.62 109.553 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.467 ' CD2' HD22 ' A' ' 419' ' ' LEU . 37.3 m-85 -62.13 127.82 33.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.081 0.467 . . . . 0.65000000000000002 111.218 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.936 HG21 HD12 ' A' ' 382' ' ' ILE . 2.4 t -82.49 34.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.518 -0.764 . . . . 1.3400000000000001 111.223 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -176.81 -48.39 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.769 -0.729 . . . . 0.81999999999999995 112.783 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.605 ' HB3' HD23 ' A' ' 423' ' ' LEU . 7.0 mp -62.75 150.37 41.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 1.6000000000000001 110.916 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.415 ' N ' HD23 ' A' ' 423' ' ' LEU . 10.7 t-20 -53.09 165.91 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.943 -0.571 . . . . 2.5299999999999998 111.157 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -64.22 -27.56 69.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 3.98 110.543 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -53.44 -39.75 64.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.802 -0.635 . . . . 3.71 111.047 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.655 ' H ' HD22 ' A' ' 423' ' ' LEU . 1.6 mm? -70.9 -34.82 71.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.178 -0.465 . . . . 1.49 110.502 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -53.76 131.56 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.798 -0.637 . . . . 1.2 111.25 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 169.72 -146.39 10.01 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.867 -0.606 . . . . 0.69999999999999996 112.209 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' TRP . . . . . 0.447 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 57.0 m95 -103.75 140.09 38.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.801 0.334 . . . . 0.60999999999999999 110.722 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.461 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 32.0 m -141.04 144.7 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.89000000000000001 111.097 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -59.0 148.69 39.43 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.961 -0.638 . . . . 1.72 112.835 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -52.3 -39.81 61.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.765 0.317 . . . . 1.73 111.316 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.539 ' ND1' ' HG3' ' A' ' 431' ' ' ARG . 6.1 p80 -57.09 -27.5 61.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 1.47 111.973 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.539 ' HG3' ' ND1' ' A' ' 430' ' ' HIS . 67.9 mtt-85 -78.51 -38.84 39.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.637 0.236 . . . . 2.8399999999999999 111.637 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.763 HD13 HG22 ' A' ' 397' ' ' VAL . 51.9 mt -87.91 131.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.46000000000000002 110.836 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.765 ' HB2' HD21 ' A' ' 439' ' ' LEU . 71.4 m -161.15 140.18 10.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.591 . . . . 0.53000000000000003 111.089 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -60.19 -24.47 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.035 -0.53 . . . . 1.3500000000000001 111.211 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.425 ' O ' ' HG ' ' A' ' 439' ' ' LEU . 24.0 t-20 -108.4 128.8 55.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.407 -0.36 . . . . 2.1600000000000001 110.944 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' ALA . . . . . 0.555 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -83.3 -40.12 19.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.75 112.058 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -47.96 -40.59 22.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.43 -0.35 . . . . 1.3400000000000001 111.386 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -70.64 -37.12 73.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 1.5600000000000001 110.902 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.765 HD21 ' HB2' ' A' ' 433' ' ' SER . 84.1 mt -57.32 -84.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.942 -0.572 . . . . 1.1200000000000001 111.778 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -172.07 40.6 0.17 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.527 -0.844 . . . . 1.3600000000000001 112.885 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.93 143.54 0.06 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.802 -0.713 . . . . 1.8300000000000001 112.861 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 C--N 1.332 -0.162 0 CA-C-O 120.756 0.312 . . . . 1.48 110.204 179.558 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.596 ' N ' ' HH ' ' A' ' 412' ' ' TYR . 68.0 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.733 0.301 . . . . 1.48 111.184 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -89.36 129.65 35.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.389 -0.369 . . . . 2.1699999999999999 110.938 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 88.8 mt -95.56 -45.96 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.92000000000000004 111.531 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 64.7 m -65.08 72.69 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.397 -0.82 . . . . 1.71 111.643 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.414 ' HG3' ' OD1' ' A' ' 378' ' ' ASN . 11.9 pt-20 -175.11 -33.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 1.9199999999999999 110.781 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' A' ' 381' ' ' LYS . 30.5 p30 -168.53 60.16 0.44 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.532 . . . . 2.1400000000000001 111.582 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.06 -37.78 79.54 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.289 1.993 . . . . 0.84999999999999998 111.543 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.8 -33.45 75.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.646 . . . . 1.21 110.881 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 86.0 tttt -51.44 134.52 28.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.104 -0.498 . . . . 1.6599999999999999 111.294 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 38.3 mm -82.95 136.26 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.025 -0.534 . . . . 0.40999999999999998 111.268 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.41 ' HB3' ' CG2' ' A' ' 432' ' ' ILE . 43.1 m-85 -114.41 143.94 44.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.554 -0.293 . . . . 0.63 110.452 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 5.3 m-85 -90.07 135.48 33.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.391 -0.368 . . . . 0.95999999999999996 110.718 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.5 mp -118.7 130.47 73.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.4 -0.364 . . . . 0.48999999999999999 110.984 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.59 ' HD2' ' O ' ' A' ' 439' ' ' LEU . 30.1 ttt85 -90.46 121.77 32.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.465 -0.334 . . . . 2.4199999999999999 110.777 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -79.08 163.03 25.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.331 -0.395 . . . . 2.2999999999999998 110.356 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -57.34 -42.62 82.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.628 0.251 . . . . 2.8199999999999998 110.85 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -60.47 -16.84 40.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.186 0.517 . . . . 1.23 110.05 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 91.47 40.84 5.28 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.417 -0.81 . . . . 1.03 112.52 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 60.9 p -120.99 111.31 17.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.97999999999999998 111.437 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.73 135.77 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.55000000000000004 111.0 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -150.0 139.01 21.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 2.4300000000000002 110.81 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -56.47 148.4 19.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.133 0.492 . . . . 2.96 111.788 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.41 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -171.48 128.01 1.52 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.461 -0.791 . . . . 0.26000000000000001 111.769 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -81.63 128.62 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.849 0.357 . . . . 1.28 111.195 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.859 HG23 HG22 ' A' ' 414' ' ' VAL . 1.0 OUTLIER -101.32 126.0 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.772 -0.455 . . . . 0.82999999999999996 109.772 178.752 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 50.7 mt -120.71 -34.46 3.57 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.674 0.62 . . . . 1.45 112.674 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 413' ' ' TYR . 70.4 mt-30 -118.97 166.97 12.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.038 0.447 . . . . 2.0800000000000001 111.807 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.7 p -165.93 151.62 8.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.679 -0.691 . . . . 0.56000000000000005 110.729 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -161.24 134.69 6.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.906 0.384 . . . . 1.55 111.314 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.584 ' O ' ' HG2' ' A' ' 409' ' ' PRO . 20.4 p -101.0 39.22 1.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 1.79 110.617 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.825 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.5 m 47.31 -174.32 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.618 -0.719 . . . . 1.95 111.004 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.825 ' H ' HG22 ' A' ' 403' ' ' THR . 0.4 OUTLIER -77.77 -40.54 40.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 3.8700000000000001 110.992 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -58.32 -51.31 70.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.513 . . . . 3.1600000000000001 111.276 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.471 ' C ' ' HD2' ' A' ' 409' ' ' PRO . . . 65.83 -175.08 0.18 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.993 0.425 . . . . 2.1800000000000002 110.366 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . 62.35 11.35 4.49 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.605 -0.725 . . . . 2.77 112.05 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.558 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -168.74 -54.78 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.466 -0.334 . . . . 2.7599999999999998 111.264 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.584 ' HG2' ' O ' ' A' ' 402' ' ' THR . 47.6 Cg_endo -68.02 148.55 75.98 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.478 2.119 . . . . 2.4900000000000002 112.386 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.552 ' HB3' HG22 ' A' ' 402' ' ' THR . 40.0 p-10 -175.51 132.54 0.28 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.901 -0.59 . . . . 2.1400000000000001 110.662 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 96.7 mt-10 -151.32 137.16 18.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 2.1000000000000001 111.202 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.627 ' CE1' ' HG2' ' A' ' 429' ' ' ARG . 3.9 m-85 -117.09 128.73 55.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.71999999999999997 111.727 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 20.0 t80 -64.05 135.82 56.75 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.953 -0.567 . . . . 0.51000000000000001 109.986 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.859 HG22 HG23 ' A' ' 397' ' ' VAL . 60.4 t -129.28 139.5 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.813 0.671 . . . . 1.1499999999999999 112.813 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -120.31 89.32 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.059 -0.973 . . . . 0.62 109.142 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.495 ' H ' ' HD1' ' A' ' 416' ' ' TYR . 7.3 m-85 -54.45 116.0 2.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.88 -0.6 . . . . 0.65000000000000002 111.349 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 65.2 t -61.6 125.83 18.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.791 -0.641 . . . . 1.3400000000000001 111.245 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.56 -43.44 1.85 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.745 -0.661 . . . . 0.81999999999999995 113.101 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.602 ' HB3' HD22 ' A' ' 423' ' ' LEU . 7.6 mp -59.74 152.11 23.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.982 0.42 . . . . 1.6000000000000001 111.389 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.403 ' HB2' HD13 ' A' ' 423' ' ' LEU . 63.1 m-80 -50.36 144.13 7.9 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.659 -0.7 . . . . 2.5299999999999998 111.837 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -58.6 -34.87 71.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.603 -0.726 . . . . 3.98 111.45 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' ARG . . . . . 0.678 ' HG3' HD12 ' A' ' 423' ' ' LEU . 14.8 ptp180 -51.35 -37.07 45.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 3.71 111.635 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.678 HD12 ' HG3' ' A' ' 422' ' ' ARG . 10.6 mp -61.1 -33.95 74.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.5 -0.318 . . . . 1.49 111.106 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -48.87 138.25 11.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.241 -0.436 . . . . 1.2 111.068 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -176.17 -137.79 2.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.647 -0.787 . . . . 0.69999999999999996 112.7 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' TRP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 38.4 m95 -130.46 141.35 50.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.063 0.458 . . . . 0.60999999999999999 110.905 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 429' ' ' ARG . 4.6 m -108.2 156.77 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.683 -0.689 . . . . 0.89000000000000001 110.888 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -79.06 35.34 1.92 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.394 -0.908 . . . . 1.72 111.503 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.77 ' H ' HG23 ' A' ' 427' ' ' VAL . 0.6 OUTLIER 66.0 -73.24 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.003 0.521 . . . . 1.73 110.651 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -52.51 -18.33 1.65 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.514 -0.312 . . . . 1.47 111.664 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.458 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 64.5 mtt85 -78.73 28.57 0.21 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.6 0.238 . . . . 2.8399999999999999 111.039 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.669 ' CD1' HG21 ' A' ' 427' ' ' VAL . 42.4 mt -150.27 138.8 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.82 0.343 . . . . 0.46000000000000002 111.036 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 68.1 m -163.96 140.62 6.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.493 . . . . 0.53000000000000003 110.785 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -55.59 -24.29 32.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 1.3500000000000001 111.278 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -108.73 129.81 55.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.113 0.482 . . . . 2.1600000000000001 111.034 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -74.24 -31.93 62.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.768 -0.651 . . . . 0.75 111.648 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -44.64 -77.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 1.3400000000000001 111.735 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -47.37 -38.52 13.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 1.5600000000000001 111.81 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.59 ' O ' ' HD2' ' A' ' 386' ' ' ARG . 96.4 mt -61.27 -42.45 98.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.882 0.327 . . . . 1.1200000000000001 111.882 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 440' ' ' GLY . . . . . 0.41 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . 165.01 21.58 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.354 -0.927 . . . . 1.3600000000000001 112.881 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 64.06 153.73 0.09 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.661 -0.78 . . . . 1.8300000000000001 112.472 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 45.9 mm . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.646 0.26 . . . . 1.48 110.451 179.743 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.598 HD11 ' CZ ' ' A' ' 429' ' ' ARG . 75.9 mt . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 113.343 0.868 . . . . 1.48 113.343 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.78 129.76 36.13 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.329 -0.619 . . . . 2.1699999999999999 109.329 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.6 mt -84.56 -40.87 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.62 0.6 . . . . 0.92000000000000004 112.62 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.6 t -49.54 -17.76 0.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.016 0.436 . . . . 1.71 111.22 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -56.39 -43.73 79.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.516 -0.766 . . . . 1.9199999999999999 111.495 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' A' ' 381' ' ' LYS . 13.6 p30 -171.11 69.1 0.49 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 2.1400000000000001 111.392 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.13 -40.05 60.37 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.418 2.079 . . . . 0.84999999999999998 112.047 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -60.55 -36.33 78.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.511 . . . . 1.21 110.844 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 58.9 tttm -52.15 132.81 33.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.18 -0.464 . . . . 1.6599999999999999 111.431 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 394' ' ' ARG . 43.2 mm -86.47 131.55 34.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.011 -0.541 . . . . 0.40999999999999998 111.029 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -105.47 143.29 33.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.547 -0.297 . . . . 0.63 110.58 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.59 140.39 29.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.347 -0.388 . . . . 0.95999999999999996 110.474 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.646 ' N ' HD12 ' A' ' 385' ' ' ILE . 0.9 OUTLIER -132.96 128.21 56.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.754 0.311 . . . . 0.48999999999999999 111.026 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.697 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 36.7 ttt85 -86.01 121.57 28.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 2.4199999999999999 110.797 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.405 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 61.7 mtp85 -72.93 159.14 34.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 2.2999999999999998 110.659 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -55.03 -45.52 75.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.513 -0.312 . . . . 2.8199999999999998 111.339 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -57.98 -29.08 64.96 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.262 -0.644 . . . . 1.23 109.262 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 111.03 37.26 1.7 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.3 -0.864 . . . . 1.03 113.267 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' THR . . . . . 0.405 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 29.9 p -121.24 111.15 17.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.878 0.37 . . . . 0.97999999999999998 111.562 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.13 137.89 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.027 -0.533 . . . . 0.55000000000000004 111.011 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -150.57 139.64 21.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 2.4300000000000002 110.957 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.408 ' HB3' HG21 ' A' ' 382' ' ' ILE . 88.3 mtm180 -56.63 147.56 22.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.815 -0.63 . . . . 2.96 111.474 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -164.98 128.43 1.79 Allowed Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.824 -0.626 . . . . 0.26000000000000001 112.238 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -83.32 110.18 17.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.686 0.279 . . . . 1.28 111.503 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.6 OUTLIER -79.09 135.04 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.82999999999999996 109.976 178.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 94.1 mt -120.24 -31.91 4.27 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.789 0.663 . . . . 1.45 112.789 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -140.19 175.3 9.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.071 0.462 . . . . 2.0800000000000001 111.931 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.6 p -165.5 149.23 8.21 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.616 -0.72 . . . . 0.56000000000000005 110.576 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 401' ' ' ARG . 14.5 ptt-85 -158.11 138.43 12.6 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.073 0.463 . . . . 1.55 111.923 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 47.2 p -75.29 139.44 42.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.948 -0.569 . . . . 1.79 110.276 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.864 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.5 m -61.76 -174.39 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.504 -0.316 . . . . 1.95 110.263 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.864 ' H ' HG22 ' A' ' 403' ' ' THR . 50.2 mt-10 -54.6 -45.76 73.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.666 0.269 . . . . 3.8700000000000001 111.573 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -59.84 -47.39 85.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 3.1600000000000001 110.864 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.573 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 64.11 -177.07 0.16 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.024 -0.534 . . . . 2.1800000000000002 110.858 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . 63.22 11.2 5.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.395 -0.82 . . . . 2.77 112.134 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.552 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -170.84 -53.1 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.558 -0.292 . . . . 2.7599999999999998 111.68 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.577 ' HB2' ' OG1' ' A' ' 403' ' ' THR . 65.4 Cg_endo -72.07 149.83 53.15 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.281 1.987 . . . . 2.4900000000000002 112.036 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.471 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 5.1 p-10 -170.32 126.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.11 0.481 . . . . 2.1400000000000001 111.493 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 400' ' ' SER . 64.8 mm-40 -109.81 134.68 51.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.496 -0.775 . . . . 2.1000000000000001 110.319 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.495 ' HB2' HD12 ' A' ' 432' ' ' ILE . 2.6 m-85 -112.81 129.26 56.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.87 0.367 . . . . 0.71999999999999997 111.872 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 26.0 t80 -69.19 129.74 40.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.899 -0.778 . . . . 0.51000000000000001 108.899 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 425' ' ' GLY . 10.3 p -131.17 136.8 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.801 0.667 . . . . 1.1499999999999999 112.801 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -114.75 89.8 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.019 -0.992 . . . . 0.62 109.582 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.556 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 35.2 m-85 -54.02 128.1 29.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.65000000000000002 111.231 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 67.0 t -71.89 127.92 34.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.996 -0.547 . . . . 1.3400000000000001 111.278 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.35 -37.14 1.56 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.841 -0.695 . . . . 0.81999999999999995 113.261 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.514 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.9 mp -59.34 159.7 7.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.237 0.542 . . . . 1.6000000000000001 111.809 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.776 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 5.6 m120 -51.07 140.55 15.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.179 -0.918 . . . . 2.5299999999999998 111.821 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -60.36 -38.36 83.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 3.98 110.733 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -60.19 -38.44 83.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 3.71 110.991 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.776 ' HG ' ' HB2' ' A' ' 420' ' ' ASN . 90.0 mt -56.65 -31.17 64.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 1.49 110.978 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -52.13 134.5 32.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 1.2 111.182 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLY . . . . . 0.465 ' O ' HG12 ' A' ' 414' ' ' VAL . . . 177.04 176.52 45.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.042 -0.599 . . . . 0.69999999999999996 112.369 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -75.2 140.44 43.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.005 0.431 . . . . 0.60999999999999999 110.997 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.545 ' CG2' HD11 ' A' ' 432' ' ' ILE . 25.4 m -133.37 138.82 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 0.89000000000000001 111.354 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -61.73 147.63 48.11 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.859 -0.686 . . . . 1.72 112.394 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.598 ' CZ ' HD11 ' A' ' 373' ' ' ILE . 23.2 tpt180 -51.49 -39.97 58.62 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.758 0.281 . . . . 1.73 111.758 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -53.31 -30.78 40.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.757 0.313 . . . . 1.47 111.466 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.427 ' HG2' HH11 ' A' ' 431' ' ' ARG . 68.0 mtt-85 -79.47 -35.05 40.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.154 -0.475 . . . . 2.8399999999999999 111.569 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.572 HG12 HG13 ' A' ' 385' ' ' ILE . 53.6 mt -88.89 140.47 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.46000000000000002 112.013 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 435' ' ' ASN . 66.8 m -159.89 139.9 11.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.675 -0.693 . . . . 0.53000000000000003 110.413 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.76 16.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 1.3500000000000001 111.773 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.449 ' H ' ' C ' ' A' ' 433' ' ' SER . 22.2 p30 -162.63 135.65 5.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.978 0.418 . . . . 2.1600000000000001 111.055 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' ALA . . . . . 0.524 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -65.35 -32.07 73.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.75 111.639 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -49.73 -40.85 42.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 1.3400000000000001 111.419 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -97.17 49.55 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.44 -0.346 . . . . 1.5600000000000001 111.173 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 436' ' ' ALA . 95.6 mt -148.55 -84.53 0.1 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.38 -0.373 . . . . 1.1200000000000001 111.286 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 440' ' ' GLY . . . . . 0.697 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -171.02 30.72 0.13 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.577 -0.821 . . . . 1.3600000000000001 112.647 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 63.99 151.35 0.06 OUTLIER Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.743 -0.742 . . . . 1.8300000000000001 112.543 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 44.8 mm . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.665 0.269 . . . . 1.48 110.464 179.575 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 70.5 mt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.805 0.336 . . . . 1.48 111.564 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.563 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 0.3 OUTLIER -93.95 130.58 39.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 2.1699999999999999 110.503 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 375' ' ' ILE . 4.7 mp -88.29 -41.25 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.125 0.417 . . . . 0.92000000000000004 112.125 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 82.1 p -47.46 -26.4 1.36 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.018 -0.537 . . . . 1.71 112.021 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.6 pt-20 -67.5 -39.23 85.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.197 -0.456 . . . . 1.9199999999999999 111.898 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 66.1 m-20 -151.87 67.31 7.11 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 112.095 0.406 . . . . 2.1400000000000001 112.095 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.7 -41.1 63.48 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.734 2.289 . . . . 0.84999999999999998 112.419 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.94 -38.28 85.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.973 -0.558 . . . . 1.21 111.324 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 87.4 tttt -48.91 127.12 13.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 1.6599999999999999 111.075 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 44.3 mm -86.32 126.68 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.989 -0.55 . . . . 0.40999999999999998 111.165 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -105.13 144.16 32.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.311 -0.404 . . . . 0.63 110.151 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.454 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 1.9 m-85 -89.88 137.32 32.44 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.929 -0.308 . . . . 0.95999999999999996 110.543 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.671 HG12 HG21 ' A' ' 414' ' ' VAL . 2.7 mp -122.89 125.57 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.329 -0.396 . . . . 0.48999999999999999 111.218 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.519 ' HE ' ' HA2' ' A' ' 390' ' ' GLY . 78.1 ttt180 -83.86 116.82 22.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 2.4199999999999999 110.261 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.453 ' HB2' ' OD1' ' A' ' 389' ' ' ASP . 51.9 mtp85 -71.53 163.98 26.71 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.941 -0.304 . . . . 2.2999999999999998 110.703 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 389' ' ' ASP . 11.5 pm0 -49.72 -39.76 38.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.309 -0.405 . . . . 2.8199999999999998 111.214 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 387' ' ' ARG . 43.1 p-10 -65.87 -35.04 79.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 1.23 111.215 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.519 ' HA2' ' HE ' ' A' ' 386' ' ' ARG . . . 129.32 -31.31 3.47 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.718 -0.753 . . . . 1.03 112.539 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 71.3 p -59.36 113.09 2.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.096 0.474 . . . . 0.97999999999999998 112.144 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 59.8 t -71.15 141.31 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.562 -0.745 . . . . 0.55000000000000004 110.902 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -148.9 134.77 18.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.484 -0.325 . . . . 2.4300000000000002 110.803 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.441 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 88.2 mtm180 -54.22 152.97 5.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.232 -0.44 . . . . 2.96 111.498 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -168.83 135.66 3.71 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.657 -0.701 . . . . 0.26000000000000001 112.089 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -87.04 110.37 20.03 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.724 0.268 . . . . 1.28 111.724 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.628 ' CG2' HD13 ' A' ' 432' ' ' ILE . 11.6 t -77.94 128.01 38.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.765 -0.828 . . . . 0.82999999999999996 108.765 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 58.2 mt -121.0 -38.27 2.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.011 0.745 . . . . 1.45 113.011 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.511 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 86.7 mt-30 -133.95 176.53 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 2.0800000000000001 112.049 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.3 p -162.16 148.03 13.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.676 -0.693 . . . . 0.56000000000000005 110.349 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -161.45 139.19 9.1 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.887 0.375 . . . . 1.55 111.536 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 67.3 p -73.4 -125.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 1.79 109.884 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.801 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.23 -173.52 3.16 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.77 -0.456 . . . . 1.95 109.77 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.801 ' H ' HG22 ' A' ' 403' ' ' THR . 55.6 mt-10 -46.11 -43.77 15.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.678 0.275 . . . . 3.8700000000000001 111.275 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -67.72 -52.62 35.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 3.1600000000000001 110.798 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 53.81 54.33 10.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.003 -0.544 . . . . 2.1800000000000002 111.658 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.517 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -149.09 10.65 0.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.517 0.675 . . . . 2.77 109.755 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.573 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -179.46 -47.71 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.628 -1.169 . . . . 2.7599999999999998 110.077 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 39.5 Cg_exo -57.53 146.79 82.36 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.509 2.139 . . . . 2.4900000000000002 112.585 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.656 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.6 p30 -174.38 138.07 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 2.1400000000000001 110.568 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.4 mt-10 -137.14 134.4 36.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 2.1000000000000001 110.375 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 0.8 OUTLIER -109.93 125.7 53.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.855 0.359 . . . . 0.71999999999999997 111.49 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.511 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 14.0 t80 -59.49 147.13 37.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.974 -0.557 . . . . 0.51000000000000001 109.516 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.671 HG21 HG12 ' A' ' 385' ' ' ILE . 7.1 p -153.66 134.55 4.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.237 0.541 . . . . 1.1499999999999999 112.055 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -120.24 101.85 8.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.455 -0.793 . . . . 0.62 109.902 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.492 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 50.1 m-85 -59.82 129.49 42.1 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.899 0.381 . . . . 0.65000000000000002 110.681 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.83 37.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.887 -0.597 . . . . 1.3400000000000001 111.109 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -175.47 -36.1 0.05 OUTLIER Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.254 -0.974 . . . . 0.81999999999999995 113.851 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.681 HD13 HD23 ' A' ' 423' ' ' LEU . 13.0 mt -62.8 -167.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.729 0.776 . . . . 1.6000000000000001 112.48 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.532 ' OD1' ' HG2' ' A' ' 422' ' ' ARG . 16.5 t-20 -81.29 149.85 28.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.55 -1.204 . . . . 2.5299999999999998 111.025 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -59.47 -40.89 88.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.91 0.386 . . . . 3.98 110.779 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' ARG . . . . . 0.532 ' HG2' ' OD1' ' A' ' 420' ' ' ASN . 16.2 ptm180 -69.19 -34.9 75.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.048 -0.524 . . . . 3.71 110.851 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.681 HD23 HD13 ' A' ' 419' ' ' LEU . 1.3 mp -56.48 -34.94 67.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.875 -0.602 . . . . 1.49 111.201 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -59.09 137.6 57.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.077 -0.51 . . . . 1.2 110.757 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -170.52 -140.51 3.03 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.619 -0.8 . . . . 0.69999999999999996 112.646 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -119.7 134.76 55.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.906 0.384 . . . . 0.60999999999999999 110.81 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.641 HG11 HG21 ' A' ' 385' ' ' ILE . 31.5 m -109.47 155.27 10.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.987 -0.551 . . . . 0.89000000000000001 111.758 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -74.11 25.27 1.04 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.918 -0.583 . . . . 1.72 113.951 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.543 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 36.2 tpt85 71.26 -46.32 0.64 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.68 0.622 . . . . 1.73 112.68 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -58.77 -19.86 44.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.944 0.402 . . . . 1.47 110.911 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.4 mtt180 -78.66 -30.32 46.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.813 -0.63 . . . . 2.8399999999999999 111.464 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.628 HD13 ' CG2' ' A' ' 397' ' ' VAL . 66.8 mt -88.02 137.29 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 120.766 0.317 . . . . 0.46000000000000002 110.728 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.437 ' HB2' HD21 ' A' ' 439' ' ' LEU . 57.9 m -160.18 139.73 11.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 0.53000000000000003 111.075 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -69.26 -23.48 63.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 1.3500000000000001 111.472 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -108.23 133.54 52.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.891 0.377 . . . . 2.1600000000000001 111.129 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 436' ' ' ALA . . . . . 0.539 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -67.85 -43.9 78.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.75 111.366 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -54.92 -39.82 69.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 1.3400000000000001 111.014 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.06 51.0 1.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 1.5600000000000001 110.948 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 436' ' ' ALA . 82.3 mt -150.13 -93.51 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 1.1200000000000001 111.106 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -177.02 48.05 0.1 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.609 -0.805 . . . . 1.3600000000000001 112.746 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.28 132.07 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.83 -0.7 . . . . 1.8300000000000001 112.848 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' ILE . . . . . 0.49 HD11 ' HB1' ' A' ' 436' ' ' ALA . 47.9 mm . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 110.247 -0.279 . . . . 1.48 110.247 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.532 HD11 HH11 ' A' ' 429' ' ' ARG . 66.8 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.845 0.355 . . . . 1.48 111.633 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.05 129.71 35.63 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.19 -0.459 . . . . 2.1699999999999999 109.989 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 379' ' ' PRO . 90.0 mt -120.93 -43.19 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.079 0.4 . . . . 0.92000000000000004 112.079 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.0 t -48.86 -30.35 5.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.044 0.449 . . . . 1.71 111.151 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.76 -36.61 36.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.752 -0.658 . . . . 1.9199999999999999 111.8 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 30.1 p30 -146.46 72.17 12.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.004 0.43 . . . . 2.1400000000000001 111.439 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 379' ' ' PRO . . . . . 0.508 ' HA ' HG23 ' A' ' 375' ' ' ILE . 21.5 Cg_endo -63.62 -36.42 53.13 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.105 1.87 . . . . 0.84999999999999998 111.286 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -64.37 -31.29 72.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 1.21 110.823 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 62.5 tttm -49.31 130.77 19.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.074 -0.512 . . . . 1.6599999999999999 111.424 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.5 HG21 ' HD2' ' A' ' 394' ' ' ARG . 33.2 mm -88.68 135.46 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.773 -0.649 . . . . 0.40999999999999998 111.109 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -117.43 143.83 45.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.537 -0.301 . . . . 0.63 110.711 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.45 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 1.8 m-85 -89.14 147.03 24.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.841 0.353 . . . . 0.95999999999999996 111.136 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.8 mp -132.22 131.68 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.48999999999999999 110.741 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 42.2 ttt-85 -84.8 123.55 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.251 -0.431 . . . . 2.4199999999999999 111.198 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -83.75 167.24 17.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.29 -0.414 . . . . 2.2999999999999998 110.461 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 388' ' ' GLU . 0.5 OUTLIER -58.36 -42.7 87.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.506 -0.315 . . . . 2.8199999999999998 111.082 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -69.86 5.13 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.403 . . . . 1.23 110.581 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 388' ' ' GLU . . . 70.76 42.71 61.06 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.902 -0.59 . . . . 1.03 112.955 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 82.5 p -120.62 111.47 17.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.958 0.408 . . . . 0.97999999999999998 111.151 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 22.6 t -69.94 135.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.55000000000000004 111.308 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -149.28 139.85 22.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 2.4300000000000002 110.742 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.5 ' HD2' HG21 ' A' ' 382' ' ' ILE . 54.9 mtm-85 -56.03 157.8 4.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.318 0.58 . . . . 2.96 112.048 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -178.56 126.56 1.08 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.125 -0.943 . . . . 0.26000000000000001 111.442 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -83.42 129.38 34.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.823 0.344 . . . . 1.28 111.791 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.756 HG22 HD13 ' A' ' 432' ' ' ILE . 8.5 t -88.9 134.69 27.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.51 -0.552 . . . . 0.82999999999999996 109.51 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 78.0 mt -120.18 -38.51 2.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.568 0.581 . . . . 1.45 112.568 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -141.65 176.12 9.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.051 0.453 . . . . 2.0800000000000001 111.809 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 97.4 p -155.62 149.66 25.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.604 -0.725 . . . . 0.56000000000000005 110.176 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 18.4 ptt-85 -149.26 134.78 18.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.229 0.538 . . . . 1.55 112.246 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 409' ' ' PRO . 46.2 p -93.65 138.1 32.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.819 -0.628 . . . . 1.79 110.065 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.844 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.5 m -61.5 -174.65 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.655 -0.248 . . . . 1.95 110.47 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.844 ' H ' HG22 ' A' ' 403' ' ' THR . 55.9 mt-10 -53.72 -39.02 64.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.571 0.224 . . . . 3.8700000000000001 111.565 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.439 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 16.0 t-20 -56.86 -49.66 74.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.423 -0.353 . . . . 3.1600000000000001 110.988 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 54.12 52.9 11.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.221 -0.445 . . . . 2.1800000000000002 111.494 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -156.5 10.83 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.844 -0.616 . . . . 2.77 110.141 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.588 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.19 -48.28 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.15 -0.932 . . . . 2.7599999999999998 110.561 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 24.0 Cg_exo -63.75 140.02 71.97 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.589 2.192 . . . . 2.4900000000000002 112.4 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.47 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 13.2 p-10 -173.82 122.63 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 2.1400000000000001 110.988 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 400' ' ' SER . 9.1 mp0 -113.94 134.24 54.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 2.1000000000000001 110.504 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.543 ' HB2' HD12 ' A' ' 432' ' ' ILE . 6.5 m-85 -109.57 125.15 52.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.71999999999999997 111.575 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.765 ' HA ' ' HA ' ' A' ' 426' ' ' TRP . 14.0 t80 -60.9 139.74 57.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.51000000000000001 110.234 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.539 HG21 HG12 ' A' ' 385' ' ' ILE . 13.0 p -133.96 137.73 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.218 0.532 . . . . 1.1499999999999999 111.928 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -119.54 96.6 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.48 -0.782 . . . . 0.62 109.889 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.404 ' HB3' HD22 ' A' ' 419' ' ' LEU . 42.3 m-85 -58.99 124.6 20.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.65000000000000002 111.024 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.79 128.54 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.911 -0.586 . . . . 1.3400000000000001 111.396 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 78.17 -40.64 1.94 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.896 -0.668 . . . . 0.81999999999999995 113.072 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 419' ' ' LEU . 7.5 mp -59.34 153.87 17.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.982 0.42 . . . . 1.6000000000000001 111.28 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.426 ' OD1' ' HB2' ' A' ' 423' ' ' LEU . 31.2 p-10 -49.31 142.22 7.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.722 -0.672 . . . . 2.5299999999999998 112.143 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 421' ' ' ARG . 45.1 mmm-85 -60.81 -36.7 79.7 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.463 -0.79 . . . . 3.98 111.96 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' ARG . . . . . 0.58 HH11 HD12 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -53.64 -29.0 36.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.907 0.385 . . . . 3.71 110.761 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.58 HD12 HH11 ' A' ' 422' ' ' ARG . 1.1 tp -63.2 -33.32 75.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 1.49 111.303 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -44.94 133.61 6.23 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.181 -0.463 . . . . 1.2 111.4 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLY . . . . . 0.463 ' O ' HG12 ' A' ' 414' ' ' VAL . . . 174.36 154.59 11.05 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.793 -0.64 . . . . 0.69999999999999996 112.053 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 426' ' ' TRP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 11.4 m95 -68.75 134.03 49.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.60999999999999999 110.296 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.468 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 35.6 m -127.05 142.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.89000000000000001 111.245 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -52.24 147.42 13.15 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.026 -0.607 . . . . 1.72 112.912 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.532 HH11 HD11 ' A' ' 373' ' ' ILE . 14.6 tpt180 -52.01 -42.03 62.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.633 0.254 . . . . 1.73 111.429 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.432 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 13.4 p-80 -56.58 -25.88 53.83 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.968 0.359 . . . . 1.47 111.968 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 56.4 mtt85 -77.89 -40.59 39.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.692 -0.231 . . . . 2.8399999999999999 111.532 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.756 HD13 HG22 ' A' ' 397' ' ' VAL . 59.7 mt -88.79 136.54 23.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.914 0.388 . . . . 0.46000000000000002 110.948 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 67.3 m -161.4 139.7 9.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.953 -0.567 . . . . 0.53000000000000003 110.743 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -76.73 16.13 0.55 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 1.3500000000000001 111.181 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -134.59 116.01 14.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.409 -0.359 . . . . 2.1600000000000001 110.734 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.33 98.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.031 -0.531 . . . . 0.75 111.595 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -57.04 -40.87 77.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 1.3400000000000001 111.13 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 439' ' ' LEU . 59.0 m-20 -83.16 45.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 1.5600000000000001 111.011 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 438' ' ' ASP . 47.6 mt -154.58 -41.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.22 -0.446 . . . . 1.1200000000000001 111.011 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 157.81 40.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.701 -0.761 . . . . 1.3600000000000001 112.132 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.418 ' O ' HD13 ' A' ' 442' ' ' ILE . . . 62.58 -128.89 41.68 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.629 -0.796 . . . . 1.8300000000000001 112.103 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' ILE . . . . . 0.418 HD13 ' O ' ' A' ' 441' ' ' GLY . 44.8 mm . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 121.106 0.479 . . . . 1.48 110.447 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 72.5 mt . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 113.069 0.766 . . . . 1.48 113.069 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -138.99 132.73 30.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.491 -0.777 . . . . 2.1699999999999999 109.852 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 82.7 mt -78.2 -40.9 26.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.089 0.403 . . . . 0.92000000000000004 112.089 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 88.1 p -47.91 -21.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.278 0.561 . . . . 1.71 110.851 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -58.11 -47.63 82.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.192 -0.913 . . . . 1.9199999999999999 110.949 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.615 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 59.4 m-20 -165.25 111.26 0.81 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.799 -0.637 . . . . 2.1400000000000001 111.29 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.3 -41.04 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.932 2.422 . . . . 0.84999999999999998 112.22 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.99 -32.37 61.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.993 -0.548 . . . . 1.21 111.666 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.2 tttp -46.35 129.31 10.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.973 0.416 . . . . 1.6599999999999999 111.556 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 50.0 mm -87.75 126.13 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.894 -0.594 . . . . 0.40999999999999998 111.276 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -99.58 143.1 30.21 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.098 -0.334 . . . . 0.63 110.098 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.499 ' C ' HD12 ' A' ' 385' ' ' ILE . 29.4 m-85 -92.73 136.25 33.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.95999999999999996 111.292 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.651 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.5 mp -116.21 129.58 72.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.078 -0.51 . . . . 0.48999999999999999 110.757 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.794 ' HB2' HD22 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -97.48 110.26 22.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 2.4199999999999999 110.232 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.444 ' O ' ' HD3' ' A' ' 386' ' ' ARG . 76.6 mtp180 -77.74 158.82 29.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.501 -0.318 . . . . 2.2999999999999998 110.983 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -54.15 -41.52 68.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.485 -0.325 . . . . 2.8199999999999998 111.449 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.406 ' OD1' ' HB2' ' A' ' 387' ' ' ARG . 54.2 p-10 -60.46 -10.12 4.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.938 0.399 . . . . 1.23 110.788 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.578 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 83.88 36.04 14.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.931 -0.577 . . . . 1.03 112.424 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 73.1 p -121.07 111.72 17.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.31 . . . . 0.97999999999999998 111.146 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.53 134.24 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.55000000000000004 110.537 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -142.63 135.93 28.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.941 0.401 . . . . 2.4300000000000002 110.751 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.448 HH11 ' HG3' ' A' ' 394' ' ' ARG . 54.4 mtm-85 -56.64 146.48 25.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 2.96 111.293 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -164.12 129.88 2.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.615 -0.72 . . . . 0.26000000000000001 112.065 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -88.36 105.07 17.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.739 0.304 . . . . 1.28 111.379 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.5 OUTLIER -71.09 129.78 34.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.964 -0.384 . . . . 0.82999999999999996 109.964 178.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 81.3 mt -121.0 -34.32 3.55 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 112.686 0.624 . . . . 1.45 112.686 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.511 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 74.2 mt-30 -129.18 175.46 8.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.036 0.446 . . . . 2.0800000000000001 111.918 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 99.4 p -166.53 148.56 6.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.612 -0.722 . . . . 0.56000000000000005 110.63 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 37.9 ptt180 -155.76 134.57 11.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.769 0.319 . . . . 1.55 110.941 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 65.2 p -72.38 -132.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.575 -0.284 . . . . 1.79 110.533 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.764 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.2 m -162.84 -173.6 3.56 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.854 -0.424 . . . . 1.95 109.854 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.764 ' H ' HG22 ' A' ' 403' ' ' THR . 67.2 mm-40 -44.55 -38.83 4.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.759 0.314 . . . . 3.8700000000000001 111.172 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 407' ' ' ALA . 25.1 t-20 -65.66 -53.08 46.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 3.1600000000000001 110.73 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 54.85 61.99 2.72 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.184 -0.462 . . . . 2.1800000000000002 111.895 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.502 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -165.07 2.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 2.77 110.708 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.621 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -175.71 -49.97 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.529 -0.76 . . . . 2.7599999999999998 110.853 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 27.3 Cg_exo -61.72 143.0 95.95 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.332 2.022 . . . . 2.4900000000000002 112.056 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.594 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.6 p30 -179.84 131.92 0.1 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.234 0.54 . . . . 2.1400000000000001 112.054 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 400' ' ' SER . 49.8 mp0 -109.47 135.82 49.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.516 -0.765 . . . . 2.1000000000000001 109.297 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 400' ' ' SER . 0.4 OUTLIER -109.33 126.35 53.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.942 0.401 . . . . 0.71999999999999997 111.61 -178.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 19.8 t80 -62.42 135.83 57.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.51000000000000001 109.673 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.617 HG21 HD11 ' A' ' 385' ' ' ILE . 14.6 p -139.93 137.71 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.333 0.587 . . . . 1.1499999999999999 112.563 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -112.23 97.4 6.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.197 -0.91 . . . . 0.62 109.762 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.512 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 7.8 m-85 -57.09 127.13 30.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 0.65000000000000002 111.133 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.98 129.4 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.037 -0.529 . . . . 1.3400000000000001 111.042 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.53 -43.28 2.08 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.828 -0.701 . . . . 0.81999999999999995 112.897 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 419' ' ' LEU . 7.5 mp -59.91 155.47 16.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.887 0.375 . . . . 1.6000000000000001 111.196 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -51.21 140.57 16.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 2.5299999999999998 110.727 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 22.8 ptt-85 -62.31 -37.43 85.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.443 . . . . 3.98 110.362 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -55.66 -40.37 72.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.519 -0.764 . . . . 3.71 110.704 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' LEU . . . . . . . . . . . . . 48.4 mt -62.57 -35.53 79.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.914 -0.584 . . . . 1.49 110.575 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 416' ' ' TYR . 9.1 m-20 -64.94 138.17 58.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.58 -0.736 . . . . 1.2 111.623 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.89 -151.26 9.16 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.702 -0.681 . . . . 0.69999999999999996 111.909 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -83.29 137.27 34.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.60999999999999999 110.76 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.623 ' CG1' HD11 ' A' ' 432' ' ' ILE . 1.9 p -127.23 139.8 50.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.89000000000000001 111.724 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -64.87 147.4 50.98 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.688 -0.687 . . . . 1.72 112.578 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 45.3 tpt85 -52.7 -39.24 61.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 1.73 111.355 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -64.47 -27.97 69.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.453 0.538 . . . . 1.47 112.453 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.589 ' HB2' ' CG2' ' A' ' 427' ' ' VAL . 61.3 mtt-85 -78.56 -30.02 46.6 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.176 0.436 . . . . 2.8399999999999999 112.176 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.623 HD11 ' CG1' ' A' ' 427' ' ' VAL . 65.1 mt -87.8 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.043 0.449 . . . . 0.46000000000000002 111.795 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.415 ' HB2' HD11 ' A' ' 439' ' ' LEU . 56.7 m -161.57 139.41 9.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.531 -0.759 . . . . 0.53000000000000003 110.27 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -74.67 16.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 1.3500000000000001 111.927 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.61 136.33 9.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.049 0.452 . . . . 2.1600000000000001 111.321 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -65.52 -31.88 73.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.707 -0.679 . . . . 0.75 111.586 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -49.37 -41.06 38.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.296 -0.411 . . . . 1.3400000000000001 111.256 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -97.98 43.01 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 1.5600000000000001 110.649 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.794 HD22 ' HB2' ' A' ' 386' ' ' ARG . 96.7 mt -150.52 -84.02 0.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.113 -0.494 . . . . 1.1200000000000001 110.993 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -173.89 41.23 0.14 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.087 -0.578 . . . . 1.3600000000000001 112.065 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 61.26 -138.71 47.48 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.881 -0.676 . . . . 1.8300000000000001 112.459 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 36.3 mm . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 121.227 0.537 . . . . 1.48 110.354 179.702 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.605 HD11 HH11 ' A' ' 429' ' ' ARG . 42.0 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.225 0.536 . . . . 1.48 111.635 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.707 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 57.5 m-20 -150.08 69.0 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.393 -0.821 . . . . 2.1699999999999999 109.91 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.862 HD11 HG12 ' A' ' 397' ' ' VAL . 60.7 mt -45.48 -35.84 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.542 -0.754 . . . . 0.92000000000000004 112.431 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 41.9 t -45.84 -35.87 4.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.433 0.531 . . . . 1.71 112.433 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 16.9 pt-20 -79.13 -36.99 39.68 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.11 0.411 . . . . 1.9199999999999999 112.11 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.691 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 66.5 m-20 -145.58 83.49 8.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 112.353 0.501 . . . . 2.1400000000000001 112.353 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 379' ' ' PRO . . . . . 0.441 ' HA ' HG23 ' A' ' 375' ' ' ILE . 37.3 Cg_exo -63.95 -41.21 24.12 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.022 2.481 . . . . 0.84999999999999998 112.875 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.413 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 1.5 m-20 -74.77 -31.97 61.92 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.162 0.431 . . . . 1.21 112.162 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.691 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 87.9 tttt -41.1 129.73 2.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.014 0.435 . . . . 1.6599999999999999 111.213 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.594 HG21 ' HD3' ' A' ' 394' ' ' ARG . 48.9 mm -83.09 132.69 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.686 -0.688 . . . . 0.40999999999999998 111.96 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -113.21 143.42 44.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.036 -0.529 . . . . 0.63 109.72 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.524 ' HB3' HG11 ' A' ' 392' ' ' VAL . 27.1 m-85 -93.7 130.51 39.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.673 0.273 . . . . 0.95999999999999996 111.029 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.668 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.1 mp -117.5 131.03 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.361 -0.382 . . . . 0.48999999999999999 110.945 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.665 ' N ' HD23 ' A' ' 439' ' ' LEU . 55.4 ttp180 -84.7 124.02 31.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.582 -0.281 . . . . 2.4199999999999999 110.997 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -73.17 -174.97 1.7 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.799 0.333 . . . . 2.2999999999999998 110.654 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -67.31 -45.3 76.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 2.8199999999999998 111.177 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -70.73 -36.1 73.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 1.23 111.8 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 141.35 -33.09 2.02 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.436 -0.888 . . . . 1.03 112.764 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 41.4 p -59.05 112.82 1.82 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.302 0.572 . . . . 0.97999999999999998 111.611 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.524 HG11 ' HB3' ' A' ' 384' ' ' PHE . 46.6 t -78.98 131.03 35.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.328 -0.851 . . . . 0.55000000000000004 111.853 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -122.79 138.33 54.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.99 -0.55 . . . . 2.4300000000000002 110.401 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.594 ' HD3' HG21 ' A' ' 382' ' ' ILE . 64.9 mtt85 -58.73 153.62 16.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.144 0.497 . . . . 2.96 111.988 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -174.37 132.39 2.23 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.501 -0.772 . . . . 0.26000000000000001 111.828 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 72.1 mt-30 -91.35 129.97 37.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.92 0.36 . . . . 1.28 111.752 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.862 HG12 HD11 ' A' ' 375' ' ' ILE . 16.0 t -84.64 136.08 23.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.821 -0.437 . . . . 0.82999999999999996 109.821 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.24 -46.58 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.116 0.413 . . . . 1.45 112.116 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.419 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 96.0 mm-40 -125.58 175.71 7.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 2.0800000000000001 111.82 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 81.0 p -165.47 145.33 6.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.457 -0.792 . . . . 0.56000000000000005 110.304 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 20.3 ptt-85 -145.64 136.66 24.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.052 0.453 . . . . 1.55 111.528 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.702 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 17.9 p -102.06 37.41 1.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.821 -0.627 . . . . 1.79 111.044 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.881 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.2 m 49.29 -173.33 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.178 -0.465 . . . . 1.95 110.659 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.881 ' H ' HG22 ' A' ' 403' ' ' THR . 59.1 mm-40 -65.08 -40.97 95.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 3.8700000000000001 111.164 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.459 ' HB2' ' HG3' ' A' ' 409' ' ' PRO . 19.9 m-20 -57.08 -55.16 38.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 3.1600000000000001 112.053 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.702 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 55.92 41.51 29.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.369 0.604 . . . . 2.1800000000000002 109.813 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.402 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -139.54 10.14 2.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.041 -0.981 . . . . 2.77 110.03 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.643 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -179.9 -50.05 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.005 -0.998 . . . . 2.7599999999999998 110.16 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 20.4 Cg_endo -59.9 147.57 92.12 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.451 2.1 . . . . 2.4900000000000002 112.138 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.549 ' HB3' HG22 ' A' ' 402' ' ' THR . 12.1 p-10 -176.85 134.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.424 . . . . 2.1400000000000001 110.982 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 400' ' ' SER . 51.4 mt-10 -145.93 134.2 21.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 2.1000000000000001 110.006 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -112.52 128.88 56.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.969 0.414 . . . . 0.71999999999999997 111.739 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.566 ' O ' HG13 ' A' ' 397' ' ' VAL . 24.5 t80 -67.78 150.37 48.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.93 -0.577 . . . . 0.51000000000000001 109.769 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.664 HG21 HG12 ' A' ' 385' ' ' ILE . 8.9 p -148.03 137.72 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.175 0.512 . . . . 1.1499999999999999 112.081 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -115.67 101.14 8.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.62 110.312 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.575 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 2.4 m-85 -63.44 124.41 21.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.437 -0.347 . . . . 0.65000000000000002 110.62 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.413 ' O ' HD23 ' A' ' 419' ' ' LEU . 91.5 t -74.98 128.36 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 1.3400000000000001 110.985 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.88 -40.92 1.67 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.895 -0.669 . . . . 0.81999999999999995 112.905 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 2.8 mm? -59.27 157.53 10.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.229 0.538 . . . . 1.6000000000000001 111.987 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.592 ' HB2' HD13 ' A' ' 423' ' ' LEU . 4.0 m120 -52.45 147.19 8.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.129 -0.941 . . . . 2.5299999999999998 111.795 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -61.54 -38.18 86.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.944 -0.571 . . . . 3.98 110.56 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 64.0 mtt-85 -54.51 -39.51 67.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.943 -0.571 . . . . 3.71 109.94 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 420' ' ' ASN . 5.3 mp -63.56 -35.66 81.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.18 -0.918 . . . . 1.49 110.321 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 416' ' ' TYR . 15.2 m-20 -65.88 133.31 50.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.54 -0.755 . . . . 1.2 111.269 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 173.98 -152.92 15.82 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.915 -0.66 . . . . 0.69999999999999996 112.178 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -96.32 139.81 31.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.854 0.359 . . . . 0.60999999999999999 110.964 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.463 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 17.8 m -143.15 144.67 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.89000000000000001 110.991 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -58.89 151.09 34.64 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.832 -0.699 . . . . 1.72 112.425 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.605 HH11 HD11 ' A' ' 373' ' ' ILE . 21.5 tpt180 -51.45 -40.16 58.86 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.769 0.285 . . . . 1.73 111.769 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -51.62 -30.95 23.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.644 0.259 . . . . 1.47 111.426 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.63 ' O ' HD21 ' A' ' 439' ' ' LEU . 99.0 mtt180 -80.16 -38.66 30.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 2.8399999999999999 111.969 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.805 HD13 HG22 ' A' ' 397' ' ' VAL . 77.5 mt -88.1 132.15 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.648 -0.421 . . . . 0.46000000000000002 110.749 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.529 ' HB2' HD11 ' A' ' 439' ' ' LEU . 75.7 m -163.42 143.43 8.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.797 -0.638 . . . . 0.53000000000000003 111.157 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.06 16.46 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 1.3500000000000001 111.224 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 433' ' ' SER . 14.6 t-20 -152.12 132.49 13.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.969 0.414 . . . . 2.1600000000000001 110.651 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' A' ' 441' ' ' GLY . . . -79.21 -34.99 42.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.913 -0.585 . . . . 0.75 112.546 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 437' ' ' ASP . . . . . 0.404 ' HB2' ' OD1' ' A' ' 435' ' ' ASN . 1.5 m-20 -48.96 -40.45 30.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.67 0.271 . . . . 1.3400000000000001 111.499 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.96 -33.69 75.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 1.5600000000000001 111.084 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 386' ' ' ARG . 7.3 mp -85.34 -86.37 0.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.85 -0.614 . . . . 1.1200000000000001 112.554 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -167.51 52.92 0.23 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.482 -0.866 . . . . 1.3600000000000001 113.045 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.604 ' O ' ' HB1' ' A' ' 436' ' ' ALA . . . 71.53 -148.35 43.55 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.831 -0.7 . . . . 1.8300000000000001 112.748 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 49.2 mm . . . . . 0 C--N 1.328 -0.334 0 N-CA-C 110.427 -0.212 . . . . 1.48 110.427 179.582 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.604 HG12 ' CZ ' ' A' ' 429' ' ' ARG . 47.9 mm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.974 0.416 . . . . 1.48 111.892 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.654 ' HB3' ' HG3' ' A' ' 377' ' ' GLU . 1.5 m-20 -90.07 140.95 29.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.833 -0.621 . . . . 2.1699999999999999 110.44 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.529 HG22 ' N ' ' A' ' 376' ' ' SER . 68.8 mt -111.65 -80.29 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.481 0.549 . . . . 0.92000000000000004 112.481 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' SER . . . . . 0.529 ' N ' HG22 ' A' ' 375' ' ' ILE . 45.4 t -52.42 -22.48 4.76 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.438 0.637 . . . . 1.71 110.818 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.654 ' HG3' ' HB3' ' A' ' 374' ' ' ASP . 21.8 mm-40 -62.48 -39.54 93.76 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.901 -1.045 . . . . 1.9199999999999999 111.138 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.459 ' ND2' ' HD3' ' A' ' 381' ' ' LYS . 27.1 p30 -155.5 64.13 3.91 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.529 . . . . 2.1400000000000001 111.109 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -51.31 -40.26 61.74 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.48 2.12 . . . . 0.84999999999999998 112.273 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -60.02 -36.69 77.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.084 -0.507 . . . . 1.21 110.933 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.459 ' HD3' ' ND2' ' A' ' 378' ' ' ASN . 62.4 tttm -54.57 130.09 38.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.064 -0.517 . . . . 1.6599999999999999 111.358 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.506 HG21 ' HD2' ' A' ' 394' ' ' ARG . 46.6 mm -87.54 136.58 22.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.116 -0.493 . . . . 0.40999999999999998 110.664 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.414 ' HD1' ' HA ' ' A' ' 396' ' ' GLN . 12.1 m-85 -110.72 144.0 40.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.738 0.304 . . . . 0.63 110.784 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.503 ' C ' HD12 ' A' ' 385' ' ' ILE . 3.3 m-85 -92.62 132.78 36.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.95999999999999996 110.884 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.719 HG12 HG11 ' A' ' 414' ' ' VAL . 2.3 mp -114.06 123.38 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.29 -0.414 . . . . 0.48999999999999999 111.023 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.566 ' HD2' ' O ' ' A' ' 387' ' ' ARG . 4.8 tmm_? -92.34 110.27 21.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 2.4199999999999999 110.273 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.602 ' HG2' ' NH2' ' A' ' 431' ' ' ARG . 70.7 mtp180 -73.81 153.55 39.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.288 -0.414 . . . . 2.2999999999999998 110.857 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 390' ' ' GLY . 49.5 mt-10 -54.15 -41.31 68.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 2.8199999999999998 111.685 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -66.7 5.21 0.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.093 0.473 . . . . 1.23 110.633 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 388' ' ' GLU . . . 74.94 35.4 50.23 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.494 -0.775 . . . . 1.03 113.707 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 49.2 p -121.44 110.73 16.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.97999999999999998 111.19 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 442' ' ' ILE . 51.6 t -73.86 140.69 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.55000000000000004 111.384 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -150.6 136.59 18.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.936 -0.574 . . . . 2.4300000000000002 110.43 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.506 ' HD2' HG21 ' A' ' 382' ' ' ILE . 69.9 mtm-85 -56.77 152.88 11.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.058 0.456 . . . . 2.96 112.019 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -173.39 134.97 3.08 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.572 -0.74 . . . . 0.26000000000000001 112.096 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' GLN . . . . . 0.414 ' HA ' ' HD1' ' A' ' 383' ' ' TYR . 89.6 mt-30 -95.37 129.56 42.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.726 0.298 . . . . 1.28 111.476 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.724 HG22 HD13 ' A' ' 432' ' ' ILE . 13.2 t -89.09 128.69 41.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.363 -0.381 . . . . 0.82999999999999996 110.323 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.409 ' HB2' ' HD2' ' A' ' 413' ' ' TYR . 89.6 mt -121.29 -40.03 2.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.096 0.406 . . . . 1.45 112.096 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.56 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 66.1 mt-30 -127.38 175.74 7.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.073 0.463 . . . . 2.0800000000000001 111.936 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 95.7 p -165.51 148.74 7.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.592 -0.731 . . . . 0.56000000000000005 110.152 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -163.45 135.69 5.16 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.036 0.446 . . . . 1.55 112.065 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 41.1 p -74.78 139.76 43.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 1.79 109.786 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.84 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.6 m -61.21 -174.84 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.281 -0.266 . . . . 1.95 110.281 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.84 ' H ' HG22 ' A' ' 403' ' ' THR . 7.5 mp0 -50.3 -40.31 48.16 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.744 0.276 . . . . 3.8700000000000001 111.744 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.558 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 15.8 t-20 -56.91 -49.39 75.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 3.1600000000000001 110.8 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.588 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.28 55.18 8.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 2.1800000000000002 111.466 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -158.7 9.77 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 2.77 110.16 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.6 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.38 -48.66 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.039 -0.982 . . . . 2.7599999999999998 110.209 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 20.2 Cg_exo -65.26 144.69 81.75 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.579 2.186 . . . . 2.4900000000000002 112.512 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.1 p30 -169.48 129.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 2.1400000000000001 110.542 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.9 mt-10 -115.87 134.65 54.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.971 -0.559 . . . . 2.1000000000000001 110.797 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.427 ' HB3' HG13 ' A' ' 397' ' ' VAL . 1.6 m-85 -109.24 123.55 49.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 0.71999999999999997 110.626 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.56 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 17.1 t80 -56.16 143.09 34.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.502 . . . . 0.51000000000000001 110.206 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.719 HG11 HG12 ' A' ' 385' ' ' ILE . 28.6 t -136.41 136.91 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.152 0.501 . . . . 1.1499999999999999 111.823 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -117.25 90.57 3.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.641 -0.709 . . . . 0.62 110.083 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.456 ' H ' ' HD1' ' A' ' 416' ' ' TYR . 4.1 m-85 -59.76 115.63 3.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.65000000000000002 110.724 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.74 130.99 29.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.0 -0.545 . . . . 1.3400000000000001 111.008 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.13 -45.71 2.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.894 -0.67 . . . . 0.81999999999999995 112.574 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 419' ' ' LEU . 7.3 mp -61.43 143.56 55.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.957 0.408 . . . . 1.6000000000000001 111.121 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -56.25 161.49 2.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.862 -0.608 . . . . 2.5299999999999998 111.327 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -59.96 -29.03 68.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.035 -0.53 . . . . 3.98 110.803 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -53.43 -39.39 64.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.72 -0.673 . . . . 3.71 111.305 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.613 ' H ' HD22 ' A' ' 423' ' ' LEU . 2.2 mm? -69.75 -35.63 75.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.232 -0.44 . . . . 1.49 110.529 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -60.51 138.41 58.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.85 -0.614 . . . . 1.2 111.089 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -173.3 -137.94 2.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.861 -0.685 . . . . 0.69999999999999996 112.475 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' TRP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 37.9 m95 -128.93 132.88 47.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.60999999999999999 110.916 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.691 HG21 HG13 ' A' ' 432' ' ' ILE . 34.0 m -115.64 150.34 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 0.89000000000000001 111.011 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -74.3 32.7 0.96 Allowed Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.807 -0.711 . . . . 1.72 113.681 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.604 ' CZ ' HG12 ' A' ' 373' ' ' ILE . 42.2 tpt85 71.55 -45.65 0.62 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.705 0.632 . . . . 1.73 112.705 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.529 ' CE1' ' HG3' ' A' ' 431' ' ' ARG . 8.7 p80 -54.62 -22.79 14.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.823 0.305 . . . . 1.47 111.823 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.602 ' NH2' ' HG2' ' A' ' 387' ' ' ARG . 75.2 mtp180 -79.44 -31.7 42.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.256 0.465 . . . . 2.8399999999999999 112.256 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.724 HD13 HG22 ' A' ' 397' ' ' VAL . 57.6 mt -87.49 136.85 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.849 0.357 . . . . 0.46000000000000002 111.333 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 63.7 m -158.7 140.65 13.77 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.98 -0.554 . . . . 0.53000000000000003 110.938 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -74.75 16.85 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.002 -0.544 . . . . 1.3500000000000001 112.084 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' A' ' 437' ' ' ASP . 14.1 t-20 -155.64 132.05 10.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 2.1600000000000001 111.203 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -73.55 -41.19 63.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.854 -0.612 . . . . 0.75 112.178 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' ASP . . . . . 0.4 ' HB2' ' OD1' ' A' ' 435' ' ' ASN . 54.0 m-20 -49.03 -40.5 31.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.503 -0.317 . . . . 1.3400000000000001 111.391 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -65.37 -44.36 87.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 1.5600000000000001 110.946 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 386' ' ' ARG . 68.0 mt -62.97 -83.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.227 -0.442 . . . . 1.1200000000000001 111.179 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -157.98 32.03 0.51 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.489 -0.862 . . . . 1.3600000000000001 112.825 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 48.98 40.99 28.45 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.924 -0.655 . . . . 1.8300000000000001 112.515 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' ILE . . . . . 0.46 ' HA ' ' HB ' ' A' ' 392' ' ' VAL . 45.6 mm . . . . . 0 C--N 1.325 -0.464 0 N-CA-C 110.178 -0.305 . . . . 1.48 110.178 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.514 ' HB ' HH12 ' A' ' 429' ' ' ARG . 86.4 mt . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 120.93 0.395 . . . . 1.48 111.836 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.06 129.72 44.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.87 -0.605 . . . . 2.1699999999999999 110.041 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.451 HD13 ' C ' ' A' ' 398' ' ' LEU . 82.9 mt -68.32 -45.24 82.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.493 -0.321 . . . . 0.92000000000000004 111.842 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 69.0 m -70.15 62.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.692 -0.685 . . . . 1.71 110.848 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -147.52 -33.71 0.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.737 -0.665 . . . . 1.9199999999999999 110.0 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.474 ' ND2' ' HD2' ' A' ' 381' ' ' LYS . 12.3 p30 -173.0 65.7 0.34 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.132 -0.94 . . . . 2.1400000000000001 110.959 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.6 -38.44 55.04 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.457 2.104 . . . . 0.84999999999999998 111.859 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.04 -36.99 83.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 1.21 110.593 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.474 ' HD2' ' ND2' ' A' ' 378' ' ' ASN . 62.3 tttp -51.64 140.45 18.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.016 -0.538 . . . . 1.6599999999999999 110.844 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.583 HG21 ' HD2' ' A' ' 394' ' ' ARG . 49.8 mm -86.23 128.89 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.40999999999999998 111.537 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -105.28 144.76 31.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.63 110.378 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.604 ' CD2' HD11 ' A' ' 442' ' ' ILE . 1.8 m-30 -90.5 133.5 35.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.446 -0.343 . . . . 0.95999999999999996 110.633 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 385' ' ' ILE . 3.0 mp -128.94 128.98 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.799 0.333 . . . . 0.48999999999999999 111.145 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 58.1 ttt-85 -92.73 123.24 35.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 2.4199999999999999 111.193 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -71.05 158.16 36.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.367 -0.379 . . . . 2.2999999999999998 110.162 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -49.53 -35.59 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 2.8199999999999998 110.828 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.97 -36.24 69.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 1.23 111.666 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.535 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 135.99 -35.17 2.17 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.378 -0.915 . . . . 1.03 113.126 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 68.7 p -58.67 112.36 1.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 0.97999999999999998 112.207 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.39 144.92 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.186 -0.916 . . . . 0.55000000000000004 111.225 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -150.48 139.74 21.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.161 -0.472 . . . . 2.4300000000000002 110.959 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.583 ' HD2' HG21 ' A' ' 382' ' ' ILE . 66.2 mtm-85 -60.07 151.29 27.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.87 -0.605 . . . . 2.96 112.168 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -169.62 135.13 3.43 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.434 -0.803 . . . . 0.26000000000000001 111.823 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -91.97 111.57 23.16 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.304 0.483 . . . . 1.28 112.304 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.747 HG22 HD13 ' A' ' 432' ' ' ILE . 24.4 t -76.43 132.87 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.483 -0.326 . . . . 0.82999999999999996 110.383 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.451 ' C ' HD13 ' A' ' 375' ' ' ILE . 96.0 mt -121.33 -42.92 2.43 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.735 0.643 . . . . 1.45 112.735 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.548 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 30.1 mm100 -129.18 177.46 7.14 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.212 0.53 . . . . 2.0800000000000001 112.208 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.0 p -153.35 157.3 39.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.454 -0.794 . . . . 0.56000000000000005 110.043 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 33.2 ptt180 -154.09 137.09 15.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.08 0.467 . . . . 1.55 112.258 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 409' ' ' PRO . 36.4 p -96.31 136.07 37.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 1.79 110.036 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.839 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.6 m -62.75 -174.52 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.469 -0.332 . . . . 1.95 110.622 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.839 ' H ' HG22 ' A' ' 403' ' ' THR . 64.9 mm-40 -53.13 -40.07 63.95 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.721 0.267 . . . . 3.8700000000000001 111.721 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.72 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 26.0 t-20 -55.95 -51.01 69.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 3.1600000000000001 110.994 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 53.49 55.96 7.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.079 0.466 . . . . 2.1800000000000002 111.89 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.554 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -160.55 10.86 0.1 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.727 -0.669 . . . . 2.77 109.456 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.594 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.64 -48.06 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.611 -1.177 . . . . 2.7599999999999998 110.213 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.72 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 38.2 Cg_exo -61.04 138.14 76.5 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.736 2.291 . . . . 2.4900000000000002 112.701 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 13.6 p-10 -173.39 123.31 0.38 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.909 -0.587 . . . . 2.1400000000000001 111.09 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 400' ' ' SER . 58.3 mp0 -112.51 142.34 45.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.774 -0.648 . . . . 2.1000000000000001 110.284 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.714 ' HB2' HD12 ' A' ' 432' ' ' ILE . 1.2 m-85 -109.03 124.17 50.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.019 0.438 . . . . 0.71999999999999997 111.804 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.548 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 18.8 t80 -62.19 150.16 39.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.722 -0.672 . . . . 0.51000000000000001 109.409 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.442 HG21 HG12 ' A' ' 385' ' ' ILE . 7.3 p -150.92 132.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.286 0.565 . . . . 1.1499999999999999 112.193 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -110.74 90.98 3.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.268 -0.878 . . . . 0.62 109.596 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.525 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 14.3 m-85 -53.03 135.68 36.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.094 0.473 . . . . 0.65000000000000002 111.25 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 418' ' ' GLY . 17.6 t -63.67 -124.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.454 -0.794 . . . . 1.3400000000000001 111.417 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.563 ' N ' HG12 ' A' ' 417' ' ' VAL . . . -39.7 -29.41 0.16 Allowed Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.248 0.459 . . . . 0.81999999999999995 114.248 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.664 ' HB3' HD23 ' A' ' 423' ' ' LEU . 7.1 mp -58.79 141.31 53.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.244 0.522 . . . . 1.6000000000000001 110.955 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.431 ' HB3' ' HG2' ' A' ' 422' ' ' ARG . 10.9 t-20 -55.42 154.89 5.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.966 -0.561 . . . . 2.5299999999999998 111.286 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 68.5 mtt-85 -53.35 -29.81 36.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.663 -0.699 . . . . 3.98 112.152 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' ARG . . . . . 0.582 ' HG3' HD13 ' A' ' 423' ' ' LEU . 16.8 ptm180 -52.65 -40.7 63.08 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.956 0.354 . . . . 3.71 111.956 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.664 HD23 ' HB3' ' A' ' 419' ' ' LEU . 1.1 mm? -71.05 -35.09 71.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.713 0.292 . . . . 1.49 111.028 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.27 130.51 46.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 1.2 111.427 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.67 -145.67 9.19 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.69999999999999996 112.012 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -100.36 140.22 34.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.60999999999999999 110.946 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.454 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 28.5 m -140.26 145.72 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.89000000000000001 110.971 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -59.83 147.55 43.54 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.914 -0.584 . . . . 1.72 113.361 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.514 HH12 ' HB ' ' A' ' 373' ' ' ILE . 15.4 tpt180 -50.93 -38.92 53.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.654 0.381 . . . . 1.73 111.72 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.439 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 24.8 p-80 -57.87 -28.83 64.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.092 0.404 . . . . 1.47 112.092 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.8 mtt180 -78.35 -38.62 41.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.993 0.368 . . . . 2.8399999999999999 111.993 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.747 HD13 HG22 ' A' ' 397' ' ' VAL . 60.1 mt -88.01 133.27 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.898 0.38 . . . . 0.46000000000000002 110.893 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.745 ' HB2' HD11 ' A' ' 439' ' ' LEU . 58.0 m -165.11 145.71 7.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.736 -0.665 . . . . 0.53000000000000003 110.806 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' ASP . . . . . 0.493 ' H ' HD11 ' A' ' 373' ' ' ILE . 52.0 p-10 -71.28 16.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 1.3500000000000001 111.911 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 433' ' ' SER . 0.5 OUTLIER -165.8 133.93 3.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 2.1600000000000001 111.095 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 436' ' ' ALA . . . . . 0.492 ' HB2' ' HD2' ' A' ' 384' ' ' PHE . . . -68.66 -13.27 62.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 0.75 111.949 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.41 -41.08 72.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.686 0.279 . . . . 1.3400000000000001 111.363 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.47 -6.46 58.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 1.5600000000000001 111.48 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.5 mp -96.68 -93.28 0.22 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.245 -0.434 . . . . 1.1200000000000001 111.598 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -171.56 38.27 0.17 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.776 -0.726 . . . . 1.3600000000000001 112.485 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.98 138.84 0.05 OUTLIER Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.865 -0.683 . . . . 1.8300000000000001 112.812 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' ILE . . . . . 0.604 HD11 ' CD2' ' A' ' 384' ' ' PHE . 43.2 mm . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 109.126 -0.694 . . . . 1.48 109.126 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.434 HG13 ' HE ' ' A' ' 429' ' ' ARG . 68.1 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.814 0.34 . . . . 1.48 110.767 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.534 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 0.9 OUTLIER -88.21 69.86 9.2 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.152 -0.476 . . . . 2.1699999999999999 110.859 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 377' ' ' GLU . 61.7 mt -45.86 -44.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.92000000000000004 111.709 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 73.1 m -63.1 73.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 1.71 111.559 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.4 pt-20 -173.97 -31.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 1.9199999999999999 110.482 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.433 ' N ' ' HD3' ' A' ' 379' ' ' PRO . 39.7 p30 -152.99 58.16 2.3 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.53 . . . . 2.1400000000000001 111.606 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 379' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 50.3 Cg_exo -53.03 -37.6 79.1 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.283 1.989 . . . . 0.84999999999999998 111.504 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.1 -34.19 75.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.7 -0.682 . . . . 1.21 110.695 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -53.38 123.22 11.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.191 -0.458 . . . . 1.6599999999999999 110.784 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 417' ' ' VAL . 45.8 mm -84.91 128.92 38.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 0.40999999999999998 111.38 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -106.93 143.38 35.11 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.069 -0.345 . . . . 0.63 110.069 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.76 ' HB2' HD11 ' A' ' 439' ' ' LEU . 5.2 m-85 -89.78 139.35 30.66 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.807 -0.357 . . . . 0.95999999999999996 110.192 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.726 HG12 HG21 ' A' ' 414' ' ' VAL . 2.6 mp -115.25 129.51 71.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.255 -0.429 . . . . 0.48999999999999999 111.829 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.76 ' CZ ' HG23 ' A' ' 392' ' ' VAL . 5.2 tpm_? -88.25 90.14 8.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.865 -0.607 . . . . 2.4199999999999999 110.176 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.616 ' HA ' ' NH2' ' A' ' 431' ' ' ARG . 58.1 mtp85 -55.88 153.6 8.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.725 0.297 . . . . 2.2999999999999998 110.816 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.76 -44.76 77.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.212 -0.449 . . . . 2.8199999999999998 111.318 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -58.27 -14.86 8.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.263 0.554 . . . . 1.23 109.749 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 91.66 39.77 5.49 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.176 -0.92 . . . . 1.03 112.561 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' THR . . . . . 0.46 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 70.8 p -121.91 110.19 15.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.591 0.234 . . . . 0.97999999999999998 110.917 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.76 HG23 ' CZ ' ' A' ' 386' ' ' ARG . 63.4 t -70.97 132.71 32.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.628 0.252 . . . . 0.55000000000000004 110.348 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -151.31 135.35 16.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.893 0.378 . . . . 2.4300000000000002 110.582 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.445 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 71.2 mtt-85 -52.85 151.8 4.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.862 -0.608 . . . . 2.96 112.135 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -170.16 131.51 2.26 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.204 -0.907 . . . . 0.26000000000000001 111.411 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' GLN . . . . . 0.413 ' HG2' HD13 ' A' ' 382' ' ' ILE . 80.1 mt-30 -87.14 128.97 35.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.769 0.318 . . . . 1.28 111.734 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.838 HG22 HD13 ' A' ' 432' ' ' ILE . 8.7 t -89.71 132.95 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.462 -0.57 . . . . 0.82999999999999996 109.462 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 68.2 mt -120.34 -37.32 3.06 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.51 0.559 . . . . 1.45 112.51 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -139.46 175.96 9.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.479 . . . . 2.0800000000000001 112.13 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.5 p -163.85 149.44 10.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.577 -0.738 . . . . 0.56000000000000005 110.344 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -158.05 136.85 11.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.869 0.366 . . . . 1.55 111.5 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 63.1 p -77.65 -128.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.356 -0.384 . . . . 1.79 109.969 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.72 HG22 ' H ' ' A' ' 404' ' ' GLU . 0.5 OUTLIER -164.84 -173.41 2.96 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 110.214 -0.291 . . . . 1.95 110.214 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.72 ' H ' HG22 ' A' ' 403' ' ' THR . 94.7 mt-10 -44.9 -45.21 10.22 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.659 0.266 . . . . 3.8700000000000001 111.588 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -66.75 -51.45 55.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.529 -0.305 . . . . 3.1600000000000001 110.953 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 52.97 52.92 12.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.131 0.491 . . . . 2.1800000000000002 111.469 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.507 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -150.66 10.75 0.65 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.694 -0.684 . . . . 2.77 109.688 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.562 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.48 -47.6 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 114.585 -1.189 . . . . 2.7599999999999998 110.055 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 31.9 Cg_exo -58.8 143.59 99.0 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.463 2.108 . . . . 2.4900000000000002 112.447 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.64 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 42.5 p-10 -176.26 136.07 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.796 -0.638 . . . . 2.1400000000000001 110.804 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.5 mt-10 -130.96 134.18 46.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 2.1000000000000001 110.342 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 2.4 m-85 -112.32 127.48 56.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.377 . . . . 0.71999999999999997 111.671 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -64.76 144.78 57.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.437 -0.579 . . . . 0.51000000000000001 109.437 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.726 HG21 HG12 ' A' ' 385' ' ' ILE . 6.4 p -143.99 129.83 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.43 0.633 . . . . 1.1499999999999999 112.625 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -111.86 89.22 3.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.929 -1.032 . . . . 0.62 109.123 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.547 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 30.0 m-85 -52.49 115.6 1.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 0.65000000000000002 110.941 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.634 HG21 HD12 ' A' ' 382' ' ' ILE . 62.1 t -62.47 130.13 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.853 -0.612 . . . . 1.3400000000000001 110.875 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.81 -42.6 2.5 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.98 -0.628 . . . . 0.81999999999999995 112.798 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.527 ' HB3' HD22 ' A' ' 423' ' ' LEU . 2.7 mm? -59.6 159.43 8.45 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.92 0.39 . . . . 1.6000000000000001 111.668 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 69.1 m-20 -53.83 142.86 22.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.79 -0.641 . . . . 2.5299999999999998 111.383 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -60.73 -36.65 79.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 3.98 111.196 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -56.37 -32.15 64.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.355 -0.384 . . . . 3.71 111.0 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 419' ' ' LEU . 1.1 tp -56.4 -29.78 61.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 1.49 111.351 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.57 140.23 11.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.085 0.469 . . . . 1.2 111.824 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -174.82 -149.83 7.43 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.681 -0.691 . . . . 0.69999999999999996 112.097 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -127.46 133.08 49.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.60999999999999999 110.808 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.838 HG21 HG13 ' A' ' 432' ' ' ILE . 5.1 m -109.43 153.17 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.955 -0.566 . . . . 0.89000000000000001 111.049 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -76.97 29.98 1.57 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.434 -0.888 . . . . 1.72 112.455 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.764 ' H ' HG23 ' A' ' 427' ' ' VAL . 39.2 tpt85 71.88 -37.41 0.39 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.181 0.437 . . . . 1.73 112.181 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -58.83 -27.36 65.04 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.712 0.264 . . . . 1.47 111.712 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.616 ' NH2' ' HA ' ' A' ' 387' ' ' ARG . 81.2 mtp180 -78.56 -38.37 40.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.958 0.355 . . . . 2.8399999999999999 111.958 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.838 HD13 HG22 ' A' ' 397' ' ' VAL . 73.2 mt -88.44 131.41 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 0.46000000000000002 110.37 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 49.0 m -154.87 139.6 17.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.006 0.432 . . . . 0.53000000000000003 111.631 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.41 -25.4 67.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.615 . . . . 1.3500000000000001 110.349 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -108.56 134.13 51.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.837 -0.619 . . . . 2.1600000000000001 110.286 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -69.26 -42.91 74.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.023 -0.535 . . . . 0.75 112.298 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -57.63 -40.54 79.45 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.584 0.216 . . . . 1.3400000000000001 111.584 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -56.3 -35.06 67.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 1.5600000000000001 110.471 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 384' ' ' PHE . 86.4 mt -57.29 -82.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.775 -0.648 . . . . 1.1200000000000001 111.184 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 440' ' ' GLY . . . . . 0.529 ' HA3' HH11 ' A' ' 386' ' ' ARG . . . -168.35 -27.98 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.05 -0.595 . . . . 1.3600000000000001 112.138 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 154.44 143.08 3.59 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.104 -0.57 . . . . 1.8300000000000001 112.117 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 44.7 mm . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.989 0.423 . . . . 1.48 110.884 179.771 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.695 0.283 . . . . 1.48 110.76 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.75 128.94 35.64 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 116.265 -0.425 . . . . 2.1699999999999999 110.727 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.69 HD11 HG12 ' A' ' 397' ' ' VAL . 95.7 mt -91.74 -33.83 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.145 -0.48 . . . . 0.92000000000000004 110.901 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.4 t -72.05 62.36 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.042 -0.526 . . . . 1.71 111.057 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -168.24 -26.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.695 -0.684 . . . . 1.9199999999999999 109.874 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.645 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 60.0 m-20 -156.63 62.41 2.86 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.347 -0.842 . . . . 2.1400000000000001 111.517 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 379' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 79.0 Cg_exo -52.68 -41.21 70.69 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.998 2.465 . . . . 0.84999999999999998 112.8 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -70.01 -32.85 71.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.226 -0.443 . . . . 1.21 111.78 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.645 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.0 tttm -44.52 127.09 5.8 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.931 0.396 . . . . 1.6599999999999999 110.967 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.695 HD12 HG21 ' A' ' 417' ' ' VAL . 41.0 mm -86.91 127.07 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.40999999999999998 111.406 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -107.72 144.0 35.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 0.63 110.004 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.457 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 3.9 m-85 -91.29 138.27 31.72 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.081 -0.247 . . . . 0.95999999999999996 110.833 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.8 mp -121.37 126.99 75.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.449 -0.341 . . . . 0.48999999999999999 110.87 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 38.4 ttt85 -91.57 122.53 34.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 2.4199999999999999 111.032 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -83.23 172.19 12.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.744 0.307 . . . . 2.2999999999999998 110.695 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -53.05 -71.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 2.8199999999999998 111.045 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -40.99 -31.64 0.19 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.068 0.461 . . . . 1.23 110.565 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 111.14 39.48 1.38 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.795 -0.639 . . . . 1.03 112.986 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 39.7 p -114.02 111.04 21.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.95 0.405 . . . . 0.97999999999999998 110.976 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 439' ' ' LEU . 46.1 t -72.53 140.74 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.55000000000000004 111.39 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -148.14 134.34 19.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.582 . . . . 2.4300000000000002 110.42 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.584 ' HD2' HG21 ' A' ' 382' ' ' ILE . 83.0 mtm180 -58.43 150.37 22.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.074 0.464 . . . . 2.96 111.94 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -172.73 132.05 2.27 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.638 -0.71 . . . . 0.26000000000000001 112.254 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -91.72 111.61 23.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.577 0.227 . . . . 1.28 111.607 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.715 HG22 HD13 ' A' ' 432' ' ' ILE . 8.7 t -66.49 134.12 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.927 -0.397 . . . . 0.82999999999999996 109.927 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 91.6 mt -119.07 -44.49 2.6 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.907 0.336 . . . . 1.45 111.907 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.555 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 84.0 mt-30 -124.5 174.33 7.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.991 0.424 . . . . 2.0800000000000001 111.645 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 87.7 p -165.88 144.95 6.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.78 -0.645 . . . . 0.56000000000000005 110.351 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.503 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 41.2 ptt180 -156.97 134.89 10.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.003 0.43 . . . . 1.55 111.448 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 14.1 p -85.99 38.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.942 -0.572 . . . . 1.79 111.041 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.841 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.8 m 51.75 -173.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.545 -0.298 . . . . 1.95 110.272 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.841 ' H ' HG22 ' A' ' 403' ' ' THR . 8.4 mp0 -54.87 -49.52 70.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.721 0.296 . . . . 3.8700000000000001 110.631 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -87.21 115.09 24.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.302 -0.408 . . . . 3.1600000000000001 110.727 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -94.91 51.84 1.41 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.832 0.349 . . . . 2.1800000000000002 111.293 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -124.98 -11.52 7.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 2.77 111.215 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.635 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -161.84 -50.48 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.868 -0.606 . . . . 2.7599999999999998 111.107 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 72.1 Cg_exo -50.17 152.06 8.43 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.498 2.132 . . . . 2.4900000000000002 112.621 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 44.0 p-10 -175.74 137.22 0.34 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.093 -0.503 . . . . 2.1400000000000001 111.134 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -150.16 135.9 18.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 2.1000000000000001 110.497 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.746 ' HB2' HD12 ' A' ' 432' ' ' ILE . 2.1 m-85 -115.66 126.48 54.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.45 -0.341 . . . . 0.71999999999999997 111.358 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 426' ' ' TRP . 12.8 t80 -65.78 142.78 57.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.195 -0.457 . . . . 0.51000000000000001 110.32 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.637 HG22 HD11 ' A' ' 432' ' ' ILE . 20.1 t -128.33 136.87 58.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 112.546 0.573 . . . . 1.1499999999999999 112.546 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -120.88 89.87 3.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.62 109.943 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.617 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 50.0 m-85 -56.5 129.25 39.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.65000000000000002 111.19 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.695 HG21 HD12 ' A' ' 382' ' ' ILE . 2.8 t -82.98 34.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.782 -0.644 . . . . 1.3400000000000001 111.259 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -178.4 -41.44 0.07 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.455 -0.879 . . . . 0.81999999999999995 113.103 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.617 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 2.2 mm? -59.77 156.77 13.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.84 0.352 . . . . 1.6000000000000001 111.081 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -49.72 144.55 6.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.021 -0.536 . . . . 2.5299999999999998 111.77 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -56.83 -39.4 74.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.88 -0.6 . . . . 3.98 111.092 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 41.4 ptt85 -62.26 -32.15 72.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.895 0.378 . . . . 3.71 110.702 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.67 -32.38 72.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.974 -0.557 . . . . 1.49 111.056 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -48.16 129.1 14.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.301 -0.409 . . . . 1.2 110.448 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.95 165.59 35.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.53 -0.843 . . . . 0.69999999999999996 112.487 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' TRP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 8.3 m95 -74.42 128.49 35.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.739 0.304 . . . . 0.60999999999999999 110.496 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.467 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 4.4 m -119.89 152.68 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.89000000000000001 110.819 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -56.87 148.59 31.55 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.954 -0.641 . . . . 1.72 112.825 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -50.2 -42.16 50.97 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.567 0.347 . . . . 1.73 111.844 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.444 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 22.2 p-80 -54.81 -28.54 50.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.289 0.477 . . . . 1.47 112.289 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.3 mtt180 -78.59 -38.3 40.36 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.601 0.593 . . . . 2.8399999999999999 112.601 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.746 HD12 ' HB2' ' A' ' 412' ' ' TYR . 68.8 mt -88.6 130.65 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 120.601 -0.44 . . . . 0.46000000000000002 111.009 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.758 ' HB2' HD11 ' A' ' 439' ' ' LEU . 44.6 m -168.11 140.42 3.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.837 -0.62 . . . . 0.53000000000000003 110.949 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -66.02 -15.53 63.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.015 -0.539 . . . . 1.3500000000000001 111.278 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.469 ' O ' HD13 ' A' ' 439' ' ' LEU . 5.8 m120 -108.48 130.9 55.25 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.841 0.353 . . . . 2.1600000000000001 110.851 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 441' ' ' GLY . . . -74.74 -34.75 62.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.75 112.03 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.03 -40.56 67.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.425 -0.352 . . . . 1.3400000000000001 111.641 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 435' ' ' ASN . 61.9 m-20 -64.11 -21.21 66.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 1.5600000000000001 111.369 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.758 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.7 mp -93.94 -88.65 0.23 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.097 -0.501 . . . . 1.1200000000000001 111.917 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 440' ' ' GLY . . . . . 0.521 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -164.43 49.92 0.29 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.021 -0.609 . . . . 1.3600000000000001 112.157 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.475 ' O ' ' HB1' ' A' ' 436' ' ' ALA . . . 69.19 -129.61 23.49 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.59 -0.814 . . . . 1.8300000000000001 112.375 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 442' ' ' ILE . . . . . 0.426 HD13 ' O ' ' A' ' 441' ' ' GLY . 43.3 mm . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 120.829 0.347 . . . . 1.48 110.651 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.678 HG12 ' CZ ' ' A' ' 429' ' ' ARG . 49.5 mm . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.888 0.375 . . . . 1.48 111.939 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -102.59 130.87 49.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.902 -0.59 . . . . 2.1699999999999999 109.996 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 77.5 mt -81.22 -42.28 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.42 0.526 . . . . 0.92000000000000004 112.42 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 41.5 t -47.93 -22.75 0.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.137 0.494 . . . . 1.71 111.308 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -54.77 -47.67 73.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.408 -0.815 . . . . 1.9199999999999999 111.118 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 379' ' ' PRO . 60.0 m-20 -167.06 112.9 0.67 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.833 -0.621 . . . . 2.1400000000000001 110.979 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 379' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 378' ' ' ASN . 12.2 Cg_exo -71.5 -41.05 2.56 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.826 2.35 . . . . 0.84999999999999998 112.699 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.407 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 55.3 m-20 -80.94 -34.24 33.39 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.125 0.417 . . . . 1.21 112.125 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 86.4 tttt -44.82 124.98 4.69 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.765 0.317 . . . . 1.6599999999999999 111.413 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.96 HD12 HG21 ' A' ' 417' ' ' VAL . 11.4 mm -77.99 131.05 35.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.132 -0.486 . . . . 0.40999999999999998 111.854 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -111.35 144.15 41.0 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.781 -0.452 . . . . 0.63 109.781 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.425 ' C ' HD12 ' A' ' 385' ' ' ILE . 46.9 m-85 -89.69 134.74 34.0 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.852 -0.339 . . . . 0.95999999999999996 110.899 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.6 mp -119.47 132.86 68.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.262 -0.426 . . . . 0.48999999999999999 110.899 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.626 ' N ' HD23 ' A' ' 439' ' ' LEU . 50.3 ttt-85 -93.92 115.78 28.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.672 0.272 . . . . 2.4199999999999999 110.819 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -76.56 157.04 32.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.524 -0.307 . . . . 2.2999999999999998 110.554 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -53.9 -44.95 70.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.581 -0.281 . . . . 2.8199999999999998 111.086 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -54.9 -27.35 42.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.253 0.549 . . . . 1.23 109.597 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 103.13 38.5 2.86 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.34 -0.845 . . . . 1.03 113.183 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 69.1 p -121.07 112.15 18.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.97999999999999998 111.455 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.33 132.28 33.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.55000000000000004 110.351 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -146.5 135.89 22.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.021 0.439 . . . . 2.4300000000000002 111.22 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.541 ' HD3' HG21 ' A' ' 382' ' ' ILE . 74.0 mtt-85 -53.84 153.67 4.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.722 -0.672 . . . . 2.96 111.875 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 415' ' ' HIS . . . -179.59 130.74 1.55 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.763 -0.653 . . . . 0.26000000000000001 112.192 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 75.5 mt-30 -91.82 134.11 35.04 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.99 0.395 . . . . 1.28 111.885 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.873 HG22 HD13 ' A' ' 432' ' ' ILE . 5.2 t -87.4 133.28 30.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.23 -0.441 . . . . 0.82999999999999996 110.722 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 85.0 mt -121.16 -46.75 2.29 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.075 0.398 . . . . 1.45 112.075 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.555 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 13.5 mm100 -127.07 176.84 7.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.916 0.389 . . . . 2.0800000000000001 111.647 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 87.9 p -162.42 139.56 8.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.79 -0.641 . . . . 0.56000000000000005 110.92 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.677 ' HD3' ' O ' ' A' ' 401' ' ' ARG . 0.1 OUTLIER -148.39 138.64 22.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 1.55 110.906 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.742 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 13.9 m -103.33 42.25 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 1.79 110.096 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.9 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.5 m 51.27 -173.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.736 -0.665 . . . . 1.95 110.648 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.9 ' H ' HG22 ' A' ' 403' ' ' THR . 95.6 mt-10 -63.98 -37.16 86.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 3.8700000000000001 110.69 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.681 ' HB2' ' HG2' ' A' ' 409' ' ' PRO . 5.1 m120 -56.25 -51.99 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.598 . . . . 3.1600000000000001 111.442 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.648 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.33 56.43 5.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 2.1800000000000002 110.863 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -161.9 -3.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 2.77 111.04 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.553 ' H ' ' CD ' ' A' ' 409' ' ' PRO . . . -169.54 -44.54 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.71 -0.677 . . . . 2.7599999999999998 111.649 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.681 ' HG2' ' HB2' ' A' ' 405' ' ' ASN . 15.7 Cg_exo -69.79 47.85 0.59 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.825 2.35 . . . . 2.4900000000000002 113.87 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.742 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 47.2 p-10 -68.59 143.84 54.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.908 0.385 . . . . 2.1400000000000001 110.893 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 50.6 mt-10 -148.72 146.69 28.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.016 -0.538 . . . . 2.1000000000000001 110.423 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -127.06 125.28 41.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.913 0.387 . . . . 0.71999999999999997 111.688 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.555 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 20.2 t80 -63.47 149.99 44.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.045 -0.724 . . . . 0.51000000000000001 109.045 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.542 HG21 HG12 ' A' ' 385' ' ' ILE . 7.8 p -158.83 133.32 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.016 0.747 . . . . 1.1499999999999999 113.016 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 415' ' ' HIS . . . . . 0.578 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 76.2 t60 -105.06 106.24 16.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.03 -0.987 . . . . 0.62 109.167 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 2.1 m-85 -62.19 100.63 0.18 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.55 0.691 . . . . 0.65000000000000002 109.939 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.96 HG21 HD12 ' A' ' 382' ' ' ILE . 44.2 t -48.63 123.74 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.555 -1.202 . . . . 1.3400000000000001 111.75 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 83.07 -33.37 2.91 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.183 -0.917 . . . . 0.81999999999999995 113.409 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.657 ' HB3' HD12 ' A' ' 423' ' ' LEU . 8.9 mt -68.23 -173.6 0.42 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.42 0.629 . . . . 1.6000000000000001 112.456 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.739 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 5.2 m120 -74.3 145.85 43.62 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 114.961 -1.018 . . . . 2.5299999999999998 111.053 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' ARG . . . . . 0.464 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 45.1 mtp85 -65.21 -39.24 92.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.22 -0.446 . . . . 3.98 111.348 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -57.44 -35.71 70.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.742 0.306 . . . . 3.71 111.122 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.739 ' HG ' ' HB2' ' A' ' 420' ' ' ASN . 85.4 mt -56.94 -33.94 67.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 1.49 111.191 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.578 ' OD1' ' HA ' ' A' ' 415' ' ' HIS . 39.8 m-20 -52.94 141.87 20.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.521 . . . . 1.2 111.759 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -171.85 -142.06 3.59 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.644 -0.707 . . . . 0.69999999999999996 111.954 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -124.29 138.07 54.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.018 0.437 . . . . 0.60999999999999999 110.715 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.829 HG21 HG13 ' A' ' 432' ' ' ILE . 15.7 m -109.08 158.58 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.925 -0.58 . . . . 0.89000000000000001 111.844 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -81.61 39.98 2.57 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.882 -0.675 . . . . 1.72 113.009 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.678 ' CZ ' HG12 ' A' ' 373' ' ' ILE . 38.4 tpt85 68.56 -72.4 0.1 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.492 0.553 . . . . 1.73 112.492 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -47.2 -15.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 1.47 113.053 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.564 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 99.5 mtt180 -78.29 -35.55 47.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.723 0.268 . . . . 2.8399999999999999 111.723 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 397' ' ' VAL . 97.4 mt -88.45 132.23 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.46000000000000002 111.16 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.683 ' HB2' HD11 ' A' ' 439' ' ' LEU . 75.0 m -166.06 139.29 4.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.855 -0.611 . . . . 0.53000000000000003 110.779 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -61.86 -23.15 66.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 1.3500000000000001 111.095 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.446 ' HB2' ' OD2' ' A' ' 438' ' ' ASP . 31.6 m120 -108.44 131.69 54.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.916 0.389 . . . . 2.1600000000000001 110.909 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -75.82 -31.96 59.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.75 111.915 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.66 -40.55 62.95 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.453 -0.34 . . . . 1.3400000000000001 111.462 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' ASP . . . . . 0.446 ' OD2' ' HB2' ' A' ' 435' ' ' ASN . 57.6 m-20 -61.96 -23.6 66.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 1.5600000000000001 111.091 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.5 mp -91.61 -84.63 0.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.82 -0.627 . . . . 1.1200000000000001 112.313 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -158.81 57.02 0.34 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.462 -0.875 . . . . 1.3600000000000001 112.995 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.68 -129.03 30.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.636 -0.793 . . . . 1.8300000000000001 112.841 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 46.2 mm . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.395 0.14 . . . . 1.48 110.912 -179.529 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 76.4 mt . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 121.17 0.51 . . . . 1.48 111.905 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 42.7 m-20 -89.47 77.36 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.833 -0.621 . . . . 2.1699999999999999 110.923 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.4 mt -48.36 -41.2 10.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 0.92000000000000004 111.648 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 77.9 p -64.94 76.14 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.545 . . . . 1.71 111.687 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 16.2 pt-20 -174.69 -27.62 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.862 -0.608 . . . . 1.9199999999999999 110.242 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.598 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 59.1 m-20 -156.14 62.3 2.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.691 -0.686 . . . . 2.1400000000000001 112.235 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.14 -40.97 75.36 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.778 2.319 . . . . 0.84999999999999998 112.542 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -70.86 -34.41 71.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.041 -0.527 . . . . 1.21 111.722 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 86.2 tttt -43.03 129.73 4.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.981 0.42 . . . . 1.6599999999999999 111.028 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.508 HG21 ' HD2' ' A' ' 394' ' ' ARG . 46.8 mm -81.64 123.26 37.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.854 -0.612 . . . . 0.40999999999999998 111.448 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -102.02 143.41 31.9 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.922 -0.399 . . . . 0.63 109.922 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.84 139.2 30.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.587 -0.279 . . . . 0.95999999999999996 110.798 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.601 ' N ' HD12 ' A' ' 385' ' ' ILE . 1.7 mp -131.94 133.45 60.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.69 0.281 . . . . 0.48999999999999999 111.168 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.634 ' CZ ' ' HA3' ' A' ' 440' ' ' GLY . 8.1 tpt180 -90.41 121.71 32.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 2.4199999999999999 110.585 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -74.53 164.22 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 2.2999999999999998 110.556 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 388' ' ' GLU . 8.7 mp0 -61.3 -45.32 94.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.335 -0.393 . . . . 2.8199999999999998 110.825 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -61.47 -12.88 16.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.133 0.492 . . . . 1.23 110.058 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.453 ' C ' ' HE ' ' A' ' 386' ' ' ARG . . . 90.78 41.78 5.26 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.409 -0.814 . . . . 1.03 112.53 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 82.8 p -121.35 112.64 18.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.679 0.276 . . . . 0.97999999999999998 111.352 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 59.4 t -68.43 134.2 30.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 0.55000000000000004 110.711 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -149.65 137.63 20.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 2.4300000000000002 110.989 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.508 ' HD2' HG21 ' A' ' 382' ' ' ILE . 77.9 mtm180 -60.79 152.53 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 2.96 111.531 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -171.01 126.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.771 -0.65 . . . . 0.26000000000000001 112.295 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 57.0 mt-30 -78.8 130.15 35.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.724 0.297 . . . . 1.28 111.514 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.7 OUTLIER -98.85 126.87 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.61 -0.515 . . . . 0.82999999999999996 109.61 178.479 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.708 ' N ' HD22 ' A' ' 398' ' ' LEU . 0.4 OUTLIER -115.05 -47.21 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.534 0.568 . . . . 1.45 112.534 -177.215 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.426 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 80.8 mt-30 -127.71 176.41 7.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 2.0800000000000001 111.726 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 84.7 p -165.47 141.93 5.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.784 -0.644 . . . . 0.56000000000000005 110.967 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.491 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 41.0 ptt180 -142.88 135.23 27.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.346 -0.388 . . . . 1.55 110.772 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.69 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 24.9 p -81.92 40.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 1.79 112.159 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.8 m 50.58 -173.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.506 -0.183 . . . . 1.95 110.506 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.88 ' H ' HG22 ' A' ' 403' ' ' THR . 48.6 mt-10 -56.73 -50.02 73.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.321 . . . . 3.8700000000000001 110.446 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -83.73 117.85 23.51 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.296 -0.411 . . . . 3.1600000000000001 110.613 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -101.43 76.68 1.71 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.964 0.411 . . . . 2.1800000000000002 111.326 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -160.68 10.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 2.77 110.65 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.696 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.52 -51.61 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.609 -0.723 . . . . 2.7599999999999998 110.903 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 49.9 Cg_exo -57.07 154.11 35.16 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.689 2.259 . . . . 2.4900000000000002 113.028 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.69 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 44.2 p-10 -178.62 130.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.852 -0.613 . . . . 2.1400000000000001 111.081 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 400' ' ' SER . 58.9 mp0 -136.85 135.28 37.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.85 -0.614 . . . . 2.1000000000000001 109.933 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 412' ' ' TYR . 0.4 OUTLIER -110.91 130.17 55.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 0.71999999999999997 111.897 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 14.6 t80 -65.03 141.62 58.7 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.516 -0.92 . . . . 0.51000000000000001 108.516 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 6.4 p -147.72 110.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.608 0.966 . . . . 1.1499999999999999 113.608 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -86.44 90.94 8.37 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.531 -0.759 . . . . 0.62 109.344 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 424' ' ' ASP . 35.6 m-85 -52.84 128.71 27.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.055 0.455 . . . . 0.65000000000000002 111.394 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 86.2 t -73.2 127.81 35.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.748 -0.66 . . . . 1.3400000000000001 111.166 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.34 -44.91 2.25 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.985 -0.626 . . . . 0.81999999999999995 113.022 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.525 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.7 mp -59.7 148.98 32.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.861 0.362 . . . . 1.6000000000000001 111.204 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -54.47 137.72 42.01 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.948 -0.569 . . . . 2.5299999999999998 111.798 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -32.31 50.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.655 -0.702 . . . . 3.98 111.368 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 422' ' ' ARG . . . . . 0.58 HH11 HD23 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -54.79 -38.85 67.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 3.71 110.52 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.58 HD23 HH11 ' A' ' 422' ' ' ARG . 96.5 mt -65.55 -35.44 80.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.019 0.438 . . . . 1.49 110.54 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.432 ' HA ' ' CD1' ' A' ' 416' ' ' TYR . 16.8 m-20 -54.84 138.32 43.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.654 -0.703 . . . . 1.2 111.602 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -179.46 -141.68 4.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.715 -0.675 . . . . 0.69999999999999996 111.938 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' TRP . . . . . 0.491 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 53.4 m95 -106.2 140.28 39.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.60999999999999999 110.695 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.538 ' CG2' HD11 ' A' ' 432' ' ' ILE . 17.1 m -132.88 141.73 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.89000000000000001 111.953 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -64.99 150.96 51.66 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.855 -0.611 . . . . 1.72 112.525 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.407 ' HD3' ' CZ ' ' A' ' 412' ' ' TYR . 41.0 tpt85 -51.74 -38.28 54.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.771 0.319 . . . . 1.73 111.269 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.574 ' ND1' ' HG3' ' A' ' 431' ' ' ARG . 6.4 p80 -60.19 -28.96 68.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.44 0.533 . . . . 1.47 112.44 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.574 ' HG3' ' ND1' ' A' ' 430' ' ' HIS . 72.1 mtt-85 -78.23 -35.62 48.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.52 0.2 . . . . 2.8399999999999999 111.537 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.545 HG12 HG13 ' A' ' 385' ' ' ILE . 66.3 mt -88.67 139.7 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.138 0.494 . . . . 0.46000000000000002 111.869 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.9 m -163.39 139.17 6.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.5 -0.773 . . . . 0.53000000000000003 110.327 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -75.83 16.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 1.3500000000000001 111.359 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 75.9 m-80 -147.88 130.76 16.15 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.879 0.371 . . . . 2.1600000000000001 110.699 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' ALA . . . . . 0.621 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -69.87 -37.85 76.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.53 . . . . 0.75 111.898 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -50.39 -40.87 51.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 1.3400000000000001 111.214 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.14 49.39 1.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 1.5600000000000001 110.999 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.621 HD12 ' HA ' ' A' ' 436' ' ' ALA . 88.7 mt -145.7 -84.87 0.12 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.521 -0.309 . . . . 1.1200000000000001 111.539 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 440' ' ' GLY . . . . . 0.634 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . -167.66 40.5 0.24 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.416 -0.897 . . . . 1.3600000000000001 113.014 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.46 144.2 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.765 -0.731 . . . . 1.8300000000000001 112.88 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 48.8 mm . . . . . 0 C--N 1.33 -0.281 0 N-CA-C 110.461 -0.2 . . . . 1.48 110.461 179.462 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.543 HG13 ' HE ' ' A' ' 429' ' ' ARG . 70.4 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.672 0.273 . . . . 1.48 110.335 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.5 129.36 36.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.877 0.37 . . . . 2.1699999999999999 111.288 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.476 HD11 HG12 ' A' ' 397' ' ' VAL . 82.5 mt -84.79 -39.43 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.92000000000000004 110.816 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.4 t -66.55 72.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.751 -0.659 . . . . 1.71 111.022 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -174.45 -28.64 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.536 -0.757 . . . . 1.9199999999999999 109.644 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 381' ' ' LYS . 35.1 p30 -172.2 57.69 0.24 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.206 -0.906 . . . . 2.1400000000000001 111.052 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 379' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 52.2 Cg_exo -52.86 -39.86 76.82 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.297 1.998 . . . . 0.84999999999999998 111.893 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.483 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 54.0 m-20 -62.57 -33.84 75.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.93 -0.577 . . . . 1.21 110.877 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 86.1 tttt -49.1 121.29 4.67 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.205 -0.452 . . . . 1.6599999999999999 110.799 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.878 HG23 HG21 ' A' ' 417' ' ' VAL . 18.6 mm -69.97 129.43 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.40999999999999998 112.0 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 395' ' ' GLY . 82.0 m-85 -109.75 144.69 37.79 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.283 -0.417 . . . . 0.63 110.234 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.526 ' C ' HD12 ' A' ' 385' ' ' ILE . 2.0 m-85 -85.6 128.5 34.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.731 0.301 . . . . 0.95999999999999996 110.884 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.765 HG12 HG21 ' A' ' 414' ' ' VAL . 1.8 mp -113.22 128.17 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.238 -0.437 . . . . 0.48999999999999999 110.66 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.681 ' HD3' ' HB3' ' A' ' 439' ' ' LEU . 25.4 tpt180 -98.27 120.62 39.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.373 -0.376 . . . . 2.4199999999999999 111.267 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -83.18 157.33 22.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 2.2999999999999998 110.556 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -55.71 -39.7 71.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 2.8199999999999998 111.301 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -71.44 5.5 2.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.442 -0.344 . . . . 1.23 111.684 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 74.08 44.14 30.72 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.018 -0.61 . . . . 1.03 113.776 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 25.3 p -122.38 111.65 17.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.828 0.314 . . . . 0.97999999999999998 111.625 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.61 HG23 ' NH1' ' A' ' 386' ' ' ARG . 72.4 t -69.36 135.61 27.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.649 -0.25 . . . . 0.55000000000000004 110.416 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -151.41 133.08 14.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.426 -0.352 . . . . 2.4300000000000002 111.046 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.77 ' HD2' HG21 ' A' ' 382' ' ' ILE . 88.9 mtm180 -59.07 153.34 18.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 2.96 112.036 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -175.44 132.45 2.16 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.798 -0.637 . . . . 0.26000000000000001 112.516 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 396' ' ' GLN . . . . . 0.494 ' HG3' HG22 ' A' ' 417' ' ' VAL . 75.3 mt-30 -96.15 112.03 23.89 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 111.773 0.286 . . . . 1.28 111.773 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.921 HG22 HD13 ' A' ' 432' ' ' ILE . 2.6 t -63.49 136.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.218 -0.29 . . . . 0.82999999999999996 110.218 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.407 ' HB2' ' HD2' ' A' ' 413' ' ' TYR . 98.8 mt -120.36 -38.92 2.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.16 0.43 . . . . 1.45 112.16 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.475 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 85.7 mt-30 -139.96 176.45 8.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.066 0.46 . . . . 2.0800000000000001 111.588 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.1 p -163.7 150.94 12.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.692 -0.686 . . . . 0.56000000000000005 110.24 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.542 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 39.2 ptt180 -156.17 134.58 11.54 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.862 0.363 . . . . 1.55 111.86 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 32.7 p -78.25 136.93 37.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 1.79 110.293 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.832 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.7 m -63.74 -174.49 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.285 -0.416 . . . . 1.95 110.777 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.832 ' H ' HG22 ' A' ' 403' ' ' THR . 49.1 mt-10 -48.76 -43.1 37.47 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.386 0.513 . . . . 3.8700000000000001 112.386 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.593 ' HB3' ' HG3' ' A' ' 409' ' ' PRO . 15.6 t-20 -55.9 -49.67 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.585 0.231 . . . . 3.1600000000000001 111.457 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.443 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 57.32 59.11 3.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.947 0.403 . . . . 2.1800000000000002 111.537 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.46 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -154.75 -2.27 0.16 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.602 . . . . 2.77 110.143 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.675 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -178.46 -49.35 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 114.848 -1.069 . . . . 2.7599999999999998 110.181 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 11.7 Cg_endo -54.62 141.39 74.84 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.44 2.093 . . . . 2.4900000000000002 112.298 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 36.6 p-10 -177.09 132.06 0.18 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.799 -0.637 . . . . 2.1400000000000001 111.077 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.4 mt-10 -108.55 135.45 49.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.595 . . . . 2.1000000000000001 109.549 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 1.0 OUTLIER -108.83 120.61 43.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.894 0.378 . . . . 0.71999999999999997 111.73 -178.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.475 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 11.9 t80 -60.89 137.47 58.21 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.914 -0.773 . . . . 0.51000000000000001 108.914 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.765 HG21 HG12 ' A' ' 385' ' ' ILE . 7.3 p -136.87 130.52 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.904 0.705 . . . . 1.1499999999999999 112.904 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 415' ' ' HIS . . . . . 0.495 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 81.5 t60 -102.1 89.49 3.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.87 -1.059 . . . . 0.62 109.018 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.622 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 22.6 m-85 -46.55 123.95 5.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.373 0.606 . . . . 0.65000000000000002 111.019 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 382' ' ' ILE . 43.5 t -74.7 125.48 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.133 -0.94 . . . . 1.3400000000000001 111.022 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.84 -42.98 2.55 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.585 -0.734 . . . . 0.81999999999999995 112.279 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 7.1 mp -65.03 151.95 44.69 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.928 0.394 . . . . 1.6000000000000001 111.44 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -57.84 160.14 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 2.5299999999999998 111.226 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' ARG . . . . . 0.45 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 68.2 mtt-85 -62.47 -26.56 68.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.257 0.551 . . . . 3.98 110.453 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -52.31 -36.35 52.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.282 -0.872 . . . . 3.71 111.829 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 423' ' ' LEU . 2.8 mm? -68.91 -34.6 75.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.451 . . . . 1.49 111.584 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 415' ' ' HIS . 1.2 m-20 -45.84 140.52 3.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.15 0.5 . . . . 1.2 112.149 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -178.18 -142.41 4.68 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.584 -0.735 . . . . 0.69999999999999996 112.176 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' TRP . . . . . 0.447 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 42.4 m95 -129.7 138.31 51.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.945 0.403 . . . . 0.60999999999999999 110.815 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.7 HG21 HG13 ' A' ' 432' ' ' ILE . 22.2 m -125.82 149.55 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.89000000000000001 111.196 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -77.01 29.49 1.59 Allowed Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.904 -0.665 . . . . 1.72 114.475 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.575 ' HB3' ' O ' ' A' ' 428' ' ' GLY . 37.4 tpt85 75.25 -43.96 0.52 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.171 0.804 . . . . 1.73 113.171 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.25 -30.47 27.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.736 0.779 . . . . 1.47 110.269 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.572 ' NH1' ' H ' ' A' ' 428' ' ' GLY . 28.8 mtt85 -78.48 -32.31 48.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.311 -1.313 . . . . 2.8399999999999999 112.595 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.921 HD13 HG22 ' A' ' 397' ' ' VAL . 77.0 mt -88.46 129.72 39.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.799 -0.36 . . . . 0.46000000000000002 110.375 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.67 ' HB2' HD11 ' A' ' 439' ' ' LEU . 63.3 m -164.92 143.67 6.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.152 -0.476 . . . . 0.53000000000000003 111.149 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -73.61 16.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 1.3500000000000001 111.721 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -159.17 135.71 9.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.94 0.4 . . . . 2.1600000000000001 111.124 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' ALA . . . . . 0.612 ' HB1' ' H ' ' A' ' 442' ' ' ILE . . . -69.37 -26.41 64.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.79 -0.641 . . . . 0.75 112.21 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -46.67 -40.76 13.75 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.49 -0.323 . . . . 1.3400000000000001 111.794 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -72.94 -33.01 65.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.004 0.43 . . . . 1.5600000000000001 111.012 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.681 ' HB3' ' HD3' ' A' ' 386' ' ' ARG . 6.7 mp -77.99 -84.39 0.08 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.706 -0.679 . . . . 1.1200000000000001 111.866 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . -148.39 28.59 1.35 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.671 -0.776 . . . . 1.3600000000000001 112.535 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 48.46 55.11 11.27 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.945 -0.645 . . . . 1.8300000000000001 112.65 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' ILE . . . . . 0.612 ' H ' ' HB1' ' A' ' 436' ' ' ALA . 31.4 mm . . . . . 0 C--N 1.326 -0.439 0 N-CA-C 110.285 -0.265 . . . . 1.48 110.285 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.535 ' HB ' HH12 ' A' ' 429' ' ' ARG . 68.8 mt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.089 0.471 . . . . 1.48 111.587 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.51 142.7 27.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 2.1699999999999999 110.354 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.552 HG22 ' HG3' ' A' ' 379' ' ' PRO . 4.6 mp -71.4 -43.31 73.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.742 0.275 . . . . 0.92000000000000004 111.742 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 49.2 m -49.11 -20.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.982 0.42 . . . . 1.71 111.52 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -58.39 -48.28 81.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.701 -0.681 . . . . 1.9199999999999999 111.773 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.468 ' ND2' ' HD3' ' A' ' 381' ' ' LYS . 11.3 p30 -174.98 73.61 0.3 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.12 -0.491 . . . . 2.1400000000000001 110.911 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 379' ' ' PRO . . . . . 0.552 ' HG3' HG22 ' A' ' 375' ' ' ILE . 78.2 Cg_exo -51.36 -40.17 62.32 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.521 2.147 . . . . 0.84999999999999998 112.477 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.536 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 1.5 m-20 -62.39 -37.29 85.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 1.21 111.199 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.468 ' HD3' ' ND2' ' A' ' 378' ' ' ASN . 79.1 tttt -50.54 127.48 17.89 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.972 0.415 . . . . 1.6599999999999999 111.006 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.833 HG23 HG21 ' A' ' 417' ' ' VAL . 20.8 mm -73.22 132.6 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.817 -0.629 . . . . 0.40999999999999998 111.859 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.532 ' HB3' HG23 ' A' ' 432' ' ' ILE . 22.4 m-85 -118.68 144.19 46.37 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.091 -0.504 . . . . 0.63 110.256 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.592 ' CD2' ' HB2' ' A' ' 436' ' ' ALA . 3.0 m-85 -85.58 138.57 32.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.841 0.353 . . . . 0.95999999999999996 111.183 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.643 HG12 HG21 ' A' ' 414' ' ' VAL . 2.5 mp -116.3 126.36 73.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.129 -0.487 . . . . 0.48999999999999999 110.852 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.444 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 36.7 ttt85 -90.57 111.44 22.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 2.4199999999999999 110.839 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.434 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 76.8 mtp180 -71.89 157.8 37.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.41 -0.359 . . . . 2.2999999999999998 110.263 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.467 ' HG2' HH22 ' A' ' 431' ' ' ARG . 48.9 mt-10 -49.32 -41.0 37.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 2.8199999999999998 111.331 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -71.33 -36.13 71.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 1.23 111.572 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 137.19 -28.15 2.82 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.427 -0.892 . . . . 1.03 112.811 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 47.5 p -58.81 112.09 1.52 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.97999999999999998 111.718 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.725 HG23 ' HA3' ' A' ' 441' ' ' GLY . 73.1 t -84.92 141.14 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.625 -0.716 . . . . 0.55000000000000004 110.88 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' HIS . . . . . 0.46 ' CG ' HD21 ' A' ' 419' ' ' LEU . 93.7 m-70 -145.45 139.92 27.21 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.987 0.422 . . . . 2.4300000000000002 111.243 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.496 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 88.0 mtm180 -55.17 152.24 8.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.793 -0.64 . . . . 2.96 112.064 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -178.74 128.16 1.23 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.481 -0.781 . . . . 0.26000000000000001 111.861 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' GLN . . . . . 0.536 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 78.4 mt-30 -84.47 130.74 34.73 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.338 0.496 . . . . 1.28 112.338 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.95 HG22 HD13 ' A' ' 432' ' ' ILE . 9.8 t -81.99 134.56 26.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.547 -0.538 . . . . 0.82999999999999996 109.547 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 413' ' ' TYR . 90.2 mt -120.78 -43.19 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.475 0.546 . . . . 1.45 112.475 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.53 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 30.5 mm100 -134.91 175.94 9.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.076 0.465 . . . . 2.0800000000000001 111.816 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.5 p -165.54 143.43 5.91 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.687 -0.688 . . . . 0.56000000000000005 110.633 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.463 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 40.6 ptt180 -151.08 135.05 16.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.952 0.406 . . . . 1.55 111.346 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 23.3 p -82.91 43.29 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 1.79 111.648 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.853 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.0 m 50.91 -174.08 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.201 -0.454 . . . . 1.95 110.869 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.853 ' H ' HG22 ' A' ' 403' ' ' THR . 93.3 mt-10 -65.38 -42.94 92.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.717 0.294 . . . . 3.8700000000000001 111.225 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -57.34 -51.31 69.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 3.1600000000000001 111.18 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.493 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 55.61 63.52 2.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.985 0.421 . . . . 2.1800000000000002 111.831 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.447 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -160.63 7.76 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.404 0.621 . . . . 2.77 110.039 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.628 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.81 -48.96 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.779 -1.1 . . . . 2.7599999999999998 109.99 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.628 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 31.4 Cg_exo -59.34 160.92 18.16 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.621 2.214 . . . . 2.4900000000000002 112.251 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.67 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.1 p30 178.43 141.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.128 -0.487 . . . . 2.1400000000000001 111.049 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.6 mt-10 -142.25 134.74 28.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.97 -0.559 . . . . 2.1000000000000001 110.285 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 0.6 OUTLIER -109.5 124.27 50.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.71999999999999997 111.469 -179.208 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.53 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 8.8 t80 -66.41 137.32 56.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.51000000000000001 109.652 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.643 HG21 HG12 ' A' ' 385' ' ' ILE . 8.0 p -135.61 137.62 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.18 0.514 . . . . 1.1499999999999999 112.248 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 415' ' ' HIS . . . . . 0.495 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 73.0 t60 -118.46 108.81 15.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.852 . . . . 0.62 109.585 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.487 ' CD1' HD22 ' A' ' 419' ' ' LEU . 97.9 m-85 -55.99 126.44 25.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.225 0.536 . . . . 0.65000000000000002 110.727 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.833 HG21 HG23 ' A' ' 382' ' ' ILE . 2.1 t -78.67 28.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.366 -0.834 . . . . 1.3400000000000001 111.81 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 173.1 -37.45 0.14 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.107 -1.045 . . . . 0.81999999999999995 113.773 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.487 HD22 ' CD1' ' A' ' 416' ' ' TYR . 7.0 mp -61.79 -166.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.371 0.605 . . . . 1.6000000000000001 112.432 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.746 ' HB3' ' HD2' ' A' ' 422' ' ' ARG . 5.0 m120 -63.65 146.73 53.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.244 -0.889 . . . . 2.5299999999999998 111.915 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -72.8 -42.24 64.12 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.165 -0.47 . . . . 3.98 110.94 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' ARG . . . . . 0.746 ' HD2' ' HB3' ' A' ' 420' ' ' ASN . 0.1 OUTLIER -64.22 -24.77 67.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 3.71 109.713 179.255 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' A' ' 420' ' ' ASN . 1.2 tp -58.04 -33.1 68.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.351 -0.84 . . . . 1.49 111.048 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.495 ' OD1' ' HA ' ' A' ' 415' ' ' HIS . 65.8 m-20 -50.5 137.13 19.72 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.897 -0.592 . . . . 1.2 111.534 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 425' ' ' GLY . . . . . 0.528 ' O ' HG12 ' A' ' 414' ' ' VAL . . . -179.18 174.09 46.1 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.782 -0.645 . . . . 0.69999999999999996 112.086 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 426' ' ' TRP . . . . . 0.463 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 15.7 m95 -81.49 140.35 34.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.38 . . . . 0.60999999999999999 110.851 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.854 HG21 HG13 ' A' ' 432' ' ' ILE . 21.8 m -108.85 160.26 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.508 . . . . 0.89000000000000001 111.527 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -75.86 24.91 1.53 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.757 -0.735 . . . . 1.72 113.045 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.644 ' H ' HG23 ' A' ' 427' ' ' VAL . 8.2 tpt180 71.93 -45.83 0.63 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.851 0.686 . . . . 1.73 112.851 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -65.61 -14.98 62.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.71 0.291 . . . . 1.47 111.494 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.467 HH22 ' HG2' ' A' ' 388' ' ' GLU . 66.2 mtt-85 -79.38 -36.31 39.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.43 -0.35 . . . . 2.8399999999999999 111.852 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.95 HD13 HG22 ' A' ' 397' ' ' VAL . 75.2 mt -87.73 132.31 33.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.031 0.444 . . . . 0.46000000000000002 111.587 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.412 ' HB2' HD21 ' A' ' 439' ' ' LEU . 59.1 m -163.91 139.37 6.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.595 -0.73 . . . . 0.53000000000000003 110.377 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.27 -22.57 66.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.359 -0.382 . . . . 1.3500000000000001 111.029 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.68 130.17 55.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.763 0.316 . . . . 2.1600000000000001 110.8 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 436' ' ' ALA . . . . . 0.684 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -80.88 -40.51 24.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.75 111.673 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -51.81 -40.79 61.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.391 -0.368 . . . . 1.3400000000000001 110.744 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -64.08 -38.1 89.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.102 0.477 . . . . 1.5600000000000001 109.894 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 436' ' ' ALA . 76.8 mt -60.47 -83.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.56 -0.745 . . . . 1.1200000000000001 110.725 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 139.28 52.19 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.99 -0.624 . . . . 1.3600000000000001 112.029 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.725 ' HA3' HG23 ' A' ' 392' ' ' VAL . . . -161.83 -70.75 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 119.565 -1.302 . . . . 1.8300000000000001 114.122 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' ILE . . . . . 0.583 ' N ' HD12 ' A' ' 442' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 109.126 -0.694 . . . . 1.48 109.126 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.062 0.458 . . . . 1.48 111.761 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 54.8 m-20 -89.71 77.2 7.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.957 -0.565 . . . . 2.1699999999999999 110.3 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 80.0 mt -42.51 -36.67 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.305 -0.407 . . . . 0.92000000000000004 111.964 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.8 t -69.17 68.86 0.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.46 . . . . 1.71 111.486 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.0 pt-20 -173.55 -26.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.009 -0.541 . . . . 1.9199999999999999 110.062 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 38.5 p30 -162.73 57.85 0.73 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.642 -0.708 . . . . 2.1400000000000001 111.931 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 379' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 53.0 Cg_exo -54.21 -35.59 83.29 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.071 1.847 . . . . 0.84999999999999998 111.179 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -66.04 -33.38 75.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.446 -0.797 . . . . 1.21 110.936 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 63.7 tttp -46.75 131.6 11.57 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.216 -0.447 . . . . 1.6599999999999999 111.379 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 417' ' ' VAL . 41.5 mm -85.92 126.13 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.40999999999999998 111.273 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -103.7 144.26 31.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.467 -0.333 . . . . 0.63 110.3 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 2.0 m-85 -85.54 132.51 34.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.95999999999999996 111.688 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.676 HG12 HG21 ' A' ' 414' ' ' VAL . 2.0 mp -114.05 118.48 58.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.083 -0.508 . . . . 0.48999999999999999 110.202 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.536 ' HB2' HD22 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -85.85 114.76 23.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.287 -0.415 . . . . 2.4199999999999999 110.969 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.49 ' O ' ' HD3' ' A' ' 386' ' ' ARG . 25.3 mmm180 -67.02 153.59 43.29 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.442 -0.344 . . . . 2.2999999999999998 110.146 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -53.17 -39.13 63.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.228 -0.442 . . . . 2.8199999999999998 110.706 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -64.66 -35.52 81.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 1.23 110.856 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 135.27 -35.56 2.16 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.584 -0.817 . . . . 1.03 113.043 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 80.8 p -58.85 112.54 1.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.043 0.449 . . . . 0.97999999999999998 112.004 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 56.5 t -74.53 143.15 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.925 -0.58 . . . . 0.55000000000000004 110.721 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -147.52 133.42 19.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 2.4300000000000002 111.113 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.444 ' HD2' HG21 ' A' ' 382' ' ' ILE . 88.4 mtm180 -56.21 155.57 6.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.903 -0.589 . . . . 2.96 111.921 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.442 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -172.04 130.67 1.98 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.532 -0.758 . . . . 0.26000000000000001 112.088 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 396' ' ' GLN . . . . . 0.434 ' HG2' HD13 ' A' ' 382' ' ' ILE . 86.9 mt-30 -81.74 110.62 17.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.938 0.347 . . . . 1.28 111.938 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 1.0 OUTLIER -82.02 132.28 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.82999999999999996 109.897 178.393 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 45.1 mt -120.95 -32.51 3.95 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.35 0.5 . . . . 1.45 112.35 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -140.27 176.31 8.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 2.0800000000000001 111.919 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.3 p -165.07 149.93 9.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.739 -0.664 . . . . 0.56000000000000005 110.723 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 38.2 ptt180 -154.55 138.42 16.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.863 0.364 . . . . 1.55 111.089 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 77.5 p -70.01 -132.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.437 -0.347 . . . . 1.79 110.988 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.794 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -162.43 -172.76 3.29 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.023 -0.362 . . . . 1.95 110.023 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.794 ' H ' HG22 ' A' ' 403' ' ' THR . 48.4 mt-10 -41.65 -45.77 3.5 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.668 0.271 . . . . 3.8700000000000001 111.47 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -67.31 -50.58 59.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.806 0.336 . . . . 3.1600000000000001 110.633 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.17 56.32 7.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.965 -0.561 . . . . 2.1800000000000002 111.591 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -151.98 9.36 0.51 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.156 0.503 . . . . 2.77 110.421 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.599 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.69 -49.0 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.262 -0.881 . . . . 2.7599999999999998 110.625 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 32.0 Cg_exo -58.29 147.26 85.58 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.321 2.014 . . . . 2.4900000000000002 112.179 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.9 p30 -177.95 131.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 2.1400000000000001 111.438 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 426' ' ' TRP . 50.2 mt-10 -115.25 136.83 52.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.693 -0.685 . . . . 2.1000000000000001 109.707 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.445 ' N ' ' CD1' ' A' ' 412' ' ' TYR . 0.6 OUTLIER -109.74 130.08 55.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.909 0.385 . . . . 0.71999999999999997 111.903 -178.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 31.3 t80 -60.56 146.64 44.38 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.627 -0.879 . . . . 0.51000000000000001 108.627 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.676 HG21 HG12 ' A' ' 385' ' ' ILE . 7.2 p -151.13 133.65 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 119.662 -0.815 . . . . 1.1499999999999999 113.181 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -116.2 107.76 15.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.996 -1.002 . . . . 0.62 109.439 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.457 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 63.0 m-85 -61.43 125.37 23.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.028 0.442 . . . . 0.65000000000000002 111.279 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 382' ' ' ILE . 2.7 t -81.62 32.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.685 -0.688 . . . . 1.3400000000000001 111.239 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -175.63 -44.2 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.436 -0.888 . . . . 0.81999999999999995 112.89 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.457 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 7.2 mp -64.88 -166.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.199 0.523 . . . . 1.6000000000000001 111.701 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.738 ' HB2' HD13 ' A' ' 423' ' ' LEU . 4.4 m120 -74.1 145.09 44.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.446 -0.797 . . . . 2.5299999999999998 111.796 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 62.2 mtm-85 -65.33 -38.58 90.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.959 -0.564 . . . . 3.98 110.71 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -55.39 -36.13 66.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.057 0.456 . . . . 3.71 110.967 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.738 HD13 ' HB2' ' A' ' 420' ' ' ASN . 4.5 mp -52.75 -25.87 12.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.468 -0.787 . . . . 1.49 111.787 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.16 135.44 21.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.989 0.423 . . . . 1.2 111.299 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 425' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 413' ' ' TYR . . . 177.24 -140.29 4.79 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.953 -0.641 . . . . 0.69999999999999996 112.302 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 426' ' ' TRP . . . . . 0.587 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 42.7 m95 -122.27 138.19 54.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.793 0.33 . . . . 0.60999999999999999 110.709 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.405 ' CG2' HD11 ' A' ' 432' ' ' ILE . 30.8 m -134.05 142.64 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.89000000000000001 111.765 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.403 ' HA3' ' NH1' ' A' ' 431' ' ' ARG . . . -63.47 144.92 49.65 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.831 -0.7 . . . . 1.72 111.994 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -55.58 -28.4 54.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.036 0.446 . . . . 1.73 111.49 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.58 -31.27 64.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.811 0.815 . . . . 1.47 109.572 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 431' ' ' ARG . 33.0 mtt85 -83.14 -36.23 24.93 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.117 -1.401 . . . . 2.8399999999999999 111.418 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.555 HG12 HG13 ' A' ' 385' ' ' ILE . 65.9 mt -88.83 135.31 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.021 0.439 . . . . 0.46000000000000002 111.766 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 435' ' ' ASN . 55.8 m -161.76 140.12 9.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.843 -0.617 . . . . 0.53000000000000003 110.619 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -72.67 16.19 0.16 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.243 -0.435 . . . . 1.3500000000000001 111.612 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 433' ' ' SER . 75.0 m-80 -146.53 131.92 18.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.938 0.399 . . . . 2.1600000000000001 110.97 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -68.17 -42.32 80.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.983 -0.553 . . . . 0.75 111.441 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -54.66 -40.74 69.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.282 -0.417 . . . . 1.3400000000000001 111.038 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.59 42.91 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 1.5600000000000001 110.848 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.536 HD22 ' HB2' ' A' ' 386' ' ' ARG . 97.5 mt -151.82 -83.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 1.1200000000000001 111.104 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -166.39 44.31 0.27 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.994 -0.622 . . . . 1.3600000000000001 112.141 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.13 -136.03 45.77 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 1.8300000000000001 112.298 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.586 0.232 . . . . 1.48 110.648 179.608 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.816 0.341 . . . . 1.48 111.046 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -88.14 110.61 20.81 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.155 -0.475 . . . . 2.1699999999999999 110.556 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.537 HD11 HG12 ' A' ' 397' ' ' VAL . 93.0 mt -66.82 -43.44 89.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.866 -0.606 . . . . 0.92000000000000004 111.972 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 75.9 p -69.84 64.84 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.101 0.477 . . . . 1.71 110.842 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -149.46 -27.99 0.27 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.9199999999999999 109.685 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -172.28 60.72 0.29 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.282 -0.872 . . . . 2.1400000000000001 111.239 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -51.32 -37.3 60.04 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.311 2.008 . . . . 0.84999999999999998 111.676 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -62.96 -34.22 77.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.762 -0.654 . . . . 1.21 110.866 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -53.86 124.68 16.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 1.6599999999999999 111.199 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.025 HD12 HG21 ' A' ' 417' ' ' VAL . 16.2 mm -79.88 124.4 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.074 -0.512 . . . . 0.40999999999999998 111.755 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.518 ' HB2' ' O ' ' A' ' 395' ' ' GLY . 4.2 m-85 -104.07 144.21 31.86 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.235 -0.283 . . . . 0.63 110.235 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.42 ' HB3' HG13 ' A' ' 392' ' ' VAL . 15.8 m-30 -94.65 135.91 35.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.012 0.434 . . . . 0.95999999999999996 110.867 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.8 mp -119.24 126.07 75.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 0.48999999999999999 110.063 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.813 ' HE ' ' HA3' ' A' ' 440' ' ' GLY . 55.7 ttt-85 -89.19 121.65 31.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 2.4199999999999999 111.048 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.478 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 59.8 mtp85 -79.63 168.3 19.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 2.2999999999999998 110.602 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -56.1 -42.87 77.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 2.8199999999999998 111.233 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -72.3 5.7 2.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 1.23 111.954 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.615 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 73.07 48.81 18.65 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.52 -0.848 . . . . 1.03 113.077 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' THR . . . . . 0.478 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 81.9 p -120.69 110.54 16.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.687 0.279 . . . . 0.97999999999999998 111.561 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 384' ' ' PHE . 58.6 t -70.52 127.56 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.082 -0.34 . . . . 0.55000000000000004 110.082 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -145.02 135.99 24.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.112 0.482 . . . . 2.4300000000000002 111.482 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.509 ' HB3' ' HB ' ' A' ' 417' ' ' VAL . 59.6 mtt85 -55.56 155.29 5.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.802 -0.635 . . . . 2.96 112.057 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 383' ' ' TYR . . . 178.02 126.64 1.0 Allowed Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.396 -0.82 . . . . 0.26000000000000001 111.371 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 396' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 85.4 mt-30 -91.74 129.22 37.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.972 0.386 . . . . 1.28 111.739 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.765 HG22 HD13 ' A' ' 432' ' ' ILE . 4.2 t -82.95 126.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.134 -0.691 . . . . 0.82999999999999996 109.134 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.41 ' C ' HD13 ' A' ' 375' ' ' ILE . 66.8 mt -120.71 -46.85 2.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.251 0.463 . . . . 1.45 112.251 -178.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.595 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 12.0 mm-40 -123.73 176.51 6.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.107 0.48 . . . . 2.0800000000000001 111.6 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 97.0 p -163.57 146.06 9.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.634 -0.712 . . . . 0.56000000000000005 110.109 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -162.57 139.03 7.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.879 0.371 . . . . 1.55 111.332 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.725 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 72.2 p -70.59 -125.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 1.79 110.033 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.778 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.76 -173.41 2.97 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.662 -0.495 . . . . 1.95 109.662 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.778 ' H ' HG22 ' A' ' 403' ' ' THR . 64.2 mm-40 -44.86 -40.39 6.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.802 0.334 . . . . 3.8700000000000001 110.856 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.638 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 55.3 t-20 -68.13 -53.66 23.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.193 -0.458 . . . . 3.1600000000000001 110.563 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.414 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 51.29 51.69 16.38 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.192 0.52 . . . . 2.1800000000000002 111.358 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.495 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -152.83 10.73 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.484 -0.78 . . . . 2.77 109.46 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.578 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -177.82 -48.25 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 114.465 -1.243 . . . . 2.7599999999999998 110.034 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 36.1 Cg_exo -60.89 149.24 89.47 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.524 2.15 . . . . 2.4900000000000002 112.383 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.725 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 12.1 p-10 -174.07 137.51 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 2.1400000000000001 110.348 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.9 mt-10 -134.83 134.68 41.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 2.1000000000000001 110.902 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 1.2 m-85 -109.76 125.66 52.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.058 0.456 . . . . 0.71999999999999997 111.175 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.595 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 14.3 t80 -62.22 144.0 56.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.71 -0.677 . . . . 0.51000000000000001 110.189 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 0.0 OUTLIER -144.56 129.66 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.624 0.602 . . . . 1.1499999999999999 112.624 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 415' ' ' HIS . . . . . 0.425 ' O ' ' HA2' ' A' ' 395' ' ' GLY . 38.4 t60 -103.38 97.15 7.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.153 -0.93 . . . . 0.62 109.169 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 36.7 m-85 -53.2 106.41 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.391 0.615 . . . . 0.65000000000000002 111.22 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 1.025 HG21 HD12 ' A' ' 382' ' ' ILE . 58.3 t -67.16 130.01 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.905 -1.043 . . . . 1.3400000000000001 111.143 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 81.4 -45.55 3.26 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.747 -0.661 . . . . 0.81999999999999995 112.608 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 6.9 mp -65.6 166.57 10.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.997 0.427 . . . . 1.6000000000000001 111.427 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 74.5 m-20 -53.86 143.37 21.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.831 -0.622 . . . . 2.5299999999999998 111.544 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 53.9 mtt85 -61.75 -38.52 88.27 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.854 -0.612 . . . . 3.98 111.286 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -56.25 -32.58 64.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 3.71 111.439 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 420' ' ' ASN . 1.9 mp -58.21 -27.95 64.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.226 -0.443 . . . . 1.49 111.822 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -48.39 139.77 8.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 1.2 111.325 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -171.66 -147.83 5.86 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.76 -0.734 . . . . 0.69999999999999996 112.466 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -128.65 138.37 52.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.021 0.439 . . . . 0.60999999999999999 111.18 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.74 HG21 HG13 ' A' ' 432' ' ' ILE . 23.0 m -115.04 155.57 16.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.692 -0.686 . . . . 0.89000000000000001 111.494 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -78.04 30.94 1.8 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.913 -0.66 . . . . 1.72 114.075 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.559 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 9.7 tpt180 72.09 -45.63 0.62 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.688 0.625 . . . . 1.73 112.688 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -62.41 -21.53 65.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.706 0.289 . . . . 1.47 111.592 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.454 ' HD2' ' HB ' ' A' ' 427' ' ' VAL . 90.7 mtt180 -79.11 -26.95 42.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.188 0.44 . . . . 2.8399999999999999 112.188 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.765 HD13 HG22 ' A' ' 397' ' ' VAL . 71.4 mt -88.11 136.8 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.965 0.412 . . . . 0.46000000000000002 111.243 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 56.4 m -159.69 138.69 10.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.53000000000000003 110.612 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.29 -26.51 62.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 1.3500000000000001 111.138 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -112.85 130.62 56.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 2.1600000000000001 110.729 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -66.91 -32.52 73.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 0.75 111.176 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -51.54 -40.88 60.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.232 -0.44 . . . . 1.3400000000000001 110.783 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.85 -38.46 83.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.171 0.51 . . . . 1.5600000000000001 110.118 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 436' ' ' ALA . 69.3 mt -61.89 -93.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.525 -0.761 . . . . 1.1200000000000001 111.238 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 440' ' ' GLY . . . . . 0.813 ' HA3' ' HE ' ' A' ' 386' ' ' ARG . . . -166.29 39.87 0.26 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.116 -0.564 . . . . 1.3600000000000001 111.931 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 67.62 131.19 0.03 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.018 -0.61 . . . . 1.8300000000000001 112.162 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' ILE . . . . . 0.672 ' H ' HD12 ' A' ' 442' ' ' ILE . 5.3 mp . . . . . 0 C--N 1.332 -0.167 0 CA-C-O 120.67 0.271 . . . . 1.48 110.322 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.772 0.32 . . . . 1.48 110.711 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.407 ' HB2' ' OE1' ' A' ' 377' ' ' GLU . 59.2 m-20 -88.92 129.45 35.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 2.1699999999999999 111.228 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 78.7 mt -84.27 -45.18 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.92000000000000004 111.16 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 48.0 t -64.11 78.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 1.71 110.859 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 374' ' ' ASP . 12.1 pt-20 -173.71 -28.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.528 -0.76 . . . . 1.9199999999999999 110.074 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.431 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 31.3 p30 -173.07 61.54 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.536 -0.757 . . . . 2.1400000000000001 111.509 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.99 -38.67 86.7 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.318 2.012 . . . . 0.84999999999999998 111.877 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.514 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 28.3 m-20 -65.34 -33.51 76.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.996 -0.547 . . . . 1.21 111.073 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 85.2 tttt -48.02 126.58 10.96 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.942 0.401 . . . . 1.6599999999999999 111.076 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.779 HG23 HG21 ' A' ' 417' ' ' VAL . 36.5 mm -71.79 120.71 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.89 -0.596 . . . . 0.40999999999999998 111.724 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -99.57 144.4 28.7 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.587 -0.523 . . . . 0.63 109.587 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.447 ' C ' HD12 ' A' ' 385' ' ' ILE . 45.1 m-85 -88.88 133.08 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.895 -0.322 . . . . 0.95999999999999996 110.795 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.661 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.1 mp -116.33 144.67 23.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.819 0.342 . . . . 0.48999999999999999 111.539 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.654 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 39.1 ttt85 -124.48 104.25 8.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 2.4199999999999999 110.525 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.479 ' HG3' ' CE1' ' A' ' 393' ' ' HIS . 10.0 mtp-105 -65.04 161.6 18.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.831 0.348 . . . . 2.2999999999999998 110.944 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.609 ' HG3' HH21 ' A' ' 431' ' ' ARG . 50.5 mp0 -48.76 -45.05 39.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.054 0.761 . . . . 2.8199999999999998 113.054 -177.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.592 ' OD2' HG23 ' A' ' 391' ' ' THR . 8.0 p-10 -60.16 -35.26 74.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.595 0.236 . . . . 1.23 111.59 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.405 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 118.45 44.3 0.52 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.605 -0.807 . . . . 1.03 112.413 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' THR . . . . . 0.592 HG23 ' OD2' ' A' ' 389' ' ' ASP . 21.5 p -116.64 112.49 21.34 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.789 0.292 . . . . 0.97999999999999998 111.789 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.495 HG11 HD13 ' A' ' 442' ' ' ILE . 86.4 t -79.56 134.23 28.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.604 -0.517 . . . . 0.55000000000000004 109.604 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' HIS . . . . . 0.487 ' HD1' ' HB ' ' A' ' 385' ' ' ILE . 0.6 OUTLIER -156.47 133.98 10.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.939 0.4 . . . . 2.4300000000000002 111.03 -178.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.498 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 99.6 mtt180 -60.07 145.18 47.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.931 -0.577 . . . . 2.96 111.75 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -174.21 128.85 1.52 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.532 -0.758 . . . . 0.26000000000000001 111.976 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' GLN . . . . . 0.514 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 68.6 mt-30 -78.31 129.68 35.31 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.689 -0.3 . . . . 1.28 111.597 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 413' ' ' TYR . 0.5 OUTLIER -88.28 132.08 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.547 -0.538 . . . . 0.82999999999999996 109.547 177.798 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 398' ' ' LEU . 4.9 mp -106.14 -49.44 3.37 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.791 0.663 . . . . 1.45 112.791 -177.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 412' ' ' TYR . 30.3 mm100 -142.94 178.02 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.004 0.431 . . . . 2.0800000000000001 111.869 -178.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.7 p -148.83 149.39 31.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.683 -0.69 . . . . 0.56000000000000005 109.987 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -158.49 139.08 12.69 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.169 0.509 . . . . 1.55 112.356 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 50.6 p -87.6 139.1 30.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.671 -0.695 . . . . 1.79 109.557 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.851 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.9 m -60.53 -174.57 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.58 0.229 . . . . 1.95 110.579 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.851 ' H ' HG22 ' A' ' 403' ' ' THR . 59.1 mm-40 -50.73 -41.74 56.6 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.798 0.295 . . . . 3.8700000000000001 111.798 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.534 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 15.6 t-20 -59.19 -49.57 77.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.569 -0.287 . . . . 3.1600000000000001 111.076 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.573 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 52.71 48.25 22.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.154 0.502 . . . . 2.1800000000000002 111.483 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.505 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -145.75 10.79 1.22 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.603 -0.726 . . . . 2.77 109.478 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.595 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.78 -47.81 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.472 -1.24 . . . . 2.7599999999999998 110.0 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 36.3 Cg_exo -57.9 143.46 95.86 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.561 2.174 . . . . 2.4900000000000002 112.513 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -170.48 136.31 1.29 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.69 -0.687 . . . . 2.1400000000000001 110.326 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 400' ' ' SER . 64.8 mm-40 -140.89 135.12 30.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.193 -0.458 . . . . 2.1000000000000001 110.886 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 399' ' ' GLN . 1.2 m-85 -109.21 119.19 38.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.145 -0.48 . . . . 0.71999999999999997 111.213 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.471 ' CE2' HD22 ' A' ' 398' ' ' LEU . 10.5 t80 -57.41 145.99 30.84 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.278 -0.638 . . . . 0.51000000000000001 109.278 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 14.4 p -154.82 129.52 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.201 0.815 . . . . 1.1499999999999999 113.201 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -101.85 113.09 25.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.344 -0.844 . . . . 0.62 109.084 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.493 ' CD2' HD22 ' A' ' 419' ' ' LEU . 65.1 m-85 -61.42 132.69 54.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.356 0.598 . . . . 0.65000000000000002 111.125 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.779 HG21 HG23 ' A' ' 382' ' ' ILE . 1.3 t -78.82 27.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.212 -0.904 . . . . 1.3400000000000001 111.406 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 172.74 -43.04 0.17 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.407 -0.901 . . . . 0.81999999999999995 113.289 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 423' ' ' LEU . 7.3 mp -59.75 151.88 24.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 1.6000000000000001 111.604 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -50.36 147.13 4.6 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.494 -0.776 . . . . 2.5299999999999998 112.203 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' ARG . . . . . 0.436 ' HA ' ' CG ' ' A' ' 424' ' ' ASP . 87.1 mtm180 -59.24 -28.88 67.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.706 -0.679 . . . . 3.98 110.927 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -53.61 -41.2 66.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.285 0.564 . . . . 3.71 110.059 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 419' ' ' LEU . 6.4 mp -71.56 -33.12 68.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.142 -0.935 . . . . 1.49 110.999 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.436 ' CG ' ' HA ' ' A' ' 421' ' ' ARG . 10.6 m-20 -53.11 131.44 36.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 1.2 110.783 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 176.43 -142.03 5.77 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.702 -0.761 . . . . 0.69999999999999996 112.51 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' TRP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 50.6 m95 -105.19 135.83 45.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.60999999999999999 110.933 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.855 HG23 HD11 ' A' ' 432' ' ' ILE . 3.4 m -128.81 134.56 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.534 . . . . 0.89000000000000001 111.634 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -57.7 150.06 31.98 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.722 -0.752 . . . . 1.72 111.99 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -47.92 -39.77 19.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.615 0.245 . . . . 1.73 111.331 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.425 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 9.1 p-80 -61.77 -32.26 72.51 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.866 0.321 . . . . 1.47 111.866 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.609 HH21 ' HG3' ' A' ' 388' ' ' GLU . 57.0 mtt85 -82.21 26.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.108 -0.237 . . . . 2.8399999999999999 111.191 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.855 HD11 HG23 ' A' ' 427' ' ' VAL . 66.0 mt -149.58 135.63 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.46000000000000002 110.868 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 435' ' ' ASN . 70.5 m -166.25 139.23 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 0.53000000000000003 110.866 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.65 16.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 1.3500000000000001 110.507 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 433' ' ' SER . 74.9 m-20 -138.79 128.26 24.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.902 -0.59 . . . . 2.1600000000000001 110.328 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.1 92.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.75 111.754 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -56.24 -40.36 74.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 1.3400000000000001 111.333 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.77 42.44 0.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 1.5600000000000001 111.601 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' LEU . . . . . . . . . . . . . 85.9 mt -150.2 -88.41 0.07 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.72 -0.218 . . . . 1.1200000000000001 111.438 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' GLY . . . . . 0.654 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -171.45 38.12 0.17 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.542 -0.837 . . . . 1.3600000000000001 112.859 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.83 141.02 0.04 OUTLIER Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.736 -0.745 . . . . 1.8300000000000001 112.869 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' ILE . . . . . 0.495 HD13 HG11 ' A' ' 392' ' ' VAL . 42.3 mm . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.985 0.421 . . . . 1.48 110.689 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.493 HG13 ' HE ' ' A' ' 429' ' ' ARG . 70.6 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.752 0.311 . . . . 1.48 111.337 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.68 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 23.6 m-20 -88.87 111.58 22.24 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 116.09 -0.505 . . . . 2.1699999999999999 110.902 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 86.4 mt -73.17 -39.68 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.709 0.29 . . . . 0.92000000000000004 111.781 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 40.1 t -46.72 -28.74 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.011 -0.54 . . . . 1.71 112.422 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.68 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 15.5 pt-20 -69.43 -38.47 77.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.508 -0.315 . . . . 1.9199999999999999 111.772 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.703 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 66.8 m-20 -153.06 69.16 6.85 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 112.322 0.49 . . . . 2.1400000000000001 112.322 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.38 -40.68 77.37 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.684 2.256 . . . . 0.84999999999999998 112.577 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -70.3 -34.09 72.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.536 . . . . 1.21 111.774 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.703 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 63.0 tttp -46.38 136.36 7.36 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.983 0.421 . . . . 1.6599999999999999 111.021 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.733 HG21 ' HD3' ' A' ' 394' ' ' ARG . 46.4 mm -84.86 130.47 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.782 -0.644 . . . . 0.40999999999999998 111.834 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -118.93 143.6 46.92 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.496 -0.557 . . . . 0.63 109.496 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.524 ' CE1' ' HG2' ' A' ' 394' ' ' ARG . 1.3 m-85 -84.83 143.74 28.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.783 0.325 . . . . 0.95999999999999996 111.351 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.712 HG12 HG11 ' A' ' 414' ' ' VAL . 2.8 mp -119.85 133.83 65.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 116.228 -0.442 . . . . 0.48999999999999999 111.492 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.551 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 28.3 tpt180 -87.0 106.01 17.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 2.4199999999999999 110.418 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.488 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 62.5 mtp85 -66.69 160.52 25.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 2.2999999999999998 111.067 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.7 -71.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.865 -0.607 . . . . 2.8199999999999998 111.048 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.414 ' OD1' HG23 ' A' ' 391' ' ' THR . 2.4 p30 -41.7 -28.9 0.16 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.052 0.453 . . . . 1.23 110.28 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 110.16 44.3 1.02 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.737 -0.665 . . . . 1.03 113.459 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' THR . . . . . 0.488 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 37.0 p -121.2 110.37 16.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.967 0.413 . . . . 0.97999999999999998 111.062 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.492 HG23 HH11 ' A' ' 386' ' ' ARG . 90.2 t -71.6 133.13 32.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 0.55000000000000004 111.352 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -151.93 138.46 18.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.111 -0.495 . . . . 2.4300000000000002 110.537 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.733 ' HD3' HG21 ' A' ' 382' ' ' ILE . 60.6 mtt85 -51.6 155.65 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.392 0.615 . . . . 2.96 112.601 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -178.61 133.37 2.1 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.103 -0.953 . . . . 0.26000000000000001 111.84 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -80.95 130.68 35.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.771 0.285 . . . . 1.28 111.771 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.605 ' CG1' ' HB3' ' A' ' 412' ' ' TYR . 14.5 t -91.43 126.61 44.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.81 -0.811 . . . . 0.82999999999999996 108.81 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.64 ' N ' HD22 ' A' ' 398' ' ' LEU . 0.3 OUTLIER -108.83 -40.08 5.15 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.023 0.749 . . . . 1.45 113.023 -177.029 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -139.95 176.02 9.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.95 0.405 . . . . 2.0800000000000001 111.901 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.2 p -163.56 150.96 12.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.829 -0.623 . . . . 0.56000000000000005 110.611 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 39.9 ptt180 -153.14 134.33 14.15 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.492 -0.322 . . . . 1.55 111.163 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 47.7 p -71.93 135.71 46.6 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.96 0.41 . . . . 1.79 110.69 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.827 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.1 m -62.51 -174.1 0.06 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.837 -0.62 . . . . 1.95 110.372 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.827 ' H ' HG22 ' A' ' 403' ' ' THR . 60.3 mm-40 -44.94 -37.04 3.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.86 0.319 . . . . 3.8700000000000001 111.86 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -57.52 -49.76 75.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.747 0.308 . . . . 3.1600000000000001 110.873 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.612 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.78 66.03 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.183 -0.462 . . . . 2.1800000000000002 111.603 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -162.65 -23.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 2.77 110.518 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.67 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -159.99 -52.33 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.683 -0.69 . . . . 2.7599999999999998 110.7 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 52.1 Cg_exo -54.96 149.2 43.66 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.196 1.93 . . . . 2.4900000000000002 111.341 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 34.4 p-10 -179.08 143.71 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.091 0.472 . . . . 2.1400000000000001 111.58 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 400' ' ' SER . 0.5 OUTLIER -106.82 135.25 48.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.756 -0.656 . . . . 2.1000000000000001 109.859 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.643 ' HB2' HD12 ' A' ' 432' ' ' ILE . 0.4 OUTLIER -109.75 128.11 55.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.345 -0.389 . . . . 0.71999999999999997 111.958 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.57 ' CD2' HD23 ' A' ' 398' ' ' LEU . 9.4 t80 -64.54 141.56 58.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.51000000000000001 109.833 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.712 HG11 HG12 ' A' ' 385' ' ' ILE . 48.6 t -132.51 132.99 60.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.153 0.797 . . . . 1.1499999999999999 113.153 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -116.13 89.9 3.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.036 -0.984 . . . . 0.62 109.304 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.465 ' H ' ' HD1' ' A' ' 416' ' ' TYR . 6.2 m-85 -55.89 127.2 29.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.953 0.406 . . . . 0.65000000000000002 111.161 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 382' ' ' ILE . 61.9 t -70.38 127.23 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.01 -0.541 . . . . 1.3400000000000001 111.375 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.53 -41.93 1.69 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.966 -0.635 . . . . 0.81999999999999995 113.182 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 419' ' ' LEU . 7.7 mp -59.43 156.92 12.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.947 0.403 . . . . 1.6000000000000001 111.375 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.545 ' OD1' HD13 ' A' ' 423' ' ' LEU . 22.5 p30 -49.58 143.38 7.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.786 -0.643 . . . . 2.5299999999999998 111.65 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 421' ' ' ARG . 57.0 mtt85 -62.77 -36.16 82.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.636 -0.711 . . . . 3.98 111.898 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -54.09 -30.04 46.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.341 . . . . 3.71 111.029 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.545 HD13 ' OD1' ' A' ' 420' ' ' ASN . 1.1 tp -59.41 -31.69 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 1.49 111.365 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.5 134.83 8.95 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.946 0.403 . . . . 1.2 111.155 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.88 155.08 12.27 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.827 -0.701 . . . . 0.69999999999999996 112.268 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 12.2 m95 -71.05 137.64 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.679 0.276 . . . . 0.60999999999999999 110.38 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.424 ' HB ' ' HD3' ' A' ' 431' ' ' ARG . 11.4 m -138.0 141.23 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.438 -0.346 . . . . 0.89000000000000001 110.843 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -50.01 150.7 4.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.668 -0.777 . . . . 1.72 112.442 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.493 ' HE ' HG13 ' A' ' 373' ' ' ILE . 32.6 tpt85 -48.7 -42.03 33.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.479 0.18 . . . . 1.73 111.477 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -55.43 -31.71 62.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.541 -0.3 . . . . 1.47 111.469 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 73.5 mtp180 -81.61 20.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.611 -0.268 . . . . 2.8399999999999999 111.228 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.643 HD12 ' HB2' ' A' ' 412' ' ' TYR . 83.5 mt -150.33 126.04 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.826 0.346 . . . . 0.46000000000000002 110.914 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 435' ' ' ASN . 65.5 m -165.67 143.4 5.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.863 -0.608 . . . . 0.53000000000000003 110.65 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' ASP . . . . . 0.498 ' OD1' ' HE3' ' A' ' 381' ' ' LYS . 27.5 m-20 -70.62 16.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 1.3500000000000001 111.293 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 433' ' ' SER . 0.2 OUTLIER -158.9 128.14 5.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.926 0.393 . . . . 2.1600000000000001 110.585 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 436' ' ' ALA . . . . . 0.617 ' HB3' HD13 ' A' ' 442' ' ' ILE . . . -68.09 -25.08 65.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.97 -0.559 . . . . 0.75 111.896 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.34 -41.19 18.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.405 -0.361 . . . . 1.3400000000000001 111.631 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -82.63 -41.68 19.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.927 0.394 . . . . 1.5600000000000001 110.948 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 436' ' ' ALA . 49.0 mt -54.63 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 1.1200000000000001 111.565 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 440' ' ' GLY . . . . . 0.551 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -157.29 38.66 0.55 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.851 -0.69 . . . . 1.3600000000000001 112.186 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.12 146.0 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.686 -0.768 . . . . 1.8300000000000001 112.199 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 442' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 436' ' ' ALA . 48.8 mm . . . . . 0 C--N 1.331 -0.22 0 N-CA-C 109.975 -0.38 . . . . 1.48 109.975 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.798 0.333 . . . . 1.48 111.057 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 30.4 m-20 -88.22 110.47 20.74 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.23 -0.441 . . . . 2.1699999999999999 110.854 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.447 HD13 ' C ' ' A' ' 398' ' ' LEU . 82.0 mt -76.48 -34.75 25.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.92000000000000004 111.623 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 80.4 p -70.17 64.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 1.71 111.643 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.4 pt-20 -174.66 -27.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.904 -0.589 . . . . 1.9199999999999999 110.073 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 47.5 m-20 -149.49 60.26 4.45 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.77 . . . . 2.1400000000000001 112.413 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 379' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 73.3 Cg_exo -55.69 -40.92 82.46 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.713 2.276 . . . . 0.84999999999999998 112.341 179.129 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -69.4 -30.05 67.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 1.21 111.94 -179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 88.1 tttt -44.92 130.03 7.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.001 0.429 . . . . 1.6599999999999999 111.005 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.536 HG21 ' HD3' ' A' ' 394' ' ' ARG . 38.4 mm -91.99 135.01 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.40999999999999998 111.5 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.662 ' HB3' HG23 ' A' ' 432' ' ' ILE . 1.6 m-85 -119.95 143.13 48.17 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.961 -0.385 . . . . 0.63 109.961 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.419 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 4.3 m-85 -92.65 136.18 33.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.777 -0.369 . . . . 0.95999999999999996 110.597 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 385' ' ' ILE . 3.1 mp -125.61 128.37 72.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.868 0.366 . . . . 0.48999999999999999 110.935 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.656 ' N ' HD23 ' A' ' 439' ' ' LEU . 78.8 ttt180 -81.8 120.65 25.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.994 -0.548 . . . . 2.4199999999999999 110.801 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.405 ' HB2' ' OD1' ' A' ' 389' ' ' ASP . 59.0 mtm180 -74.63 166.59 23.31 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.759 -0.377 . . . . 2.2999999999999998 110.623 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.474 ' H ' ' CD ' ' A' ' 388' ' ' GLU . 9.0 mp0 -49.66 -44.67 47.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.29 -0.414 . . . . 2.8199999999999998 111.398 -179.451 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 387' ' ' ARG . 41.4 p-10 -65.72 -35.11 79.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.429 -0.351 . . . . 1.23 111.353 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.524 ' HA2' ' HE ' ' A' ' 386' ' ' ARG . . . 130.2 -29.21 3.72 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.76 -0.734 . . . . 1.03 112.293 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 51.3 p -59.48 113.63 2.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.241 0.544 . . . . 0.97999999999999998 111.843 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 49.1 t -72.62 143.09 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.399 -0.818 . . . . 0.55000000000000004 111.49 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -146.56 145.09 30.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.707 -0.679 . . . . 2.4300000000000002 109.35 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.547 ' HB2' ' CG1' ' A' ' 417' ' ' VAL . 55.0 mtt85 -74.07 145.93 44.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.482 0.658 . . . . 2.96 111.604 -178.275 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -146.42 125.05 2.14 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 114.891 -1.05 . . . . 0.26000000000000001 110.996 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -81.84 84.07 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.783 0.325 . . . . 1.28 111.132 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.893 HG23 HG22 ' A' ' 414' ' ' VAL . 0.6 OUTLIER -59.0 132.31 23.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.144 -0.48 . . . . 0.82999999999999996 110.457 179.9 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.447 ' C ' HD13 ' A' ' 375' ' ' ILE . 59.4 mt -120.64 -38.8 2.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.157 -0.474 . . . . 1.45 112.128 -178.401 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -119.8 170.51 9.16 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.177 0.513 . . . . 2.0800000000000001 112.076 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.1 p -165.69 151.22 9.05 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.437 -0.801 . . . . 0.56000000000000005 109.9 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -162.3 137.43 7.07 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.388 0.514 . . . . 1.55 112.388 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.516 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 35.9 p -86.34 135.61 33.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.86 -0.609 . . . . 1.79 109.429 177.642 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.856 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.3 m -60.29 -174.7 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.67 0.272 . . . . 1.95 110.917 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.856 ' H ' HG22 ' A' ' 403' ' ' THR . 4.8 mm-40 -50.66 -42.61 56.75 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.992 0.367 . . . . 3.8700000000000001 111.992 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.577 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 15.2 t-20 -56.65 -48.87 76.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.719 0.295 . . . . 3.1600000000000001 110.837 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 53.19 52.16 14.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 2.1800000000000002 111.529 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.469 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -153.53 10.23 0.42 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.44 0.638 . . . . 2.77 109.642 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.81 -48.32 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.688 -1.142 . . . . 2.7599999999999998 110.122 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 36.3 Cg_exo -60.57 141.64 95.81 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.677 2.252 . . . . 2.4900000000000002 112.745 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -173.16 127.73 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.652 -0.704 . . . . 2.1400000000000001 110.784 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 400' ' ' SER . 9.2 mp0 -120.42 134.59 55.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.782 -0.645 . . . . 2.1000000000000001 109.675 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.452 ' N ' ' CD1' ' A' ' 412' ' ' TYR . 1.2 m-85 -110.03 123.45 49.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.806 0.336 . . . . 0.71999999999999997 111.649 -178.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 19.7 t80 -63.86 119.3 9.74 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.317 -0.624 . . . . 0.51000000000000001 109.317 178.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.893 HG22 HG23 ' A' ' 397' ' ' VAL . 22.6 t -112.36 135.77 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.461 0.912 . . . . 1.1499999999999999 113.461 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -111.14 89.38 3.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.996 -1.002 . . . . 0.62 108.543 177.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 62.5 m-85 -52.18 103.16 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.281 0.563 . . . . 0.65000000000000002 110.904 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.547 ' CG1' ' HB2' ' A' ' 394' ' ' ARG . 11.3 p -62.44 136.46 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.147 -0.933 . . . . 1.3400000000000001 110.932 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 80.43 -47.97 3.54 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.235 -0.746 . . . . 0.81999999999999995 111.235 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.525 ' HB3' HD22 ' A' ' 423' ' ' LEU . 2.0 mm? -65.68 159.77 24.22 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.74 0.305 . . . . 1.6000000000000001 110.634 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.553 ' OD1' HD13 ' A' ' 423' ' ' LEU . 21.3 p30 -51.62 141.67 15.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 2.5299999999999998 111.082 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 31.9 ptt85 -60.55 -33.05 72.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.233 -0.44 . . . . 3.98 111.918 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -56.4 -29.61 61.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 3.71 111.1 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.553 HD13 ' OD1' ' A' ' 420' ' ' ASN . 1.2 tp -58.1 -26.7 62.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 1.49 111.661 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -44.79 135.17 5.21 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.948 0.404 . . . . 1.2 111.174 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -178.82 145.98 7.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.01 -0.614 . . . . 0.69999999999999996 112.189 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -67.49 121.3 15.51 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.99 -0.374 . . . . 0.60999999999999999 109.99 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.512 HG22 ' CG2' ' A' ' 414' ' ' VAL . 6.4 m -118.79 149.59 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 0.89000000000000001 111.537 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -63.27 146.97 50.61 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.625 -0.798 . . . . 1.72 111.674 178.772 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 37.1 tpt85 -51.34 -29.73 16.21 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.684 0.253 . . . . 1.73 111.684 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.414 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 22.7 p-80 -60.37 -31.94 70.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.955 0.354 . . . . 1.47 111.955 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 99.4 mtt180 -79.03 -30.94 44.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.355 -0.384 . . . . 2.8399999999999999 110.93 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.662 HG23 ' HB3' ' A' ' 383' ' ' TYR . 95.7 mt -89.03 129.93 39.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.46000000000000002 111.603 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.71 ' HB2' HD11 ' A' ' 439' ' ' LEU . 69.6 m -169.09 140.05 2.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.803 -0.635 . . . . 0.53000000000000003 110.5 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -75.82 16.21 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.415 -0.357 . . . . 1.3500000000000001 111.269 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.485 ' O ' HD13 ' A' ' 439' ' ' LEU . 15.1 t-20 -139.45 131.39 27.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.891 0.377 . . . . 2.1600000000000001 110.652 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -71.72 -37.17 70.65 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.627 0.603 . . . . 0.75 112.627 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 437' ' ' ASP . . . . . 0.444 ' HB2' ' OD1' ' A' ' 435' ' ' ASN . 55.5 m-20 -52.51 -40.72 62.75 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.727 0.299 . . . . 1.3400000000000001 111.597 -178.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 438' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 435' ' ' ASN . 61.5 m-20 -64.19 -24.58 67.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.391 -0.368 . . . . 1.5600000000000001 111.335 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.4 mp -94.81 -85.46 0.31 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.159 -0.473 . . . . 1.1200000000000001 112.191 -179.038 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -179.65 51.85 0.09 OUTLIER Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.097 -1.049 . . . . 1.3600000000000001 113.661 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 68.31 143.97 0.11 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.724 -0.751 . . . . 1.8300000000000001 113.363 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 46.8 mm . . . . . 0 C--N 1.33 -0.27 0 N-CA-C 110.485 -0.191 . . . . 1.48 110.485 179.394 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 21.9 mm . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.923 0.392 . . . . 1.48 110.254 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -87.09 110.49 20.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.125 0.488 . . . . 2.1699999999999999 111.084 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.75 HD11 HG12 ' A' ' 397' ' ' VAL . 72.0 mt -79.89 -39.01 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.678 -0.692 . . . . 0.92000000000000004 111.248 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 58.1 m -70.71 58.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.597 -0.729 . . . . 1.71 111.983 -179.013 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -174.47 -30.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 1.9199999999999999 110.47 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 35.2 p30 -156.12 58.41 1.74 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.796 -0.638 . . . . 2.1400000000000001 111.172 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 379' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 51.3 Cg_exo -53.72 -39.33 84.0 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.198 1.932 . . . . 0.84999999999999998 111.461 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.41 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 1.4 m-20 -64.32 -31.59 72.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.67 -0.696 . . . . 1.21 111.175 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 83.7 tttt -45.83 125.45 6.17 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.016 0.436 . . . . 1.6599999999999999 110.805 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.839 HD12 HG21 ' A' ' 417' ' ' VAL . 21.4 mm -79.71 123.75 36.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.91 -0.586 . . . . 0.40999999999999998 111.902 -179.117 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -110.08 143.86 39.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.627 -0.508 . . . . 0.63 109.627 178.489 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.531 ' HB2' ' CD1' ' A' ' 439' ' ' LEU . 19.6 m-85 -91.47 138.83 31.27 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.822 -0.351 . . . . 0.95999999999999996 110.617 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.742 HG12 HG21 ' A' ' 414' ' ' VAL . 2.7 mp -124.33 130.35 73.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.313 -0.403 . . . . 0.48999999999999999 111.439 -179.045 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 439' ' ' LEU . 57.4 ttt-85 -99.05 122.23 42.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 2.4199999999999999 110.926 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -82.7 -173.25 4.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.506 -0.316 . . . . 2.2999999999999998 110.74 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.444 ' N ' ' OE1' ' A' ' 388' ' ' GLU . 0.4 OUTLIER -63.71 -44.62 93.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.835 0.35 . . . . 2.8199999999999998 110.828 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -71.17 5.57 2.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.115 -0.493 . . . . 1.23 111.249 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 71.35 28.89 69.05 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.021 -0.609 . . . . 1.03 113.074 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 42.3 p -93.9 110.33 22.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.668 0.27 . . . . 0.97999999999999998 111.04 179.274 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.713 HG11 HD13 ' A' ' 442' ' ' ILE . 42.1 t -74.59 131.57 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.852 -0.425 . . . . 0.55000000000000004 109.852 179.13 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -145.39 135.52 23.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.454 -0.339 . . . . 2.4300000000000002 111.038 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.515 ' HD3' HG21 ' A' ' 382' ' ' ILE . 58.9 mtt85 -58.9 150.59 23.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.967 0.413 . . . . 2.96 111.576 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -177.05 132.84 2.11 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.755 -0.657 . . . . 0.26000000000000001 112.097 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 396' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 76.7 mt-30 -90.51 129.72 36.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.64 0.257 . . . . 1.28 111.535 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.855 HG22 HD13 ' A' ' 432' ' ' ILE . 5.8 t -85.4 126.85 40.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 109.613 -0.514 . . . . 0.82999999999999996 109.613 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 70.5 mt -121.12 -40.14 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.214 0.45 . . . . 1.45 112.214 -178.758 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.546 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 98.3 mm-40 -128.6 176.45 7.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.987 0.422 . . . . 2.0800000000000001 112.04 -178.668 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 87.7 p -161.83 149.4 14.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.684 -0.689 . . . . 0.56000000000000005 110.594 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -162.49 143.8 10.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.107 0.479 . . . . 1.55 111.33 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.721 HG22 ' HA ' ' A' ' 410' ' ' ASP . 30.2 p -115.13 134.03 55.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.741 -0.663 . . . . 1.79 109.489 178.336 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.777 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.9 m -58.42 -174.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.889 -0.411 . . . . 1.95 109.889 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.777 ' H ' HG22 ' A' ' 403' ' ' THR . 4.8 mm-40 -39.64 -44.78 1.55 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 3.8700000000000001 110.207 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -94.09 129.29 40.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.712 -0.676 . . . . 3.1600000000000001 109.345 178.001 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -113.89 57.6 0.69 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.164 0.506 . . . . 2.1800000000000002 111.489 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -138.71 11.35 2.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.623 -0.717 . . . . 2.77 110.028 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -173.8 -46.01 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.077 -0.965 . . . . 2.7599999999999998 110.951 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 19.8 Cg_exo -68.62 38.85 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 123.162 2.574 . . . . 2.4900000000000002 113.897 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.721 ' HA ' HG22 ' A' ' 402' ' ' THR . 1.2 m-20 -81.28 131.78 35.31 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.417 -0.586 . . . . 2.1400000000000001 109.417 178.456 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 50.1 mt-10 -136.79 134.97 37.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.731 0.3 . . . . 2.1000000000000001 111.265 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 429' ' ' ARG . 1.4 m-85 -119.21 127.62 53.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.482 -0.326 . . . . 0.71999999999999997 111.113 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.546 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 15.0 t80 -57.82 143.5 42.08 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.483 -0.562 . . . . 0.51000000000000001 109.483 178.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.742 HG21 HG12 ' A' ' 385' ' ' ILE . 5.7 p -143.8 110.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.688 0.625 . . . . 1.1499999999999999 112.688 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -90.58 96.49 10.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.483 -0.78 . . . . 0.62 109.254 178.238 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.527 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 54.4 m-85 -51.83 125.88 16.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.248 0.547 . . . . 0.65000000000000002 111.067 -178.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.839 HG21 HD12 ' A' ' 382' ' ' ILE . 2.5 t -79.32 34.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.256 -0.884 . . . . 1.3400000000000001 111.105 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -179.53 -45.88 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.564 -0.744 . . . . 0.81999999999999995 112.679 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.851 HD23 HD23 ' A' ' 423' ' ' LEU . 7.0 mp -63.98 155.55 30.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.137 0.494 . . . . 1.6000000000000001 111.458 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.494 ' HB2' HD13 ' A' ' 423' ' ' LEU . 1.8 m120 -50.43 142.31 10.68 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.45 -0.796 . . . . 2.5299999999999998 111.693 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 421' ' ' ARG . . . . . 0.729 ' HD2' ' N ' ' A' ' 422' ' ' ARG . 7.1 ppt_? -58.4 -29.88 66.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.176 -0.466 . . . . 3.98 110.822 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 422' ' ' ARG . . . . . 0.729 ' N ' ' HD2' ' A' ' 421' ' ' ARG . 38.0 ptt180 -63.98 -37.15 86.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 3.71 110.321 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.851 HD23 HD23 ' A' ' 419' ' ' LEU . 7.0 mp -61.92 -33.35 74.08 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.877 -0.601 . . . . 1.49 110.755 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -50.63 138.19 18.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.681 -0.69 . . . . 1.2 111.141 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -170.99 -141.18 3.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.824 -0.703 . . . . 0.69999999999999996 112.506 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -122.26 132.58 54.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.859 0.361 . . . . 0.60999999999999999 110.873 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.624 HG21 HG13 ' A' ' 432' ' ' ILE . 20.3 m -110.81 155.64 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 0.89000000000000001 111.693 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.489 ' H ' ' NH1' ' A' ' 431' ' ' ARG . . . -71.35 21.32 0.69 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.065 -0.588 . . . . 1.72 113.935 -179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.51 ' HB2' ' CD1' ' A' ' 412' ' ' TYR . 37.7 tpt85 70.64 -46.17 0.62 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.138 0.792 . . . . 1.73 113.138 178.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -59.89 -14.69 16.58 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.67 0.748 . . . . 1.47 109.33 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.489 ' NH1' ' H ' ' A' ' 428' ' ' GLY . 58.0 mtt85 -79.06 -34.89 43.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.571 -1.195 . . . . 2.8399999999999999 111.221 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.855 HD13 HG22 ' A' ' 397' ' ' VAL . 65.8 mt -87.63 137.34 21.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.857 0.36 . . . . 0.46000000000000002 110.869 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.0 m -159.69 138.8 11.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.53000000000000003 110.721 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.17 -18.89 60.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 1.3500000000000001 110.811 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -108.59 132.93 53.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.105 -0.498 . . . . 2.1600000000000001 111.017 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 436' ' ' ALA . . . . . 0.457 ' HB1' HG12 ' A' ' 442' ' ' ILE . . . -66.23 -38.73 88.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.75 111.519 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -51.87 -40.73 61.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.308 -0.406 . . . . 1.3400000000000001 111.257 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -81.69 41.1 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 1.5600000000000001 110.624 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.556 ' O ' ' HD2' ' A' ' 386' ' ' ARG . 54.7 mt -152.62 -85.88 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.42 . . . . 1.1200000000000001 111.34 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.01 32.91 0.25 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.444 -0.884 . . . . 1.3600000000000001 112.857 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 54.25 36.94 58.28 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 121.144 -0.55 . . . . 1.8300000000000001 113.604 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 442' ' ' ILE . . . . . 0.713 HD13 HG11 ' A' ' 392' ' ' VAL . 48.0 mm . . . . . 0 C--N 1.327 -0.388 0 N-CA-C 111.76 0.281 . . . . 1.48 111.76 178.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.622 HD11 ' NH1' ' A' ' 429' ' ' ARG . 67.5 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.873 0.368 . . . . 1.48 111.782 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.573 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 3.6 m-20 -91.68 68.53 5.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.026 -0.534 . . . . 2.1699999999999999 110.372 178.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.543 HD11 HG12 ' A' ' 397' ' ' VAL . 75.3 mt -51.86 -34.74 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.92000000000000004 112.073 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 37.6 t -47.8 -24.8 1.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.192 -0.458 . . . . 1.71 112.201 -178.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 11.9 pt-20 -69.22 -37.82 78.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.321 -0.4 . . . . 1.9199999999999999 111.848 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -154.17 65.0 4.89 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 111.695 0.257 . . . . 2.1400000000000001 111.695 -179.086 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.85 -37.66 85.24 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.396 2.064 . . . . 0.84999999999999998 111.673 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -64.29 -33.67 76.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.684 -0.689 . . . . 1.21 111.168 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -52.19 127.96 23.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.944 0.402 . . . . 1.6599999999999999 110.935 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.452 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 45.1 mm -87.36 131.42 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.971 -0.559 . . . . 0.40999999999999998 111.604 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -111.24 144.29 40.66 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.255 -0.429 . . . . 0.63 110.026 179.104 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.52 ' C ' HD12 ' A' ' 385' ' ' ILE . 18.2 m-85 -88.92 142.43 27.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.979 -0.288 . . . . 0.95999999999999996 110.673 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.643 HG12 HG21 ' A' ' 414' ' ' VAL . 3.4 mp -123.96 133.53 69.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.981 0.42 . . . . 0.48999999999999999 111.92 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.577 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 42.7 ttt85 -87.14 117.0 25.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 2.4199999999999999 110.455 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.429 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 58.3 mtp85 -70.12 169.52 13.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.754 0.311 . . . . 2.2999999999999998 111.142 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -51.72 -45.52 63.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.191 -0.459 . . . . 2.8199999999999998 111.339 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.53 -36.05 76.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.316 -0.402 . . . . 1.23 111.021 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 120.29 36.14 0.82 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.966 -0.635 . . . . 1.03 112.5 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 391' ' ' THR . . . . . 0.429 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 17.5 p -110.71 114.48 27.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.188 0.518 . . . . 0.97999999999999998 111.289 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 439' ' ' LEU . 91.9 t -66.66 135.02 29.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.456 -0.793 . . . . 0.55000000000000004 111.842 -178.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -153.77 132.26 12.11 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.411 -0.813 . . . . 2.4300000000000002 110.38 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.452 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 73.6 mtt-85 -54.56 154.07 5.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.355 0.598 . . . . 2.96 112.354 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -169.59 135.14 3.44 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.145 -0.934 . . . . 0.26000000000000001 111.499 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -91.61 111.21 22.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.807 0.303 . . . . 1.28 111.76 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.74 HG22 HD13 ' A' ' 432' ' ' ILE . 4.1 t -74.87 129.09 36.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 109.942 -0.392 . . . . 0.82999999999999996 109.942 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 77.0 mt -121.2 -41.28 2.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.362 0.504 . . . . 1.45 112.362 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.526 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 72.5 mt-30 -135.47 177.03 8.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.963 0.411 . . . . 2.0800000000000001 111.577 -178.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 412' ' ' TYR . 80.8 p -151.53 139.39 19.91 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.901 -0.59 . . . . 0.56000000000000005 110.72 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -154.69 144.08 21.3 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.334 -0.394 . . . . 1.55 111.136 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.542 HG22 ' HA ' ' A' ' 410' ' ' ASP . 41.6 p -94.47 -121.72 0.1 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.713 -0.477 . . . . 1.79 109.713 178.224 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.755 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.71 -173.38 2.98 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.607 -0.516 . . . . 1.95 109.607 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.755 ' H ' HG22 ' A' ' 403' ' ' THR . 48.9 mt-10 -43.67 -43.42 5.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.758 0.313 . . . . 3.8700000000000001 111.389 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -70.28 -51.88 27.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 3.1600000000000001 111.308 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.08 53.06 11.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.328 0.585 . . . . 2.1800000000000002 110.864 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.431 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -162.35 12.38 0.07 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.172 -0.922 . . . . 2.77 109.273 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.697 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -161.04 -41.52 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.448 -1.251 . . . . 2.7599999999999998 111.716 -178.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.697 ' HD2' ' H ' ' A' ' 408' ' ' ALA . 75.5 Cg_exo -52.21 -62.27 0.39 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.234 1.956 . . . . 2.4900000000000002 113.708 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.542 ' HA ' HG22 ' A' ' 402' ' ' THR . 6.6 p-10 36.02 74.39 0.07 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.228 0.537 . . . . 2.1400000000000001 111.231 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.41 147.72 30.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 2.1000000000000001 110.779 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 6.0 m-85 -127.21 125.15 40.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.374 . . . . 0.71999999999999997 111.203 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.526 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 15.5 t80 -57.84 149.89 21.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.923 -0.58 . . . . 0.51000000000000001 110.414 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.643 HG21 HG12 ' A' ' 385' ' ' ILE . 11.2 p -155.82 138.05 6.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.143 0.497 . . . . 1.1499999999999999 112.212 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -115.02 101.49 9.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.68 -0.691 . . . . 0.62 110.386 179.417 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 8.6 m-85 -62.1 116.1 4.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.193 -0.458 . . . . 0.65000000000000002 111.298 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.442 ' O ' HD23 ' A' ' 419' ' ' LEU . 63.1 t -67.58 130.42 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 1.3400000000000001 111.054 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.77 -42.8 1.83 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.859 -0.686 . . . . 0.81999999999999995 112.761 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 2.0 mm? -59.33 152.85 20.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.862 0.363 . . . . 1.6000000000000001 111.209 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.754 HD21 HD13 ' A' ' 423' ' ' LEU . 11.8 p-10 -49.73 136.53 17.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 2.5299999999999998 111.349 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 421' ' ' ARG . . . . . 0.423 HH11 ' HG3' ' A' ' 421' ' ' ARG . 60.9 mtt85 -57.35 -40.47 78.13 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.84 0.682 . . . . 3.98 112.84 -178.378 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 422' ' ' ARG . . . . . 0.434 ' CG ' HD22 ' A' ' 420' ' ' ASN . 16.9 ptp180 -53.84 -29.15 39.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.777 0.323 . . . . 3.71 110.864 -179.398 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.754 HD13 HD21 ' A' ' 420' ' ' ASN . 1.2 tp -59.26 -34.13 71.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 1.49 110.858 179.056 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -48.21 138.14 9.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.945 -0.57 . . . . 1.2 111.311 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.87 -142.91 4.82 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.001 -0.618 . . . . 0.69999999999999996 112.121 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -128.6 134.59 48.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.376 . . . . 0.60999999999999999 110.639 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.765 HG21 HG13 ' A' ' 432' ' ' ILE . 29.3 m -109.38 158.76 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.944 -0.571 . . . . 0.89000000000000001 111.887 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -77.46 35.01 1.56 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.834 -0.621 . . . . 1.72 114.441 -179.135 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.622 ' NH1' HD11 ' A' ' 373' ' ' ILE . 23.6 tpt180 70.69 -70.37 0.15 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.248 0.833 . . . . 1.73 113.248 178.619 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -45.39 -16.12 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.947 0.403 . . . . 1.47 111.707 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.586 ' HB3' HG23 ' A' ' 385' ' ' ILE . 53.4 mtt85 -77.47 -39.06 47.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.956 -0.565 . . . . 2.8399999999999999 111.333 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.765 HG13 HG21 ' A' ' 427' ' ' VAL . 86.7 mt -87.04 132.07 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.155 -0.313 . . . . 0.46000000000000002 110.155 179.152 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.756 ' HB2' HD11 ' A' ' 439' ' ' LEU . 61.0 m -164.0 142.13 7.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.53000000000000003 111.136 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -58.72 -26.09 63.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.076 -0.511 . . . . 1.3500000000000001 110.793 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -121.78 135.15 54.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.161 -0.472 . . . . 2.1600000000000001 110.851 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 436' ' ' ALA . . . . . 0.498 ' HA ' HD13 ' A' ' 439' ' ' LEU . . . -70.75 -10.96 60.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.75 111.635 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.07 -40.99 77.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 1.3400000000000001 111.716 -179.288 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 438' ' ' ASP . . . . . 0.54 ' C ' HD12 ' A' ' 439' ' ' LEU . 61.1 m-20 -83.03 18.23 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.826 0.346 . . . . 1.5600000000000001 111.337 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.756 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.4 mp -118.02 -96.54 0.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.1200000000000001 111.216 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 440' ' ' GLY . . . . . 0.577 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -173.9 41.61 0.14 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.323 -0.942 . . . . 1.3600000000000001 113.431 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.9 149.76 0.09 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.662 -0.78 . . . . 1.8300000000000001 113.28 179.074 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 442' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 442' ' ' ILE . 1.5 mp . . . . . 0 CA--C 1.518 -0.28 0 N-CA-C 109.128 -0.693 . . . . 1.48 109.128 178.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.72 HG13 ' HE ' ' A' ' 429' ' ' ARG . 85.7 mt . . . . . 0 N--CA 1.462 0.13 0 CA-C-O 120.763 0.316 . . . . 1.48 111.622 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.418 ' HB2' ' CD ' ' A' ' 377' ' ' GLU . 31.6 m-20 -89.56 129.52 36.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 2.1699999999999999 109.914 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.803 HD11 HG12 ' A' ' 397' ' ' VAL . 95.5 mt -88.26 -41.51 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.409 0.522 . . . . 0.92000000000000004 112.409 -179.176 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.7 t -46.74 -21.13 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.284 -0.417 . . . . 1.71 111.865 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.418 ' CD ' ' HB2' ' A' ' 374' ' ' ASP . 6.7 mt-10 -61.77 -42.39 98.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.855 -0.611 . . . . 1.9199999999999999 111.369 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.49 ' ND2' ' HD3' ' A' ' 381' ' ' LYS . 14.0 p30 -167.64 69.79 0.91 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 2.1400000000000001 111.188 -179.21 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.47 -39.66 54.52 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.57 2.18 . . . . 0.84999999999999998 112.158 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.79 -39.29 84.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 1.21 110.69 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.49 ' HD3' ' ND2' ' A' ' 378' ' ' ASN . 82.0 tttt -54.66 130.83 41.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.144 -0.48 . . . . 1.6599999999999999 111.048 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.553 HG21 ' HB3' ' A' ' 394' ' ' ARG . 28.7 mm -84.72 135.68 24.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.072 -0.513 . . . . 0.40999999999999998 111.442 -179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -108.17 143.8 36.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.374 -0.375 . . . . 0.63 110.388 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.428 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 7.1 m-85 -88.22 133.64 33.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.603 0.24 . . . . 0.95999999999999996 110.659 179.585 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 385' ' ' ILE . 1.9 mp -121.77 130.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.75 0.31 . . . . 0.48999999999999999 110.699 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.492 ' CZ ' ' HA2' ' A' ' 390' ' ' GLY . 60.7 ttt-85 -80.71 117.15 21.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.373 -0.376 . . . . 2.4199999999999999 110.648 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.751 ' HE ' ' HA ' ' A' ' 387' ' ' ARG . 2.0 mmp_? -68.17 164.81 19.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 2.2999999999999998 110.571 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' A' ' 388' ' ' GLU . 0.5 OUTLIER -51.71 -45.02 63.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 2.8199999999999998 111.615 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.406 ' N ' ' HG2' ' A' ' 388' ' ' GLU . 40.8 p-10 -69.63 -35.72 75.48 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.679 0.252 . . . . 1.23 111.679 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.492 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 138.8 -32.45 2.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.583 -0.818 . . . . 1.03 112.561 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 72.4 p -59.1 112.24 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.082 0.468 . . . . 0.97999999999999998 111.657 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 57.1 t -72.88 140.92 17.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.738 -0.665 . . . . 0.55000000000000004 111.274 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -139.7 137.57 35.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 2.4300000000000002 110.718 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.553 ' HB3' HG21 ' A' ' 382' ' ' ILE . 55.5 mtt85 -62.38 145.04 55.01 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.914 0.388 . . . . 2.96 110.923 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -164.14 134.4 3.35 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.022 -0.608 . . . . 0.26000000000000001 112.397 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 396' ' ' GLN . . . . . 0.541 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 90.0 mt-30 -82.19 132.28 35.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.531 0.205 . . . . 1.28 111.506 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.803 HG12 HD11 ' A' ' 375' ' ' ILE . 11.7 t -99.82 122.19 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.067 -0.716 . . . . 0.82999999999999996 109.067 178.141 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.716 ' N ' HD22 ' A' ' 398' ' ' LEU . 0.7 OUTLIER -111.64 -41.91 3.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.703 0.631 . . . . 1.45 112.703 -177.026 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -132.95 176.45 8.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.993 0.425 . . . . 2.0800000000000001 111.77 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.2 p -164.27 147.45 9.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.753 -0.658 . . . . 0.56000000000000005 110.863 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -160.66 134.2 6.8 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.002 0.43 . . . . 1.55 111.41 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.752 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 35.5 p -81.42 137.44 35.66 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.246 -0.434 . . . . 1.79 110.004 178.46 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.821 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.1 m -62.13 -174.03 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 1.95 110.761 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.821 ' H ' HG22 ' A' ' 403' ' ' THR . 50.6 mt-10 -42.28 -41.84 2.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.977 0.362 . . . . 3.8700000000000001 111.977 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.732 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 24.0 t-20 -57.43 -48.48 79.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 3.1600000000000001 110.673 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.752 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.63 57.23 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 2.1800000000000002 111.997 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.521 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -168.95 10.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 2.77 110.629 179.684 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.474 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . 179.85 -43.8 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.729 -0.669 . . . . 2.7599999999999998 111.918 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.732 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 11.7 Cg_exo -71.73 49.56 1.23 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.77 2.314 . . . . 2.4900000000000002 114.193 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.8 p30 -78.17 126.73 31.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.847 0.356 . . . . 2.1400000000000001 110.504 178.599 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 400' ' ' SER . 47.4 mt-10 -114.05 134.63 54.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 2.1000000000000001 110.482 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.569 ' HB3' HG13 ' A' ' 397' ' ' VAL . 1.6 m-85 -111.91 134.05 53.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.973 0.416 . . . . 0.71999999999999997 111.941 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 17.8 t80 -66.57 138.41 57.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.691 -0.855 . . . . 0.51000000000000001 108.691 177.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.551 HG11 HG12 ' A' ' 385' ' ' ILE . 21.7 t -140.78 110.08 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 113.202 0.815 . . . . 1.1499999999999999 113.202 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 415' ' ' HIS . . . . . 0.484 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 86.4 t60 -90.1 88.5 7.29 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.661 -0.866 . . . . 0.62 108.661 177.176 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 416' ' ' TYR . . . . . 0.631 ' HB2' HD11 ' A' ' 419' ' ' LEU . 4.7 m-85 -57.95 116.01 3.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.807 0.813 . . . . 0.65000000000000002 111.482 -178.675 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.482 HG21 ' CB ' ' A' ' 394' ' ' ARG . 5.5 m -53.87 129.56 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 CA-C-N 114.027 -1.442 . . . . 1.3400000000000001 112.818 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 81.88 -52.1 4.55 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 115.415 0.926 . . . . 0.81999999999999995 115.415 177.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.924 HD13 HD23 ' A' ' 423' ' ' LEU . 0.5 OUTLIER -62.18 162.52 9.48 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.901 0.851 . . . . 1.6000000000000001 112.561 -177.706 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.461 ' O ' HD13 ' A' ' 419' ' ' LEU . 10.9 t-20 -59.68 143.51 50.5 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.507 -0.77 . . . . 2.5299999999999998 111.877 -179.28 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 421' ' ' ARG . . . . . 0.66 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 99.3 mtt180 -53.39 -20.21 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 3.98 111.716 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -55.32 -40.34 71.04 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.854 -0.612 . . . . 3.71 112.157 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.924 HD23 HD13 ' A' ' 419' ' ' LEU . 2.1 mm? -70.62 -35.13 72.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.87 0.322 . . . . 1.49 111.87 -179.249 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.66 ' OD2' ' HA ' ' A' ' 421' ' ' ARG . 62.3 m-20 -48.71 132.38 17.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.97 0.415 . . . . 1.2 111.407 -178.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.28 179.99 46.17 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.856 -0.687 . . . . 0.69999999999999996 112.33 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 426' ' ' TRP . . . . . 0.57 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 36.2 m95 -76.8 139.21 40.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.605 0.24 . . . . 0.60999999999999999 110.45 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.417 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 12.3 m -140.39 146.75 24.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.966 0.412 . . . . 0.89000000000000001 111.492 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.453 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -59.21 149.16 39.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.873 -0.68 . . . . 1.72 112.407 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.72 ' HE ' HG13 ' A' ' 373' ' ' ILE . 37.9 tpt85 -52.09 -39.62 60.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.727 0.269 . . . . 1.73 111.727 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.453 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 19.5 p-80 -55.97 -26.7 49.33 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.143 0.423 . . . . 1.47 112.143 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.417 ' HD2' ' HB ' ' A' ' 427' ' ' VAL . 57.3 mtt85 -78.09 -38.58 43.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.845 0.313 . . . . 2.8399999999999999 111.845 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.523 HG21 HG21 ' A' ' 397' ' ' VAL . 59.6 mt -88.75 134.78 27.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.88 0.371 . . . . 0.46000000000000002 111.154 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.746 ' HB2' HD21 ' A' ' 439' ' ' LEU . 71.1 m -160.64 139.74 10.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.53000000000000003 110.928 -179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -74.37 16.75 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 1.3500000000000001 111.719 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -138.47 131.31 29.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.986 0.422 . . . . 2.1600000000000001 111.133 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -67.33 -72.77 0.16 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.892 -0.594 . . . . 0.75 111.62 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -40.71 -39.3 1.05 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.927 -0.579 . . . . 1.3400000000000001 111.715 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.87 47.37 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.301 -0.409 . . . . 1.5600000000000001 111.298 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 433' ' ' SER . 94.7 mt -149.87 -84.81 0.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.644 -0.253 . . . . 1.1200000000000001 111.405 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -163.3 40.91 0.33 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.508 -0.853 . . . . 1.3600000000000001 113.089 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.21 146.83 0.32 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 1.8300000000000001 113.237 179.339 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.671 0.272 . . . . 1.48 110.99 179.843 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 77.5 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.922 0.391 . . . . 1.48 111.977 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 21.8 m-20 -88.95 137.7 32.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 2.1699999999999999 110.673 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.562 HD11 HG12 ' A' ' 397' ' ' VAL . 79.4 mt -96.48 -46.62 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.206 0.527 . . . . 0.92000000000000004 111.464 -180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 56.8 m -53.9 -18.15 3.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.297 -0.865 . . . . 1.71 111.613 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 24.1 pt-20 -74.97 -40.47 60.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.134 -0.485 . . . . 1.9199999999999999 111.917 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 378' ' ' ASN . . . . . 0.616 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 64.4 m-20 -154.86 74.57 5.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 2.1400000000000001 112.029 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.44 -40.74 81.91 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.68 2.254 . . . . 0.84999999999999998 112.172 179.313 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -67.58 -37.56 82.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.848 -0.614 . . . . 1.21 111.36 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.616 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 63.9 tttp -50.35 129.44 21.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 1.6599999999999999 111.261 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 40.2 mm -88.62 132.82 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.037 -0.529 . . . . 0.40999999999999998 111.189 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.88 143.62 34.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.931 -0.396 . . . . 0.63 109.931 179.018 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -89.72 122.9 33.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.95999999999999996 110.779 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.1 mp -106.09 123.09 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 0.48999999999999999 111.328 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.588 ' HB2' HD22 ' A' ' 439' ' ' LEU . 38.4 ttt85 -84.08 118.53 24.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 2.4199999999999999 110.534 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -71.45 157.28 38.31 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.887 -0.325 . . . . 2.2999999999999998 110.566 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.616 ' HA ' HH12 ' A' ' 431' ' ' ARG . 16.3 pt-20 -49.66 -41.2 42.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 2.8199999999999998 111.74 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -67.01 -36.24 81.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.683 -0.235 . . . . 1.23 111.138 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.411 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 136.44 -33.68 2.33 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.448 -0.882 . . . . 1.03 112.842 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 57.6 p -59.17 113.87 2.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.317 0.579 . . . . 0.97999999999999998 112.149 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.17 144.6 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.321 -0.854 . . . . 0.55000000000000004 111.351 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -151.59 129.75 11.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.006 -0.543 . . . . 2.4300000000000002 110.684 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.447 HH11 ' HG3' ' A' ' 394' ' ' ARG . 61.3 mtt85 -55.4 153.85 6.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.878 -0.601 . . . . 2.96 112.137 -179.353 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 395' ' ' GLY . . . . . 0.454 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -175.75 135.24 2.91 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.416 -0.811 . . . . 0.26000000000000001 112.114 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 396' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 24.6 mt-30 -91.5 138.06 31.87 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.944 -0.151 . . . . 1.28 111.007 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 397' ' ' VAL . . . . . 0.638 ' CG2' HD13 ' A' ' 432' ' ' ILE . 14.5 t -92.09 102.19 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.211 -0.662 . . . . 0.82999999999999996 109.211 178.27 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 398' ' ' LEU . 6.2 mp -84.95 -36.81 21.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.594 -0.73 . . . . 1.45 112.473 -177.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 399' ' ' GLN . . . . . 0.546 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 66.0 mt-30 -141.0 175.66 9.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.976 0.417 . . . . 2.0800000000000001 111.333 -178.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 93.2 p -165.63 144.22 6.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.689 -0.687 . . . . 0.56000000000000005 110.589 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.591 ' HG3' ' HB3' ' A' ' 410' ' ' ASP . 36.1 ptt180 -118.74 175.4 5.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 1.55 109.989 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 410' ' ' ASP . 26.6 p -127.82 133.38 49.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.128 0.489 . . . . 1.79 111.956 -179.161 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 403' ' ' THR . . . . . 0.813 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.4 m -63.19 -170.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.488 -0.778 . . . . 1.95 110.363 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.813 ' H ' HG22 ' A' ' 403' ' ' THR . 49.9 mt-10 -42.44 -35.61 1.08 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.667 0.27 . . . . 3.8700000000000001 110.566 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -54.17 -46.42 72.32 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.697 -0.483 . . . . 3.1600000000000001 109.697 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 402' ' ' THR . . . 62.07 64.33 1.0 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.38 -0.827 . . . . 2.1800000000000002 111.409 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -166.91 -25.1 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.416 0.524 . . . . 2.77 112.416 -179.727 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 408' ' ' ALA . . . . . 0.527 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -165.46 -47.26 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 114.101 1.148 . . . . 2.7599999999999998 114.101 -179.045 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 55.7 Cg_exo -55.51 -155.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.676 2.25 . . . . 2.4900000000000002 114.868 -177.808 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 410' ' ' ASP . . . . . 0.591 ' HB3' ' HG3' ' A' ' 401' ' ' ARG . 0.1 OUTLIER 80.38 -160.1 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.794 -1.094 . . . . 2.1400000000000001 113.056 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 426' ' ' TRP . 95.1 mt-10 -106.48 149.02 27.5 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.067 -0.515 . . . . 2.1000000000000001 111.554 -177.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.535 ' N ' ' HD1' ' A' ' 412' ' ' TYR . 0.4 OUTLIER -112.0 134.93 53.25 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.652 -0.704 . . . . 0.71999999999999997 112.176 -177.952 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.546 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 14.8 t80 -67.05 145.43 55.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.75 -0.659 . . . . 0.51000000000000001 110.419 179.318 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.519 HG11 HG12 ' A' ' 385' ' ' ILE . 13.7 t -148.57 129.48 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.127 0.788 . . . . 1.1499999999999999 113.127 -179.261 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 415' ' ' HIS . . . . . 0.46 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 56.0 t60 -105.32 104.03 13.68 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.87 -0.605 . . . . 0.62 109.539 177.38 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 416' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -66.22 128.84 37.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.933 0.397 . . . . 0.65000000000000002 111.162 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.24 128.91 36.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.86 -0.609 . . . . 1.3400000000000001 111.823 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 75.29 -47.17 1.97 Allowed Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.781 -0.645 . . . . 0.81999999999999995 113.363 179.269 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.575 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.6 mp -59.74 161.95 5.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.418 . . . . 1.6000000000000001 111.62 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 420' ' ' ASN . . . . . 0.469 ' HB3' ' HG2' ' A' ' 422' ' ' ARG . 75.8 m-20 -50.11 139.73 13.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.634 -0.712 . . . . 2.5299999999999998 111.82 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -63.59 -31.21 72.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.659 -0.701 . . . . 3.98 111.199 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 422' ' ' ARG . . . . . 0.469 ' HG2' ' HB3' ' A' ' 420' ' ' ASN . 14.6 ptp180 -52.77 -35.02 55.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 3.71 111.196 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 423' ' ' LEU . . . . . 0.575 HD12 ' HB3' ' A' ' 419' ' ' LEU . 50.8 mt -56.09 -32.13 63.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 1.49 111.357 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' A' ' 415' ' ' HIS . 1.1 m-20 -47.73 134.1 13.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.906 0.384 . . . . 1.2 111.327 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 425' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 413' ' ' TYR . . . -179.84 -142.62 5.16 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.749 . . . . 0.69999999999999996 112.242 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 426' ' ' TRP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 37.3 m95 -122.49 138.56 54.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.937 0.399 . . . . 0.60999999999999999 110.574 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.815 HG21 HG13 ' A' ' 432' ' ' ILE . 10.3 m -109.37 158.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.89000000000000001 111.652 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -75.31 27.17 1.23 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.651 -0.785 . . . . 1.72 113.391 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.672 ' H ' HG23 ' A' ' 427' ' ' VAL . 40.8 tpt85 70.9 -47.0 0.65 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.869 0.468 . . . . 1.73 112.144 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -69.95 -7.09 37.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 1.47 110.801 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.635 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 39.2 mmt180 -79.2 -37.3 38.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 2.8399999999999999 110.817 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.815 HG13 HG21 ' A' ' 427' ' ' VAL . 56.4 mt -87.88 135.8 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.46000000000000002 110.784 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 54.0 m -157.65 139.51 14.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.255 -0.43 . . . . 0.53000000000000003 111.015 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -79.21 16.31 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 1.3500000000000001 111.902 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -145.64 132.82 20.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.958 0.408 . . . . 2.1600000000000001 111.096 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 436' ' ' ALA . . . . . 0.445 ' HB1' HD11 ' A' ' 442' ' ' ILE . . . -70.52 -43.72 69.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.75 111.434 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -55.09 -40.37 70.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.225 -0.443 . . . . 1.3400000000000001 111.2 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -79.26 46.38 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 1.5600000000000001 111.164 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.588 HD22 ' HB2' ' A' ' 386' ' ' ARG . 98.3 mt -151.08 -84.04 0.09 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.502 -0.317 . . . . 1.1200000000000001 111.133 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 440' ' ' GLY . . . . . 0.541 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -175.0 52.3 0.13 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.927 -0.654 . . . . 1.3600000000000001 112.402 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 72.36 -139.51 28.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.839 -0.696 . . . . 1.8300000000000001 112.407 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 442' ' ' ILE . . . . . 0.445 HD11 ' HB1' ' A' ' 436' ' ' ALA . 33.9 mm . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 109.95 -0.389 . . . . 1.48 109.95 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 112.534 -0.227 . . . . 11.640000000000001 112.534 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 79.8 p -172.57 130.8 0.56 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.683 0.277 . . . . 9.8599999999999994 110.726 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 70.0 t60 59.35 109.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.947 -0.57 . . . . 8.0700000000000003 111.084 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 26.5 mmt -71.87 130.44 41.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 5.5099999999999998 110.793 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -59.87 150.98 66.35 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 6.0599999999999996 110.58 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.87 38.39 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.603 2.202 . . . . 6.1600000000000001 112.809 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.482 ' C ' HD13 ' A' ' 369' ' ' LEU . 2.8 tm? -170.24 -40.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 6.9400000000000004 110.461 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.419 ' O ' ' HG3' ' A' ' 370' ' ' MET . 13.9 tpt -77.67 34.42 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 5.6299999999999999 110.565 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 372' ' ' LYS . 83.8 mt-30 -80.97 63.03 5.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 5.04 110.643 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.608 ' HB2' ' OH ' ' A' ' 412' ' ' TYR . 63.5 pttt 53.04 138.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.04 0.837 . . . . 5.3899999999999997 112.298 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.417 HD11 ' NH2' ' A' ' 429' ' ' ARG . 70.1 mt -48.68 129.15 5.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.61 -0.723 . . . . 1.48 112.14 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -89.74 130.72 35.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.694 -0.685 . . . . 2.1699999999999999 110.689 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.5 mt -81.73 -43.63 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.92000000000000004 111.394 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 72.7 p -65.46 74.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.979 -0.555 . . . . 1.71 111.211 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -173.83 -27.19 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.561 -0.745 . . . . 1.9199999999999999 109.964 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 34.9 p30 -165.67 57.7 0.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.372 -0.831 . . . . 2.1400000000000001 111.392 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 51.2 Cg_exo -53.67 -39.12 84.46 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.247 1.964 . . . . 0.84999999999999998 111.604 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.46 -32.4 73.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.751 -0.659 . . . . 1.21 110.943 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 84.6 tttt -50.4 127.06 16.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.241 -0.436 . . . . 1.6599999999999999 111.117 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 47.4 mm -83.46 127.39 39.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.40999999999999998 110.743 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -102.32 143.34 32.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.313 . . . . 0.63 110.694 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -92.25 140.01 30.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.272 -0.422 . . . . 0.95999999999999996 110.282 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 385' ' ' ILE . 1.0 OUTLIER -133.49 126.88 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.48999999999999999 111.111 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 45.2 ttt85 -79.83 116.77 20.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.008 -0.542 . . . . 2.4199999999999999 110.431 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -69.98 155.55 40.42 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.677 -0.409 . . . . 2.2999999999999998 110.21 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -51.26 -45.24 61.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 2.8199999999999998 111.55 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -56.96 -34.61 68.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.086 -0.709 . . . . 1.23 109.086 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 132.57 -36.72 2.13 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.494 -0.775 . . . . 1.03 112.947 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 82.3 p -59.57 112.83 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.182 0.515 . . . . 0.97999999999999998 112.163 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.5 142.38 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.707 -0.679 . . . . 0.55000000000000004 110.696 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -147.94 143.94 27.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.38 . . . . 2.4300000000000002 111.254 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -55.84 154.64 6.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.906 -0.588 . . . . 2.96 111.809 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -171.35 129.68 1.82 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.688 -0.687 . . . . 0.26000000000000001 112.316 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -84.89 128.5 34.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.75 0.309 . . . . 1.28 110.752 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.7 OUTLIER -97.2 134.5 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.507 -0.315 . . . . 0.82999999999999996 110.424 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 76.3 mt -120.57 -43.76 2.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.971 0.73 . . . . 1.45 112.971 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.413 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 80.5 mt-30 -122.75 174.78 6.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.117 0.484 . . . . 2.0800000000000001 112.228 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.4 p -166.3 144.92 5.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.513 -0.767 . . . . 0.56000000000000005 110.608 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.51 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 39.3 ptt180 -143.54 134.72 25.76 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.809 0.337 . . . . 1.55 110.842 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.633 HG22 ' HB3' ' A' ' 410' ' ' ASP . 18.0 p -98.85 38.02 1.43 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.098 0.407 . . . . 1.79 112.098 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.907 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.0 m 47.52 -173.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.285 -0.416 . . . . 1.95 111.249 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.907 ' H ' HG22 ' A' ' 403' ' ' THR . 94.4 mt-10 -68.68 -41.62 78.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.799 0.333 . . . . 3.8700000000000001 111.402 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.558 ' OD1' ' HB3' ' A' ' 407' ' ' ALA . 24.3 t-20 -54.57 -52.48 61.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.154 -0.476 . . . . 3.1600000000000001 111.311 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 55.55 59.67 3.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 2.1800000000000002 111.756 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.558 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -163.51 11.08 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.459 0.647 . . . . 2.77 110.024 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.638 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -177.57 -49.77 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 114.808 -1.087 . . . . 2.7599999999999998 110.23 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 30.8 Cg_endo -62.2 145.62 96.17 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.408 2.072 . . . . 2.4900000000000002 112.425 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.633 ' HB3' HG22 ' A' ' 402' ' ' THR . 12.5 p-10 -178.47 124.65 0.11 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.047 -0.524 . . . . 2.1400000000000001 110.763 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 400' ' ' SER . 10.8 mp0 -129.89 137.89 50.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.947 -0.57 . . . . 2.1000000000000001 110.127 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.608 ' OH ' ' HB2' ' A' ' 372' ' ' LYS . 1.4 m-85 -109.76 133.41 53.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.883 0.373 . . . . 0.71999999999999997 111.664 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 30.9 t80 -72.9 120.72 18.92 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.439 -0.578 . . . . 0.51000000000000001 109.439 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.483 HG21 HG12 ' A' ' 385' ' ' ILE . 8.8 p -112.56 138.75 40.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.584 0.587 . . . . 1.1499999999999999 112.584 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' HIS . . . . . 0.513 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 83.8 t60 -120.81 88.95 3.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.218 -0.901 . . . . 0.62 109.412 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.413 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 59.9 m-85 -52.85 116.2 2.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.65000000000000002 111.318 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.3 t -62.11 128.89 24.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 1.3400000000000001 111.371 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.39 -42.44 1.95 Allowed Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.776 -0.647 . . . . 0.81999999999999995 113.351 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.675 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.8 mp -59.45 161.06 6.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.013 0.435 . . . . 1.6000000000000001 111.576 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.616 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 4.9 m120 -49.78 140.91 10.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.514 -0.766 . . . . 2.5299999999999998 111.925 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ARG . . . . . 0.522 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 88.7 mtm180 -65.23 -36.45 84.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.867 -0.606 . . . . 3.98 110.829 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 420' ' ' ASN . 3.7 ptm85 -55.65 -35.57 66.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.281 -0.418 . . . . 3.71 110.643 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 419' ' ' LEU . 76.7 mt -59.02 -35.17 72.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 1.49 111.394 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.522 ' OD2' ' HA ' ' A' ' 421' ' ' ARG . 48.9 m-20 -54.69 139.7 38.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 1.2 111.901 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 179.45 -153.35 12.11 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.472 -0.785 . . . . 0.69999999999999996 111.852 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' TRP . . . . . 0.51 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 77.0 m95 -94.93 140.48 29.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.833 0.349 . . . . 0.60999999999999999 111.082 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.53 ' CG2' HD11 ' A' ' 432' ' ' ILE . 16.1 m -138.76 137.5 42.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.032 -0.531 . . . . 0.89000000000000001 111.399 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.495 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -62.22 150.13 47.03 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.819 -0.628 . . . . 1.72 112.591 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.417 ' NH2' HD11 ' A' ' 373' ' ' ILE . 41.0 tpt85 -53.61 -38.17 63.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 1.73 111.302 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.495 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 19.5 p-80 -58.08 -29.86 65.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.952 0.352 . . . . 1.47 111.952 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.05 -36.13 48.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.578 -0.283 . . . . 2.8399999999999999 111.215 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 412' ' ' TYR . 54.1 mt -89.28 139.7 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.945 0.402 . . . . 0.46000000000000002 111.366 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.6 m -160.97 139.51 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.53000000000000003 110.651 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -63.78 -26.46 68.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 1.3500000000000001 111.281 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.455 ' OD1' ' HB2' ' A' ' 437' ' ' ASP . 12.0 t-20 -109.62 134.06 52.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.92 0.39 . . . . 2.1600000000000001 110.691 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -73.37 -39.85 64.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.75 112.275 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' ASP . . . . . 0.534 ' HA ' ' HA2' ' A' ' 441' ' ' GLY . 57.0 m-20 -49.69 -40.87 41.66 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.787 0.291 . . . . 1.3400000000000001 111.787 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.4 -40.96 94.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.348 . . . . 1.5600000000000001 110.97 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.88 -83.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 1.1200000000000001 111.558 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -138.59 34.36 2.12 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.492 -0.861 . . . . 1.3600000000000001 113.077 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 437' ' ' ASP . . . 43.63 44.17 6.67 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.365 -0.445 . . . . 1.8300000000000001 113.732 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 442' ' ' ILE . 48.0 mm 70.99 73.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.534 0.683 . . . . 1.48 111.476 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.526 ' O ' HG22 ' A' ' 443' ' ' THR . 36.4 m 45.45 59.13 3.74 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.579 0.955 . . . . 3.0499999999999998 113.579 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 441' ' ' GLY . 16.1 m -151.72 127.43 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 115.756 -0.656 . . . . 4.1799999999999997 110.123 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.34 126.05 86.9 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.409 -0.359 . . . . 4.9900000000000002 111.31 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.76 140.28 35.24 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.62 2.214 . . . . 7.4000000000000004 112.055 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . -54.66 128.08 61.16 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.339 -0.391 . . . . 9.0600000000000005 110.966 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 447' ' ' ALA . 36.2 Cg_exo -60.44 131.36 37.94 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.535 2.157 . . . . 11.06 112.436 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 22.7 Cg_exo -64.68 133.19 35.63 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.623 2.215 . . . . 13.5 112.161 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 94.3 mt -80.99 46.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 15.76 110.986 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . 57.72 62.92 5.01 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.313 -0.403 . . . . 16.739999999999998 110.932 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.65 135.27 41.27 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.519 2.146 . . . . 18.530000000000001 112.648 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -171.8 128.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.892 -0.594 . . . . 20.550000000000001 110.513 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.207 -0.902 . . . . 21.219999999999999 110.915 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 112.452 -0.259 . . . . 11.640000000000001 112.452 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.5 t 64.25 131.41 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.953 0.406 . . . . 9.8599999999999994 111.278 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -174.37 58.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.097 -0.502 . . . . 8.0700000000000003 110.502 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 67.9 mtm -58.54 140.52 54.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 5.5099999999999998 110.826 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.52 ' HB2' ' HG2' ' A' ' 370' ' ' MET . 55.3 m-20 61.03 120.22 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.005 -0.543 . . . . 6.0599999999999996 111.563 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.67 49.17 3.09 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.657 2.238 . . . . 6.1600000000000001 112.861 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.672 HD12 ' N ' ' A' ' 370' ' ' MET . 4.5 pp -155.42 -33.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.709 -0.223 . . . . 6.9400000000000004 111.586 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.672 ' N ' HD12 ' A' ' 369' ' ' LEU . 22.4 ptm -78.53 42.9 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.599 -0.273 . . . . 5.6299999999999999 111.449 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -56.25 134.12 53.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.653 0.263 . . . . 5.04 110.473 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.421 ' HD2' ' CZ ' ' A' ' 429' ' ' ARG . 48.3 mmtm -145.74 135.27 23.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.464 -0.335 . . . . 5.3899999999999997 111.374 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.659 HG22 HG13 ' A' ' 375' ' ' ILE . 31.4 mm 57.04 127.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.793 -0.64 . . . . 1.48 112.448 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 377' ' ' GLU . 45.5 m-20 -106.19 69.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.711 -0.677 . . . . 2.1699999999999999 110.489 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.844 HD11 HG12 ' A' ' 397' ' ' VAL . 73.5 mt -60.67 -82.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.036 0.754 . . . . 0.92000000000000004 113.036 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 375' ' ' ILE . 52.0 m -49.93 -28.73 7.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.121 -0.49 . . . . 1.71 111.814 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 374' ' ' ASP . 8.5 mt-10 -70.44 -38.25 74.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.698 -0.683 . . . . 1.9199999999999999 111.144 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.527 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 51.1 m-20 -146.04 66.17 11.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 2.1400000000000001 111.68 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.13 -40.65 76.33 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.691 2.261 . . . . 0.84999999999999998 112.227 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.05 -37.13 85.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.887 -0.597 . . . . 1.21 111.327 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.3 tttp -51.17 125.63 14.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.399 . . . . 1.6599999999999999 111.124 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.936 HD12 HG21 ' A' ' 417' ' ' VAL . 42.5 mm -87.04 132.87 31.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.973 -0.558 . . . . 0.40999999999999998 111.47 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -107.25 143.69 35.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.371 -0.377 . . . . 0.63 110.361 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 436' ' ' ALA . 2.7 m-85 -92.64 138.35 31.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.667 0.27 . . . . 0.95999999999999996 110.641 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 385' ' ' ILE . 3.0 mp -123.01 135.45 63.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.893 0.378 . . . . 0.48999999999999999 111.267 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.662 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 56.3 ttt-85 -92.44 121.73 34.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 2.4199999999999999 111.204 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -79.52 156.64 27.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.546 -0.297 . . . . 2.2999999999999998 110.412 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -51.54 -45.45 62.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 2.8199999999999998 111.036 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -59.44 -32.53 70.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 1.23 110.295 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 112.33 37.75 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.894 -0.593 . . . . 1.03 112.828 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 62.9 p -120.84 112.34 18.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.863 0.363 . . . . 0.97999999999999998 111.342 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 87.0 t -69.6 138.92 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.55000000000000004 111.21 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -149.37 138.81 21.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.11 -0.496 . . . . 2.4300000000000002 110.978 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.495 ' HD2' HG21 ' A' ' 382' ' ' ILE . 73.8 mtm-85 -57.41 150.28 18.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.545 . . . . 2.96 111.802 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -175.7 132.98 2.26 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.586 -0.734 . . . . 0.26000000000000001 111.856 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 26.1 mt-30 -95.2 129.99 42.1 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.851 0.315 . . . . 1.28 111.851 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.844 HG12 HD11 ' A' ' 375' ' ' ILE . 21.5 t -85.9 132.38 32.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.94 -0.393 . . . . 0.82999999999999996 109.94 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.429 ' C ' HD13 ' A' ' 375' ' ' ILE . 91.9 mt -121.02 -40.82 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.575 0.583 . . . . 1.45 112.575 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.48 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 30.4 mm100 -136.86 176.46 8.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.231 0.538 . . . . 2.0800000000000001 112.25 -178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.7 p -158.0 140.13 14.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.369 -0.832 . . . . 0.56000000000000005 109.947 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.447 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 38.0 ptt180 -142.31 137.05 30.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.066 0.46 . . . . 1.55 112.035 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 409' ' ' PRO . 42.1 p -77.42 137.46 38.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 1.79 110.312 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.808 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.7 m -62.4 -174.29 0.06 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.03 -0.359 . . . . 1.95 110.03 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.808 ' H ' HG22 ' A' ' 403' ' ' THR . 55.5 mt-10 -48.21 -40.69 25.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.8 0.333 . . . . 3.8700000000000001 110.695 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.517 ' O ' ' HD2' ' A' ' 409' ' ' PRO . 50.1 t30 -80.5 54.19 2.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.979 -0.555 . . . . 3.1600000000000001 110.664 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . -51.43 98.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.131 0.491 . . . . 2.1800000000000002 110.995 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -177.28 -29.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.378 -0.828 . . . . 2.77 109.978 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.666 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -145.57 -51.21 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.106 -0.952 . . . . 2.7599999999999998 111.259 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.666 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 51.0 Cg_exo -55.46 145.71 66.97 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.457 2.105 . . . . 2.4900000000000002 112.354 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.402 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 12.8 p-10 -173.01 128.62 0.47 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.153 0.502 . . . . 2.1400000000000001 111.326 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 400' ' ' SER . 52.2 mp0 -108.73 144.25 36.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.643 -0.708 . . . . 2.1000000000000001 109.98 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.433 ' N ' ' HD1' ' A' ' 412' ' ' TYR . 0.8 OUTLIER -109.15 124.18 50.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.079 0.466 . . . . 0.71999999999999997 111.841 -178.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 11.9 t80 -63.96 149.9 46.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.567 -0.742 . . . . 0.51000000000000001 109.341 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 12.3 p -153.78 137.52 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.199 0.523 . . . . 1.1499999999999999 112.356 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -118.46 107.46 13.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.415 -0.811 . . . . 0.62 109.553 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.467 ' CD2' HD22 ' A' ' 419' ' ' LEU . 37.3 m-85 -62.13 127.82 33.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.081 0.467 . . . . 0.65000000000000002 111.218 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.936 HG21 HD12 ' A' ' 382' ' ' ILE . 2.4 t -82.49 34.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.518 -0.764 . . . . 1.3400000000000001 111.223 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -176.81 -48.39 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.769 -0.729 . . . . 0.81999999999999995 112.783 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.605 ' HB3' HD23 ' A' ' 423' ' ' LEU . 7.0 mp -62.75 150.37 41.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 1.6000000000000001 110.916 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.415 ' N ' HD23 ' A' ' 423' ' ' LEU . 10.7 t-20 -53.09 165.91 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.943 -0.571 . . . . 2.5299999999999998 111.157 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -64.22 -27.56 69.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 3.98 110.543 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -53.44 -39.75 64.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.802 -0.635 . . . . 3.71 111.047 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.655 ' H ' HD22 ' A' ' 423' ' ' LEU . 1.6 mm? -70.9 -34.82 71.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.178 -0.465 . . . . 1.49 110.502 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -53.76 131.56 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.798 -0.637 . . . . 1.2 111.25 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 169.72 -146.39 10.01 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.867 -0.606 . . . . 0.69999999999999996 112.209 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' TRP . . . . . 0.447 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 57.0 m95 -103.75 140.09 38.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.801 0.334 . . . . 0.60999999999999999 110.722 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.461 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 32.0 m -141.04 144.7 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.89000000000000001 111.097 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -59.0 148.69 39.43 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.961 -0.638 . . . . 1.72 112.835 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.421 ' CZ ' ' HD2' ' A' ' 372' ' ' LYS . 18.3 tpt180 -52.3 -39.81 61.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.765 0.317 . . . . 1.73 111.316 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.539 ' ND1' ' HG3' ' A' ' 431' ' ' ARG . 6.1 p80 -57.09 -27.5 61.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 1.47 111.973 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.539 ' HG3' ' ND1' ' A' ' 430' ' ' HIS . 67.9 mtt-85 -78.51 -38.84 39.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.637 0.236 . . . . 2.8399999999999999 111.637 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.763 HD13 HG22 ' A' ' 397' ' ' VAL . 51.9 mt -87.91 131.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.46000000000000002 110.836 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.765 ' HB2' HD21 ' A' ' 439' ' ' LEU . 71.4 m -161.15 140.18 10.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.591 . . . . 0.53000000000000003 111.089 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -60.19 -24.47 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.035 -0.53 . . . . 1.3500000000000001 111.211 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.425 ' O ' ' HG ' ' A' ' 439' ' ' LEU . 24.0 t-20 -108.4 128.8 55.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.407 -0.36 . . . . 2.1600000000000001 110.944 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' ALA . . . . . 0.555 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -83.3 -40.12 19.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.75 112.058 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -47.96 -40.59 22.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.43 -0.35 . . . . 1.3400000000000001 111.386 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -70.64 -37.12 73.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 1.5600000000000001 110.902 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.765 HD21 ' HB2' ' A' ' 433' ' ' SER . 84.1 mt -57.32 -84.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.942 -0.572 . . . . 1.1200000000000001 111.778 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -172.07 40.6 0.17 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.527 -0.844 . . . . 1.3600000000000001 112.885 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.93 143.54 0.06 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.802 -0.713 . . . . 1.8300000000000001 112.861 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.8 82.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.756 0.312 . . . . 1.48 110.204 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.699 ' O ' HG12 ' A' ' 444' ' ' VAL . 21.5 m 62.69 133.22 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.94 -0.573 . . . . 3.0499999999999998 110.767 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.699 HG12 ' O ' ' A' ' 443' ' ' THR . 0.8 OUTLIER 57.76 132.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.368 -0.833 . . . . 4.1799999999999997 111.707 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.517 HD23 ' N ' ' A' ' 445' ' ' LEU . 2.3 pt? -152.84 139.29 12.33 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.693 -0.685 . . . . 4.9900000000000002 110.944 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.04 144.5 58.1 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.742 2.295 . . . . 7.4000000000000004 112.778 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -169.24 139.34 1.79 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.851 -0.613 . . . . 9.0600000000000005 110.787 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.58 135.98 63.1 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.512 2.141 . . . . 11.06 112.056 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.8 119.12 6.08 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.251 1.967 . . . . 13.5 112.201 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 450' ' ' LEU . 39.6 tp 179.22 44.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.855 -0.611 . . . . 15.76 109.948 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 453' ' ' ASP . . . -173.95 150.61 1.67 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.861 -0.608 . . . . 16.739999999999998 110.769 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.24 30.18 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.43 2.087 . . . . 18.530000000000001 112.802 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 451' ' ' ALA . 50.6 p-10 -76.04 148.28 38.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.49 -0.323 . . . . 20.550000000000001 110.625 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.237 -0.887 . . . . 21.219999999999999 110.936 -179.857 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.454 -0.259 . . . . 11.640000000000001 112.454 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 51.4 m -80.15 45.94 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.735 0.302 . . . . 9.8599999999999994 110.99 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -63.08 141.03 58.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 8.0700000000000003 111.098 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' MET . . . . . 0.488 ' CE ' ' HA ' ' A' ' 408' ' ' ALA . 18.0 ptp -67.85 135.97 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.357 -0.383 . . . . 5.5099999999999998 110.426 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 371' ' ' GLN . 55.9 m-20 -62.31 122.14 71.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.424 -0.353 . . . . 6.0599999999999996 110.969 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.05 36.33 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.369 2.046 . . . . 6.1600000000000001 112.223 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.832 HD12 ' N ' ' A' ' 370' ' ' MET . 2.2 pp -153.19 -31.69 0.13 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.01 -0.541 . . . . 6.9400000000000004 111.113 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.832 ' N ' HD12 ' A' ' 369' ' ' LEU . 69.0 mtm -154.19 55.54 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 5.6299999999999999 110.209 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.573 ' O ' ' HG3' ' A' ' 372' ' ' LYS . 17.2 pt20 -75.38 30.34 0.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.023 -0.535 . . . . 5.04 111.823 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.584 ' NZ ' ' HB2' ' A' ' 372' ' ' LYS . 9.8 mtmp? -164.87 134.0 3.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.682 -0.69 . . . . 5.3899999999999997 110.435 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.404 ' HB ' ' CE2' ' A' ' 412' ' ' TYR . 68.0 mt -78.2 136.56 23.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.199 -0.455 . . . . 1.48 111.184 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -89.36 129.65 35.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.389 -0.369 . . . . 2.1699999999999999 110.938 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 88.8 mt -95.56 -45.96 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.92000000000000004 111.531 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 64.7 m -65.08 72.69 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.397 -0.82 . . . . 1.71 111.643 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.414 ' HG3' ' OD1' ' A' ' 378' ' ' ASN . 11.9 pt-20 -175.11 -33.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 1.9199999999999999 110.781 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' A' ' 381' ' ' LYS . 30.5 p30 -168.53 60.16 0.44 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.532 . . . . 2.1400000000000001 111.582 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.06 -37.78 79.54 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.289 1.993 . . . . 0.84999999999999998 111.543 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.8 -33.45 75.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.646 . . . . 1.21 110.881 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 86.0 tttt -51.44 134.52 28.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.104 -0.498 . . . . 1.6599999999999999 111.294 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 38.3 mm -82.95 136.26 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.025 -0.534 . . . . 0.40999999999999998 111.268 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.41 ' HB3' ' CG2' ' A' ' 432' ' ' ILE . 43.1 m-85 -114.41 143.94 44.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.554 -0.293 . . . . 0.63 110.452 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 5.3 m-85 -90.07 135.48 33.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.391 -0.368 . . . . 0.95999999999999996 110.718 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.5 mp -118.7 130.47 73.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.4 -0.364 . . . . 0.48999999999999999 110.984 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.59 ' HD2' ' O ' ' A' ' 439' ' ' LEU . 30.1 ttt85 -90.46 121.77 32.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.465 -0.334 . . . . 2.4199999999999999 110.777 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -79.08 163.03 25.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.331 -0.395 . . . . 2.2999999999999998 110.356 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -57.34 -42.62 82.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.628 0.251 . . . . 2.8199999999999998 110.85 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -60.47 -16.84 40.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.186 0.517 . . . . 1.23 110.05 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 91.47 40.84 5.28 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.417 -0.81 . . . . 1.03 112.52 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.882 HG22 HD11 ' A' ' 445' ' ' LEU . 60.9 p -120.99 111.31 17.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.97999999999999998 111.437 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.73 135.77 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.55000000000000004 111.0 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -150.0 139.01 21.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 2.4300000000000002 110.81 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -56.47 148.4 19.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.133 0.492 . . . . 2.96 111.788 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.41 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -171.48 128.01 1.52 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.461 -0.791 . . . . 0.26000000000000001 111.769 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -81.63 128.62 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.849 0.357 . . . . 1.28 111.195 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.859 HG23 HG22 ' A' ' 414' ' ' VAL . 1.0 OUTLIER -101.32 126.0 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.772 -0.455 . . . . 0.82999999999999996 109.772 178.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 50.7 mt -120.71 -34.46 3.57 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.674 0.62 . . . . 1.45 112.674 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 413' ' ' TYR . 70.4 mt-30 -118.97 166.97 12.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.038 0.447 . . . . 2.0800000000000001 111.807 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.7 p -165.93 151.62 8.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.679 -0.691 . . . . 0.56000000000000005 110.729 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -161.24 134.69 6.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.906 0.384 . . . . 1.55 111.314 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.584 ' O ' ' HG2' ' A' ' 409' ' ' PRO . 20.4 p -101.0 39.22 1.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 1.79 110.617 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.825 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.5 m 47.31 -174.32 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.618 -0.719 . . . . 1.95 111.004 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.825 ' H ' HG22 ' A' ' 403' ' ' THR . 0.4 OUTLIER -77.77 -40.54 40.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 3.8700000000000001 110.992 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -58.32 -51.31 70.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.513 . . . . 3.1600000000000001 111.276 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.471 ' C ' ' HD2' ' A' ' 409' ' ' PRO . . . 65.83 -175.08 0.18 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.993 0.425 . . . . 2.1800000000000002 110.366 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . 62.35 11.35 4.49 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.605 -0.725 . . . . 2.77 112.05 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.558 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -168.74 -54.78 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.466 -0.334 . . . . 2.7599999999999998 111.264 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.584 ' HG2' ' O ' ' A' ' 402' ' ' THR . 47.6 Cg_endo -68.02 148.55 75.98 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.478 2.119 . . . . 2.4900000000000002 112.386 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.552 ' HB3' HG22 ' A' ' 402' ' ' THR . 40.0 p-10 -175.51 132.54 0.28 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.901 -0.59 . . . . 2.1400000000000001 110.662 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 96.7 mt-10 -151.32 137.16 18.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 2.1000000000000001 111.202 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.627 ' CE1' ' HG2' ' A' ' 429' ' ' ARG . 3.9 m-85 -117.09 128.73 55.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.71999999999999997 111.727 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 20.0 t80 -64.05 135.82 56.75 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.953 -0.567 . . . . 0.51000000000000001 109.986 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.859 HG22 HG23 ' A' ' 397' ' ' VAL . 60.4 t -129.28 139.5 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.813 0.671 . . . . 1.1499999999999999 112.813 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -120.31 89.32 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.059 -0.973 . . . . 0.62 109.142 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.495 ' H ' ' HD1' ' A' ' 416' ' ' TYR . 7.3 m-85 -54.45 116.0 2.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.88 -0.6 . . . . 0.65000000000000002 111.349 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 65.2 t -61.6 125.83 18.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.791 -0.641 . . . . 1.3400000000000001 111.245 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.56 -43.44 1.85 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.745 -0.661 . . . . 0.81999999999999995 113.101 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.602 ' HB3' HD22 ' A' ' 423' ' ' LEU . 7.6 mp -59.74 152.11 23.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.982 0.42 . . . . 1.6000000000000001 111.389 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.403 ' HB2' HD13 ' A' ' 423' ' ' LEU . 63.1 m-80 -50.36 144.13 7.9 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.659 -0.7 . . . . 2.5299999999999998 111.837 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -58.6 -34.87 71.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.603 -0.726 . . . . 3.98 111.45 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' ARG . . . . . 0.678 ' HG3' HD12 ' A' ' 423' ' ' LEU . 14.8 ptp180 -51.35 -37.07 45.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 3.71 111.635 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.678 HD12 ' HG3' ' A' ' 422' ' ' ARG . 10.6 mp -61.1 -33.95 74.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.5 -0.318 . . . . 1.49 111.106 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -48.87 138.25 11.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.241 -0.436 . . . . 1.2 111.068 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -176.17 -137.79 2.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.647 -0.787 . . . . 0.69999999999999996 112.7 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' TRP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 38.4 m95 -130.46 141.35 50.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.063 0.458 . . . . 0.60999999999999999 110.905 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 429' ' ' ARG . 4.6 m -108.2 156.77 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.683 -0.689 . . . . 0.89000000000000001 110.888 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -79.06 35.34 1.92 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.394 -0.908 . . . . 1.72 111.503 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.77 ' H ' HG23 ' A' ' 427' ' ' VAL . 0.6 OUTLIER 66.0 -73.24 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.003 0.521 . . . . 1.73 110.651 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -52.51 -18.33 1.65 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.514 -0.312 . . . . 1.47 111.664 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.458 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 64.5 mtt85 -78.73 28.57 0.21 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.6 0.238 . . . . 2.8399999999999999 111.039 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.669 ' CD1' HG21 ' A' ' 427' ' ' VAL . 42.4 mt -150.27 138.8 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.82 0.343 . . . . 0.46000000000000002 111.036 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 68.1 m -163.96 140.62 6.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.493 . . . . 0.53000000000000003 110.785 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -55.59 -24.29 32.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 1.3500000000000001 111.278 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -108.73 129.81 55.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.113 0.482 . . . . 2.1600000000000001 111.034 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -74.24 -31.93 62.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.768 -0.651 . . . . 0.75 111.648 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -44.64 -77.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 1.3400000000000001 111.735 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -47.37 -38.52 13.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 1.5600000000000001 111.81 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.59 ' O ' ' HD2' ' A' ' 386' ' ' ARG . 96.4 mt -61.27 -42.45 98.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.882 0.327 . . . . 1.1200000000000001 111.882 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 440' ' ' GLY . . . . . 0.41 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . 165.01 21.58 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.354 -0.927 . . . . 1.3600000000000001 112.881 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 443' ' ' THR . . . 64.06 153.73 0.09 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.661 -0.78 . . . . 1.8300000000000001 112.472 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.516 ' O ' HG23 ' A' ' 444' ' ' VAL . 45.9 mm -58.26 84.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.646 0.26 . . . . 1.48 110.451 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 441' ' ' GLY . 14.8 t 44.38 35.79 1.42 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.789 0.804 . . . . 3.0499999999999998 111.398 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 442' ' ' ILE . 40.7 t -99.31 65.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.566 -1.197 . . . . 4.1799999999999997 110.958 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.882 HD11 HG22 ' A' ' 391' ' ' THR . 7.0 mp -64.98 135.81 96.55 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.504 -0.317 . . . . 4.9900000000000002 110.87 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.36 138.05 78.41 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.745 2.297 . . . . 7.4000000000000004 112.69 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -172.24 132.13 0.71 Allowed Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.946 -0.57 . . . . 9.0600000000000005 110.815 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 52.3 Cg_endo -69.75 133.15 24.9 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.465 2.11 . . . . 11.06 112.577 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 27.1 Cg_exo -62.09 140.26 83.12 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.766 2.311 . . . . 13.5 112.277 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 92.1 mt 60.74 61.65 1.64 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.235 -0.439 . . . . 15.76 110.931 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -148.34 135.52 10.54 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 16.739999999999998 111.076 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.0 134.85 44.86 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.627 2.218 . . . . 18.530000000000001 112.356 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 36.2 t70 64.37 135.89 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.952 -0.567 . . . . 20.550000000000001 111.365 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.151 -0.928 . . . . 21.219999999999999 110.91 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.485 -0.246 . . . . 11.640000000000001 112.485 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 50.6 m 58.03 -142.04 0.71 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.692 -0.114 . . . . 9.8599999999999994 110.692 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 64.66 139.59 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.882 0.373 . . . . 8.0700000000000003 110.848 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 21.1 ptt? -146.55 56.65 1.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.947 0.403 . . . . 5.5099999999999998 111.338 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 62.29 122.88 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.631 -0.713 . . . . 6.0599999999999996 112.298 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -85.1 49.56 2.59 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.953 2.436 . . . . 6.1600000000000001 112.276 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.515 ' C ' HD13 ' A' ' 369' ' ' LEU . 2.4 tm? -158.7 -54.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 6.9400000000000004 110.728 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' MET . . . . . . . . . . . . . 54.4 ttp -82.66 56.94 3.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.226 -0.443 . . . . 5.6299999999999999 110.28 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -49.65 120.25 4.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.901 -0.591 . . . . 5.04 111.249 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 373' ' ' ILE . 21.7 pttp 34.52 56.98 0.69 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.365 -0.834 . . . . 5.3899999999999997 112.66 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.598 HD11 ' CZ ' ' A' ' 429' ' ' ARG . 75.9 mt 52.14 126.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.343 0.868 . . . . 1.48 113.343 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.78 129.76 36.13 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.329 -0.619 . . . . 2.1699999999999999 109.329 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.6 mt -84.56 -40.87 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.62 0.6 . . . . 0.92000000000000004 112.62 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.6 t -49.54 -17.76 0.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.016 0.436 . . . . 1.71 111.22 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -56.39 -43.73 79.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.516 -0.766 . . . . 1.9199999999999999 111.495 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' A' ' 381' ' ' LYS . 13.6 p30 -171.11 69.1 0.49 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 2.1400000000000001 111.392 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.13 -40.05 60.37 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.418 2.079 . . . . 0.84999999999999998 112.047 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -60.55 -36.33 78.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.511 . . . . 1.21 110.844 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 58.9 tttm -52.15 132.81 33.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.18 -0.464 . . . . 1.6599999999999999 111.431 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 394' ' ' ARG . 43.2 mm -86.47 131.55 34.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.011 -0.541 . . . . 0.40999999999999998 111.029 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -105.47 143.29 33.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.547 -0.297 . . . . 0.63 110.58 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.59 140.39 29.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.347 -0.388 . . . . 0.95999999999999996 110.474 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.646 ' N ' HD12 ' A' ' 385' ' ' ILE . 0.9 OUTLIER -132.96 128.21 56.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.754 0.311 . . . . 0.48999999999999999 111.026 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.697 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 36.7 ttt85 -86.01 121.57 28.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 2.4199999999999999 110.797 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.405 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 61.7 mtp85 -72.93 159.14 34.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 2.2999999999999998 110.659 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -55.03 -45.52 75.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.513 -0.312 . . . . 2.8199999999999998 111.339 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -57.98 -29.08 64.96 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.262 -0.644 . . . . 1.23 109.262 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 111.03 37.26 1.7 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.3 -0.864 . . . . 1.03 113.267 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.439 HG22 HD21 ' A' ' 445' ' ' LEU . 29.9 p -121.24 111.15 17.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.878 0.37 . . . . 0.97999999999999998 111.562 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.13 137.89 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.027 -0.533 . . . . 0.55000000000000004 111.011 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -150.57 139.64 21.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 2.4300000000000002 110.957 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.408 ' HB3' HG21 ' A' ' 382' ' ' ILE . 88.3 mtm180 -56.63 147.56 22.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.815 -0.63 . . . . 2.96 111.474 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -164.98 128.43 1.79 Allowed Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.824 -0.626 . . . . 0.26000000000000001 112.238 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -83.32 110.18 17.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.686 0.279 . . . . 1.28 111.503 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.6 OUTLIER -79.09 135.04 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.82999999999999996 109.976 178.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 94.1 mt -120.24 -31.91 4.27 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.789 0.663 . . . . 1.45 112.789 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -140.19 175.3 9.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.071 0.462 . . . . 2.0800000000000001 111.931 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.6 p -165.5 149.23 8.21 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.616 -0.72 . . . . 0.56000000000000005 110.576 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 401' ' ' ARG . 14.5 ptt-85 -158.11 138.43 12.6 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.073 0.463 . . . . 1.55 111.923 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 47.2 p -75.29 139.44 42.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.948 -0.569 . . . . 1.79 110.276 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.864 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.5 m -61.76 -174.39 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.504 -0.316 . . . . 1.95 110.263 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.864 ' H ' HG22 ' A' ' 403' ' ' THR . 50.2 mt-10 -54.6 -45.76 73.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.666 0.269 . . . . 3.8700000000000001 111.573 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -59.84 -47.39 85.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 3.1600000000000001 110.864 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.573 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 64.11 -177.07 0.16 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.024 -0.534 . . . . 2.1800000000000002 110.858 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . 63.22 11.2 5.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.395 -0.82 . . . . 2.77 112.134 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.552 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -170.84 -53.1 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.558 -0.292 . . . . 2.7599999999999998 111.68 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.577 ' HB2' ' OG1' ' A' ' 403' ' ' THR . 65.4 Cg_endo -72.07 149.83 53.15 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.281 1.987 . . . . 2.4900000000000002 112.036 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.471 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 5.1 p-10 -170.32 126.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.11 0.481 . . . . 2.1400000000000001 111.493 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 400' ' ' SER . 64.8 mm-40 -109.81 134.68 51.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.496 -0.775 . . . . 2.1000000000000001 110.319 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.495 ' HB2' HD12 ' A' ' 432' ' ' ILE . 2.6 m-85 -112.81 129.26 56.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.87 0.367 . . . . 0.71999999999999997 111.872 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 26.0 t80 -69.19 129.74 40.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.899 -0.778 . . . . 0.51000000000000001 108.899 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 425' ' ' GLY . 10.3 p -131.17 136.8 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.801 0.667 . . . . 1.1499999999999999 112.801 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -114.75 89.8 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.019 -0.992 . . . . 0.62 109.582 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.556 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 35.2 m-85 -54.02 128.1 29.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.65000000000000002 111.231 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 67.0 t -71.89 127.92 34.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.996 -0.547 . . . . 1.3400000000000001 111.278 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.35 -37.14 1.56 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.841 -0.695 . . . . 0.81999999999999995 113.261 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.514 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.9 mp -59.34 159.7 7.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.237 0.542 . . . . 1.6000000000000001 111.809 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.776 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 5.6 m120 -51.07 140.55 15.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.179 -0.918 . . . . 2.5299999999999998 111.821 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -60.36 -38.36 83.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 3.98 110.733 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -60.19 -38.44 83.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 3.71 110.991 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.776 ' HG ' ' HB2' ' A' ' 420' ' ' ASN . 90.0 mt -56.65 -31.17 64.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 1.49 110.978 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -52.13 134.5 32.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 1.2 111.182 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLY . . . . . 0.465 ' O ' HG12 ' A' ' 414' ' ' VAL . . . 177.04 176.52 45.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.042 -0.599 . . . . 0.69999999999999996 112.369 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -75.2 140.44 43.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.005 0.431 . . . . 0.60999999999999999 110.997 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.545 ' CG2' HD11 ' A' ' 432' ' ' ILE . 25.4 m -133.37 138.82 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 0.89000000000000001 111.354 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -61.73 147.63 48.11 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.859 -0.686 . . . . 1.72 112.394 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.598 ' CZ ' HD11 ' A' ' 373' ' ' ILE . 23.2 tpt180 -51.49 -39.97 58.62 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.758 0.281 . . . . 1.73 111.758 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -53.31 -30.78 40.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.757 0.313 . . . . 1.47 111.466 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.427 ' HG2' HH11 ' A' ' 431' ' ' ARG . 68.0 mtt-85 -79.47 -35.05 40.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.154 -0.475 . . . . 2.8399999999999999 111.569 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.572 HG12 HG13 ' A' ' 385' ' ' ILE . 53.6 mt -88.89 140.47 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.46000000000000002 112.013 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 435' ' ' ASN . 66.8 m -159.89 139.9 11.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.675 -0.693 . . . . 0.53000000000000003 110.413 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.76 16.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 1.3500000000000001 111.773 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.449 ' H ' ' C ' ' A' ' 433' ' ' SER . 22.2 p30 -162.63 135.65 5.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.978 0.418 . . . . 2.1600000000000001 111.055 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' ALA . . . . . 0.524 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -65.35 -32.07 73.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.75 111.639 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -49.73 -40.85 42.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 1.3400000000000001 111.419 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -97.17 49.55 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.44 -0.346 . . . . 1.5600000000000001 111.173 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 436' ' ' ALA . 95.6 mt -148.55 -84.53 0.1 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.38 -0.373 . . . . 1.1200000000000001 111.286 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 440' ' ' GLY . . . . . 0.697 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -171.02 30.72 0.13 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.577 -0.821 . . . . 1.3600000000000001 112.647 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 63.99 151.35 0.06 OUTLIER Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.743 -0.742 . . . . 1.8300000000000001 112.543 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 44.8 mm -64.18 79.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.665 0.269 . . . . 1.48 110.464 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 9.7 t 40.74 44.39 1.86 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.005 0.907 . . . . 3.0499999999999998 111.71 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 15.6 m -94.64 49.14 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.029 -1.441 . . . . 4.1799999999999997 111.221 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 445' ' ' LEU . 0.4 OUTLIER -96.77 143.77 26.7 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.46 -0.791 . . . . 4.9900000000000002 111.861 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.87 148.05 89.71 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.617 2.211 . . . . 7.4000000000000004 111.862 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . -49.17 133.0 16.34 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.288 -0.414 . . . . 9.0600000000000005 111.143 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 35.3 Cg_exo -57.84 135.64 70.32 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.624 2.216 . . . . 11.06 112.478 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 32.4 Cg_exo -58.59 137.59 81.05 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.72 2.28 . . . . 13.5 112.295 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 450' ' ' LEU . 6.6 mp 64.83 143.41 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.031 -0.532 . . . . 15.76 111.502 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -163.84 127.19 1.75 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.915 -0.584 . . . . 16.739999999999998 110.926 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.06 137.77 53.9 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.701 2.268 . . . . 18.530000000000001 112.63 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 65.11 135.65 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.003 -0.544 . . . . 20.550000000000001 111.497 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.22 -0.895 . . . . 21.219999999999999 111.036 179.912 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.495 -0.242 . . . . 11.640000000000001 112.495 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 364' ' ' SER . . . . . 0.557 ' HB3' ' NZ ' ' A' ' 372' ' ' LYS . 45.0 t -61.61 -41.06 96.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.707 0.289 . . . . 9.8599999999999994 110.889 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 74.5 t60 65.68 139.12 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.017 -0.538 . . . . 8.0700000000000003 111.295 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 27.9 ttt -166.41 128.08 1.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.895 -0.593 . . . . 5.5099999999999998 110.593 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.419 ' HB3' HD23 ' A' ' 369' ' ' LEU . 62.2 m-20 59.75 119.34 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 115.997 -0.547 . . . . 6.0599999999999996 111.56 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.56 42.17 1.25 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.553 2.169 . . . . 6.1600000000000001 112.762 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.419 HD23 ' HB3' ' A' ' 367' ' ' ASP . 1.9 pt? -170.01 -25.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.713 0.292 . . . . 6.9400000000000004 111.218 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.412 ' H ' HD23 ' A' ' 369' ' ' LEU . 44.2 ttp -135.01 62.88 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 5.6299999999999999 111.307 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -59.68 137.31 58.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.368 -0.378 . . . . 5.04 110.454 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.557 ' NZ ' ' HB3' ' A' ' 364' ' ' SER . 23.7 pttm -49.85 130.23 21.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 5.3899999999999997 111.455 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.05 128.45 31.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.929 -0.578 . . . . 1.48 111.564 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.563 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 0.3 OUTLIER -93.95 130.58 39.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 2.1699999999999999 110.503 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 375' ' ' ILE . 4.7 mp -88.29 -41.25 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.125 0.417 . . . . 0.92000000000000004 112.125 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 82.1 p -47.46 -26.4 1.36 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.018 -0.537 . . . . 1.71 112.021 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.6 pt-20 -67.5 -39.23 85.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.197 -0.456 . . . . 1.9199999999999999 111.898 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 66.1 m-20 -151.87 67.31 7.11 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 112.095 0.406 . . . . 2.1400000000000001 112.095 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.7 -41.1 63.48 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.734 2.289 . . . . 0.84999999999999998 112.419 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.94 -38.28 85.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.973 -0.558 . . . . 1.21 111.324 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 87.4 tttt -48.91 127.12 13.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 1.6599999999999999 111.075 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 44.3 mm -86.32 126.68 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.989 -0.55 . . . . 0.40999999999999998 111.165 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -105.13 144.16 32.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.311 -0.404 . . . . 0.63 110.151 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.454 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 1.9 m-85 -89.88 137.32 32.44 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.929 -0.308 . . . . 0.95999999999999996 110.543 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.671 HG12 HG21 ' A' ' 414' ' ' VAL . 2.7 mp -122.89 125.57 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.329 -0.396 . . . . 0.48999999999999999 111.218 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.519 ' HE ' ' HA2' ' A' ' 390' ' ' GLY . 78.1 ttt180 -83.86 116.82 22.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 2.4199999999999999 110.261 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.453 ' HB2' ' OD1' ' A' ' 389' ' ' ASP . 51.9 mtp85 -71.53 163.98 26.71 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.941 -0.304 . . . . 2.2999999999999998 110.703 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 389' ' ' ASP . 11.5 pm0 -49.72 -39.76 38.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.309 -0.405 . . . . 2.8199999999999998 111.214 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 387' ' ' ARG . 43.1 p-10 -65.87 -35.04 79.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 1.23 111.215 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.519 ' HA2' ' HE ' ' A' ' 386' ' ' ARG . . . 129.32 -31.31 3.47 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.718 -0.753 . . . . 1.03 112.539 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 71.3 p -59.36 113.09 2.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.096 0.474 . . . . 0.97999999999999998 112.144 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 59.8 t -71.15 141.31 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.562 -0.745 . . . . 0.55000000000000004 110.902 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -148.9 134.77 18.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.484 -0.325 . . . . 2.4300000000000002 110.803 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.441 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 88.2 mtm180 -54.22 152.97 5.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.232 -0.44 . . . . 2.96 111.498 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -168.83 135.66 3.71 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.657 -0.701 . . . . 0.26000000000000001 112.089 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -87.04 110.37 20.03 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.724 0.268 . . . . 1.28 111.724 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.628 ' CG2' HD13 ' A' ' 432' ' ' ILE . 11.6 t -77.94 128.01 38.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.765 -0.828 . . . . 0.82999999999999996 108.765 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 58.2 mt -121.0 -38.27 2.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.011 0.745 . . . . 1.45 113.011 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.511 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 86.7 mt-30 -133.95 176.53 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 2.0800000000000001 112.049 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.3 p -162.16 148.03 13.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.676 -0.693 . . . . 0.56000000000000005 110.349 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -161.45 139.19 9.1 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.887 0.375 . . . . 1.55 111.536 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 67.3 p -73.4 -125.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 1.79 109.884 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.801 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.23 -173.52 3.16 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.77 -0.456 . . . . 1.95 109.77 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.801 ' H ' HG22 ' A' ' 403' ' ' THR . 55.6 mt-10 -46.11 -43.77 15.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.678 0.275 . . . . 3.8700000000000001 111.275 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -67.72 -52.62 35.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 3.1600000000000001 110.798 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 53.81 54.33 10.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.003 -0.544 . . . . 2.1800000000000002 111.658 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.517 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -149.09 10.65 0.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.517 0.675 . . . . 2.77 109.755 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.573 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -179.46 -47.71 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.628 -1.169 . . . . 2.7599999999999998 110.077 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 39.5 Cg_exo -57.53 146.79 82.36 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.509 2.139 . . . . 2.4900000000000002 112.585 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.656 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.6 p30 -174.38 138.07 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 2.1400000000000001 110.568 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.4 mt-10 -137.14 134.4 36.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 2.1000000000000001 110.375 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 0.8 OUTLIER -109.93 125.7 53.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.855 0.359 . . . . 0.71999999999999997 111.49 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.511 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 14.0 t80 -59.49 147.13 37.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.974 -0.557 . . . . 0.51000000000000001 109.516 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.671 HG21 HG12 ' A' ' 385' ' ' ILE . 7.1 p -153.66 134.55 4.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.237 0.541 . . . . 1.1499999999999999 112.055 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -120.24 101.85 8.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.455 -0.793 . . . . 0.62 109.902 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.492 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 50.1 m-85 -59.82 129.49 42.1 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.899 0.381 . . . . 0.65000000000000002 110.681 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.83 37.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.887 -0.597 . . . . 1.3400000000000001 111.109 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -175.47 -36.1 0.05 OUTLIER Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.254 -0.974 . . . . 0.81999999999999995 113.851 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.681 HD13 HD23 ' A' ' 423' ' ' LEU . 13.0 mt -62.8 -167.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.729 0.776 . . . . 1.6000000000000001 112.48 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.532 ' OD1' ' HG2' ' A' ' 422' ' ' ARG . 16.5 t-20 -81.29 149.85 28.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.55 -1.204 . . . . 2.5299999999999998 111.025 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -59.47 -40.89 88.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.91 0.386 . . . . 3.98 110.779 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' ARG . . . . . 0.532 ' HG2' ' OD1' ' A' ' 420' ' ' ASN . 16.2 ptm180 -69.19 -34.9 75.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.048 -0.524 . . . . 3.71 110.851 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.681 HD23 HD13 ' A' ' 419' ' ' LEU . 1.3 mp -56.48 -34.94 67.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.875 -0.602 . . . . 1.49 111.201 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -59.09 137.6 57.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.077 -0.51 . . . . 1.2 110.757 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -170.52 -140.51 3.03 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.619 -0.8 . . . . 0.69999999999999996 112.646 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -119.7 134.76 55.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.906 0.384 . . . . 0.60999999999999999 110.81 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.641 HG11 HG21 ' A' ' 385' ' ' ILE . 31.5 m -109.47 155.27 10.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.987 -0.551 . . . . 0.89000000000000001 111.758 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -74.11 25.27 1.04 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.918 -0.583 . . . . 1.72 113.951 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.543 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 36.2 tpt85 71.26 -46.32 0.64 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.68 0.622 . . . . 1.73 112.68 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -58.77 -19.86 44.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.944 0.402 . . . . 1.47 110.911 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.4 mtt180 -78.66 -30.32 46.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.813 -0.63 . . . . 2.8399999999999999 111.464 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.628 HD13 ' CG2' ' A' ' 397' ' ' VAL . 66.8 mt -88.02 137.29 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 120.766 0.317 . . . . 0.46000000000000002 110.728 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.437 ' HB2' HD21 ' A' ' 439' ' ' LEU . 57.9 m -160.18 139.73 11.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 0.53000000000000003 111.075 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -69.26 -23.48 63.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 1.3500000000000001 111.472 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -108.23 133.54 52.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.891 0.377 . . . . 2.1600000000000001 111.129 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' ALA . . . . . 0.539 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -67.85 -43.9 78.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.75 111.366 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -54.92 -39.82 69.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 1.3400000000000001 111.014 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.06 51.0 1.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 1.5600000000000001 110.948 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 436' ' ' ALA . 82.3 mt -150.13 -93.51 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 1.1200000000000001 111.106 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -177.02 48.05 0.1 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.609 -0.805 . . . . 1.3600000000000001 112.746 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.28 132.07 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.83 -0.7 . . . . 1.8300000000000001 112.848 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 444' ' ' VAL . 47.9 mm -67.51 107.96 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 110.247 -0.279 . . . . 1.48 110.247 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.601 HG22 HG22 ' A' ' 442' ' ' ILE . 11.8 t 40.23 41.21 0.94 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.644 0.735 . . . . 3.0499999999999998 111.757 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 442' ' ' ILE . 77.7 t -145.69 131.93 14.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.866 -1.061 . . . . 4.1799999999999997 111.1 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 96.1 mt -146.09 139.14 14.29 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.726 -0.67 . . . . 4.9900000000000002 110.465 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.53 131.31 43.07 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.543 2.162 . . . . 7.4000000000000004 112.651 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -67.97 144.48 97.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 9.0600000000000005 111.118 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.75 133.58 54.89 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.448 2.098 . . . . 11.06 112.189 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.33 130.8 23.31 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.437 2.091 . . . . 13.5 112.56 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 73.1 mt 62.53 127.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.863 -0.608 . . . . 15.76 111.621 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . 53.38 88.25 0.12 Allowed Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.88 -0.6 . . . . 16.739999999999998 111.802 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.54 130.39 18.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.494 2.129 . . . . 18.530000000000001 112.276 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -175.52 139.84 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 20.550000000000001 110.888 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' GLN . . . . . 0.445 ' N ' ' OE1' ' A' ' 454' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.281 -0.866 . . . . 21.219999999999999 110.894 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.467 -0.253 . . . . 11.640000000000001 112.467 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.9 t -64.45 126.66 28.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.86 0.362 . . . . 9.8599999999999994 110.877 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -73.07 139.97 46.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 8.0700000000000003 110.78 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 62.3 mtt -63.43 118.57 8.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.404 -0.362 . . . . 5.5099999999999998 110.534 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.1 138.58 68.66 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 6.0599999999999996 111.169 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.09 38.1 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.561 2.174 . . . . 6.1600000000000001 112.317 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.442 ' C ' HD12 ' A' ' 369' ' ' LEU . 1.9 pp -152.3 27.68 0.58 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.079 0.466 . . . . 6.9400000000000004 111.042 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' MET . . . . . . . . . . . . . 44.2 ttp -170.81 49.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.768 -0.651 . . . . 5.6299999999999999 110.284 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.436 ' OE1' ' N ' ' A' ' 371' ' ' GLN . 0.5 OUTLIER -54.47 133.02 45.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.051 -0.522 . . . . 5.04 110.7 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.528 ' HB2' ' OH ' ' A' ' 412' ' ' TYR . 48.0 mmtm -56.72 132.87 53.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 5.3899999999999997 111.004 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.532 HD11 HH11 ' A' ' 429' ' ' ARG . 66.8 mt 58.15 101.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.837 -0.62 . . . . 1.48 111.633 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.05 129.71 35.63 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.19 -0.459 . . . . 2.1699999999999999 109.989 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 379' ' ' PRO . 90.0 mt -120.93 -43.19 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.079 0.4 . . . . 0.92000000000000004 112.079 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.0 t -48.86 -30.35 5.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.044 0.449 . . . . 1.71 111.151 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.76 -36.61 36.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.752 -0.658 . . . . 1.9199999999999999 111.8 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 30.1 p30 -146.46 72.17 12.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.004 0.43 . . . . 2.1400000000000001 111.439 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 379' ' ' PRO . . . . . 0.508 ' HA ' HG23 ' A' ' 375' ' ' ILE . 21.5 Cg_endo -63.62 -36.42 53.13 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.105 1.87 . . . . 0.84999999999999998 111.286 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -64.37 -31.29 72.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 1.21 110.823 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 62.5 tttm -49.31 130.77 19.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.074 -0.512 . . . . 1.6599999999999999 111.424 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.5 HG21 ' HD2' ' A' ' 394' ' ' ARG . 33.2 mm -88.68 135.46 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.773 -0.649 . . . . 0.40999999999999998 111.109 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -117.43 143.83 45.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.537 -0.301 . . . . 0.63 110.711 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.45 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 1.8 m-85 -89.14 147.03 24.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.841 0.353 . . . . 0.95999999999999996 111.136 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.8 mp -132.22 131.68 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.48999999999999999 110.741 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 42.2 ttt-85 -84.8 123.55 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.251 -0.431 . . . . 2.4199999999999999 111.198 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -83.75 167.24 17.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.29 -0.414 . . . . 2.2999999999999998 110.461 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 388' ' ' GLU . 0.5 OUTLIER -58.36 -42.7 87.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.506 -0.315 . . . . 2.8199999999999998 111.082 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -69.86 5.13 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.403 . . . . 1.23 110.581 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 388' ' ' GLU . . . 70.76 42.71 61.06 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.902 -0.59 . . . . 1.03 112.955 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.5 ' HB ' HG23 ' A' ' 443' ' ' THR . 82.5 p -120.62 111.47 17.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.958 0.408 . . . . 0.97999999999999998 111.151 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 22.6 t -69.94 135.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.55000000000000004 111.308 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -149.28 139.85 22.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 2.4300000000000002 110.742 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.5 ' HD2' HG21 ' A' ' 382' ' ' ILE . 54.9 mtm-85 -56.03 157.8 4.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.318 0.58 . . . . 2.96 112.048 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -178.56 126.56 1.08 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.125 -0.943 . . . . 0.26000000000000001 111.442 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -83.42 129.38 34.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.823 0.344 . . . . 1.28 111.791 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.756 HG22 HD13 ' A' ' 432' ' ' ILE . 8.5 t -88.9 134.69 27.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.51 -0.552 . . . . 0.82999999999999996 109.51 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 78.0 mt -120.18 -38.51 2.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.568 0.581 . . . . 1.45 112.568 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -141.65 176.12 9.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.051 0.453 . . . . 2.0800000000000001 111.809 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 97.4 p -155.62 149.66 25.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.604 -0.725 . . . . 0.56000000000000005 110.176 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 18.4 ptt-85 -149.26 134.78 18.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.229 0.538 . . . . 1.55 112.246 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 409' ' ' PRO . 46.2 p -93.65 138.1 32.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.819 -0.628 . . . . 1.79 110.065 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.844 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.5 m -61.5 -174.65 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.655 -0.248 . . . . 1.95 110.47 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.844 ' H ' HG22 ' A' ' 403' ' ' THR . 55.9 mt-10 -53.72 -39.02 64.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.571 0.224 . . . . 3.8700000000000001 111.565 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.439 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 16.0 t-20 -56.86 -49.66 74.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.423 -0.353 . . . . 3.1600000000000001 110.988 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 54.12 52.9 11.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.221 -0.445 . . . . 2.1800000000000002 111.494 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -156.5 10.83 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.844 -0.616 . . . . 2.77 110.141 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.588 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.19 -48.28 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.15 -0.932 . . . . 2.7599999999999998 110.561 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 24.0 Cg_exo -63.75 140.02 71.97 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.589 2.192 . . . . 2.4900000000000002 112.4 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.47 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 13.2 p-10 -173.82 122.63 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 2.1400000000000001 110.988 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 400' ' ' SER . 9.1 mp0 -113.94 134.24 54.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 2.1000000000000001 110.504 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.543 ' HB2' HD12 ' A' ' 432' ' ' ILE . 6.5 m-85 -109.57 125.15 52.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.71999999999999997 111.575 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.765 ' HA ' ' HA ' ' A' ' 426' ' ' TRP . 14.0 t80 -60.9 139.74 57.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.51000000000000001 110.234 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.539 HG21 HG12 ' A' ' 385' ' ' ILE . 13.0 p -133.96 137.73 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.218 0.532 . . . . 1.1499999999999999 111.928 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -119.54 96.6 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.48 -0.782 . . . . 0.62 109.889 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.404 ' HB3' HD22 ' A' ' 419' ' ' LEU . 42.3 m-85 -58.99 124.6 20.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.65000000000000002 111.024 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.79 128.54 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.911 -0.586 . . . . 1.3400000000000001 111.396 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 78.17 -40.64 1.94 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.896 -0.668 . . . . 0.81999999999999995 113.072 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 419' ' ' LEU . 7.5 mp -59.34 153.87 17.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.982 0.42 . . . . 1.6000000000000001 111.28 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.426 ' OD1' ' HB2' ' A' ' 423' ' ' LEU . 31.2 p-10 -49.31 142.22 7.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.722 -0.672 . . . . 2.5299999999999998 112.143 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 421' ' ' ARG . 45.1 mmm-85 -60.81 -36.7 79.7 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.463 -0.79 . . . . 3.98 111.96 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' ARG . . . . . 0.58 HH11 HD12 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -53.64 -29.0 36.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.907 0.385 . . . . 3.71 110.761 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.58 HD12 HH11 ' A' ' 422' ' ' ARG . 1.1 tp -63.2 -33.32 75.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 1.49 111.303 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -44.94 133.61 6.23 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.181 -0.463 . . . . 1.2 111.4 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLY . . . . . 0.463 ' O ' HG12 ' A' ' 414' ' ' VAL . . . 174.36 154.59 11.05 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.793 -0.64 . . . . 0.69999999999999996 112.053 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' TRP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 11.4 m95 -68.75 134.03 49.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.60999999999999999 110.296 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.468 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 35.6 m -127.05 142.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.89000000000000001 111.245 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -52.24 147.42 13.15 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.026 -0.607 . . . . 1.72 112.912 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.532 HH11 HD11 ' A' ' 373' ' ' ILE . 14.6 tpt180 -52.01 -42.03 62.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.633 0.254 . . . . 1.73 111.429 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.432 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 13.4 p-80 -56.58 -25.88 53.83 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.968 0.359 . . . . 1.47 111.968 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 56.4 mtt85 -77.89 -40.59 39.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.692 -0.231 . . . . 2.8399999999999999 111.532 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.756 HD13 HG22 ' A' ' 397' ' ' VAL . 59.7 mt -88.79 136.54 23.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.914 0.388 . . . . 0.46000000000000002 110.948 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 67.3 m -161.4 139.7 9.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.953 -0.567 . . . . 0.53000000000000003 110.743 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -76.73 16.13 0.55 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 1.3500000000000001 111.181 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -134.59 116.01 14.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.409 -0.359 . . . . 2.1600000000000001 110.734 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.33 98.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.031 -0.531 . . . . 0.75 111.595 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -57.04 -40.87 77.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 1.3400000000000001 111.13 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 439' ' ' LEU . 59.0 m-20 -83.16 45.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 1.5600000000000001 111.011 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 438' ' ' ASP . 47.6 mt -154.58 -41.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.22 -0.446 . . . . 1.1200000000000001 111.011 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 157.81 40.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.701 -0.761 . . . . 1.3600000000000001 112.132 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.418 ' O ' HD13 ' A' ' 442' ' ' ILE . . . 62.58 -128.89 41.68 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.629 -0.796 . . . . 1.8300000000000001 112.103 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.486 ' O ' HG23 ' A' ' 444' ' ' VAL . 44.8 mm -126.04 71.69 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.106 0.479 . . . . 1.48 110.447 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.581 ' O ' HG22 ' A' ' 443' ' ' THR . 56.2 m 52.36 45.84 27.76 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.593 -0.73 . . . . 3.0499999999999998 110.719 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 442' ' ' ILE . 87.7 t -150.9 121.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.725 -0.67 . . . . 4.1799999999999997 111.017 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.56 130.55 38.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 4.9900000000000002 110.564 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.54 127.06 15.77 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.438 2.092 . . . . 7.4000000000000004 112.335 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . 53.87 64.38 6.65 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 9.0600000000000005 111.459 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.7 130.41 18.15 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.315 2.01 . . . . 11.06 112.243 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.88 53.82 4.58 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.788 2.325 . . . . 13.5 112.69 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 450' ' ' LEU . 8.6 tt -165.23 124.51 1.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.917 0.389 . . . . 15.76 110.878 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -76.66 142.21 69.94 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.982 -0.554 . . . . 16.739999999999998 111.08 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.25 -146.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.684 2.256 . . . . 18.530000000000001 112.646 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -59.06 -48.51 81.34 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.285 -0.416 . . . . 20.550000000000001 111.066 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.155 -0.926 . . . . 21.219999999999999 111.019 -179.911 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.441 -0.264 . . . . 11.640000000000001 112.441 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 49.9 m -61.59 130.41 45.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.77 0.319 . . . . 9.8599999999999994 110.945 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -81.26 37.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 8.0700000000000003 111.307 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 23.6 ttt 63.23 146.34 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.244 -0.435 . . . . 5.5099999999999998 111.005 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.14 126.03 25.62 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 6.0599999999999996 111.301 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.29 37.7 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.676 2.251 . . . . 6.1600000000000001 112.81 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.2 tp -178.29 -51.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.214 -0.448 . . . . 6.9400000000000004 110.407 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 370' ' ' MET . 14.3 tpt -82.6 33.9 0.43 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.207 0.527 . . . . 5.6299999999999999 109.861 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -80.64 48.8 1.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.8 -0.636 . . . . 5.04 111.077 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 373' ' ' ILE . 62.7 mttp 60.3 116.01 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.758 -0.655 . . . . 5.3899999999999997 111.952 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 372' ' ' LYS . 72.5 mt 55.38 140.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 113.069 0.766 . . . . 1.48 113.069 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -138.99 132.73 30.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.491 -0.777 . . . . 2.1699999999999999 109.852 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 82.7 mt -78.2 -40.9 26.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.089 0.403 . . . . 0.92000000000000004 112.089 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 88.1 p -47.91 -21.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.278 0.561 . . . . 1.71 110.851 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -58.11 -47.63 82.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.192 -0.913 . . . . 1.9199999999999999 110.949 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.615 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 59.4 m-20 -165.25 111.26 0.81 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.799 -0.637 . . . . 2.1400000000000001 111.29 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.3 -41.04 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.932 2.422 . . . . 0.84999999999999998 112.22 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.99 -32.37 61.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.993 -0.548 . . . . 1.21 111.666 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.2 tttp -46.35 129.31 10.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.973 0.416 . . . . 1.6599999999999999 111.556 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 50.0 mm -87.75 126.13 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.894 -0.594 . . . . 0.40999999999999998 111.276 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -99.58 143.1 30.21 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.098 -0.334 . . . . 0.63 110.098 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.499 ' C ' HD12 ' A' ' 385' ' ' ILE . 29.4 m-85 -92.73 136.25 33.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.95999999999999996 111.292 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.651 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.5 mp -116.21 129.58 72.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.078 -0.51 . . . . 0.48999999999999999 110.757 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.794 ' HB2' HD22 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -97.48 110.26 22.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 2.4199999999999999 110.232 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.444 ' O ' ' HD3' ' A' ' 386' ' ' ARG . 76.6 mtp180 -77.74 158.82 29.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.501 -0.318 . . . . 2.2999999999999998 110.983 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -54.15 -41.52 68.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.485 -0.325 . . . . 2.8199999999999998 111.449 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.406 ' OD1' ' HB2' ' A' ' 387' ' ' ARG . 54.2 p-10 -60.46 -10.12 4.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.938 0.399 . . . . 1.23 110.788 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.578 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 83.88 36.04 14.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.931 -0.577 . . . . 1.03 112.424 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.596 HG22 HD13 ' A' ' 445' ' ' LEU . 73.1 p -121.07 111.72 17.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.31 . . . . 0.97999999999999998 111.146 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.53 134.24 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.55000000000000004 110.537 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -142.63 135.93 28.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.941 0.401 . . . . 2.4300000000000002 110.751 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.448 HH11 ' HG3' ' A' ' 394' ' ' ARG . 54.4 mtm-85 -56.64 146.48 25.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 2.96 111.293 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -164.12 129.88 2.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.615 -0.72 . . . . 0.26000000000000001 112.065 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -88.36 105.07 17.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.739 0.304 . . . . 1.28 111.379 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.5 OUTLIER -71.09 129.78 34.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.964 -0.384 . . . . 0.82999999999999996 109.964 178.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 81.3 mt -121.0 -34.32 3.55 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 112.686 0.624 . . . . 1.45 112.686 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.511 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 74.2 mt-30 -129.18 175.46 8.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.036 0.446 . . . . 2.0800000000000001 111.918 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 99.4 p -166.53 148.56 6.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.612 -0.722 . . . . 0.56000000000000005 110.63 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 37.9 ptt180 -155.76 134.57 11.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.769 0.319 . . . . 1.55 110.941 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 65.2 p -72.38 -132.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.575 -0.284 . . . . 1.79 110.533 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.764 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.2 m -162.84 -173.6 3.56 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.854 -0.424 . . . . 1.95 109.854 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.764 ' H ' HG22 ' A' ' 403' ' ' THR . 67.2 mm-40 -44.55 -38.83 4.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.759 0.314 . . . . 3.8700000000000001 111.172 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 407' ' ' ALA . 25.1 t-20 -65.66 -53.08 46.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 3.1600000000000001 110.73 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 54.85 61.99 2.72 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.184 -0.462 . . . . 2.1800000000000002 111.895 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.502 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -165.07 2.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 2.77 110.708 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.621 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -175.71 -49.97 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.529 -0.76 . . . . 2.7599999999999998 110.853 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 27.3 Cg_exo -61.72 143.0 95.95 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.332 2.022 . . . . 2.4900000000000002 112.056 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.594 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.6 p30 -179.84 131.92 0.1 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.234 0.54 . . . . 2.1400000000000001 112.054 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 400' ' ' SER . 49.8 mp0 -109.47 135.82 49.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.516 -0.765 . . . . 2.1000000000000001 109.297 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 400' ' ' SER . 0.4 OUTLIER -109.33 126.35 53.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.942 0.401 . . . . 0.71999999999999997 111.61 -178.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 19.8 t80 -62.42 135.83 57.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.51000000000000001 109.673 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.617 HG21 HD11 ' A' ' 385' ' ' ILE . 14.6 p -139.93 137.71 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.333 0.587 . . . . 1.1499999999999999 112.563 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -112.23 97.4 6.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.197 -0.91 . . . . 0.62 109.762 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.512 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 7.8 m-85 -57.09 127.13 30.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 0.65000000000000002 111.133 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.98 129.4 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.037 -0.529 . . . . 1.3400000000000001 111.042 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.53 -43.28 2.08 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.828 -0.701 . . . . 0.81999999999999995 112.897 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 419' ' ' LEU . 7.5 mp -59.91 155.47 16.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.887 0.375 . . . . 1.6000000000000001 111.196 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -51.21 140.57 16.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 2.5299999999999998 110.727 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 22.8 ptt-85 -62.31 -37.43 85.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.443 . . . . 3.98 110.362 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -55.66 -40.37 72.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.519 -0.764 . . . . 3.71 110.704 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' LEU . . . . . . . . . . . . . 48.4 mt -62.57 -35.53 79.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.914 -0.584 . . . . 1.49 110.575 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 416' ' ' TYR . 9.1 m-20 -64.94 138.17 58.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.58 -0.736 . . . . 1.2 111.623 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.89 -151.26 9.16 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.702 -0.681 . . . . 0.69999999999999996 111.909 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -83.29 137.27 34.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.60999999999999999 110.76 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.623 ' CG1' HD11 ' A' ' 432' ' ' ILE . 1.9 p -127.23 139.8 50.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.89000000000000001 111.724 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -64.87 147.4 50.98 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.688 -0.687 . . . . 1.72 112.578 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 45.3 tpt85 -52.7 -39.24 61.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 1.73 111.355 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -64.47 -27.97 69.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.453 0.538 . . . . 1.47 112.453 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.589 ' HB2' ' CG2' ' A' ' 427' ' ' VAL . 61.3 mtt-85 -78.56 -30.02 46.6 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.176 0.436 . . . . 2.8399999999999999 112.176 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.623 HD11 ' CG1' ' A' ' 427' ' ' VAL . 65.1 mt -87.8 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.043 0.449 . . . . 0.46000000000000002 111.795 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.415 ' HB2' HD11 ' A' ' 439' ' ' LEU . 56.7 m -161.57 139.41 9.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.531 -0.759 . . . . 0.53000000000000003 110.27 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -74.67 16.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 1.3500000000000001 111.927 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.61 136.33 9.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.049 0.452 . . . . 2.1600000000000001 111.321 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -65.52 -31.88 73.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.707 -0.679 . . . . 0.75 111.586 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -49.37 -41.06 38.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.296 -0.411 . . . . 1.3400000000000001 111.256 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -97.98 43.01 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 1.5600000000000001 110.649 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.794 HD22 ' HB2' ' A' ' 386' ' ' ARG . 96.7 mt -150.52 -84.02 0.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.113 -0.494 . . . . 1.1200000000000001 110.993 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -173.89 41.23 0.14 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.087 -0.578 . . . . 1.3600000000000001 112.065 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 61.26 -138.71 47.48 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.881 -0.676 . . . . 1.8300000000000001 112.459 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 36.3 mm -119.83 61.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.227 0.537 . . . . 1.48 110.354 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.585 ' O ' HG22 ' A' ' 443' ' ' THR . 59.2 m 48.46 45.62 20.78 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.442 -0.799 . . . . 3.0499999999999998 110.902 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 444' ' ' VAL . 18.4 t -96.18 51.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.361 0.6 . . . . 4.1799999999999997 110.761 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.596 HD13 HG22 ' A' ' 391' ' ' THR . 5.3 mp -83.13 135.22 44.88 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.48 -0.782 . . . . 4.9900000000000002 111.218 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.2 137.35 28.54 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.572 2.181 . . . . 7.4000000000000004 112.397 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . -170.08 123.97 0.65 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.252 -0.431 . . . . 9.0600000000000005 111.022 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 448' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 447' ' ' ALA . 16.7 Cg_exo -67.58 129.1 19.31 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.605 2.203 . . . . 11.06 112.251 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.54 50.18 3.42 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.683 2.255 . . . . 13.5 112.503 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' LEU . . . . . 0.533 ' N ' HD23 ' A' ' 450' ' ' LEU . 2.1 pt? -170.92 137.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 15.76 111.115 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -64.33 137.9 97.27 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 16.739999999999998 111.009 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.85 139.42 74.24 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.653 2.235 . . . . 18.530000000000001 112.378 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -170.7 137.28 1.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 20.550000000000001 111.077 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.275 -0.869 . . . . 21.219999999999999 110.773 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.407 -0.277 . . . . 11.640000000000001 112.407 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 46.9 t -61.61 -49.7 75.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.727 0.299 . . . . 9.8599999999999994 110.953 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -176.29 37.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 8.0700000000000003 110.944 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' MET . . . . . 0.661 ' HG2' ' HA ' ' A' ' 407' ' ' ALA . 0.0 OUTLIER 65.38 141.53 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.083 -0.508 . . . . 5.5099999999999998 110.694 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.55 ' HB3' ' CD2' ' A' ' 369' ' ' LEU . 1.4 m-20 -47.52 128.89 10.54 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.177 -0.465 . . . . 6.0599999999999996 111.293 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.5 46.12 2.1 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.892 2.395 . . . . 6.1600000000000001 113.575 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.55 ' CD2' ' HB3' ' A' ' 367' ' ' ASP . 2.5 pt? -161.15 -27.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.652 0.263 . . . . 6.9400000000000004 111.138 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.45 ' O ' ' HG3' ' A' ' 370' ' ' MET . 43.6 tpp -75.3 32.33 0.1 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.056 0.455 . . . . 5.6299999999999999 111.084 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.446 ' H ' ' C ' ' A' ' 369' ' ' LEU . 73.6 mt-30 -111.27 41.16 1.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.365 0.602 . . . . 5.04 109.932 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.407 ' HE3' ' HE ' ' A' ' 429' ' ' ARG . 50.1 mtmt -78.18 167.08 21.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.249 -0.887 . . . . 5.3899999999999997 111.935 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.605 HD11 HH11 ' A' ' 429' ' ' ARG . 42.0 mt 68.56 136.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 115.518 -0.765 . . . . 1.48 111.635 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.707 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 57.5 m-20 -150.08 69.0 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.393 -0.821 . . . . 2.1699999999999999 109.91 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.862 HD11 HG12 ' A' ' 397' ' ' VAL . 60.7 mt -45.48 -35.84 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.542 -0.754 . . . . 0.92000000000000004 112.431 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 41.9 t -45.84 -35.87 4.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.433 0.531 . . . . 1.71 112.433 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 16.9 pt-20 -79.13 -36.99 39.68 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.11 0.411 . . . . 1.9199999999999999 112.11 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.691 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 66.5 m-20 -145.58 83.49 8.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 112.353 0.501 . . . . 2.1400000000000001 112.353 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' PRO . . . . . 0.441 ' HA ' HG23 ' A' ' 375' ' ' ILE . 37.3 Cg_exo -63.95 -41.21 24.12 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.022 2.481 . . . . 0.84999999999999998 112.875 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.413 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 1.5 m-20 -74.77 -31.97 61.92 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.162 0.431 . . . . 1.21 112.162 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.691 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 87.9 tttt -41.1 129.73 2.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.014 0.435 . . . . 1.6599999999999999 111.213 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.594 HG21 ' HD3' ' A' ' 394' ' ' ARG . 48.9 mm -83.09 132.69 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.686 -0.688 . . . . 0.40999999999999998 111.96 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -113.21 143.42 44.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.036 -0.529 . . . . 0.63 109.72 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.524 ' HB3' HG11 ' A' ' 392' ' ' VAL . 27.1 m-85 -93.7 130.51 39.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.673 0.273 . . . . 0.95999999999999996 111.029 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.668 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.1 mp -117.5 131.03 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.361 -0.382 . . . . 0.48999999999999999 110.945 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.665 ' N ' HD23 ' A' ' 439' ' ' LEU . 55.4 ttp180 -84.7 124.02 31.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.582 -0.281 . . . . 2.4199999999999999 110.997 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -73.17 -174.97 1.7 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.799 0.333 . . . . 2.2999999999999998 110.654 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -67.31 -45.3 76.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 2.8199999999999998 111.177 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -70.73 -36.1 73.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 1.23 111.8 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.735 ' HA3' HD23 ' A' ' 445' ' ' LEU . . . 141.35 -33.09 2.02 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.436 -0.888 . . . . 1.03 112.764 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.468 ' HB ' ' HA ' ' A' ' 443' ' ' THR . 41.4 p -59.05 112.82 1.82 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.302 0.572 . . . . 0.97999999999999998 111.611 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.524 HG11 ' HB3' ' A' ' 384' ' ' PHE . 46.6 t -78.98 131.03 35.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.328 -0.851 . . . . 0.55000000000000004 111.853 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -122.79 138.33 54.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.99 -0.55 . . . . 2.4300000000000002 110.401 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.594 ' HD3' HG21 ' A' ' 382' ' ' ILE . 64.9 mtt85 -58.73 153.62 16.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.144 0.497 . . . . 2.96 111.988 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -174.37 132.39 2.23 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.501 -0.772 . . . . 0.26000000000000001 111.828 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 72.1 mt-30 -91.35 129.97 37.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.92 0.36 . . . . 1.28 111.752 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.862 HG12 HD11 ' A' ' 375' ' ' ILE . 16.0 t -84.64 136.08 23.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.821 -0.437 . . . . 0.82999999999999996 109.821 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.24 -46.58 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.116 0.413 . . . . 1.45 112.116 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.419 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 96.0 mm-40 -125.58 175.71 7.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 2.0800000000000001 111.82 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 81.0 p -165.47 145.33 6.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.457 -0.792 . . . . 0.56000000000000005 110.304 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 20.3 ptt-85 -145.64 136.66 24.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.052 0.453 . . . . 1.55 111.528 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.702 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 17.9 p -102.06 37.41 1.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.821 -0.627 . . . . 1.79 111.044 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.881 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.2 m 49.29 -173.33 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.178 -0.465 . . . . 1.95 110.659 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.881 ' H ' HG22 ' A' ' 403' ' ' THR . 59.1 mm-40 -65.08 -40.97 95.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 3.8700000000000001 111.164 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.459 ' HB2' ' HG3' ' A' ' 409' ' ' PRO . 19.9 m-20 -57.08 -55.16 38.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 3.1600000000000001 112.053 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.702 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 55.92 41.51 29.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.369 0.604 . . . . 2.1800000000000002 109.813 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.661 ' HA ' ' HG2' ' A' ' 366' ' ' MET . . . -139.54 10.14 2.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.041 -0.981 . . . . 2.77 110.03 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.643 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -179.9 -50.05 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.005 -0.998 . . . . 2.7599999999999998 110.16 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 20.4 Cg_endo -59.9 147.57 92.12 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.451 2.1 . . . . 2.4900000000000002 112.138 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.549 ' HB3' HG22 ' A' ' 402' ' ' THR . 12.1 p-10 -176.85 134.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.424 . . . . 2.1400000000000001 110.982 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 400' ' ' SER . 51.4 mt-10 -145.93 134.2 21.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 2.1000000000000001 110.006 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -112.52 128.88 56.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.969 0.414 . . . . 0.71999999999999997 111.739 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.566 ' O ' HG13 ' A' ' 397' ' ' VAL . 24.5 t80 -67.78 150.37 48.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.93 -0.577 . . . . 0.51000000000000001 109.769 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.664 HG21 HG12 ' A' ' 385' ' ' ILE . 8.9 p -148.03 137.72 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.175 0.512 . . . . 1.1499999999999999 112.081 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -115.67 101.14 8.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.62 110.312 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.575 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 2.4 m-85 -63.44 124.41 21.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.437 -0.347 . . . . 0.65000000000000002 110.62 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.413 ' O ' HD23 ' A' ' 419' ' ' LEU . 91.5 t -74.98 128.36 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 1.3400000000000001 110.985 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.88 -40.92 1.67 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.895 -0.669 . . . . 0.81999999999999995 112.905 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 2.8 mm? -59.27 157.53 10.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.229 0.538 . . . . 1.6000000000000001 111.987 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.592 ' HB2' HD13 ' A' ' 423' ' ' LEU . 4.0 m120 -52.45 147.19 8.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.129 -0.941 . . . . 2.5299999999999998 111.795 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -61.54 -38.18 86.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.944 -0.571 . . . . 3.98 110.56 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 64.0 mtt-85 -54.51 -39.51 67.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.943 -0.571 . . . . 3.71 109.94 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 420' ' ' ASN . 5.3 mp -63.56 -35.66 81.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.18 -0.918 . . . . 1.49 110.321 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 416' ' ' TYR . 15.2 m-20 -65.88 133.31 50.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.54 -0.755 . . . . 1.2 111.269 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 173.98 -152.92 15.82 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.915 -0.66 . . . . 0.69999999999999996 112.178 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -96.32 139.81 31.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.854 0.359 . . . . 0.60999999999999999 110.964 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.463 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 17.8 m -143.15 144.67 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.89000000000000001 110.991 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -58.89 151.09 34.64 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.832 -0.699 . . . . 1.72 112.425 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.605 HH11 HD11 ' A' ' 373' ' ' ILE . 21.5 tpt180 -51.45 -40.16 58.86 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.769 0.285 . . . . 1.73 111.769 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -51.62 -30.95 23.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.644 0.259 . . . . 1.47 111.426 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.63 ' O ' HD21 ' A' ' 439' ' ' LEU . 99.0 mtt180 -80.16 -38.66 30.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 2.8399999999999999 111.969 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.805 HD13 HG22 ' A' ' 397' ' ' VAL . 77.5 mt -88.1 132.15 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.648 -0.421 . . . . 0.46000000000000002 110.749 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.529 ' HB2' HD11 ' A' ' 439' ' ' LEU . 75.7 m -163.42 143.43 8.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.797 -0.638 . . . . 0.53000000000000003 111.157 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.06 16.46 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 1.3500000000000001 111.224 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 433' ' ' SER . 14.6 t-20 -152.12 132.49 13.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.969 0.414 . . . . 2.1600000000000001 110.651 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' A' ' 441' ' ' GLY . . . -79.21 -34.99 42.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.913 -0.585 . . . . 0.75 112.546 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 437' ' ' ASP . . . . . 0.404 ' HB2' ' OD1' ' A' ' 435' ' ' ASN . 1.5 m-20 -48.96 -40.45 30.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.67 0.271 . . . . 1.3400000000000001 111.499 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.96 -33.69 75.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 1.5600000000000001 111.084 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 386' ' ' ARG . 7.3 mp -85.34 -86.37 0.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.85 -0.614 . . . . 1.1200000000000001 112.554 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -167.51 52.92 0.23 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.482 -0.866 . . . . 1.3600000000000001 113.045 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.604 ' O ' ' HB1' ' A' ' 436' ' ' ALA . . . 71.53 -148.35 43.55 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.831 -0.7 . . . . 1.8300000000000001 112.748 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.633 HG22 HG22 ' A' ' 443' ' ' THR . 49.2 mm -118.28 108.86 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.427 -0.212 . . . . 1.48 110.427 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.633 HG22 HG22 ' A' ' 442' ' ' ILE . 10.0 t 38.18 39.14 0.25 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.4 0.619 . . . . 3.0499999999999998 112.074 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 442' ' ' ILE . 81.7 t -149.49 122.23 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.102 -0.954 . . . . 4.1799999999999997 111.302 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.735 HD23 ' HA3' ' A' ' 390' ' ' GLY . 36.8 tp 175.26 68.2 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.219 0 CA-C-N 115.821 -0.627 . . . . 4.9900000000000002 110.265 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -52.49 135.58 55.24 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.791 2.328 . . . . 7.4000000000000004 112.902 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -173.24 135.48 0.7 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.705 -0.68 . . . . 9.0600000000000005 110.589 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.85 136.32 71.6 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.42 2.08 . . . . 11.06 112.2 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.38 132.04 36.69 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.514 2.143 . . . . 13.5 112.232 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' LEU . . . . . 0.459 ' N ' HD23 ' A' ' 450' ' ' LEU . 2.1 pt? -62.01 131.16 48.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 15.76 110.856 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . -70.64 131.41 87.95 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.037 -0.529 . . . . 16.739999999999998 110.968 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 451' ' ' ALA . 32.0 Cg_exo -58.58 130.75 38.71 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.378 2.052 . . . . 18.530000000000001 112.032 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 452' ' ' PRO . 63.7 t0 74.09 -46.24 0.61 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.007 -0.542 . . . . 20.550000000000001 111.496 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.251 -0.88 . . . . 21.219999999999999 110.264 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.4 -0.28 . . . . 11.640000000000001 112.4 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 59.1 m -160.38 41.71 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.819 0.342 . . . . 9.8599999999999994 110.88 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -67.66 -27.04 66.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 8.0700000000000003 110.575 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 95.4 mmm 65.99 51.36 1.34 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.38 -0.827 . . . . 5.5099999999999998 111.33 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.419 ' OD2' ' HE2' ' A' ' 372' ' ' LYS . 57.9 m-20 61.92 154.02 0.11 Allowed Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.119 -0.491 . . . . 6.0599999999999996 111.8 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' PRO . . . . . 0.534 ' HG2' ' HG3' ' A' ' 371' ' ' GLN . 77.2 Cg_exo -50.75 -20.46 6.7 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.605 2.203 . . . . 6.1600000000000001 112.41 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.569 HD22 ' O ' ' A' ' 369' ' ' LEU . 1.1 tm? 178.75 -52.47 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.313 -1.312 . . . . 6.9400000000000004 109.939 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.532 ' CB ' HD13 ' A' ' 369' ' ' LEU . 4.2 tpt -170.6 33.24 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.776 -0.647 . . . . 5.6299999999999999 109.62 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.534 ' HG3' ' HG2' ' A' ' 368' ' ' PRO . 8.3 mm100 -70.98 106.13 3.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.611 -0.722 . . . . 5.04 111.012 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.545 ' HD2' ' NE ' ' A' ' 429' ' ' ARG . 67.4 mmtt -160.0 -179.52 7.86 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.235 -0.439 . . . . 5.3899999999999997 110.988 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.604 HG12 ' CZ ' ' A' ' 429' ' ' ARG . 47.9 mm -59.85 131.43 24.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.008 -0.542 . . . . 1.48 111.892 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.654 ' HB3' ' HG3' ' A' ' 377' ' ' GLU . 1.5 m-20 -90.07 140.95 29.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.833 -0.621 . . . . 2.1699999999999999 110.44 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.529 HG22 ' N ' ' A' ' 376' ' ' SER . 68.8 mt -111.65 -80.29 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.481 0.549 . . . . 0.92000000000000004 112.481 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.529 ' N ' HG22 ' A' ' 375' ' ' ILE . 45.4 t -52.42 -22.48 4.76 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.438 0.637 . . . . 1.71 110.818 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.654 ' HG3' ' HB3' ' A' ' 374' ' ' ASP . 21.8 mm-40 -62.48 -39.54 93.76 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.901 -1.045 . . . . 1.9199999999999999 111.138 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.459 ' ND2' ' HD3' ' A' ' 381' ' ' LYS . 27.1 p30 -155.5 64.13 3.91 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.529 . . . . 2.1400000000000001 111.109 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -51.31 -40.26 61.74 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.48 2.12 . . . . 0.84999999999999998 112.273 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -60.02 -36.69 77.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.084 -0.507 . . . . 1.21 110.933 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.459 ' HD3' ' ND2' ' A' ' 378' ' ' ASN . 62.4 tttm -54.57 130.09 38.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.064 -0.517 . . . . 1.6599999999999999 111.358 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.506 HG21 ' HD2' ' A' ' 394' ' ' ARG . 46.6 mm -87.54 136.58 22.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.116 -0.493 . . . . 0.40999999999999998 110.664 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.414 ' HD1' ' HA ' ' A' ' 396' ' ' GLN . 12.1 m-85 -110.72 144.0 40.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.738 0.304 . . . . 0.63 110.784 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.503 ' C ' HD12 ' A' ' 385' ' ' ILE . 3.3 m-85 -92.62 132.78 36.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.95999999999999996 110.884 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.719 HG12 HG11 ' A' ' 414' ' ' VAL . 2.3 mp -114.06 123.38 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.29 -0.414 . . . . 0.48999999999999999 111.023 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.566 ' HD2' ' O ' ' A' ' 387' ' ' ARG . 4.8 tmm_? -92.34 110.27 21.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 2.4199999999999999 110.273 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.602 ' HG2' ' NH2' ' A' ' 431' ' ' ARG . 70.7 mtp180 -73.81 153.55 39.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.288 -0.414 . . . . 2.2999999999999998 110.857 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 390' ' ' GLY . 49.5 mt-10 -54.15 -41.31 68.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 2.8199999999999998 111.685 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -66.7 5.21 0.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.093 0.473 . . . . 1.23 110.633 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.515 ' O ' HD12 ' A' ' 445' ' ' LEU . . . 74.94 35.4 50.23 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.494 -0.775 . . . . 1.03 113.707 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 49.2 p -121.44 110.73 16.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.97999999999999998 111.19 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 442' ' ' ILE . 51.6 t -73.86 140.69 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.55000000000000004 111.384 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -150.6 136.59 18.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.936 -0.574 . . . . 2.4300000000000002 110.43 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.506 ' HD2' HG21 ' A' ' 382' ' ' ILE . 69.9 mtm-85 -56.77 152.88 11.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.058 0.456 . . . . 2.96 112.019 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -173.39 134.97 3.08 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.572 -0.74 . . . . 0.26000000000000001 112.096 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' GLN . . . . . 0.414 ' HA ' ' HD1' ' A' ' 383' ' ' TYR . 89.6 mt-30 -95.37 129.56 42.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.726 0.298 . . . . 1.28 111.476 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.724 HG22 HD13 ' A' ' 432' ' ' ILE . 13.2 t -89.09 128.69 41.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.363 -0.381 . . . . 0.82999999999999996 110.323 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.409 ' HB2' ' HD2' ' A' ' 413' ' ' TYR . 89.6 mt -121.29 -40.03 2.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.096 0.406 . . . . 1.45 112.096 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.56 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 66.1 mt-30 -127.38 175.74 7.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.073 0.463 . . . . 2.0800000000000001 111.936 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 95.7 p -165.51 148.74 7.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.592 -0.731 . . . . 0.56000000000000005 110.152 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -163.45 135.69 5.16 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.036 0.446 . . . . 1.55 112.065 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 41.1 p -74.78 139.76 43.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 1.79 109.786 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.84 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.6 m -61.21 -174.84 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.281 -0.266 . . . . 1.95 110.281 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.84 ' H ' HG22 ' A' ' 403' ' ' THR . 7.5 mp0 -50.3 -40.31 48.16 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.744 0.276 . . . . 3.8700000000000001 111.744 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.558 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 15.8 t-20 -56.91 -49.39 75.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 3.1600000000000001 110.8 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.588 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.28 55.18 8.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 2.1800000000000002 111.466 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -158.7 9.77 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 2.77 110.16 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.6 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.38 -48.66 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.039 -0.982 . . . . 2.7599999999999998 110.209 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 20.2 Cg_exo -65.26 144.69 81.75 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.579 2.186 . . . . 2.4900000000000002 112.512 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.1 p30 -169.48 129.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 2.1400000000000001 110.542 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.9 mt-10 -115.87 134.65 54.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.971 -0.559 . . . . 2.1000000000000001 110.797 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.427 ' HB3' HG13 ' A' ' 397' ' ' VAL . 1.6 m-85 -109.24 123.55 49.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 0.71999999999999997 110.626 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.56 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 17.1 t80 -56.16 143.09 34.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.502 . . . . 0.51000000000000001 110.206 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.719 HG11 HG12 ' A' ' 385' ' ' ILE . 28.6 t -136.41 136.91 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.152 0.501 . . . . 1.1499999999999999 111.823 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -117.25 90.57 3.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.641 -0.709 . . . . 0.62 110.083 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.456 ' H ' ' HD1' ' A' ' 416' ' ' TYR . 4.1 m-85 -59.76 115.63 3.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.65000000000000002 110.724 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.74 130.99 29.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.0 -0.545 . . . . 1.3400000000000001 111.008 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.13 -45.71 2.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.894 -0.67 . . . . 0.81999999999999995 112.574 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 419' ' ' LEU . 7.3 mp -61.43 143.56 55.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.957 0.408 . . . . 1.6000000000000001 111.121 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -56.25 161.49 2.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.862 -0.608 . . . . 2.5299999999999998 111.327 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -59.96 -29.03 68.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.035 -0.53 . . . . 3.98 110.803 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -53.43 -39.39 64.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.72 -0.673 . . . . 3.71 111.305 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.613 ' H ' HD22 ' A' ' 423' ' ' LEU . 2.2 mm? -69.75 -35.63 75.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.232 -0.44 . . . . 1.49 110.529 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -60.51 138.41 58.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.85 -0.614 . . . . 1.2 111.089 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -173.3 -137.94 2.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.861 -0.685 . . . . 0.69999999999999996 112.475 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' TRP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 37.9 m95 -128.93 132.88 47.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.60999999999999999 110.916 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.691 HG21 HG13 ' A' ' 432' ' ' ILE . 34.0 m -115.64 150.34 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 0.89000000000000001 111.011 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -74.3 32.7 0.96 Allowed Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.807 -0.711 . . . . 1.72 113.681 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.604 ' CZ ' HG12 ' A' ' 373' ' ' ILE . 42.2 tpt85 71.55 -45.65 0.62 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.705 0.632 . . . . 1.73 112.705 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.529 ' CE1' ' HG3' ' A' ' 431' ' ' ARG . 8.7 p80 -54.62 -22.79 14.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.823 0.305 . . . . 1.47 111.823 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.602 ' NH2' ' HG2' ' A' ' 387' ' ' ARG . 75.2 mtp180 -79.44 -31.7 42.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.256 0.465 . . . . 2.8399999999999999 112.256 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.724 HD13 HG22 ' A' ' 397' ' ' VAL . 57.6 mt -87.49 136.85 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.849 0.357 . . . . 0.46000000000000002 111.333 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 63.7 m -158.7 140.65 13.77 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.98 -0.554 . . . . 0.53000000000000003 110.938 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -74.75 16.85 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.002 -0.544 . . . . 1.3500000000000001 112.084 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' A' ' 437' ' ' ASP . 14.1 t-20 -155.64 132.05 10.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 2.1600000000000001 111.203 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -73.55 -41.19 63.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.854 -0.612 . . . . 0.75 112.178 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' ASP . . . . . 0.4 ' HB2' ' OD1' ' A' ' 435' ' ' ASN . 54.0 m-20 -49.03 -40.5 31.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.503 -0.317 . . . . 1.3400000000000001 111.391 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -65.37 -44.36 87.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 1.5600000000000001 110.946 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 386' ' ' ARG . 68.0 mt -62.97 -83.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.227 -0.442 . . . . 1.1200000000000001 111.179 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -157.98 32.03 0.51 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.489 -0.862 . . . . 1.3600000000000001 112.825 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 48.98 40.99 28.45 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.924 -0.655 . . . . 1.8300000000000001 112.515 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.571 ' O ' HG23 ' A' ' 444' ' ' VAL . 45.6 mm 57.27 102.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.178 -0.305 . . . . 1.48 110.178 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.633 HG23 HG23 ' A' ' 444' ' ' VAL . 15.2 t 41.5 -145.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.322 0.389 . . . . 3.0499999999999998 110.621 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.633 HG23 HG23 ' A' ' 443' ' ' THR . 3.1 t 58.78 63.85 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.369 -0.378 . . . . 4.1799999999999997 111.88 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 390' ' ' GLY . 83.4 mt -136.89 130.77 17.76 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.753 0.311 . . . . 4.9900000000000002 111.172 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 145.92 52.78 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.788 2.325 . . . . 7.4000000000000004 112.621 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -54.3 143.97 43.1 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.017 -0.538 . . . . 9.0600000000000005 111.171 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.18 136.87 62.92 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.582 2.188 . . . . 11.06 112.377 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.63 135.91 63.58 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.579 2.186 . . . . 13.5 112.276 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 1.3 pp -78.24 33.65 0.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 15.76 111.603 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -63.24 137.58 97.11 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 16.739999999999998 111.122 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.62 139.03 73.34 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.555 2.17 . . . . 18.530000000000001 112.213 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 34.3 t70 66.2 134.08 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.961 -0.563 . . . . 20.550000000000001 111.175 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' GLN . . . . . 0.433 ' N ' ' OE1' ' A' ' 454' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.293 -0.86 . . . . 21.219999999999999 110.883 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.424 ' HA3' ' OG ' ' A' ' 376' ' ' SER . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.464 -0.254 . . . . 11.640000000000001 112.464 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 75.7 p -67.23 -124.82 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.518 0.199 . . . . 9.8599999999999994 110.902 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' HIS . . . . . 0.55 ' HE2' ' HB2' ' A' ' 372' ' ' LYS . 8.4 p80 -161.19 -152.67 0.27 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 110.332 -0.247 . . . . 8.0700000000000003 110.332 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -78.1 46.67 0.61 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.881 0.372 . . . . 5.5099999999999998 111.217 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -62.97 116.26 23.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 6.0599999999999996 111.469 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' PRO . . . . . 0.703 ' HD2' ' HG3' ' A' ' 371' ' ' GLN . 74.3 Cg_exo -50.52 -21.29 7.38 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.968 2.446 . . . . 6.1600000000000001 113.104 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 370' ' ' MET . 2.3 pt? -171.92 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.898 -1.046 . . . . 6.9400000000000004 110.307 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.534 ' H ' HD23 ' A' ' 369' ' ' LEU . 4.6 tmm? 178.73 38.14 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.51 -0.768 . . . . 5.6299999999999999 109.503 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.703 ' HG3' ' HD2' ' A' ' 368' ' ' PRO . 22.5 mt-30 -77.95 141.95 38.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.571 . . . . 5.04 111.015 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.55 ' HB2' ' HE2' ' A' ' 365' ' ' HIS . 67.8 mttm 63.14 144.45 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.074 -0.512 . . . . 5.3899999999999997 111.602 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.56 ' H ' HH22 ' A' ' 429' ' ' ARG . 86.4 mt -50.4 129.39 8.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.932 -0.576 . . . . 1.48 111.836 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.06 129.72 44.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.87 -0.605 . . . . 2.1699999999999999 110.041 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.451 HD13 ' C ' ' A' ' 398' ' ' LEU . 82.9 mt -68.32 -45.24 82.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.493 -0.321 . . . . 0.92000000000000004 111.842 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.424 ' OG ' ' HA3' ' A' ' 363' ' ' GLY . 69.0 m -70.15 62.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.692 -0.685 . . . . 1.71 110.848 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -147.52 -33.71 0.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.737 -0.665 . . . . 1.9199999999999999 110.0 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.474 ' ND2' ' HD2' ' A' ' 381' ' ' LYS . 12.3 p30 -173.0 65.7 0.34 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.132 -0.94 . . . . 2.1400000000000001 110.959 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.6 -38.44 55.04 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.457 2.104 . . . . 0.84999999999999998 111.859 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.04 -36.99 83.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 1.21 110.593 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.474 ' HD2' ' ND2' ' A' ' 378' ' ' ASN . 62.3 tttp -51.64 140.45 18.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.016 -0.538 . . . . 1.6599999999999999 110.844 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.583 HG21 ' HD2' ' A' ' 394' ' ' ARG . 49.8 mm -86.23 128.89 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.40999999999999998 111.537 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -105.28 144.76 31.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.63 110.378 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.604 ' CD2' HD11 ' A' ' 442' ' ' ILE . 1.8 m-30 -90.5 133.5 35.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.446 -0.343 . . . . 0.95999999999999996 110.633 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 385' ' ' ILE . 3.0 mp -128.94 128.98 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.799 0.333 . . . . 0.48999999999999999 111.145 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 58.1 ttt-85 -92.73 123.24 35.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 2.4199999999999999 111.193 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -71.05 158.16 36.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.367 -0.379 . . . . 2.2999999999999998 110.162 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -49.53 -35.59 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 2.8199999999999998 110.828 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.97 -36.24 69.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 1.23 111.666 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.535 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 135.99 -35.17 2.17 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.378 -0.915 . . . . 1.03 113.126 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.485 ' HA ' HD12 ' A' ' 445' ' ' LEU . 68.7 p -58.67 112.36 1.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 0.97999999999999998 112.207 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.39 144.92 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.186 -0.916 . . . . 0.55000000000000004 111.225 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -150.48 139.74 21.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.161 -0.472 . . . . 2.4300000000000002 110.959 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.583 ' HD2' HG21 ' A' ' 382' ' ' ILE . 66.2 mtm-85 -60.07 151.29 27.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.87 -0.605 . . . . 2.96 112.168 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -169.62 135.13 3.43 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.434 -0.803 . . . . 0.26000000000000001 111.823 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -91.97 111.57 23.16 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.304 0.483 . . . . 1.28 112.304 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.747 HG22 HD13 ' A' ' 432' ' ' ILE . 24.4 t -76.43 132.87 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.483 -0.326 . . . . 0.82999999999999996 110.383 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.451 ' C ' HD13 ' A' ' 375' ' ' ILE . 96.0 mt -121.33 -42.92 2.43 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.735 0.643 . . . . 1.45 112.735 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.548 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 30.1 mm100 -129.18 177.46 7.14 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.212 0.53 . . . . 2.0800000000000001 112.208 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.0 p -153.35 157.3 39.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.454 -0.794 . . . . 0.56000000000000005 110.043 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 33.2 ptt180 -154.09 137.09 15.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.08 0.467 . . . . 1.55 112.258 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 409' ' ' PRO . 36.4 p -96.31 136.07 37.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 1.79 110.036 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.839 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.6 m -62.75 -174.52 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.469 -0.332 . . . . 1.95 110.622 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.839 ' H ' HG22 ' A' ' 403' ' ' THR . 64.9 mm-40 -53.13 -40.07 63.95 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.721 0.267 . . . . 3.8700000000000001 111.721 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.72 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 26.0 t-20 -55.95 -51.01 69.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 3.1600000000000001 110.994 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 53.49 55.96 7.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.079 0.466 . . . . 2.1800000000000002 111.89 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.554 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -160.55 10.86 0.1 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.727 -0.669 . . . . 2.77 109.456 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.594 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.64 -48.06 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.611 -1.177 . . . . 2.7599999999999998 110.213 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.72 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 38.2 Cg_exo -61.04 138.14 76.5 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.736 2.291 . . . . 2.4900000000000002 112.701 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 13.6 p-10 -173.39 123.31 0.38 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.909 -0.587 . . . . 2.1400000000000001 111.09 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 400' ' ' SER . 58.3 mp0 -112.51 142.34 45.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.774 -0.648 . . . . 2.1000000000000001 110.284 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.714 ' HB2' HD12 ' A' ' 432' ' ' ILE . 1.2 m-85 -109.03 124.17 50.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.019 0.438 . . . . 0.71999999999999997 111.804 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.548 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 18.8 t80 -62.19 150.16 39.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.722 -0.672 . . . . 0.51000000000000001 109.409 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.442 HG21 HG12 ' A' ' 385' ' ' ILE . 7.3 p -150.92 132.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.286 0.565 . . . . 1.1499999999999999 112.193 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -110.74 90.98 3.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.268 -0.878 . . . . 0.62 109.596 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.525 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 14.3 m-85 -53.03 135.68 36.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.094 0.473 . . . . 0.65000000000000002 111.25 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 418' ' ' GLY . 17.6 t -63.67 -124.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.454 -0.794 . . . . 1.3400000000000001 111.417 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.563 ' N ' HG12 ' A' ' 417' ' ' VAL . . . -39.7 -29.41 0.16 Allowed Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.248 0.459 . . . . 0.81999999999999995 114.248 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.664 ' HB3' HD23 ' A' ' 423' ' ' LEU . 7.1 mp -58.79 141.31 53.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.244 0.522 . . . . 1.6000000000000001 110.955 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.431 ' HB3' ' HG2' ' A' ' 422' ' ' ARG . 10.9 t-20 -55.42 154.89 5.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.966 -0.561 . . . . 2.5299999999999998 111.286 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 68.5 mtt-85 -53.35 -29.81 36.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.663 -0.699 . . . . 3.98 112.152 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' ARG . . . . . 0.582 ' HG3' HD13 ' A' ' 423' ' ' LEU . 16.8 ptm180 -52.65 -40.7 63.08 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.956 0.354 . . . . 3.71 111.956 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.664 HD23 ' HB3' ' A' ' 419' ' ' LEU . 1.1 mm? -71.05 -35.09 71.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.713 0.292 . . . . 1.49 111.028 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.27 130.51 46.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 1.2 111.427 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.67 -145.67 9.19 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.69999999999999996 112.012 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -100.36 140.22 34.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.60999999999999999 110.946 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.454 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 28.5 m -140.26 145.72 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.89000000000000001 110.971 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -59.83 147.55 43.54 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.914 -0.584 . . . . 1.72 113.361 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.56 HH22 ' H ' ' A' ' 373' ' ' ILE . 15.4 tpt180 -50.93 -38.92 53.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.654 0.381 . . . . 1.73 111.72 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.439 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 24.8 p-80 -57.87 -28.83 64.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.092 0.404 . . . . 1.47 112.092 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.8 mtt180 -78.35 -38.62 41.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.993 0.368 . . . . 2.8399999999999999 111.993 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.747 HD13 HG22 ' A' ' 397' ' ' VAL . 60.1 mt -88.01 133.27 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.898 0.38 . . . . 0.46000000000000002 110.893 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.745 ' HB2' HD11 ' A' ' 439' ' ' LEU . 58.0 m -165.11 145.71 7.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.736 -0.665 . . . . 0.53000000000000003 110.806 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ASP . . . . . 0.493 ' H ' HD11 ' A' ' 373' ' ' ILE . 52.0 p-10 -71.28 16.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 1.3500000000000001 111.911 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 433' ' ' SER . 0.5 OUTLIER -165.8 133.93 3.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 2.1600000000000001 111.095 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 436' ' ' ALA . . . . . 0.492 ' HB2' ' HD2' ' A' ' 384' ' ' PHE . . . -68.66 -13.27 62.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 0.75 111.949 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.41 -41.08 72.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.686 0.279 . . . . 1.3400000000000001 111.363 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.47 -6.46 58.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 1.5600000000000001 111.48 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.5 mp -96.68 -93.28 0.22 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.245 -0.434 . . . . 1.1200000000000001 111.598 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' GLY . . . . . 0.521 ' O ' HD11 ' A' ' 445' ' ' LEU . . . -171.56 38.27 0.17 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.776 -0.726 . . . . 1.3600000000000001 112.485 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.98 138.84 0.05 OUTLIER Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.865 -0.683 . . . . 1.8300000000000001 112.812 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.604 HD11 ' CD2' ' A' ' 384' ' ' PHE . 43.2 mm -63.84 125.9 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 109.126 -0.694 . . . . 1.48 109.126 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.491 ' O ' ' HG ' ' A' ' 445' ' ' LEU . 13.1 t 41.8 -152.23 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.857 0.723 . . . . 3.0499999999999998 111.776 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 444' ' ' VAL . 7.4 p 45.04 57.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.627 0.727 . . . . 4.1799999999999997 112.333 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.521 HD11 ' O ' ' A' ' 440' ' ' GLY . 96.4 mt -134.0 141.55 40.06 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.54 -0.755 . . . . 4.9900000000000002 110.567 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.66 45.97 1.57 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.726 2.284 . . . . 7.4000000000000004 112.868 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -61.95 135.64 94.74 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.392 -0.367 . . . . 9.0600000000000005 110.738 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.13 130.0 25.98 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.352 2.035 . . . . 11.06 111.999 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.04 124.7 12.1 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.361 2.041 . . . . 13.5 112.332 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 57.6 tp -88.29 136.61 32.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 15.76 111.03 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -60.96 137.37 93.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 16.739999999999998 110.824 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.33 130.99 34.17 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.425 2.083 . . . . 18.530000000000001 112.237 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -176.06 44.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.136 -0.483 . . . . 20.550000000000001 110.993 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.247 -0.882 . . . . 21.219999999999999 110.896 179.813 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.523 -0.231 . . . . 11.640000000000001 112.523 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 69.1 m -164.09 -45.49 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.81 0.338 . . . . 9.8599999999999994 110.834 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -62.26 139.65 58.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 8.0700000000000003 110.785 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' MET . . . . . 0.568 ' HB3' ' HG2' ' A' ' 371' ' ' GLN . 65.8 mtt -67.27 128.11 35.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.387 -0.37 . . . . 5.5099999999999998 110.405 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -66.14 136.2 95.3 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.366 -0.379 . . . . 6.0599999999999996 110.768 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.3 37.26 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.476 2.117 . . . . 6.1600000000000001 112.389 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.491 ' C ' HD12 ' A' ' 369' ' ' LEU . 2.4 pp -163.42 0.87 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.149 -0.478 . . . . 6.9400000000000004 111.199 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.415 ' C ' ' H ' ' A' ' 372' ' ' LYS . 55.5 ttp -174.44 66.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.127 -0.488 . . . . 5.6299999999999999 110.741 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.568 ' HG2' ' HB3' ' A' ' 366' ' ' MET . 34.3 mt-30 -77.83 35.64 0.2 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.979 0.419 . . . . 5.04 111.172 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.486 ' HD2' ' O ' ' A' ' 372' ' ' LYS . 0.0 OUTLIER 177.3 141.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.623 -0.717 . . . . 5.3899999999999997 110.263 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.434 HG13 ' HE ' ' A' ' 429' ' ' ARG . 68.1 mt -61.56 130.18 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.814 0.34 . . . . 1.48 110.767 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.534 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 0.9 OUTLIER -88.21 69.86 9.2 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.152 -0.476 . . . . 2.1699999999999999 110.859 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 377' ' ' GLU . 61.7 mt -45.86 -44.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.92000000000000004 111.709 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 73.1 m -63.1 73.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 1.71 111.559 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.4 pt-20 -173.97 -31.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 1.9199999999999999 110.482 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.433 ' N ' ' HD3' ' A' ' 379' ' ' PRO . 39.7 p30 -152.99 58.16 2.3 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.53 . . . . 2.1400000000000001 111.606 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 50.3 Cg_exo -53.03 -37.6 79.1 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.283 1.989 . . . . 0.84999999999999998 111.504 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.1 -34.19 75.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.7 -0.682 . . . . 1.21 110.695 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -53.38 123.22 11.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.191 -0.458 . . . . 1.6599999999999999 110.784 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 417' ' ' VAL . 45.8 mm -84.91 128.92 38.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 0.40999999999999998 111.38 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -106.93 143.38 35.11 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.069 -0.345 . . . . 0.63 110.069 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.76 ' HB2' HD11 ' A' ' 439' ' ' LEU . 5.2 m-85 -89.78 139.35 30.66 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.807 -0.357 . . . . 0.95999999999999996 110.192 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.726 HG12 HG21 ' A' ' 414' ' ' VAL . 2.6 mp -115.25 129.51 71.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.255 -0.429 . . . . 0.48999999999999999 111.829 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.76 ' CZ ' HG23 ' A' ' 392' ' ' VAL . 5.2 tpm_? -88.25 90.14 8.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.865 -0.607 . . . . 2.4199999999999999 110.176 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.616 ' HA ' ' NH2' ' A' ' 431' ' ' ARG . 58.1 mtp85 -55.88 153.6 8.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.725 0.297 . . . . 2.2999999999999998 110.816 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.76 -44.76 77.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.212 -0.449 . . . . 2.8199999999999998 111.318 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -58.27 -14.86 8.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.263 0.554 . . . . 1.23 109.749 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 91.66 39.77 5.49 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.176 -0.92 . . . . 1.03 112.561 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.46 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 70.8 p -121.91 110.19 15.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.591 0.234 . . . . 0.97999999999999998 110.917 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.76 HG23 ' CZ ' ' A' ' 386' ' ' ARG . 63.4 t -70.97 132.71 32.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.628 0.252 . . . . 0.55000000000000004 110.348 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -151.31 135.35 16.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.893 0.378 . . . . 2.4300000000000002 110.582 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.445 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 71.2 mtt-85 -52.85 151.8 4.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.862 -0.608 . . . . 2.96 112.135 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -170.16 131.51 2.26 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.204 -0.907 . . . . 0.26000000000000001 111.411 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' GLN . . . . . 0.413 ' HG2' HD13 ' A' ' 382' ' ' ILE . 80.1 mt-30 -87.14 128.97 35.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.769 0.318 . . . . 1.28 111.734 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.838 HG22 HD13 ' A' ' 432' ' ' ILE . 8.7 t -89.71 132.95 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.462 -0.57 . . . . 0.82999999999999996 109.462 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 68.2 mt -120.34 -37.32 3.06 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.51 0.559 . . . . 1.45 112.51 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -139.46 175.96 9.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.479 . . . . 2.0800000000000001 112.13 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.5 p -163.85 149.44 10.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.577 -0.738 . . . . 0.56000000000000005 110.344 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -158.05 136.85 11.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.869 0.366 . . . . 1.55 111.5 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 63.1 p -77.65 -128.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.356 -0.384 . . . . 1.79 109.969 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.72 HG22 ' H ' ' A' ' 404' ' ' GLU . 0.5 OUTLIER -164.84 -173.41 2.96 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 110.214 -0.291 . . . . 1.95 110.214 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.72 ' H ' HG22 ' A' ' 403' ' ' THR . 94.7 mt-10 -44.9 -45.21 10.22 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.659 0.266 . . . . 3.8700000000000001 111.588 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -66.75 -51.45 55.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.529 -0.305 . . . . 3.1600000000000001 110.953 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 52.97 52.92 12.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.131 0.491 . . . . 2.1800000000000002 111.469 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.507 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -150.66 10.75 0.65 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.694 -0.684 . . . . 2.77 109.688 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.562 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.48 -47.6 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 114.585 -1.189 . . . . 2.7599999999999998 110.055 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 31.9 Cg_exo -58.8 143.59 99.0 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.463 2.108 . . . . 2.4900000000000002 112.447 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.64 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 42.5 p-10 -176.26 136.07 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.796 -0.638 . . . . 2.1400000000000001 110.804 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.5 mt-10 -130.96 134.18 46.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 2.1000000000000001 110.342 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 2.4 m-85 -112.32 127.48 56.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.377 . . . . 0.71999999999999997 111.671 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -64.76 144.78 57.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.437 -0.579 . . . . 0.51000000000000001 109.437 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.726 HG21 HG12 ' A' ' 385' ' ' ILE . 6.4 p -143.99 129.83 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.43 0.633 . . . . 1.1499999999999999 112.625 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -111.86 89.22 3.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.929 -1.032 . . . . 0.62 109.123 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.547 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 30.0 m-85 -52.49 115.6 1.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 0.65000000000000002 110.941 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.634 HG21 HD12 ' A' ' 382' ' ' ILE . 62.1 t -62.47 130.13 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.853 -0.612 . . . . 1.3400000000000001 110.875 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.81 -42.6 2.5 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.98 -0.628 . . . . 0.81999999999999995 112.798 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.527 ' HB3' HD22 ' A' ' 423' ' ' LEU . 2.7 mm? -59.6 159.43 8.45 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.92 0.39 . . . . 1.6000000000000001 111.668 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 69.1 m-20 -53.83 142.86 22.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.79 -0.641 . . . . 2.5299999999999998 111.383 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -60.73 -36.65 79.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 3.98 111.196 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -56.37 -32.15 64.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.355 -0.384 . . . . 3.71 111.0 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 419' ' ' LEU . 1.1 tp -56.4 -29.78 61.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 1.49 111.351 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.57 140.23 11.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.085 0.469 . . . . 1.2 111.824 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -174.82 -149.83 7.43 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.681 -0.691 . . . . 0.69999999999999996 112.097 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -127.46 133.08 49.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.60999999999999999 110.808 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.838 HG21 HG13 ' A' ' 432' ' ' ILE . 5.1 m -109.43 153.17 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.955 -0.566 . . . . 0.89000000000000001 111.049 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -76.97 29.98 1.57 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.434 -0.888 . . . . 1.72 112.455 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.764 ' H ' HG23 ' A' ' 427' ' ' VAL . 39.2 tpt85 71.88 -37.41 0.39 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.181 0.437 . . . . 1.73 112.181 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -58.83 -27.36 65.04 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.712 0.264 . . . . 1.47 111.712 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.616 ' NH2' ' HA ' ' A' ' 387' ' ' ARG . 81.2 mtp180 -78.56 -38.37 40.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.958 0.355 . . . . 2.8399999999999999 111.958 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.838 HD13 HG22 ' A' ' 397' ' ' VAL . 73.2 mt -88.44 131.41 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 0.46000000000000002 110.37 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 49.0 m -154.87 139.6 17.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.006 0.432 . . . . 0.53000000000000003 111.631 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.41 -25.4 67.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.615 . . . . 1.3500000000000001 110.349 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -108.56 134.13 51.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.837 -0.619 . . . . 2.1600000000000001 110.286 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -69.26 -42.91 74.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.023 -0.535 . . . . 0.75 112.298 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -57.63 -40.54 79.45 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.584 0.216 . . . . 1.3400000000000001 111.584 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -56.3 -35.06 67.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 1.5600000000000001 110.471 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 384' ' ' PHE . 86.4 mt -57.29 -82.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.775 -0.648 . . . . 1.1200000000000001 111.184 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' GLY . . . . . 0.529 ' HA3' HH11 ' A' ' 386' ' ' ARG . . . -168.35 -27.98 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.05 -0.595 . . . . 1.3600000000000001 112.138 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 443' ' ' THR . . . 154.44 143.08 3.59 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.104 -0.57 . . . . 1.8300000000000001 112.117 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 44.7 mm -62.56 78.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 120.989 0.423 . . . . 1.48 110.884 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.758 HG22 HD11 ' A' ' 445' ' ' LEU . 21.8 m -95.84 55.32 1.6 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.363 0.602 . . . . 3.0499999999999998 110.359 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.623 HG12 ' HD3' ' A' ' 446' ' ' PRO . 30.1 t -89.75 119.05 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.574 -0.739 . . . . 4.1799999999999997 111.383 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.758 HD11 HG22 ' A' ' 443' ' ' THR . 0.0 OUTLIER -151.31 57.93 2.58 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.311 -0.404 . . . . 4.9900000000000002 111.629 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.623 ' HD3' HG12 ' A' ' 444' ' ' VAL . 15.5 Cg_exo -68.23 151.56 76.63 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.924 2.416 . . . . 7.4000000000000004 112.024 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . -49.59 138.49 16.43 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.319 -0.401 . . . . 9.0600000000000005 110.878 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 447' ' ' ALA . 39.7 Cg_exo -57.34 116.64 3.36 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.433 2.089 . . . . 11.06 112.606 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 6.0 Cg_endo -86.72 -159.91 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.155 2.57 . . . . 13.5 112.274 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 83.0 mt -85.23 48.95 1.65 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.954 -0.566 . . . . 15.76 110.652 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . 67.13 129.66 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.99 -0.55 . . . . 16.739999999999998 111.2 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.77 138.18 37.2 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.637 2.224 . . . . 18.530000000000001 112.884 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 64.17 136.38 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.965 -0.561 . . . . 20.550000000000001 111.57 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.246 -0.883 . . . . 21.219999999999999 111.027 179.771 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.46 -0.256 . . . . 11.640000000000001 112.46 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 82.9 p -174.55 130.08 0.34 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 9.8599999999999994 110.686 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -71.44 132.85 45.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 8.0700000000000003 110.815 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 27.8 ttt -174.62 126.02 0.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 5.5099999999999998 110.523 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 49.88 78.18 0.42 Allowed Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 116.251 -0.431 . . . . 6.0599999999999996 111.04 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.57 40.15 0.53 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.727 2.285 . . . . 6.1600000000000001 112.921 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 370' ' ' MET . 2.4 pt? -168.6 -41.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 6.9400000000000004 110.42 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.576 ' HA ' ' HE3' ' A' ' 370' ' ' MET . 3.9 tpt -90.96 45.84 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.263 0.554 . . . . 5.6299999999999999 110.217 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -62.59 141.63 58.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.001 -0.545 . . . . 5.04 111.252 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.517 ' NZ ' ' HB2' ' A' ' 372' ' ' LYS . 0.0 OUTLIER -55.6 141.15 38.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.534 -0.757 . . . . 5.3899999999999997 111.468 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.65 133.07 25.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.255 -0.43 . . . . 1.48 110.76 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.75 128.94 35.64 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 116.265 -0.425 . . . . 2.1699999999999999 110.727 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.69 HD11 HG12 ' A' ' 397' ' ' VAL . 95.7 mt -91.74 -33.83 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.145 -0.48 . . . . 0.92000000000000004 110.901 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.4 t -72.05 62.36 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.042 -0.526 . . . . 1.71 111.057 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -168.24 -26.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.695 -0.684 . . . . 1.9199999999999999 109.874 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.645 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 60.0 m-20 -156.63 62.41 2.86 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.347 -0.842 . . . . 2.1400000000000001 111.517 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 79.0 Cg_exo -52.68 -41.21 70.69 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.998 2.465 . . . . 0.84999999999999998 112.8 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -70.01 -32.85 71.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.226 -0.443 . . . . 1.21 111.78 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.645 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.0 tttm -44.52 127.09 5.8 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.931 0.396 . . . . 1.6599999999999999 110.967 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.695 HD12 HG21 ' A' ' 417' ' ' VAL . 41.0 mm -86.91 127.07 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.40999999999999998 111.406 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -107.72 144.0 35.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 0.63 110.004 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.457 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 3.9 m-85 -91.29 138.27 31.72 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.081 -0.247 . . . . 0.95999999999999996 110.833 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.8 mp -121.37 126.99 75.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.449 -0.341 . . . . 0.48999999999999999 110.87 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 38.4 ttt85 -91.57 122.53 34.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 2.4199999999999999 111.032 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -83.23 172.19 12.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.744 0.307 . . . . 2.2999999999999998 110.695 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -53.05 -71.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 2.8199999999999998 111.045 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -40.99 -31.64 0.19 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.068 0.461 . . . . 1.23 110.565 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 111.14 39.48 1.38 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.795 -0.639 . . . . 1.03 112.986 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 39.7 p -114.02 111.04 21.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.95 0.405 . . . . 0.97999999999999998 110.976 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 439' ' ' LEU . 46.1 t -72.53 140.74 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.55000000000000004 111.39 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -148.14 134.34 19.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.582 . . . . 2.4300000000000002 110.42 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.584 ' HD2' HG21 ' A' ' 382' ' ' ILE . 83.0 mtm180 -58.43 150.37 22.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.074 0.464 . . . . 2.96 111.94 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -172.73 132.05 2.27 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.638 -0.71 . . . . 0.26000000000000001 112.254 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -91.72 111.61 23.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.577 0.227 . . . . 1.28 111.607 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.715 HG22 HD13 ' A' ' 432' ' ' ILE . 8.7 t -66.49 134.12 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.927 -0.397 . . . . 0.82999999999999996 109.927 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 91.6 mt -119.07 -44.49 2.6 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.907 0.336 . . . . 1.45 111.907 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.555 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 84.0 mt-30 -124.5 174.33 7.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.991 0.424 . . . . 2.0800000000000001 111.645 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 87.7 p -165.88 144.95 6.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.78 -0.645 . . . . 0.56000000000000005 110.351 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.503 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 41.2 ptt180 -156.97 134.89 10.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.003 0.43 . . . . 1.55 111.448 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 14.1 p -85.99 38.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.942 -0.572 . . . . 1.79 111.041 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.841 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.8 m 51.75 -173.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.545 -0.298 . . . . 1.95 110.272 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.841 ' H ' HG22 ' A' ' 403' ' ' THR . 8.4 mp0 -54.87 -49.52 70.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.721 0.296 . . . . 3.8700000000000001 110.631 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -87.21 115.09 24.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.302 -0.408 . . . . 3.1600000000000001 110.727 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -94.91 51.84 1.41 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.832 0.349 . . . . 2.1800000000000002 111.293 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -124.98 -11.52 7.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 2.77 111.215 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.635 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -161.84 -50.48 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.868 -0.606 . . . . 2.7599999999999998 111.107 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 72.1 Cg_exo -50.17 152.06 8.43 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.498 2.132 . . . . 2.4900000000000002 112.621 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 44.0 p-10 -175.74 137.22 0.34 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.093 -0.503 . . . . 2.1400000000000001 111.134 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -150.16 135.9 18.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 2.1000000000000001 110.497 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.746 ' HB2' HD12 ' A' ' 432' ' ' ILE . 2.1 m-85 -115.66 126.48 54.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.45 -0.341 . . . . 0.71999999999999997 111.358 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 426' ' ' TRP . 12.8 t80 -65.78 142.78 57.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.195 -0.457 . . . . 0.51000000000000001 110.32 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.637 HG22 HD11 ' A' ' 432' ' ' ILE . 20.1 t -128.33 136.87 58.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 112.546 0.573 . . . . 1.1499999999999999 112.546 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -120.88 89.87 3.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.62 109.943 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.617 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 50.0 m-85 -56.5 129.25 39.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.65000000000000002 111.19 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.695 HG21 HD12 ' A' ' 382' ' ' ILE . 2.8 t -82.98 34.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.782 -0.644 . . . . 1.3400000000000001 111.259 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -178.4 -41.44 0.07 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.455 -0.879 . . . . 0.81999999999999995 113.103 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.617 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 2.2 mm? -59.77 156.77 13.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.84 0.352 . . . . 1.6000000000000001 111.081 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -49.72 144.55 6.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.021 -0.536 . . . . 2.5299999999999998 111.77 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -56.83 -39.4 74.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.88 -0.6 . . . . 3.98 111.092 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 41.4 ptt85 -62.26 -32.15 72.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.895 0.378 . . . . 3.71 110.702 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.67 -32.38 72.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.974 -0.557 . . . . 1.49 111.056 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -48.16 129.1 14.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.301 -0.409 . . . . 1.2 110.448 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.95 165.59 35.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.53 -0.843 . . . . 0.69999999999999996 112.487 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' TRP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 8.3 m95 -74.42 128.49 35.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.739 0.304 . . . . 0.60999999999999999 110.496 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.467 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 4.4 m -119.89 152.68 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.89000000000000001 110.819 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -56.87 148.59 31.55 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.954 -0.641 . . . . 1.72 112.825 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -50.2 -42.16 50.97 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.567 0.347 . . . . 1.73 111.844 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.444 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 22.2 p-80 -54.81 -28.54 50.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.289 0.477 . . . . 1.47 112.289 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.3 mtt180 -78.59 -38.3 40.36 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.601 0.593 . . . . 2.8399999999999999 112.601 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.746 HD12 ' HB2' ' A' ' 412' ' ' TYR . 68.8 mt -88.6 130.65 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 120.601 -0.44 . . . . 0.46000000000000002 111.009 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.758 ' HB2' HD11 ' A' ' 439' ' ' LEU . 44.6 m -168.11 140.42 3.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.837 -0.62 . . . . 0.53000000000000003 110.949 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -66.02 -15.53 63.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.015 -0.539 . . . . 1.3500000000000001 111.278 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.469 ' O ' HD13 ' A' ' 439' ' ' LEU . 5.8 m120 -108.48 130.9 55.25 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.841 0.353 . . . . 2.1600000000000001 110.851 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 441' ' ' GLY . . . -74.74 -34.75 62.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.75 112.03 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.03 -40.56 67.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.425 -0.352 . . . . 1.3400000000000001 111.641 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 435' ' ' ASN . 61.9 m-20 -64.11 -21.21 66.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 1.5600000000000001 111.369 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.758 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.7 mp -93.94 -88.65 0.23 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.097 -0.501 . . . . 1.1200000000000001 111.917 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 440' ' ' GLY . . . . . 0.521 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -164.43 49.92 0.29 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.021 -0.609 . . . . 1.3600000000000001 112.157 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.475 ' O ' ' HB1' ' A' ' 436' ' ' ALA . . . 69.19 -129.61 23.49 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.59 -0.814 . . . . 1.8300000000000001 112.375 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.426 HD13 ' O ' ' A' ' 441' ' ' GLY . 43.3 mm -128.54 65.8 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.829 0.347 . . . . 1.48 110.651 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 392' ' ' VAL . 9.9 t 39.64 51.47 2.33 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.756 0.789 . . . . 3.0499999999999998 111.55 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 444' ' ' VAL . 8.4 p -146.05 60.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.671 -1.15 . . . . 4.1799999999999997 110.868 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 94.7 mt -50.71 146.31 9.99 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.443 -0.799 . . . . 4.9900000000000002 111.075 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -47.82 142.62 14.38 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.756 2.304 . . . . 7.4000000000000004 112.551 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . -157.66 138.56 9.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.531 . . . . 9.0600000000000005 110.94 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 447' ' ' ALA . 31.9 Cg_exo -58.58 131.73 44.17 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.612 2.208 . . . . 11.06 112.684 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.32 144.8 75.6 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.784 2.323 . . . . 13.5 112.224 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' LEU . . . . . 0.638 ' O ' HD12 ' A' ' 450' ' ' LEU . 3.6 pp -53.79 147.15 12.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 15.76 111.212 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . 64.93 129.63 0.03 OUTLIER Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 115.872 -0.604 . . . . 16.739999999999998 111.301 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.87 133.26 28.75 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.489 2.126 . . . . 18.530000000000001 112.507 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -174.53 126.33 0.31 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.07 -0.513 . . . . 20.550000000000001 110.573 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.247 -0.882 . . . . 21.219999999999999 110.854 179.998 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.111 0 N-CA-C 112.456 -0.258 . . . . 11.640000000000001 112.456 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 67.6 m -159.65 44.73 0.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.967 0.413 . . . . 9.8599999999999994 110.783 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' HIS . . . . . 0.554 ' HE1' ' HA ' ' A' ' 368' ' ' PRO . 15.0 p80 -169.84 138.62 1.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.984 -0.553 . . . . 8.0700000000000003 110.542 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' A' ' 366' ' ' MET . 1.6 mpt? -64.59 129.83 41.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 5.5099999999999998 111.49 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 58.64 126.44 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.696 -0.684 . . . . 6.0599999999999996 112.229 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' PRO . . . . . 0.554 ' HA ' ' HE1' ' A' ' 365' ' ' HIS . 72.4 Cg_endo -78.63 40.35 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.596 2.197 . . . . 6.1600000000000001 112.436 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 369' ' ' LEU . 1.0 OUTLIER -150.84 26.23 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.977 0.417 . . . . 6.9400000000000004 111.247 -179.468 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.404 ' O ' ' HG3' ' A' ' 370' ' ' MET . 12.2 tpt -172.8 66.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.873 -0.603 . . . . 5.6299999999999999 110.468 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -58.82 126.31 27.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.804 -0.635 . . . . 5.04 111.093 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.541 ' HE2' ' HA ' ' A' ' 365' ' ' HIS . 54.6 mtmt -59.58 151.39 24.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.863 -0.608 . . . . 5.3899999999999997 110.924 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.678 HG12 ' CZ ' ' A' ' 429' ' ' ARG . 49.5 mm -46.09 128.7 2.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.139 -0.482 . . . . 1.48 111.939 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -102.59 130.87 49.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.902 -0.59 . . . . 2.1699999999999999 109.996 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 77.5 mt -81.22 -42.28 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.42 0.526 . . . . 0.92000000000000004 112.42 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 41.5 t -47.93 -22.75 0.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.137 0.494 . . . . 1.71 111.308 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -54.77 -47.67 73.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.408 -0.815 . . . . 1.9199999999999999 111.118 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 379' ' ' PRO . 60.0 m-20 -167.06 112.9 0.67 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.833 -0.621 . . . . 2.1400000000000001 110.979 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 379' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 378' ' ' ASN . 12.2 Cg_exo -71.5 -41.05 2.56 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.826 2.35 . . . . 0.84999999999999998 112.699 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.407 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 55.3 m-20 -80.94 -34.24 33.39 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.125 0.417 . . . . 1.21 112.125 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 86.4 tttt -44.82 124.98 4.69 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.765 0.317 . . . . 1.6599999999999999 111.413 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.96 HD12 HG21 ' A' ' 417' ' ' VAL . 11.4 mm -77.99 131.05 35.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.132 -0.486 . . . . 0.40999999999999998 111.854 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -111.35 144.15 41.0 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.781 -0.452 . . . . 0.63 109.781 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.425 ' C ' HD12 ' A' ' 385' ' ' ILE . 46.9 m-85 -89.69 134.74 34.0 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.852 -0.339 . . . . 0.95999999999999996 110.899 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.6 mp -119.47 132.86 68.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.262 -0.426 . . . . 0.48999999999999999 110.899 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.626 ' N ' HD23 ' A' ' 439' ' ' LEU . 50.3 ttt-85 -93.92 115.78 28.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.672 0.272 . . . . 2.4199999999999999 110.819 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -76.56 157.04 32.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.524 -0.307 . . . . 2.2999999999999998 110.554 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -53.9 -44.95 70.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.581 -0.281 . . . . 2.8199999999999998 111.086 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -54.9 -27.35 42.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.253 0.549 . . . . 1.23 109.597 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 103.13 38.5 2.86 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.34 -0.845 . . . . 1.03 113.183 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 69.1 p -121.07 112.15 18.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.97999999999999998 111.455 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.33 132.28 33.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.55000000000000004 110.351 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -146.5 135.89 22.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.021 0.439 . . . . 2.4300000000000002 111.22 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.541 ' HD3' HG21 ' A' ' 382' ' ' ILE . 74.0 mtt-85 -53.84 153.67 4.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.722 -0.672 . . . . 2.96 111.875 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 415' ' ' HIS . . . -179.59 130.74 1.55 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.763 -0.653 . . . . 0.26000000000000001 112.192 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 75.5 mt-30 -91.82 134.11 35.04 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.99 0.395 . . . . 1.28 111.885 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.873 HG22 HD13 ' A' ' 432' ' ' ILE . 5.2 t -87.4 133.28 30.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.23 -0.441 . . . . 0.82999999999999996 110.722 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 85.0 mt -121.16 -46.75 2.29 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.075 0.398 . . . . 1.45 112.075 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.555 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 13.5 mm100 -127.07 176.84 7.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.916 0.389 . . . . 2.0800000000000001 111.647 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 87.9 p -162.42 139.56 8.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.79 -0.641 . . . . 0.56000000000000005 110.92 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.677 ' HD3' ' O ' ' A' ' 401' ' ' ARG . 0.1 OUTLIER -148.39 138.64 22.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 1.55 110.906 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.742 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 13.9 m -103.33 42.25 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 1.79 110.096 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.9 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.5 m 51.27 -173.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.736 -0.665 . . . . 1.95 110.648 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.9 ' H ' HG22 ' A' ' 403' ' ' THR . 95.6 mt-10 -63.98 -37.16 86.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 3.8700000000000001 110.69 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.681 ' HB2' ' HG2' ' A' ' 409' ' ' PRO . 5.1 m120 -56.25 -51.99 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.598 . . . . 3.1600000000000001 111.442 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.648 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.33 56.43 5.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 2.1800000000000002 110.863 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -161.9 -3.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 2.77 111.04 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.553 ' H ' ' CD ' ' A' ' 409' ' ' PRO . . . -169.54 -44.54 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.71 -0.677 . . . . 2.7599999999999998 111.649 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.681 ' HG2' ' HB2' ' A' ' 405' ' ' ASN . 15.7 Cg_exo -69.79 47.85 0.59 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.825 2.35 . . . . 2.4900000000000002 113.87 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.742 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 47.2 p-10 -68.59 143.84 54.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.908 0.385 . . . . 2.1400000000000001 110.893 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 50.6 mt-10 -148.72 146.69 28.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.016 -0.538 . . . . 2.1000000000000001 110.423 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -127.06 125.28 41.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.913 0.387 . . . . 0.71999999999999997 111.688 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.555 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 20.2 t80 -63.47 149.99 44.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.045 -0.724 . . . . 0.51000000000000001 109.045 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.542 HG21 HG12 ' A' ' 385' ' ' ILE . 7.8 p -158.83 133.32 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.016 0.747 . . . . 1.1499999999999999 113.016 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' HIS . . . . . 0.578 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 76.2 t60 -105.06 106.24 16.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.03 -0.987 . . . . 0.62 109.167 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 2.1 m-85 -62.19 100.63 0.18 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.55 0.691 . . . . 0.65000000000000002 109.939 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.96 HG21 HD12 ' A' ' 382' ' ' ILE . 44.2 t -48.63 123.74 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.555 -1.202 . . . . 1.3400000000000001 111.75 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 83.07 -33.37 2.91 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.183 -0.917 . . . . 0.81999999999999995 113.409 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.657 ' HB3' HD12 ' A' ' 423' ' ' LEU . 8.9 mt -68.23 -173.6 0.42 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.42 0.629 . . . . 1.6000000000000001 112.456 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.739 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 5.2 m120 -74.3 145.85 43.62 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 114.961 -1.018 . . . . 2.5299999999999998 111.053 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' ARG . . . . . 0.464 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 45.1 mtp85 -65.21 -39.24 92.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.22 -0.446 . . . . 3.98 111.348 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -57.44 -35.71 70.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.742 0.306 . . . . 3.71 111.122 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.739 ' HG ' ' HB2' ' A' ' 420' ' ' ASN . 85.4 mt -56.94 -33.94 67.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 1.49 111.191 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.578 ' OD1' ' HA ' ' A' ' 415' ' ' HIS . 39.8 m-20 -52.94 141.87 20.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.521 . . . . 1.2 111.759 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -171.85 -142.06 3.59 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.644 -0.707 . . . . 0.69999999999999996 111.954 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -124.29 138.07 54.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.018 0.437 . . . . 0.60999999999999999 110.715 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.829 HG21 HG13 ' A' ' 432' ' ' ILE . 15.7 m -109.08 158.58 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.925 -0.58 . . . . 0.89000000000000001 111.844 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -81.61 39.98 2.57 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.882 -0.675 . . . . 1.72 113.009 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.678 ' CZ ' HG12 ' A' ' 373' ' ' ILE . 38.4 tpt85 68.56 -72.4 0.1 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.492 0.553 . . . . 1.73 112.492 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -47.2 -15.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 1.47 113.053 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.564 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 99.5 mtt180 -78.29 -35.55 47.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.723 0.268 . . . . 2.8399999999999999 111.723 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 397' ' ' VAL . 97.4 mt -88.45 132.23 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.46000000000000002 111.16 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.683 ' HB2' HD11 ' A' ' 439' ' ' LEU . 75.0 m -166.06 139.29 4.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.855 -0.611 . . . . 0.53000000000000003 110.779 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -61.86 -23.15 66.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 1.3500000000000001 111.095 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.446 ' HB2' ' OD2' ' A' ' 438' ' ' ASP . 31.6 m120 -108.44 131.69 54.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.916 0.389 . . . . 2.1600000000000001 110.909 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -75.82 -31.96 59.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.75 111.915 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.66 -40.55 62.95 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.453 -0.34 . . . . 1.3400000000000001 111.462 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' ASP . . . . . 0.446 ' OD2' ' HB2' ' A' ' 435' ' ' ASN . 57.6 m-20 -61.96 -23.6 66.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 1.5600000000000001 111.091 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.5 mp -91.61 -84.63 0.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.82 -0.627 . . . . 1.1200000000000001 112.313 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -158.81 57.02 0.34 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.462 -0.875 . . . . 1.3600000000000001 112.995 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.68 -129.03 30.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.636 -0.793 . . . . 1.8300000000000001 112.841 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.55 ' O ' HG22 ' A' ' 443' ' ' THR . 46.2 mm -136.41 144.46 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.395 0.14 . . . . 1.48 110.912 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 442' ' ' ILE . 8.3 t 49.91 179.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.835 0.709 . . . . 3.0499999999999998 112.585 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 35.3 m -57.31 131.57 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.134 -0.939 . . . . 4.1799999999999997 112.216 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.527 HD23 ' N ' ' A' ' 445' ' ' LEU . 2.1 pt? -147.99 60.57 5.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.355 -0.839 . . . . 4.9900000000000002 110.422 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.99 134.1 8.1 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.737 2.291 . . . . 7.4000000000000004 113.021 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . 63.28 130.16 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.81 -0.632 . . . . 9.0600000000000005 111.868 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.43 146.23 49.65 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.716 2.277 . . . . 11.06 112.119 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.8 134.97 49.57 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.482 2.121 . . . . 13.5 112.203 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' LEU . . . . . 0.722 HD23 ' N ' ' A' ' 451' ' ' ALA . 6.6 tt -173.65 143.54 1.02 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.046 -0.524 . . . . 15.76 110.216 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.722 ' N ' HD23 ' A' ' 450' ' ' LEU . . . -46.42 143.75 3.7 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.136 -0.484 . . . . 16.739999999999998 111.569 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.489 ' C ' HE22 ' A' ' 454' ' ' GLN . 72.5 Cg_endo -74.5 43.04 0.85 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.967 2.445 . . . . 18.530000000000001 113.071 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.85 -41.53 12.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.673 -0.24 . . . . 20.550000000000001 111.27 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' GLN . . . . . 0.489 HE22 ' C ' ' A' ' 452' ' ' PRO . 4.4 mp0 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.207 -0.902 . . . . 21.219999999999999 110.852 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.434 -0.267 . . . . 11.640000000000001 112.434 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 52.2 m 56.6 45.15 22.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.799 0.333 . . . . 9.8599999999999994 110.943 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -59.12 136.61 58.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 8.0700000000000003 110.503 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' A' ' 366' ' ' MET . 1.2 mpt? -59.1 121.9 12.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.081 0.467 . . . . 5.5099999999999998 111.282 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -79.01 139.17 56.92 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.801 -0.636 . . . . 6.0599999999999996 111.217 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.72 42.46 1.31 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.68 2.253 . . . . 6.1600000000000001 112.603 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.476 HD23 ' C ' ' A' ' 369' ' ' LEU . 6.8 tt -171.68 -49.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 6.9400000000000004 109.904 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.437 ' HA ' ' OD1' ' A' ' 374' ' ' ASP . 53.2 ttp -102.74 61.04 0.8 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 5.6299999999999999 110.314 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.99 103.79 0.07 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.275 -0.421 . . . . 5.04 111.078 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.655 ' HB3' ' OH ' ' A' ' 412' ' ' TYR . 63.1 mttp 44.42 59.14 3.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.779 -0.646 . . . . 5.3899999999999997 111.804 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 76.4 mt 62.96 131.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.988 -0.551 . . . . 1.48 111.905 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 42.7 m-20 -89.47 77.36 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.833 -0.621 . . . . 2.1699999999999999 110.923 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.4 mt -48.36 -41.2 10.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 0.92000000000000004 111.648 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 77.9 p -64.94 76.14 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.545 . . . . 1.71 111.687 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 16.2 pt-20 -174.69 -27.62 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.862 -0.608 . . . . 1.9199999999999999 110.242 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.598 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 59.1 m-20 -156.14 62.3 2.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.691 -0.686 . . . . 2.1400000000000001 112.235 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.14 -40.97 75.36 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.778 2.319 . . . . 0.84999999999999998 112.542 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -70.86 -34.41 71.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.041 -0.527 . . . . 1.21 111.722 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 86.2 tttt -43.03 129.73 4.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.981 0.42 . . . . 1.6599999999999999 111.028 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.508 HG21 ' HD2' ' A' ' 394' ' ' ARG . 46.8 mm -81.64 123.26 37.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.854 -0.612 . . . . 0.40999999999999998 111.448 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -102.02 143.41 31.9 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.922 -0.399 . . . . 0.63 109.922 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.84 139.2 30.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.587 -0.279 . . . . 0.95999999999999996 110.798 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.601 ' N ' HD12 ' A' ' 385' ' ' ILE . 1.7 mp -131.94 133.45 60.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.69 0.281 . . . . 0.48999999999999999 111.168 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.634 ' CZ ' ' HA3' ' A' ' 440' ' ' GLY . 8.1 tpt180 -90.41 121.71 32.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 2.4199999999999999 110.585 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -74.53 164.22 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 2.2999999999999998 110.556 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 388' ' ' GLU . 8.7 mp0 -61.3 -45.32 94.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.335 -0.393 . . . . 2.8199999999999998 110.825 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -61.47 -12.88 16.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.133 0.492 . . . . 1.23 110.058 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.453 ' C ' ' HE ' ' A' ' 386' ' ' ARG . . . 90.78 41.78 5.26 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.409 -0.814 . . . . 1.03 112.53 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.838 HG22 ' HG ' ' A' ' 445' ' ' LEU . 82.8 p -121.35 112.64 18.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.679 0.276 . . . . 0.97999999999999998 111.352 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 59.4 t -68.43 134.2 30.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 0.55000000000000004 110.711 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -149.65 137.63 20.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 2.4300000000000002 110.989 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.508 ' HD2' HG21 ' A' ' 382' ' ' ILE . 77.9 mtm180 -60.79 152.53 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 2.96 111.531 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -171.01 126.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.771 -0.65 . . . . 0.26000000000000001 112.295 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 57.0 mt-30 -78.8 130.15 35.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.724 0.297 . . . . 1.28 111.514 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.7 OUTLIER -98.85 126.87 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.61 -0.515 . . . . 0.82999999999999996 109.61 178.479 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.708 ' N ' HD22 ' A' ' 398' ' ' LEU . 0.4 OUTLIER -115.05 -47.21 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.534 0.568 . . . . 1.45 112.534 -177.215 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.426 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 80.8 mt-30 -127.71 176.41 7.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 2.0800000000000001 111.726 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 84.7 p -165.47 141.93 5.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.784 -0.644 . . . . 0.56000000000000005 110.967 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.491 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 41.0 ptt180 -142.88 135.23 27.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.346 -0.388 . . . . 1.55 110.772 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.69 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 24.9 p -81.92 40.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 1.79 112.159 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.8 m 50.58 -173.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.506 -0.183 . . . . 1.95 110.506 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.88 ' H ' HG22 ' A' ' 403' ' ' THR . 48.6 mt-10 -56.73 -50.02 73.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.321 . . . . 3.8700000000000001 110.446 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -83.73 117.85 23.51 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.296 -0.411 . . . . 3.1600000000000001 110.613 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -101.43 76.68 1.71 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.964 0.411 . . . . 2.1800000000000002 111.326 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -160.68 10.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 2.77 110.65 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.696 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.52 -51.61 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.609 -0.723 . . . . 2.7599999999999998 110.903 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 49.9 Cg_exo -57.07 154.11 35.16 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.689 2.259 . . . . 2.4900000000000002 113.028 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.69 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 44.2 p-10 -178.62 130.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.852 -0.613 . . . . 2.1400000000000001 111.081 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 400' ' ' SER . 58.9 mp0 -136.85 135.28 37.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.85 -0.614 . . . . 2.1000000000000001 109.933 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.655 ' OH ' ' HB3' ' A' ' 372' ' ' LYS . 0.4 OUTLIER -110.91 130.17 55.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 0.71999999999999997 111.897 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 14.6 t80 -65.03 141.62 58.7 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.516 -0.92 . . . . 0.51000000000000001 108.516 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 6.4 p -147.72 110.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.608 0.966 . . . . 1.1499999999999999 113.608 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -86.44 90.94 8.37 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.531 -0.759 . . . . 0.62 109.344 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 424' ' ' ASP . 35.6 m-85 -52.84 128.71 27.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.055 0.455 . . . . 0.65000000000000002 111.394 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 86.2 t -73.2 127.81 35.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.748 -0.66 . . . . 1.3400000000000001 111.166 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.34 -44.91 2.25 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.985 -0.626 . . . . 0.81999999999999995 113.022 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.525 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.7 mp -59.7 148.98 32.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.861 0.362 . . . . 1.6000000000000001 111.204 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -54.47 137.72 42.01 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.948 -0.569 . . . . 2.5299999999999998 111.798 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -32.31 50.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.655 -0.702 . . . . 3.98 111.368 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 422' ' ' ARG . . . . . 0.58 HH11 HD23 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -54.79 -38.85 67.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 3.71 110.52 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.58 HD23 HH11 ' A' ' 422' ' ' ARG . 96.5 mt -65.55 -35.44 80.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.019 0.438 . . . . 1.49 110.54 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.432 ' HA ' ' CD1' ' A' ' 416' ' ' TYR . 16.8 m-20 -54.84 138.32 43.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.654 -0.703 . . . . 1.2 111.602 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -179.46 -141.68 4.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.715 -0.675 . . . . 0.69999999999999996 111.938 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' TRP . . . . . 0.491 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 53.4 m95 -106.2 140.28 39.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.60999999999999999 110.695 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.538 ' CG2' HD11 ' A' ' 432' ' ' ILE . 17.1 m -132.88 141.73 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.89000000000000001 111.953 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -64.99 150.96 51.66 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.855 -0.611 . . . . 1.72 112.525 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.407 ' HD3' ' CZ ' ' A' ' 412' ' ' TYR . 41.0 tpt85 -51.74 -38.28 54.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.771 0.319 . . . . 1.73 111.269 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.574 ' ND1' ' HG3' ' A' ' 431' ' ' ARG . 6.4 p80 -60.19 -28.96 68.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.44 0.533 . . . . 1.47 112.44 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.574 ' HG3' ' ND1' ' A' ' 430' ' ' HIS . 72.1 mtt-85 -78.23 -35.62 48.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.52 0.2 . . . . 2.8399999999999999 111.537 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.545 HG12 HG13 ' A' ' 385' ' ' ILE . 66.3 mt -88.67 139.7 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.138 0.494 . . . . 0.46000000000000002 111.869 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.9 m -163.39 139.17 6.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.5 -0.773 . . . . 0.53000000000000003 110.327 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -75.83 16.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 1.3500000000000001 111.359 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 75.9 m-80 -147.88 130.76 16.15 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.879 0.371 . . . . 2.1600000000000001 110.699 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' ALA . . . . . 0.621 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -69.87 -37.85 76.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.53 . . . . 0.75 111.898 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -50.39 -40.87 51.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 1.3400000000000001 111.214 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.14 49.39 1.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 1.5600000000000001 110.999 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.621 HD12 ' HA ' ' A' ' 436' ' ' ALA . 88.7 mt -145.7 -84.87 0.12 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.521 -0.309 . . . . 1.1200000000000001 111.539 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 440' ' ' GLY . . . . . 0.634 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . -167.66 40.5 0.24 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.416 -0.897 . . . . 1.3600000000000001 113.014 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.46 144.2 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.765 -0.731 . . . . 1.8300000000000001 112.88 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 48.8 mm -59.19 90.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 110.461 -0.2 . . . . 1.48 110.461 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.479 ' HA ' HD11 ' A' ' 445' ' ' LEU . 8.9 t 39.53 42.39 0.89 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.614 0.721 . . . . 3.0499999999999998 111.634 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 444' ' ' VAL . 12.8 t -89.82 50.77 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.934 -1.03 . . . . 4.1799999999999997 111.854 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.838 ' HG ' HG22 ' A' ' 391' ' ' THR . 0.0 OUTLIER -109.34 146.79 34.67 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 4.9900000000000002 111.165 179.372 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -51.85 148.3 22.96 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.901 2.401 . . . . 7.4000000000000004 112.707 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -157.64 142.48 12.03 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.022 -0.535 . . . . 9.0600000000000005 110.912 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.52 129.38 19.8 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.78 2.32 . . . . 11.06 112.91 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.11 151.43 34.64 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.931 2.421 . . . . 13.5 112.578 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 450' ' ' LEU . 3.2 mm? 65.74 148.12 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.093 -0.503 . . . . 15.76 111.513 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -157.77 138.28 9.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.64 . . . . 16.739999999999998 110.743 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.78 41.51 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.568 2.179 . . . . 18.530000000000001 112.88 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -73.37 -137.62 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.501 -0.318 . . . . 20.550000000000001 110.559 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.178 -0.915 . . . . 21.219999999999999 110.927 179.716 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 112.479 -0.249 . . . . 11.640000000000001 112.479 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.0 t -60.56 -47.02 88.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.796 0.331 . . . . 9.8599999999999994 110.844 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' HIS . . . . . 0.441 ' ND1' ' N ' ' A' ' 366' ' ' MET . 26.6 t-80 -70.33 -129.03 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.138 -0.483 . . . . 8.0700000000000003 109.915 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 371' ' ' GLN . 0.0 OUTLIER -172.17 46.55 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.829 -0.434 . . . . 5.5099999999999998 109.829 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.446 ' OD2' ' HA ' ' A' ' 372' ' ' LYS . 55.1 m-20 48.36 85.13 0.19 Allowed Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.703 -0.681 . . . . 6.0599999999999996 111.344 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.57 49.54 2.44 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.627 2.218 . . . . 6.1600000000000001 112.304 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.575 ' HG ' ' HG2' ' A' ' 370' ' ' MET . 2.0 pt? -162.11 -22.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 6.9400000000000004 110.47 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.575 ' HG2' ' HG ' ' A' ' 369' ' ' LEU . 19.1 ptp -158.17 13.88 0.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.178 -0.465 . . . . 5.6299999999999999 111.37 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.641 ' O ' ' HB3' ' A' ' 372' ' ' LYS . 98.4 mm-40 36.11 32.8 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.261 -0.881 . . . . 5.04 112.477 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.641 ' HB3' ' O ' ' A' ' 371' ' ' GLN . 24.1 pttm 139.16 144.9 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.614 1.196 . . . . 5.3899999999999997 110.488 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.543 HG13 ' HE ' ' A' ' 429' ' ' ARG . 70.4 mt -59.92 128.24 20.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.672 0.273 . . . . 1.48 110.335 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.507 ' OD1' ' HB2' ' A' ' 370' ' ' MET . 1.4 m-20 -89.5 129.36 36.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.877 0.37 . . . . 2.1699999999999999 111.288 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.476 HD11 HG12 ' A' ' 397' ' ' VAL . 82.5 mt -84.79 -39.43 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.92000000000000004 110.816 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.4 t -66.55 72.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.751 -0.659 . . . . 1.71 111.022 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -174.45 -28.64 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.536 -0.757 . . . . 1.9199999999999999 109.644 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 381' ' ' LYS . 35.1 p30 -172.2 57.69 0.24 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.206 -0.906 . . . . 2.1400000000000001 111.052 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 379' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 52.2 Cg_exo -52.86 -39.86 76.82 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.297 1.998 . . . . 0.84999999999999998 111.893 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.483 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 54.0 m-20 -62.57 -33.84 75.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.93 -0.577 . . . . 1.21 110.877 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 86.1 tttt -49.1 121.29 4.67 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.205 -0.452 . . . . 1.6599999999999999 110.799 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.878 HG23 HG21 ' A' ' 417' ' ' VAL . 18.6 mm -69.97 129.43 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.40999999999999998 112.0 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 395' ' ' GLY . 82.0 m-85 -109.75 144.69 37.79 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.283 -0.417 . . . . 0.63 110.234 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.526 ' C ' HD12 ' A' ' 385' ' ' ILE . 2.0 m-85 -85.6 128.5 34.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.731 0.301 . . . . 0.95999999999999996 110.884 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.765 HG12 HG21 ' A' ' 414' ' ' VAL . 1.8 mp -113.22 128.17 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.238 -0.437 . . . . 0.48999999999999999 110.66 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.681 ' HD3' ' HB3' ' A' ' 439' ' ' LEU . 25.4 tpt180 -98.27 120.62 39.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.373 -0.376 . . . . 2.4199999999999999 111.267 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -83.18 157.33 22.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 2.2999999999999998 110.556 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -55.71 -39.7 71.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 2.8199999999999998 111.301 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -71.44 5.5 2.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.442 -0.344 . . . . 1.23 111.684 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 74.08 44.14 30.72 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.018 -0.61 . . . . 1.03 113.776 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.429 HG22 HG21 ' A' ' 444' ' ' VAL . 25.3 p -122.38 111.65 17.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.828 0.314 . . . . 0.97999999999999998 111.625 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.61 HG23 ' NH1' ' A' ' 386' ' ' ARG . 72.4 t -69.36 135.61 27.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.649 -0.25 . . . . 0.55000000000000004 110.416 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -151.41 133.08 14.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.426 -0.352 . . . . 2.4300000000000002 111.046 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.77 ' HD2' HG21 ' A' ' 382' ' ' ILE . 88.9 mtm180 -59.07 153.34 18.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 2.96 112.036 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -175.44 132.45 2.16 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.798 -0.637 . . . . 0.26000000000000001 112.516 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' GLN . . . . . 0.494 ' HG3' HG22 ' A' ' 417' ' ' VAL . 75.3 mt-30 -96.15 112.03 23.89 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 111.773 0.286 . . . . 1.28 111.773 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.921 HG22 HD13 ' A' ' 432' ' ' ILE . 2.6 t -63.49 136.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.218 -0.29 . . . . 0.82999999999999996 110.218 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.407 ' HB2' ' HD2' ' A' ' 413' ' ' TYR . 98.8 mt -120.36 -38.92 2.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.16 0.43 . . . . 1.45 112.16 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.475 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 85.7 mt-30 -139.96 176.45 8.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.066 0.46 . . . . 2.0800000000000001 111.588 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.1 p -163.7 150.94 12.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.692 -0.686 . . . . 0.56000000000000005 110.24 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.542 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 39.2 ptt180 -156.17 134.58 11.54 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.862 0.363 . . . . 1.55 111.86 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 32.7 p -78.25 136.93 37.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 1.79 110.293 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.832 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.7 m -63.74 -174.49 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.285 -0.416 . . . . 1.95 110.777 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.832 ' H ' HG22 ' A' ' 403' ' ' THR . 49.1 mt-10 -48.76 -43.1 37.47 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.386 0.513 . . . . 3.8700000000000001 112.386 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.593 ' HB3' ' HG3' ' A' ' 409' ' ' PRO . 15.6 t-20 -55.9 -49.67 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.585 0.231 . . . . 3.1600000000000001 111.457 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.443 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 57.32 59.11 3.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.947 0.403 . . . . 2.1800000000000002 111.537 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.46 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -154.75 -2.27 0.16 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.602 . . . . 2.77 110.143 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.675 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -178.46 -49.35 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 114.848 -1.069 . . . . 2.7599999999999998 110.181 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 11.7 Cg_endo -54.62 141.39 74.84 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.44 2.093 . . . . 2.4900000000000002 112.298 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 36.6 p-10 -177.09 132.06 0.18 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.799 -0.637 . . . . 2.1400000000000001 111.077 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.4 mt-10 -108.55 135.45 49.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.595 . . . . 2.1000000000000001 109.549 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.472 ' OH ' ' HB2' ' A' ' 372' ' ' LYS . 1.0 OUTLIER -108.83 120.61 43.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.894 0.378 . . . . 0.71999999999999997 111.73 -178.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.475 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 11.9 t80 -60.89 137.47 58.21 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.914 -0.773 . . . . 0.51000000000000001 108.914 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.765 HG21 HG12 ' A' ' 385' ' ' ILE . 7.3 p -136.87 130.52 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.904 0.705 . . . . 1.1499999999999999 112.904 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' HIS . . . . . 0.495 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 81.5 t60 -102.1 89.49 3.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.87 -1.059 . . . . 0.62 109.018 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.622 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 22.6 m-85 -46.55 123.95 5.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.373 0.606 . . . . 0.65000000000000002 111.019 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 382' ' ' ILE . 43.5 t -74.7 125.48 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.133 -0.94 . . . . 1.3400000000000001 111.022 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.84 -42.98 2.55 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.585 -0.734 . . . . 0.81999999999999995 112.279 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.832 HD11 ' HG2' ' A' ' 446' ' ' PRO . 7.1 mp -65.03 151.95 44.69 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.928 0.394 . . . . 1.6000000000000001 111.44 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -57.84 160.14 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 2.5299999999999998 111.226 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' ARG . . . . . 0.45 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 68.2 mtt-85 -62.47 -26.56 68.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.257 0.551 . . . . 3.98 110.453 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -52.31 -36.35 52.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.282 -0.872 . . . . 3.71 111.829 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 423' ' ' LEU . 2.8 mm? -68.91 -34.6 75.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.451 . . . . 1.49 111.584 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 415' ' ' HIS . 1.2 m-20 -45.84 140.52 3.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.15 0.5 . . . . 1.2 112.149 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -178.18 -142.41 4.68 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.584 -0.735 . . . . 0.69999999999999996 112.176 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' TRP . . . . . 0.447 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 42.4 m95 -129.7 138.31 51.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.945 0.403 . . . . 0.60999999999999999 110.815 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.7 HG21 HG13 ' A' ' 432' ' ' ILE . 22.2 m -125.82 149.55 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.89000000000000001 111.196 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -77.01 29.49 1.59 Allowed Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.904 -0.665 . . . . 1.72 114.475 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.575 ' HB3' ' O ' ' A' ' 428' ' ' GLY . 37.4 tpt85 75.25 -43.96 0.52 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.171 0.804 . . . . 1.73 113.171 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.25 -30.47 27.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.736 0.779 . . . . 1.47 110.269 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.572 ' NH1' ' H ' ' A' ' 428' ' ' GLY . 28.8 mtt85 -78.48 -32.31 48.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.311 -1.313 . . . . 2.8399999999999999 112.595 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.921 HD13 HG22 ' A' ' 397' ' ' VAL . 77.0 mt -88.46 129.72 39.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.799 -0.36 . . . . 0.46000000000000002 110.375 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.67 ' HB2' HD11 ' A' ' 439' ' ' LEU . 63.3 m -164.92 143.67 6.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.152 -0.476 . . . . 0.53000000000000003 111.149 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -73.61 16.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 1.3500000000000001 111.721 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -159.17 135.71 9.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.94 0.4 . . . . 2.1600000000000001 111.124 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' ALA . . . . . 0.612 ' HB1' ' H ' ' A' ' 442' ' ' ILE . . . -69.37 -26.41 64.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.79 -0.641 . . . . 0.75 112.21 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -46.67 -40.76 13.75 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.49 -0.323 . . . . 1.3400000000000001 111.794 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -72.94 -33.01 65.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.004 0.43 . . . . 1.5600000000000001 111.012 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.681 ' HB3' ' HD3' ' A' ' 386' ' ' ARG . 6.7 mp -77.99 -84.39 0.08 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.706 -0.679 . . . . 1.1200000000000001 111.866 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . -148.39 28.59 1.35 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.671 -0.776 . . . . 1.3600000000000001 112.535 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 48.46 55.11 11.27 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.945 -0.645 . . . . 1.8300000000000001 112.65 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.612 ' H ' ' HB1' ' A' ' 436' ' ' ALA . 31.4 mm 62.83 113.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 110.285 -0.265 . . . . 1.48 110.285 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.751 HG22 HG23 ' A' ' 444' ' ' VAL . 86.8 m -160.94 131.16 5.1 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.866 0.365 . . . . 3.0499999999999998 111.97 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.751 HG23 HG22 ' A' ' 443' ' ' THR . 33.0 t 48.5 61.69 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 CA-C-N 115.785 -0.643 . . . . 4.1799999999999997 111.25 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 445' ' ' LEU . 2.4 mm? -89.48 133.64 34.2 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.176 -0.466 . . . . 4.9900000000000002 111.155 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.832 ' HG2' HD11 ' A' ' 419' ' ' LEU . 32.5 Cg_exo -57.5 141.81 95.2 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.835 2.357 . . . . 7.4000000000000004 112.531 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -167.99 127.09 1.02 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.041 -0.527 . . . . 9.0600000000000005 110.792 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 56.8 Cg_endo -70.33 133.28 24.16 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.535 2.157 . . . . 11.06 112.424 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 28.1 Cg_exo -61.65 129.94 29.68 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.416 2.077 . . . . 13.5 111.818 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 99.1 mt 64.06 132.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.26 -0.427 . . . . 15.76 111.04 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . -61.47 124.22 79.95 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 16.739999999999998 111.281 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 451' ' ' ALA . 5.8 Cg_exo -78.93 41.93 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.028 2.485 . . . . 18.530000000000001 112.273 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -153.25 135.62 15.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 20.550000000000001 110.884 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.259 -0.877 . . . . 21.219999999999999 110.864 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.427 -0.269 . . . . 11.640000000000001 112.427 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 80.2 p -172.71 44.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 9.8599999999999994 110.698 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 57.31 52.72 8.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 8.0700000000000003 110.352 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 27.7 ttt -57.19 128.13 35.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.885 -0.598 . . . . 5.5099999999999998 110.633 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.01 121.16 76.86 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 6.0599999999999996 111.272 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.3 44.06 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.828 2.352 . . . . 6.1600000000000001 112.681 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.431 HD23 ' H ' ' A' ' 370' ' ' MET . 2.2 pt? -164.23 -41.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.567 -0.288 . . . . 6.9400000000000004 111.24 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.431 ' H ' HD23 ' A' ' 369' ' ' LEU . 0.0 OUTLIER -82.54 46.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.078 0.466 . . . . 5.6299999999999999 110.482 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.418 ' O ' ' HB2' ' A' ' 372' ' ' LYS . 3.4 mm100 -83.18 43.37 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 5.04 111.144 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 371' ' ' GLN . 47.7 mmtm 67.01 139.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.101 0.477 . . . . 5.3899999999999997 111.561 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.535 ' HB ' HH12 ' A' ' 429' ' ' ARG . 68.8 mt 55.56 90.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.695 -0.684 . . . . 1.48 111.587 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.51 142.7 27.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 2.1699999999999999 110.354 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.552 HG22 ' HG3' ' A' ' 379' ' ' PRO . 4.6 mp -71.4 -43.31 73.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.742 0.275 . . . . 0.92000000000000004 111.742 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 49.2 m -49.11 -20.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.982 0.42 . . . . 1.71 111.52 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -58.39 -48.28 81.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.701 -0.681 . . . . 1.9199999999999999 111.773 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.468 ' ND2' ' HD3' ' A' ' 381' ' ' LYS . 11.3 p30 -174.98 73.61 0.3 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.12 -0.491 . . . . 2.1400000000000001 110.911 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' PRO . . . . . 0.552 ' HG3' HG22 ' A' ' 375' ' ' ILE . 78.2 Cg_exo -51.36 -40.17 62.32 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.521 2.147 . . . . 0.84999999999999998 112.477 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.536 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 1.5 m-20 -62.39 -37.29 85.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 1.21 111.199 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.468 ' HD3' ' ND2' ' A' ' 378' ' ' ASN . 79.1 tttt -50.54 127.48 17.89 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.972 0.415 . . . . 1.6599999999999999 111.006 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.833 HG23 HG21 ' A' ' 417' ' ' VAL . 20.8 mm -73.22 132.6 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.817 -0.629 . . . . 0.40999999999999998 111.859 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.532 ' HB3' HG23 ' A' ' 432' ' ' ILE . 22.4 m-85 -118.68 144.19 46.37 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.091 -0.504 . . . . 0.63 110.256 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.592 ' CD2' ' HB2' ' A' ' 436' ' ' ALA . 3.0 m-85 -85.58 138.57 32.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.841 0.353 . . . . 0.95999999999999996 111.183 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.643 HG12 HG21 ' A' ' 414' ' ' VAL . 2.5 mp -116.3 126.36 73.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.129 -0.487 . . . . 0.48999999999999999 110.852 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.444 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 36.7 ttt85 -90.57 111.44 22.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 2.4199999999999999 110.839 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.434 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 76.8 mtp180 -71.89 157.8 37.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.41 -0.359 . . . . 2.2999999999999998 110.263 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.467 ' HG2' HH22 ' A' ' 431' ' ' ARG . 48.9 mt-10 -49.32 -41.0 37.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 2.8199999999999998 111.331 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -71.33 -36.13 71.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 1.23 111.572 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 137.19 -28.15 2.82 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.427 -0.892 . . . . 1.03 112.811 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 47.5 p -58.81 112.09 1.52 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.97999999999999998 111.718 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.725 HG23 ' HA3' ' A' ' 441' ' ' GLY . 73.1 t -84.92 141.14 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.625 -0.716 . . . . 0.55000000000000004 110.88 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' HIS . . . . . 0.46 ' CG ' HD21 ' A' ' 419' ' ' LEU . 93.7 m-70 -145.45 139.92 27.21 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.987 0.422 . . . . 2.4300000000000002 111.243 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.496 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 88.0 mtm180 -55.17 152.24 8.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.793 -0.64 . . . . 2.96 112.064 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -178.74 128.16 1.23 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.481 -0.781 . . . . 0.26000000000000001 111.861 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' GLN . . . . . 0.536 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 78.4 mt-30 -84.47 130.74 34.73 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.338 0.496 . . . . 1.28 112.338 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.95 HG22 HD13 ' A' ' 432' ' ' ILE . 9.8 t -81.99 134.56 26.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.547 -0.538 . . . . 0.82999999999999996 109.547 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 413' ' ' TYR . 90.2 mt -120.78 -43.19 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.475 0.546 . . . . 1.45 112.475 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.53 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 30.5 mm100 -134.91 175.94 9.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.076 0.465 . . . . 2.0800000000000001 111.816 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.5 p -165.54 143.43 5.91 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.687 -0.688 . . . . 0.56000000000000005 110.633 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.463 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 40.6 ptt180 -151.08 135.05 16.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.952 0.406 . . . . 1.55 111.346 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 23.3 p -82.91 43.29 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 1.79 111.648 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.853 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.0 m 50.91 -174.08 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.201 -0.454 . . . . 1.95 110.869 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.853 ' H ' HG22 ' A' ' 403' ' ' THR . 93.3 mt-10 -65.38 -42.94 92.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.717 0.294 . . . . 3.8700000000000001 111.225 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -57.34 -51.31 69.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 3.1600000000000001 111.18 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.493 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 55.61 63.52 2.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.985 0.421 . . . . 2.1800000000000002 111.831 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.447 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -160.63 7.76 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.404 0.621 . . . . 2.77 110.039 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.628 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.81 -48.96 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.779 -1.1 . . . . 2.7599999999999998 109.99 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.628 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 31.4 Cg_exo -59.34 160.92 18.16 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.621 2.214 . . . . 2.4900000000000002 112.251 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.67 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.1 p30 178.43 141.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.128 -0.487 . . . . 2.1400000000000001 111.049 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.6 mt-10 -142.25 134.74 28.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.97 -0.559 . . . . 2.1000000000000001 110.285 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 0.6 OUTLIER -109.5 124.27 50.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.71999999999999997 111.469 -179.208 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.53 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 8.8 t80 -66.41 137.32 56.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.51000000000000001 109.652 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.643 HG21 HG12 ' A' ' 385' ' ' ILE . 8.0 p -135.61 137.62 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.18 0.514 . . . . 1.1499999999999999 112.248 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' HIS . . . . . 0.495 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 73.0 t60 -118.46 108.81 15.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.852 . . . . 0.62 109.585 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.487 ' CD1' HD22 ' A' ' 419' ' ' LEU . 97.9 m-85 -55.99 126.44 25.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.225 0.536 . . . . 0.65000000000000002 110.727 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.833 HG21 HG23 ' A' ' 382' ' ' ILE . 2.1 t -78.67 28.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.366 -0.834 . . . . 1.3400000000000001 111.81 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 173.1 -37.45 0.14 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.107 -1.045 . . . . 0.81999999999999995 113.773 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.487 HD22 ' CD1' ' A' ' 416' ' ' TYR . 7.0 mp -61.79 -166.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.371 0.605 . . . . 1.6000000000000001 112.432 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.746 ' HB3' ' HD2' ' A' ' 422' ' ' ARG . 5.0 m120 -63.65 146.73 53.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.244 -0.889 . . . . 2.5299999999999998 111.915 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -72.8 -42.24 64.12 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.165 -0.47 . . . . 3.98 110.94 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' ARG . . . . . 0.746 ' HD2' ' HB3' ' A' ' 420' ' ' ASN . 0.1 OUTLIER -64.22 -24.77 67.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 3.71 109.713 179.255 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' A' ' 420' ' ' ASN . 1.2 tp -58.04 -33.1 68.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.351 -0.84 . . . . 1.49 111.048 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.495 ' OD1' ' HA ' ' A' ' 415' ' ' HIS . 65.8 m-20 -50.5 137.13 19.72 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.897 -0.592 . . . . 1.2 111.534 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLY . . . . . 0.528 ' O ' HG12 ' A' ' 414' ' ' VAL . . . -179.18 174.09 46.1 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.782 -0.645 . . . . 0.69999999999999996 112.086 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 426' ' ' TRP . . . . . 0.463 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 15.7 m95 -81.49 140.35 34.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.38 . . . . 0.60999999999999999 110.851 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.854 HG21 HG13 ' A' ' 432' ' ' ILE . 21.8 m -108.85 160.26 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.508 . . . . 0.89000000000000001 111.527 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -75.86 24.91 1.53 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.757 -0.735 . . . . 1.72 113.045 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.644 ' H ' HG23 ' A' ' 427' ' ' VAL . 8.2 tpt180 71.93 -45.83 0.63 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.851 0.686 . . . . 1.73 112.851 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -65.61 -14.98 62.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.71 0.291 . . . . 1.47 111.494 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.467 HH22 ' HG2' ' A' ' 388' ' ' GLU . 66.2 mtt-85 -79.38 -36.31 39.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.43 -0.35 . . . . 2.8399999999999999 111.852 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.95 HD13 HG22 ' A' ' 397' ' ' VAL . 75.2 mt -87.73 132.31 33.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.031 0.444 . . . . 0.46000000000000002 111.587 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.412 ' HB2' HD21 ' A' ' 439' ' ' LEU . 59.1 m -163.91 139.37 6.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.595 -0.73 . . . . 0.53000000000000003 110.377 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.27 -22.57 66.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.359 -0.382 . . . . 1.3500000000000001 111.029 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.68 130.17 55.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.763 0.316 . . . . 2.1600000000000001 110.8 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' ALA . . . . . 0.684 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -80.88 -40.51 24.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.75 111.673 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -51.81 -40.79 61.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.391 -0.368 . . . . 1.3400000000000001 110.744 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -64.08 -38.1 89.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.102 0.477 . . . . 1.5600000000000001 109.894 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 436' ' ' ALA . 76.8 mt -60.47 -83.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.56 -0.745 . . . . 1.1200000000000001 110.725 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 139.28 52.19 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.99 -0.624 . . . . 1.3600000000000001 112.029 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.793 ' HA2' HD21 ' A' ' 445' ' ' LEU . . . -161.83 -70.75 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 119.565 -1.302 . . . . 1.8300000000000001 114.122 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.583 ' N ' HD12 ' A' ' 442' ' ' ILE . 1.6 mp 61.99 151.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.126 -0.694 . . . . 1.48 109.126 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 57.6 m -46.63 110.57 0.29 Allowed 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.256 -0.577 . . . . 3.0499999999999998 110.361 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 91.1 t 63.55 117.65 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.631 -0.713 . . . . 4.1799999999999997 111.28 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.793 HD21 ' HA2' ' A' ' 441' ' ' GLY . 43.8 mt -71.76 139.63 83.33 Favored Pre-proline 0 N--CA 1.463 0.18 0 CA-C-N 116.027 -0.533 . . . . 4.9900000000000002 111.372 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 445' ' ' LEU . 25.3 Cg_exo -64.02 -148.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.98 2.453 . . . . 7.4000000000000004 112.53 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -156.52 75.79 4.53 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 9.0600000000000005 110.962 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 27.8 Cg_endo -62.11 133.25 43.0 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.727 2.285 . . . . 11.06 112.778 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 24.3 Cg_exo -63.33 139.77 73.28 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.71 2.273 . . . . 13.5 112.244 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 450' ' ' LEU . . . . . 0.473 ' N ' HD12 ' A' ' 450' ' ' LEU . 6.6 mp -65.31 127.69 32.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.412 . . . . 15.76 111.084 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . 61.19 122.0 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 115.9 -0.591 . . . . 16.739999999999998 111.756 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.14 125.89 6.73 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.47 2.113 . . . . 18.530000000000001 112.392 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 8.9 t70 50.3 51.15 17.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.214 -0.448 . . . . 20.550000000000001 110.623 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.309 -0.853 . . . . 21.219999999999999 110.918 -179.807 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.432 -0.267 . . . . 11.640000000000001 112.432 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 57.0 m -161.51 132.97 5.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.769 0.319 . . . . 9.8599999999999994 110.767 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -65.82 133.72 51.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 8.0700000000000003 110.773 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 88.0 mmm -65.72 127.24 31.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 5.5099999999999998 110.954 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' A' ' 368' ' ' PRO . 9.2 t70 -63.31 130.68 94.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.429 -0.351 . . . . 6.0599999999999996 110.861 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 367' ' ' ASP . 12.3 Cg_exo -69.74 -44.44 2.1 Favored 'Trans proline' 0 CA--C 1.514 -0.504 0 C-N-CA 122.805 2.337 . . . . 6.1600000000000001 112.953 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.664 HD23 ' HG2' ' A' ' 370' ' ' MET . 7.1 tt -53.41 -48.58 68.57 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.696 -1.138 . . . . 6.9400000000000004 110.249 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.664 ' HG2' HD23 ' A' ' 369' ' ' LEU . 63.7 mmm -161.15 119.8 2.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.956 -0.565 . . . . 5.6299999999999999 110.888 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -71.76 95.35 1.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 5.04 109.972 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.539 ' HB2' ' OH ' ' A' ' 412' ' ' TYR . 68.1 mttm 64.29 136.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.912 -0.586 . . . . 5.3899999999999997 111.354 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.5 mt 61.21 116.83 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.652 -0.704 . . . . 1.48 111.761 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 54.8 m-20 -89.71 77.2 7.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.957 -0.565 . . . . 2.1699999999999999 110.3 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 80.0 mt -42.51 -36.67 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.305 -0.407 . . . . 0.92000000000000004 111.964 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.8 t -69.17 68.86 0.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.46 . . . . 1.71 111.486 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.0 pt-20 -173.55 -26.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.009 -0.541 . . . . 1.9199999999999999 110.062 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 38.5 p30 -162.73 57.85 0.73 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.642 -0.708 . . . . 2.1400000000000001 111.931 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 379' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 53.0 Cg_exo -54.21 -35.59 83.29 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.071 1.847 . . . . 0.84999999999999998 111.179 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -66.04 -33.38 75.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.446 -0.797 . . . . 1.21 110.936 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 63.7 tttp -46.75 131.6 11.57 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.216 -0.447 . . . . 1.6599999999999999 111.379 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 417' ' ' VAL . 41.5 mm -85.92 126.13 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.40999999999999998 111.273 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -103.7 144.26 31.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.467 -0.333 . . . . 0.63 110.3 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 2.0 m-85 -85.54 132.51 34.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.95999999999999996 111.688 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.676 HG12 HG21 ' A' ' 414' ' ' VAL . 2.0 mp -114.05 118.48 58.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.083 -0.508 . . . . 0.48999999999999999 110.202 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.536 ' HB2' HD22 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -85.85 114.76 23.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.287 -0.415 . . . . 2.4199999999999999 110.969 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.49 ' O ' ' HD3' ' A' ' 386' ' ' ARG . 25.3 mmm180 -67.02 153.59 43.29 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.442 -0.344 . . . . 2.2999999999999998 110.146 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -53.17 -39.13 63.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.228 -0.442 . . . . 2.8199999999999998 110.706 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -64.66 -35.52 81.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 1.23 110.856 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 135.27 -35.56 2.16 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.584 -0.817 . . . . 1.03 113.043 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 80.8 p -58.85 112.54 1.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.043 0.449 . . . . 0.97999999999999998 112.004 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 56.5 t -74.53 143.15 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.925 -0.58 . . . . 0.55000000000000004 110.721 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -147.52 133.42 19.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 2.4300000000000002 111.113 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.444 ' HD2' HG21 ' A' ' 382' ' ' ILE . 88.4 mtm180 -56.21 155.57 6.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.903 -0.589 . . . . 2.96 111.921 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.442 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -172.04 130.67 1.98 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.532 -0.758 . . . . 0.26000000000000001 112.088 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' GLN . . . . . 0.434 ' HG2' HD13 ' A' ' 382' ' ' ILE . 86.9 mt-30 -81.74 110.62 17.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.938 0.347 . . . . 1.28 111.938 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 1.0 OUTLIER -82.02 132.28 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.82999999999999996 109.897 178.393 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 45.1 mt -120.95 -32.51 3.95 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.35 0.5 . . . . 1.45 112.35 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -140.27 176.31 8.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 2.0800000000000001 111.919 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.3 p -165.07 149.93 9.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.739 -0.664 . . . . 0.56000000000000005 110.723 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 38.2 ptt180 -154.55 138.42 16.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.863 0.364 . . . . 1.55 111.089 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 77.5 p -70.01 -132.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.437 -0.347 . . . . 1.79 110.988 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.794 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -162.43 -172.76 3.29 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.023 -0.362 . . . . 1.95 110.023 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.794 ' H ' HG22 ' A' ' 403' ' ' THR . 48.4 mt-10 -41.65 -45.77 3.5 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.668 0.271 . . . . 3.8700000000000001 111.47 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -67.31 -50.58 59.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.806 0.336 . . . . 3.1600000000000001 110.633 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.17 56.32 7.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.965 -0.561 . . . . 2.1800000000000002 111.591 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -151.98 9.36 0.51 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.156 0.503 . . . . 2.77 110.421 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.599 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.69 -49.0 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.262 -0.881 . . . . 2.7599999999999998 110.625 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 32.0 Cg_exo -58.29 147.26 85.58 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.321 2.014 . . . . 2.4900000000000002 112.179 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.9 p30 -177.95 131.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 2.1400000000000001 111.438 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 426' ' ' TRP . 50.2 mt-10 -115.25 136.83 52.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.693 -0.685 . . . . 2.1000000000000001 109.707 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.539 ' OH ' ' HB2' ' A' ' 372' ' ' LYS . 0.6 OUTLIER -109.74 130.08 55.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.909 0.385 . . . . 0.71999999999999997 111.903 -178.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 31.3 t80 -60.56 146.64 44.38 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.627 -0.879 . . . . 0.51000000000000001 108.627 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.676 HG21 HG12 ' A' ' 385' ' ' ILE . 7.2 p -151.13 133.65 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 119.662 -0.815 . . . . 1.1499999999999999 113.181 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -116.2 107.76 15.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.996 -1.002 . . . . 0.62 109.439 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.457 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 63.0 m-85 -61.43 125.37 23.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.028 0.442 . . . . 0.65000000000000002 111.279 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 382' ' ' ILE . 2.7 t -81.62 32.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.685 -0.688 . . . . 1.3400000000000001 111.239 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -175.63 -44.2 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.436 -0.888 . . . . 0.81999999999999995 112.89 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.457 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 7.2 mp -64.88 -166.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.199 0.523 . . . . 1.6000000000000001 111.701 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.738 ' HB2' HD13 ' A' ' 423' ' ' LEU . 4.4 m120 -74.1 145.09 44.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.446 -0.797 . . . . 2.5299999999999998 111.796 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 62.2 mtm-85 -65.33 -38.58 90.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.959 -0.564 . . . . 3.98 110.71 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -55.39 -36.13 66.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.057 0.456 . . . . 3.71 110.967 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.738 HD13 ' HB2' ' A' ' 420' ' ' ASN . 4.5 mp -52.75 -25.87 12.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.468 -0.787 . . . . 1.49 111.787 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.16 135.44 21.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.989 0.423 . . . . 1.2 111.299 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 413' ' ' TYR . . . 177.24 -140.29 4.79 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.953 -0.641 . . . . 0.69999999999999996 112.302 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' TRP . . . . . 0.587 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 42.7 m95 -122.27 138.19 54.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.793 0.33 . . . . 0.60999999999999999 110.709 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.405 ' CG2' HD11 ' A' ' 432' ' ' ILE . 30.8 m -134.05 142.64 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.89000000000000001 111.765 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.403 ' HA3' ' NH1' ' A' ' 431' ' ' ARG . . . -63.47 144.92 49.65 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.831 -0.7 . . . . 1.72 111.994 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.472 HH12 ' HB3' ' A' ' 372' ' ' LYS . 12.4 tpt180 -55.58 -28.4 54.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.036 0.446 . . . . 1.73 111.49 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.58 -31.27 64.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.811 0.815 . . . . 1.47 109.572 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 431' ' ' ARG . 33.0 mtt85 -83.14 -36.23 24.93 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.117 -1.401 . . . . 2.8399999999999999 111.418 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.555 HG12 HG13 ' A' ' 385' ' ' ILE . 65.9 mt -88.83 135.31 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.021 0.439 . . . . 0.46000000000000002 111.766 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 435' ' ' ASN . 55.8 m -161.76 140.12 9.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.843 -0.617 . . . . 0.53000000000000003 110.619 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -72.67 16.19 0.16 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.243 -0.435 . . . . 1.3500000000000001 111.612 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 433' ' ' SER . 75.0 m-80 -146.53 131.92 18.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.938 0.399 . . . . 2.1600000000000001 110.97 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -68.17 -42.32 80.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.983 -0.553 . . . . 0.75 111.441 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -54.66 -40.74 69.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.282 -0.417 . . . . 1.3400000000000001 111.038 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.59 42.91 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 1.5600000000000001 110.848 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.536 HD22 ' HB2' ' A' ' 386' ' ' ARG . 97.5 mt -151.82 -83.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 1.1200000000000001 111.104 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -166.39 44.31 0.27 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.994 -0.622 . . . . 1.3600000000000001 112.141 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.13 -136.03 45.77 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 1.8300000000000001 112.298 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.515 HG22 HG22 ' A' ' 443' ' ' THR . 50.1 mm -126.64 105.48 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.586 0.232 . . . . 1.48 110.648 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 442' ' ' ILE . 13.4 t 39.1 35.76 0.15 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.581 0.705 . . . . 3.0499999999999998 111.758 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 442' ' ' ILE . 96.3 t -153.25 127.57 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.655 -1.157 . . . . 4.1799999999999997 110.725 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.586 HD12 ' HD2' ' A' ' 446' ' ' PRO . 3.0 tp -97.55 123.47 52.08 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 116.293 -0.412 . . . . 4.9900000000000002 110.723 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.586 ' HD2' HD12 ' A' ' 445' ' ' LEU . 3.3 Cg_exo -76.64 59.65 6.34 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.113 2.542 . . . . 7.4000000000000004 112.656 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.495 ' N ' ' HD3' ' A' ' 448' ' ' PRO . . . -164.19 58.07 0.63 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 111.849 0.314 . . . . 9.0600000000000005 111.849 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 448' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 447' ' ' ALA . 28.5 Cg_exo -61.37 134.3 51.07 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.398 2.065 . . . . 11.06 111.859 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.48 43.77 1.49 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.457 2.105 . . . . 13.5 112.782 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 450' ' ' LEU . 6.2 mp 46.32 39.7 6.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.825 -0.625 . . . . 15.76 111.383 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -174.68 133.63 0.51 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.438 -0.346 . . . . 16.739999999999998 111.363 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.36 137.45 36.64 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.585 2.19 . . . . 18.530000000000001 112.197 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -170.68 55.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.175 0.512 . . . . 20.550000000000001 110.381 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.287 -0.863 . . . . 21.219999999999999 110.827 -179.82 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.477 -0.249 . . . . 11.640000000000001 112.477 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 79.7 p -172.58 46.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.769 0.319 . . . . 9.8599999999999994 110.791 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -60.35 -35.59 76.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.243 0.544 . . . . 8.0700000000000003 110.392 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 15.3 tpt 60.13 53.72 4.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.217 -0.901 . . . . 5.5099999999999998 111.698 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' A' ' 368' ' ' PRO . 10.1 t70 63.91 139.46 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.23 -0.441 . . . . 6.0599999999999996 111.548 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 370' ' ' MET . 14.7 Cg_exo -70.42 -155.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.178 1.918 . . . . 6.1600000000000001 110.308 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 369' ' ' LEU . 3.3 pp 37.82 21.39 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.615 0.572 . . . . 6.9400000000000004 112.301 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.517 ' N ' ' O ' ' A' ' 368' ' ' PRO . 42.6 ttp -169.94 48.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 5.6299999999999999 110.41 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.81 124.35 18.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 5.04 111.225 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -68.45 139.87 55.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.05 -0.523 . . . . 5.3899999999999997 110.788 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 63.8 mt -56.23 134.7 20.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.318 -0.401 . . . . 1.48 111.046 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -88.14 110.61 20.81 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.155 -0.475 . . . . 2.1699999999999999 110.556 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.537 HD11 HG12 ' A' ' 397' ' ' VAL . 93.0 mt -66.82 -43.44 89.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.866 -0.606 . . . . 0.92000000000000004 111.972 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 75.9 p -69.84 64.84 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.101 0.477 . . . . 1.71 110.842 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -149.46 -27.99 0.27 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.9199999999999999 109.685 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -172.28 60.72 0.29 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.282 -0.872 . . . . 2.1400000000000001 111.239 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -51.32 -37.3 60.04 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.311 2.008 . . . . 0.84999999999999998 111.676 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -62.96 -34.22 77.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.762 -0.654 . . . . 1.21 110.866 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -53.86 124.68 16.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 1.6599999999999999 111.199 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.025 HD12 HG21 ' A' ' 417' ' ' VAL . 16.2 mm -79.88 124.4 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.074 -0.512 . . . . 0.40999999999999998 111.755 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.518 ' HB2' ' O ' ' A' ' 395' ' ' GLY . 4.2 m-85 -104.07 144.21 31.86 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.235 -0.283 . . . . 0.63 110.235 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.42 ' HB3' HG13 ' A' ' 392' ' ' VAL . 15.8 m-30 -94.65 135.91 35.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.012 0.434 . . . . 0.95999999999999996 110.867 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.8 mp -119.24 126.07 75.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 0.48999999999999999 110.063 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.813 ' HE ' ' HA3' ' A' ' 440' ' ' GLY . 55.7 ttt-85 -89.19 121.65 31.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 2.4199999999999999 111.048 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.478 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 59.8 mtp85 -79.63 168.3 19.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 2.2999999999999998 110.602 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -56.1 -42.87 77.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 2.8199999999999998 111.233 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -72.3 5.7 2.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 1.23 111.954 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.615 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 73.07 48.81 18.65 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.52 -0.848 . . . . 1.03 113.077 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.478 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 81.9 p -120.69 110.54 16.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.687 0.279 . . . . 0.97999999999999998 111.561 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 384' ' ' PHE . 58.6 t -70.52 127.56 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.082 -0.34 . . . . 0.55000000000000004 110.082 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' HIS . . . . . 0.444 ' HE1' HG13 ' A' ' 444' ' ' VAL . 89.8 m-70 -145.02 135.99 24.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.112 0.482 . . . . 2.4300000000000002 111.482 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.509 ' HB3' ' HB ' ' A' ' 417' ' ' VAL . 59.6 mtt85 -55.56 155.29 5.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.802 -0.635 . . . . 2.96 112.057 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 383' ' ' TYR . . . 178.02 126.64 1.0 Allowed Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.396 -0.82 . . . . 0.26000000000000001 111.371 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 396' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 85.4 mt-30 -91.74 129.22 37.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.972 0.386 . . . . 1.28 111.739 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.765 HG22 HD13 ' A' ' 432' ' ' ILE . 4.2 t -82.95 126.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.134 -0.691 . . . . 0.82999999999999996 109.134 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.41 ' C ' HD13 ' A' ' 375' ' ' ILE . 66.8 mt -120.71 -46.85 2.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.251 0.463 . . . . 1.45 112.251 -178.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.595 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 12.0 mm-40 -123.73 176.51 6.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.107 0.48 . . . . 2.0800000000000001 111.6 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 97.0 p -163.57 146.06 9.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.634 -0.712 . . . . 0.56000000000000005 110.109 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -162.57 139.03 7.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.879 0.371 . . . . 1.55 111.332 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.725 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 72.2 p -70.59 -125.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 1.79 110.033 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.778 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.76 -173.41 2.97 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.662 -0.495 . . . . 1.95 109.662 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.778 ' H ' HG22 ' A' ' 403' ' ' THR . 64.2 mm-40 -44.86 -40.39 6.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.802 0.334 . . . . 3.8700000000000001 110.856 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.638 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 55.3 t-20 -68.13 -53.66 23.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.193 -0.458 . . . . 3.1600000000000001 110.563 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.414 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 51.29 51.69 16.38 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.192 0.52 . . . . 2.1800000000000002 111.358 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.495 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -152.83 10.73 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.484 -0.78 . . . . 2.77 109.46 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.578 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -177.82 -48.25 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 114.465 -1.243 . . . . 2.7599999999999998 110.034 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 36.1 Cg_exo -60.89 149.24 89.47 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.524 2.15 . . . . 2.4900000000000002 112.383 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.725 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 12.1 p-10 -174.07 137.51 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 2.1400000000000001 110.348 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.9 mt-10 -134.83 134.68 41.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 2.1000000000000001 110.902 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 1.2 m-85 -109.76 125.66 52.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.058 0.456 . . . . 0.71999999999999997 111.175 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.595 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 14.3 t80 -62.22 144.0 56.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.71 -0.677 . . . . 0.51000000000000001 110.189 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 0.0 OUTLIER -144.56 129.66 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.624 0.602 . . . . 1.1499999999999999 112.624 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 415' ' ' HIS . . . . . 0.425 ' O ' ' HA2' ' A' ' 395' ' ' GLY . 38.4 t60 -103.38 97.15 7.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.153 -0.93 . . . . 0.62 109.169 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 36.7 m-85 -53.2 106.41 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.391 0.615 . . . . 0.65000000000000002 111.22 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 1.025 HG21 HD12 ' A' ' 382' ' ' ILE . 58.3 t -67.16 130.01 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.905 -1.043 . . . . 1.3400000000000001 111.143 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 81.4 -45.55 3.26 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.747 -0.661 . . . . 0.81999999999999995 112.608 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 6.9 mp -65.6 166.57 10.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.997 0.427 . . . . 1.6000000000000001 111.427 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 74.5 m-20 -53.86 143.37 21.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.831 -0.622 . . . . 2.5299999999999998 111.544 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 53.9 mtt85 -61.75 -38.52 88.27 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.854 -0.612 . . . . 3.98 111.286 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -56.25 -32.58 64.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 3.71 111.439 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 420' ' ' ASN . 1.9 mp -58.21 -27.95 64.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.226 -0.443 . . . . 1.49 111.822 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -48.39 139.77 8.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 1.2 111.325 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -171.66 -147.83 5.86 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.76 -0.734 . . . . 0.69999999999999996 112.466 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -128.65 138.37 52.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.021 0.439 . . . . 0.60999999999999999 111.18 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.74 HG21 HG13 ' A' ' 432' ' ' ILE . 23.0 m -115.04 155.57 16.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.692 -0.686 . . . . 0.89000000000000001 111.494 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -78.04 30.94 1.8 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.913 -0.66 . . . . 1.72 114.075 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.559 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 9.7 tpt180 72.09 -45.63 0.62 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.688 0.625 . . . . 1.73 112.688 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -62.41 -21.53 65.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.706 0.289 . . . . 1.47 111.592 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.454 ' HD2' ' HB ' ' A' ' 427' ' ' VAL . 90.7 mtt180 -79.11 -26.95 42.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.188 0.44 . . . . 2.8399999999999999 112.188 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.765 HD13 HG22 ' A' ' 397' ' ' VAL . 71.4 mt -88.11 136.8 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.965 0.412 . . . . 0.46000000000000002 111.243 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 56.4 m -159.69 138.69 10.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.53000000000000003 110.612 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.29 -26.51 62.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 1.3500000000000001 111.138 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -112.85 130.62 56.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 2.1600000000000001 110.729 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -66.91 -32.52 73.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 0.75 111.176 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -51.54 -40.88 60.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.232 -0.44 . . . . 1.3400000000000001 110.783 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.85 -38.46 83.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.171 0.51 . . . . 1.5600000000000001 110.118 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 436' ' ' ALA . 69.3 mt -61.89 -93.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.525 -0.761 . . . . 1.1200000000000001 111.238 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 440' ' ' GLY . . . . . 0.813 ' HA3' ' HE ' ' A' ' 386' ' ' ARG . . . -166.29 39.87 0.26 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.116 -0.564 . . . . 1.3600000000000001 111.931 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 443' ' ' THR . . . 67.62 131.19 0.03 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.018 -0.61 . . . . 1.8300000000000001 112.162 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.672 ' H ' HD12 ' A' ' 442' ' ' ILE . 5.3 mp -58.48 113.9 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.67 0.271 . . . . 1.48 110.322 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 441' ' ' GLY . 11.5 t -167.6 130.2 1.62 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.309 0.576 . . . . 3.0499999999999998 112.307 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.727 HG12 ' HD3' ' A' ' 446' ' ' PRO . 67.9 t -100.57 124.47 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 115.405 -0.816 . . . . 4.1799999999999997 110.135 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 34.0 mt -115.45 69.83 2.97 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.162 -0.472 . . . . 4.9900000000000002 111.006 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.727 ' HD3' HG12 ' A' ' 444' ' ' VAL . 36.8 Cg_exo -60.28 119.4 6.57 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.473 2.115 . . . . 7.4000000000000004 112.394 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . 59.45 122.97 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 115.943 -0.571 . . . . 9.0600000000000005 111.752 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 447' ' ' ALA . 19.9 Cg_exo -65.59 128.62 20.49 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.404 2.07 . . . . 11.06 111.771 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.18 123.0 10.9 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.218 1.945 . . . . 13.5 112.15 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' LEU . . . . . 0.633 HD23 ' H ' ' A' ' 450' ' ' LEU . 2.3 pt? -72.32 135.62 45.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 15.76 110.923 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' A' ' 453' ' ' ASP . . . 55.46 75.7 0.57 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 16.739999999999998 111.115 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.73 16.37 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.333 2.022 . . . . 18.530000000000001 112.606 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 451' ' ' ALA . 7.8 t70 -84.91 128.44 34.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.461 . . . . 20.550000000000001 110.223 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.195 -0.907 . . . . 21.219999999999999 110.438 -179.877 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.488 -0.245 . . . . 11.640000000000001 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 32.1 t 56.87 -128.7 1.82 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 110.616 -0.142 . . . . 9.8599999999999994 110.616 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -168.48 119.25 0.77 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.878 0.37 . . . . 8.0700000000000003 110.957 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' MET . . . . . 0.481 ' HG3' ' HE3' ' A' ' 372' ' ' LYS . 1.5 mpt? -94.93 125.57 39.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 5.5099999999999998 110.342 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -72.2 110.85 8.84 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.425 -0.352 . . . . 6.0599999999999996 111.103 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 366' ' ' MET . 91.9 Cg_endo -85.07 34.26 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.545 2.163 . . . . 6.1600000000000001 112.252 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.675 HD12 ' HG2' ' A' ' 370' ' ' MET . 0.9 OUTLIER -151.76 9.17 0.52 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 112.305 0.483 . . . . 6.9400000000000004 112.305 -179.121 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.675 ' HG2' HD12 ' A' ' 369' ' ' LEU . 27.5 ptt? -173.57 9.17 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.894 0.378 . . . . 5.6299999999999999 111.135 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.417 ' H ' ' H ' ' A' ' 370' ' ' MET . 78.5 mt-30 41.97 -163.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.274 -0.875 . . . . 5.04 111.815 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.481 ' HE3' ' HG3' ' A' ' 366' ' ' MET . 42.7 mmtm -73.41 150.35 41.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.166 -0.47 . . . . 5.3899999999999997 110.698 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.1 mt -52.22 135.61 13.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.437 -0.347 . . . . 1.48 110.711 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.407 ' HB2' ' OE1' ' A' ' 377' ' ' GLU . 59.2 m-20 -88.92 129.45 35.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 2.1699999999999999 111.228 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 78.7 mt -84.27 -45.18 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.92000000000000004 111.16 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 48.0 t -64.11 78.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 1.71 110.859 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 374' ' ' ASP . 12.1 pt-20 -173.71 -28.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.528 -0.76 . . . . 1.9199999999999999 110.074 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.431 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 31.3 p30 -173.07 61.54 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.536 -0.757 . . . . 2.1400000000000001 111.509 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.99 -38.67 86.7 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.318 2.012 . . . . 0.84999999999999998 111.877 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.514 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 28.3 m-20 -65.34 -33.51 76.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.996 -0.547 . . . . 1.21 111.073 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 85.2 tttt -48.02 126.58 10.96 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.942 0.401 . . . . 1.6599999999999999 111.076 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.779 HG23 HG21 ' A' ' 417' ' ' VAL . 36.5 mm -71.79 120.71 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.89 -0.596 . . . . 0.40999999999999998 111.724 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -99.57 144.4 28.7 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.587 -0.523 . . . . 0.63 109.587 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.447 ' C ' HD12 ' A' ' 385' ' ' ILE . 45.1 m-85 -88.88 133.08 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.895 -0.322 . . . . 0.95999999999999996 110.795 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.661 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.1 mp -116.33 144.67 23.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.819 0.342 . . . . 0.48999999999999999 111.539 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.654 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 39.1 ttt85 -124.48 104.25 8.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 2.4199999999999999 110.525 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.479 ' HG3' ' CE1' ' A' ' 393' ' ' HIS . 10.0 mtp-105 -65.04 161.6 18.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.831 0.348 . . . . 2.2999999999999998 110.944 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.609 ' HG3' HH21 ' A' ' 431' ' ' ARG . 50.5 mp0 -48.76 -45.05 39.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.054 0.761 . . . . 2.8199999999999998 113.054 -177.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.592 ' OD2' HG23 ' A' ' 391' ' ' THR . 8.0 p-10 -60.16 -35.26 74.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.595 0.236 . . . . 1.23 111.59 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.405 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 118.45 44.3 0.52 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.605 -0.807 . . . . 1.03 112.413 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.592 HG23 ' OD2' ' A' ' 389' ' ' ASP . 21.5 p -116.64 112.49 21.34 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.789 0.292 . . . . 0.97999999999999998 111.789 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.495 HG11 HD13 ' A' ' 442' ' ' ILE . 86.4 t -79.56 134.23 28.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.604 -0.517 . . . . 0.55000000000000004 109.604 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' HIS . . . . . 0.487 ' HD1' ' HB ' ' A' ' 385' ' ' ILE . 0.6 OUTLIER -156.47 133.98 10.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.939 0.4 . . . . 2.4300000000000002 111.03 -178.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.498 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 99.6 mtt180 -60.07 145.18 47.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.931 -0.577 . . . . 2.96 111.75 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -174.21 128.85 1.52 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.532 -0.758 . . . . 0.26000000000000001 111.976 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' GLN . . . . . 0.514 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 68.6 mt-30 -78.31 129.68 35.31 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.689 -0.3 . . . . 1.28 111.597 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 413' ' ' TYR . 0.5 OUTLIER -88.28 132.08 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.547 -0.538 . . . . 0.82999999999999996 109.547 177.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 398' ' ' LEU . 4.9 mp -106.14 -49.44 3.37 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.791 0.663 . . . . 1.45 112.791 -177.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 412' ' ' TYR . 30.3 mm100 -142.94 178.02 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.004 0.431 . . . . 2.0800000000000001 111.869 -178.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.7 p -148.83 149.39 31.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.683 -0.69 . . . . 0.56000000000000005 109.987 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -158.49 139.08 12.69 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.169 0.509 . . . . 1.55 112.356 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 50.6 p -87.6 139.1 30.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.671 -0.695 . . . . 1.79 109.557 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.851 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.9 m -60.53 -174.57 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.58 0.229 . . . . 1.95 110.579 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.851 ' H ' HG22 ' A' ' 403' ' ' THR . 59.1 mm-40 -50.73 -41.74 56.6 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.798 0.295 . . . . 3.8700000000000001 111.798 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.534 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 15.6 t-20 -59.19 -49.57 77.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.569 -0.287 . . . . 3.1600000000000001 111.076 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.573 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 52.71 48.25 22.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.154 0.502 . . . . 2.1800000000000002 111.483 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.505 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -145.75 10.79 1.22 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.603 -0.726 . . . . 2.77 109.478 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.595 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.78 -47.81 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.472 -1.24 . . . . 2.7599999999999998 110.0 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 36.3 Cg_exo -57.9 143.46 95.86 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.561 2.174 . . . . 2.4900000000000002 112.513 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -170.48 136.31 1.29 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.69 -0.687 . . . . 2.1400000000000001 110.326 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 400' ' ' SER . 64.8 mm-40 -140.89 135.12 30.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.193 -0.458 . . . . 2.1000000000000001 110.886 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.475 ' OH ' ' HB3' ' A' ' 372' ' ' LYS . 1.2 m-85 -109.21 119.19 38.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.145 -0.48 . . . . 0.71999999999999997 111.213 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.471 ' CE2' HD22 ' A' ' 398' ' ' LEU . 10.5 t80 -57.41 145.99 30.84 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.278 -0.638 . . . . 0.51000000000000001 109.278 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 14.4 p -154.82 129.52 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.201 0.815 . . . . 1.1499999999999999 113.201 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -101.85 113.09 25.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.344 -0.844 . . . . 0.62 109.084 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.493 ' CD2' HD22 ' A' ' 419' ' ' LEU . 65.1 m-85 -61.42 132.69 54.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.356 0.598 . . . . 0.65000000000000002 111.125 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.779 HG21 HG23 ' A' ' 382' ' ' ILE . 1.3 t -78.82 27.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.212 -0.904 . . . . 1.3400000000000001 111.406 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 172.74 -43.04 0.17 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.407 -0.901 . . . . 0.81999999999999995 113.289 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 423' ' ' LEU . 7.3 mp -59.75 151.88 24.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 1.6000000000000001 111.604 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -50.36 147.13 4.6 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.494 -0.776 . . . . 2.5299999999999998 112.203 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' ARG . . . . . 0.436 ' HA ' ' CG ' ' A' ' 424' ' ' ASP . 87.1 mtm180 -59.24 -28.88 67.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.706 -0.679 . . . . 3.98 110.927 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -53.61 -41.2 66.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.285 0.564 . . . . 3.71 110.059 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 419' ' ' LEU . 6.4 mp -71.56 -33.12 68.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.142 -0.935 . . . . 1.49 110.999 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.436 ' CG ' ' HA ' ' A' ' 421' ' ' ARG . 10.6 m-20 -53.11 131.44 36.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 1.2 110.783 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 176.43 -142.03 5.77 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.702 -0.761 . . . . 0.69999999999999996 112.51 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' TRP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 50.6 m95 -105.19 135.83 45.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.60999999999999999 110.933 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.855 HG23 HD11 ' A' ' 432' ' ' ILE . 3.4 m -128.81 134.56 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.534 . . . . 0.89000000000000001 111.634 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -57.7 150.06 31.98 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.722 -0.752 . . . . 1.72 111.99 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -47.92 -39.77 19.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.615 0.245 . . . . 1.73 111.331 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.425 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 9.1 p-80 -61.77 -32.26 72.51 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.866 0.321 . . . . 1.47 111.866 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.609 HH21 ' HG3' ' A' ' 388' ' ' GLU . 57.0 mtt85 -82.21 26.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.108 -0.237 . . . . 2.8399999999999999 111.191 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.855 HD11 HG23 ' A' ' 427' ' ' VAL . 66.0 mt -149.58 135.63 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.46000000000000002 110.868 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 435' ' ' ASN . 70.5 m -166.25 139.23 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 0.53000000000000003 110.866 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.65 16.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 1.3500000000000001 110.507 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 433' ' ' SER . 74.9 m-20 -138.79 128.26 24.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.902 -0.59 . . . . 2.1600000000000001 110.328 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.1 92.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.75 111.754 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -56.24 -40.36 74.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 1.3400000000000001 111.333 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.77 42.44 0.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 1.5600000000000001 111.601 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' LEU . . . . . . . . . . . . . 85.9 mt -150.2 -88.41 0.07 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.72 -0.218 . . . . 1.1200000000000001 111.438 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' GLY . . . . . 0.654 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -171.45 38.12 0.17 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.542 -0.837 . . . . 1.3600000000000001 112.859 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.83 141.02 0.04 OUTLIER Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.736 -0.745 . . . . 1.8300000000000001 112.869 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.495 HD13 HG11 ' A' ' 392' ' ' VAL . 42.3 mm -70.06 67.65 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.985 0.421 . . . . 1.48 110.689 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 67.9 m -164.85 136.43 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 3.0499999999999998 110.991 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.486 ' HA ' HG22 ' A' ' 391' ' ' THR . 23.9 m -79.58 54.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 4.1799999999999997 111.568 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.706 ' O ' HD12 ' A' ' 445' ' ' LEU . 4.5 pp -65.69 137.47 96.29 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.74 -0.664 . . . . 4.9900000000000002 111.101 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.69 142.05 17.75 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.702 2.268 . . . . 7.4000000000000004 112.601 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -171.43 134.59 0.92 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 9.0600000000000005 111.034 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 18.3 Cg_endo -60.37 133.77 51.25 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.468 2.112 . . . . 11.06 112.01 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 24.3 Cg_exo -63.76 127.5 19.78 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.459 2.106 . . . . 13.5 112.331 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 92.4 mt -74.78 137.65 42.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 15.76 110.701 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . -59.08 124.87 76.35 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 16.739999999999998 111.229 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 451' ' ' ALA . 21.1 Cg_exo -66.63 -149.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.794 2.329 . . . . 18.530000000000001 112.467 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -66.76 -45.74 77.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.367 -0.379 . . . . 20.550000000000001 110.775 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.205 -0.902 . . . . 21.219999999999999 111.007 -179.877 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.526 -0.23 . . . . 11.640000000000001 112.526 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.9 t -174.46 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.876 0.37 . . . . 9.8599999999999994 110.853 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -58.45 138.17 56.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 8.0700000000000003 111.207 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' MET . . . . . 0.446 ' SD ' ' HB2' ' A' ' 408' ' ' ALA . 64.7 mtt -126.52 122.26 34.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 5.5099999999999998 110.408 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.505 ' HB3' HD13 ' A' ' 369' ' ' LEU . 30.1 m-20 -73.45 125.82 90.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.159 -0.473 . . . . 6.0599999999999996 111.559 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -84.27 40.4 0.87 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.698 2.265 . . . . 6.1600000000000001 112.644 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.679 HD22 ' N ' ' A' ' 370' ' ' MET . 0.0 OUTLIER -160.25 -30.99 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.739 -0.664 . . . . 6.9400000000000004 109.634 179.433 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.679 ' N ' HD22 ' A' ' 369' ' ' LEU . 0.0 OUTLIER -94.63 58.08 2.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.583 -0.735 . . . . 5.6299999999999999 109.031 178.63 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -71.31 51.51 0.17 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.718 -0.674 . . . . 5.04 112.338 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.496 ' HB3' ' OH ' ' A' ' 412' ' ' TYR . 74.9 mmtt 62.15 147.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.277 0.56 . . . . 5.3899999999999997 112.461 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.493 HG13 ' HE ' ' A' ' 429' ' ' ARG . 70.6 mt -55.94 131.62 19.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.527 -0.76 . . . . 1.48 111.337 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.68 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 23.6 m-20 -88.87 111.58 22.24 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 116.09 -0.505 . . . . 2.1699999999999999 110.902 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 86.4 mt -73.17 -39.68 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.709 0.29 . . . . 0.92000000000000004 111.781 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 40.1 t -46.72 -28.74 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.011 -0.54 . . . . 1.71 112.422 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.68 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 15.5 pt-20 -69.43 -38.47 77.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.508 -0.315 . . . . 1.9199999999999999 111.772 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.703 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 66.8 m-20 -153.06 69.16 6.85 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 112.322 0.49 . . . . 2.1400000000000001 112.322 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.38 -40.68 77.37 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.684 2.256 . . . . 0.84999999999999998 112.577 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -70.3 -34.09 72.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.536 . . . . 1.21 111.774 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.703 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 63.0 tttp -46.38 136.36 7.36 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.983 0.421 . . . . 1.6599999999999999 111.021 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.733 HG21 ' HD3' ' A' ' 394' ' ' ARG . 46.4 mm -84.86 130.47 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.782 -0.644 . . . . 0.40999999999999998 111.834 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -118.93 143.6 46.92 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.496 -0.557 . . . . 0.63 109.496 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.524 ' CE1' ' HG2' ' A' ' 394' ' ' ARG . 1.3 m-85 -84.83 143.74 28.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.783 0.325 . . . . 0.95999999999999996 111.351 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.712 HG12 HG11 ' A' ' 414' ' ' VAL . 2.8 mp -119.85 133.83 65.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 116.228 -0.442 . . . . 0.48999999999999999 111.492 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.551 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 28.3 tpt180 -87.0 106.01 17.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 2.4199999999999999 110.418 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.488 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 62.5 mtp85 -66.69 160.52 25.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 2.2999999999999998 111.067 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.7 -71.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.865 -0.607 . . . . 2.8199999999999998 111.048 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.414 ' OD1' HG23 ' A' ' 391' ' ' THR . 2.4 p30 -41.7 -28.9 0.16 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.052 0.453 . . . . 1.23 110.28 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 110.16 44.3 1.02 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.737 -0.665 . . . . 1.03 113.459 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.488 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 37.0 p -121.2 110.37 16.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.967 0.413 . . . . 0.97999999999999998 111.062 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.492 HG23 HH11 ' A' ' 386' ' ' ARG . 90.2 t -71.6 133.13 32.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 0.55000000000000004 111.352 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -151.93 138.46 18.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.111 -0.495 . . . . 2.4300000000000002 110.537 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.733 ' HD3' HG21 ' A' ' 382' ' ' ILE . 60.6 mtt85 -51.6 155.65 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.392 0.615 . . . . 2.96 112.601 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -178.61 133.37 2.1 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.103 -0.953 . . . . 0.26000000000000001 111.84 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -80.95 130.68 35.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.771 0.285 . . . . 1.28 111.771 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.605 ' CG1' ' HB3' ' A' ' 412' ' ' TYR . 14.5 t -91.43 126.61 44.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.81 -0.811 . . . . 0.82999999999999996 108.81 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.64 ' N ' HD22 ' A' ' 398' ' ' LEU . 0.3 OUTLIER -108.83 -40.08 5.15 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.023 0.749 . . . . 1.45 113.023 -177.029 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -139.95 176.02 9.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.95 0.405 . . . . 2.0800000000000001 111.901 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.2 p -163.56 150.96 12.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.829 -0.623 . . . . 0.56000000000000005 110.611 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 39.9 ptt180 -153.14 134.33 14.15 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.492 -0.322 . . . . 1.55 111.163 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 47.7 p -71.93 135.71 46.6 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.96 0.41 . . . . 1.79 110.69 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.827 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.1 m -62.51 -174.1 0.06 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.837 -0.62 . . . . 1.95 110.372 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.827 ' H ' HG22 ' A' ' 403' ' ' THR . 60.3 mm-40 -44.94 -37.04 3.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.86 0.319 . . . . 3.8700000000000001 111.86 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -57.52 -49.76 75.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.747 0.308 . . . . 3.1600000000000001 110.873 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.612 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.78 66.03 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.183 -0.462 . . . . 2.1800000000000002 111.603 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -162.65 -23.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 2.77 110.518 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.67 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -159.99 -52.33 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.683 -0.69 . . . . 2.7599999999999998 110.7 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 52.1 Cg_exo -54.96 149.2 43.66 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.196 1.93 . . . . 2.4900000000000002 111.341 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 34.4 p-10 -179.08 143.71 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.091 0.472 . . . . 2.1400000000000001 111.58 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 400' ' ' SER . 0.5 OUTLIER -106.82 135.25 48.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.756 -0.656 . . . . 2.1000000000000001 109.859 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.643 ' HB2' HD12 ' A' ' 432' ' ' ILE . 0.4 OUTLIER -109.75 128.11 55.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.345 -0.389 . . . . 0.71999999999999997 111.958 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.57 ' CD2' HD23 ' A' ' 398' ' ' LEU . 9.4 t80 -64.54 141.56 58.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.51000000000000001 109.833 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.712 HG11 HG12 ' A' ' 385' ' ' ILE . 48.6 t -132.51 132.99 60.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.153 0.797 . . . . 1.1499999999999999 113.153 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -116.13 89.9 3.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.036 -0.984 . . . . 0.62 109.304 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.465 ' H ' ' HD1' ' A' ' 416' ' ' TYR . 6.2 m-85 -55.89 127.2 29.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.953 0.406 . . . . 0.65000000000000002 111.161 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 382' ' ' ILE . 61.9 t -70.38 127.23 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.01 -0.541 . . . . 1.3400000000000001 111.375 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.53 -41.93 1.69 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.966 -0.635 . . . . 0.81999999999999995 113.182 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 419' ' ' LEU . 7.7 mp -59.43 156.92 12.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.947 0.403 . . . . 1.6000000000000001 111.375 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.545 ' OD1' HD13 ' A' ' 423' ' ' LEU . 22.5 p30 -49.58 143.38 7.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.786 -0.643 . . . . 2.5299999999999998 111.65 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 421' ' ' ARG . 57.0 mtt85 -62.77 -36.16 82.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.636 -0.711 . . . . 3.98 111.898 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -54.09 -30.04 46.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.341 . . . . 3.71 111.029 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.545 HD13 ' OD1' ' A' ' 420' ' ' ASN . 1.1 tp -59.41 -31.69 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 1.49 111.365 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.5 134.83 8.95 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.946 0.403 . . . . 1.2 111.155 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.88 155.08 12.27 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.827 -0.701 . . . . 0.69999999999999996 112.268 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 12.2 m95 -71.05 137.64 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.679 0.276 . . . . 0.60999999999999999 110.38 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.424 ' HB ' ' HD3' ' A' ' 431' ' ' ARG . 11.4 m -138.0 141.23 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.438 -0.346 . . . . 0.89000000000000001 110.843 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -50.01 150.7 4.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.668 -0.777 . . . . 1.72 112.442 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.493 ' HE ' HG13 ' A' ' 373' ' ' ILE . 32.6 tpt85 -48.7 -42.03 33.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.479 0.18 . . . . 1.73 111.477 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -55.43 -31.71 62.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.541 -0.3 . . . . 1.47 111.469 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 73.5 mtp180 -81.61 20.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.611 -0.268 . . . . 2.8399999999999999 111.228 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.643 HD12 ' HB2' ' A' ' 412' ' ' TYR . 83.5 mt -150.33 126.04 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.826 0.346 . . . . 0.46000000000000002 110.914 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 435' ' ' ASN . 65.5 m -165.67 143.4 5.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.863 -0.608 . . . . 0.53000000000000003 110.65 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ASP . . . . . 0.498 ' OD1' ' HE3' ' A' ' 381' ' ' LYS . 27.5 m-20 -70.62 16.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 1.3500000000000001 111.293 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 433' ' ' SER . 0.2 OUTLIER -158.9 128.14 5.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.926 0.393 . . . . 2.1600000000000001 110.585 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 436' ' ' ALA . . . . . 0.617 ' HB3' HD13 ' A' ' 442' ' ' ILE . . . -68.09 -25.08 65.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.97 -0.559 . . . . 0.75 111.896 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.34 -41.19 18.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.405 -0.361 . . . . 1.3400000000000001 111.631 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -82.63 -41.68 19.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.927 0.394 . . . . 1.5600000000000001 110.948 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 436' ' ' ALA . 49.0 mt -54.63 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 1.1200000000000001 111.565 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 440' ' ' GLY . . . . . 0.551 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -157.29 38.66 0.55 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.851 -0.69 . . . . 1.3600000000000001 112.186 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.12 146.0 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.686 -0.768 . . . . 1.8300000000000001 112.199 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 436' ' ' ALA . 48.8 mm -48.51 115.65 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.975 -0.38 . . . . 1.48 109.975 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 3.2 m -60.31 117.35 5.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.259 -0.428 . . . . 3.0499999999999998 110.976 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 444' ' ' VAL . 60.9 t -142.97 63.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.204 0.526 . . . . 4.1799999999999997 110.733 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.663 ' N ' ' HD3' ' A' ' 446' ' ' PRO . 1.8 pt? -155.01 52.67 0.74 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 4.9900000000000002 111.344 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.663 ' HD3' ' N ' ' A' ' 445' ' ' LEU . 10.2 Cg_exo -65.61 148.37 87.17 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.958 2.439 . . . . 7.4000000000000004 111.968 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -55.58 129.67 70.25 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 110.315 -0.254 . . . . 9.0600000000000005 110.315 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.52 111.06 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.392 2.061 . . . . 11.06 112.663 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -82.47 -162.72 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.711 2.274 . . . . 13.5 112.068 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 93.8 mt -81.93 31.03 0.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.386 -0.37 . . . . 15.76 110.89 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.485 ' HB1' ' OD1' ' A' ' 453' ' ' ASP . . . -84.12 132.67 47.26 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 16.739999999999998 111.241 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.46 29.61 0.43 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.417 2.078 . . . . 18.530000000000001 112.595 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.485 ' OD1' ' HB1' ' A' ' 451' ' ' ALA . 1.3 m-20 -75.17 136.1 41.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.914 0.388 . . . . 20.550000000000001 110.945 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.231 -0.89 . . . . 21.219999999999999 110.946 179.904 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.539 -0.224 . . . . 11.640000000000001 112.539 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 22.7 t 57.68 -137.62 0.93 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 110.481 -0.192 . . . . 9.8599999999999994 110.481 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 365' ' ' HIS . . . . . 0.526 ' HE1' ' HA ' ' A' ' 368' ' ' PRO . 28.8 t-80 56.03 58.39 4.41 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.89 0.376 . . . . 8.0700000000000003 110.393 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 24.2 ptm -55.6 125.34 20.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.173 -0.467 . . . . 5.5099999999999998 111.117 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 54.97 113.23 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.823 -0.626 . . . . 6.0599999999999996 111.713 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 368' ' ' PRO . . . . . 0.526 ' HA ' ' HE1' ' A' ' 365' ' ' HIS . 60.6 Cg_endo -75.59 34.08 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.464 2.109 . . . . 6.1600000000000001 112.71 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 27.6 tp -178.88 -48.4 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.268 -0.424 . . . . 6.9400000000000004 110.684 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 370' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.7 31.47 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.134 0.492 . . . . 5.6299999999999999 109.999 179.378 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -79.55 158.58 27.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.953 -0.567 . . . . 5.04 110.956 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -46.07 146.0 1.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.064 -0.517 . . . . 5.3899999999999997 111.648 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 69.3 mt -51.12 135.17 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.756 -0.656 . . . . 1.48 111.057 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 30.4 m-20 -88.22 110.47 20.74 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.23 -0.441 . . . . 2.1699999999999999 110.854 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.447 HD13 ' C ' ' A' ' 398' ' ' LEU . 82.0 mt -76.48 -34.75 25.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.92000000000000004 111.623 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 80.4 p -70.17 64.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 1.71 111.643 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.4 pt-20 -174.66 -27.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.904 -0.589 . . . . 1.9199999999999999 110.073 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 47.5 m-20 -149.49 60.26 4.45 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.77 . . . . 2.1400000000000001 112.413 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 379' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 73.3 Cg_exo -55.69 -40.92 82.46 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.713 2.276 . . . . 0.84999999999999998 112.341 179.129 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -69.4 -30.05 67.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 1.21 111.94 -179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 88.1 tttt -44.92 130.03 7.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.001 0.429 . . . . 1.6599999999999999 111.005 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.536 HG21 ' HD3' ' A' ' 394' ' ' ARG . 38.4 mm -91.99 135.01 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.40999999999999998 111.5 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.662 ' HB3' HG23 ' A' ' 432' ' ' ILE . 1.6 m-85 -119.95 143.13 48.17 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.961 -0.385 . . . . 0.63 109.961 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.419 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 4.3 m-85 -92.65 136.18 33.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.777 -0.369 . . . . 0.95999999999999996 110.597 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 385' ' ' ILE . 3.1 mp -125.61 128.37 72.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.868 0.366 . . . . 0.48999999999999999 110.935 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.656 ' N ' HD23 ' A' ' 439' ' ' LEU . 78.8 ttt180 -81.8 120.65 25.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.994 -0.548 . . . . 2.4199999999999999 110.801 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.405 ' HB2' ' OD1' ' A' ' 389' ' ' ASP . 59.0 mtm180 -74.63 166.59 23.31 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.759 -0.377 . . . . 2.2999999999999998 110.623 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.474 ' H ' ' CD ' ' A' ' 388' ' ' GLU . 9.0 mp0 -49.66 -44.67 47.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.29 -0.414 . . . . 2.8199999999999998 111.398 -179.451 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 387' ' ' ARG . 41.4 p-10 -65.72 -35.11 79.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.429 -0.351 . . . . 1.23 111.353 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.524 ' HA2' ' HE ' ' A' ' 386' ' ' ARG . . . 130.2 -29.21 3.72 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.76 -0.734 . . . . 1.03 112.293 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 51.3 p -59.48 113.63 2.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.241 0.544 . . . . 0.97999999999999998 111.843 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 49.1 t -72.62 143.09 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.399 -0.818 . . . . 0.55000000000000004 111.49 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -146.56 145.09 30.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.707 -0.679 . . . . 2.4300000000000002 109.35 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.547 ' HB2' ' CG1' ' A' ' 417' ' ' VAL . 55.0 mtt85 -74.07 145.93 44.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.482 0.658 . . . . 2.96 111.604 -178.275 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -146.42 125.05 2.14 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 114.891 -1.05 . . . . 0.26000000000000001 110.996 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -81.84 84.07 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.783 0.325 . . . . 1.28 111.132 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.893 HG23 HG22 ' A' ' 414' ' ' VAL . 0.6 OUTLIER -59.0 132.31 23.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.144 -0.48 . . . . 0.82999999999999996 110.457 179.9 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.447 ' C ' HD13 ' A' ' 375' ' ' ILE . 59.4 mt -120.64 -38.8 2.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.157 -0.474 . . . . 1.45 112.128 -178.401 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -119.8 170.51 9.16 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.177 0.513 . . . . 2.0800000000000001 112.076 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.1 p -165.69 151.22 9.05 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.437 -0.801 . . . . 0.56000000000000005 109.9 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -162.3 137.43 7.07 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.388 0.514 . . . . 1.55 112.388 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.516 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 35.9 p -86.34 135.61 33.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.86 -0.609 . . . . 1.79 109.429 177.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.856 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.3 m -60.29 -174.7 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.67 0.272 . . . . 1.95 110.917 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.856 ' H ' HG22 ' A' ' 403' ' ' THR . 4.8 mm-40 -50.66 -42.61 56.75 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.992 0.367 . . . . 3.8700000000000001 111.992 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.577 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 15.2 t-20 -56.65 -48.87 76.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.719 0.295 . . . . 3.1600000000000001 110.837 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 53.19 52.16 14.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 2.1800000000000002 111.529 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.469 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -153.53 10.23 0.42 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.44 0.638 . . . . 2.77 109.642 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.81 -48.32 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.688 -1.142 . . . . 2.7599999999999998 110.122 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 36.3 Cg_exo -60.57 141.64 95.81 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.677 2.252 . . . . 2.4900000000000002 112.745 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -173.16 127.73 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.652 -0.704 . . . . 2.1400000000000001 110.784 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 400' ' ' SER . 9.2 mp0 -120.42 134.59 55.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.782 -0.645 . . . . 2.1000000000000001 109.675 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.452 ' N ' ' CD1' ' A' ' 412' ' ' TYR . 1.2 m-85 -110.03 123.45 49.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.806 0.336 . . . . 0.71999999999999997 111.649 -178.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 19.7 t80 -63.86 119.3 9.74 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.317 -0.624 . . . . 0.51000000000000001 109.317 178.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.893 HG22 HG23 ' A' ' 397' ' ' VAL . 22.6 t -112.36 135.77 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.461 0.912 . . . . 1.1499999999999999 113.461 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -111.14 89.38 3.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.996 -1.002 . . . . 0.62 108.543 177.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 62.5 m-85 -52.18 103.16 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.281 0.563 . . . . 0.65000000000000002 110.904 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.547 ' CG1' ' HB2' ' A' ' 394' ' ' ARG . 11.3 p -62.44 136.46 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.147 -0.933 . . . . 1.3400000000000001 110.932 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 80.43 -47.97 3.54 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.235 -0.746 . . . . 0.81999999999999995 111.235 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.525 ' HB3' HD22 ' A' ' 423' ' ' LEU . 2.0 mm? -65.68 159.77 24.22 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.74 0.305 . . . . 1.6000000000000001 110.634 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.553 ' OD1' HD13 ' A' ' 423' ' ' LEU . 21.3 p30 -51.62 141.67 15.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 2.5299999999999998 111.082 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 31.9 ptt85 -60.55 -33.05 72.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.233 -0.44 . . . . 3.98 111.918 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -56.4 -29.61 61.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 3.71 111.1 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.553 HD13 ' OD1' ' A' ' 420' ' ' ASN . 1.2 tp -58.1 -26.7 62.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 1.49 111.661 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -44.79 135.17 5.21 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.948 0.404 . . . . 1.2 111.174 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -178.82 145.98 7.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.01 -0.614 . . . . 0.69999999999999996 112.189 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -67.49 121.3 15.51 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.99 -0.374 . . . . 0.60999999999999999 109.99 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.512 HG22 ' CG2' ' A' ' 414' ' ' VAL . 6.4 m -118.79 149.59 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 0.89000000000000001 111.537 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -63.27 146.97 50.61 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.625 -0.798 . . . . 1.72 111.674 178.772 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 37.1 tpt85 -51.34 -29.73 16.21 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.684 0.253 . . . . 1.73 111.684 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.414 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 22.7 p-80 -60.37 -31.94 70.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.955 0.354 . . . . 1.47 111.955 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 99.4 mtt180 -79.03 -30.94 44.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.355 -0.384 . . . . 2.8399999999999999 110.93 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.662 HG23 ' HB3' ' A' ' 383' ' ' TYR . 95.7 mt -89.03 129.93 39.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.46000000000000002 111.603 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.71 ' HB2' HD11 ' A' ' 439' ' ' LEU . 69.6 m -169.09 140.05 2.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.803 -0.635 . . . . 0.53000000000000003 110.5 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -75.82 16.21 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.415 -0.357 . . . . 1.3500000000000001 111.269 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.485 ' O ' HD13 ' A' ' 439' ' ' LEU . 15.1 t-20 -139.45 131.39 27.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.891 0.377 . . . . 2.1600000000000001 110.652 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -71.72 -37.17 70.65 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.627 0.603 . . . . 0.75 112.627 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 437' ' ' ASP . . . . . 0.444 ' HB2' ' OD1' ' A' ' 435' ' ' ASN . 55.5 m-20 -52.51 -40.72 62.75 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.727 0.299 . . . . 1.3400000000000001 111.597 -178.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 438' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 435' ' ' ASN . 61.5 m-20 -64.19 -24.58 67.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.391 -0.368 . . . . 1.5600000000000001 111.335 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.4 mp -94.81 -85.46 0.31 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.159 -0.473 . . . . 1.1200000000000001 112.191 -179.038 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -179.65 51.85 0.09 OUTLIER Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.097 -1.049 . . . . 1.3600000000000001 113.661 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 68.31 143.97 0.11 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.724 -0.751 . . . . 1.8300000000000001 113.363 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.488 HG22 HG22 ' A' ' 443' ' ' THR . 46.8 mm -65.59 95.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.485 -0.191 . . . . 1.48 110.485 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.488 HG22 HG22 ' A' ' 442' ' ' ILE . 8.1 t 37.35 53.29 1.3 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.855 0.836 . . . . 3.0499999999999998 111.385 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 6.4 p -148.12 132.07 9.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.627 -1.17 . . . . 4.1799999999999997 111.431 -179.505 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 446' ' ' PRO . 95.8 mt -151.61 131.68 7.07 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.777 -0.647 . . . . 4.9900000000000002 110.573 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 445' ' ' LEU . 23.9 Cg_exo -64.81 -154.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.694 2.263 . . . . 7.4000000000000004 112.702 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.92 137.6 69.5 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.894 -0.594 . . . . 9.0600000000000005 111.583 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.85 140.32 72.85 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.673 2.248 . . . . 11.06 112.068 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.74 131.12 31.95 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.524 2.149 . . . . 13.5 112.288 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 79.4 mt -66.34 129.68 40.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 15.76 110.819 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . -175.55 130.83 0.41 Allowed Pre-proline 0 C--N 1.333 -0.13 0 CA-C-N 116.36 -0.382 . . . . 16.739999999999998 111.279 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 451' ' ' ALA . 12.4 Cg_exo -70.23 143.4 48.47 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.878 2.385 . . . . 18.530000000000001 112.114 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 38.7 t70 59.81 49.16 8.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.217 -0.447 . . . . 20.550000000000001 110.919 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.237 -0.887 . . . . 21.219999999999999 110.669 179.966 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.472 -0.251 . . . . 11.640000000000001 112.472 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 79.5 p -61.6 -45.33 94.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.783 0.325 . . . . 9.8599999999999994 110.828 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -159.4 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.196 -0.457 . . . . 8.0700000000000003 110.48 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 366' ' ' MET . . . . . 0.542 ' HG3' ' HA ' ' A' ' 408' ' ' ALA . 94.7 mmm -63.36 147.81 50.12 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.678 0.275 . . . . 5.5099999999999998 110.675 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -118.56 61.23 4.6 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 112.036 0.384 . . . . 6.0599999999999996 112.036 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 368' ' ' PRO . . . . . 0.486 ' HD3' ' C ' ' A' ' 366' ' ' MET . 89.0 Cg_endo -83.94 34.98 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.534 2.156 . . . . 6.1600000000000001 111.593 179.179 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.706 HD12 ' N ' ' A' ' 370' ' ' MET . 4.2 pp -154.77 -32.15 0.1 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.542 -0.754 . . . . 6.9400000000000004 110.142 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.706 ' N ' HD12 ' A' ' 369' ' ' LEU . 41.4 ttp -107.55 31.48 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.838 -0.619 . . . . 5.6299999999999999 110.091 179.213 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -64.04 139.8 58.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.526 . . . . 5.04 111.067 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.451 ' O ' HD13 ' A' ' 373' ' ' ILE . 91.4 mttt -147.78 57.92 1.11 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.879 0.371 . . . . 5.3899999999999997 111.44 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 372' ' ' LYS . 21.9 mm -137.72 74.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 1.48 110.254 179.266 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -87.09 110.49 20.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.125 0.488 . . . . 2.1699999999999999 111.084 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.75 HD11 HG12 ' A' ' 397' ' ' VAL . 72.0 mt -79.89 -39.01 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.678 -0.692 . . . . 0.92000000000000004 111.248 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 58.1 m -70.71 58.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.597 -0.729 . . . . 1.71 111.983 -179.013 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -174.47 -30.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 1.9199999999999999 110.47 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 35.2 p30 -156.12 58.41 1.74 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.796 -0.638 . . . . 2.1400000000000001 111.172 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 379' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 51.3 Cg_exo -53.72 -39.33 84.0 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.198 1.932 . . . . 0.84999999999999998 111.461 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.41 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 1.4 m-20 -64.32 -31.59 72.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.67 -0.696 . . . . 1.21 111.175 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 83.7 tttt -45.83 125.45 6.17 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.016 0.436 . . . . 1.6599999999999999 110.805 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.839 HD12 HG21 ' A' ' 417' ' ' VAL . 21.4 mm -79.71 123.75 36.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.91 -0.586 . . . . 0.40999999999999998 111.902 -179.117 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -110.08 143.86 39.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.627 -0.508 . . . . 0.63 109.627 178.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.531 ' HB2' ' CD1' ' A' ' 439' ' ' LEU . 19.6 m-85 -91.47 138.83 31.27 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.822 -0.351 . . . . 0.95999999999999996 110.617 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.742 HG12 HG21 ' A' ' 414' ' ' VAL . 2.7 mp -124.33 130.35 73.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.313 -0.403 . . . . 0.48999999999999999 111.439 -179.045 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 439' ' ' LEU . 57.4 ttt-85 -99.05 122.23 42.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 2.4199999999999999 110.926 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -82.7 -173.25 4.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.506 -0.316 . . . . 2.2999999999999998 110.74 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.444 ' N ' ' OE1' ' A' ' 388' ' ' GLU . 0.4 OUTLIER -63.71 -44.62 93.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.835 0.35 . . . . 2.8199999999999998 110.828 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -71.17 5.57 2.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.115 -0.493 . . . . 1.23 111.249 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 71.35 28.89 69.05 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.021 -0.609 . . . . 1.03 113.074 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 444' ' ' VAL . 42.3 p -93.9 110.33 22.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.668 0.27 . . . . 0.97999999999999998 111.04 179.274 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.713 HG11 HD13 ' A' ' 442' ' ' ILE . 42.1 t -74.59 131.57 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.852 -0.425 . . . . 0.55000000000000004 109.852 179.13 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -145.39 135.52 23.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.454 -0.339 . . . . 2.4300000000000002 111.038 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.515 ' HD3' HG21 ' A' ' 382' ' ' ILE . 58.9 mtt85 -58.9 150.59 23.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.967 0.413 . . . . 2.96 111.576 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -177.05 132.84 2.11 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.755 -0.657 . . . . 0.26000000000000001 112.097 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 396' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 76.7 mt-30 -90.51 129.72 36.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.64 0.257 . . . . 1.28 111.535 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.855 HG22 HD13 ' A' ' 432' ' ' ILE . 5.8 t -85.4 126.85 40.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 109.613 -0.514 . . . . 0.82999999999999996 109.613 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 70.5 mt -121.12 -40.14 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.214 0.45 . . . . 1.45 112.214 -178.758 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.546 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 98.3 mm-40 -128.6 176.45 7.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.987 0.422 . . . . 2.0800000000000001 112.04 -178.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 87.7 p -161.83 149.4 14.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.684 -0.689 . . . . 0.56000000000000005 110.594 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -162.49 143.8 10.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.107 0.479 . . . . 1.55 111.33 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.721 HG22 ' HA ' ' A' ' 410' ' ' ASP . 30.2 p -115.13 134.03 55.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.741 -0.663 . . . . 1.79 109.489 178.336 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.777 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.9 m -58.42 -174.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.889 -0.411 . . . . 1.95 109.889 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.777 ' H ' HG22 ' A' ' 403' ' ' THR . 4.8 mm-40 -39.64 -44.78 1.55 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 3.8700000000000001 110.207 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -94.09 129.29 40.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.712 -0.676 . . . . 3.1600000000000001 109.345 178.001 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -113.89 57.6 0.69 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.164 0.506 . . . . 2.1800000000000002 111.489 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -138.71 11.35 2.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.623 -0.717 . . . . 2.77 110.028 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.542 ' HA ' ' HG3' ' A' ' 366' ' ' MET . . . -173.8 -46.01 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.077 -0.965 . . . . 2.7599999999999998 110.951 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 19.8 Cg_exo -68.62 38.85 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 123.162 2.574 . . . . 2.4900000000000002 113.897 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.721 ' HA ' HG22 ' A' ' 402' ' ' THR . 1.2 m-20 -81.28 131.78 35.31 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.417 -0.586 . . . . 2.1400000000000001 109.417 178.456 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 50.1 mt-10 -136.79 134.97 37.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.731 0.3 . . . . 2.1000000000000001 111.265 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 429' ' ' ARG . 1.4 m-85 -119.21 127.62 53.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.482 -0.326 . . . . 0.71999999999999997 111.113 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.546 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 15.0 t80 -57.82 143.5 42.08 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.483 -0.562 . . . . 0.51000000000000001 109.483 178.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.742 HG21 HG12 ' A' ' 385' ' ' ILE . 5.7 p -143.8 110.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.688 0.625 . . . . 1.1499999999999999 112.688 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -90.58 96.49 10.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.483 -0.78 . . . . 0.62 109.254 178.238 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.527 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 54.4 m-85 -51.83 125.88 16.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.248 0.547 . . . . 0.65000000000000002 111.067 -178.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.839 HG21 HD12 ' A' ' 382' ' ' ILE . 2.5 t -79.32 34.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.256 -0.884 . . . . 1.3400000000000001 111.105 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -179.53 -45.88 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.564 -0.744 . . . . 0.81999999999999995 112.679 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.851 HD23 HD23 ' A' ' 423' ' ' LEU . 7.0 mp -63.98 155.55 30.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.137 0.494 . . . . 1.6000000000000001 111.458 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.494 ' HB2' HD13 ' A' ' 423' ' ' LEU . 1.8 m120 -50.43 142.31 10.68 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.45 -0.796 . . . . 2.5299999999999998 111.693 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 421' ' ' ARG . . . . . 0.729 ' HD2' ' N ' ' A' ' 422' ' ' ARG . 7.1 ppt_? -58.4 -29.88 66.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.176 -0.466 . . . . 3.98 110.822 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 422' ' ' ARG . . . . . 0.729 ' N ' ' HD2' ' A' ' 421' ' ' ARG . 38.0 ptt180 -63.98 -37.15 86.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 3.71 110.321 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.851 HD23 HD23 ' A' ' 419' ' ' LEU . 7.0 mp -61.92 -33.35 74.08 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.877 -0.601 . . . . 1.49 110.755 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -50.63 138.19 18.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.681 -0.69 . . . . 1.2 111.141 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -170.99 -141.18 3.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.824 -0.703 . . . . 0.69999999999999996 112.506 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -122.26 132.58 54.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.859 0.361 . . . . 0.60999999999999999 110.873 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.624 HG21 HG13 ' A' ' 432' ' ' ILE . 20.3 m -110.81 155.64 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 0.89000000000000001 111.693 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.489 ' H ' ' NH1' ' A' ' 431' ' ' ARG . . . -71.35 21.32 0.69 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.065 -0.588 . . . . 1.72 113.935 -179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.51 ' HB2' ' CD1' ' A' ' 412' ' ' TYR . 37.7 tpt85 70.64 -46.17 0.62 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.138 0.792 . . . . 1.73 113.138 178.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -59.89 -14.69 16.58 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.67 0.748 . . . . 1.47 109.33 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.489 ' NH1' ' H ' ' A' ' 428' ' ' GLY . 58.0 mtt85 -79.06 -34.89 43.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.571 -1.195 . . . . 2.8399999999999999 111.221 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.855 HD13 HG22 ' A' ' 397' ' ' VAL . 65.8 mt -87.63 137.34 21.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.857 0.36 . . . . 0.46000000000000002 110.869 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.0 m -159.69 138.8 11.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.53000000000000003 110.721 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.17 -18.89 60.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 1.3500000000000001 110.811 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -108.59 132.93 53.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.105 -0.498 . . . . 2.1600000000000001 111.017 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 436' ' ' ALA . . . . . 0.457 ' HB1' HG12 ' A' ' 442' ' ' ILE . . . -66.23 -38.73 88.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.75 111.519 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -51.87 -40.73 61.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.308 -0.406 . . . . 1.3400000000000001 111.257 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -81.69 41.1 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 1.5600000000000001 110.624 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.556 ' O ' ' HD2' ' A' ' 386' ' ' ARG . 54.7 mt -152.62 -85.88 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.42 . . . . 1.1200000000000001 111.34 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 440' ' ' GLY . . . . . 0.585 ' O ' HG22 ' A' ' 443' ' ' THR . . . -165.01 32.91 0.25 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.444 -0.884 . . . . 1.3600000000000001 112.857 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 54.25 36.94 58.28 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 121.144 -0.55 . . . . 1.8300000000000001 113.604 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.713 HD13 HG11 ' A' ' 392' ' ' VAL . 48.0 mm 47.05 80.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 111.76 0.281 . . . . 1.48 111.76 178.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 440' ' ' GLY . 15.1 t -172.81 133.37 0.57 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.202 0.525 . . . . 3.0499999999999998 112.043 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.443 ' HA ' HG22 ' A' ' 391' ' ' THR . 28.8 m -87.66 121.56 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.604 -0.725 . . . . 4.1799999999999997 111.18 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 445' ' ' LEU . 7.2 mp -76.64 120.29 81.03 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.486 . . . . 4.9900000000000002 110.973 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.57 146.21 60.66 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.968 2.445 . . . . 7.4000000000000004 112.592 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . 62.85 71.83 0.64 Allowed Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.03 -0.532 . . . . 9.0600000000000005 111.841 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.26 133.64 35.96 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.545 2.163 . . . . 11.06 112.182 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -77.15 50.22 3.06 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.634 2.222 . . . . 13.5 112.847 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 59.7 tp -174.49 136.86 0.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.241 -0.436 . . . . 15.76 110.955 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . 64.92 128.36 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 115.958 -0.564 . . . . 16.739999999999998 111.404 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 451' ' ' ALA . 24.7 Cg_exo -63.23 135.41 50.35 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.759 2.306 . . . . 18.530000000000001 112.262 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -79.29 43.0 0.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 20.550000000000001 111.172 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.166 -0.921 . . . . 21.219999999999999 110.85 179.797 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.534 -0.226 . . . . 11.640000000000001 112.534 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 49.6 m -60.17 -48.21 82.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.347 . . . . 9.8599999999999994 110.75 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -65.53 132.88 50.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 8.0700000000000003 110.694 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 51.0 ttm -114.88 133.74 55.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 5.5099999999999998 111.072 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.465 ' OD1' ' HG2' ' A' ' 371' ' ' GLN . 2.0 p30 -61.65 131.23 92.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.068 -0.515 . . . . 6.0599999999999996 110.594 179.567 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -87.05 44.25 1.1 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.639 2.226 . . . . 6.1600000000000001 113.557 -179.113 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.426 ' N ' HD23 ' A' ' 369' ' ' LEU . 2.5 pt? -164.69 -42.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.744 -0.382 . . . . 6.9400000000000004 111.652 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 370' ' ' MET . . . . . . . . . . . . . 36.6 ttp -86.82 46.87 1.41 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.926 0.393 . . . . 5.6299999999999999 111.148 -179.365 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.465 ' HG2' ' OD1' ' A' ' 367' ' ' ASP . 49.4 mm-40 -134.75 41.3 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.12 0.486 . . . . 5.04 110.516 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -155.43 142.64 19.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.333 -0.849 . . . . 5.3899999999999997 110.169 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.622 HD11 ' NH1' ' A' ' 429' ' ' ARG . 67.5 mt -141.34 121.24 11.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.873 0.368 . . . . 1.48 111.782 -179.661 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.573 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 3.6 m-20 -91.68 68.53 5.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.026 -0.534 . . . . 2.1699999999999999 110.372 178.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.543 HD11 HG12 ' A' ' 397' ' ' VAL . 75.3 mt -51.86 -34.74 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.92000000000000004 112.073 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 37.6 t -47.8 -24.8 1.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.192 -0.458 . . . . 1.71 112.201 -178.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 11.9 pt-20 -69.22 -37.82 78.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.321 -0.4 . . . . 1.9199999999999999 111.848 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 378' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -154.17 65.0 4.89 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 111.695 0.257 . . . . 2.1400000000000001 111.695 -179.086 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.85 -37.66 85.24 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.396 2.064 . . . . 0.84999999999999998 111.673 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -64.29 -33.67 76.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.684 -0.689 . . . . 1.21 111.168 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -52.19 127.96 23.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.944 0.402 . . . . 1.6599999999999999 110.935 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.452 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 45.1 mm -87.36 131.42 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.971 -0.559 . . . . 0.40999999999999998 111.604 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -111.24 144.29 40.66 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.255 -0.429 . . . . 0.63 110.026 179.104 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.52 ' C ' HD12 ' A' ' 385' ' ' ILE . 18.2 m-85 -88.92 142.43 27.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.979 -0.288 . . . . 0.95999999999999996 110.673 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.643 HG12 HG21 ' A' ' 414' ' ' VAL . 3.4 mp -123.96 133.53 69.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.981 0.42 . . . . 0.48999999999999999 111.92 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.577 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 42.7 ttt85 -87.14 117.0 25.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 2.4199999999999999 110.455 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.429 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 58.3 mtp85 -70.12 169.52 13.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.754 0.311 . . . . 2.2999999999999998 111.142 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -51.72 -45.52 63.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.191 -0.459 . . . . 2.8199999999999998 111.339 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.53 -36.05 76.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.316 -0.402 . . . . 1.23 111.021 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 120.29 36.14 0.82 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.966 -0.635 . . . . 1.03 112.5 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 443' ' ' THR . 17.5 p -110.71 114.48 27.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.188 0.518 . . . . 0.97999999999999998 111.289 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 439' ' ' LEU . 91.9 t -66.66 135.02 29.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.456 -0.793 . . . . 0.55000000000000004 111.842 -178.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -153.77 132.26 12.11 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.411 -0.813 . . . . 2.4300000000000002 110.38 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.452 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 73.6 mtt-85 -54.56 154.07 5.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.355 0.598 . . . . 2.96 112.354 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -169.59 135.14 3.44 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.145 -0.934 . . . . 0.26000000000000001 111.499 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -91.61 111.21 22.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.807 0.303 . . . . 1.28 111.76 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.74 HG22 HD13 ' A' ' 432' ' ' ILE . 4.1 t -74.87 129.09 36.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 109.942 -0.392 . . . . 0.82999999999999996 109.942 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 77.0 mt -121.2 -41.28 2.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.362 0.504 . . . . 1.45 112.362 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.526 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 72.5 mt-30 -135.47 177.03 8.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.963 0.411 . . . . 2.0800000000000001 111.577 -178.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 412' ' ' TYR . 80.8 p -151.53 139.39 19.91 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.901 -0.59 . . . . 0.56000000000000005 110.72 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -154.69 144.08 21.3 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.334 -0.394 . . . . 1.55 111.136 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.542 HG22 ' HA ' ' A' ' 410' ' ' ASP . 41.6 p -94.47 -121.72 0.1 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.713 -0.477 . . . . 1.79 109.713 178.224 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.755 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.71 -173.38 2.98 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.607 -0.516 . . . . 1.95 109.607 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.755 ' H ' HG22 ' A' ' 403' ' ' THR . 48.9 mt-10 -43.67 -43.42 5.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.758 0.313 . . . . 3.8700000000000001 111.389 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -70.28 -51.88 27.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 3.1600000000000001 111.308 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.08 53.06 11.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.328 0.585 . . . . 2.1800000000000002 110.864 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.431 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -162.35 12.38 0.07 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.172 -0.922 . . . . 2.77 109.273 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.697 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -161.04 -41.52 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.448 -1.251 . . . . 2.7599999999999998 111.716 -178.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.697 ' HD2' ' H ' ' A' ' 408' ' ' ALA . 75.5 Cg_exo -52.21 -62.27 0.39 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.234 1.956 . . . . 2.4900000000000002 113.708 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.542 ' HA ' HG22 ' A' ' 402' ' ' THR . 6.6 p-10 36.02 74.39 0.07 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.228 0.537 . . . . 2.1400000000000001 111.231 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.41 147.72 30.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 2.1000000000000001 110.779 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 6.0 m-85 -127.21 125.15 40.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.374 . . . . 0.71999999999999997 111.203 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.526 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 15.5 t80 -57.84 149.89 21.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.923 -0.58 . . . . 0.51000000000000001 110.414 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.643 HG21 HG12 ' A' ' 385' ' ' ILE . 11.2 p -155.82 138.05 6.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.143 0.497 . . . . 1.1499999999999999 112.212 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -115.02 101.49 9.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.68 -0.691 . . . . 0.62 110.386 179.417 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 8.6 m-85 -62.1 116.1 4.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.193 -0.458 . . . . 0.65000000000000002 111.298 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.442 ' O ' HD23 ' A' ' 419' ' ' LEU . 63.1 t -67.58 130.42 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 1.3400000000000001 111.054 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.77 -42.8 1.83 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.859 -0.686 . . . . 0.81999999999999995 112.761 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 2.0 mm? -59.33 152.85 20.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.862 0.363 . . . . 1.6000000000000001 111.209 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.754 HD21 HD13 ' A' ' 423' ' ' LEU . 11.8 p-10 -49.73 136.53 17.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 2.5299999999999998 111.349 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 421' ' ' ARG . . . . . 0.423 HH11 ' HG3' ' A' ' 421' ' ' ARG . 60.9 mtt85 -57.35 -40.47 78.13 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.84 0.682 . . . . 3.98 112.84 -178.378 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 422' ' ' ARG . . . . . 0.434 ' CG ' HD22 ' A' ' 420' ' ' ASN . 16.9 ptp180 -53.84 -29.15 39.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.777 0.323 . . . . 3.71 110.864 -179.398 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.754 HD13 HD21 ' A' ' 420' ' ' ASN . 1.2 tp -59.26 -34.13 71.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 1.49 110.858 179.056 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -48.21 138.14 9.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.945 -0.57 . . . . 1.2 111.311 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.87 -142.91 4.82 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.001 -0.618 . . . . 0.69999999999999996 112.121 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -128.6 134.59 48.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.376 . . . . 0.60999999999999999 110.639 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.765 HG21 HG13 ' A' ' 432' ' ' ILE . 29.3 m -109.38 158.76 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.944 -0.571 . . . . 0.89000000000000001 111.887 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -77.46 35.01 1.56 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.834 -0.621 . . . . 1.72 114.441 -179.135 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.622 ' NH1' HD11 ' A' ' 373' ' ' ILE . 23.6 tpt180 70.69 -70.37 0.15 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.248 0.833 . . . . 1.73 113.248 178.619 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -45.39 -16.12 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.947 0.403 . . . . 1.47 111.707 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.586 ' HB3' HG23 ' A' ' 385' ' ' ILE . 53.4 mtt85 -77.47 -39.06 47.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.956 -0.565 . . . . 2.8399999999999999 111.333 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.765 HG13 HG21 ' A' ' 427' ' ' VAL . 86.7 mt -87.04 132.07 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.155 -0.313 . . . . 0.46000000000000002 110.155 179.152 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.756 ' HB2' HD11 ' A' ' 439' ' ' LEU . 61.0 m -164.0 142.13 7.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.53000000000000003 111.136 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -58.72 -26.09 63.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.076 -0.511 . . . . 1.3500000000000001 110.793 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -121.78 135.15 54.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.161 -0.472 . . . . 2.1600000000000001 110.851 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 436' ' ' ALA . . . . . 0.498 ' HA ' HD13 ' A' ' 439' ' ' LEU . . . -70.75 -10.96 60.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.75 111.635 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.07 -40.99 77.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 1.3400000000000001 111.716 -179.288 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 438' ' ' ASP . . . . . 0.54 ' C ' HD12 ' A' ' 439' ' ' LEU . 61.1 m-20 -83.03 18.23 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.826 0.346 . . . . 1.5600000000000001 111.337 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.756 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.4 mp -118.02 -96.54 0.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.1200000000000001 111.216 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 440' ' ' GLY . . . . . 0.577 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -173.9 41.61 0.14 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.323 -0.942 . . . . 1.3600000000000001 113.431 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 444' ' ' VAL . . . 65.9 149.76 0.09 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.662 -0.78 . . . . 1.8300000000000001 113.28 179.074 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 442' ' ' ILE . 1.5 mp -61.97 89.42 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 109.128 -0.693 . . . . 1.48 109.128 178.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.615 ' O ' HG22 ' A' ' 443' ' ' THR . 57.9 m 48.71 38.46 11.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.894 -1.048 . . . . 3.0499999999999998 110.681 -178.751 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.462 ' O ' ' HA3' ' A' ' 441' ' ' GLY . 70.2 t -155.95 127.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.995 -1.002 . . . . 4.1799999999999997 110.308 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 445' ' ' LEU . 3.6 mm? -70.88 125.45 92.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.502 -0.317 . . . . 4.9900000000000002 111.064 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 445' ' ' LEU . 25.3 Cg_exo -62.81 137.84 65.46 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.602 2.201 . . . . 7.4000000000000004 112.075 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -169.15 60.21 0.4 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 9.0600000000000005 111.263 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 448' ' ' PRO . . . . . 0.732 ' HB2' HD13 ' A' ' 450' ' ' LEU . 71.0 Cg_endo -76.08 131.93 13.54 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.525 2.15 . . . . 11.06 112.377 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.469 ' C ' HD12 ' A' ' 450' ' ' LEU . 95.2 Cg_endo -78.08 49.66 3.06 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.682 2.254 . . . . 13.5 112.595 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 450' ' ' LEU . . . . . 0.732 HD13 ' HB2' ' A' ' 448' ' ' PRO . 5.8 mp -117.2 139.38 50.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 15.76 110.952 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . -168.96 133.32 1.29 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 16.739999999999998 110.99 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.442 ' O ' ' HB3' ' A' ' 453' ' ' ASP . 27.9 Cg_exo -61.34 132.5 41.43 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.532 2.155 . . . . 18.530000000000001 112.19 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 452' ' ' PRO . 30.2 t70 70.22 -64.66 0.35 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.938 -0.574 . . . . 20.550000000000001 111.619 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.3 -0.857 . . . . 21.219999999999999 110.767 179.981 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.629 -0.188 . . . . 11.640000000000001 112.629 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 52.5 m -72.57 133.82 44.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.767 0.318 . . . . 9.8599999999999994 111.103 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.87 -29.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 8.0700000000000003 111.068 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 49.8 tpp -178.33 131.91 0.14 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.68 -0.691 . . . . 5.5099999999999998 110.442 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.461 ' OD2' ' HG ' ' A' ' 369' ' ' LEU . 37.4 t70 -63.8 121.88 73.55 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.447 -0.342 . . . . 6.0599999999999996 110.612 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 368' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 367' ' ' ASP . 6.3 Cg_exo -74.08 -48.01 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.911 2.407 . . . . 6.1600000000000001 113.786 -178.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.541 HD12 ' CB ' ' A' ' 370' ' ' MET . 4.3 pp -53.88 -30.82 47.53 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.063 -0.971 . . . . 6.9400000000000004 110.579 -179.391 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.541 ' CB ' HD12 ' A' ' 369' ' ' LEU . 54.4 ttp -168.24 116.78 0.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.807 -0.633 . . . . 5.6299999999999999 109.921 179.404 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.416 ' H ' ' CD ' ' A' ' 371' ' ' GLN . 16.0 mp0 -62.25 108.25 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.828 0.347 . . . . 5.04 110.634 -179.468 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.432 ' HB3' ' OH ' ' A' ' 412' ' ' TYR . 93.6 mttt 60.65 129.06 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.604 -0.725 . . . . 5.3899999999999997 111.401 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.72 HG13 ' HE ' ' A' ' 429' ' ' ARG . 85.7 mt -65.5 133.25 30.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.295 -0.411 . . . . 1.48 111.622 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.418 ' HB2' ' CD ' ' A' ' 377' ' ' GLU . 31.6 m-20 -89.56 129.52 36.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 2.1699999999999999 109.914 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.803 HD11 HG12 ' A' ' 397' ' ' VAL . 95.5 mt -88.26 -41.51 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.409 0.522 . . . . 0.92000000000000004 112.409 -179.176 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.7 t -46.74 -21.13 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.284 -0.417 . . . . 1.71 111.865 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.418 ' CD ' ' HB2' ' A' ' 374' ' ' ASP . 6.7 mt-10 -61.77 -42.39 98.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.855 -0.611 . . . . 1.9199999999999999 111.369 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.49 ' ND2' ' HD3' ' A' ' 381' ' ' LYS . 14.0 p30 -167.64 69.79 0.91 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 2.1400000000000001 111.188 -179.21 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.47 -39.66 54.52 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.57 2.18 . . . . 0.84999999999999998 112.158 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.79 -39.29 84.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 1.21 110.69 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.49 ' HD3' ' ND2' ' A' ' 378' ' ' ASN . 82.0 tttt -54.66 130.83 41.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.144 -0.48 . . . . 1.6599999999999999 111.048 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.553 HG21 ' HB3' ' A' ' 394' ' ' ARG . 28.7 mm -84.72 135.68 24.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.072 -0.513 . . . . 0.40999999999999998 111.442 -179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -108.17 143.8 36.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.374 -0.375 . . . . 0.63 110.388 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.428 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 7.1 m-85 -88.22 133.64 33.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.603 0.24 . . . . 0.95999999999999996 110.659 179.585 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 385' ' ' ILE . 1.9 mp -121.77 130.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.75 0.31 . . . . 0.48999999999999999 110.699 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.492 ' CZ ' ' HA2' ' A' ' 390' ' ' GLY . 60.7 ttt-85 -80.71 117.15 21.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.373 -0.376 . . . . 2.4199999999999999 110.648 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.751 ' HE ' ' HA ' ' A' ' 387' ' ' ARG . 2.0 mmp_? -68.17 164.81 19.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 2.2999999999999998 110.571 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' A' ' 388' ' ' GLU . 0.5 OUTLIER -51.71 -45.02 63.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 2.8199999999999998 111.615 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.406 ' N ' ' HG2' ' A' ' 388' ' ' GLU . 40.8 p-10 -69.63 -35.72 75.48 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.679 0.252 . . . . 1.23 111.679 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.492 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 138.8 -32.45 2.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.583 -0.818 . . . . 1.03 112.561 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 72.4 p -59.1 112.24 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.082 0.468 . . . . 0.97999999999999998 111.657 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 57.1 t -72.88 140.92 17.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.738 -0.665 . . . . 0.55000000000000004 111.274 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -139.7 137.57 35.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 2.4300000000000002 110.718 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.553 ' HB3' HG21 ' A' ' 382' ' ' ILE . 55.5 mtt85 -62.38 145.04 55.01 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.914 0.388 . . . . 2.96 110.923 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -164.14 134.4 3.35 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.022 -0.608 . . . . 0.26000000000000001 112.397 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 396' ' ' GLN . . . . . 0.541 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 90.0 mt-30 -82.19 132.28 35.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.531 0.205 . . . . 1.28 111.506 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.803 HG12 HD11 ' A' ' 375' ' ' ILE . 11.7 t -99.82 122.19 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.067 -0.716 . . . . 0.82999999999999996 109.067 178.141 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.716 ' N ' HD22 ' A' ' 398' ' ' LEU . 0.7 OUTLIER -111.64 -41.91 3.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.703 0.631 . . . . 1.45 112.703 -177.026 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -132.95 176.45 8.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.993 0.425 . . . . 2.0800000000000001 111.77 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.2 p -164.27 147.45 9.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.753 -0.658 . . . . 0.56000000000000005 110.863 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -160.66 134.2 6.8 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.002 0.43 . . . . 1.55 111.41 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.752 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 35.5 p -81.42 137.44 35.66 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.246 -0.434 . . . . 1.79 110.004 178.46 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.821 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.1 m -62.13 -174.03 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 1.95 110.761 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.821 ' H ' HG22 ' A' ' 403' ' ' THR . 50.6 mt-10 -42.28 -41.84 2.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.977 0.362 . . . . 3.8700000000000001 111.977 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.732 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 24.0 t-20 -57.43 -48.48 79.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 3.1600000000000001 110.673 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.752 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.63 57.23 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 2.1800000000000002 111.997 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.521 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -168.95 10.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 2.77 110.629 179.684 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.474 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . 179.85 -43.8 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.729 -0.669 . . . . 2.7599999999999998 111.918 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.732 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 11.7 Cg_exo -71.73 49.56 1.23 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.77 2.314 . . . . 2.4900000000000002 114.193 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.8 p30 -78.17 126.73 31.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.847 0.356 . . . . 2.1400000000000001 110.504 178.599 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 400' ' ' SER . 47.4 mt-10 -114.05 134.63 54.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 2.1000000000000001 110.482 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.569 ' HB3' HG13 ' A' ' 397' ' ' VAL . 1.6 m-85 -111.91 134.05 53.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.973 0.416 . . . . 0.71999999999999997 111.941 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 17.8 t80 -66.57 138.41 57.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.691 -0.855 . . . . 0.51000000000000001 108.691 177.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.551 HG11 HG12 ' A' ' 385' ' ' ILE . 21.7 t -140.78 110.08 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 113.202 0.815 . . . . 1.1499999999999999 113.202 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 415' ' ' HIS . . . . . 0.484 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 86.4 t60 -90.1 88.5 7.29 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.661 -0.866 . . . . 0.62 108.661 177.176 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 416' ' ' TYR . . . . . 0.631 ' HB2' HD11 ' A' ' 419' ' ' LEU . 4.7 m-85 -57.95 116.01 3.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.807 0.813 . . . . 0.65000000000000002 111.482 -178.675 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.482 HG21 ' CB ' ' A' ' 394' ' ' ARG . 5.5 m -53.87 129.56 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 CA-C-N 114.027 -1.442 . . . . 1.3400000000000001 112.818 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 81.88 -52.1 4.55 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 115.415 0.926 . . . . 0.81999999999999995 115.415 177.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.924 HD13 HD23 ' A' ' 423' ' ' LEU . 0.5 OUTLIER -62.18 162.52 9.48 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.901 0.851 . . . . 1.6000000000000001 112.561 -177.706 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.461 ' O ' HD13 ' A' ' 419' ' ' LEU . 10.9 t-20 -59.68 143.51 50.5 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.507 -0.77 . . . . 2.5299999999999998 111.877 -179.28 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 421' ' ' ARG . . . . . 0.66 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 99.3 mtt180 -53.39 -20.21 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 3.98 111.716 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -55.32 -40.34 71.04 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.854 -0.612 . . . . 3.71 112.157 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.924 HD23 HD13 ' A' ' 419' ' ' LEU . 2.1 mm? -70.62 -35.13 72.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.87 0.322 . . . . 1.49 111.87 -179.249 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.66 ' OD2' ' HA ' ' A' ' 421' ' ' ARG . 62.3 m-20 -48.71 132.38 17.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.97 0.415 . . . . 1.2 111.407 -178.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.28 179.99 46.17 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.856 -0.687 . . . . 0.69999999999999996 112.33 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 426' ' ' TRP . . . . . 0.57 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 36.2 m95 -76.8 139.21 40.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.605 0.24 . . . . 0.60999999999999999 110.45 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.417 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 12.3 m -140.39 146.75 24.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.966 0.412 . . . . 0.89000000000000001 111.492 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.453 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -59.21 149.16 39.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.873 -0.68 . . . . 1.72 112.407 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.72 ' HE ' HG13 ' A' ' 373' ' ' ILE . 37.9 tpt85 -52.09 -39.62 60.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.727 0.269 . . . . 1.73 111.727 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.453 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 19.5 p-80 -55.97 -26.7 49.33 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.143 0.423 . . . . 1.47 112.143 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.417 ' HD2' ' HB ' ' A' ' 427' ' ' VAL . 57.3 mtt85 -78.09 -38.58 43.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.845 0.313 . . . . 2.8399999999999999 111.845 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.523 HG21 HG21 ' A' ' 397' ' ' VAL . 59.6 mt -88.75 134.78 27.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.88 0.371 . . . . 0.46000000000000002 111.154 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.746 ' HB2' HD21 ' A' ' 439' ' ' LEU . 71.1 m -160.64 139.74 10.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.53000000000000003 110.928 -179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -74.37 16.75 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 1.3500000000000001 111.719 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -138.47 131.31 29.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.986 0.422 . . . . 2.1600000000000001 111.133 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -67.33 -72.77 0.16 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.892 -0.594 . . . . 0.75 111.62 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -40.71 -39.3 1.05 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.927 -0.579 . . . . 1.3400000000000001 111.715 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.87 47.37 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.301 -0.409 . . . . 1.5600000000000001 111.298 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 433' ' ' SER . 94.7 mt -149.87 -84.81 0.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.644 -0.253 . . . . 1.1200000000000001 111.405 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -163.3 40.91 0.33 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.508 -0.853 . . . . 1.3600000000000001 113.089 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.21 146.83 0.32 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 1.8300000000000001 113.237 179.339 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 47.2 mm -57.0 145.92 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.671 0.272 . . . . 1.48 110.99 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 8.1 t -48.1 156.75 0.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 3.0499999999999998 111.757 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 444' ' ' VAL . 45.9 t 65.93 59.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.382 0.61 . . . . 4.1799999999999997 111.009 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 91.0 mt -67.82 139.46 93.48 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.613 -0.722 . . . . 4.9900000000000002 110.658 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.61 127.62 26.12 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.383 2.055 . . . . 7.4000000000000004 112.305 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -73.6 130.35 83.91 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 9.0600000000000005 111.453 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 448' ' ' PRO . . . . . 0.731 ' HG2' ' HB2' ' A' ' 451' ' ' ALA . 31.9 Cg_endo -64.81 141.92 73.85 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.428 2.085 . . . . 11.06 112.034 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.82 133.88 53.64 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.637 2.225 . . . . 13.5 112.637 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 18.4 tp 52.9 42.12 32.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.879 -0.6 . . . . 15.76 110.992 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.731 ' HB2' ' HG2' ' A' ' 448' ' ' PRO . . . -73.51 133.69 80.04 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 16.739999999999998 111.232 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 453' ' ' ASP . 41.0 Cg_endo -67.21 129.39 20.35 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.322 2.015 . . . . 18.530000000000001 111.901 179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 452' ' ' PRO . 2.5 p30 54.48 135.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.822 0.701 . . . . 20.550000000000001 112.191 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.239 -0.886 . . . . 21.219999999999999 111.059 -179.883 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.572 -0.211 . . . . 11.640000000000001 112.572 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.4 t -60.97 -42.1 97.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.638 0.256 . . . . 9.8599999999999994 110.889 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 75.6 t60 65.01 133.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.009 -0.541 . . . . 8.0700000000000003 111.155 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 14.1 tpt -174.66 143.62 0.79 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 5.5099999999999998 110.287 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.522 ' HB2' ' H ' ' A' ' 371' ' ' GLN . 12.0 p-10 -53.09 112.3 3.45 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.398 -0.365 . . . . 6.0599999999999996 111.069 -179.613 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 368' ' ' PRO . . . . . 0.843 ' HD2' ' HG2' ' A' ' 371' ' ' GLN . 87.9 Cg_endo -80.42 42.58 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.891 1.727 . . . . 6.1600000000000001 113.914 -178.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 370' ' ' MET . 2.0 tm? 166.75 -60.94 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.03 -0.73 . . . . 6.9400000000000004 109.03 179.612 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 370' ' ' MET . . . . . 0.704 ' HG3' ' HE3' ' A' ' 372' ' ' LYS . 24.7 ttt 165.9 43.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.022 -1.444 . . . . 5.6299999999999999 107.883 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.843 ' HG2' ' HD2' ' A' ' 368' ' ' PRO . 1.4 pt20 -75.56 50.03 0.52 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.103 -0.953 . . . . 5.04 112.298 -178.3 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.933 ' HG2' ' HB1' ' A' ' 408' ' ' ALA . 0.0 OUTLIER -139.8 57.98 1.61 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.571 0.7 . . . . 5.3899999999999997 110.841 178.936 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 77.5 mt 59.15 97.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.136 -0.938 . . . . 1.48 111.977 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 21.8 m-20 -88.95 137.7 32.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 2.1699999999999999 110.673 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.562 HD11 HG12 ' A' ' 397' ' ' VAL . 79.4 mt -96.48 -46.62 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.206 0.527 . . . . 0.92000000000000004 111.464 -180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 56.8 m -53.9 -18.15 3.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.297 -0.865 . . . . 1.71 111.613 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 24.1 pt-20 -74.97 -40.47 60.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.134 -0.485 . . . . 1.9199999999999999 111.917 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 378' ' ' ASN . . . . . 0.616 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 64.4 m-20 -154.86 74.57 5.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 2.1400000000000001 112.029 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.44 -40.74 81.91 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.68 2.254 . . . . 0.84999999999999998 112.172 179.313 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -67.58 -37.56 82.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.848 -0.614 . . . . 1.21 111.36 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.616 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 63.9 tttp -50.35 129.44 21.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 1.6599999999999999 111.261 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 40.2 mm -88.62 132.82 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.037 -0.529 . . . . 0.40999999999999998 111.189 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.88 143.62 34.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.931 -0.396 . . . . 0.63 109.931 179.018 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -89.72 122.9 33.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.95999999999999996 110.779 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.1 mp -106.09 123.09 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 0.48999999999999999 111.328 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.588 ' HB2' HD22 ' A' ' 439' ' ' LEU . 38.4 ttt85 -84.08 118.53 24.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 2.4199999999999999 110.534 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -71.45 157.28 38.31 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.887 -0.325 . . . . 2.2999999999999998 110.566 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.616 ' HA ' HH12 ' A' ' 431' ' ' ARG . 16.3 pt-20 -49.66 -41.2 42.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 2.8199999999999998 111.74 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -67.01 -36.24 81.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.683 -0.235 . . . . 1.23 111.138 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.492 ' HA3' HD21 ' A' ' 445' ' ' LEU . . . 136.44 -33.68 2.33 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.448 -0.882 . . . . 1.03 112.842 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 57.6 p -59.17 113.87 2.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.317 0.579 . . . . 0.97999999999999998 112.149 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.17 144.6 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.321 -0.854 . . . . 0.55000000000000004 111.351 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -151.59 129.75 11.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.006 -0.543 . . . . 2.4300000000000002 110.684 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.447 HH11 ' HG3' ' A' ' 394' ' ' ARG . 61.3 mtt85 -55.4 153.85 6.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.878 -0.601 . . . . 2.96 112.137 -179.353 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.454 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -175.75 135.24 2.91 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.416 -0.811 . . . . 0.26000000000000001 112.114 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 396' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 24.6 mt-30 -91.5 138.06 31.87 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.944 -0.151 . . . . 1.28 111.007 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.638 ' CG2' HD13 ' A' ' 432' ' ' ILE . 14.5 t -92.09 102.19 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.211 -0.662 . . . . 0.82999999999999996 109.211 178.27 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 398' ' ' LEU . 6.2 mp -84.95 -36.81 21.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.594 -0.73 . . . . 1.45 112.473 -177.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 399' ' ' GLN . . . . . 0.546 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 66.0 mt-30 -141.0 175.66 9.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.976 0.417 . . . . 2.0800000000000001 111.333 -178.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 93.2 p -165.63 144.22 6.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.689 -0.687 . . . . 0.56000000000000005 110.589 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.591 ' HG3' ' HB3' ' A' ' 410' ' ' ASP . 36.1 ptt180 -118.74 175.4 5.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 1.55 109.989 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 410' ' ' ASP . 26.6 p -127.82 133.38 49.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.128 0.489 . . . . 1.79 111.956 -179.161 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 403' ' ' THR . . . . . 0.813 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.4 m -63.19 -170.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.488 -0.778 . . . . 1.95 110.363 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.813 ' H ' HG22 ' A' ' 403' ' ' THR . 49.9 mt-10 -42.44 -35.61 1.08 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.667 0.27 . . . . 3.8700000000000001 110.566 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -54.17 -46.42 72.32 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.697 -0.483 . . . . 3.1600000000000001 109.697 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 402' ' ' THR . . . 62.07 64.33 1.0 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.38 -0.827 . . . . 2.1800000000000002 111.409 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -166.91 -25.1 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.416 0.524 . . . . 2.77 112.416 -179.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 408' ' ' ALA . . . . . 0.933 ' HB1' ' HG2' ' A' ' 372' ' ' LYS . . . -165.46 -47.26 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 114.101 1.148 . . . . 2.7599999999999998 114.101 -179.045 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 55.7 Cg_exo -55.51 -155.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.676 2.25 . . . . 2.4900000000000002 114.868 -177.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 410' ' ' ASP . . . . . 0.591 ' HB3' ' HG3' ' A' ' 401' ' ' ARG . 0.1 OUTLIER 80.38 -160.1 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.794 -1.094 . . . . 2.1400000000000001 113.056 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 426' ' ' TRP . 95.1 mt-10 -106.48 149.02 27.5 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.067 -0.515 . . . . 2.1000000000000001 111.554 -177.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.535 ' N ' ' HD1' ' A' ' 412' ' ' TYR . 0.4 OUTLIER -112.0 134.93 53.25 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.652 -0.704 . . . . 0.71999999999999997 112.176 -177.952 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.546 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 14.8 t80 -67.05 145.43 55.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.75 -0.659 . . . . 0.51000000000000001 110.419 179.318 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.519 HG11 HG12 ' A' ' 385' ' ' ILE . 13.7 t -148.57 129.48 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.127 0.788 . . . . 1.1499999999999999 113.127 -179.261 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 415' ' ' HIS . . . . . 0.46 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 56.0 t60 -105.32 104.03 13.68 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.87 -0.605 . . . . 0.62 109.539 177.38 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 416' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -66.22 128.84 37.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.933 0.397 . . . . 0.65000000000000002 111.162 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.24 128.91 36.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.86 -0.609 . . . . 1.3400000000000001 111.823 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 75.29 -47.17 1.97 Allowed Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.781 -0.645 . . . . 0.81999999999999995 113.363 179.269 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.575 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.6 mp -59.74 161.95 5.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.418 . . . . 1.6000000000000001 111.62 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 420' ' ' ASN . . . . . 0.469 ' HB3' ' HG2' ' A' ' 422' ' ' ARG . 75.8 m-20 -50.11 139.73 13.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.634 -0.712 . . . . 2.5299999999999998 111.82 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -63.59 -31.21 72.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.659 -0.701 . . . . 3.98 111.199 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 422' ' ' ARG . . . . . 0.469 ' HG2' ' HB3' ' A' ' 420' ' ' ASN . 14.6 ptp180 -52.77 -35.02 55.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 3.71 111.196 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 423' ' ' LEU . . . . . 0.575 HD12 ' HB3' ' A' ' 419' ' ' LEU . 50.8 mt -56.09 -32.13 63.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 1.49 111.357 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' A' ' 415' ' ' HIS . 1.1 m-20 -47.73 134.1 13.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.906 0.384 . . . . 1.2 111.327 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 425' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 413' ' ' TYR . . . -179.84 -142.62 5.16 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.749 . . . . 0.69999999999999996 112.242 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 426' ' ' TRP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 37.3 m95 -122.49 138.56 54.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.937 0.399 . . . . 0.60999999999999999 110.574 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.815 HG21 HG13 ' A' ' 432' ' ' ILE . 10.3 m -109.37 158.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.89000000000000001 111.652 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -75.31 27.17 1.23 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.651 -0.785 . . . . 1.72 113.391 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.672 ' H ' HG23 ' A' ' 427' ' ' VAL . 40.8 tpt85 70.9 -47.0 0.65 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.869 0.468 . . . . 1.73 112.144 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -69.95 -7.09 37.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 1.47 110.801 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.635 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 39.2 mmt180 -79.2 -37.3 38.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 2.8399999999999999 110.817 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.815 HG13 HG21 ' A' ' 427' ' ' VAL . 56.4 mt -87.88 135.8 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.46000000000000002 110.784 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 54.0 m -157.65 139.51 14.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.255 -0.43 . . . . 0.53000000000000003 111.015 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -79.21 16.31 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 1.3500000000000001 111.902 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -145.64 132.82 20.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.958 0.408 . . . . 2.1600000000000001 111.096 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 436' ' ' ALA . . . . . 0.445 ' HB1' HD11 ' A' ' 442' ' ' ILE . . . -70.52 -43.72 69.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.75 111.434 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -55.09 -40.37 70.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.225 -0.443 . . . . 1.3400000000000001 111.2 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -79.26 46.38 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 1.5600000000000001 111.164 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.588 HD22 ' HB2' ' A' ' 386' ' ' ARG . 98.3 mt -151.08 -84.04 0.09 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.502 -0.317 . . . . 1.1200000000000001 111.133 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 440' ' ' GLY . . . . . 0.541 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -175.0 52.3 0.13 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.927 -0.654 . . . . 1.3600000000000001 112.402 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 72.36 -139.51 28.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.839 -0.696 . . . . 1.8300000000000001 112.407 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 442' ' ' ILE . . . . . 0.621 HG22 HG22 ' A' ' 443' ' ' THR . 33.9 mm -148.52 120.6 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.95 -0.389 . . . . 1.48 109.95 179.484 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.66 ' O ' HG12 ' A' ' 444' ' ' VAL . 8.9 t 46.47 126.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 124.099 0.875 . . . . 3.0499999999999998 112.834 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.66 HG12 ' O ' ' A' ' 443' ' ' THR . 1.6 p 55.12 128.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.358 -0.837 . . . . 4.1799999999999997 112.058 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.492 HD21 ' HA3' ' A' ' 390' ' ' GLY . 92.3 mt -69.21 119.46 70.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.703 -0.68 . . . . 4.9900000000000002 111.256 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -78.42 137.28 14.7 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.627 2.218 . . . . 7.4000000000000004 112.201 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -171.51 132.13 0.8 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.507 -0.315 . . . . 9.0600000000000005 111.471 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.68 142.17 69.3 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.671 2.247 . . . . 11.06 112.114 179.615 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.38 116.65 3.48 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.348 2.032 . . . . 13.5 112.132 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 450' ' ' LEU . . . . . 0.648 HD13 ' N ' ' A' ' 451' ' ' ALA . 1.9 tm? -82.64 131.72 35.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 15.76 110.206 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.648 ' N ' HD13 ' A' ' 450' ' ' LEU . . . -172.88 131.51 0.62 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.361 -0.381 . . . . 16.739999999999998 111.191 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.22 39.9 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.588 2.192 . . . . 18.530000000000001 112.441 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -174.67 52.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.065 0.46 . . . . 20.550000000000001 110.474 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.217 -0.897 . . . . 21.219999999999999 110.759 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.417 HD11 ' NH2' ' A' ' 429' ' ' ARG . 70.1 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.004 0.431 . . . . 1.48 112.14 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -89.74 130.72 35.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.694 -0.685 . . . . 2.17 110.689 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.5 mt -81.73 -43.63 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.92 111.394 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 72.7 p -65.46 74.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.979 -0.555 . . . . 1.71 111.211 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -173.83 -27.19 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.561 -0.745 . . . . 1.92 109.964 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 0.1 OUTLIER -165.67 57.7 0.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.372 -0.831 . . . . 2.14 111.392 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 51.2 Cg_exo -53.67 -39.12 84.46 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.247 1.964 . . . . 0.85 111.604 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.46 -32.4 73.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.751 -0.659 . . . . 1.21 110.943 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 84.6 tttt -50.4 127.06 16.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.241 -0.436 . . . . 1.66 111.117 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 47.4 mm -83.46 127.39 39.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.41 110.743 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -102.32 143.34 32.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.313 . . . . 0.63 110.694 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -92.25 140.01 30.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.272 -0.422 . . . . 0.96 110.282 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 385' ' ' ILE . 1.0 OUTLIER -133.49 126.88 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.49 111.111 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 45.2 ttt85 -79.83 116.77 20.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.008 -0.542 . . . . 2.42 110.431 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -69.98 155.55 40.42 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.677 -0.409 . . . . 2.3 110.21 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -51.26 -45.24 61.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 2.82 111.55 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -56.96 -34.61 68.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.086 -0.709 . . . . 1.23 109.086 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 132.57 -36.72 2.13 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.494 -0.775 . . . . 1.03 112.947 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 82.3 p -59.57 112.83 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.182 0.515 . . . . 0.98 112.163 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.5 142.38 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.707 -0.679 . . . . 0.55 110.696 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -147.94 143.94 27.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.38 . . . . 2.43 111.254 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -55.84 154.64 6.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.906 -0.588 . . . . 2.96 111.809 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -171.35 129.68 1.82 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.688 -0.687 . . . . 0.26 112.316 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -84.89 128.5 34.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.75 0.309 . . . . 1.28 110.752 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.7 OUTLIER -97.2 134.5 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.507 -0.315 . . . . 0.83 110.424 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 76.3 mt -120.57 -43.76 2.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.971 0.73 . . . . 1.45 112.971 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.413 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 23.8 mt-30 -122.75 174.78 6.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.117 0.484 . . . . 2.08 112.228 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.4 p -166.3 144.92 5.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.513 -0.767 . . . . 0.56 110.608 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.51 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 39.3 ptt180 -143.54 134.72 25.76 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.809 0.337 . . . . 1.55 110.842 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.633 HG22 ' HB3' ' A' ' 410' ' ' ASP . 18.0 p -98.85 38.02 1.43 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.098 0.407 . . . . 1.79 112.098 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.907 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.0 m 47.52 -173.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.285 -0.416 . . . . 1.95 111.249 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.907 ' H ' HG22 ' A' ' 403' ' ' THR . 94.4 mt-10 -68.68 -41.62 78.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.799 0.333 . . . . 3.87 111.402 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.558 ' OD1' ' HB3' ' A' ' 407' ' ' ALA . 24.3 t-20 -54.57 -52.48 61.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.154 -0.476 . . . . 3.16 111.311 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 55.55 59.67 3.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 2.18 111.756 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.558 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -163.51 11.08 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.459 0.647 . . . . 2.77 110.024 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.638 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -177.57 -49.77 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 114.808 -1.087 . . . . 2.76 110.23 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 30.8 Cg_endo -62.2 145.62 96.17 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.408 2.072 . . . . 2.49 112.425 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.633 ' HB3' HG22 ' A' ' 402' ' ' THR . 12.5 p-10 -178.47 124.65 0.11 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.047 -0.524 . . . . 2.14 110.763 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 400' ' ' SER . 10.8 mp0 -129.89 137.89 50.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.947 -0.57 . . . . 2.1 110.127 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.606 ' HB2' HD12 ' A' ' 432' ' ' ILE . 1.4 m-85 -109.76 133.41 53.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.883 0.373 . . . . 0.72 111.664 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 30.9 t80 -72.9 120.72 18.92 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.439 -0.578 . . . . 0.51 109.439 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.483 HG21 HG12 ' A' ' 385' ' ' ILE . 8.8 p -112.56 138.75 40.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.584 0.587 . . . . 1.15 112.584 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . 0.513 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 83.8 t60 -120.81 88.95 3.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.218 -0.901 . . . . 0.62 109.412 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.413 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 59.9 m-85 -52.85 116.2 2.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.65 111.318 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.3 t -62.11 128.89 24.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 1.34 111.371 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.39 -42.44 1.95 Allowed Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.776 -0.647 . . . . 0.82 113.351 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.675 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.8 mp -59.45 161.06 6.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.013 0.435 . . . . 1.6 111.576 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.616 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 4.9 m120 -49.78 140.91 10.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.514 -0.766 . . . . 2.53 111.925 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.522 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 88.7 mtm180 -65.23 -36.45 84.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.867 -0.606 . . . . 3.98 110.829 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 420' ' ' ASN . 3.7 ptm85 -55.65 -35.57 66.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.281 -0.418 . . . . 3.71 110.643 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 419' ' ' LEU . 76.7 mt -59.02 -35.17 72.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 1.49 111.394 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.522 ' OD2' ' HA ' ' A' ' 421' ' ' ARG . 48.9 m-20 -54.69 139.7 38.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 1.2 111.901 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 179.45 -153.35 12.11 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.472 -0.785 . . . . 0.7 111.852 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . 0.51 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 77.0 m95 -94.93 140.48 29.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.833 0.349 . . . . 0.61 111.082 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.53 ' CG2' HD11 ' A' ' 432' ' ' ILE . 16.1 m -138.76 137.5 42.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.032 -0.531 . . . . 0.89 111.399 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.495 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -62.22 150.13 47.03 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.819 -0.628 . . . . 1.72 112.591 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.417 ' NH2' HD11 ' A' ' 373' ' ' ILE . 41.0 tpt85 -53.61 -38.17 63.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 1.73 111.302 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.495 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 19.5 p-80 -58.08 -29.86 65.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.952 0.352 . . . . 1.47 111.952 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.05 -36.13 48.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.578 -0.283 . . . . 2.84 111.215 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 412' ' ' TYR . 54.1 mt -89.28 139.7 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.945 0.402 . . . . 0.46 111.366 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.6 m -160.97 139.51 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.53 110.651 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -63.78 -26.46 68.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 1.35 111.281 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.636 HD21 ' HB2' ' A' ' 437' ' ' ASP . 45.8 t30 -109.62 134.06 52.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.92 0.39 . . . . 2.16 110.691 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -73.37 -39.85 64.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.75 112.275 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . 0.636 ' HB2' HD21 ' A' ' 435' ' ' ASN . 57.0 m-20 -49.69 -40.87 41.66 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.787 0.291 . . . . 1.34 111.787 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.4 -40.96 94.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.348 . . . . 1.56 110.97 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.88 -83.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 1.12 111.558 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -138.59 34.36 2.12 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.492 -0.861 . . . . 1.36 113.077 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 437' ' ' ASP . . . 43.63 44.17 6.67 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.365 -0.445 . . . . 1.83 113.732 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 442' ' ' ILE . 48.0 mm . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.534 0.683 . . . . 1.48 111.476 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.659 HG22 HG13 ' A' ' 375' ' ' ILE . 31.4 mm . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 121.315 0.579 . . . . 1.48 112.448 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 377' ' ' GLU . 45.5 m-20 -106.19 69.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.711 -0.677 . . . . 2.17 110.489 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.844 HD11 HG12 ' A' ' 397' ' ' VAL . 73.5 mt -60.67 -82.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.036 0.754 . . . . 0.92 113.036 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 375' ' ' ILE . 52.0 m -49.93 -28.73 7.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.121 -0.49 . . . . 1.71 111.814 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 374' ' ' ASP . 8.5 mt-10 -70.44 -38.25 74.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.698 -0.683 . . . . 1.92 111.144 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.527 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 3.9 m120 -146.04 66.17 11.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 2.14 111.68 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.13 -40.65 76.33 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.691 2.261 . . . . 0.85 112.227 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.05 -37.13 85.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.887 -0.597 . . . . 1.21 111.327 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.3 tttp -51.17 125.63 14.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.399 . . . . 1.66 111.124 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.936 HD12 HG21 ' A' ' 417' ' ' VAL . 42.5 mm -87.04 132.87 31.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.973 -0.558 . . . . 0.41 111.47 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -107.25 143.69 35.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.371 -0.377 . . . . 0.63 110.361 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 436' ' ' ALA . 2.7 m-85 -92.64 138.35 31.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.667 0.27 . . . . 0.96 110.641 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 385' ' ' ILE . 3.0 mp -123.01 135.45 63.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.893 0.378 . . . . 0.49 111.267 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.662 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 56.3 ttt-85 -92.44 121.73 34.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 2.42 111.204 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -79.52 156.64 27.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.546 -0.297 . . . . 2.3 110.412 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -51.54 -45.45 62.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 2.82 111.036 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -59.44 -32.53 70.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 1.23 110.295 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 112.33 37.75 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.894 -0.593 . . . . 1.03 112.828 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 62.9 p -120.84 112.34 18.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.863 0.363 . . . . 0.98 111.342 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 87.0 t -69.6 138.92 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.55 111.21 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -149.37 138.81 21.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.11 -0.496 . . . . 2.43 110.978 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.495 ' HD2' HG21 ' A' ' 382' ' ' ILE . 73.8 mtm-85 -57.41 150.28 18.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.545 . . . . 2.96 111.802 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -175.7 132.98 2.26 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.586 -0.734 . . . . 0.26 111.856 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 82.8 mt-30 -95.2 129.99 42.1 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.851 0.315 . . . . 1.28 111.851 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.844 HG12 HD11 ' A' ' 375' ' ' ILE . 21.5 t -85.9 132.38 32.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.94 -0.393 . . . . 0.83 109.94 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.429 ' C ' HD13 ' A' ' 375' ' ' ILE . 91.9 mt -121.02 -40.82 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.575 0.583 . . . . 1.45 112.575 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.48 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 97.9 mm-40 -136.86 176.46 8.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.231 0.538 . . . . 2.08 112.25 -178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.7 p -158.0 140.13 14.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.369 -0.832 . . . . 0.56 109.947 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.447 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 38.0 ptt180 -142.31 137.05 30.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.066 0.46 . . . . 1.55 112.035 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 409' ' ' PRO . 42.1 p -77.42 137.46 38.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 1.79 110.312 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.808 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.7 m -62.4 -174.29 0.06 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.03 -0.359 . . . . 1.95 110.03 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.808 ' H ' HG22 ' A' ' 403' ' ' THR . 55.5 mt-10 -48.21 -40.69 25.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.8 0.333 . . . . 3.87 110.695 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.517 ' O ' ' HD2' ' A' ' 409' ' ' PRO . 50.1 t30 -80.5 54.19 2.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.979 -0.555 . . . . 3.16 110.664 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . -51.43 98.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.131 0.491 . . . . 2.18 110.995 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -177.28 -29.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.378 -0.828 . . . . 2.77 109.978 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.666 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -145.57 -51.21 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.106 -0.952 . . . . 2.76 111.259 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.666 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 51.0 Cg_exo -55.46 145.71 66.97 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.457 2.105 . . . . 2.49 112.354 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.402 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 12.8 p-10 -173.01 128.62 0.47 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.153 0.502 . . . . 2.14 111.326 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 400' ' ' SER . 52.2 mp0 -108.73 144.25 36.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.643 -0.708 . . . . 2.1 109.98 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.433 ' N ' ' HD1' ' A' ' 412' ' ' TYR . 0.8 OUTLIER -109.15 124.18 50.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.079 0.466 . . . . 0.72 111.841 -178.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 11.9 t80 -63.96 149.9 46.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.567 -0.742 . . . . 0.51 109.341 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 12.3 p -153.78 137.52 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.199 0.523 . . . . 1.15 112.356 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -118.46 107.46 13.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.415 -0.811 . . . . 0.62 109.553 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.467 ' CD2' HD22 ' A' ' 419' ' ' LEU . 37.3 m-85 -62.13 127.82 33.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.081 0.467 . . . . 0.65 111.218 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.936 HG21 HD12 ' A' ' 382' ' ' ILE . 2.4 t -82.49 34.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.518 -0.764 . . . . 1.34 111.223 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -176.81 -48.39 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.769 -0.729 . . . . 0.82 112.783 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.605 ' HB3' HD23 ' A' ' 423' ' ' LEU . 7.0 mp -62.75 150.37 41.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 1.6 110.916 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.415 ' N ' HD23 ' A' ' 423' ' ' LEU . 48.5 t30 -53.09 165.91 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.943 -0.571 . . . . 2.53 111.157 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -64.22 -27.56 69.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 3.98 110.543 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -53.44 -39.75 64.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.802 -0.635 . . . . 3.71 111.047 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.655 HD22 ' H ' ' A' ' 423' ' ' LEU . 1.6 mm? -70.9 -34.82 71.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.178 -0.465 . . . . 1.49 110.502 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -53.76 131.56 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.798 -0.637 . . . . 1.2 111.25 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 169.72 -146.39 10.01 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.867 -0.606 . . . . 0.7 112.209 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . 0.447 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 57.0 m95 -103.75 140.09 38.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.801 0.334 . . . . 0.61 110.722 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.461 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 32.0 m -141.04 144.7 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.89 111.097 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -59.0 148.69 39.43 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.961 -0.638 . . . . 1.72 112.835 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -52.3 -39.81 61.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.765 0.317 . . . . 1.73 111.316 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.539 ' ND1' ' HG3' ' A' ' 431' ' ' ARG . 6.1 p80 -57.09 -27.5 61.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 1.47 111.973 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.539 ' HG3' ' ND1' ' A' ' 430' ' ' HIS . 67.9 mtt-85 -78.51 -38.84 39.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.637 0.236 . . . . 2.84 111.637 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.763 HD13 HG22 ' A' ' 397' ' ' VAL . 51.9 mt -87.91 131.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.46 110.836 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.765 ' HB2' HD21 ' A' ' 439' ' ' LEU . 71.4 m -161.15 140.18 10.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.591 . . . . 0.53 111.089 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -60.19 -24.47 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.035 -0.53 . . . . 1.35 111.211 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.425 ' O ' ' HG ' ' A' ' 439' ' ' LEU . 24.0 t-20 -108.4 128.8 55.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.407 -0.36 . . . . 2.16 110.944 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . 0.555 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -83.3 -40.12 19.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.75 112.058 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -47.96 -40.59 22.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.43 -0.35 . . . . 1.34 111.386 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -70.64 -37.12 73.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 1.56 110.902 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.765 HD21 ' HB2' ' A' ' 433' ' ' SER . 84.1 mt -57.32 -84.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.942 -0.572 . . . . 1.12 111.778 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -172.07 40.6 0.17 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.527 -0.844 . . . . 1.36 112.885 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.93 143.54 0.06 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.802 -0.713 . . . . 1.83 112.861 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 C--N 1.332 -0.162 0 CA-C-O 120.756 0.312 . . . . 1.48 110.204 179.558 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.596 ' N ' ' HH ' ' A' ' 412' ' ' TYR . 68.0 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.733 0.301 . . . . 1.48 111.184 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -89.36 129.65 35.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.389 -0.369 . . . . 2.17 110.938 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 88.8 mt -95.56 -45.96 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.92 111.531 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 64.7 m -65.08 72.69 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.397 -0.82 . . . . 1.71 111.643 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.564 ' HG3' ' ND2' ' A' ' 378' ' ' ASN . 11.9 pt-20 -175.11 -33.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 1.92 110.781 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.564 ' ND2' ' HG3' ' A' ' 377' ' ' GLU . 0.1 OUTLIER -168.53 60.16 0.44 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.532 . . . . 2.14 111.582 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.06 -37.78 79.54 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.289 1.993 . . . . 0.85 111.543 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.8 -33.45 75.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.646 . . . . 1.21 110.881 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 86.0 tttt -51.44 134.52 28.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.104 -0.498 . . . . 1.66 111.294 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 38.3 mm -82.95 136.26 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.025 -0.534 . . . . 0.41 111.268 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.41 ' HB3' ' CG2' ' A' ' 432' ' ' ILE . 43.1 m-85 -114.41 143.94 44.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.554 -0.293 . . . . 0.63 110.452 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 5.3 m-85 -90.07 135.48 33.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.391 -0.368 . . . . 0.96 110.718 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.5 mp -118.7 130.47 73.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.4 -0.364 . . . . 0.49 110.984 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.59 ' HD2' ' O ' ' A' ' 439' ' ' LEU . 30.1 ttt85 -90.46 121.77 32.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.465 -0.334 . . . . 2.42 110.777 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -79.08 163.03 25.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.331 -0.395 . . . . 2.3 110.356 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -57.34 -42.62 82.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.628 0.251 . . . . 2.82 110.85 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -60.47 -16.84 40.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.186 0.517 . . . . 1.23 110.05 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 91.47 40.84 5.28 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.417 -0.81 . . . . 1.03 112.52 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 60.9 p -120.99 111.31 17.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.98 111.437 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.73 135.77 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.55 111.0 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -150.0 139.01 21.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 2.43 110.81 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -56.47 148.4 19.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.133 0.492 . . . . 2.96 111.788 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.41 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -171.48 128.01 1.52 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.461 -0.791 . . . . 0.26 111.769 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -81.63 128.62 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.849 0.357 . . . . 1.28 111.195 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.859 HG23 HG22 ' A' ' 414' ' ' VAL . 1.0 OUTLIER -101.32 126.0 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.772 -0.455 . . . . 0.83 109.772 178.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 50.7 mt -120.71 -34.46 3.57 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.674 0.62 . . . . 1.45 112.674 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 413' ' ' TYR . 70.4 mt-30 -118.97 166.97 12.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.038 0.447 . . . . 2.08 111.807 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.7 p -165.93 151.62 8.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.679 -0.691 . . . . 0.56 110.729 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -161.24 134.69 6.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.906 0.384 . . . . 1.55 111.314 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.584 ' O ' ' HG2' ' A' ' 409' ' ' PRO . 20.4 p -101.0 39.22 1.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 1.79 110.617 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.825 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.5 m 47.31 -174.32 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.618 -0.719 . . . . 1.95 111.004 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.825 ' H ' HG22 ' A' ' 403' ' ' THR . 0.4 OUTLIER -77.77 -40.54 40.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 3.87 110.992 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.32 -51.31 70.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.513 . . . . 3.16 111.276 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.471 ' C ' ' HD2' ' A' ' 409' ' ' PRO . . . 65.83 -175.08 0.18 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.993 0.425 . . . . 2.18 110.366 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . 62.35 11.35 4.49 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.605 -0.725 . . . . 2.77 112.05 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.558 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -168.74 -54.78 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.466 -0.334 . . . . 2.76 111.264 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.584 ' HG2' ' O ' ' A' ' 402' ' ' THR . 47.6 Cg_endo -68.02 148.55 75.98 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.478 2.119 . . . . 2.49 112.386 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.552 ' HB3' HG22 ' A' ' 402' ' ' THR . 40.0 p-10 -175.51 132.54 0.28 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.901 -0.59 . . . . 2.14 110.662 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 96.7 mt-10 -151.32 137.16 18.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 2.1 111.202 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.627 ' CE1' ' HG2' ' A' ' 429' ' ' ARG . 3.9 m-85 -117.09 128.73 55.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.72 111.727 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 20.0 t80 -64.05 135.82 56.75 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.953 -0.567 . . . . 0.51 109.986 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.859 HG22 HG23 ' A' ' 397' ' ' VAL . 60.4 t -129.28 139.5 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.813 0.671 . . . . 1.15 112.813 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -120.31 89.32 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.059 -0.973 . . . . 0.62 109.142 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.495 ' HD1' ' H ' ' A' ' 416' ' ' TYR . 7.3 m-85 -54.45 116.0 2.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.88 -0.6 . . . . 0.65 111.349 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 65.2 t -61.6 125.83 18.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.791 -0.641 . . . . 1.34 111.245 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.56 -43.44 1.85 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.745 -0.661 . . . . 0.82 113.101 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.602 ' HB3' HD22 ' A' ' 423' ' ' LEU . 7.6 mp -59.74 152.11 23.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.982 0.42 . . . . 1.6 111.389 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.403 ' HB2' HD13 ' A' ' 423' ' ' LEU . 63.1 m-80 -50.36 144.13 7.9 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.659 -0.7 . . . . 2.53 111.837 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -58.6 -34.87 71.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.603 -0.726 . . . . 3.98 111.45 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . 0.678 ' HG3' HD12 ' A' ' 423' ' ' LEU . 14.8 ptp180 -51.35 -37.07 45.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 3.71 111.635 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.678 HD12 ' HG3' ' A' ' 422' ' ' ARG . 10.6 mp -61.1 -33.95 74.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.5 -0.318 . . . . 1.49 111.106 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -48.87 138.25 11.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.241 -0.436 . . . . 1.2 111.068 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -176.17 -137.79 2.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.647 -0.787 . . . . 0.7 112.7 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 38.4 m95 -130.46 141.35 50.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.063 0.458 . . . . 0.61 110.905 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 429' ' ' ARG . 4.6 m -108.2 156.77 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.683 -0.689 . . . . 0.89 110.888 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -79.06 35.34 1.92 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.394 -0.908 . . . . 1.72 111.503 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.77 ' H ' HG23 ' A' ' 427' ' ' VAL . 0.6 OUTLIER 66.0 -73.24 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.003 0.521 . . . . 1.73 110.651 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -52.51 -18.33 1.65 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.514 -0.312 . . . . 1.47 111.664 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.458 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 64.5 mtt85 -78.73 28.57 0.21 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.6 0.238 . . . . 2.84 111.039 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.669 ' CD1' HG21 ' A' ' 427' ' ' VAL . 42.4 mt -150.27 138.8 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.82 0.343 . . . . 0.46 111.036 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 68.1 m -163.96 140.62 6.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.493 . . . . 0.53 110.785 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -55.59 -24.29 32.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 1.35 111.278 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -108.73 129.81 55.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.113 0.482 . . . . 2.16 111.034 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -74.24 -31.93 62.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.768 -0.651 . . . . 0.75 111.648 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -44.64 -77.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 1.34 111.735 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -47.37 -38.52 13.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 1.56 111.81 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.59 ' O ' ' HD2' ' A' ' 386' ' ' ARG . 96.4 mt -61.27 -42.45 98.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.882 0.327 . . . . 1.12 111.882 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . 0.41 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . 165.01 21.58 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.354 -0.927 . . . . 1.36 112.881 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 64.06 153.73 0.09 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.661 -0.78 . . . . 1.83 112.472 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 45.9 mm . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.646 0.26 . . . . 1.48 110.451 179.743 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.598 HD11 ' CZ ' ' A' ' 429' ' ' ARG . 75.9 mt . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 113.343 0.868 . . . . 1.48 113.343 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.78 129.76 36.13 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.329 -0.619 . . . . 2.17 109.329 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.6 mt -84.56 -40.87 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.62 0.6 . . . . 0.92 112.62 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.6 t -49.54 -17.76 0.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.016 0.436 . . . . 1.71 111.22 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -56.39 -43.73 79.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.516 -0.766 . . . . 1.92 111.495 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' A' ' 381' ' ' LYS . 0.1 OUTLIER -171.11 69.1 0.49 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 2.14 111.392 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.13 -40.05 60.37 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.418 2.079 . . . . 0.85 112.047 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -60.55 -36.33 78.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.511 . . . . 1.21 110.844 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 58.9 tttm -52.15 132.81 33.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.18 -0.464 . . . . 1.66 111.431 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 394' ' ' ARG . 43.2 mm -86.47 131.55 34.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.011 -0.541 . . . . 0.41 111.029 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -105.47 143.29 33.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.547 -0.297 . . . . 0.63 110.58 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.59 140.39 29.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.347 -0.388 . . . . 0.96 110.474 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.646 ' N ' HD12 ' A' ' 385' ' ' ILE . 0.9 OUTLIER -132.96 128.21 56.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.754 0.311 . . . . 0.49 111.026 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.697 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 36.7 ttt85 -86.01 121.57 28.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 2.42 110.797 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.405 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 61.7 mtp85 -72.93 159.14 34.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 2.3 110.659 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -55.03 -45.52 75.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.513 -0.312 . . . . 2.82 111.339 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -57.98 -29.08 64.96 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.262 -0.644 . . . . 1.23 109.262 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 111.03 37.26 1.7 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.3 -0.864 . . . . 1.03 113.267 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . 0.405 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 29.9 p -121.24 111.15 17.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.878 0.37 . . . . 0.98 111.562 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.13 137.89 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.027 -0.533 . . . . 0.55 111.011 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -150.57 139.64 21.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 2.43 110.957 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.408 ' HB3' HG21 ' A' ' 382' ' ' ILE . 88.3 mtm180 -56.63 147.56 22.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.815 -0.63 . . . . 2.96 111.474 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -164.98 128.43 1.79 Allowed Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.824 -0.626 . . . . 0.26 112.238 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -83.32 110.18 17.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.686 0.279 . . . . 1.28 111.503 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.6 OUTLIER -79.09 135.04 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.83 109.976 178.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 94.1 mt -120.24 -31.91 4.27 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.789 0.663 . . . . 1.45 112.789 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -140.19 175.3 9.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.071 0.462 . . . . 2.08 111.931 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.6 p -165.5 149.23 8.21 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.616 -0.72 . . . . 0.56 110.576 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 401' ' ' ARG . 14.5 ptt-85 -158.11 138.43 12.6 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.073 0.463 . . . . 1.55 111.923 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 47.2 p -75.29 139.44 42.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.948 -0.569 . . . . 1.79 110.276 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.864 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.5 m -61.76 -174.39 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.504 -0.316 . . . . 1.95 110.263 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.864 ' H ' HG22 ' A' ' 403' ' ' THR . 50.2 mt-10 -54.6 -45.76 73.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.666 0.269 . . . . 3.87 111.573 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -59.84 -47.39 85.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 3.16 110.864 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.573 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 64.11 -177.07 0.16 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.024 -0.534 . . . . 2.18 110.858 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . 63.22 11.2 5.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.395 -0.82 . . . . 2.77 112.134 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.552 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -170.84 -53.1 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.558 -0.292 . . . . 2.76 111.68 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.577 ' HB2' ' OG1' ' A' ' 403' ' ' THR . 65.4 Cg_endo -72.07 149.83 53.15 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.281 1.987 . . . . 2.49 112.036 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.471 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 5.1 p-10 -170.32 126.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.11 0.481 . . . . 2.14 111.493 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 400' ' ' SER . 64.8 mm-40 -109.81 134.68 51.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.496 -0.775 . . . . 2.1 110.319 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.495 ' HB2' HD12 ' A' ' 432' ' ' ILE . 2.6 m-85 -112.81 129.26 56.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.87 0.367 . . . . 0.72 111.872 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 26.0 t80 -69.19 129.74 40.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.899 -0.778 . . . . 0.51 108.899 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 425' ' ' GLY . 10.3 p -131.17 136.8 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.801 0.667 . . . . 1.15 112.801 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -114.75 89.8 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.019 -0.992 . . . . 0.62 109.582 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.556 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 35.2 m-85 -54.02 128.1 29.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.65 111.231 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 67.0 t -71.89 127.92 34.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.996 -0.547 . . . . 1.34 111.278 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.35 -37.14 1.56 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.841 -0.695 . . . . 0.82 113.261 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.514 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.9 mp -59.34 159.7 7.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.237 0.542 . . . . 1.6 111.809 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.776 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 5.6 m120 -51.07 140.55 15.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.179 -0.918 . . . . 2.53 111.821 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -60.36 -38.36 83.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 3.98 110.733 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -60.19 -38.44 83.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 3.71 110.991 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.776 ' HG ' ' HB2' ' A' ' 420' ' ' ASN . 90.0 mt -56.65 -31.17 64.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 1.49 110.978 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -52.13 134.5 32.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 1.2 111.182 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . 0.465 ' O ' HG12 ' A' ' 414' ' ' VAL . . . 177.04 176.52 45.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.042 -0.599 . . . . 0.7 112.369 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -75.2 140.44 43.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.005 0.431 . . . . 0.61 110.997 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.545 ' CG2' HD11 ' A' ' 432' ' ' ILE . 25.4 m -133.37 138.82 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 0.89 111.354 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -61.73 147.63 48.11 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.859 -0.686 . . . . 1.72 112.394 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.598 ' CZ ' HD11 ' A' ' 373' ' ' ILE . 23.2 tpt180 -51.49 -39.97 58.62 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.758 0.281 . . . . 1.73 111.758 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -53.31 -30.78 40.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.757 0.313 . . . . 1.47 111.466 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.427 HH11 ' HG2' ' A' ' 431' ' ' ARG . 68.0 mtt-85 -79.47 -35.05 40.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.154 -0.475 . . . . 2.84 111.569 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.572 HG12 HG13 ' A' ' 385' ' ' ILE . 53.6 mt -88.89 140.47 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.46 112.013 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 435' ' ' ASN . 66.8 m -159.89 139.9 11.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.675 -0.693 . . . . 0.53 110.413 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.76 16.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 1.35 111.773 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.449 ' H ' ' C ' ' A' ' 433' ' ' SER . 22.2 p30 -162.63 135.65 5.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.978 0.418 . . . . 2.16 111.055 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . 0.524 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -65.35 -32.07 73.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.75 111.639 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -49.73 -40.85 42.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 1.34 111.419 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -97.17 49.55 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.44 -0.346 . . . . 1.56 111.173 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 436' ' ' ALA . 95.6 mt -148.55 -84.53 0.1 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.38 -0.373 . . . . 1.12 111.286 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . 0.697 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -171.02 30.72 0.13 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.577 -0.821 . . . . 1.36 112.647 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 63.99 151.35 0.06 OUTLIER Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.743 -0.742 . . . . 1.83 112.543 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 44.8 mm . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.665 0.269 . . . . 1.48 110.464 179.575 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 70.5 mt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.805 0.336 . . . . 1.48 111.564 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.563 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 0.3 OUTLIER -93.95 130.58 39.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 2.17 110.503 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 375' ' ' ILE . 4.7 mp -88.29 -41.25 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.125 0.417 . . . . 0.92 112.125 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 82.1 p -47.46 -26.4 1.36 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.018 -0.537 . . . . 1.71 112.021 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.6 pt-20 -67.5 -39.23 85.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.197 -0.456 . . . . 1.92 111.898 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 5.6 m120 -151.87 67.31 7.11 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 112.095 0.406 . . . . 2.14 112.095 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.7 -41.1 63.48 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.734 2.289 . . . . 0.85 112.419 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.94 -38.28 85.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.973 -0.558 . . . . 1.21 111.324 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 87.4 tttt -48.91 127.12 13.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 1.66 111.075 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 44.3 mm -86.32 126.68 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.989 -0.55 . . . . 0.41 111.165 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -105.13 144.16 32.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.311 -0.404 . . . . 0.63 110.151 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.454 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 1.9 m-85 -89.88 137.32 32.44 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.929 -0.308 . . . . 0.96 110.543 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.671 HG12 HG21 ' A' ' 414' ' ' VAL . 2.7 mp -122.89 125.57 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.329 -0.396 . . . . 0.49 111.218 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.519 ' HE ' ' HA2' ' A' ' 390' ' ' GLY . 78.1 ttt180 -83.86 116.82 22.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 2.42 110.261 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.453 ' HB2' ' OD1' ' A' ' 389' ' ' ASP . 51.9 mtp85 -71.53 163.98 26.71 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.941 -0.304 . . . . 2.3 110.703 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 389' ' ' ASP . 11.5 pm0 -49.72 -39.76 38.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.309 -0.405 . . . . 2.82 111.214 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 387' ' ' ARG . 43.1 p-10 -65.87 -35.04 79.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 1.23 111.215 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.519 ' HA2' ' HE ' ' A' ' 386' ' ' ARG . . . 129.32 -31.31 3.47 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.718 -0.753 . . . . 1.03 112.539 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 71.3 p -59.36 113.09 2.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.096 0.474 . . . . 0.98 112.144 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 59.8 t -71.15 141.31 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.562 -0.745 . . . . 0.55 110.902 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -148.9 134.77 18.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.484 -0.325 . . . . 2.43 110.803 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.441 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 88.2 mtm180 -54.22 152.97 5.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.232 -0.44 . . . . 2.96 111.498 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -168.83 135.66 3.71 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.657 -0.701 . . . . 0.26 112.089 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -87.04 110.37 20.03 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.724 0.268 . . . . 1.28 111.724 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.628 ' CG2' HD13 ' A' ' 432' ' ' ILE . 11.6 t -77.94 128.01 38.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.765 -0.828 . . . . 0.83 108.765 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 58.2 mt -121.0 -38.27 2.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.011 0.745 . . . . 1.45 113.011 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.511 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 26.0 mt-30 -133.95 176.53 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 2.08 112.049 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.3 p -162.16 148.03 13.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.676 -0.693 . . . . 0.56 110.349 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -161.45 139.19 9.1 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.887 0.375 . . . . 1.55 111.536 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 67.3 p -73.4 -125.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 1.79 109.884 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.801 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.23 -173.52 3.16 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.77 -0.456 . . . . 1.95 109.77 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.801 ' H ' HG22 ' A' ' 403' ' ' THR . 55.6 mt-10 -46.11 -43.77 15.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.678 0.275 . . . . 3.87 111.275 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.554 HD21 ' HB3' ' A' ' 407' ' ' ALA . 47.7 t30 -67.72 -52.62 35.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 3.16 110.798 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 53.81 54.33 10.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.003 -0.544 . . . . 2.18 111.658 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.554 ' HB3' HD21 ' A' ' 405' ' ' ASN . . . -149.09 10.65 0.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.517 0.675 . . . . 2.77 109.755 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.573 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -179.46 -47.71 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.628 -1.169 . . . . 2.76 110.077 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 39.5 Cg_exo -57.53 146.79 82.36 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.509 2.139 . . . . 2.49 112.585 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.656 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.6 p30 -174.38 138.07 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 2.14 110.568 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.4 mt-10 -137.14 134.4 36.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 2.1 110.375 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 0.8 OUTLIER -109.93 125.7 53.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.855 0.359 . . . . 0.72 111.49 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.511 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 14.0 t80 -59.49 147.13 37.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.974 -0.557 . . . . 0.51 109.516 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.671 HG21 HG12 ' A' ' 385' ' ' ILE . 7.1 p -153.66 134.55 4.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.237 0.541 . . . . 1.15 112.055 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -120.24 101.85 8.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.455 -0.793 . . . . 0.62 109.902 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.492 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 50.1 m-85 -59.82 129.49 42.1 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.899 0.381 . . . . 0.65 110.681 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.83 37.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.887 -0.597 . . . . 1.34 111.109 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -175.47 -36.1 0.05 OUTLIER Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.254 -0.974 . . . . 0.82 113.851 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.681 HD13 HD23 ' A' ' 423' ' ' LEU . 13.0 mt -62.8 -167.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.729 0.776 . . . . 1.6 112.48 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.532 ' OD1' ' HG2' ' A' ' 422' ' ' ARG . 16.5 t-20 -81.29 149.85 28.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.55 -1.204 . . . . 2.53 111.025 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -59.47 -40.89 88.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.91 0.386 . . . . 3.98 110.779 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . 0.532 ' HG2' ' OD1' ' A' ' 420' ' ' ASN . 16.2 ptm180 -69.19 -34.9 75.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.048 -0.524 . . . . 3.71 110.851 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.681 HD23 HD13 ' A' ' 419' ' ' LEU . 1.3 mp -56.48 -34.94 67.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.875 -0.602 . . . . 1.49 111.201 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -59.09 137.6 57.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.077 -0.51 . . . . 1.2 110.757 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -170.52 -140.51 3.03 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.619 -0.8 . . . . 0.7 112.646 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -119.7 134.76 55.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.906 0.384 . . . . 0.61 110.81 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.641 HG11 HG21 ' A' ' 385' ' ' ILE . 31.5 m -109.47 155.27 10.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.987 -0.551 . . . . 0.89 111.758 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -74.11 25.27 1.04 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.918 -0.583 . . . . 1.72 113.951 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.543 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 36.2 tpt85 71.26 -46.32 0.64 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.68 0.622 . . . . 1.73 112.68 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -58.77 -19.86 44.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.944 0.402 . . . . 1.47 110.911 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.4 mtt180 -78.66 -30.32 46.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.813 -0.63 . . . . 2.84 111.464 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.628 HD13 ' CG2' ' A' ' 397' ' ' VAL . 66.8 mt -88.02 137.29 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 120.766 0.317 . . . . 0.46 110.728 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.437 ' HB2' HD21 ' A' ' 439' ' ' LEU . 57.9 m -160.18 139.73 11.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 0.53 111.075 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . 0.417 ' C ' HD22 ' A' ' 435' ' ' ASN . 51.3 p-10 -69.26 -23.48 63.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 1.35 111.472 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.417 HD22 ' C ' ' A' ' 434' ' ' ASP . 3.0 m120 -108.23 133.54 52.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.891 0.377 . . . . 2.16 111.129 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . 0.539 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -67.85 -43.9 78.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.75 111.366 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -54.92 -39.82 69.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 1.34 111.014 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.06 51.0 1.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 1.56 110.948 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 436' ' ' ALA . 82.3 mt -150.13 -93.51 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 1.12 111.106 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -177.02 48.05 0.1 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.609 -0.805 . . . . 1.36 112.746 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.28 132.07 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.83 -0.7 . . . . 1.83 112.848 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . 0.49 HD11 ' HB1' ' A' ' 436' ' ' ALA . 47.9 mm . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 110.247 -0.279 . . . . 1.48 110.247 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.532 HD11 HH11 ' A' ' 429' ' ' ARG . 66.8 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.845 0.355 . . . . 1.48 111.633 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.05 129.71 35.63 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.19 -0.459 . . . . 2.17 109.989 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 379' ' ' PRO . 90.0 mt -120.93 -43.19 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.079 0.4 . . . . 0.92 112.079 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.0 t -48.86 -30.35 5.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.044 0.449 . . . . 1.71 111.151 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.76 -36.61 36.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.752 -0.658 . . . . 1.92 111.8 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.469 HD22 ' C ' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -146.46 72.17 12.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.004 0.43 . . . . 2.14 111.439 -179.428 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . 0.508 ' HA ' HG23 ' A' ' 375' ' ' ILE . 21.5 Cg_endo -63.62 -36.42 53.13 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.105 1.87 . . . . 0.85 111.286 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -64.37 -31.29 72.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 1.21 110.823 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 62.5 tttm -49.31 130.77 19.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.074 -0.512 . . . . 1.66 111.424 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.5 HG21 ' HD2' ' A' ' 394' ' ' ARG . 33.2 mm -88.68 135.46 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.773 -0.649 . . . . 0.41 111.109 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -117.43 143.83 45.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.537 -0.301 . . . . 0.63 110.711 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.45 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 1.8 m-85 -89.14 147.03 24.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.841 0.353 . . . . 0.96 111.136 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.8 mp -132.22 131.68 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.49 110.741 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 42.2 ttt-85 -84.8 123.55 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.251 -0.431 . . . . 2.42 111.198 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -83.75 167.24 17.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.29 -0.414 . . . . 2.3 110.461 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 388' ' ' GLU . 0.5 OUTLIER -58.36 -42.7 87.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.506 -0.315 . . . . 2.82 111.082 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -69.86 5.13 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.403 . . . . 1.23 110.581 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 388' ' ' GLU . . . 70.76 42.71 61.06 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.902 -0.59 . . . . 1.03 112.955 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 82.5 p -120.62 111.47 17.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.958 0.408 . . . . 0.98 111.151 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 22.6 t -69.94 135.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.55 111.308 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -149.28 139.85 22.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 2.43 110.742 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.5 ' HD2' HG21 ' A' ' 382' ' ' ILE . 54.9 mtm-85 -56.03 157.8 4.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.318 0.58 . . . . 2.96 112.048 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -178.56 126.56 1.08 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.125 -0.943 . . . . 0.26 111.442 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -83.42 129.38 34.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.823 0.344 . . . . 1.28 111.791 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.756 HG22 HD13 ' A' ' 432' ' ' ILE . 8.5 t -88.9 134.69 27.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.51 -0.552 . . . . 0.83 109.51 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 78.0 mt -120.18 -38.51 2.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.568 0.581 . . . . 1.45 112.568 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -141.65 176.12 9.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.051 0.453 . . . . 2.08 111.809 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 97.4 p -155.62 149.66 25.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.604 -0.725 . . . . 0.56 110.176 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 18.4 ptt-85 -149.26 134.78 18.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.229 0.538 . . . . 1.55 112.246 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 409' ' ' PRO . 46.2 p -93.65 138.1 32.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.819 -0.628 . . . . 1.79 110.065 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.844 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.5 m -61.5 -174.65 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.655 -0.248 . . . . 1.95 110.47 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.844 ' H ' HG22 ' A' ' 403' ' ' THR . 55.9 mt-10 -53.72 -39.02 64.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.571 0.224 . . . . 3.87 111.565 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 407' ' ' ALA . 50.2 t30 -56.86 -49.66 74.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.423 -0.353 . . . . 3.16 110.988 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 54.12 52.9 11.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.221 -0.445 . . . . 2.18 111.494 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.463 ' HB3' ' ND2' ' A' ' 405' ' ' ASN . . . -156.5 10.83 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.844 -0.616 . . . . 2.77 110.141 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.588 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.19 -48.28 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.15 -0.932 . . . . 2.76 110.561 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 24.0 Cg_exo -63.75 140.02 71.97 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.589 2.192 . . . . 2.49 112.4 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.47 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 13.2 p-10 -173.82 122.63 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 2.14 110.988 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 400' ' ' SER . 9.1 mp0 -113.94 134.24 54.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 2.1 110.504 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.543 ' HB2' HD12 ' A' ' 432' ' ' ILE . 6.5 m-85 -109.57 125.15 52.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.72 111.575 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.765 ' HA ' ' HA ' ' A' ' 426' ' ' TRP . 14.0 t80 -60.9 139.74 57.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.51 110.234 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.539 HG21 HG12 ' A' ' 385' ' ' ILE . 13.0 p -133.96 137.73 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.218 0.532 . . . . 1.15 111.928 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -119.54 96.6 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.48 -0.782 . . . . 0.62 109.889 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.404 ' HB3' HD22 ' A' ' 419' ' ' LEU . 42.3 m-85 -58.99 124.6 20.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.65 111.024 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.79 128.54 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.911 -0.586 . . . . 1.34 111.396 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 78.17 -40.64 1.94 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.896 -0.668 . . . . 0.82 113.072 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 419' ' ' LEU . 7.5 mp -59.34 153.87 17.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.982 0.42 . . . . 1.6 111.28 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.746 HD21 HD13 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -49.31 142.22 7.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.722 -0.672 . . . . 2.53 112.143 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 421' ' ' ARG . 45.1 mmm-85 -60.81 -36.7 79.7 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.463 -0.79 . . . . 3.98 111.96 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . 0.58 HH11 HD12 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -53.64 -29.0 36.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.907 0.385 . . . . 3.71 110.761 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.746 HD13 HD21 ' A' ' 420' ' ' ASN . 1.1 tp -63.2 -33.32 75.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 1.49 111.303 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -44.94 133.61 6.23 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.181 -0.463 . . . . 1.2 111.4 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . 0.463 ' O ' HG12 ' A' ' 414' ' ' VAL . . . 174.36 154.59 11.05 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.793 -0.64 . . . . 0.7 112.053 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 11.4 m95 -68.75 134.03 49.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.61 110.296 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.468 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 35.6 m -127.05 142.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.89 111.245 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -52.24 147.42 13.15 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.026 -0.607 . . . . 1.72 112.912 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.532 HH11 HD11 ' A' ' 373' ' ' ILE . 14.6 tpt180 -52.01 -42.03 62.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.633 0.254 . . . . 1.73 111.429 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.432 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 13.4 p-80 -56.58 -25.88 53.83 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.968 0.359 . . . . 1.47 111.968 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 56.4 mtt85 -77.89 -40.59 39.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.692 -0.231 . . . . 2.84 111.532 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.756 HD13 HG22 ' A' ' 397' ' ' VAL . 59.7 mt -88.79 136.54 23.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.914 0.388 . . . . 0.46 110.948 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 67.3 m -161.4 139.7 9.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.953 -0.567 . . . . 0.53 110.743 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -76.73 16.13 0.55 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 1.35 111.181 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -134.59 116.01 14.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.409 -0.359 . . . . 2.16 110.734 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.33 98.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.031 -0.531 . . . . 0.75 111.595 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -57.04 -40.87 77.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 1.34 111.13 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 439' ' ' LEU . 59.0 m-20 -83.16 45.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 1.56 111.011 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 438' ' ' ASP . 47.6 mt -154.58 -41.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.22 -0.446 . . . . 1.12 111.011 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 157.81 40.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.701 -0.761 . . . . 1.36 112.132 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.418 ' O ' HD13 ' A' ' 442' ' ' ILE . . . 62.58 -128.89 41.68 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.629 -0.796 . . . . 1.83 112.103 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . 0.418 HD13 ' O ' ' A' ' 441' ' ' GLY . 44.8 mm . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 121.106 0.479 . . . . 1.48 110.447 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 72.5 mt . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 113.069 0.766 . . . . 1.48 113.069 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -138.99 132.73 30.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.491 -0.777 . . . . 2.17 109.852 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 82.7 mt -78.2 -40.9 26.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.089 0.403 . . . . 0.92 112.089 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 88.1 p -47.91 -21.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.278 0.561 . . . . 1.71 110.851 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -58.11 -47.63 82.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.192 -0.913 . . . . 1.92 110.949 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.615 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 7.5 m120 -165.25 111.26 0.81 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.799 -0.637 . . . . 2.14 111.29 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.3 -41.04 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.932 2.422 . . . . 0.85 112.22 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.99 -32.37 61.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.993 -0.548 . . . . 1.21 111.666 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.2 tttp -46.35 129.31 10.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.973 0.416 . . . . 1.66 111.556 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 50.0 mm -87.75 126.13 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.894 -0.594 . . . . 0.41 111.276 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -99.58 143.1 30.21 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.098 -0.334 . . . . 0.63 110.098 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.499 ' C ' HD12 ' A' ' 385' ' ' ILE . 29.4 m-85 -92.73 136.25 33.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.96 111.292 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.651 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.5 mp -116.21 129.58 72.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.078 -0.51 . . . . 0.49 110.757 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.794 ' HB2' HD22 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -97.48 110.26 22.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 2.42 110.232 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.444 ' O ' ' HD3' ' A' ' 386' ' ' ARG . 76.6 mtp180 -77.74 158.82 29.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.501 -0.318 . . . . 2.3 110.983 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -54.15 -41.52 68.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.485 -0.325 . . . . 2.82 111.449 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.406 ' OD1' ' HB2' ' A' ' 387' ' ' ARG . 54.2 p-10 -60.46 -10.12 4.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.938 0.399 . . . . 1.23 110.788 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.578 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 83.88 36.04 14.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.931 -0.577 . . . . 1.03 112.424 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 73.1 p -121.07 111.72 17.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.31 . . . . 0.98 111.146 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.53 134.24 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.55 110.537 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -142.63 135.93 28.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.941 0.401 . . . . 2.43 110.751 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.448 ' HG3' HH11 ' A' ' 394' ' ' ARG . 54.4 mtm-85 -56.64 146.48 25.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 2.96 111.293 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -164.12 129.88 2.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.615 -0.72 . . . . 0.26 112.065 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -88.36 105.07 17.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.739 0.304 . . . . 1.28 111.379 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.5 OUTLIER -71.09 129.78 34.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.964 -0.384 . . . . 0.83 109.964 178.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 81.3 mt -121.0 -34.32 3.55 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 112.686 0.624 . . . . 1.45 112.686 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.511 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 74.2 mt-30 -129.18 175.46 8.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.036 0.446 . . . . 2.08 111.918 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 99.4 p -166.53 148.56 6.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.612 -0.722 . . . . 0.56 110.63 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 37.9 ptt180 -155.76 134.57 11.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.769 0.319 . . . . 1.55 110.941 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 65.2 p -72.38 -132.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.575 -0.284 . . . . 1.79 110.533 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.764 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.2 m -162.84 -173.6 3.56 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.854 -0.424 . . . . 1.95 109.854 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.764 ' H ' HG22 ' A' ' 403' ' ' THR . 67.2 mm-40 -44.55 -38.83 4.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.759 0.314 . . . . 3.87 111.172 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 407' ' ' ALA . 25.1 t-20 -65.66 -53.08 46.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 3.16 110.73 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 54.85 61.99 2.72 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.184 -0.462 . . . . 2.18 111.895 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.502 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -165.07 2.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 2.77 110.708 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.621 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -175.71 -49.97 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.529 -0.76 . . . . 2.76 110.853 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 27.3 Cg_exo -61.72 143.0 95.95 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.332 2.022 . . . . 2.49 112.056 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.594 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.6 p30 -179.84 131.92 0.1 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.234 0.54 . . . . 2.14 112.054 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 400' ' ' SER . 49.8 mp0 -109.47 135.82 49.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.516 -0.765 . . . . 2.1 109.297 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 400' ' ' SER . 0.4 OUTLIER -109.33 126.35 53.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.942 0.401 . . . . 0.72 111.61 -178.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 19.8 t80 -62.42 135.83 57.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.51 109.673 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.617 HG21 HD11 ' A' ' 385' ' ' ILE . 14.6 p -139.93 137.71 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.333 0.587 . . . . 1.15 112.563 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -112.23 97.4 6.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.197 -0.91 . . . . 0.62 109.762 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.512 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 7.8 m-85 -57.09 127.13 30.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 0.65 111.133 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.98 129.4 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.037 -0.529 . . . . 1.34 111.042 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.53 -43.28 2.08 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.828 -0.701 . . . . 0.82 112.897 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 419' ' ' LEU . 7.5 mp -59.91 155.47 16.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.887 0.375 . . . . 1.6 111.196 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -51.21 140.57 16.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 2.53 110.727 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 22.8 ptt-85 -62.31 -37.43 85.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.443 . . . . 3.98 110.362 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -55.66 -40.37 72.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.519 -0.764 . . . . 3.71 110.704 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . . . . . . . . . 48.4 mt -62.57 -35.53 79.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.914 -0.584 . . . . 1.49 110.575 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 416' ' ' TYR . 9.1 m-20 -64.94 138.17 58.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.58 -0.736 . . . . 1.2 111.623 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.89 -151.26 9.16 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.702 -0.681 . . . . 0.7 111.909 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -83.29 137.27 34.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.61 110.76 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.623 ' CG1' HD11 ' A' ' 432' ' ' ILE . 1.9 p -127.23 139.8 50.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.89 111.724 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -64.87 147.4 50.98 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.688 -0.687 . . . . 1.72 112.578 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 45.3 tpt85 -52.7 -39.24 61.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 1.73 111.355 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -64.47 -27.97 69.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.453 0.538 . . . . 1.47 112.453 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.589 ' HB2' ' CG2' ' A' ' 427' ' ' VAL . 61.3 mtt-85 -78.56 -30.02 46.6 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.176 0.436 . . . . 2.84 112.176 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.623 HD11 ' CG1' ' A' ' 427' ' ' VAL . 65.1 mt -87.8 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.043 0.449 . . . . 0.46 111.795 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.415 ' HB2' HD11 ' A' ' 439' ' ' LEU . 56.7 m -161.57 139.41 9.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.531 -0.759 . . . . 0.53 110.27 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -74.67 16.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 1.35 111.927 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.566 HD22 ' HB2' ' A' ' 437' ' ' ASP . 16.3 p-10 -159.61 136.33 9.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.049 0.452 . . . . 2.16 111.321 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -65.52 -31.88 73.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.707 -0.679 . . . . 0.75 111.586 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . 0.566 ' HB2' HD22 ' A' ' 435' ' ' ASN . 31.6 m-20 -49.37 -41.06 38.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.296 -0.411 . . . . 1.34 111.256 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . 0.4 ' CG ' HD21 ' A' ' 435' ' ' ASN . 39.8 m-20 -97.98 43.01 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 1.56 110.649 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.794 HD22 ' HB2' ' A' ' 386' ' ' ARG . 96.7 mt -150.52 -84.02 0.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.113 -0.494 . . . . 1.12 110.993 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -173.89 41.23 0.14 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.087 -0.578 . . . . 1.36 112.065 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 61.26 -138.71 47.48 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.881 -0.676 . . . . 1.83 112.459 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 36.3 mm . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 121.227 0.537 . . . . 1.48 110.354 179.702 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.605 HD11 HH11 ' A' ' 429' ' ' ARG . 42.0 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.225 0.536 . . . . 1.48 111.635 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.707 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 57.5 m-20 -150.08 69.0 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.393 -0.821 . . . . 2.17 109.91 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.862 HD11 HG12 ' A' ' 397' ' ' VAL . 60.7 mt -45.48 -35.84 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.542 -0.754 . . . . 0.92 112.431 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 41.9 t -45.84 -35.87 4.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.433 0.531 . . . . 1.71 112.433 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 16.9 pt-20 -79.13 -36.99 39.68 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.11 0.411 . . . . 1.92 112.11 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.691 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 6.8 m120 -145.58 83.49 8.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 112.353 0.501 . . . . 2.14 112.353 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . 0.441 ' HA ' HG23 ' A' ' 375' ' ' ILE . 37.3 Cg_exo -63.95 -41.21 24.12 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.022 2.481 . . . . 0.85 112.875 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.413 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 1.5 m-20 -74.77 -31.97 61.92 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.162 0.431 . . . . 1.21 112.162 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.691 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 87.9 tttt -41.1 129.73 2.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.014 0.435 . . . . 1.66 111.213 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.594 HG21 ' HD3' ' A' ' 394' ' ' ARG . 48.9 mm -83.09 132.69 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.686 -0.688 . . . . 0.41 111.96 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -113.21 143.42 44.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.036 -0.529 . . . . 0.63 109.72 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.524 ' HB3' HG11 ' A' ' 392' ' ' VAL . 27.1 m-85 -93.7 130.51 39.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.673 0.273 . . . . 0.96 111.029 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.668 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.1 mp -117.5 131.03 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.361 -0.382 . . . . 0.49 110.945 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.665 ' N ' HD23 ' A' ' 439' ' ' LEU . 55.4 ttp180 -84.7 124.02 31.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.582 -0.281 . . . . 2.42 110.997 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -73.17 -174.97 1.7 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.799 0.333 . . . . 2.3 110.654 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -67.31 -45.3 76.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 2.82 111.177 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -70.73 -36.1 73.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 1.23 111.8 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 141.35 -33.09 2.02 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.436 -0.888 . . . . 1.03 112.764 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 41.4 p -59.05 112.82 1.82 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.302 0.572 . . . . 0.98 111.611 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.524 HG11 ' HB3' ' A' ' 384' ' ' PHE . 46.6 t -78.98 131.03 35.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.328 -0.851 . . . . 0.55 111.853 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -122.79 138.33 54.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.99 -0.55 . . . . 2.43 110.401 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.594 ' HD3' HG21 ' A' ' 382' ' ' ILE . 64.9 mtt85 -58.73 153.62 16.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.144 0.497 . . . . 2.96 111.988 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -174.37 132.39 2.23 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.501 -0.772 . . . . 0.26 111.828 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 72.1 mt-30 -91.35 129.97 37.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.92 0.36 . . . . 1.28 111.752 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.862 HG12 HD11 ' A' ' 375' ' ' ILE . 16.0 t -84.64 136.08 23.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.821 -0.437 . . . . 0.83 109.821 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.24 -46.58 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.116 0.413 . . . . 1.45 112.116 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.419 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 96.0 mm-40 -125.58 175.71 7.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 2.08 111.82 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 81.0 p -165.47 145.33 6.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.457 -0.792 . . . . 0.56 110.304 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 20.3 ptt-85 -145.64 136.66 24.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.052 0.453 . . . . 1.55 111.528 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.702 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 17.9 p -102.06 37.41 1.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.821 -0.627 . . . . 1.79 111.044 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.881 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.2 m 49.29 -173.33 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.178 -0.465 . . . . 1.95 110.659 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.881 ' H ' HG22 ' A' ' 403' ' ' THR . 59.1 mm-40 -65.08 -40.97 95.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 3.87 111.164 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.459 ' HB2' ' HG3' ' A' ' 409' ' ' PRO . 19.9 m-20 -57.08 -55.16 38.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 3.16 112.053 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.702 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 55.92 41.51 29.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.369 0.604 . . . . 2.18 109.813 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.402 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -139.54 10.14 2.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.041 -0.981 . . . . 2.77 110.03 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.643 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -179.9 -50.05 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.005 -0.998 . . . . 2.76 110.16 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 20.4 Cg_endo -59.9 147.57 92.12 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.451 2.1 . . . . 2.49 112.138 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.549 ' HB3' HG22 ' A' ' 402' ' ' THR . 12.1 p-10 -176.85 134.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.424 . . . . 2.14 110.982 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 400' ' ' SER . 51.4 mt-10 -145.93 134.2 21.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 2.1 110.006 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -112.52 128.88 56.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.969 0.414 . . . . 0.72 111.739 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.566 ' O ' HG13 ' A' ' 397' ' ' VAL . 24.5 t80 -67.78 150.37 48.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.93 -0.577 . . . . 0.51 109.769 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.664 HG21 HG12 ' A' ' 385' ' ' ILE . 8.9 p -148.03 137.72 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.175 0.512 . . . . 1.15 112.081 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -115.67 101.14 8.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.62 110.312 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.575 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 2.4 m-85 -63.44 124.41 21.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.437 -0.347 . . . . 0.65 110.62 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.413 ' O ' HD23 ' A' ' 419' ' ' LEU . 91.5 t -74.98 128.36 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 1.34 110.985 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.88 -40.92 1.67 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.895 -0.669 . . . . 0.82 112.905 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 2.8 mm? -59.27 157.53 10.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.229 0.538 . . . . 1.6 111.987 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.592 ' HB2' HD13 ' A' ' 423' ' ' LEU . 4.0 m120 -52.45 147.19 8.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.129 -0.941 . . . . 2.53 111.795 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -61.54 -38.18 86.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.944 -0.571 . . . . 3.98 110.56 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 64.0 mtt-85 -54.51 -39.51 67.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.943 -0.571 . . . . 3.71 109.94 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 420' ' ' ASN . 5.3 mp -63.56 -35.66 81.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.18 -0.918 . . . . 1.49 110.321 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 416' ' ' TYR . 15.2 m-20 -65.88 133.31 50.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.54 -0.755 . . . . 1.2 111.269 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 173.98 -152.92 15.82 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.915 -0.66 . . . . 0.7 112.178 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -96.32 139.81 31.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.854 0.359 . . . . 0.61 110.964 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.463 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 17.8 m -143.15 144.67 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.89 110.991 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -58.89 151.09 34.64 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.832 -0.699 . . . . 1.72 112.425 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.605 HH11 HD11 ' A' ' 373' ' ' ILE . 21.5 tpt180 -51.45 -40.16 58.86 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.769 0.285 . . . . 1.73 111.769 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -51.62 -30.95 23.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.644 0.259 . . . . 1.47 111.426 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.63 ' O ' HD21 ' A' ' 439' ' ' LEU . 99.0 mtt180 -80.16 -38.66 30.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 2.84 111.969 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.805 HD13 HG22 ' A' ' 397' ' ' VAL . 77.5 mt -88.1 132.15 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.648 -0.421 . . . . 0.46 110.749 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.529 ' HB2' HD11 ' A' ' 439' ' ' LEU . 75.7 m -163.42 143.43 8.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.797 -0.638 . . . . 0.53 111.157 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.06 16.46 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 1.35 111.224 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.82 HD21 ' HB2' ' A' ' 437' ' ' ASP . 52.6 t30 -152.12 132.49 13.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.969 0.414 . . . . 2.16 110.651 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' A' ' 441' ' ' GLY . . . -79.21 -34.99 42.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.913 -0.585 . . . . 0.75 112.546 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . 0.82 ' HB2' HD21 ' A' ' 435' ' ' ASN . 1.5 m-20 -48.96 -40.45 30.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.67 0.271 . . . . 1.34 111.499 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.96 -33.69 75.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 1.56 111.084 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 386' ' ' ARG . 7.3 mp -85.34 -86.37 0.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.85 -0.614 . . . . 1.12 112.554 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -167.51 52.92 0.23 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.482 -0.866 . . . . 1.36 113.045 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.604 ' O ' ' HB1' ' A' ' 436' ' ' ALA . . . 71.53 -148.35 43.55 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.831 -0.7 . . . . 1.83 112.748 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 49.2 mm . . . . . 0 C--N 1.328 -0.334 0 N-CA-C 110.427 -0.212 . . . . 1.48 110.427 179.582 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.604 HG12 ' CZ ' ' A' ' 429' ' ' ARG . 47.9 mm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.974 0.416 . . . . 1.48 111.892 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.654 ' HB3' ' HG3' ' A' ' 377' ' ' GLU . 1.5 m-20 -90.07 140.95 29.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.833 -0.621 . . . . 2.17 110.44 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.529 HG22 ' N ' ' A' ' 376' ' ' SER . 68.8 mt -111.65 -80.29 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.481 0.549 . . . . 0.92 112.481 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.529 ' N ' HG22 ' A' ' 375' ' ' ILE . 45.4 t -52.42 -22.48 4.76 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.438 0.637 . . . . 1.71 110.818 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.654 ' HG3' ' HB3' ' A' ' 374' ' ' ASP . 21.8 mm-40 -62.48 -39.54 93.76 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.901 -1.045 . . . . 1.92 111.138 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.414 ' C ' HD22 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -155.5 64.13 3.91 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.529 . . . . 2.14 111.109 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -51.31 -40.26 61.74 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.48 2.12 . . . . 0.85 112.273 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -60.02 -36.69 77.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.084 -0.507 . . . . 1.21 110.933 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -54.57 130.09 38.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.064 -0.517 . . . . 1.66 111.358 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.506 HG21 ' HD2' ' A' ' 394' ' ' ARG . 46.6 mm -87.54 136.58 22.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.116 -0.493 . . . . 0.41 110.664 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.414 ' HD1' ' HA ' ' A' ' 396' ' ' GLN . 12.1 m-85 -110.72 144.0 40.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.738 0.304 . . . . 0.63 110.784 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.503 ' C ' HD12 ' A' ' 385' ' ' ILE . 3.3 m-85 -92.62 132.78 36.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.96 110.884 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.719 HG12 HG11 ' A' ' 414' ' ' VAL . 2.3 mp -114.06 123.38 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.29 -0.414 . . . . 0.49 111.023 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.566 ' HD2' ' O ' ' A' ' 387' ' ' ARG . 4.8 tmm_? -92.34 110.27 21.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 2.42 110.273 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.602 ' HG2' ' NH2' ' A' ' 431' ' ' ARG . 70.7 mtp180 -73.81 153.55 39.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.288 -0.414 . . . . 2.3 110.857 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 390' ' ' GLY . 49.5 mt-10 -54.15 -41.31 68.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 2.82 111.685 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -66.7 5.21 0.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.093 0.473 . . . . 1.23 110.633 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 388' ' ' GLU . . . 74.94 35.4 50.23 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.494 -0.775 . . . . 1.03 113.707 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 49.2 p -121.44 110.73 16.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.98 111.19 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 442' ' ' ILE . 51.6 t -73.86 140.69 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.55 111.384 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -150.6 136.59 18.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.936 -0.574 . . . . 2.43 110.43 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.506 ' HD2' HG21 ' A' ' 382' ' ' ILE . 69.9 mtm-85 -56.77 152.88 11.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.058 0.456 . . . . 2.96 112.019 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -173.39 134.97 3.08 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.572 -0.74 . . . . 0.26 112.096 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . 0.414 ' HA ' ' HD1' ' A' ' 383' ' ' TYR . 89.6 mt-30 -95.37 129.56 42.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.726 0.298 . . . . 1.28 111.476 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.724 HG22 HD13 ' A' ' 432' ' ' ILE . 13.2 t -89.09 128.69 41.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.363 -0.381 . . . . 0.83 110.323 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.409 ' HB2' ' HD2' ' A' ' 413' ' ' TYR . 89.6 mt -121.29 -40.03 2.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.096 0.406 . . . . 1.45 112.096 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.56 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 66.1 mt-30 -127.38 175.74 7.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.073 0.463 . . . . 2.08 111.936 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 95.7 p -165.51 148.74 7.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.592 -0.731 . . . . 0.56 110.152 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -163.45 135.69 5.16 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.036 0.446 . . . . 1.55 112.065 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 41.1 p -74.78 139.76 43.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 1.79 109.786 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.84 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.6 m -61.21 -174.84 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.281 -0.266 . . . . 1.95 110.281 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.84 ' H ' HG22 ' A' ' 403' ' ' THR . 7.5 mp0 -50.3 -40.31 48.16 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.744 0.276 . . . . 3.87 111.744 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.558 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 49.3 t30 -56.91 -49.39 75.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 3.16 110.8 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.588 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.28 55.18 8.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 2.18 111.466 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.476 ' HB3' ' ND2' ' A' ' 405' ' ' ASN . . . -158.7 9.77 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 2.77 110.16 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.6 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.38 -48.66 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.039 -0.982 . . . . 2.76 110.209 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 20.2 Cg_exo -65.26 144.69 81.75 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.579 2.186 . . . . 2.49 112.512 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.1 p30 -169.48 129.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 2.14 110.542 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.9 mt-10 -115.87 134.65 54.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.971 -0.559 . . . . 2.1 110.797 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.427 ' HB3' HG13 ' A' ' 397' ' ' VAL . 1.6 m-85 -109.24 123.55 49.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 0.72 110.626 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.56 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 17.1 t80 -56.16 143.09 34.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.502 . . . . 0.51 110.206 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.719 HG11 HG12 ' A' ' 385' ' ' ILE . 28.6 t -136.41 136.91 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.152 0.501 . . . . 1.15 111.823 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -117.25 90.57 3.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.641 -0.709 . . . . 0.62 110.083 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.456 ' HD1' ' H ' ' A' ' 416' ' ' TYR . 4.1 m-85 -59.76 115.63 3.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.65 110.724 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.74 130.99 29.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.0 -0.545 . . . . 1.34 111.008 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.13 -45.71 2.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.894 -0.67 . . . . 0.82 112.574 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 419' ' ' LEU . 7.3 mp -61.43 143.56 55.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.957 0.408 . . . . 1.6 111.121 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.577 HD22 ' HB3' ' A' ' 422' ' ' ARG . 53.1 t30 -56.25 161.49 2.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.862 -0.608 . . . . 2.53 111.327 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -59.96 -29.03 68.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.035 -0.53 . . . . 3.98 110.803 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . 0.577 ' HB3' HD22 ' A' ' 420' ' ' ASN . 12.5 tpt180 -53.43 -39.39 64.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.72 -0.673 . . . . 3.71 111.305 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.613 HD22 ' H ' ' A' ' 423' ' ' LEU . 2.2 mm? -69.75 -35.63 75.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.232 -0.44 . . . . 1.49 110.529 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -60.51 138.41 58.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.85 -0.614 . . . . 1.2 111.089 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -173.3 -137.94 2.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.861 -0.685 . . . . 0.7 112.475 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 37.9 m95 -128.93 132.88 47.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.61 110.916 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.691 HG21 HG13 ' A' ' 432' ' ' ILE . 34.0 m -115.64 150.34 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 0.89 111.011 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -74.3 32.7 0.96 Allowed Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.807 -0.711 . . . . 1.72 113.681 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.604 ' CZ ' HG12 ' A' ' 373' ' ' ILE . 42.2 tpt85 71.55 -45.65 0.62 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.705 0.632 . . . . 1.73 112.705 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.529 ' CE1' ' HG3' ' A' ' 431' ' ' ARG . 8.7 p80 -54.62 -22.79 14.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.823 0.305 . . . . 1.47 111.823 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.602 ' NH2' ' HG2' ' A' ' 387' ' ' ARG . 75.2 mtp180 -79.44 -31.7 42.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.256 0.465 . . . . 2.84 112.256 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.724 HD13 HG22 ' A' ' 397' ' ' VAL . 57.6 mt -87.49 136.85 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.849 0.357 . . . . 0.46 111.333 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 63.7 m -158.7 140.65 13.77 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.98 -0.554 . . . . 0.53 110.938 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -74.75 16.85 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.002 -0.544 . . . . 1.35 112.084 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.78 HD21 ' HB2' ' A' ' 437' ' ' ASP . 53.5 t30 -155.64 132.05 10.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 2.16 111.203 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -73.55 -41.19 63.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.854 -0.612 . . . . 0.75 112.178 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . 0.78 ' HB2' HD21 ' A' ' 435' ' ' ASN . 54.0 m-20 -49.03 -40.5 31.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.503 -0.317 . . . . 1.34 111.391 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -65.37 -44.36 87.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 1.56 110.946 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 386' ' ' ARG . 68.0 mt -62.97 -83.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.227 -0.442 . . . . 1.12 111.179 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -157.98 32.03 0.51 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.489 -0.862 . . . . 1.36 112.825 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 48.98 40.99 28.45 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.924 -0.655 . . . . 1.83 112.515 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . 0.46 ' HA ' ' HB ' ' A' ' 392' ' ' VAL . 45.6 mm . . . . . 0 C--N 1.325 -0.464 0 N-CA-C 110.178 -0.305 . . . . 1.48 110.178 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.514 ' HB ' HH12 ' A' ' 429' ' ' ARG . 86.4 mt . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 120.93 0.395 . . . . 1.48 111.836 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.06 129.72 44.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.87 -0.605 . . . . 2.17 110.041 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.451 HD13 ' C ' ' A' ' 398' ' ' LEU . 82.9 mt -68.32 -45.24 82.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.493 -0.321 . . . . 0.92 111.842 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 69.0 m -70.15 62.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.692 -0.685 . . . . 1.71 110.848 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -147.52 -33.71 0.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.737 -0.665 . . . . 1.92 110.0 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -173.0 65.7 0.34 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.132 -0.94 . . . . 2.14 110.959 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.6 -38.44 55.04 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.457 2.104 . . . . 0.85 111.859 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.04 -36.99 83.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 1.21 110.593 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -51.64 140.45 18.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.016 -0.538 . . . . 1.66 110.844 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.583 HG21 ' HD2' ' A' ' 394' ' ' ARG . 49.8 mm -86.23 128.89 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.41 111.537 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -105.28 144.76 31.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.63 110.378 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.604 ' CD2' HD11 ' A' ' 442' ' ' ILE . 1.8 m-30 -90.5 133.5 35.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.446 -0.343 . . . . 0.96 110.633 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 385' ' ' ILE . 3.0 mp -128.94 128.98 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.799 0.333 . . . . 0.49 111.145 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 58.1 ttt-85 -92.73 123.24 35.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 2.42 111.193 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -71.05 158.16 36.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.367 -0.379 . . . . 2.3 110.162 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -49.53 -35.59 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 2.82 110.828 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.97 -36.24 69.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 1.23 111.666 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.535 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 135.99 -35.17 2.17 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.378 -0.915 . . . . 1.03 113.126 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 68.7 p -58.67 112.36 1.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 0.98 112.207 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.39 144.92 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.186 -0.916 . . . . 0.55 111.225 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -150.48 139.74 21.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.161 -0.472 . . . . 2.43 110.959 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.583 ' HD2' HG21 ' A' ' 382' ' ' ILE . 66.2 mtm-85 -60.07 151.29 27.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.87 -0.605 . . . . 2.96 112.168 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -169.62 135.13 3.43 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.434 -0.803 . . . . 0.26 111.823 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -91.97 111.57 23.16 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.304 0.483 . . . . 1.28 112.304 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.747 HG22 HD13 ' A' ' 432' ' ' ILE . 24.4 t -76.43 132.87 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.483 -0.326 . . . . 0.83 110.383 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.451 ' C ' HD13 ' A' ' 375' ' ' ILE . 96.0 mt -121.33 -42.92 2.43 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.735 0.643 . . . . 1.45 112.735 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.548 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 97.5 mm-40 -129.18 177.46 7.14 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.212 0.53 . . . . 2.08 112.208 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.0 p -153.35 157.3 39.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.454 -0.794 . . . . 0.56 110.043 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 33.2 ptt180 -154.09 137.09 15.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.08 0.467 . . . . 1.55 112.258 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 409' ' ' PRO . 36.4 p -96.31 136.07 37.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 1.79 110.036 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.839 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.6 m -62.75 -174.52 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.469 -0.332 . . . . 1.95 110.622 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.839 ' H ' HG22 ' A' ' 403' ' ' THR . 64.9 mm-40 -53.13 -40.07 63.95 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.721 0.267 . . . . 3.87 111.721 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.72 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 26.0 t-20 -55.95 -51.01 69.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 3.16 110.994 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 53.49 55.96 7.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.079 0.466 . . . . 2.18 111.89 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.554 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -160.55 10.86 0.1 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.727 -0.669 . . . . 2.77 109.456 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.594 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.64 -48.06 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.611 -1.177 . . . . 2.76 110.213 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.72 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 38.2 Cg_exo -61.04 138.14 76.5 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.736 2.291 . . . . 2.49 112.701 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 13.6 p-10 -173.39 123.31 0.38 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.909 -0.587 . . . . 2.14 111.09 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 400' ' ' SER . 58.3 mp0 -112.51 142.34 45.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.774 -0.648 . . . . 2.1 110.284 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.714 ' HB2' HD12 ' A' ' 432' ' ' ILE . 1.2 m-85 -109.03 124.17 50.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.019 0.438 . . . . 0.72 111.804 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.548 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 18.8 t80 -62.19 150.16 39.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.722 -0.672 . . . . 0.51 109.409 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.442 HG21 HG12 ' A' ' 385' ' ' ILE . 7.3 p -150.92 132.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.286 0.565 . . . . 1.15 112.193 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -110.74 90.98 3.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.268 -0.878 . . . . 0.62 109.596 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.525 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 14.3 m-85 -53.03 135.68 36.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.094 0.473 . . . . 0.65 111.25 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 418' ' ' GLY . 17.6 t -63.67 -124.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.454 -0.794 . . . . 1.34 111.417 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.563 ' N ' HG12 ' A' ' 417' ' ' VAL . . . -39.7 -29.41 0.16 Allowed Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.248 0.459 . . . . 0.82 114.248 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.664 ' HB3' HD23 ' A' ' 423' ' ' LEU . 7.1 mp -58.79 141.31 53.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.244 0.522 . . . . 1.6 110.955 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.431 ' HB3' ' HG2' ' A' ' 422' ' ' ARG . 49.2 t30 -55.42 154.89 5.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.966 -0.561 . . . . 2.53 111.286 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 68.5 mtt-85 -53.35 -29.81 36.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.663 -0.699 . . . . 3.98 112.152 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . 0.582 ' HG3' HD13 ' A' ' 423' ' ' LEU . 16.8 ptm180 -52.65 -40.7 63.08 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.956 0.354 . . . . 3.71 111.956 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.664 HD23 ' HB3' ' A' ' 419' ' ' LEU . 1.1 mm? -71.05 -35.09 71.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.713 0.292 . . . . 1.49 111.028 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.27 130.51 46.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 1.2 111.427 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.67 -145.67 9.19 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.7 112.012 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -100.36 140.22 34.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.61 110.946 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.454 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 28.5 m -140.26 145.72 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.89 110.971 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -59.83 147.55 43.54 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.914 -0.584 . . . . 1.72 113.361 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.514 HH12 ' HB ' ' A' ' 373' ' ' ILE . 15.4 tpt180 -50.93 -38.92 53.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.654 0.381 . . . . 1.73 111.72 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.439 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 24.8 p-80 -57.87 -28.83 64.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.092 0.404 . . . . 1.47 112.092 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.8 mtt180 -78.35 -38.62 41.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.993 0.368 . . . . 2.84 111.993 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.747 HD13 HG22 ' A' ' 397' ' ' VAL . 60.1 mt -88.01 133.27 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.898 0.38 . . . . 0.46 110.893 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.745 ' HB2' HD11 ' A' ' 439' ' ' LEU . 58.0 m -165.11 145.71 7.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.736 -0.665 . . . . 0.53 110.806 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . 0.493 ' H ' HD11 ' A' ' 373' ' ' ILE . 52.0 p-10 -71.28 16.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 1.35 111.911 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 433' ' ' SER . 20.7 p30 -165.8 133.93 3.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 2.16 111.095 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . 0.492 ' HB2' ' HD2' ' A' ' 384' ' ' PHE . . . -68.66 -13.27 62.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 0.75 111.949 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.41 -41.08 72.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.686 0.279 . . . . 1.34 111.363 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.47 -6.46 58.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 1.56 111.48 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.5 mp -96.68 -93.28 0.22 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.245 -0.434 . . . . 1.12 111.598 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -171.56 38.27 0.17 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.776 -0.726 . . . . 1.36 112.485 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.98 138.84 0.05 OUTLIER Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.865 -0.683 . . . . 1.83 112.812 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . 0.604 HD11 ' CD2' ' A' ' 384' ' ' PHE . 43.2 mm . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 109.126 -0.694 . . . . 1.48 109.126 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.434 HG13 ' HE ' ' A' ' 429' ' ' ARG . 68.1 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.814 0.34 . . . . 1.48 110.767 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.534 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 0.9 OUTLIER -88.21 69.86 9.2 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.152 -0.476 . . . . 2.17 110.859 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 377' ' ' GLU . 61.7 mt -45.86 -44.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.92 111.709 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 73.1 m -63.1 73.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 1.71 111.559 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.4 pt-20 -173.97 -31.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 1.92 110.482 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.49 HD22 ' C ' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -152.99 58.16 2.3 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.53 . . . . 2.14 111.606 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 50.3 Cg_exo -53.03 -37.6 79.1 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.283 1.989 . . . . 0.85 111.504 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.1 -34.19 75.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.7 -0.682 . . . . 1.21 110.695 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -53.38 123.22 11.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.191 -0.458 . . . . 1.66 110.784 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 417' ' ' VAL . 45.8 mm -84.91 128.92 38.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 0.41 111.38 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -106.93 143.38 35.11 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.069 -0.345 . . . . 0.63 110.069 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.76 ' HB2' HD11 ' A' ' 439' ' ' LEU . 5.2 m-85 -89.78 139.35 30.66 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.807 -0.357 . . . . 0.96 110.192 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.726 HG12 HG21 ' A' ' 414' ' ' VAL . 2.6 mp -115.25 129.51 71.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.255 -0.429 . . . . 0.49 111.829 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.76 ' CZ ' HG23 ' A' ' 392' ' ' VAL . 5.2 tpm_? -88.25 90.14 8.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.865 -0.607 . . . . 2.42 110.176 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.616 ' HA ' ' NH2' ' A' ' 431' ' ' ARG . 58.1 mtp85 -55.88 153.6 8.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.725 0.297 . . . . 2.3 110.816 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.76 -44.76 77.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.212 -0.449 . . . . 2.82 111.318 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -58.27 -14.86 8.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.263 0.554 . . . . 1.23 109.749 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 91.66 39.77 5.49 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.176 -0.92 . . . . 1.03 112.561 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . 0.46 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 70.8 p -121.91 110.19 15.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.591 0.234 . . . . 0.98 110.917 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.76 HG23 ' CZ ' ' A' ' 386' ' ' ARG . 63.4 t -70.97 132.71 32.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.628 0.252 . . . . 0.55 110.348 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -151.31 135.35 16.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.893 0.378 . . . . 2.43 110.582 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.445 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 71.2 mtt-85 -52.85 151.8 4.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.862 -0.608 . . . . 2.96 112.135 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -170.16 131.51 2.26 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.204 -0.907 . . . . 0.26 111.411 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . 0.413 ' HG2' HD13 ' A' ' 382' ' ' ILE . 80.1 mt-30 -87.14 128.97 35.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.769 0.318 . . . . 1.28 111.734 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.838 HG22 HD13 ' A' ' 432' ' ' ILE . 8.7 t -89.71 132.95 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.462 -0.57 . . . . 0.83 109.462 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 68.2 mt -120.34 -37.32 3.06 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.51 0.559 . . . . 1.45 112.51 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -139.46 175.96 9.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.479 . . . . 2.08 112.13 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.5 p -163.85 149.44 10.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.577 -0.738 . . . . 0.56 110.344 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -158.05 136.85 11.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.869 0.366 . . . . 1.55 111.5 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 63.1 p -77.65 -128.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.356 -0.384 . . . . 1.79 109.969 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.72 HG22 ' H ' ' A' ' 404' ' ' GLU . 0.5 OUTLIER -164.84 -173.41 2.96 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 110.214 -0.291 . . . . 1.95 110.214 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.72 ' H ' HG22 ' A' ' 403' ' ' THR . 94.7 mt-10 -44.9 -45.21 10.22 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.659 0.266 . . . . 3.87 111.588 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.531 HD21 ' HB3' ' A' ' 407' ' ' ALA . 49.6 t30 -66.75 -51.45 55.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.529 -0.305 . . . . 3.16 110.953 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 52.97 52.92 12.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.131 0.491 . . . . 2.18 111.469 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.531 ' HB3' HD21 ' A' ' 405' ' ' ASN . . . -150.66 10.75 0.65 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.694 -0.684 . . . . 2.77 109.688 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.562 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.48 -47.6 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 114.585 -1.189 . . . . 2.76 110.055 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 31.9 Cg_exo -58.8 143.59 99.0 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.463 2.108 . . . . 2.49 112.447 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.64 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 42.5 p-10 -176.26 136.07 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.796 -0.638 . . . . 2.14 110.804 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.5 mt-10 -130.96 134.18 46.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 2.1 110.342 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 2.4 m-85 -112.32 127.48 56.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.377 . . . . 0.72 111.671 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -64.76 144.78 57.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.437 -0.579 . . . . 0.51 109.437 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.726 HG21 HG12 ' A' ' 385' ' ' ILE . 6.4 p -143.99 129.83 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.43 0.633 . . . . 1.15 112.625 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -111.86 89.22 3.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.929 -1.032 . . . . 0.62 109.123 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.547 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 30.0 m-85 -52.49 115.6 1.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 0.65 110.941 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.634 HG21 HD12 ' A' ' 382' ' ' ILE . 62.1 t -62.47 130.13 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.853 -0.612 . . . . 1.34 110.875 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.81 -42.6 2.5 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.98 -0.628 . . . . 0.82 112.798 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.527 ' HB3' HD22 ' A' ' 423' ' ' LEU . 2.7 mm? -59.6 159.43 8.45 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.92 0.39 . . . . 1.6 111.668 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 69.1 m-20 -53.83 142.86 22.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.79 -0.641 . . . . 2.53 111.383 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -60.73 -36.65 79.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 3.98 111.196 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -56.37 -32.15 64.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.355 -0.384 . . . . 3.71 111.0 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 419' ' ' LEU . 1.1 tp -56.4 -29.78 61.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 1.49 111.351 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.57 140.23 11.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.085 0.469 . . . . 1.2 111.824 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -174.82 -149.83 7.43 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.681 -0.691 . . . . 0.7 112.097 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -127.46 133.08 49.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.61 110.808 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.838 HG21 HG13 ' A' ' 432' ' ' ILE . 5.1 m -109.43 153.17 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.955 -0.566 . . . . 0.89 111.049 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -76.97 29.98 1.57 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.434 -0.888 . . . . 1.72 112.455 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.764 ' H ' HG23 ' A' ' 427' ' ' VAL . 39.2 tpt85 71.88 -37.41 0.39 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.181 0.437 . . . . 1.73 112.181 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -58.83 -27.36 65.04 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.712 0.264 . . . . 1.47 111.712 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.616 ' NH2' ' HA ' ' A' ' 387' ' ' ARG . 81.2 mtp180 -78.56 -38.37 40.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.958 0.355 . . . . 2.84 111.958 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.838 HD13 HG22 ' A' ' 397' ' ' VAL . 73.2 mt -88.44 131.41 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 0.46 110.37 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 49.0 m -154.87 139.6 17.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.006 0.432 . . . . 0.53 111.631 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.41 -25.4 67.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.615 . . . . 1.35 110.349 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.732 HD21 ' HB2' ' A' ' 437' ' ' ASP . 48.4 t30 -108.56 134.13 51.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.837 -0.619 . . . . 2.16 110.286 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -69.26 -42.91 74.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.023 -0.535 . . . . 0.75 112.298 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . 0.732 ' HB2' HD21 ' A' ' 435' ' ' ASN . 54.4 m-20 -57.63 -40.54 79.45 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.584 0.216 . . . . 1.34 111.584 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -56.3 -35.06 67.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 1.56 110.471 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 384' ' ' PHE . 86.4 mt -57.29 -82.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.775 -0.648 . . . . 1.12 111.184 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . 0.529 ' HA3' HH11 ' A' ' 386' ' ' ARG . . . -168.35 -27.98 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.05 -0.595 . . . . 1.36 112.138 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 154.44 143.08 3.59 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.104 -0.57 . . . . 1.83 112.117 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 44.7 mm . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.989 0.423 . . . . 1.48 110.884 179.771 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.695 0.283 . . . . 1.48 110.76 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.75 128.94 35.64 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 116.265 -0.425 . . . . 2.17 110.727 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.69 HD11 HG12 ' A' ' 397' ' ' VAL . 95.7 mt -91.74 -33.83 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.145 -0.48 . . . . 0.92 110.901 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.4 t -72.05 62.36 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.042 -0.526 . . . . 1.71 111.057 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -168.24 -26.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.695 -0.684 . . . . 1.92 109.874 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.645 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 3.5 m120 -156.63 62.41 2.86 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.347 -0.842 . . . . 2.14 111.517 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 79.0 Cg_exo -52.68 -41.21 70.69 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.998 2.465 . . . . 0.85 112.8 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -70.01 -32.85 71.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.226 -0.443 . . . . 1.21 111.78 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.645 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.0 tttm -44.52 127.09 5.8 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.931 0.396 . . . . 1.66 110.967 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.695 HD12 HG21 ' A' ' 417' ' ' VAL . 41.0 mm -86.91 127.07 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.41 111.406 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -107.72 144.0 35.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 0.63 110.004 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.457 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 3.9 m-85 -91.29 138.27 31.72 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.081 -0.247 . . . . 0.96 110.833 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.8 mp -121.37 126.99 75.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.449 -0.341 . . . . 0.49 110.87 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 38.4 ttt85 -91.57 122.53 34.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 2.42 111.032 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -83.23 172.19 12.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.744 0.307 . . . . 2.3 110.695 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -53.05 -71.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 2.82 111.045 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -40.99 -31.64 0.19 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.068 0.461 . . . . 1.23 110.565 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 111.14 39.48 1.38 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.795 -0.639 . . . . 1.03 112.986 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 39.7 p -114.02 111.04 21.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.95 0.405 . . . . 0.98 110.976 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 439' ' ' LEU . 46.1 t -72.53 140.74 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.55 111.39 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -148.14 134.34 19.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.582 . . . . 2.43 110.42 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.584 ' HD2' HG21 ' A' ' 382' ' ' ILE . 83.0 mtm180 -58.43 150.37 22.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.074 0.464 . . . . 2.96 111.94 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -172.73 132.05 2.27 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.638 -0.71 . . . . 0.26 112.254 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -91.72 111.61 23.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.577 0.227 . . . . 1.28 111.607 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.715 HG22 HD13 ' A' ' 432' ' ' ILE . 8.7 t -66.49 134.12 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.927 -0.397 . . . . 0.83 109.927 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 91.6 mt -119.07 -44.49 2.6 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.907 0.336 . . . . 1.45 111.907 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.555 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 84.0 mt-30 -124.5 174.33 7.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.991 0.424 . . . . 2.08 111.645 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 87.7 p -165.88 144.95 6.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.78 -0.645 . . . . 0.56 110.351 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.503 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 41.2 ptt180 -156.97 134.89 10.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.003 0.43 . . . . 1.55 111.448 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 14.1 p -85.99 38.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.942 -0.572 . . . . 1.79 111.041 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.841 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.8 m 51.75 -173.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.545 -0.298 . . . . 1.95 110.272 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.841 ' H ' HG22 ' A' ' 403' ' ' THR . 8.4 mp0 -54.87 -49.52 70.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.721 0.296 . . . . 3.87 110.631 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.661 HD21 ' HB3' ' A' ' 407' ' ' ALA . 41.8 t30 -87.21 115.09 24.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.302 -0.408 . . . . 3.16 110.727 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -94.91 51.84 1.41 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.832 0.349 . . . . 2.18 111.293 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.661 ' HB3' HD21 ' A' ' 405' ' ' ASN . . . -124.98 -11.52 7.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 2.77 111.215 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.635 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -161.84 -50.48 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.868 -0.606 . . . . 2.76 111.107 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 72.1 Cg_exo -50.17 152.06 8.43 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.498 2.132 . . . . 2.49 112.621 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 44.0 p-10 -175.74 137.22 0.34 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.093 -0.503 . . . . 2.14 111.134 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -150.16 135.9 18.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 2.1 110.497 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.746 ' HB2' HD12 ' A' ' 432' ' ' ILE . 2.1 m-85 -115.66 126.48 54.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.45 -0.341 . . . . 0.72 111.358 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 426' ' ' TRP . 12.8 t80 -65.78 142.78 57.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.195 -0.457 . . . . 0.51 110.32 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.637 HG22 HD11 ' A' ' 432' ' ' ILE . 20.1 t -128.33 136.87 58.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 112.546 0.573 . . . . 1.15 112.546 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -120.88 89.87 3.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.62 109.943 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.617 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 50.0 m-85 -56.5 129.25 39.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.65 111.19 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.695 HG21 HD12 ' A' ' 382' ' ' ILE . 2.8 t -82.98 34.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.782 -0.644 . . . . 1.34 111.259 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -178.4 -41.44 0.07 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.455 -0.879 . . . . 0.82 113.103 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.617 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 2.2 mm? -59.77 156.77 13.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.84 0.352 . . . . 1.6 111.081 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -49.72 144.55 6.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.021 -0.536 . . . . 2.53 111.77 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -56.83 -39.4 74.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.88 -0.6 . . . . 3.98 111.092 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 41.4 ptt85 -62.26 -32.15 72.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.895 0.378 . . . . 3.71 110.702 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.67 -32.38 72.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.974 -0.557 . . . . 1.49 111.056 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -48.16 129.1 14.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.301 -0.409 . . . . 1.2 110.448 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.95 165.59 35.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.53 -0.843 . . . . 0.7 112.487 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 8.3 m95 -74.42 128.49 35.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.739 0.304 . . . . 0.61 110.496 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.467 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 4.4 m -119.89 152.68 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.89 110.819 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -56.87 148.59 31.55 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.954 -0.641 . . . . 1.72 112.825 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -50.2 -42.16 50.97 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.567 0.347 . . . . 1.73 111.844 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.444 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 22.2 p-80 -54.81 -28.54 50.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.289 0.477 . . . . 1.47 112.289 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.3 mtt180 -78.59 -38.3 40.36 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.601 0.593 . . . . 2.84 112.601 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.746 HD12 ' HB2' ' A' ' 412' ' ' TYR . 68.8 mt -88.6 130.65 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 120.601 -0.44 . . . . 0.46 111.009 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.758 ' HB2' HD11 ' A' ' 439' ' ' LEU . 44.6 m -168.11 140.42 3.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.837 -0.62 . . . . 0.53 110.949 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -66.02 -15.53 63.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.015 -0.539 . . . . 1.35 111.278 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.469 ' O ' HD13 ' A' ' 439' ' ' LEU . 5.8 m120 -108.48 130.9 55.25 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.841 0.353 . . . . 2.16 110.851 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 441' ' ' GLY . . . -74.74 -34.75 62.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.75 112.03 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.03 -40.56 67.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.425 -0.352 . . . . 1.34 111.641 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 435' ' ' ASN . 61.9 m-20 -64.11 -21.21 66.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 1.56 111.369 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.758 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.7 mp -93.94 -88.65 0.23 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.097 -0.501 . . . . 1.12 111.917 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . 0.521 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -164.43 49.92 0.29 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.021 -0.609 . . . . 1.36 112.157 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.475 ' O ' ' HB1' ' A' ' 436' ' ' ALA . . . 69.19 -129.61 23.49 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.59 -0.814 . . . . 1.83 112.375 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . 0.426 HD13 ' O ' ' A' ' 441' ' ' GLY . 43.3 mm . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 120.829 0.347 . . . . 1.48 110.651 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.678 HG12 ' CZ ' ' A' ' 429' ' ' ARG . 49.5 mm . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.888 0.375 . . . . 1.48 111.939 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -102.59 130.87 49.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.902 -0.59 . . . . 2.17 109.996 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 77.5 mt -81.22 -42.28 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.42 0.526 . . . . 0.92 112.42 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 41.5 t -47.93 -22.75 0.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.137 0.494 . . . . 1.71 111.308 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -54.77 -47.67 73.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.408 -0.815 . . . . 1.92 111.118 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 379' ' ' PRO . 8.2 m120 -167.06 112.9 0.67 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.833 -0.621 . . . . 2.14 110.979 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 378' ' ' ASN . 12.2 Cg_exo -71.5 -41.05 2.56 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.826 2.35 . . . . 0.85 112.699 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.407 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 55.3 m-20 -80.94 -34.24 33.39 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.125 0.417 . . . . 1.21 112.125 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 86.4 tttt -44.82 124.98 4.69 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.765 0.317 . . . . 1.66 111.413 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.96 HD12 HG21 ' A' ' 417' ' ' VAL . 11.4 mm -77.99 131.05 35.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.132 -0.486 . . . . 0.41 111.854 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -111.35 144.15 41.0 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.781 -0.452 . . . . 0.63 109.781 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.425 ' C ' HD12 ' A' ' 385' ' ' ILE . 46.9 m-85 -89.69 134.74 34.0 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.852 -0.339 . . . . 0.96 110.899 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.6 mp -119.47 132.86 68.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.262 -0.426 . . . . 0.49 110.899 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.626 ' N ' HD23 ' A' ' 439' ' ' LEU . 50.3 ttt-85 -93.92 115.78 28.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.672 0.272 . . . . 2.42 110.819 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -76.56 157.04 32.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.524 -0.307 . . . . 2.3 110.554 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -53.9 -44.95 70.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.581 -0.281 . . . . 2.82 111.086 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -54.9 -27.35 42.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.253 0.549 . . . . 1.23 109.597 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 103.13 38.5 2.86 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.34 -0.845 . . . . 1.03 113.183 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 69.1 p -121.07 112.15 18.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.98 111.455 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.33 132.28 33.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.55 110.351 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -146.5 135.89 22.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.021 0.439 . . . . 2.43 111.22 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.541 ' HD3' HG21 ' A' ' 382' ' ' ILE . 74.0 mtt-85 -53.84 153.67 4.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.722 -0.672 . . . . 2.96 111.875 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 415' ' ' HIS . . . -179.59 130.74 1.55 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.763 -0.653 . . . . 0.26 112.192 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 75.5 mt-30 -91.82 134.11 35.04 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.99 0.395 . . . . 1.28 111.885 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.873 HG22 HD13 ' A' ' 432' ' ' ILE . 5.2 t -87.4 133.28 30.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.23 -0.441 . . . . 0.83 110.722 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 85.0 mt -121.16 -46.75 2.29 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.075 0.398 . . . . 1.45 112.075 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.555 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 13.5 mm100 -127.07 176.84 7.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.916 0.389 . . . . 2.08 111.647 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 87.9 p -162.42 139.56 8.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.79 -0.641 . . . . 0.56 110.92 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.677 ' O ' ' HD3' ' A' ' 401' ' ' ARG . 0.1 OUTLIER -148.39 138.64 22.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 1.55 110.906 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.742 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 13.9 m -103.33 42.25 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 1.79 110.096 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.9 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.5 m 51.27 -173.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.736 -0.665 . . . . 1.95 110.648 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.9 ' H ' HG22 ' A' ' 403' ' ' THR . 95.6 mt-10 -63.98 -37.16 86.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 3.87 110.69 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.681 ' HB2' ' HG2' ' A' ' 409' ' ' PRO . 5.1 m120 -56.25 -51.99 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.598 . . . . 3.16 111.442 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.648 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.33 56.43 5.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 2.18 110.863 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -161.9 -3.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 2.77 111.04 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.553 ' H ' ' CD ' ' A' ' 409' ' ' PRO . . . -169.54 -44.54 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.71 -0.677 . . . . 2.76 111.649 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.681 ' HG2' ' HB2' ' A' ' 405' ' ' ASN . 15.7 Cg_exo -69.79 47.85 0.59 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.825 2.35 . . . . 2.49 113.87 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.742 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 47.2 p-10 -68.59 143.84 54.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.908 0.385 . . . . 2.14 110.893 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 50.6 mt-10 -148.72 146.69 28.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.016 -0.538 . . . . 2.1 110.423 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -127.06 125.28 41.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.913 0.387 . . . . 0.72 111.688 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.555 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 20.2 t80 -63.47 149.99 44.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.045 -0.724 . . . . 0.51 109.045 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.542 HG21 HG12 ' A' ' 385' ' ' ILE . 7.8 p -158.83 133.32 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.016 0.747 . . . . 1.15 113.016 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . 0.578 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 76.2 t60 -105.06 106.24 16.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.03 -0.987 . . . . 0.62 109.167 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 2.1 m-85 -62.19 100.63 0.18 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.55 0.691 . . . . 0.65 109.939 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.96 HG21 HD12 ' A' ' 382' ' ' ILE . 44.2 t -48.63 123.74 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.555 -1.202 . . . . 1.34 111.75 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 83.07 -33.37 2.91 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.183 -0.917 . . . . 0.82 113.409 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.657 ' HB3' HD12 ' A' ' 423' ' ' LEU . 8.9 mt -68.23 -173.6 0.42 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.42 0.629 . . . . 1.6 112.456 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.739 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 5.2 m120 -74.3 145.85 43.62 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 114.961 -1.018 . . . . 2.53 111.053 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.464 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 45.1 mtp85 -65.21 -39.24 92.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.22 -0.446 . . . . 3.98 111.348 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -57.44 -35.71 70.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.742 0.306 . . . . 3.71 111.122 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.739 ' HG ' ' HB2' ' A' ' 420' ' ' ASN . 85.4 mt -56.94 -33.94 67.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 1.49 111.191 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.578 ' OD1' ' HA ' ' A' ' 415' ' ' HIS . 39.8 m-20 -52.94 141.87 20.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.521 . . . . 1.2 111.759 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -171.85 -142.06 3.59 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.644 -0.707 . . . . 0.7 111.954 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -124.29 138.07 54.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.018 0.437 . . . . 0.61 110.715 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.829 HG21 HG13 ' A' ' 432' ' ' ILE . 15.7 m -109.08 158.58 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.925 -0.58 . . . . 0.89 111.844 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -81.61 39.98 2.57 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.882 -0.675 . . . . 1.72 113.009 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.678 ' CZ ' HG12 ' A' ' 373' ' ' ILE . 38.4 tpt85 68.56 -72.4 0.1 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.492 0.553 . . . . 1.73 112.492 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -47.2 -15.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 1.47 113.053 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.564 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 99.5 mtt180 -78.29 -35.55 47.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.723 0.268 . . . . 2.84 111.723 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 397' ' ' VAL . 97.4 mt -88.45 132.23 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.46 111.16 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.683 ' HB2' HD11 ' A' ' 439' ' ' LEU . 75.0 m -166.06 139.29 4.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.855 -0.611 . . . . 0.53 110.779 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -61.86 -23.15 66.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 1.35 111.095 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.446 ' HB2' ' OD2' ' A' ' 438' ' ' ASP . 80.3 m-20 -108.44 131.69 54.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.916 0.389 . . . . 2.16 110.909 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -75.82 -31.96 59.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.75 111.915 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.66 -40.55 62.95 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.453 -0.34 . . . . 1.34 111.462 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . 0.446 ' OD2' ' HB2' ' A' ' 435' ' ' ASN . 57.6 m-20 -61.96 -23.6 66.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 1.56 111.091 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.5 mp -91.61 -84.63 0.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.82 -0.627 . . . . 1.12 112.313 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -158.81 57.02 0.34 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.462 -0.875 . . . . 1.36 112.995 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.68 -129.03 30.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.636 -0.793 . . . . 1.83 112.841 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 46.2 mm . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.395 0.14 . . . . 1.48 110.912 -179.529 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 76.4 mt . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 121.17 0.51 . . . . 1.48 111.905 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 42.7 m-20 -89.47 77.36 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.833 -0.621 . . . . 2.17 110.923 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.4 mt -48.36 -41.2 10.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 0.92 111.648 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 77.9 p -64.94 76.14 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.545 . . . . 1.71 111.687 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 16.2 pt-20 -174.69 -27.62 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.862 -0.608 . . . . 1.92 110.242 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.598 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 3.5 m120 -156.14 62.3 2.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.691 -0.686 . . . . 2.14 112.235 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.14 -40.97 75.36 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.778 2.319 . . . . 0.85 112.542 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -70.86 -34.41 71.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.041 -0.527 . . . . 1.21 111.722 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 86.2 tttt -43.03 129.73 4.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.981 0.42 . . . . 1.66 111.028 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.508 HG21 ' HD2' ' A' ' 394' ' ' ARG . 46.8 mm -81.64 123.26 37.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.854 -0.612 . . . . 0.41 111.448 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -102.02 143.41 31.9 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.922 -0.399 . . . . 0.63 109.922 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.84 139.2 30.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.587 -0.279 . . . . 0.96 110.798 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.601 ' N ' HD12 ' A' ' 385' ' ' ILE . 1.7 mp -131.94 133.45 60.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.69 0.281 . . . . 0.49 111.168 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.634 ' CZ ' ' HA3' ' A' ' 440' ' ' GLY . 8.1 tpt180 -90.41 121.71 32.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 2.42 110.585 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -74.53 164.22 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 2.3 110.556 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 388' ' ' GLU . 8.7 mp0 -61.3 -45.32 94.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.335 -0.393 . . . . 2.82 110.825 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -61.47 -12.88 16.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.133 0.492 . . . . 1.23 110.058 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.453 ' C ' ' HE ' ' A' ' 386' ' ' ARG . . . 90.78 41.78 5.26 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.409 -0.814 . . . . 1.03 112.53 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 82.8 p -121.35 112.64 18.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.679 0.276 . . . . 0.98 111.352 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 59.4 t -68.43 134.2 30.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 0.55 110.711 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -149.65 137.63 20.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 2.43 110.989 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.508 ' HD2' HG21 ' A' ' 382' ' ' ILE . 77.9 mtm180 -60.79 152.53 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 2.96 111.531 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -171.01 126.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.771 -0.65 . . . . 0.26 112.295 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 57.0 mt-30 -78.8 130.15 35.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.724 0.297 . . . . 1.28 111.514 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.7 OUTLIER -98.85 126.87 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.61 -0.515 . . . . 0.83 109.61 178.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.708 HD22 ' N ' ' A' ' 398' ' ' LEU . 0.4 OUTLIER -115.05 -47.21 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.534 0.568 . . . . 1.45 112.534 -177.215 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.426 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 24.2 mt-30 -127.71 176.41 7.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 2.08 111.726 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 84.7 p -165.47 141.93 5.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.784 -0.644 . . . . 0.56 110.967 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.491 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 41.0 ptt180 -142.88 135.23 27.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.346 -0.388 . . . . 1.55 110.772 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.69 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 24.9 p -81.92 40.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 1.79 112.159 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.8 m 50.58 -173.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.506 -0.183 . . . . 1.95 110.506 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.88 ' H ' HG22 ' A' ' 403' ' ' THR . 48.6 mt-10 -56.73 -50.02 73.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.321 . . . . 3.87 110.446 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -83.73 117.85 23.51 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.296 -0.411 . . . . 3.16 110.613 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -101.43 76.68 1.71 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.964 0.411 . . . . 2.18 111.326 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -160.68 10.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 2.77 110.65 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.696 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.52 -51.61 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.609 -0.723 . . . . 2.76 110.903 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 49.9 Cg_exo -57.07 154.11 35.16 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.689 2.259 . . . . 2.49 113.028 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.69 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 44.2 p-10 -178.62 130.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.852 -0.613 . . . . 2.14 111.081 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 400' ' ' SER . 58.9 mp0 -136.85 135.28 37.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.85 -0.614 . . . . 2.1 109.933 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 412' ' ' TYR . 0.4 OUTLIER -110.91 130.17 55.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 0.72 111.897 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 14.6 t80 -65.03 141.62 58.7 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.516 -0.92 . . . . 0.51 108.516 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 6.4 p -147.72 110.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.608 0.966 . . . . 1.15 113.608 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -86.44 90.94 8.37 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.531 -0.759 . . . . 0.62 109.344 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 424' ' ' ASP . 35.6 m-85 -52.84 128.71 27.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.055 0.455 . . . . 0.65 111.394 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 86.2 t -73.2 127.81 35.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.748 -0.66 . . . . 1.34 111.166 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.34 -44.91 2.25 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.985 -0.626 . . . . 0.82 113.022 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.525 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.7 mp -59.7 148.98 32.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.861 0.362 . . . . 1.6 111.204 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -54.47 137.72 42.01 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.948 -0.569 . . . . 2.53 111.798 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -32.31 50.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.655 -0.702 . . . . 3.98 111.368 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . 0.58 HH11 HD23 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -54.79 -38.85 67.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 3.71 110.52 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.58 HD23 HH11 ' A' ' 422' ' ' ARG . 96.5 mt -65.55 -35.44 80.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.019 0.438 . . . . 1.49 110.54 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.432 ' HA ' ' CD1' ' A' ' 416' ' ' TYR . 16.8 m-20 -54.84 138.32 43.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.654 -0.703 . . . . 1.2 111.602 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -179.46 -141.68 4.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.715 -0.675 . . . . 0.7 111.938 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . 0.491 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 53.4 m95 -106.2 140.28 39.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.61 110.695 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.538 ' CG2' HD11 ' A' ' 432' ' ' ILE . 17.1 m -132.88 141.73 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.89 111.953 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -64.99 150.96 51.66 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.855 -0.611 . . . . 1.72 112.525 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.407 ' HD3' ' CZ ' ' A' ' 412' ' ' TYR . 41.0 tpt85 -51.74 -38.28 54.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.771 0.319 . . . . 1.73 111.269 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.574 ' ND1' ' HG3' ' A' ' 431' ' ' ARG . 6.4 p80 -60.19 -28.96 68.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.44 0.533 . . . . 1.47 112.44 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.574 ' HG3' ' ND1' ' A' ' 430' ' ' HIS . 72.1 mtt-85 -78.23 -35.62 48.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.52 0.2 . . . . 2.84 111.537 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.545 HG12 HG13 ' A' ' 385' ' ' ILE . 66.3 mt -88.67 139.7 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.138 0.494 . . . . 0.46 111.869 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.9 m -163.39 139.17 6.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.5 -0.773 . . . . 0.53 110.327 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -75.83 16.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 1.35 111.359 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 75.9 m-80 -147.88 130.76 16.15 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.879 0.371 . . . . 2.16 110.699 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . 0.621 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -69.87 -37.85 76.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.53 . . . . 0.75 111.898 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -50.39 -40.87 51.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 1.34 111.214 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.14 49.39 1.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 1.56 110.999 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.621 HD12 ' HA ' ' A' ' 436' ' ' ALA . 88.7 mt -145.7 -84.87 0.12 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.521 -0.309 . . . . 1.12 111.539 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . 0.634 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . -167.66 40.5 0.24 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.416 -0.897 . . . . 1.36 113.014 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.46 144.2 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.765 -0.731 . . . . 1.83 112.88 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 48.8 mm . . . . . 0 C--N 1.33 -0.281 0 N-CA-C 110.461 -0.2 . . . . 1.48 110.461 179.462 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.543 HG13 ' HE ' ' A' ' 429' ' ' ARG . 70.4 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.672 0.273 . . . . 1.48 110.335 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.5 129.36 36.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.877 0.37 . . . . 2.17 111.288 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.476 HD11 HG12 ' A' ' 397' ' ' VAL . 82.5 mt -84.79 -39.43 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.92 110.816 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.4 t -66.55 72.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.751 -0.659 . . . . 1.71 111.022 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.473 ' HG3' ' ND2' ' A' ' 378' ' ' ASN . 12.2 pt-20 -174.45 -28.64 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.536 -0.757 . . . . 1.92 109.644 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.478 HD22 ' C ' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -172.2 57.69 0.24 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.206 -0.906 . . . . 2.14 111.052 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 52.2 Cg_exo -52.86 -39.86 76.82 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.297 1.998 . . . . 0.85 111.893 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.483 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 54.0 m-20 -62.57 -33.84 75.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.93 -0.577 . . . . 1.21 110.877 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 86.1 tttt -49.1 121.29 4.67 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.205 -0.452 . . . . 1.66 110.799 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.878 HG23 HG21 ' A' ' 417' ' ' VAL . 18.6 mm -69.97 129.43 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.41 112.0 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 395' ' ' GLY . 82.0 m-85 -109.75 144.69 37.79 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.283 -0.417 . . . . 0.63 110.234 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.526 ' C ' HD12 ' A' ' 385' ' ' ILE . 2.0 m-85 -85.6 128.5 34.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.731 0.301 . . . . 0.96 110.884 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.765 HG12 HG21 ' A' ' 414' ' ' VAL . 1.8 mp -113.22 128.17 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.238 -0.437 . . . . 0.49 110.66 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.681 ' HD3' ' HB3' ' A' ' 439' ' ' LEU . 25.4 tpt180 -98.27 120.62 39.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.373 -0.376 . . . . 2.42 111.267 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -83.18 157.33 22.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 2.3 110.556 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -55.71 -39.7 71.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 2.82 111.301 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -71.44 5.5 2.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.442 -0.344 . . . . 1.23 111.684 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 74.08 44.14 30.72 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.018 -0.61 . . . . 1.03 113.776 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 25.3 p -122.38 111.65 17.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.828 0.314 . . . . 0.98 111.625 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.61 HG23 ' NH1' ' A' ' 386' ' ' ARG . 72.4 t -69.36 135.61 27.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.649 -0.25 . . . . 0.55 110.416 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -151.41 133.08 14.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.426 -0.352 . . . . 2.43 111.046 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.77 ' HD2' HG21 ' A' ' 382' ' ' ILE . 88.9 mtm180 -59.07 153.34 18.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 2.96 112.036 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -175.44 132.45 2.16 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.798 -0.637 . . . . 0.26 112.516 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . 0.494 ' HG3' HG22 ' A' ' 417' ' ' VAL . 75.3 mt-30 -96.15 112.03 23.89 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 111.773 0.286 . . . . 1.28 111.773 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.921 HG22 HD13 ' A' ' 432' ' ' ILE . 2.6 t -63.49 136.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.218 -0.29 . . . . 0.83 110.218 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.407 ' HB2' ' HD2' ' A' ' 413' ' ' TYR . 98.8 mt -120.36 -38.92 2.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.16 0.43 . . . . 1.45 112.16 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.475 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 85.7 mt-30 -139.96 176.45 8.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.066 0.46 . . . . 2.08 111.588 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.1 p -163.7 150.94 12.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.692 -0.686 . . . . 0.56 110.24 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.542 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 39.2 ptt180 -156.17 134.58 11.54 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.862 0.363 . . . . 1.55 111.86 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 32.7 p -78.25 136.93 37.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 1.79 110.293 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.832 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.7 m -63.74 -174.49 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.285 -0.416 . . . . 1.95 110.777 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.832 ' H ' HG22 ' A' ' 403' ' ' THR . 49.1 mt-10 -48.76 -43.1 37.47 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.386 0.513 . . . . 3.87 112.386 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.61 ' ND2' ' HB3' ' A' ' 407' ' ' ALA . 50.9 t30 -55.9 -49.67 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.585 0.231 . . . . 3.16 111.457 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.443 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 57.32 59.11 3.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.947 0.403 . . . . 2.18 111.537 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.61 ' HB3' ' ND2' ' A' ' 405' ' ' ASN . . . -154.75 -2.27 0.16 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.602 . . . . 2.77 110.143 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.675 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -178.46 -49.35 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 114.848 -1.069 . . . . 2.76 110.181 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 11.7 Cg_endo -54.62 141.39 74.84 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.44 2.093 . . . . 2.49 112.298 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 36.6 p-10 -177.09 132.06 0.18 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.799 -0.637 . . . . 2.14 111.077 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.4 mt-10 -108.55 135.45 49.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.595 . . . . 2.1 109.549 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 1.0 OUTLIER -108.83 120.61 43.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.894 0.378 . . . . 0.72 111.73 -178.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.475 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 11.9 t80 -60.89 137.47 58.21 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.914 -0.773 . . . . 0.51 108.914 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.765 HG21 HG12 ' A' ' 385' ' ' ILE . 7.3 p -136.87 130.52 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.904 0.705 . . . . 1.15 112.904 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . 0.495 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 81.5 t60 -102.1 89.49 3.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.87 -1.059 . . . . 0.62 109.018 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.622 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 22.6 m-85 -46.55 123.95 5.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.373 0.606 . . . . 0.65 111.019 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 382' ' ' ILE . 43.5 t -74.7 125.48 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.133 -0.94 . . . . 1.34 111.022 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.84 -42.98 2.55 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.585 -0.734 . . . . 0.82 112.279 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 7.1 mp -65.03 151.95 44.69 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.928 0.394 . . . . 1.6 111.44 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.557 HD22 ' HB3' ' A' ' 422' ' ' ARG . 55.9 t30 -57.84 160.14 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 2.53 111.226 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.45 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 68.2 mtt-85 -62.47 -26.56 68.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.257 0.551 . . . . 3.98 110.453 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . 0.557 ' HB3' HD22 ' A' ' 420' ' ' ASN . 68.2 ttt180 -52.31 -36.35 52.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.282 -0.872 . . . . 3.71 111.829 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 423' ' ' LEU . 2.8 mm? -68.91 -34.6 75.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.451 . . . . 1.49 111.584 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 415' ' ' HIS . 1.2 m-20 -45.84 140.52 3.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.15 0.5 . . . . 1.2 112.149 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -178.18 -142.41 4.68 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.584 -0.735 . . . . 0.7 112.176 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . 0.447 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 42.4 m95 -129.7 138.31 51.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.945 0.403 . . . . 0.61 110.815 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.7 HG21 HG13 ' A' ' 432' ' ' ILE . 22.2 m -125.82 149.55 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.89 111.196 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -77.01 29.49 1.59 Allowed Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.904 -0.665 . . . . 1.72 114.475 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.575 ' HB3' ' O ' ' A' ' 428' ' ' GLY . 37.4 tpt85 75.25 -43.96 0.52 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.171 0.804 . . . . 1.73 113.171 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.542 ' H ' ' CD2' ' A' ' 430' ' ' HIS . 2.0 m170 -52.25 -30.47 27.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.736 0.779 . . . . 1.47 110.269 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.572 ' NH1' ' H ' ' A' ' 428' ' ' GLY . 28.8 mtt85 -78.48 -32.31 48.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.311 -1.313 . . . . 2.84 112.595 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.921 HD13 HG22 ' A' ' 397' ' ' VAL . 77.0 mt -88.46 129.72 39.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.799 -0.36 . . . . 0.46 110.375 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.67 ' HB2' HD11 ' A' ' 439' ' ' LEU . 63.3 m -164.92 143.67 6.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.152 -0.476 . . . . 0.53 111.149 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -73.61 16.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 1.35 111.721 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -159.17 135.71 9.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.94 0.4 . . . . 2.16 111.124 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . 0.612 ' HB1' ' H ' ' A' ' 442' ' ' ILE . . . -69.37 -26.41 64.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.79 -0.641 . . . . 0.75 112.21 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -46.67 -40.76 13.75 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.49 -0.323 . . . . 1.34 111.794 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -72.94 -33.01 65.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.004 0.43 . . . . 1.56 111.012 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.681 ' HB3' ' HD3' ' A' ' 386' ' ' ARG . 6.7 mp -77.99 -84.39 0.08 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.706 -0.679 . . . . 1.12 111.866 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . -148.39 28.59 1.35 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.671 -0.776 . . . . 1.36 112.535 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 48.46 55.11 11.27 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.945 -0.645 . . . . 1.83 112.65 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . 0.612 ' H ' ' HB1' ' A' ' 436' ' ' ALA . 31.4 mm . . . . . 0 C--N 1.326 -0.439 0 N-CA-C 110.285 -0.265 . . . . 1.48 110.285 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.535 ' HB ' HH12 ' A' ' 429' ' ' ARG . 68.8 mt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.089 0.471 . . . . 1.48 111.587 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.51 142.7 27.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 2.17 110.354 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.552 HG22 ' HG3' ' A' ' 379' ' ' PRO . 4.6 mp -71.4 -43.31 73.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.742 0.275 . . . . 0.92 111.742 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 49.2 m -49.11 -20.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.982 0.42 . . . . 1.71 111.52 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -58.39 -48.28 81.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.701 -0.681 . . . . 1.92 111.773 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.44 ' N ' ' ND2' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -174.98 73.61 0.3 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.12 -0.491 . . . . 2.14 110.911 -179.105 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . 0.552 ' HG3' HG22 ' A' ' 375' ' ' ILE . 78.2 Cg_exo -51.36 -40.17 62.32 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.521 2.147 . . . . 0.85 112.477 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.536 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 1.5 m-20 -62.39 -37.29 85.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 1.21 111.199 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 79.1 tttt -50.54 127.48 17.89 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.972 0.415 . . . . 1.66 111.006 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.833 HG23 HG21 ' A' ' 417' ' ' VAL . 20.8 mm -73.22 132.6 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.817 -0.629 . . . . 0.41 111.859 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.532 ' HB3' HG23 ' A' ' 432' ' ' ILE . 22.4 m-85 -118.68 144.19 46.37 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.091 -0.504 . . . . 0.63 110.256 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.592 ' CD2' ' HB2' ' A' ' 436' ' ' ALA . 3.0 m-85 -85.58 138.57 32.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.841 0.353 . . . . 0.96 111.183 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.643 HG12 HG21 ' A' ' 414' ' ' VAL . 2.5 mp -116.3 126.36 73.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.129 -0.487 . . . . 0.49 110.852 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.444 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 36.7 ttt85 -90.57 111.44 22.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 2.42 110.839 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.434 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 76.8 mtp180 -71.89 157.8 37.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.41 -0.359 . . . . 2.3 110.263 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.467 ' HG2' HH22 ' A' ' 431' ' ' ARG . 48.9 mt-10 -49.32 -41.0 37.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 2.82 111.331 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -71.33 -36.13 71.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 1.23 111.572 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 137.19 -28.15 2.82 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.427 -0.892 . . . . 1.03 112.811 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 47.5 p -58.81 112.09 1.52 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.98 111.718 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.725 HG23 ' HA3' ' A' ' 441' ' ' GLY . 73.1 t -84.92 141.14 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.625 -0.716 . . . . 0.55 110.88 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . 0.46 ' CG ' HD21 ' A' ' 419' ' ' LEU . 93.7 m-70 -145.45 139.92 27.21 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.987 0.422 . . . . 2.43 111.243 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.496 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 88.0 mtm180 -55.17 152.24 8.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.793 -0.64 . . . . 2.96 112.064 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -178.74 128.16 1.23 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.481 -0.781 . . . . 0.26 111.861 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . 0.536 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 78.4 mt-30 -84.47 130.74 34.73 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.338 0.496 . . . . 1.28 112.338 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.95 HG22 HD13 ' A' ' 432' ' ' ILE . 9.8 t -81.99 134.56 26.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.547 -0.538 . . . . 0.83 109.547 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 413' ' ' TYR . 90.2 mt -120.78 -43.19 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.475 0.546 . . . . 1.45 112.475 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.53 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 97.6 mm-40 -134.91 175.94 9.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.076 0.465 . . . . 2.08 111.816 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.5 p -165.54 143.43 5.91 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.687 -0.688 . . . . 0.56 110.633 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.463 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 40.6 ptt180 -151.08 135.05 16.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.952 0.406 . . . . 1.55 111.346 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 23.3 p -82.91 43.29 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 1.79 111.648 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.853 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.0 m 50.91 -174.08 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.201 -0.454 . . . . 1.95 110.869 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.853 ' H ' HG22 ' A' ' 403' ' ' THR . 93.3 mt-10 -65.38 -42.94 92.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.717 0.294 . . . . 3.87 111.225 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -57.34 -51.31 69.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 3.16 111.18 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.493 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 55.61 63.52 2.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.985 0.421 . . . . 2.18 111.831 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.447 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -160.63 7.76 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.404 0.621 . . . . 2.77 110.039 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.628 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.81 -48.96 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.779 -1.1 . . . . 2.76 109.99 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.628 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 31.4 Cg_exo -59.34 160.92 18.16 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.621 2.214 . . . . 2.49 112.251 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.67 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.1 p30 178.43 141.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.128 -0.487 . . . . 2.14 111.049 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.6 mt-10 -142.25 134.74 28.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.97 -0.559 . . . . 2.1 110.285 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 0.6 OUTLIER -109.5 124.27 50.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.72 111.469 -179.208 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.53 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 8.8 t80 -66.41 137.32 56.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.51 109.652 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.643 HG21 HG12 ' A' ' 385' ' ' ILE . 8.0 p -135.61 137.62 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.18 0.514 . . . . 1.15 112.248 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . 0.495 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 73.0 t60 -118.46 108.81 15.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.852 . . . . 0.62 109.585 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.487 ' CD1' HD22 ' A' ' 419' ' ' LEU . 97.9 m-85 -55.99 126.44 25.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.225 0.536 . . . . 0.65 110.727 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.833 HG21 HG23 ' A' ' 382' ' ' ILE . 2.1 t -78.67 28.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.366 -0.834 . . . . 1.34 111.81 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 173.1 -37.45 0.14 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.107 -1.045 . . . . 0.82 113.773 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.487 HD22 ' CD1' ' A' ' 416' ' ' TYR . 7.0 mp -61.79 -166.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.371 0.605 . . . . 1.6 112.432 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.746 ' HB3' ' HD2' ' A' ' 422' ' ' ARG . 5.0 m120 -63.65 146.73 53.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.244 -0.889 . . . . 2.53 111.915 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -72.8 -42.24 64.12 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.165 -0.47 . . . . 3.98 110.94 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . 0.746 ' HD2' ' HB3' ' A' ' 420' ' ' ASN . 0.1 OUTLIER -64.22 -24.77 67.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 3.71 109.713 179.255 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' A' ' 420' ' ' ASN . 1.2 tp -58.04 -33.1 68.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.351 -0.84 . . . . 1.49 111.048 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.495 ' OD1' ' HA ' ' A' ' 415' ' ' HIS . 65.8 m-20 -50.5 137.13 19.72 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.897 -0.592 . . . . 1.2 111.534 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . 0.528 ' O ' HG12 ' A' ' 414' ' ' VAL . . . -179.18 174.09 46.1 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.782 -0.645 . . . . 0.7 112.086 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . 0.463 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 15.7 m95 -81.49 140.35 34.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.38 . . . . 0.61 110.851 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.854 HG21 HG13 ' A' ' 432' ' ' ILE . 21.8 m -108.85 160.26 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.508 . . . . 0.89 111.527 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -75.86 24.91 1.53 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.757 -0.735 . . . . 1.72 113.045 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.644 ' H ' HG23 ' A' ' 427' ' ' VAL . 8.2 tpt180 71.93 -45.83 0.63 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.851 0.686 . . . . 1.73 112.851 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -65.61 -14.98 62.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.71 0.291 . . . . 1.47 111.494 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.467 HH22 ' HG2' ' A' ' 388' ' ' GLU . 66.2 mtt-85 -79.38 -36.31 39.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.43 -0.35 . . . . 2.84 111.852 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.95 HD13 HG22 ' A' ' 397' ' ' VAL . 75.2 mt -87.73 132.31 33.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.031 0.444 . . . . 0.46 111.587 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.412 ' HB2' HD21 ' A' ' 439' ' ' LEU . 59.1 m -163.91 139.37 6.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.595 -0.73 . . . . 0.53 110.377 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.27 -22.57 66.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.359 -0.382 . . . . 1.35 111.029 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.68 130.17 55.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.763 0.316 . . . . 2.16 110.8 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . 0.684 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -80.88 -40.51 24.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.75 111.673 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -51.81 -40.79 61.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.391 -0.368 . . . . 1.34 110.744 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -64.08 -38.1 89.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.102 0.477 . . . . 1.56 109.894 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 436' ' ' ALA . 76.8 mt -60.47 -83.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.56 -0.745 . . . . 1.12 110.725 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 139.28 52.19 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.99 -0.624 . . . . 1.36 112.029 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.725 ' HA3' HG23 ' A' ' 392' ' ' VAL . . . -161.83 -70.75 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 119.565 -1.302 . . . . 1.83 114.122 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . 0.583 HD12 ' N ' ' A' ' 442' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 109.126 -0.694 . . . . 1.48 109.126 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.062 0.458 . . . . 1.48 111.761 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 54.8 m-20 -89.71 77.2 7.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.957 -0.565 . . . . 2.17 110.3 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 80.0 mt -42.51 -36.67 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.305 -0.407 . . . . 0.92 111.964 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.8 t -69.17 68.86 0.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.46 . . . . 1.71 111.486 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.0 pt-20 -173.55 -26.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.009 -0.541 . . . . 1.92 110.062 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 0.1 OUTLIER -162.73 57.85 0.73 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.642 -0.708 . . . . 2.14 111.931 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 53.0 Cg_exo -54.21 -35.59 83.29 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.071 1.847 . . . . 0.85 111.179 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -66.04 -33.38 75.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.446 -0.797 . . . . 1.21 110.936 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 63.7 tttp -46.75 131.6 11.57 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.216 -0.447 . . . . 1.66 111.379 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 417' ' ' VAL . 41.5 mm -85.92 126.13 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.41 111.273 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -103.7 144.26 31.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.467 -0.333 . . . . 0.63 110.3 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 2.0 m-85 -85.54 132.51 34.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.96 111.688 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.676 HG12 HG21 ' A' ' 414' ' ' VAL . 2.0 mp -114.05 118.48 58.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.083 -0.508 . . . . 0.49 110.202 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.536 ' HB2' HD22 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -85.85 114.76 23.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.287 -0.415 . . . . 2.42 110.969 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.49 ' O ' ' HD3' ' A' ' 386' ' ' ARG . 25.3 mmm180 -67.02 153.59 43.29 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.442 -0.344 . . . . 2.3 110.146 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -53.17 -39.13 63.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.228 -0.442 . . . . 2.82 110.706 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -64.66 -35.52 81.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 1.23 110.856 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 135.27 -35.56 2.16 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.584 -0.817 . . . . 1.03 113.043 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 80.8 p -58.85 112.54 1.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.043 0.449 . . . . 0.98 112.004 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 56.5 t -74.53 143.15 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.925 -0.58 . . . . 0.55 110.721 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -147.52 133.42 19.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 2.43 111.113 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.444 ' HD2' HG21 ' A' ' 382' ' ' ILE . 88.4 mtm180 -56.21 155.57 6.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.903 -0.589 . . . . 2.96 111.921 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.442 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -172.04 130.67 1.98 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.532 -0.758 . . . . 0.26 112.088 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . 0.434 ' HG2' HD13 ' A' ' 382' ' ' ILE . 86.9 mt-30 -81.74 110.62 17.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.938 0.347 . . . . 1.28 111.938 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 1.0 OUTLIER -82.02 132.28 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.83 109.897 178.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 45.1 mt -120.95 -32.51 3.95 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.35 0.5 . . . . 1.45 112.35 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -140.27 176.31 8.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 2.08 111.919 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.3 p -165.07 149.93 9.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.739 -0.664 . . . . 0.56 110.723 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 38.2 ptt180 -154.55 138.42 16.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.863 0.364 . . . . 1.55 111.089 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 77.5 p -70.01 -132.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.437 -0.347 . . . . 1.79 110.988 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.794 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -162.43 -172.76 3.29 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.023 -0.362 . . . . 1.95 110.023 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.794 ' H ' HG22 ' A' ' 403' ' ' THR . 48.4 mt-10 -41.65 -45.77 3.5 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.668 0.271 . . . . 3.87 111.47 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.525 HD21 ' HB3' ' A' ' 407' ' ' ALA . 50.0 t30 -67.31 -50.58 59.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.806 0.336 . . . . 3.16 110.633 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.17 56.32 7.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.965 -0.561 . . . . 2.18 111.591 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.525 ' HB3' HD21 ' A' ' 405' ' ' ASN . . . -151.98 9.36 0.51 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.156 0.503 . . . . 2.77 110.421 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.599 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.69 -49.0 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.262 -0.881 . . . . 2.76 110.625 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 32.0 Cg_exo -58.29 147.26 85.58 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.321 2.014 . . . . 2.49 112.179 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.9 p30 -177.95 131.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 2.14 111.438 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 426' ' ' TRP . 50.2 mt-10 -115.25 136.83 52.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.693 -0.685 . . . . 2.1 109.707 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 412' ' ' TYR . 0.6 OUTLIER -109.74 130.08 55.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.909 0.385 . . . . 0.72 111.903 -178.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 31.3 t80 -60.56 146.64 44.38 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.627 -0.879 . . . . 0.51 108.627 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.676 HG21 HG12 ' A' ' 385' ' ' ILE . 7.2 p -151.13 133.65 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 119.662 -0.815 . . . . 1.15 113.181 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -116.2 107.76 15.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.996 -1.002 . . . . 0.62 109.439 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.457 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 63.0 m-85 -61.43 125.37 23.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.028 0.442 . . . . 0.65 111.279 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 382' ' ' ILE . 2.7 t -81.62 32.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.685 -0.688 . . . . 1.34 111.239 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -175.63 -44.2 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.436 -0.888 . . . . 0.82 112.89 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.457 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 7.2 mp -64.88 -166.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.199 0.523 . . . . 1.6 111.701 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.738 ' HB2' HD13 ' A' ' 423' ' ' LEU . 4.4 m120 -74.1 145.09 44.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.446 -0.797 . . . . 2.53 111.796 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 62.2 mtm-85 -65.33 -38.58 90.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.959 -0.564 . . . . 3.98 110.71 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -55.39 -36.13 66.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.057 0.456 . . . . 3.71 110.967 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.738 HD13 ' HB2' ' A' ' 420' ' ' ASN . 4.5 mp -52.75 -25.87 12.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.468 -0.787 . . . . 1.49 111.787 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.16 135.44 21.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.989 0.423 . . . . 1.2 111.299 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 413' ' ' TYR . . . 177.24 -140.29 4.79 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.953 -0.641 . . . . 0.7 112.302 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . 0.587 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 42.7 m95 -122.27 138.19 54.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.793 0.33 . . . . 0.61 110.709 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.405 ' CG2' HD11 ' A' ' 432' ' ' ILE . 30.8 m -134.05 142.64 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.89 111.765 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.403 ' HA3' ' NH1' ' A' ' 431' ' ' ARG . . . -63.47 144.92 49.65 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.831 -0.7 . . . . 1.72 111.994 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -55.58 -28.4 54.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.036 0.446 . . . . 1.73 111.49 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.681 ' H ' ' CD2' ' A' ' 430' ' ' HIS . 0.9 OUTLIER -56.58 -31.27 64.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.811 0.815 . . . . 1.47 109.572 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.418 ' HG3' HH11 ' A' ' 431' ' ' ARG . 33.0 mtt85 -83.14 -36.23 24.93 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.117 -1.401 . . . . 2.84 111.418 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.555 HG12 HG13 ' A' ' 385' ' ' ILE . 65.9 mt -88.83 135.31 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.021 0.439 . . . . 0.46 111.766 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 435' ' ' ASN . 55.8 m -161.76 140.12 9.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.843 -0.617 . . . . 0.53 110.619 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -72.67 16.19 0.16 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.243 -0.435 . . . . 1.35 111.612 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 433' ' ' SER . 75.0 m-80 -146.53 131.92 18.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.938 0.399 . . . . 2.16 110.97 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -68.17 -42.32 80.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.983 -0.553 . . . . 0.75 111.441 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -54.66 -40.74 69.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.282 -0.417 . . . . 1.34 111.038 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.59 42.91 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 1.56 110.848 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.536 HD22 ' HB2' ' A' ' 386' ' ' ARG . 97.5 mt -151.82 -83.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 1.12 111.104 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -166.39 44.31 0.27 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.994 -0.622 . . . . 1.36 112.141 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.13 -136.03 45.77 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 1.83 112.298 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.586 0.232 . . . . 1.48 110.648 179.608 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.816 0.341 . . . . 1.48 111.046 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -88.14 110.61 20.81 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.155 -0.475 . . . . 2.17 110.556 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.537 HD11 HG12 ' A' ' 397' ' ' VAL . 93.0 mt -66.82 -43.44 89.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.866 -0.606 . . . . 0.92 111.972 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 75.9 p -69.84 64.84 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.101 0.477 . . . . 1.71 110.842 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -149.46 -27.99 0.27 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.92 109.685 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.44 ' C ' HD22 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -172.28 60.72 0.29 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.282 -0.872 . . . . 2.14 111.239 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -51.32 -37.3 60.04 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.311 2.008 . . . . 0.85 111.676 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -62.96 -34.22 77.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.762 -0.654 . . . . 1.21 110.866 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -53.86 124.68 16.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 1.66 111.199 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.025 HD12 HG21 ' A' ' 417' ' ' VAL . 16.2 mm -79.88 124.4 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.074 -0.512 . . . . 0.41 111.755 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.518 ' HB2' ' O ' ' A' ' 395' ' ' GLY . 4.2 m-85 -104.07 144.21 31.86 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.235 -0.283 . . . . 0.63 110.235 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.42 ' HB3' HG13 ' A' ' 392' ' ' VAL . 15.8 m-30 -94.65 135.91 35.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.012 0.434 . . . . 0.96 110.867 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.8 mp -119.24 126.07 75.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 0.49 110.063 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.813 ' HE ' ' HA3' ' A' ' 440' ' ' GLY . 55.7 ttt-85 -89.19 121.65 31.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 2.42 111.048 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.478 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 59.8 mtp85 -79.63 168.3 19.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 2.3 110.602 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -56.1 -42.87 77.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 2.82 111.233 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -72.3 5.7 2.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 1.23 111.954 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.615 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 73.07 48.81 18.65 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.52 -0.848 . . . . 1.03 113.077 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . 0.478 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 81.9 p -120.69 110.54 16.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.687 0.279 . . . . 0.98 111.561 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 384' ' ' PHE . 58.6 t -70.52 127.56 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.082 -0.34 . . . . 0.55 110.082 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -145.02 135.99 24.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.112 0.482 . . . . 2.43 111.482 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.509 ' HB3' ' HB ' ' A' ' 417' ' ' VAL . 59.6 mtt85 -55.56 155.29 5.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.802 -0.635 . . . . 2.96 112.057 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 383' ' ' TYR . . . 178.02 126.64 1.0 Allowed Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.396 -0.82 . . . . 0.26 111.371 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 85.4 mt-30 -91.74 129.22 37.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.972 0.386 . . . . 1.28 111.739 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.765 HG22 HD13 ' A' ' 432' ' ' ILE . 4.2 t -82.95 126.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.134 -0.691 . . . . 0.83 109.134 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.41 ' C ' HD13 ' A' ' 375' ' ' ILE . 66.8 mt -120.71 -46.85 2.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.251 0.463 . . . . 1.45 112.251 -178.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.595 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 12.0 mm-40 -123.73 176.51 6.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.107 0.48 . . . . 2.08 111.6 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 97.0 p -163.57 146.06 9.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.634 -0.712 . . . . 0.56 110.109 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -162.57 139.03 7.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.879 0.371 . . . . 1.55 111.332 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.725 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 72.2 p -70.59 -125.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 1.79 110.033 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.778 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.76 -173.41 2.97 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.662 -0.495 . . . . 1.95 109.662 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.778 ' H ' HG22 ' A' ' 403' ' ' THR . 64.2 mm-40 -44.86 -40.39 6.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.802 0.334 . . . . 3.87 110.856 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.638 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 0.7 OUTLIER -68.13 -53.66 23.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.193 -0.458 . . . . 3.16 110.563 179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.414 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 51.29 51.69 16.38 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.192 0.52 . . . . 2.18 111.358 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.495 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -152.83 10.73 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.484 -0.78 . . . . 2.77 109.46 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.578 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -177.82 -48.25 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 114.465 -1.243 . . . . 2.76 110.034 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 36.1 Cg_exo -60.89 149.24 89.47 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.524 2.15 . . . . 2.49 112.383 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.725 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 12.1 p-10 -174.07 137.51 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 2.14 110.348 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.9 mt-10 -134.83 134.68 41.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 2.1 110.902 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 1.2 m-85 -109.76 125.66 52.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.058 0.456 . . . . 0.72 111.175 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.595 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 14.3 t80 -62.22 144.0 56.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.71 -0.677 . . . . 0.51 110.189 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 0.0 OUTLIER -144.56 129.66 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.624 0.602 . . . . 1.15 112.624 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . 0.425 ' O ' ' HA2' ' A' ' 395' ' ' GLY . 38.4 t60 -103.38 97.15 7.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.153 -0.93 . . . . 0.62 109.169 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 36.7 m-85 -53.2 106.41 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.391 0.615 . . . . 0.65 111.22 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 1.025 HG21 HD12 ' A' ' 382' ' ' ILE . 58.3 t -67.16 130.01 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.905 -1.043 . . . . 1.34 111.143 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 81.4 -45.55 3.26 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.747 -0.661 . . . . 0.82 112.608 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 6.9 mp -65.6 166.57 10.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.997 0.427 . . . . 1.6 111.427 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 74.5 m-20 -53.86 143.37 21.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.831 -0.622 . . . . 2.53 111.544 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 53.9 mtt85 -61.75 -38.52 88.27 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.854 -0.612 . . . . 3.98 111.286 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -56.25 -32.58 64.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 3.71 111.439 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 420' ' ' ASN . 1.9 mp -58.21 -27.95 64.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.226 -0.443 . . . . 1.49 111.822 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -48.39 139.77 8.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 1.2 111.325 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -171.66 -147.83 5.86 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.76 -0.734 . . . . 0.7 112.466 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -128.65 138.37 52.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.021 0.439 . . . . 0.61 111.18 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.74 HG21 HG13 ' A' ' 432' ' ' ILE . 23.0 m -115.04 155.57 16.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.692 -0.686 . . . . 0.89 111.494 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -78.04 30.94 1.8 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.913 -0.66 . . . . 1.72 114.075 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.559 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 9.7 tpt180 72.09 -45.63 0.62 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.688 0.625 . . . . 1.73 112.688 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -62.41 -21.53 65.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.706 0.289 . . . . 1.47 111.592 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.454 ' HD2' ' HB ' ' A' ' 427' ' ' VAL . 90.7 mtt180 -79.11 -26.95 42.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.188 0.44 . . . . 2.84 112.188 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.765 HD13 HG22 ' A' ' 397' ' ' VAL . 71.4 mt -88.11 136.8 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.965 0.412 . . . . 0.46 111.243 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 56.4 m -159.69 138.69 10.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.53 110.612 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.29 -26.51 62.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 1.35 111.138 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -112.85 130.62 56.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 2.16 110.729 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -66.91 -32.52 73.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 0.75 111.176 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -51.54 -40.88 60.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.232 -0.44 . . . . 1.34 110.783 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.85 -38.46 83.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.171 0.51 . . . . 1.56 110.118 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 436' ' ' ALA . 69.3 mt -61.89 -93.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.525 -0.761 . . . . 1.12 111.238 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . 0.813 ' HA3' ' HE ' ' A' ' 386' ' ' ARG . . . -166.29 39.87 0.26 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.116 -0.564 . . . . 1.36 111.931 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 67.62 131.19 0.03 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.018 -0.61 . . . . 1.83 112.162 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . 0.672 HD12 ' H ' ' A' ' 442' ' ' ILE . 5.3 mp . . . . . 0 C--N 1.332 -0.167 0 CA-C-O 120.67 0.271 . . . . 1.48 110.322 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.772 0.32 . . . . 1.48 110.711 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.407 ' HB2' ' OE1' ' A' ' 377' ' ' GLU . 59.2 m-20 -88.92 129.45 35.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 2.17 111.228 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 78.7 mt -84.27 -45.18 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.92 111.16 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 48.0 t -64.11 78.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 1.71 110.859 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.551 ' HG3' ' ND2' ' A' ' 378' ' ' ASN . 12.1 pt-20 -173.71 -28.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.528 -0.76 . . . . 1.92 110.074 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.551 ' ND2' ' HG3' ' A' ' 377' ' ' GLU . 0.1 OUTLIER -173.07 61.54 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.536 -0.757 . . . . 2.14 111.509 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.99 -38.67 86.7 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.318 2.012 . . . . 0.85 111.877 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.514 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 28.3 m-20 -65.34 -33.51 76.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.996 -0.547 . . . . 1.21 111.073 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 85.2 tttt -48.02 126.58 10.96 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.942 0.401 . . . . 1.66 111.076 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.779 HG23 HG21 ' A' ' 417' ' ' VAL . 36.5 mm -71.79 120.71 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.89 -0.596 . . . . 0.41 111.724 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -99.57 144.4 28.7 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.587 -0.523 . . . . 0.63 109.587 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.447 ' C ' HD12 ' A' ' 385' ' ' ILE . 45.1 m-85 -88.88 133.08 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.895 -0.322 . . . . 0.96 110.795 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.661 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.1 mp -116.33 144.67 23.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.819 0.342 . . . . 0.49 111.539 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.654 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 39.1 ttt85 -124.48 104.25 8.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 2.42 110.525 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.479 ' HG3' ' CE1' ' A' ' 393' ' ' HIS . 10.0 mtp-105 -65.04 161.6 18.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.831 0.348 . . . . 2.3 110.944 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.609 ' HG3' HH21 ' A' ' 431' ' ' ARG . 50.5 mp0 -48.76 -45.05 39.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.054 0.761 . . . . 2.82 113.054 -177.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.592 ' OD2' HG23 ' A' ' 391' ' ' THR . 8.0 p-10 -60.16 -35.26 74.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.595 0.236 . . . . 1.23 111.59 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.405 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 118.45 44.3 0.52 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.605 -0.807 . . . . 1.03 112.413 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . 0.592 HG23 ' OD2' ' A' ' 389' ' ' ASP . 21.5 p -116.64 112.49 21.34 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.789 0.292 . . . . 0.98 111.789 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.495 HG11 HD13 ' A' ' 442' ' ' ILE . 86.4 t -79.56 134.23 28.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.604 -0.517 . . . . 0.55 109.604 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . 0.487 ' HD1' ' HB ' ' A' ' 385' ' ' ILE . 0.6 OUTLIER -156.47 133.98 10.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.939 0.4 . . . . 2.43 111.03 -178.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.498 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 99.6 mtt180 -60.07 145.18 47.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.931 -0.577 . . . . 2.96 111.75 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -174.21 128.85 1.52 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.532 -0.758 . . . . 0.26 111.976 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . 0.514 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 68.6 mt-30 -78.31 129.68 35.31 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.689 -0.3 . . . . 1.28 111.597 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 413' ' ' TYR . 0.5 OUTLIER -88.28 132.08 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.547 -0.538 . . . . 0.83 109.547 177.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 398' ' ' LEU . 4.9 mp -106.14 -49.44 3.37 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.791 0.663 . . . . 1.45 112.791 -177.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 412' ' ' TYR . 98.1 mm-40 -142.94 178.02 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.004 0.431 . . . . 2.08 111.869 -178.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.7 p -148.83 149.39 31.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.683 -0.69 . . . . 0.56 109.987 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -158.49 139.08 12.69 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.169 0.509 . . . . 1.55 112.356 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 50.6 p -87.6 139.1 30.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.671 -0.695 . . . . 1.79 109.557 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.851 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.9 m -60.53 -174.57 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.58 0.229 . . . . 1.95 110.579 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.851 ' H ' HG22 ' A' ' 403' ' ' THR . 59.1 mm-40 -50.73 -41.74 56.6 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.798 0.295 . . . . 3.87 111.798 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.597 ' ND2' ' HB3' ' A' ' 407' ' ' ALA . 50.8 t30 -59.19 -49.57 77.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.569 -0.287 . . . . 3.16 111.076 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.573 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 52.71 48.25 22.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.154 0.502 . . . . 2.18 111.483 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.597 ' HB3' ' ND2' ' A' ' 405' ' ' ASN . . . -145.75 10.79 1.22 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.603 -0.726 . . . . 2.77 109.478 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.595 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.78 -47.81 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.472 -1.24 . . . . 2.76 110.0 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 36.3 Cg_exo -57.9 143.46 95.86 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.561 2.174 . . . . 2.49 112.513 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -170.48 136.31 1.29 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.69 -0.687 . . . . 2.14 110.326 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 400' ' ' SER . 64.8 mm-40 -140.89 135.12 30.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.193 -0.458 . . . . 2.1 110.886 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 399' ' ' GLN . 1.2 m-85 -109.21 119.19 38.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.145 -0.48 . . . . 0.72 111.213 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.471 ' CE2' HD22 ' A' ' 398' ' ' LEU . 10.5 t80 -57.41 145.99 30.84 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.278 -0.638 . . . . 0.51 109.278 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 14.4 p -154.82 129.52 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.201 0.815 . . . . 1.15 113.201 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -101.85 113.09 25.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.344 -0.844 . . . . 0.62 109.084 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.493 ' CD2' HD22 ' A' ' 419' ' ' LEU . 65.1 m-85 -61.42 132.69 54.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.356 0.598 . . . . 0.65 111.125 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.779 HG21 HG23 ' A' ' 382' ' ' ILE . 1.3 t -78.82 27.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.212 -0.904 . . . . 1.34 111.406 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 172.74 -43.04 0.17 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.407 -0.901 . . . . 0.82 113.289 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 423' ' ' LEU . 7.3 mp -59.75 151.88 24.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 1.6 111.604 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -50.36 147.13 4.6 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.494 -0.776 . . . . 2.53 112.203 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.436 ' HA ' ' CG ' ' A' ' 424' ' ' ASP . 87.1 mtm180 -59.24 -28.88 67.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.706 -0.679 . . . . 3.98 110.927 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -53.61 -41.2 66.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.285 0.564 . . . . 3.71 110.059 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 419' ' ' LEU . 6.4 mp -71.56 -33.12 68.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.142 -0.935 . . . . 1.49 110.999 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.436 ' CG ' ' HA ' ' A' ' 421' ' ' ARG . 10.6 m-20 -53.11 131.44 36.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 1.2 110.783 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 176.43 -142.03 5.77 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.702 -0.761 . . . . 0.7 112.51 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 50.6 m95 -105.19 135.83 45.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.61 110.933 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.855 HG23 HD11 ' A' ' 432' ' ' ILE . 3.4 m -128.81 134.56 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.534 . . . . 0.89 111.634 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -57.7 150.06 31.98 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.722 -0.752 . . . . 1.72 111.99 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -47.92 -39.77 19.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.615 0.245 . . . . 1.73 111.331 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.425 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 9.1 p-80 -61.77 -32.26 72.51 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.866 0.321 . . . . 1.47 111.866 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.609 HH21 ' HG3' ' A' ' 388' ' ' GLU . 57.0 mtt85 -82.21 26.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.108 -0.237 . . . . 2.84 111.191 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.855 HD11 HG23 ' A' ' 427' ' ' VAL . 66.0 mt -149.58 135.63 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.46 110.868 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 435' ' ' ASN . 70.5 m -166.25 139.23 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 0.53 110.866 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.65 16.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 1.35 110.507 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 433' ' ' SER . 74.9 m-20 -138.79 128.26 24.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.902 -0.59 . . . . 2.16 110.328 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.1 92.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.75 111.754 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -56.24 -40.36 74.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 1.34 111.333 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.77 42.44 0.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 1.56 111.601 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . . . . . . . . . 85.9 mt -150.2 -88.41 0.07 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.72 -0.218 . . . . 1.12 111.438 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . 0.654 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -171.45 38.12 0.17 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.542 -0.837 . . . . 1.36 112.859 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.83 141.02 0.04 OUTLIER Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.736 -0.745 . . . . 1.83 112.869 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . 0.495 HD13 HG11 ' A' ' 392' ' ' VAL . 42.3 mm . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.985 0.421 . . . . 1.48 110.689 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.493 HG13 ' HE ' ' A' ' 429' ' ' ARG . 70.6 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.752 0.311 . . . . 1.48 111.337 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.68 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 23.6 m-20 -88.87 111.58 22.24 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 116.09 -0.505 . . . . 2.17 110.902 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 86.4 mt -73.17 -39.68 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.709 0.29 . . . . 0.92 111.781 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 40.1 t -46.72 -28.74 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.011 -0.54 . . . . 1.71 112.422 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.68 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 15.5 pt-20 -69.43 -38.47 77.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.508 -0.315 . . . . 1.92 111.772 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.703 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 5.5 m120 -153.06 69.16 6.85 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 112.322 0.49 . . . . 2.14 112.322 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.38 -40.68 77.37 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.684 2.256 . . . . 0.85 112.577 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -70.3 -34.09 72.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.536 . . . . 1.21 111.774 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.703 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 63.0 tttp -46.38 136.36 7.36 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.983 0.421 . . . . 1.66 111.021 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.733 HG21 ' HD3' ' A' ' 394' ' ' ARG . 46.4 mm -84.86 130.47 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.782 -0.644 . . . . 0.41 111.834 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -118.93 143.6 46.92 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.496 -0.557 . . . . 0.63 109.496 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.524 ' CE1' ' HG2' ' A' ' 394' ' ' ARG . 1.3 m-85 -84.83 143.74 28.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.783 0.325 . . . . 0.96 111.351 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.712 HG12 HG11 ' A' ' 414' ' ' VAL . 2.8 mp -119.85 133.83 65.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 116.228 -0.442 . . . . 0.49 111.492 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.551 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 28.3 tpt180 -87.0 106.01 17.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 2.42 110.418 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.488 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 62.5 mtp85 -66.69 160.52 25.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 2.3 111.067 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.7 -71.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.865 -0.607 . . . . 2.82 111.048 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.414 ' OD1' HG23 ' A' ' 391' ' ' THR . 2.4 p30 -41.7 -28.9 0.16 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.052 0.453 . . . . 1.23 110.28 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 110.16 44.3 1.02 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.737 -0.665 . . . . 1.03 113.459 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . 0.488 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 37.0 p -121.2 110.37 16.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.967 0.413 . . . . 0.98 111.062 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.492 HG23 HH11 ' A' ' 386' ' ' ARG . 90.2 t -71.6 133.13 32.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 0.55 111.352 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -151.93 138.46 18.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.111 -0.495 . . . . 2.43 110.537 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.733 ' HD3' HG21 ' A' ' 382' ' ' ILE . 60.6 mtt85 -51.6 155.65 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.392 0.615 . . . . 2.96 112.601 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -178.61 133.37 2.1 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.103 -0.953 . . . . 0.26 111.84 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -80.95 130.68 35.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.771 0.285 . . . . 1.28 111.771 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.605 ' CG1' ' HB3' ' A' ' 412' ' ' TYR . 14.5 t -91.43 126.61 44.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.81 -0.811 . . . . 0.83 108.81 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.64 HD22 ' N ' ' A' ' 398' ' ' LEU . 0.3 OUTLIER -108.83 -40.08 5.15 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.023 0.749 . . . . 1.45 113.023 -177.029 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -139.95 176.02 9.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.95 0.405 . . . . 2.08 111.901 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.2 p -163.56 150.96 12.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.829 -0.623 . . . . 0.56 110.611 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 39.9 ptt180 -153.14 134.33 14.15 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.492 -0.322 . . . . 1.55 111.163 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 47.7 p -71.93 135.71 46.6 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.96 0.41 . . . . 1.79 110.69 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.827 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.1 m -62.51 -174.1 0.06 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.837 -0.62 . . . . 1.95 110.372 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.827 ' H ' HG22 ' A' ' 403' ' ' THR . 60.3 mm-40 -44.94 -37.04 3.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.86 0.319 . . . . 3.87 111.86 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.579 HD22 ' HD2' ' A' ' 409' ' ' PRO . 45.4 t30 -57.52 -49.76 75.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.747 0.308 . . . . 3.16 110.873 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.612 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.78 66.03 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.183 -0.462 . . . . 2.18 111.603 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.53 ' HB3' ' ND2' ' A' ' 405' ' ' ASN . . . -162.65 -23.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 2.77 110.518 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.67 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -159.99 -52.33 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.683 -0.69 . . . . 2.76 110.7 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 52.1 Cg_exo -54.96 149.2 43.66 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.196 1.93 . . . . 2.49 111.341 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 34.4 p-10 -179.08 143.71 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.091 0.472 . . . . 2.14 111.58 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 400' ' ' SER . 0.5 OUTLIER -106.82 135.25 48.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.756 -0.656 . . . . 2.1 109.859 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.643 ' HB2' HD12 ' A' ' 432' ' ' ILE . 0.4 OUTLIER -109.75 128.11 55.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.345 -0.389 . . . . 0.72 111.958 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.57 ' CD2' HD23 ' A' ' 398' ' ' LEU . 9.4 t80 -64.54 141.56 58.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.51 109.833 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.712 HG11 HG12 ' A' ' 385' ' ' ILE . 48.6 t -132.51 132.99 60.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.153 0.797 . . . . 1.15 113.153 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -116.13 89.9 3.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.036 -0.984 . . . . 0.62 109.304 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.465 ' HD1' ' H ' ' A' ' 416' ' ' TYR . 6.2 m-85 -55.89 127.2 29.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.953 0.406 . . . . 0.65 111.161 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 382' ' ' ILE . 61.9 t -70.38 127.23 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.01 -0.541 . . . . 1.34 111.375 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.53 -41.93 1.69 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.966 -0.635 . . . . 0.82 113.182 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 419' ' ' LEU . 7.7 mp -59.43 156.92 12.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.947 0.403 . . . . 1.6 111.375 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.545 ' OD1' HD13 ' A' ' 423' ' ' LEU . 22.5 p30 -49.58 143.38 7.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.786 -0.643 . . . . 2.53 111.65 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 421' ' ' ARG . 57.0 mtt85 -62.77 -36.16 82.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.636 -0.711 . . . . 3.98 111.898 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -54.09 -30.04 46.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.341 . . . . 3.71 111.029 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.545 HD13 ' OD1' ' A' ' 420' ' ' ASN . 1.1 tp -59.41 -31.69 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 1.49 111.365 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.5 134.83 8.95 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.946 0.403 . . . . 1.2 111.155 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.88 155.08 12.27 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.827 -0.701 . . . . 0.7 112.268 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 12.2 m95 -71.05 137.64 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.679 0.276 . . . . 0.61 110.38 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.424 ' HB ' ' HD3' ' A' ' 431' ' ' ARG . 11.4 m -138.0 141.23 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.438 -0.346 . . . . 0.89 110.843 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -50.01 150.7 4.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.668 -0.777 . . . . 1.72 112.442 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.493 ' HE ' HG13 ' A' ' 373' ' ' ILE . 32.6 tpt85 -48.7 -42.03 33.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.479 0.18 . . . . 1.73 111.477 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -55.43 -31.71 62.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.541 -0.3 . . . . 1.47 111.469 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 73.5 mtp180 -81.61 20.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.611 -0.268 . . . . 2.84 111.228 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.643 HD12 ' HB2' ' A' ' 412' ' ' TYR . 83.5 mt -150.33 126.04 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.826 0.346 . . . . 0.46 110.914 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 435' ' ' ASN . 65.5 m -165.67 143.4 5.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.863 -0.608 . . . . 0.53 110.65 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . 0.498 ' OD1' ' HE3' ' A' ' 381' ' ' LYS . 27.5 m-20 -70.62 16.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 1.35 111.293 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 433' ' ' SER . 16.1 p-10 -158.9 128.14 5.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.926 0.393 . . . . 2.16 110.585 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . 0.617 ' HB3' HD13 ' A' ' 442' ' ' ILE . . . -68.09 -25.08 65.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.97 -0.559 . . . . 0.75 111.896 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.34 -41.19 18.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.405 -0.361 . . . . 1.34 111.631 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -82.63 -41.68 19.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.927 0.394 . . . . 1.56 110.948 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 436' ' ' ALA . 49.0 mt -54.63 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 1.12 111.565 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . 0.551 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -157.29 38.66 0.55 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.851 -0.69 . . . . 1.36 112.186 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.12 146.0 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.686 -0.768 . . . . 1.83 112.199 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 436' ' ' ALA . 48.8 mm . . . . . 0 C--N 1.331 -0.22 0 N-CA-C 109.975 -0.38 . . . . 1.48 109.975 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.798 0.333 . . . . 1.48 111.057 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 30.4 m-20 -88.22 110.47 20.74 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.23 -0.441 . . . . 2.17 110.854 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.447 HD13 ' C ' ' A' ' 398' ' ' LEU . 82.0 mt -76.48 -34.75 25.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.92 111.623 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 80.4 p -70.17 64.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 1.71 111.643 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.4 pt-20 -174.66 -27.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.904 -0.589 . . . . 1.92 110.073 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 2.7 m120 -149.49 60.26 4.45 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.77 . . . . 2.14 112.413 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 73.3 Cg_exo -55.69 -40.92 82.46 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.713 2.276 . . . . 0.85 112.341 179.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -69.4 -30.05 67.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 1.21 111.94 -179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 88.1 tttt -44.92 130.03 7.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.001 0.429 . . . . 1.66 111.005 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.536 HG21 ' HD3' ' A' ' 394' ' ' ARG . 38.4 mm -91.99 135.01 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.41 111.5 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.662 ' HB3' HG23 ' A' ' 432' ' ' ILE . 1.6 m-85 -119.95 143.13 48.17 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.961 -0.385 . . . . 0.63 109.961 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.419 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 4.3 m-85 -92.65 136.18 33.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.777 -0.369 . . . . 0.96 110.597 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 385' ' ' ILE . 3.1 mp -125.61 128.37 72.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.868 0.366 . . . . 0.49 110.935 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.656 ' N ' HD23 ' A' ' 439' ' ' LEU . 78.8 ttt180 -81.8 120.65 25.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.994 -0.548 . . . . 2.42 110.801 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.405 ' HB2' ' OD1' ' A' ' 389' ' ' ASP . 59.0 mtm180 -74.63 166.59 23.31 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.759 -0.377 . . . . 2.3 110.623 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' A' ' 388' ' ' GLU . 9.0 mp0 -49.66 -44.67 47.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.29 -0.414 . . . . 2.82 111.398 -179.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 387' ' ' ARG . 41.4 p-10 -65.72 -35.11 79.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.429 -0.351 . . . . 1.23 111.353 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.524 ' HA2' ' HE ' ' A' ' 386' ' ' ARG . . . 130.2 -29.21 3.72 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.76 -0.734 . . . . 1.03 112.293 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 51.3 p -59.48 113.63 2.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.241 0.544 . . . . 0.98 111.843 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 49.1 t -72.62 143.09 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.399 -0.818 . . . . 0.55 111.49 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -146.56 145.09 30.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.707 -0.679 . . . . 2.43 109.35 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.547 ' HB2' ' CG1' ' A' ' 417' ' ' VAL . 55.0 mtt85 -74.07 145.93 44.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.482 0.658 . . . . 2.96 111.604 -178.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -146.42 125.05 2.14 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 114.891 -1.05 . . . . 0.26 110.996 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -81.84 84.07 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.783 0.325 . . . . 1.28 111.132 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.893 HG23 HG22 ' A' ' 414' ' ' VAL . 0.6 OUTLIER -59.0 132.31 23.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.144 -0.48 . . . . 0.83 110.457 179.9 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.447 ' C ' HD13 ' A' ' 375' ' ' ILE . 59.4 mt -120.64 -38.8 2.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.157 -0.474 . . . . 1.45 112.128 -178.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -119.8 170.51 9.16 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.177 0.513 . . . . 2.08 112.076 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.1 p -165.69 151.22 9.05 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.437 -0.801 . . . . 0.56 109.9 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -162.3 137.43 7.07 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.388 0.514 . . . . 1.55 112.388 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.516 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 35.9 p -86.34 135.61 33.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.86 -0.609 . . . . 1.79 109.429 177.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.856 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.3 m -60.29 -174.7 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.67 0.272 . . . . 1.95 110.917 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.856 ' H ' HG22 ' A' ' 403' ' ' THR . 4.8 mm-40 -50.66 -42.61 56.75 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.992 0.367 . . . . 3.87 111.992 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.577 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 50.8 t30 -56.65 -48.87 76.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.719 0.295 . . . . 3.16 110.837 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 53.19 52.16 14.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 2.18 111.529 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.484 ' HB3' ' ND2' ' A' ' 405' ' ' ASN . . . -153.53 10.23 0.42 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.44 0.638 . . . . 2.77 109.642 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.81 -48.32 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.688 -1.142 . . . . 2.76 110.122 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 36.3 Cg_exo -60.57 141.64 95.81 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.677 2.252 . . . . 2.49 112.745 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -173.16 127.73 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.652 -0.704 . . . . 2.14 110.784 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 400' ' ' SER . 9.2 mp0 -120.42 134.59 55.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.782 -0.645 . . . . 2.1 109.675 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 412' ' ' TYR . 1.2 m-85 -110.03 123.45 49.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.806 0.336 . . . . 0.72 111.649 -178.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 19.7 t80 -63.86 119.3 9.74 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.317 -0.624 . . . . 0.51 109.317 178.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.893 HG22 HG23 ' A' ' 397' ' ' VAL . 22.6 t -112.36 135.77 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.461 0.912 . . . . 1.15 113.461 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -111.14 89.38 3.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.996 -1.002 . . . . 0.62 108.543 177.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 62.5 m-85 -52.18 103.16 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.281 0.563 . . . . 0.65 110.904 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.547 ' CG1' ' HB2' ' A' ' 394' ' ' ARG . 11.3 p -62.44 136.46 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.147 -0.933 . . . . 1.34 110.932 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 80.43 -47.97 3.54 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.235 -0.746 . . . . 0.82 111.235 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.525 ' HB3' HD22 ' A' ' 423' ' ' LEU . 2.0 mm? -65.68 159.77 24.22 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.74 0.305 . . . . 1.6 110.634 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.553 ' OD1' HD13 ' A' ' 423' ' ' LEU . 21.3 p30 -51.62 141.67 15.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 2.53 111.082 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 31.9 ptt85 -60.55 -33.05 72.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.233 -0.44 . . . . 3.98 111.918 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -56.4 -29.61 61.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 3.71 111.1 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.553 HD13 ' OD1' ' A' ' 420' ' ' ASN . 1.2 tp -58.1 -26.7 62.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 1.49 111.661 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -44.79 135.17 5.21 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.948 0.404 . . . . 1.2 111.174 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -178.82 145.98 7.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.01 -0.614 . . . . 0.7 112.189 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -67.49 121.3 15.51 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.99 -0.374 . . . . 0.61 109.99 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.512 HG22 ' CG2' ' A' ' 414' ' ' VAL . 6.4 m -118.79 149.59 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 0.89 111.537 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -63.27 146.97 50.61 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.625 -0.798 . . . . 1.72 111.674 178.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 37.1 tpt85 -51.34 -29.73 16.21 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.684 0.253 . . . . 1.73 111.684 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.414 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 22.7 p-80 -60.37 -31.94 70.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.955 0.354 . . . . 1.47 111.955 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 99.4 mtt180 -79.03 -30.94 44.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.355 -0.384 . . . . 2.84 110.93 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.662 HG23 ' HB3' ' A' ' 383' ' ' TYR . 95.7 mt -89.03 129.93 39.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.46 111.603 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.71 ' HB2' HD11 ' A' ' 439' ' ' LEU . 69.6 m -169.09 140.05 2.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.803 -0.635 . . . . 0.53 110.5 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -75.82 16.21 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.415 -0.357 . . . . 1.35 111.269 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.787 HD21 ' HB2' ' A' ' 437' ' ' ASP . 51.9 t30 -139.45 131.39 27.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.891 0.377 . . . . 2.16 110.652 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -71.72 -37.17 70.65 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.627 0.603 . . . . 0.75 112.627 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . 0.787 ' HB2' HD21 ' A' ' 435' ' ' ASN . 55.5 m-20 -52.51 -40.72 62.75 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.727 0.299 . . . . 1.34 111.597 -178.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 435' ' ' ASN . 61.5 m-20 -64.19 -24.58 67.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.391 -0.368 . . . . 1.56 111.335 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.4 mp -94.81 -85.46 0.31 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.159 -0.473 . . . . 1.12 112.191 -179.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -179.65 51.85 0.09 OUTLIER Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.097 -1.049 . . . . 1.36 113.661 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 68.31 143.97 0.11 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.724 -0.751 . . . . 1.83 113.363 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 46.8 mm . . . . . 0 C--N 1.33 -0.27 0 N-CA-C 110.485 -0.191 . . . . 1.48 110.485 179.394 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 21.9 mm . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.923 0.392 . . . . 1.48 110.254 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -87.09 110.49 20.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.125 0.488 . . . . 2.17 111.084 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.75 HD11 HG12 ' A' ' 397' ' ' VAL . 72.0 mt -79.89 -39.01 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.678 -0.692 . . . . 0.92 111.248 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 58.1 m -70.71 58.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.597 -0.729 . . . . 1.71 111.983 -179.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -174.47 -30.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 1.92 110.47 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.497 HD22 ' C ' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -156.12 58.41 1.74 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.796 -0.638 . . . . 2.14 111.172 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 51.3 Cg_exo -53.72 -39.33 84.0 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.198 1.932 . . . . 0.85 111.461 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.41 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 1.4 m-20 -64.32 -31.59 72.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.67 -0.696 . . . . 1.21 111.175 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 83.7 tttt -45.83 125.45 6.17 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.016 0.436 . . . . 1.66 110.805 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.839 HD12 HG21 ' A' ' 417' ' ' VAL . 21.4 mm -79.71 123.75 36.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.91 -0.586 . . . . 0.41 111.902 -179.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -110.08 143.86 39.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.627 -0.508 . . . . 0.63 109.627 178.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.531 ' HB2' ' CD1' ' A' ' 439' ' ' LEU . 19.6 m-85 -91.47 138.83 31.27 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.822 -0.351 . . . . 0.96 110.617 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.742 HG12 HG21 ' A' ' 414' ' ' VAL . 2.7 mp -124.33 130.35 73.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.313 -0.403 . . . . 0.49 111.439 -179.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 439' ' ' LEU . 57.4 ttt-85 -99.05 122.23 42.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 2.42 110.926 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -82.7 -173.25 4.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.506 -0.316 . . . . 2.3 110.74 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.444 ' N ' ' OE1' ' A' ' 388' ' ' GLU . 0.4 OUTLIER -63.71 -44.62 93.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.835 0.35 . . . . 2.82 110.828 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -71.17 5.57 2.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.115 -0.493 . . . . 1.23 111.249 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 71.35 28.89 69.05 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.021 -0.609 . . . . 1.03 113.074 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 42.3 p -93.9 110.33 22.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.668 0.27 . . . . 0.98 111.04 179.274 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.713 HG11 HD13 ' A' ' 442' ' ' ILE . 42.1 t -74.59 131.57 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.852 -0.425 . . . . 0.55 109.852 179.13 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -145.39 135.52 23.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.454 -0.339 . . . . 2.43 111.038 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.515 ' HD3' HG21 ' A' ' 382' ' ' ILE . 58.9 mtt85 -58.9 150.59 23.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.967 0.413 . . . . 2.96 111.576 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -177.05 132.84 2.11 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.755 -0.657 . . . . 0.26 112.097 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 76.7 mt-30 -90.51 129.72 36.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.64 0.257 . . . . 1.28 111.535 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.855 HG22 HD13 ' A' ' 432' ' ' ILE . 5.8 t -85.4 126.85 40.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 109.613 -0.514 . . . . 0.83 109.613 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 70.5 mt -121.12 -40.14 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.214 0.45 . . . . 1.45 112.214 -178.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.546 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 98.3 mm-40 -128.6 176.45 7.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.987 0.422 . . . . 2.08 112.04 -178.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 87.7 p -161.83 149.4 14.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.684 -0.689 . . . . 0.56 110.594 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -162.49 143.8 10.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.107 0.479 . . . . 1.55 111.33 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.721 HG22 ' HA ' ' A' ' 410' ' ' ASP . 30.2 p -115.13 134.03 55.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.741 -0.663 . . . . 1.79 109.489 178.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.777 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.9 m -58.42 -174.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.889 -0.411 . . . . 1.95 109.889 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.777 ' H ' HG22 ' A' ' 403' ' ' THR . 4.8 mm-40 -39.64 -44.78 1.55 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 3.87 110.207 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -94.09 129.29 40.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.712 -0.676 . . . . 3.16 109.345 178.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -113.89 57.6 0.69 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.164 0.506 . . . . 2.18 111.489 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -138.71 11.35 2.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.623 -0.717 . . . . 2.77 110.028 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -173.8 -46.01 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.077 -0.965 . . . . 2.76 110.951 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 19.8 Cg_exo -68.62 38.85 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 123.162 2.574 . . . . 2.49 113.897 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.721 ' HA ' HG22 ' A' ' 402' ' ' THR . 1.2 m-20 -81.28 131.78 35.31 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.417 -0.586 . . . . 2.14 109.417 178.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 50.1 mt-10 -136.79 134.97 37.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.731 0.3 . . . . 2.1 111.265 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 429' ' ' ARG . 1.4 m-85 -119.21 127.62 53.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.482 -0.326 . . . . 0.72 111.113 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.546 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 15.0 t80 -57.82 143.5 42.08 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.483 -0.562 . . . . 0.51 109.483 178.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.742 HG21 HG12 ' A' ' 385' ' ' ILE . 5.7 p -143.8 110.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.688 0.625 . . . . 1.15 112.688 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -90.58 96.49 10.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.483 -0.78 . . . . 0.62 109.254 178.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.527 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 54.4 m-85 -51.83 125.88 16.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.248 0.547 . . . . 0.65 111.067 -178.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.839 HG21 HD12 ' A' ' 382' ' ' ILE . 2.5 t -79.32 34.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.256 -0.884 . . . . 1.34 111.105 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -179.53 -45.88 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.564 -0.744 . . . . 0.82 112.679 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.851 HD23 HD23 ' A' ' 423' ' ' LEU . 7.0 mp -63.98 155.55 30.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.137 0.494 . . . . 1.6 111.458 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.494 ' HB2' HD13 ' A' ' 423' ' ' LEU . 1.8 m120 -50.43 142.31 10.68 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.45 -0.796 . . . . 2.53 111.693 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.729 ' HD2' ' N ' ' A' ' 422' ' ' ARG . 7.1 ppt_? -58.4 -29.88 66.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.176 -0.466 . . . . 3.98 110.822 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . 0.729 ' N ' ' HD2' ' A' ' 421' ' ' ARG . 38.0 ptt180 -63.98 -37.15 86.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 3.71 110.321 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.851 HD23 HD23 ' A' ' 419' ' ' LEU . 7.0 mp -61.92 -33.35 74.08 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.877 -0.601 . . . . 1.49 110.755 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -50.63 138.19 18.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.681 -0.69 . . . . 1.2 111.141 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -170.99 -141.18 3.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.824 -0.703 . . . . 0.7 112.506 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -122.26 132.58 54.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.859 0.361 . . . . 0.61 110.873 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.624 HG21 HG13 ' A' ' 432' ' ' ILE . 20.3 m -110.81 155.64 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 0.89 111.693 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.489 ' H ' ' NH1' ' A' ' 431' ' ' ARG . . . -71.35 21.32 0.69 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.065 -0.588 . . . . 1.72 113.935 -179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.51 ' HB2' ' CD1' ' A' ' 412' ' ' TYR . 37.7 tpt85 70.64 -46.17 0.62 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.138 0.792 . . . . 1.73 113.138 178.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -59.89 -14.69 16.58 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.67 0.748 . . . . 1.47 109.33 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.489 ' NH1' ' H ' ' A' ' 428' ' ' GLY . 58.0 mtt85 -79.06 -34.89 43.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.571 -1.195 . . . . 2.84 111.221 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.855 HD13 HG22 ' A' ' 397' ' ' VAL . 65.8 mt -87.63 137.34 21.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.857 0.36 . . . . 0.46 110.869 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.0 m -159.69 138.8 11.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.53 110.721 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.17 -18.89 60.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 1.35 110.811 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -108.59 132.93 53.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.105 -0.498 . . . . 2.16 111.017 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . 0.457 ' HB1' HG12 ' A' ' 442' ' ' ILE . . . -66.23 -38.73 88.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.75 111.519 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -51.87 -40.73 61.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.308 -0.406 . . . . 1.34 111.257 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -81.69 41.1 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 1.56 110.624 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.556 ' O ' ' HD2' ' A' ' 386' ' ' ARG . 54.7 mt -152.62 -85.88 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.42 . . . . 1.12 111.34 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.01 32.91 0.25 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.444 -0.884 . . . . 1.36 112.857 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 54.25 36.94 58.28 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 121.144 -0.55 . . . . 1.83 113.604 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . 0.713 HD13 HG11 ' A' ' 392' ' ' VAL . 48.0 mm . . . . . 0 C--N 1.327 -0.388 0 N-CA-C 111.76 0.281 . . . . 1.48 111.76 178.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.622 HD11 ' NH1' ' A' ' 429' ' ' ARG . 67.5 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.873 0.368 . . . . 1.48 111.782 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.573 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 3.6 m-20 -91.68 68.53 5.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.026 -0.534 . . . . 2.17 110.372 178.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.543 HD11 HG12 ' A' ' 397' ' ' VAL . 75.3 mt -51.86 -34.74 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.92 112.073 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 37.6 t -47.8 -24.8 1.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.192 -0.458 . . . . 1.71 112.201 -178.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 11.9 pt-20 -69.22 -37.82 78.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.321 -0.4 . . . . 1.92 111.848 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.453 HD22 ' C ' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -154.17 65.0 4.89 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 111.695 0.257 . . . . 2.14 111.695 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.85 -37.66 85.24 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.396 2.064 . . . . 0.85 111.673 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -64.29 -33.67 76.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.684 -0.689 . . . . 1.21 111.168 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -52.19 127.96 23.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.944 0.402 . . . . 1.66 110.935 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.452 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 45.1 mm -87.36 131.42 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.971 -0.559 . . . . 0.41 111.604 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -111.24 144.29 40.66 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.255 -0.429 . . . . 0.63 110.026 179.104 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.52 ' C ' HD12 ' A' ' 385' ' ' ILE . 18.2 m-85 -88.92 142.43 27.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.979 -0.288 . . . . 0.96 110.673 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.643 HG12 HG21 ' A' ' 414' ' ' VAL . 3.4 mp -123.96 133.53 69.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.981 0.42 . . . . 0.49 111.92 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.577 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 42.7 ttt85 -87.14 117.0 25.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 2.42 110.455 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.429 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 58.3 mtp85 -70.12 169.52 13.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.754 0.311 . . . . 2.3 111.142 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -51.72 -45.52 63.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.191 -0.459 . . . . 2.82 111.339 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.53 -36.05 76.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.316 -0.402 . . . . 1.23 111.021 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 120.29 36.14 0.82 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.966 -0.635 . . . . 1.03 112.5 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . 0.429 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 17.5 p -110.71 114.48 27.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.188 0.518 . . . . 0.98 111.289 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 439' ' ' LEU . 91.9 t -66.66 135.02 29.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.456 -0.793 . . . . 0.55 111.842 -178.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -153.77 132.26 12.11 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.411 -0.813 . . . . 2.43 110.38 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.452 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 73.6 mtt-85 -54.56 154.07 5.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.355 0.598 . . . . 2.96 112.354 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -169.59 135.14 3.44 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.145 -0.934 . . . . 0.26 111.499 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -91.61 111.21 22.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.807 0.303 . . . . 1.28 111.76 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.74 HG22 HD13 ' A' ' 432' ' ' ILE . 4.1 t -74.87 129.09 36.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 109.942 -0.392 . . . . 0.83 109.942 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 77.0 mt -121.2 -41.28 2.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.362 0.504 . . . . 1.45 112.362 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.526 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 72.5 mt-30 -135.47 177.03 8.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.963 0.411 . . . . 2.08 111.577 -178.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 412' ' ' TYR . 80.8 p -151.53 139.39 19.91 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.901 -0.59 . . . . 0.56 110.72 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -154.69 144.08 21.3 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.334 -0.394 . . . . 1.55 111.136 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.542 HG22 ' HA ' ' A' ' 410' ' ' ASP . 41.6 p -94.47 -121.72 0.1 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.713 -0.477 . . . . 1.79 109.713 178.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.755 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.71 -173.38 2.98 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.607 -0.516 . . . . 1.95 109.607 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.755 ' H ' HG22 ' A' ' 403' ' ' THR . 48.9 mt-10 -43.67 -43.42 5.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.758 0.313 . . . . 3.87 111.389 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -70.28 -51.88 27.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 3.16 111.308 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.08 53.06 11.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.328 0.585 . . . . 2.18 110.864 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.431 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -162.35 12.38 0.07 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.172 -0.922 . . . . 2.77 109.273 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.697 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -161.04 -41.52 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.448 -1.251 . . . . 2.76 111.716 -178.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.697 ' HD2' ' H ' ' A' ' 408' ' ' ALA . 75.5 Cg_exo -52.21 -62.27 0.39 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.234 1.956 . . . . 2.49 113.708 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.542 ' HA ' HG22 ' A' ' 402' ' ' THR . 6.6 p-10 36.02 74.39 0.07 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.228 0.537 . . . . 2.14 111.231 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.41 147.72 30.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 2.1 110.779 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 6.0 m-85 -127.21 125.15 40.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.374 . . . . 0.72 111.203 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.526 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 15.5 t80 -57.84 149.89 21.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.923 -0.58 . . . . 0.51 110.414 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.643 HG21 HG12 ' A' ' 385' ' ' ILE . 11.2 p -155.82 138.05 6.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.143 0.497 . . . . 1.15 112.212 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -115.02 101.49 9.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.68 -0.691 . . . . 0.62 110.386 179.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 8.6 m-85 -62.1 116.1 4.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.193 -0.458 . . . . 0.65 111.298 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.442 ' O ' HD23 ' A' ' 419' ' ' LEU . 63.1 t -67.58 130.42 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 1.34 111.054 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.77 -42.8 1.83 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.859 -0.686 . . . . 0.82 112.761 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 2.0 mm? -59.33 152.85 20.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.862 0.363 . . . . 1.6 111.209 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.754 HD21 HD13 ' A' ' 423' ' ' LEU . 11.8 p-10 -49.73 136.53 17.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 2.53 111.349 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.423 HH11 ' HG3' ' A' ' 421' ' ' ARG . 60.9 mtt85 -57.35 -40.47 78.13 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.84 0.682 . . . . 3.98 112.84 -178.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . 0.434 ' CG ' HD22 ' A' ' 420' ' ' ASN . 16.9 ptp180 -53.84 -29.15 39.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.777 0.323 . . . . 3.71 110.864 -179.398 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.754 HD13 HD21 ' A' ' 420' ' ' ASN . 1.2 tp -59.26 -34.13 71.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 1.49 110.858 179.056 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -48.21 138.14 9.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.945 -0.57 . . . . 1.2 111.311 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.87 -142.91 4.82 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.001 -0.618 . . . . 0.7 112.121 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -128.6 134.59 48.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.376 . . . . 0.61 110.639 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.765 HG21 HG13 ' A' ' 432' ' ' ILE . 29.3 m -109.38 158.76 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.944 -0.571 . . . . 0.89 111.887 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -77.46 35.01 1.56 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.834 -0.621 . . . . 1.72 114.441 -179.135 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.622 ' NH1' HD11 ' A' ' 373' ' ' ILE . 23.6 tpt180 70.69 -70.37 0.15 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.248 0.833 . . . . 1.73 113.248 178.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -45.39 -16.12 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.947 0.403 . . . . 1.47 111.707 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.586 ' HB3' HG23 ' A' ' 385' ' ' ILE . 53.4 mtt85 -77.47 -39.06 47.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.956 -0.565 . . . . 2.84 111.333 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.765 HG13 HG21 ' A' ' 427' ' ' VAL . 86.7 mt -87.04 132.07 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.155 -0.313 . . . . 0.46 110.155 179.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.756 ' HB2' HD11 ' A' ' 439' ' ' LEU . 61.0 m -164.0 142.13 7.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.53 111.136 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -58.72 -26.09 63.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.076 -0.511 . . . . 1.35 110.793 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -121.78 135.15 54.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.161 -0.472 . . . . 2.16 110.851 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . 0.498 ' HA ' HD13 ' A' ' 439' ' ' LEU . . . -70.75 -10.96 60.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.75 111.635 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.07 -40.99 77.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 1.34 111.716 -179.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . 0.54 ' C ' HD12 ' A' ' 439' ' ' LEU . 61.1 m-20 -83.03 18.23 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.826 0.346 . . . . 1.56 111.337 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.756 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.4 mp -118.02 -96.54 0.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.12 111.216 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . 0.577 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -173.9 41.61 0.14 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.323 -0.942 . . . . 1.36 113.431 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.9 149.76 0.09 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.662 -0.78 . . . . 1.83 113.28 179.074 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 442' ' ' ILE . 1.5 mp . . . . . 0 CA--C 1.518 -0.28 0 N-CA-C 109.128 -0.693 . . . . 1.48 109.128 178.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.72 HG13 ' HE ' ' A' ' 429' ' ' ARG . 85.7 mt . . . . . 0 N--CA 1.462 0.13 0 CA-C-O 120.763 0.316 . . . . 1.48 111.622 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.418 ' HB2' ' CD ' ' A' ' 377' ' ' GLU . 31.6 m-20 -89.56 129.52 36.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 2.17 109.914 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.803 HD11 HG12 ' A' ' 397' ' ' VAL . 95.5 mt -88.26 -41.51 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.409 0.522 . . . . 0.92 112.409 -179.176 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.7 t -46.74 -21.13 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.284 -0.417 . . . . 1.71 111.865 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.418 ' CD ' ' HB2' ' A' ' 374' ' ' ASP . 6.7 mt-10 -61.77 -42.39 98.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.855 -0.611 . . . . 1.92 111.369 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.415 ' N ' ' ND2' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -167.64 69.79 0.91 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 2.14 111.188 -179.21 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.47 -39.66 54.52 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.57 2.18 . . . . 0.85 112.158 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.79 -39.29 84.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 1.21 110.69 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 82.0 tttt -54.66 130.83 41.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.144 -0.48 . . . . 1.66 111.048 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.553 HG21 ' HB3' ' A' ' 394' ' ' ARG . 28.7 mm -84.72 135.68 24.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.072 -0.513 . . . . 0.41 111.442 -179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -108.17 143.8 36.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.374 -0.375 . . . . 0.63 110.388 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.428 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 7.1 m-85 -88.22 133.64 33.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.603 0.24 . . . . 0.96 110.659 179.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 385' ' ' ILE . 1.9 mp -121.77 130.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.75 0.31 . . . . 0.49 110.699 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.492 ' CZ ' ' HA2' ' A' ' 390' ' ' GLY . 60.7 ttt-85 -80.71 117.15 21.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.373 -0.376 . . . . 2.42 110.648 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.751 ' HA ' ' HE ' ' A' ' 387' ' ' ARG . 2.0 mmp_? -68.17 164.81 19.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 2.3 110.571 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 388' ' ' GLU . 0.5 OUTLIER -51.71 -45.02 63.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 2.82 111.615 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.406 ' N ' ' HG2' ' A' ' 388' ' ' GLU . 40.8 p-10 -69.63 -35.72 75.48 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.679 0.252 . . . . 1.23 111.679 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.492 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 138.8 -32.45 2.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.583 -0.818 . . . . 1.03 112.561 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 72.4 p -59.1 112.24 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.082 0.468 . . . . 0.98 111.657 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 57.1 t -72.88 140.92 17.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.738 -0.665 . . . . 0.55 111.274 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -139.7 137.57 35.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 2.43 110.718 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.553 ' HB3' HG21 ' A' ' 382' ' ' ILE . 55.5 mtt85 -62.38 145.04 55.01 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.914 0.388 . . . . 2.96 110.923 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -164.14 134.4 3.35 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.022 -0.608 . . . . 0.26 112.397 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . 0.541 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 90.0 mt-30 -82.19 132.28 35.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.531 0.205 . . . . 1.28 111.506 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.803 HG12 HD11 ' A' ' 375' ' ' ILE . 11.7 t -99.82 122.19 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.067 -0.716 . . . . 0.83 109.067 178.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.716 HD22 ' N ' ' A' ' 398' ' ' LEU . 0.7 OUTLIER -111.64 -41.91 3.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.703 0.631 . . . . 1.45 112.703 -177.026 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -132.95 176.45 8.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.993 0.425 . . . . 2.08 111.77 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.2 p -164.27 147.45 9.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.753 -0.658 . . . . 0.56 110.863 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -160.66 134.2 6.8 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.002 0.43 . . . . 1.55 111.41 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.752 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 35.5 p -81.42 137.44 35.66 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.246 -0.434 . . . . 1.79 110.004 178.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.821 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.1 m -62.13 -174.03 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 1.95 110.761 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.821 ' H ' HG22 ' A' ' 403' ' ' THR . 50.6 mt-10 -42.28 -41.84 2.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.977 0.362 . . . . 3.87 111.977 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.732 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 24.0 t-20 -57.43 -48.48 79.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 3.16 110.673 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.752 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.63 57.23 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 2.18 111.997 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.521 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -168.95 10.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 2.77 110.629 179.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.474 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . 179.85 -43.8 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.729 -0.669 . . . . 2.76 111.918 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.732 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 11.7 Cg_exo -71.73 49.56 1.23 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.77 2.314 . . . . 2.49 114.193 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.8 p30 -78.17 126.73 31.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.847 0.356 . . . . 2.14 110.504 178.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 400' ' ' SER . 47.4 mt-10 -114.05 134.63 54.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 2.1 110.482 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.569 ' HB3' HG13 ' A' ' 397' ' ' VAL . 1.6 m-85 -111.91 134.05 53.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.973 0.416 . . . . 0.72 111.941 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 17.8 t80 -66.57 138.41 57.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.691 -0.855 . . . . 0.51 108.691 177.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.551 HG11 HG12 ' A' ' 385' ' ' ILE . 21.7 t -140.78 110.08 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 113.202 0.815 . . . . 1.15 113.202 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . 0.484 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 86.4 t60 -90.1 88.5 7.29 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.661 -0.866 . . . . 0.62 108.661 177.176 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . 0.631 ' HB2' HD11 ' A' ' 419' ' ' LEU . 4.7 m-85 -57.95 116.01 3.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.807 0.813 . . . . 0.65 111.482 -178.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.482 HG21 ' CB ' ' A' ' 394' ' ' ARG . 5.5 m -53.87 129.56 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 CA-C-N 114.027 -1.442 . . . . 1.34 112.818 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 81.88 -52.1 4.55 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 115.415 0.926 . . . . 0.82 115.415 177.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.924 HD13 HD23 ' A' ' 423' ' ' LEU . 0.5 OUTLIER -62.18 162.52 9.48 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.901 0.851 . . . . 1.6 112.561 -177.706 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.617 HD22 ' HB3' ' A' ' 422' ' ' ARG . 56.0 t30 -59.68 143.51 50.5 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.507 -0.77 . . . . 2.53 111.877 -179.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . 0.66 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 99.3 mtt180 -53.39 -20.21 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 3.98 111.716 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . 0.617 ' HB3' HD22 ' A' ' 420' ' ' ASN . 2.6 tpm_? -55.32 -40.34 71.04 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.854 -0.612 . . . . 3.71 112.157 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.924 HD23 HD13 ' A' ' 419' ' ' LEU . 2.1 mm? -70.62 -35.13 72.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.87 0.322 . . . . 1.49 111.87 -179.249 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.66 ' OD2' ' HA ' ' A' ' 421' ' ' ARG . 62.3 m-20 -48.71 132.38 17.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.97 0.415 . . . . 1.2 111.407 -178.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.28 179.99 46.17 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.856 -0.687 . . . . 0.7 112.33 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . 0.57 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 36.2 m95 -76.8 139.21 40.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.605 0.24 . . . . 0.61 110.45 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.417 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 12.3 m -140.39 146.75 24.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.966 0.412 . . . . 0.89 111.492 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.453 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -59.21 149.16 39.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.873 -0.68 . . . . 1.72 112.407 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.72 ' HE ' HG13 ' A' ' 373' ' ' ILE . 37.9 tpt85 -52.09 -39.62 60.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.727 0.269 . . . . 1.73 111.727 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.453 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 19.5 p-80 -55.97 -26.7 49.33 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.143 0.423 . . . . 1.47 112.143 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.417 ' HD2' ' HB ' ' A' ' 427' ' ' VAL . 57.3 mtt85 -78.09 -38.58 43.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.845 0.313 . . . . 2.84 111.845 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 412' ' ' TYR . 59.6 mt -88.75 134.78 27.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.88 0.371 . . . . 0.46 111.154 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.746 ' HB2' HD21 ' A' ' 439' ' ' LEU . 71.1 m -160.64 139.74 10.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.53 110.928 -179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -74.37 16.75 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 1.35 111.719 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -138.47 131.31 29.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.986 0.422 . . . . 2.16 111.133 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -67.33 -72.77 0.16 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.892 -0.594 . . . . 0.75 111.62 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -40.71 -39.3 1.05 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.927 -0.579 . . . . 1.34 111.715 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.87 47.37 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.301 -0.409 . . . . 1.56 111.298 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 433' ' ' SER . 94.7 mt -149.87 -84.81 0.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.644 -0.253 . . . . 1.12 111.405 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -163.3 40.91 0.33 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.508 -0.853 . . . . 1.36 113.089 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.21 146.83 0.32 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 1.83 113.237 179.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.671 0.272 . . . . 1.48 110.99 179.843 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 77.5 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.922 0.391 . . . . 1.48 111.977 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 21.8 m-20 -88.95 137.7 32.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 2.17 110.673 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.562 HD11 HG12 ' A' ' 397' ' ' VAL . 79.4 mt -96.48 -46.62 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.206 0.527 . . . . 0.92 111.464 -180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 56.8 m -53.9 -18.15 3.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.297 -0.865 . . . . 1.71 111.613 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 24.1 pt-20 -74.97 -40.47 60.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.134 -0.485 . . . . 1.92 111.917 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 378' ' ' ASN . . . . . 0.616 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 6.0 m120 -154.86 74.57 5.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 2.14 112.029 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.44 -40.74 81.91 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.68 2.254 . . . . 0.85 112.172 179.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -67.58 -37.56 82.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.848 -0.614 . . . . 1.21 111.36 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.616 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 63.9 tttp -50.35 129.44 21.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 1.66 111.261 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 40.2 mm -88.62 132.82 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.037 -0.529 . . . . 0.41 111.189 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.88 143.62 34.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.931 -0.396 . . . . 0.63 109.931 179.018 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -89.72 122.9 33.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.96 110.779 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.1 mp -106.09 123.09 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 0.49 111.328 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.588 ' HB2' HD22 ' A' ' 439' ' ' LEU . 38.4 ttt85 -84.08 118.53 24.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 2.42 110.534 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -71.45 157.28 38.31 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.887 -0.325 . . . . 2.3 110.566 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.616 ' HA ' HH12 ' A' ' 431' ' ' ARG . 16.3 pt-20 -49.66 -41.2 42.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 2.82 111.74 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -67.01 -36.24 81.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.683 -0.235 . . . . 1.23 111.138 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.411 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 136.44 -33.68 2.33 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.448 -0.882 . . . . 1.03 112.842 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 57.6 p -59.17 113.87 2.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.317 0.579 . . . . 0.98 112.149 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.17 144.6 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.321 -0.854 . . . . 0.55 111.351 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -151.59 129.75 11.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.006 -0.543 . . . . 2.43 110.684 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.447 ' HG3' HH11 ' A' ' 394' ' ' ARG . 61.3 mtt85 -55.4 153.85 6.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.878 -0.601 . . . . 2.96 112.137 -179.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 395' ' ' GLY . . . . . 0.454 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -175.75 135.24 2.91 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.416 -0.811 . . . . 0.26 112.114 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 74.7 mt-30 -91.5 138.06 31.87 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.944 -0.151 . . . . 1.28 111.007 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 397' ' ' VAL . . . . . 0.638 ' CG2' HD13 ' A' ' 432' ' ' ILE . 14.5 t -92.09 102.19 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.211 -0.662 . . . . 0.83 109.211 178.27 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 398' ' ' LEU . 6.2 mp -84.95 -36.81 21.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.594 -0.73 . . . . 1.45 112.473 -177.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 399' ' ' GLN . . . . . 0.546 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 66.0 mt-30 -141.0 175.66 9.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.976 0.417 . . . . 2.08 111.333 -178.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 93.2 p -165.63 144.22 6.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.689 -0.687 . . . . 0.56 110.589 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.591 ' HG3' ' HB3' ' A' ' 410' ' ' ASP . 36.1 ptt180 -118.74 175.4 5.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 1.55 109.989 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 410' ' ' ASP . 26.6 p -127.82 133.38 49.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.128 0.489 . . . . 1.79 111.956 -179.161 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 403' ' ' THR . . . . . 0.813 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.4 m -63.19 -170.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.488 -0.778 . . . . 1.95 110.363 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.813 ' H ' HG22 ' A' ' 403' ' ' THR . 49.9 mt-10 -42.44 -35.61 1.08 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.667 0.27 . . . . 3.87 110.566 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -54.17 -46.42 72.32 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.697 -0.483 . . . . 3.16 109.697 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 402' ' ' THR . . . 62.07 64.33 1.0 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.38 -0.827 . . . . 2.18 111.409 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -166.91 -25.1 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.416 0.524 . . . . 2.77 112.416 -179.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 408' ' ' ALA . . . . . 0.527 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -165.46 -47.26 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 114.101 1.148 . . . . 2.76 114.101 -179.045 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 55.7 Cg_exo -55.51 -155.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.676 2.25 . . . . 2.49 114.868 -177.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 410' ' ' ASP . . . . . 0.591 ' HB3' ' HG3' ' A' ' 401' ' ' ARG . 0.1 OUTLIER 80.38 -160.1 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.794 -1.094 . . . . 2.14 113.056 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 426' ' ' TRP . 95.1 mt-10 -106.48 149.02 27.5 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.067 -0.515 . . . . 2.1 111.554 -177.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.535 ' N ' ' HD1' ' A' ' 412' ' ' TYR . 0.4 OUTLIER -112.0 134.93 53.25 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.652 -0.704 . . . . 0.72 112.176 -177.952 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.546 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 14.8 t80 -67.05 145.43 55.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.75 -0.659 . . . . 0.51 110.419 179.318 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.519 HG11 HG12 ' A' ' 385' ' ' ILE . 13.7 t -148.57 129.48 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.127 0.788 . . . . 1.15 113.127 -179.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 415' ' ' HIS . . . . . 0.46 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 56.0 t60 -105.32 104.03 13.68 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.87 -0.605 . . . . 0.62 109.539 177.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 416' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -66.22 128.84 37.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.933 0.397 . . . . 0.65 111.162 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.24 128.91 36.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.86 -0.609 . . . . 1.34 111.823 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 75.29 -47.17 1.97 Allowed Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.781 -0.645 . . . . 0.82 113.363 179.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.575 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.6 mp -59.74 161.95 5.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.418 . . . . 1.6 111.62 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 420' ' ' ASN . . . . . 0.469 ' HB3' ' HG2' ' A' ' 422' ' ' ARG . 75.8 m-20 -50.11 139.73 13.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.634 -0.712 . . . . 2.53 111.82 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -63.59 -31.21 72.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.659 -0.701 . . . . 3.98 111.199 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . 0.469 ' HG2' ' HB3' ' A' ' 420' ' ' ASN . 14.6 ptp180 -52.77 -35.02 55.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 3.71 111.196 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 423' ' ' LEU . . . . . 0.575 HD12 ' HB3' ' A' ' 419' ' ' LEU . 50.8 mt -56.09 -32.13 63.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 1.49 111.357 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' A' ' 415' ' ' HIS . 1.1 m-20 -47.73 134.1 13.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.906 0.384 . . . . 1.2 111.327 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 413' ' ' TYR . . . -179.84 -142.62 5.16 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.749 . . . . 0.7 112.242 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 426' ' ' TRP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 37.3 m95 -122.49 138.56 54.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.937 0.399 . . . . 0.61 110.574 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.815 HG21 HG13 ' A' ' 432' ' ' ILE . 10.3 m -109.37 158.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.89 111.652 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -75.31 27.17 1.23 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.651 -0.785 . . . . 1.72 113.391 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.672 ' H ' HG23 ' A' ' 427' ' ' VAL . 40.8 tpt85 70.9 -47.0 0.65 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.869 0.468 . . . . 1.73 112.144 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.415 ' HE1' ' NE ' ' A' ' 431' ' ' ARG . 10.6 p80 -69.95 -7.09 37.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 1.47 110.801 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.635 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 39.2 mmt180 -79.2 -37.3 38.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 2.84 110.817 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.815 HG13 HG21 ' A' ' 427' ' ' VAL . 56.4 mt -87.88 135.8 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.46 110.784 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 54.0 m -157.65 139.51 14.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.255 -0.43 . . . . 0.53 111.015 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -79.21 16.31 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 1.35 111.902 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -145.64 132.82 20.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.958 0.408 . . . . 2.16 111.096 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 436' ' ' ALA . . . . . 0.445 ' HB1' HD11 ' A' ' 442' ' ' ILE . . . -70.52 -43.72 69.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.75 111.434 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -55.09 -40.37 70.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.225 -0.443 . . . . 1.34 111.2 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -79.26 46.38 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 1.56 111.164 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.588 HD22 ' HB2' ' A' ' 386' ' ' ARG . 98.3 mt -151.08 -84.04 0.09 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.502 -0.317 . . . . 1.12 111.133 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . 0.541 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -175.0 52.3 0.13 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.927 -0.654 . . . . 1.36 112.402 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 72.36 -139.51 28.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.839 -0.696 . . . . 1.83 112.407 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 442' ' ' ILE . . . . . 0.445 HD11 ' HB1' ' A' ' 436' ' ' ALA . 33.9 mm . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 109.95 -0.389 . . . . 1.48 109.95 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 112.534 -0.227 . . . . 11.64 112.534 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 79.8 p -172.57 130.8 0.56 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.683 0.277 . . . . 9.86 110.726 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 70.0 t60 59.35 109.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.947 -0.57 . . . . 8.07 111.084 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 26.5 mmt -71.87 130.44 41.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 5.51 110.793 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -59.87 150.98 66.35 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 6.06 110.58 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.87 38.39 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.603 2.202 . . . . 6.16 112.809 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.482 ' C ' HD13 ' A' ' 369' ' ' LEU . 2.8 tm? -170.24 -40.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 6.94 110.461 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.419 ' O ' ' HG3' ' A' ' 370' ' ' MET . 13.9 tpt -77.67 34.42 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 5.63 110.565 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 372' ' ' LYS . 25.8 mt-30 -80.97 63.03 5.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 5.04 110.643 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.608 ' HB2' ' OH ' ' A' ' 412' ' ' TYR . 63.5 pttt 53.04 138.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.04 0.837 . . . . 5.39 112.298 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.417 HD11 ' NH2' ' A' ' 429' ' ' ARG . 70.1 mt -48.68 129.15 5.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.61 -0.723 . . . . 1.48 112.14 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -89.74 130.72 35.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.694 -0.685 . . . . 2.17 110.689 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.5 mt -81.73 -43.63 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.92 111.394 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 72.7 p -65.46 74.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.979 -0.555 . . . . 1.71 111.211 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -173.83 -27.19 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.561 -0.745 . . . . 1.92 109.964 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 0.1 OUTLIER -165.67 57.7 0.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.372 -0.831 . . . . 2.14 111.392 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 51.2 Cg_exo -53.67 -39.12 84.46 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.247 1.964 . . . . 0.85 111.604 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.46 -32.4 73.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.751 -0.659 . . . . 1.21 110.943 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 84.6 tttt -50.4 127.06 16.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.241 -0.436 . . . . 1.66 111.117 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 47.4 mm -83.46 127.39 39.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.41 110.743 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -102.32 143.34 32.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.313 . . . . 0.63 110.694 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -92.25 140.01 30.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.272 -0.422 . . . . 0.96 110.282 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 385' ' ' ILE . 1.0 OUTLIER -133.49 126.88 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.49 111.111 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 45.2 ttt85 -79.83 116.77 20.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.008 -0.542 . . . . 2.42 110.431 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -69.98 155.55 40.42 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.677 -0.409 . . . . 2.3 110.21 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -51.26 -45.24 61.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 2.82 111.55 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -56.96 -34.61 68.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.086 -0.709 . . . . 1.23 109.086 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 132.57 -36.72 2.13 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.494 -0.775 . . . . 1.03 112.947 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 82.3 p -59.57 112.83 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.182 0.515 . . . . 0.98 112.163 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.5 142.38 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.707 -0.679 . . . . 0.55 110.696 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -147.94 143.94 27.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.38 . . . . 2.43 111.254 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -55.84 154.64 6.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.906 -0.588 . . . . 2.96 111.809 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -171.35 129.68 1.82 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.688 -0.687 . . . . 0.26 112.316 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -84.89 128.5 34.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.75 0.309 . . . . 1.28 110.752 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.7 OUTLIER -97.2 134.5 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.507 -0.315 . . . . 0.83 110.424 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 76.3 mt -120.57 -43.76 2.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.971 0.73 . . . . 1.45 112.971 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.413 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 23.8 mt-30 -122.75 174.78 6.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.117 0.484 . . . . 2.08 112.228 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.4 p -166.3 144.92 5.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.513 -0.767 . . . . 0.56 110.608 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.51 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 39.3 ptt180 -143.54 134.72 25.76 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.809 0.337 . . . . 1.55 110.842 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.633 HG22 ' HB3' ' A' ' 410' ' ' ASP . 18.0 p -98.85 38.02 1.43 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.098 0.407 . . . . 1.79 112.098 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.907 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.0 m 47.52 -173.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.285 -0.416 . . . . 1.95 111.249 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.907 ' H ' HG22 ' A' ' 403' ' ' THR . 94.4 mt-10 -68.68 -41.62 78.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.799 0.333 . . . . 3.87 111.402 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.558 ' OD1' ' HB3' ' A' ' 407' ' ' ALA . 24.3 t-20 -54.57 -52.48 61.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.154 -0.476 . . . . 3.16 111.311 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 55.55 59.67 3.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 2.18 111.756 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.558 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -163.51 11.08 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.459 0.647 . . . . 2.77 110.024 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.638 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -177.57 -49.77 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 114.808 -1.087 . . . . 2.76 110.23 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 30.8 Cg_endo -62.2 145.62 96.17 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.408 2.072 . . . . 2.49 112.425 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.633 ' HB3' HG22 ' A' ' 402' ' ' THR . 12.5 p-10 -178.47 124.65 0.11 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.047 -0.524 . . . . 2.14 110.763 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 400' ' ' SER . 10.8 mp0 -129.89 137.89 50.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.947 -0.57 . . . . 2.1 110.127 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.608 ' OH ' ' HB2' ' A' ' 372' ' ' LYS . 1.4 m-85 -109.76 133.41 53.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.883 0.373 . . . . 0.72 111.664 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 30.9 t80 -72.9 120.72 18.92 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.439 -0.578 . . . . 0.51 109.439 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.483 HG21 HG12 ' A' ' 385' ' ' ILE . 8.8 p -112.56 138.75 40.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.584 0.587 . . . . 1.15 112.584 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . 0.513 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 83.8 t60 -120.81 88.95 3.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.218 -0.901 . . . . 0.62 109.412 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.413 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 59.9 m-85 -52.85 116.2 2.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.65 111.318 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.3 t -62.11 128.89 24.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 1.34 111.371 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.39 -42.44 1.95 Allowed Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.776 -0.647 . . . . 0.82 113.351 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.675 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.8 mp -59.45 161.06 6.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.013 0.435 . . . . 1.6 111.576 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.616 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 4.9 m120 -49.78 140.91 10.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.514 -0.766 . . . . 2.53 111.925 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.522 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 88.7 mtm180 -65.23 -36.45 84.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.867 -0.606 . . . . 3.98 110.829 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 420' ' ' ASN . 3.7 ptm85 -55.65 -35.57 66.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.281 -0.418 . . . . 3.71 110.643 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 419' ' ' LEU . 76.7 mt -59.02 -35.17 72.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 1.49 111.394 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.522 ' OD2' ' HA ' ' A' ' 421' ' ' ARG . 48.9 m-20 -54.69 139.7 38.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 1.2 111.901 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 179.45 -153.35 12.11 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.472 -0.785 . . . . 0.7 111.852 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . 0.51 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 77.0 m95 -94.93 140.48 29.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.833 0.349 . . . . 0.61 111.082 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.53 ' CG2' HD11 ' A' ' 432' ' ' ILE . 16.1 m -138.76 137.5 42.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.032 -0.531 . . . . 0.89 111.399 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.495 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -62.22 150.13 47.03 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.819 -0.628 . . . . 1.72 112.591 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.417 ' NH2' HD11 ' A' ' 373' ' ' ILE . 41.0 tpt85 -53.61 -38.17 63.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 1.73 111.302 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.495 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 19.5 p-80 -58.08 -29.86 65.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.952 0.352 . . . . 1.47 111.952 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.05 -36.13 48.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.578 -0.283 . . . . 2.84 111.215 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 412' ' ' TYR . 54.1 mt -89.28 139.7 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.945 0.402 . . . . 0.46 111.366 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.6 m -160.97 139.51 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.53 110.651 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -63.78 -26.46 68.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 1.35 111.281 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.636 HD21 ' HB2' ' A' ' 437' ' ' ASP . 45.8 t30 -109.62 134.06 52.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.92 0.39 . . . . 2.16 110.691 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -73.37 -39.85 64.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.75 112.275 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . 0.636 ' HB2' HD21 ' A' ' 435' ' ' ASN . 57.0 m-20 -49.69 -40.87 41.66 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.787 0.291 . . . . 1.34 111.787 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.4 -40.96 94.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.348 . . . . 1.56 110.97 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.88 -83.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 1.12 111.558 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -138.59 34.36 2.12 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.492 -0.861 . . . . 1.36 113.077 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 437' ' ' ASP . . . 43.63 44.17 6.67 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.365 -0.445 . . . . 1.83 113.732 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 442' ' ' ILE . 48.0 mm 70.99 73.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.534 0.683 . . . . 1.48 111.476 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 443' ' ' THR . 36.4 m 45.45 59.13 3.74 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.579 0.955 . . . . 3.05 113.579 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 441' ' ' GLY . 16.1 m -151.72 127.43 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 115.756 -0.656 . . . . 4.18 110.123 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.34 126.05 86.9 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.409 -0.359 . . . . 4.99 111.31 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.76 140.28 35.24 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.62 2.214 . . . . 7.4 112.055 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . -54.66 128.08 61.16 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.339 -0.391 . . . . 9.06 110.966 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 447' ' ' ALA . 36.2 Cg_exo -60.44 131.36 37.94 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.535 2.157 . . . . 11.06 112.436 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 22.7 Cg_exo -64.68 133.19 35.63 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.623 2.215 . . . . 13.5 112.161 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 94.3 mt -80.99 46.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 15.76 110.986 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . 57.72 62.92 5.01 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.313 -0.403 . . . . 16.74 110.932 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.65 135.27 41.27 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.519 2.146 . . . . 18.53 112.648 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -171.8 128.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.892 -0.594 . . . . 20.55 110.513 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.207 -0.902 . . . . 21.22 110.915 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 112.452 -0.259 . . . . 11.64 112.452 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.5 t 64.25 131.41 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.953 0.406 . . . . 9.86 111.278 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -174.37 58.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.097 -0.502 . . . . 8.07 110.502 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 67.9 mtm -58.54 140.52 54.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 5.51 110.826 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.52 ' HB2' ' HG2' ' A' ' 370' ' ' MET . 55.3 m-20 61.03 120.22 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.005 -0.543 . . . . 6.06 111.563 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.67 49.17 3.09 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.657 2.238 . . . . 6.16 112.861 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.672 HD12 ' N ' ' A' ' 370' ' ' MET . 4.5 pp -155.42 -33.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.709 -0.223 . . . . 6.94 111.586 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.672 ' N ' HD12 ' A' ' 369' ' ' LEU . 22.4 ptm -78.53 42.9 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.599 -0.273 . . . . 5.63 111.449 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -56.25 134.12 53.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.653 0.263 . . . . 5.04 110.473 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.421 ' HD2' ' CZ ' ' A' ' 429' ' ' ARG . 48.3 mmtm -145.74 135.27 23.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.464 -0.335 . . . . 5.39 111.374 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.659 HG22 HG13 ' A' ' 375' ' ' ILE . 31.4 mm 57.04 127.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.793 -0.64 . . . . 1.48 112.448 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 377' ' ' GLU . 45.5 m-20 -106.19 69.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.711 -0.677 . . . . 2.17 110.489 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.844 HD11 HG12 ' A' ' 397' ' ' VAL . 73.5 mt -60.67 -82.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.036 0.754 . . . . 0.92 113.036 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 375' ' ' ILE . 52.0 m -49.93 -28.73 7.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.121 -0.49 . . . . 1.71 111.814 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 374' ' ' ASP . 8.5 mt-10 -70.44 -38.25 74.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.698 -0.683 . . . . 1.92 111.144 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.527 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 3.9 m120 -146.04 66.17 11.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 2.14 111.68 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.13 -40.65 76.33 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.691 2.261 . . . . 0.85 112.227 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.05 -37.13 85.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.887 -0.597 . . . . 1.21 111.327 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.3 tttp -51.17 125.63 14.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.399 . . . . 1.66 111.124 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.936 HD12 HG21 ' A' ' 417' ' ' VAL . 42.5 mm -87.04 132.87 31.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.973 -0.558 . . . . 0.41 111.47 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -107.25 143.69 35.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.371 -0.377 . . . . 0.63 110.361 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 436' ' ' ALA . 2.7 m-85 -92.64 138.35 31.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.667 0.27 . . . . 0.96 110.641 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 385' ' ' ILE . 3.0 mp -123.01 135.45 63.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.893 0.378 . . . . 0.49 111.267 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.662 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 56.3 ttt-85 -92.44 121.73 34.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 2.42 111.204 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -79.52 156.64 27.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.546 -0.297 . . . . 2.3 110.412 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -51.54 -45.45 62.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 2.82 111.036 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -59.44 -32.53 70.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 1.23 110.295 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 112.33 37.75 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.894 -0.593 . . . . 1.03 112.828 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 62.9 p -120.84 112.34 18.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.863 0.363 . . . . 0.98 111.342 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 87.0 t -69.6 138.92 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.55 111.21 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -149.37 138.81 21.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.11 -0.496 . . . . 2.43 110.978 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.495 ' HD2' HG21 ' A' ' 382' ' ' ILE . 73.8 mtm-85 -57.41 150.28 18.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.545 . . . . 2.96 111.802 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -175.7 132.98 2.26 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.586 -0.734 . . . . 0.26 111.856 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 82.8 mt-30 -95.2 129.99 42.1 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.851 0.315 . . . . 1.28 111.851 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.844 HG12 HD11 ' A' ' 375' ' ' ILE . 21.5 t -85.9 132.38 32.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.94 -0.393 . . . . 0.83 109.94 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.429 ' C ' HD13 ' A' ' 375' ' ' ILE . 91.9 mt -121.02 -40.82 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.575 0.583 . . . . 1.45 112.575 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.48 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 97.9 mm-40 -136.86 176.46 8.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.231 0.538 . . . . 2.08 112.25 -178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.7 p -158.0 140.13 14.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.369 -0.832 . . . . 0.56 109.947 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.447 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 38.0 ptt180 -142.31 137.05 30.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.066 0.46 . . . . 1.55 112.035 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 409' ' ' PRO . 42.1 p -77.42 137.46 38.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 1.79 110.312 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.808 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.7 m -62.4 -174.29 0.06 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.03 -0.359 . . . . 1.95 110.03 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.808 ' H ' HG22 ' A' ' 403' ' ' THR . 55.5 mt-10 -48.21 -40.69 25.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.8 0.333 . . . . 3.87 110.695 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.517 ' O ' ' HD2' ' A' ' 409' ' ' PRO . 50.1 t30 -80.5 54.19 2.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.979 -0.555 . . . . 3.16 110.664 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . -51.43 98.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.131 0.491 . . . . 2.18 110.995 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -177.28 -29.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.378 -0.828 . . . . 2.77 109.978 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.666 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -145.57 -51.21 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.106 -0.952 . . . . 2.76 111.259 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.666 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 51.0 Cg_exo -55.46 145.71 66.97 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.457 2.105 . . . . 2.49 112.354 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.402 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 12.8 p-10 -173.01 128.62 0.47 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.153 0.502 . . . . 2.14 111.326 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 400' ' ' SER . 52.2 mp0 -108.73 144.25 36.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.643 -0.708 . . . . 2.1 109.98 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.433 ' N ' ' HD1' ' A' ' 412' ' ' TYR . 0.8 OUTLIER -109.15 124.18 50.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.079 0.466 . . . . 0.72 111.841 -178.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 11.9 t80 -63.96 149.9 46.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.567 -0.742 . . . . 0.51 109.341 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 12.3 p -153.78 137.52 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.199 0.523 . . . . 1.15 112.356 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -118.46 107.46 13.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.415 -0.811 . . . . 0.62 109.553 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.467 ' CD2' HD22 ' A' ' 419' ' ' LEU . 37.3 m-85 -62.13 127.82 33.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.081 0.467 . . . . 0.65 111.218 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.936 HG21 HD12 ' A' ' 382' ' ' ILE . 2.4 t -82.49 34.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.518 -0.764 . . . . 1.34 111.223 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -176.81 -48.39 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.769 -0.729 . . . . 0.82 112.783 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.605 ' HB3' HD23 ' A' ' 423' ' ' LEU . 7.0 mp -62.75 150.37 41.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 1.6 110.916 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.415 ' N ' HD23 ' A' ' 423' ' ' LEU . 48.5 t30 -53.09 165.91 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.943 -0.571 . . . . 2.53 111.157 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -64.22 -27.56 69.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 3.98 110.543 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -53.44 -39.75 64.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.802 -0.635 . . . . 3.71 111.047 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.655 HD22 ' H ' ' A' ' 423' ' ' LEU . 1.6 mm? -70.9 -34.82 71.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.178 -0.465 . . . . 1.49 110.502 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -53.76 131.56 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.798 -0.637 . . . . 1.2 111.25 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 169.72 -146.39 10.01 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.867 -0.606 . . . . 0.7 112.209 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . 0.447 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 57.0 m95 -103.75 140.09 38.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.801 0.334 . . . . 0.61 110.722 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.461 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 32.0 m -141.04 144.7 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.89 111.097 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -59.0 148.69 39.43 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.961 -0.638 . . . . 1.72 112.835 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.421 ' CZ ' ' HD2' ' A' ' 372' ' ' LYS . 18.3 tpt180 -52.3 -39.81 61.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.765 0.317 . . . . 1.73 111.316 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.539 ' ND1' ' HG3' ' A' ' 431' ' ' ARG . 6.1 p80 -57.09 -27.5 61.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 1.47 111.973 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.539 ' HG3' ' ND1' ' A' ' 430' ' ' HIS . 67.9 mtt-85 -78.51 -38.84 39.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.637 0.236 . . . . 2.84 111.637 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.763 HD13 HG22 ' A' ' 397' ' ' VAL . 51.9 mt -87.91 131.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.46 110.836 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.765 ' HB2' HD21 ' A' ' 439' ' ' LEU . 71.4 m -161.15 140.18 10.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.591 . . . . 0.53 111.089 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -60.19 -24.47 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.035 -0.53 . . . . 1.35 111.211 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.425 ' O ' ' HG ' ' A' ' 439' ' ' LEU . 24.0 t-20 -108.4 128.8 55.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.407 -0.36 . . . . 2.16 110.944 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . 0.555 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -83.3 -40.12 19.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.75 112.058 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -47.96 -40.59 22.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.43 -0.35 . . . . 1.34 111.386 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -70.64 -37.12 73.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 1.56 110.902 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.765 HD21 ' HB2' ' A' ' 433' ' ' SER . 84.1 mt -57.32 -84.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.942 -0.572 . . . . 1.12 111.778 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -172.07 40.6 0.17 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.527 -0.844 . . . . 1.36 112.885 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.93 143.54 0.06 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.802 -0.713 . . . . 1.83 112.861 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.8 82.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.756 0.312 . . . . 1.48 110.204 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.699 ' O ' HG12 ' A' ' 444' ' ' VAL . 21.5 m 62.69 133.22 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.94 -0.573 . . . . 3.05 110.767 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.699 HG12 ' O ' ' A' ' 443' ' ' THR . 0.8 OUTLIER 57.76 132.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.368 -0.833 . . . . 4.18 111.707 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.517 ' N ' HD23 ' A' ' 445' ' ' LEU . 2.3 pt? -152.84 139.29 12.33 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.693 -0.685 . . . . 4.99 110.944 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.04 144.5 58.1 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.742 2.295 . . . . 7.4 112.778 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -169.24 139.34 1.79 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.851 -0.613 . . . . 9.06 110.787 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.58 135.98 63.1 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.512 2.141 . . . . 11.06 112.056 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.8 119.12 6.08 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.251 1.967 . . . . 13.5 112.201 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 450' ' ' LEU . 39.6 tp 179.22 44.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.855 -0.611 . . . . 15.76 109.948 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 453' ' ' ASP . . . -173.95 150.61 1.67 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.861 -0.608 . . . . 16.74 110.769 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.24 30.18 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.43 2.087 . . . . 18.53 112.802 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 451' ' ' ALA . 50.6 p-10 -76.04 148.28 38.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.49 -0.323 . . . . 20.55 110.625 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.237 -0.887 . . . . 21.22 110.936 -179.857 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.454 -0.259 . . . . 11.64 112.454 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 51.4 m -80.15 45.94 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.735 0.302 . . . . 9.86 110.99 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -63.08 141.03 58.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 8.07 111.098 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . 0.488 ' CE ' ' HA ' ' A' ' 408' ' ' ALA . 18.0 ptp -67.85 135.97 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.357 -0.383 . . . . 5.51 110.426 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 371' ' ' GLN . 55.9 m-20 -62.31 122.14 71.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.424 -0.353 . . . . 6.06 110.969 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.05 36.33 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.369 2.046 . . . . 6.16 112.223 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.832 HD12 ' N ' ' A' ' 370' ' ' MET . 2.2 pp -153.19 -31.69 0.13 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.01 -0.541 . . . . 6.94 111.113 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.832 ' N ' HD12 ' A' ' 369' ' ' LEU . 69.0 mtm -154.19 55.54 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 5.63 110.209 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.573 ' O ' ' HG3' ' A' ' 372' ' ' LYS . 17.2 pt20 -75.38 30.34 0.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.023 -0.535 . . . . 5.04 111.823 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.584 ' HB2' ' NZ ' ' A' ' 372' ' ' LYS . 9.8 mtmp? -164.87 134.0 3.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.682 -0.69 . . . . 5.39 110.435 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.404 ' HB ' ' CE2' ' A' ' 412' ' ' TYR . 68.0 mt -78.2 136.56 23.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.199 -0.455 . . . . 1.48 111.184 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -89.36 129.65 35.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.389 -0.369 . . . . 2.17 110.938 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 88.8 mt -95.56 -45.96 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.92 111.531 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 64.7 m -65.08 72.69 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.397 -0.82 . . . . 1.71 111.643 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.564 ' HG3' ' ND2' ' A' ' 378' ' ' ASN . 11.9 pt-20 -175.11 -33.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 1.92 110.781 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.564 ' ND2' ' HG3' ' A' ' 377' ' ' GLU . 0.1 OUTLIER -168.53 60.16 0.44 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.532 . . . . 2.14 111.582 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.06 -37.78 79.54 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.289 1.993 . . . . 0.85 111.543 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.8 -33.45 75.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.646 . . . . 1.21 110.881 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 86.0 tttt -51.44 134.52 28.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.104 -0.498 . . . . 1.66 111.294 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 38.3 mm -82.95 136.26 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.025 -0.534 . . . . 0.41 111.268 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.41 ' HB3' ' CG2' ' A' ' 432' ' ' ILE . 43.1 m-85 -114.41 143.94 44.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.554 -0.293 . . . . 0.63 110.452 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 5.3 m-85 -90.07 135.48 33.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.391 -0.368 . . . . 0.96 110.718 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.5 mp -118.7 130.47 73.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.4 -0.364 . . . . 0.49 110.984 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.59 ' HD2' ' O ' ' A' ' 439' ' ' LEU . 30.1 ttt85 -90.46 121.77 32.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.465 -0.334 . . . . 2.42 110.777 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -79.08 163.03 25.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.331 -0.395 . . . . 2.3 110.356 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -57.34 -42.62 82.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.628 0.251 . . . . 2.82 110.85 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -60.47 -16.84 40.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.186 0.517 . . . . 1.23 110.05 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 91.47 40.84 5.28 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.417 -0.81 . . . . 1.03 112.52 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.882 HG22 HD11 ' A' ' 445' ' ' LEU . 60.9 p -120.99 111.31 17.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.98 111.437 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.73 135.77 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.55 111.0 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -150.0 139.01 21.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 2.43 110.81 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -56.47 148.4 19.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.133 0.492 . . . . 2.96 111.788 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.41 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -171.48 128.01 1.52 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.461 -0.791 . . . . 0.26 111.769 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -81.63 128.62 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.849 0.357 . . . . 1.28 111.195 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.859 HG23 HG22 ' A' ' 414' ' ' VAL . 1.0 OUTLIER -101.32 126.0 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.772 -0.455 . . . . 0.83 109.772 178.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 50.7 mt -120.71 -34.46 3.57 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.674 0.62 . . . . 1.45 112.674 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 413' ' ' TYR . 70.4 mt-30 -118.97 166.97 12.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.038 0.447 . . . . 2.08 111.807 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.7 p -165.93 151.62 8.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.679 -0.691 . . . . 0.56 110.729 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -161.24 134.69 6.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.906 0.384 . . . . 1.55 111.314 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.584 ' O ' ' HG2' ' A' ' 409' ' ' PRO . 20.4 p -101.0 39.22 1.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 1.79 110.617 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.825 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.5 m 47.31 -174.32 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.618 -0.719 . . . . 1.95 111.004 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.825 ' H ' HG22 ' A' ' 403' ' ' THR . 0.4 OUTLIER -77.77 -40.54 40.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 3.87 110.992 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.32 -51.31 70.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.513 . . . . 3.16 111.276 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.471 ' C ' ' HD2' ' A' ' 409' ' ' PRO . . . 65.83 -175.08 0.18 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.993 0.425 . . . . 2.18 110.366 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . 62.35 11.35 4.49 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.605 -0.725 . . . . 2.77 112.05 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.558 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -168.74 -54.78 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.466 -0.334 . . . . 2.76 111.264 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.584 ' HG2' ' O ' ' A' ' 402' ' ' THR . 47.6 Cg_endo -68.02 148.55 75.98 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.478 2.119 . . . . 2.49 112.386 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.552 ' HB3' HG22 ' A' ' 402' ' ' THR . 40.0 p-10 -175.51 132.54 0.28 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.901 -0.59 . . . . 2.14 110.662 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 96.7 mt-10 -151.32 137.16 18.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 2.1 111.202 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.627 ' CE1' ' HG2' ' A' ' 429' ' ' ARG . 3.9 m-85 -117.09 128.73 55.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.72 111.727 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 20.0 t80 -64.05 135.82 56.75 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.953 -0.567 . . . . 0.51 109.986 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.859 HG22 HG23 ' A' ' 397' ' ' VAL . 60.4 t -129.28 139.5 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.813 0.671 . . . . 1.15 112.813 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -120.31 89.32 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.059 -0.973 . . . . 0.62 109.142 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.495 ' HD1' ' H ' ' A' ' 416' ' ' TYR . 7.3 m-85 -54.45 116.0 2.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.88 -0.6 . . . . 0.65 111.349 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 65.2 t -61.6 125.83 18.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.791 -0.641 . . . . 1.34 111.245 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.56 -43.44 1.85 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.745 -0.661 . . . . 0.82 113.101 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.602 ' HB3' HD22 ' A' ' 423' ' ' LEU . 7.6 mp -59.74 152.11 23.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.982 0.42 . . . . 1.6 111.389 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.403 ' HB2' HD13 ' A' ' 423' ' ' LEU . 63.1 m-80 -50.36 144.13 7.9 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.659 -0.7 . . . . 2.53 111.837 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -58.6 -34.87 71.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.603 -0.726 . . . . 3.98 111.45 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . 0.678 ' HG3' HD12 ' A' ' 423' ' ' LEU . 14.8 ptp180 -51.35 -37.07 45.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 3.71 111.635 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.678 HD12 ' HG3' ' A' ' 422' ' ' ARG . 10.6 mp -61.1 -33.95 74.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.5 -0.318 . . . . 1.49 111.106 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -48.87 138.25 11.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.241 -0.436 . . . . 1.2 111.068 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -176.17 -137.79 2.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.647 -0.787 . . . . 0.7 112.7 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 38.4 m95 -130.46 141.35 50.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.063 0.458 . . . . 0.61 110.905 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 429' ' ' ARG . 4.6 m -108.2 156.77 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.683 -0.689 . . . . 0.89 110.888 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -79.06 35.34 1.92 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.394 -0.908 . . . . 1.72 111.503 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.77 ' H ' HG23 ' A' ' 427' ' ' VAL . 0.6 OUTLIER 66.0 -73.24 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.003 0.521 . . . . 1.73 110.651 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -52.51 -18.33 1.65 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.514 -0.312 . . . . 1.47 111.664 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.458 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 64.5 mtt85 -78.73 28.57 0.21 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.6 0.238 . . . . 2.84 111.039 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.669 ' CD1' HG21 ' A' ' 427' ' ' VAL . 42.4 mt -150.27 138.8 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.82 0.343 . . . . 0.46 111.036 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 68.1 m -163.96 140.62 6.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.493 . . . . 0.53 110.785 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -55.59 -24.29 32.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 1.35 111.278 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -108.73 129.81 55.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.113 0.482 . . . . 2.16 111.034 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -74.24 -31.93 62.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.768 -0.651 . . . . 0.75 111.648 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -44.64 -77.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 1.34 111.735 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -47.37 -38.52 13.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 1.56 111.81 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.59 ' O ' ' HD2' ' A' ' 386' ' ' ARG . 96.4 mt -61.27 -42.45 98.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.882 0.327 . . . . 1.12 111.882 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . 0.41 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . 165.01 21.58 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.354 -0.927 . . . . 1.36 112.881 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 443' ' ' THR . . . 64.06 153.73 0.09 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.661 -0.78 . . . . 1.83 112.472 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.516 ' O ' HG23 ' A' ' 444' ' ' VAL . 45.9 mm -58.26 84.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.646 0.26 . . . . 1.48 110.451 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 441' ' ' GLY . 14.8 t 44.38 35.79 1.42 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.789 0.804 . . . . 3.05 111.398 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 442' ' ' ILE . 40.7 t -99.31 65.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.566 -1.197 . . . . 4.18 110.958 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.882 HD11 HG22 ' A' ' 391' ' ' THR . 7.0 mp -64.98 135.81 96.55 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.504 -0.317 . . . . 4.99 110.87 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.36 138.05 78.41 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.745 2.297 . . . . 7.4 112.69 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -172.24 132.13 0.71 Allowed Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.946 -0.57 . . . . 9.06 110.815 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 52.3 Cg_endo -69.75 133.15 24.9 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.465 2.11 . . . . 11.06 112.577 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 27.1 Cg_exo -62.09 140.26 83.12 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.766 2.311 . . . . 13.5 112.277 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 92.1 mt 60.74 61.65 1.64 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.235 -0.439 . . . . 15.76 110.931 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -148.34 135.52 10.54 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 16.74 111.076 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.0 134.85 44.86 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.627 2.218 . . . . 18.53 112.356 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 36.2 t70 64.37 135.89 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.952 -0.567 . . . . 20.55 111.365 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.151 -0.928 . . . . 21.22 110.91 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.485 -0.246 . . . . 11.64 112.485 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 50.6 m 58.03 -142.04 0.71 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.692 -0.114 . . . . 9.86 110.692 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 64.66 139.59 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.882 0.373 . . . . 8.07 110.848 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 21.1 ptt? -146.55 56.65 1.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.947 0.403 . . . . 5.51 111.338 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 62.29 122.88 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.631 -0.713 . . . . 6.06 112.298 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -85.1 49.56 2.59 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.953 2.436 . . . . 6.16 112.276 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.515 ' C ' HD13 ' A' ' 369' ' ' LEU . 2.4 tm? -158.7 -54.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 6.94 110.728 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . . . . . . . . . 54.4 ttp -82.66 56.94 3.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.226 -0.443 . . . . 5.63 110.28 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -49.65 120.25 4.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.901 -0.591 . . . . 5.04 111.249 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 373' ' ' ILE . 21.7 pttp 34.52 56.98 0.69 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.365 -0.834 . . . . 5.39 112.66 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.598 HD11 ' CZ ' ' A' ' 429' ' ' ARG . 75.9 mt 52.14 126.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.343 0.868 . . . . 1.48 113.343 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.78 129.76 36.13 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.329 -0.619 . . . . 2.17 109.329 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.6 mt -84.56 -40.87 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.62 0.6 . . . . 0.92 112.62 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.6 t -49.54 -17.76 0.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.016 0.436 . . . . 1.71 111.22 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -56.39 -43.73 79.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.516 -0.766 . . . . 1.92 111.495 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' A' ' 381' ' ' LYS . 0.1 OUTLIER -171.11 69.1 0.49 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 2.14 111.392 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.13 -40.05 60.37 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.418 2.079 . . . . 0.85 112.047 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -60.55 -36.33 78.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.511 . . . . 1.21 110.844 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 58.9 tttm -52.15 132.81 33.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.18 -0.464 . . . . 1.66 111.431 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 394' ' ' ARG . 43.2 mm -86.47 131.55 34.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.011 -0.541 . . . . 0.41 111.029 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -105.47 143.29 33.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.547 -0.297 . . . . 0.63 110.58 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.59 140.39 29.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.347 -0.388 . . . . 0.96 110.474 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.646 ' N ' HD12 ' A' ' 385' ' ' ILE . 0.9 OUTLIER -132.96 128.21 56.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.754 0.311 . . . . 0.49 111.026 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.697 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 36.7 ttt85 -86.01 121.57 28.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 2.42 110.797 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.405 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 61.7 mtp85 -72.93 159.14 34.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 2.3 110.659 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -55.03 -45.52 75.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.513 -0.312 . . . . 2.82 111.339 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -57.98 -29.08 64.96 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.262 -0.644 . . . . 1.23 109.262 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 111.03 37.26 1.7 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.3 -0.864 . . . . 1.03 113.267 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.439 HG22 HD21 ' A' ' 445' ' ' LEU . 29.9 p -121.24 111.15 17.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.878 0.37 . . . . 0.98 111.562 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.13 137.89 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.027 -0.533 . . . . 0.55 111.011 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -150.57 139.64 21.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 2.43 110.957 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.408 ' HB3' HG21 ' A' ' 382' ' ' ILE . 88.3 mtm180 -56.63 147.56 22.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.815 -0.63 . . . . 2.96 111.474 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -164.98 128.43 1.79 Allowed Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.824 -0.626 . . . . 0.26 112.238 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -83.32 110.18 17.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.686 0.279 . . . . 1.28 111.503 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.6 OUTLIER -79.09 135.04 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.83 109.976 178.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 94.1 mt -120.24 -31.91 4.27 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.789 0.663 . . . . 1.45 112.789 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -140.19 175.3 9.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.071 0.462 . . . . 2.08 111.931 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.6 p -165.5 149.23 8.21 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.616 -0.72 . . . . 0.56 110.576 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 401' ' ' ARG . 14.5 ptt-85 -158.11 138.43 12.6 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.073 0.463 . . . . 1.55 111.923 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 47.2 p -75.29 139.44 42.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.948 -0.569 . . . . 1.79 110.276 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.864 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.5 m -61.76 -174.39 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.504 -0.316 . . . . 1.95 110.263 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.864 ' H ' HG22 ' A' ' 403' ' ' THR . 50.2 mt-10 -54.6 -45.76 73.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.666 0.269 . . . . 3.87 111.573 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -59.84 -47.39 85.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 3.16 110.864 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.573 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 64.11 -177.07 0.16 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.024 -0.534 . . . . 2.18 110.858 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . 63.22 11.2 5.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.395 -0.82 . . . . 2.77 112.134 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.552 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -170.84 -53.1 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.558 -0.292 . . . . 2.76 111.68 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.577 ' HB2' ' OG1' ' A' ' 403' ' ' THR . 65.4 Cg_endo -72.07 149.83 53.15 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.281 1.987 . . . . 2.49 112.036 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.471 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 5.1 p-10 -170.32 126.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.11 0.481 . . . . 2.14 111.493 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 400' ' ' SER . 64.8 mm-40 -109.81 134.68 51.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.496 -0.775 . . . . 2.1 110.319 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.495 ' HB2' HD12 ' A' ' 432' ' ' ILE . 2.6 m-85 -112.81 129.26 56.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.87 0.367 . . . . 0.72 111.872 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 26.0 t80 -69.19 129.74 40.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.899 -0.778 . . . . 0.51 108.899 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 425' ' ' GLY . 10.3 p -131.17 136.8 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.801 0.667 . . . . 1.15 112.801 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -114.75 89.8 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.019 -0.992 . . . . 0.62 109.582 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.556 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 35.2 m-85 -54.02 128.1 29.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.65 111.231 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 67.0 t -71.89 127.92 34.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.996 -0.547 . . . . 1.34 111.278 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.35 -37.14 1.56 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.841 -0.695 . . . . 0.82 113.261 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.514 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.9 mp -59.34 159.7 7.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.237 0.542 . . . . 1.6 111.809 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.776 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 5.6 m120 -51.07 140.55 15.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.179 -0.918 . . . . 2.53 111.821 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -60.36 -38.36 83.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 3.98 110.733 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -60.19 -38.44 83.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 3.71 110.991 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.776 ' HG ' ' HB2' ' A' ' 420' ' ' ASN . 90.0 mt -56.65 -31.17 64.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 1.49 110.978 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -52.13 134.5 32.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 1.2 111.182 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . 0.465 ' O ' HG12 ' A' ' 414' ' ' VAL . . . 177.04 176.52 45.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.042 -0.599 . . . . 0.7 112.369 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -75.2 140.44 43.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.005 0.431 . . . . 0.61 110.997 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.545 ' CG2' HD11 ' A' ' 432' ' ' ILE . 25.4 m -133.37 138.82 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 0.89 111.354 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -61.73 147.63 48.11 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.859 -0.686 . . . . 1.72 112.394 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.598 ' CZ ' HD11 ' A' ' 373' ' ' ILE . 23.2 tpt180 -51.49 -39.97 58.62 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.758 0.281 . . . . 1.73 111.758 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -53.31 -30.78 40.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.757 0.313 . . . . 1.47 111.466 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.427 HH11 ' HG2' ' A' ' 431' ' ' ARG . 68.0 mtt-85 -79.47 -35.05 40.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.154 -0.475 . . . . 2.84 111.569 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.572 HG12 HG13 ' A' ' 385' ' ' ILE . 53.6 mt -88.89 140.47 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.46 112.013 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 435' ' ' ASN . 66.8 m -159.89 139.9 11.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.675 -0.693 . . . . 0.53 110.413 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.76 16.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 1.35 111.773 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.449 ' H ' ' C ' ' A' ' 433' ' ' SER . 22.2 p30 -162.63 135.65 5.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.978 0.418 . . . . 2.16 111.055 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . 0.524 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -65.35 -32.07 73.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.75 111.639 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -49.73 -40.85 42.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 1.34 111.419 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -97.17 49.55 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.44 -0.346 . . . . 1.56 111.173 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 436' ' ' ALA . 95.6 mt -148.55 -84.53 0.1 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.38 -0.373 . . . . 1.12 111.286 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . 0.697 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -171.02 30.72 0.13 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.577 -0.821 . . . . 1.36 112.647 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 63.99 151.35 0.06 OUTLIER Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.743 -0.742 . . . . 1.83 112.543 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 44.8 mm -64.18 79.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.665 0.269 . . . . 1.48 110.464 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 9.7 t 40.74 44.39 1.86 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.005 0.907 . . . . 3.05 111.71 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 15.6 m -94.64 49.14 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.029 -1.441 . . . . 4.18 111.221 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 445' ' ' LEU . 0.4 OUTLIER -96.77 143.77 26.7 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.46 -0.791 . . . . 4.99 111.861 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.87 148.05 89.71 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.617 2.211 . . . . 7.4 111.862 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . -49.17 133.0 16.34 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.288 -0.414 . . . . 9.06 111.143 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 35.3 Cg_exo -57.84 135.64 70.32 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.624 2.216 . . . . 11.06 112.478 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 32.4 Cg_exo -58.59 137.59 81.05 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.72 2.28 . . . . 13.5 112.295 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 450' ' ' LEU . 6.6 mp 64.83 143.41 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.031 -0.532 . . . . 15.76 111.502 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -163.84 127.19 1.75 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.915 -0.584 . . . . 16.74 110.926 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.06 137.77 53.9 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.701 2.268 . . . . 18.53 112.63 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 65.11 135.65 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.003 -0.544 . . . . 20.55 111.497 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.22 -0.895 . . . . 21.22 111.036 179.912 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.495 -0.242 . . . . 11.64 112.495 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . 0.557 ' HB3' ' NZ ' ' A' ' 372' ' ' LYS . 45.0 t -61.61 -41.06 96.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.707 0.289 . . . . 9.86 110.889 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 74.5 t60 65.68 139.12 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.017 -0.538 . . . . 8.07 111.295 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 27.9 ttt -166.41 128.08 1.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.895 -0.593 . . . . 5.51 110.593 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.419 ' HB3' HD23 ' A' ' 369' ' ' LEU . 62.2 m-20 59.75 119.34 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 115.997 -0.547 . . . . 6.06 111.56 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.56 42.17 1.25 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.553 2.169 . . . . 6.16 112.762 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.419 HD23 ' HB3' ' A' ' 367' ' ' ASP . 1.9 pt? -170.01 -25.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.713 0.292 . . . . 6.94 111.218 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.412 ' H ' HD23 ' A' ' 369' ' ' LEU . 44.2 ttp -135.01 62.88 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 5.63 111.307 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -59.68 137.31 58.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.368 -0.378 . . . . 5.04 110.454 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.557 ' NZ ' ' HB3' ' A' ' 364' ' ' SER . 23.7 pttm -49.85 130.23 21.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 5.39 111.455 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.05 128.45 31.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.929 -0.578 . . . . 1.48 111.564 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.563 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 0.3 OUTLIER -93.95 130.58 39.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 2.17 110.503 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 375' ' ' ILE . 4.7 mp -88.29 -41.25 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.125 0.417 . . . . 0.92 112.125 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 82.1 p -47.46 -26.4 1.36 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.018 -0.537 . . . . 1.71 112.021 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.6 pt-20 -67.5 -39.23 85.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.197 -0.456 . . . . 1.92 111.898 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 5.6 m120 -151.87 67.31 7.11 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 112.095 0.406 . . . . 2.14 112.095 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.7 -41.1 63.48 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.734 2.289 . . . . 0.85 112.419 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.94 -38.28 85.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.973 -0.558 . . . . 1.21 111.324 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 87.4 tttt -48.91 127.12 13.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 1.66 111.075 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 44.3 mm -86.32 126.68 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.989 -0.55 . . . . 0.41 111.165 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -105.13 144.16 32.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.311 -0.404 . . . . 0.63 110.151 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.454 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 1.9 m-85 -89.88 137.32 32.44 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.929 -0.308 . . . . 0.96 110.543 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.671 HG12 HG21 ' A' ' 414' ' ' VAL . 2.7 mp -122.89 125.57 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.329 -0.396 . . . . 0.49 111.218 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.519 ' HE ' ' HA2' ' A' ' 390' ' ' GLY . 78.1 ttt180 -83.86 116.82 22.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 2.42 110.261 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.453 ' HB2' ' OD1' ' A' ' 389' ' ' ASP . 51.9 mtp85 -71.53 163.98 26.71 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.941 -0.304 . . . . 2.3 110.703 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 389' ' ' ASP . 11.5 pm0 -49.72 -39.76 38.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.309 -0.405 . . . . 2.82 111.214 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 387' ' ' ARG . 43.1 p-10 -65.87 -35.04 79.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 1.23 111.215 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.519 ' HA2' ' HE ' ' A' ' 386' ' ' ARG . . . 129.32 -31.31 3.47 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.718 -0.753 . . . . 1.03 112.539 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 71.3 p -59.36 113.09 2.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.096 0.474 . . . . 0.98 112.144 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 59.8 t -71.15 141.31 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.562 -0.745 . . . . 0.55 110.902 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -148.9 134.77 18.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.484 -0.325 . . . . 2.43 110.803 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.441 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 88.2 mtm180 -54.22 152.97 5.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.232 -0.44 . . . . 2.96 111.498 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -168.83 135.66 3.71 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.657 -0.701 . . . . 0.26 112.089 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -87.04 110.37 20.03 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.724 0.268 . . . . 1.28 111.724 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.628 ' CG2' HD13 ' A' ' 432' ' ' ILE . 11.6 t -77.94 128.01 38.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.765 -0.828 . . . . 0.83 108.765 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 58.2 mt -121.0 -38.27 2.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.011 0.745 . . . . 1.45 113.011 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.511 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 26.0 mt-30 -133.95 176.53 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 2.08 112.049 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.3 p -162.16 148.03 13.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.676 -0.693 . . . . 0.56 110.349 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -161.45 139.19 9.1 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.887 0.375 . . . . 1.55 111.536 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 67.3 p -73.4 -125.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 1.79 109.884 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.801 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.23 -173.52 3.16 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.77 -0.456 . . . . 1.95 109.77 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.801 ' H ' HG22 ' A' ' 403' ' ' THR . 55.6 mt-10 -46.11 -43.77 15.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.678 0.275 . . . . 3.87 111.275 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.554 HD21 ' HB3' ' A' ' 407' ' ' ALA . 47.7 t30 -67.72 -52.62 35.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 3.16 110.798 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 53.81 54.33 10.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.003 -0.544 . . . . 2.18 111.658 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.554 ' HB3' HD21 ' A' ' 405' ' ' ASN . . . -149.09 10.65 0.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.517 0.675 . . . . 2.77 109.755 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.573 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -179.46 -47.71 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.628 -1.169 . . . . 2.76 110.077 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 39.5 Cg_exo -57.53 146.79 82.36 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.509 2.139 . . . . 2.49 112.585 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.656 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.6 p30 -174.38 138.07 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 2.14 110.568 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.4 mt-10 -137.14 134.4 36.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 2.1 110.375 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 0.8 OUTLIER -109.93 125.7 53.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.855 0.359 . . . . 0.72 111.49 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.511 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 14.0 t80 -59.49 147.13 37.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.974 -0.557 . . . . 0.51 109.516 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.671 HG21 HG12 ' A' ' 385' ' ' ILE . 7.1 p -153.66 134.55 4.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.237 0.541 . . . . 1.15 112.055 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -120.24 101.85 8.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.455 -0.793 . . . . 0.62 109.902 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.492 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 50.1 m-85 -59.82 129.49 42.1 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.899 0.381 . . . . 0.65 110.681 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.83 37.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.887 -0.597 . . . . 1.34 111.109 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -175.47 -36.1 0.05 OUTLIER Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.254 -0.974 . . . . 0.82 113.851 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.681 HD13 HD23 ' A' ' 423' ' ' LEU . 13.0 mt -62.8 -167.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.729 0.776 . . . . 1.6 112.48 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.532 ' OD1' ' HG2' ' A' ' 422' ' ' ARG . 16.5 t-20 -81.29 149.85 28.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.55 -1.204 . . . . 2.53 111.025 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -59.47 -40.89 88.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.91 0.386 . . . . 3.98 110.779 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . 0.532 ' HG2' ' OD1' ' A' ' 420' ' ' ASN . 16.2 ptm180 -69.19 -34.9 75.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.048 -0.524 . . . . 3.71 110.851 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.681 HD23 HD13 ' A' ' 419' ' ' LEU . 1.3 mp -56.48 -34.94 67.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.875 -0.602 . . . . 1.49 111.201 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -59.09 137.6 57.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.077 -0.51 . . . . 1.2 110.757 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -170.52 -140.51 3.03 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.619 -0.8 . . . . 0.7 112.646 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -119.7 134.76 55.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.906 0.384 . . . . 0.61 110.81 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.641 HG11 HG21 ' A' ' 385' ' ' ILE . 31.5 m -109.47 155.27 10.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.987 -0.551 . . . . 0.89 111.758 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -74.11 25.27 1.04 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.918 -0.583 . . . . 1.72 113.951 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.543 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 36.2 tpt85 71.26 -46.32 0.64 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.68 0.622 . . . . 1.73 112.68 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -58.77 -19.86 44.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.944 0.402 . . . . 1.47 110.911 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.4 mtt180 -78.66 -30.32 46.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.813 -0.63 . . . . 2.84 111.464 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.628 HD13 ' CG2' ' A' ' 397' ' ' VAL . 66.8 mt -88.02 137.29 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 120.766 0.317 . . . . 0.46 110.728 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.437 ' HB2' HD21 ' A' ' 439' ' ' LEU . 57.9 m -160.18 139.73 11.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 0.53 111.075 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . 0.417 ' C ' HD22 ' A' ' 435' ' ' ASN . 51.3 p-10 -69.26 -23.48 63.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 1.35 111.472 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.417 HD22 ' C ' ' A' ' 434' ' ' ASP . 3.0 m120 -108.23 133.54 52.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.891 0.377 . . . . 2.16 111.129 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . 0.539 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -67.85 -43.9 78.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.75 111.366 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -54.92 -39.82 69.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 1.34 111.014 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.06 51.0 1.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 1.56 110.948 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 436' ' ' ALA . 82.3 mt -150.13 -93.51 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 1.12 111.106 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -177.02 48.05 0.1 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.609 -0.805 . . . . 1.36 112.746 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.28 132.07 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.83 -0.7 . . . . 1.83 112.848 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 444' ' ' VAL . 47.9 mm -67.51 107.96 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 110.247 -0.279 . . . . 1.48 110.247 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.601 HG22 HG22 ' A' ' 442' ' ' ILE . 11.8 t 40.23 41.21 0.94 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.644 0.735 . . . . 3.05 111.757 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 442' ' ' ILE . 77.7 t -145.69 131.93 14.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.866 -1.061 . . . . 4.18 111.1 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 96.1 mt -146.09 139.14 14.29 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.726 -0.67 . . . . 4.99 110.465 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.53 131.31 43.07 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.543 2.162 . . . . 7.4 112.651 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -67.97 144.48 97.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 9.06 111.118 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.75 133.58 54.89 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.448 2.098 . . . . 11.06 112.189 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.33 130.8 23.31 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.437 2.091 . . . . 13.5 112.56 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 73.1 mt 62.53 127.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.863 -0.608 . . . . 15.76 111.621 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . 53.38 88.25 0.12 Allowed Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.88 -0.6 . . . . 16.74 111.802 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.54 130.39 18.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.494 2.129 . . . . 18.53 112.276 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -175.52 139.84 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 20.55 110.888 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . 0.445 ' OE1' ' N ' ' A' ' 454' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.281 -0.866 . . . . 21.22 110.894 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.467 -0.253 . . . . 11.64 112.467 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.9 t -64.45 126.66 28.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.86 0.362 . . . . 9.86 110.877 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -73.07 139.97 46.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 8.07 110.78 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 62.3 mtt -63.43 118.57 8.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.404 -0.362 . . . . 5.51 110.534 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.1 138.58 68.66 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 6.06 111.169 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.09 38.1 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.561 2.174 . . . . 6.16 112.317 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.442 ' C ' HD12 ' A' ' 369' ' ' LEU . 1.9 pp -152.3 27.68 0.58 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.079 0.466 . . . . 6.94 111.042 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . . . . . . . . . 44.2 ttp -170.81 49.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.768 -0.651 . . . . 5.63 110.284 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.436 ' OE1' ' N ' ' A' ' 371' ' ' GLN . 0.5 OUTLIER -54.47 133.02 45.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.051 -0.522 . . . . 5.04 110.7 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.528 ' HB2' ' OH ' ' A' ' 412' ' ' TYR . 48.0 mmtm -56.72 132.87 53.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 5.39 111.004 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.532 HD11 HH11 ' A' ' 429' ' ' ARG . 66.8 mt 58.15 101.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.837 -0.62 . . . . 1.48 111.633 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.05 129.71 35.63 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.19 -0.459 . . . . 2.17 109.989 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 379' ' ' PRO . 90.0 mt -120.93 -43.19 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.079 0.4 . . . . 0.92 112.079 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.0 t -48.86 -30.35 5.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.044 0.449 . . . . 1.71 111.151 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.76 -36.61 36.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.752 -0.658 . . . . 1.92 111.8 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.469 HD22 ' C ' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -146.46 72.17 12.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.004 0.43 . . . . 2.14 111.439 -179.428 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . 0.508 ' HA ' HG23 ' A' ' 375' ' ' ILE . 21.5 Cg_endo -63.62 -36.42 53.13 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.105 1.87 . . . . 0.85 111.286 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -64.37 -31.29 72.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 1.21 110.823 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 62.5 tttm -49.31 130.77 19.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.074 -0.512 . . . . 1.66 111.424 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.5 HG21 ' HD2' ' A' ' 394' ' ' ARG . 33.2 mm -88.68 135.46 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.773 -0.649 . . . . 0.41 111.109 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -117.43 143.83 45.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.537 -0.301 . . . . 0.63 110.711 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.45 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 1.8 m-85 -89.14 147.03 24.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.841 0.353 . . . . 0.96 111.136 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.8 mp -132.22 131.68 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.49 110.741 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 42.2 ttt-85 -84.8 123.55 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.251 -0.431 . . . . 2.42 111.198 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -83.75 167.24 17.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.29 -0.414 . . . . 2.3 110.461 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 388' ' ' GLU . 0.5 OUTLIER -58.36 -42.7 87.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.506 -0.315 . . . . 2.82 111.082 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -69.86 5.13 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.403 . . . . 1.23 110.581 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 388' ' ' GLU . . . 70.76 42.71 61.06 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.902 -0.59 . . . . 1.03 112.955 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.5 ' HB ' HG23 ' A' ' 443' ' ' THR . 82.5 p -120.62 111.47 17.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.958 0.408 . . . . 0.98 111.151 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 22.6 t -69.94 135.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.55 111.308 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -149.28 139.85 22.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 2.43 110.742 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.5 ' HD2' HG21 ' A' ' 382' ' ' ILE . 54.9 mtm-85 -56.03 157.8 4.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.318 0.58 . . . . 2.96 112.048 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -178.56 126.56 1.08 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.125 -0.943 . . . . 0.26 111.442 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -83.42 129.38 34.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.823 0.344 . . . . 1.28 111.791 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.756 HG22 HD13 ' A' ' 432' ' ' ILE . 8.5 t -88.9 134.69 27.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.51 -0.552 . . . . 0.83 109.51 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 78.0 mt -120.18 -38.51 2.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.568 0.581 . . . . 1.45 112.568 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -141.65 176.12 9.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.051 0.453 . . . . 2.08 111.809 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 97.4 p -155.62 149.66 25.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.604 -0.725 . . . . 0.56 110.176 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 18.4 ptt-85 -149.26 134.78 18.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.229 0.538 . . . . 1.55 112.246 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 409' ' ' PRO . 46.2 p -93.65 138.1 32.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.819 -0.628 . . . . 1.79 110.065 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.844 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.5 m -61.5 -174.65 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.655 -0.248 . . . . 1.95 110.47 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.844 ' H ' HG22 ' A' ' 403' ' ' THR . 55.9 mt-10 -53.72 -39.02 64.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.571 0.224 . . . . 3.87 111.565 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 407' ' ' ALA . 50.2 t30 -56.86 -49.66 74.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.423 -0.353 . . . . 3.16 110.988 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 54.12 52.9 11.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.221 -0.445 . . . . 2.18 111.494 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.463 ' HB3' ' ND2' ' A' ' 405' ' ' ASN . . . -156.5 10.83 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.844 -0.616 . . . . 2.77 110.141 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.588 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.19 -48.28 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.15 -0.932 . . . . 2.76 110.561 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 24.0 Cg_exo -63.75 140.02 71.97 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.589 2.192 . . . . 2.49 112.4 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.47 ' OD2' ' HE1' ' A' ' 412' ' ' TYR . 13.2 p-10 -173.82 122.63 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 2.14 110.988 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 400' ' ' SER . 9.1 mp0 -113.94 134.24 54.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 2.1 110.504 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.543 ' HB2' HD12 ' A' ' 432' ' ' ILE . 6.5 m-85 -109.57 125.15 52.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.72 111.575 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.765 ' HA ' ' HA ' ' A' ' 426' ' ' TRP . 14.0 t80 -60.9 139.74 57.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.51 110.234 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.539 HG21 HG12 ' A' ' 385' ' ' ILE . 13.0 p -133.96 137.73 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.218 0.532 . . . . 1.15 111.928 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -119.54 96.6 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.48 -0.782 . . . . 0.62 109.889 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.404 ' HB3' HD22 ' A' ' 419' ' ' LEU . 42.3 m-85 -58.99 124.6 20.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.65 111.024 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.79 128.54 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.911 -0.586 . . . . 1.34 111.396 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 78.17 -40.64 1.94 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.896 -0.668 . . . . 0.82 113.072 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 419' ' ' LEU . 7.5 mp -59.34 153.87 17.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.982 0.42 . . . . 1.6 111.28 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.746 HD21 HD13 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -49.31 142.22 7.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.722 -0.672 . . . . 2.53 112.143 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 421' ' ' ARG . 45.1 mmm-85 -60.81 -36.7 79.7 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.463 -0.79 . . . . 3.98 111.96 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . 0.58 HH11 HD12 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -53.64 -29.0 36.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.907 0.385 . . . . 3.71 110.761 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.746 HD13 HD21 ' A' ' 420' ' ' ASN . 1.1 tp -63.2 -33.32 75.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 1.49 111.303 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -44.94 133.61 6.23 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.181 -0.463 . . . . 1.2 111.4 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . 0.463 ' O ' HG12 ' A' ' 414' ' ' VAL . . . 174.36 154.59 11.05 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.793 -0.64 . . . . 0.7 112.053 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 11.4 m95 -68.75 134.03 49.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.61 110.296 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.468 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 35.6 m -127.05 142.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.89 111.245 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -52.24 147.42 13.15 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.026 -0.607 . . . . 1.72 112.912 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.532 HH11 HD11 ' A' ' 373' ' ' ILE . 14.6 tpt180 -52.01 -42.03 62.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.633 0.254 . . . . 1.73 111.429 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.432 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 13.4 p-80 -56.58 -25.88 53.83 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.968 0.359 . . . . 1.47 111.968 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 56.4 mtt85 -77.89 -40.59 39.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.692 -0.231 . . . . 2.84 111.532 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.756 HD13 HG22 ' A' ' 397' ' ' VAL . 59.7 mt -88.79 136.54 23.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.914 0.388 . . . . 0.46 110.948 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 67.3 m -161.4 139.7 9.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.953 -0.567 . . . . 0.53 110.743 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -76.73 16.13 0.55 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 1.35 111.181 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -134.59 116.01 14.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.409 -0.359 . . . . 2.16 110.734 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.33 98.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.031 -0.531 . . . . 0.75 111.595 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -57.04 -40.87 77.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 1.34 111.13 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 439' ' ' LEU . 59.0 m-20 -83.16 45.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 1.56 111.011 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 438' ' ' ASP . 47.6 mt -154.58 -41.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.22 -0.446 . . . . 1.12 111.011 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 157.81 40.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.701 -0.761 . . . . 1.36 112.132 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.418 ' O ' HD13 ' A' ' 442' ' ' ILE . . . 62.58 -128.89 41.68 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.629 -0.796 . . . . 1.83 112.103 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.486 ' O ' HG23 ' A' ' 444' ' ' VAL . 44.8 mm -126.04 71.69 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.106 0.479 . . . . 1.48 110.447 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 443' ' ' THR . 56.2 m 52.36 45.84 27.76 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.593 -0.73 . . . . 3.05 110.719 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 442' ' ' ILE . 87.7 t -150.9 121.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.725 -0.67 . . . . 4.18 111.017 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.56 130.55 38.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 4.99 110.564 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.54 127.06 15.77 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.438 2.092 . . . . 7.4 112.335 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . 53.87 64.38 6.65 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 9.06 111.459 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.7 130.41 18.15 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.315 2.01 . . . . 11.06 112.243 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.88 53.82 4.58 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.788 2.325 . . . . 13.5 112.69 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . 0.43 ' C ' HD23 ' A' ' 450' ' ' LEU . 8.6 tt -165.23 124.51 1.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.917 0.389 . . . . 15.76 110.878 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -76.66 142.21 69.94 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.982 -0.554 . . . . 16.74 111.08 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.25 -146.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.684 2.256 . . . . 18.53 112.646 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -59.06 -48.51 81.34 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.285 -0.416 . . . . 20.55 111.066 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.155 -0.926 . . . . 21.22 111.019 -179.911 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.441 -0.264 . . . . 11.64 112.441 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 49.9 m -61.59 130.41 45.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.77 0.319 . . . . 9.86 110.945 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -81.26 37.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 8.07 111.307 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 23.6 ttt 63.23 146.34 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.244 -0.435 . . . . 5.51 111.005 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.14 126.03 25.62 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 6.06 111.301 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.29 37.7 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.676 2.251 . . . . 6.16 112.81 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.2 tp -178.29 -51.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.214 -0.448 . . . . 6.94 110.407 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 370' ' ' MET . 14.3 tpt -82.6 33.9 0.43 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.207 0.527 . . . . 5.63 109.861 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -80.64 48.8 1.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.8 -0.636 . . . . 5.04 111.077 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 373' ' ' ILE . 62.7 mttp 60.3 116.01 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.758 -0.655 . . . . 5.39 111.952 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 372' ' ' LYS . 72.5 mt 55.38 140.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 113.069 0.766 . . . . 1.48 113.069 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -138.99 132.73 30.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.491 -0.777 . . . . 2.17 109.852 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 82.7 mt -78.2 -40.9 26.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.089 0.403 . . . . 0.92 112.089 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 88.1 p -47.91 -21.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.278 0.561 . . . . 1.71 110.851 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -58.11 -47.63 82.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.192 -0.913 . . . . 1.92 110.949 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.615 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 7.5 m120 -165.25 111.26 0.81 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.799 -0.637 . . . . 2.14 111.29 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.3 -41.04 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.932 2.422 . . . . 0.85 112.22 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.99 -32.37 61.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.993 -0.548 . . . . 1.21 111.666 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.2 tttp -46.35 129.31 10.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.973 0.416 . . . . 1.66 111.556 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 50.0 mm -87.75 126.13 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.894 -0.594 . . . . 0.41 111.276 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -99.58 143.1 30.21 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.098 -0.334 . . . . 0.63 110.098 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.499 ' C ' HD12 ' A' ' 385' ' ' ILE . 29.4 m-85 -92.73 136.25 33.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.96 111.292 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.651 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.5 mp -116.21 129.58 72.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.078 -0.51 . . . . 0.49 110.757 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.794 ' HB2' HD22 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -97.48 110.26 22.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 2.42 110.232 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.444 ' O ' ' HD3' ' A' ' 386' ' ' ARG . 76.6 mtp180 -77.74 158.82 29.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.501 -0.318 . . . . 2.3 110.983 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -54.15 -41.52 68.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.485 -0.325 . . . . 2.82 111.449 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.406 ' OD1' ' HB2' ' A' ' 387' ' ' ARG . 54.2 p-10 -60.46 -10.12 4.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.938 0.399 . . . . 1.23 110.788 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.578 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 83.88 36.04 14.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.931 -0.577 . . . . 1.03 112.424 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.596 HG22 HD13 ' A' ' 445' ' ' LEU . 73.1 p -121.07 111.72 17.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.31 . . . . 0.98 111.146 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.53 134.24 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.55 110.537 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -142.63 135.93 28.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.941 0.401 . . . . 2.43 110.751 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.448 ' HG3' HH11 ' A' ' 394' ' ' ARG . 54.4 mtm-85 -56.64 146.48 25.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 2.96 111.293 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -164.12 129.88 2.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.615 -0.72 . . . . 0.26 112.065 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -88.36 105.07 17.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.739 0.304 . . . . 1.28 111.379 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.5 OUTLIER -71.09 129.78 34.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.964 -0.384 . . . . 0.83 109.964 178.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 81.3 mt -121.0 -34.32 3.55 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 112.686 0.624 . . . . 1.45 112.686 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.511 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 74.2 mt-30 -129.18 175.46 8.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.036 0.446 . . . . 2.08 111.918 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 99.4 p -166.53 148.56 6.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.612 -0.722 . . . . 0.56 110.63 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 37.9 ptt180 -155.76 134.57 11.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.769 0.319 . . . . 1.55 110.941 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 65.2 p -72.38 -132.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.575 -0.284 . . . . 1.79 110.533 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.764 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.2 m -162.84 -173.6 3.56 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.854 -0.424 . . . . 1.95 109.854 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.764 ' H ' HG22 ' A' ' 403' ' ' THR . 67.2 mm-40 -44.55 -38.83 4.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.759 0.314 . . . . 3.87 111.172 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 407' ' ' ALA . 25.1 t-20 -65.66 -53.08 46.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 3.16 110.73 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 54.85 61.99 2.72 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.184 -0.462 . . . . 2.18 111.895 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.502 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -165.07 2.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 2.77 110.708 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.621 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -175.71 -49.97 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.529 -0.76 . . . . 2.76 110.853 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 27.3 Cg_exo -61.72 143.0 95.95 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.332 2.022 . . . . 2.49 112.056 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.594 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.6 p30 -179.84 131.92 0.1 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.234 0.54 . . . . 2.14 112.054 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 400' ' ' SER . 49.8 mp0 -109.47 135.82 49.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.516 -0.765 . . . . 2.1 109.297 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 400' ' ' SER . 0.4 OUTLIER -109.33 126.35 53.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.942 0.401 . . . . 0.72 111.61 -178.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 19.8 t80 -62.42 135.83 57.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.51 109.673 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.617 HG21 HD11 ' A' ' 385' ' ' ILE . 14.6 p -139.93 137.71 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.333 0.587 . . . . 1.15 112.563 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -112.23 97.4 6.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.197 -0.91 . . . . 0.62 109.762 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.512 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 7.8 m-85 -57.09 127.13 30.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 0.65 111.133 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.98 129.4 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.037 -0.529 . . . . 1.34 111.042 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.53 -43.28 2.08 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.828 -0.701 . . . . 0.82 112.897 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 419' ' ' LEU . 7.5 mp -59.91 155.47 16.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.887 0.375 . . . . 1.6 111.196 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -51.21 140.57 16.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 2.53 110.727 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 22.8 ptt-85 -62.31 -37.43 85.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.443 . . . . 3.98 110.362 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -55.66 -40.37 72.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.519 -0.764 . . . . 3.71 110.704 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . . . . . . . . . 48.4 mt -62.57 -35.53 79.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.914 -0.584 . . . . 1.49 110.575 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 416' ' ' TYR . 9.1 m-20 -64.94 138.17 58.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.58 -0.736 . . . . 1.2 111.623 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.89 -151.26 9.16 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.702 -0.681 . . . . 0.7 111.909 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -83.29 137.27 34.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.61 110.76 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.623 ' CG1' HD11 ' A' ' 432' ' ' ILE . 1.9 p -127.23 139.8 50.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.89 111.724 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -64.87 147.4 50.98 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.688 -0.687 . . . . 1.72 112.578 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 45.3 tpt85 -52.7 -39.24 61.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 1.73 111.355 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -64.47 -27.97 69.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.453 0.538 . . . . 1.47 112.453 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.589 ' HB2' ' CG2' ' A' ' 427' ' ' VAL . 61.3 mtt-85 -78.56 -30.02 46.6 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.176 0.436 . . . . 2.84 112.176 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.623 HD11 ' CG1' ' A' ' 427' ' ' VAL . 65.1 mt -87.8 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.043 0.449 . . . . 0.46 111.795 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.415 ' HB2' HD11 ' A' ' 439' ' ' LEU . 56.7 m -161.57 139.41 9.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.531 -0.759 . . . . 0.53 110.27 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -74.67 16.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 1.35 111.927 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.566 HD22 ' HB2' ' A' ' 437' ' ' ASP . 16.3 p-10 -159.61 136.33 9.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.049 0.452 . . . . 2.16 111.321 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -65.52 -31.88 73.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.707 -0.679 . . . . 0.75 111.586 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . 0.566 ' HB2' HD22 ' A' ' 435' ' ' ASN . 31.6 m-20 -49.37 -41.06 38.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.296 -0.411 . . . . 1.34 111.256 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . 0.4 ' CG ' HD21 ' A' ' 435' ' ' ASN . 39.8 m-20 -97.98 43.01 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 1.56 110.649 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.794 HD22 ' HB2' ' A' ' 386' ' ' ARG . 96.7 mt -150.52 -84.02 0.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.113 -0.494 . . . . 1.12 110.993 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -173.89 41.23 0.14 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.087 -0.578 . . . . 1.36 112.065 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 61.26 -138.71 47.48 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.881 -0.676 . . . . 1.83 112.459 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 36.3 mm -119.83 61.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.227 0.537 . . . . 1.48 110.354 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 443' ' ' THR . 59.2 m 48.46 45.62 20.78 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.442 -0.799 . . . . 3.05 110.902 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 444' ' ' VAL . 18.4 t -96.18 51.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.361 0.6 . . . . 4.18 110.761 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.596 HD13 HG22 ' A' ' 391' ' ' THR . 5.3 mp -83.13 135.22 44.88 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.48 -0.782 . . . . 4.99 111.218 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.2 137.35 28.54 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.572 2.181 . . . . 7.4 112.397 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . -170.08 123.97 0.65 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.252 -0.431 . . . . 9.06 111.022 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 447' ' ' ALA . 16.7 Cg_exo -67.58 129.1 19.31 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.605 2.203 . . . . 11.06 112.251 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.54 50.18 3.42 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.683 2.255 . . . . 13.5 112.503 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 450' ' ' LEU . 2.1 pt? -170.92 137.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 15.76 111.115 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -64.33 137.9 97.27 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 16.74 111.009 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.85 139.42 74.24 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.653 2.235 . . . . 18.53 112.378 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -170.7 137.28 1.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 20.55 111.077 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . 0.682 ' NE2' ' H ' ' A' ' 454' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.275 -0.869 . . . . 21.22 110.773 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.407 -0.277 . . . . 11.64 112.407 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 46.9 t -61.61 -49.7 75.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.727 0.299 . . . . 9.86 110.953 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -176.29 37.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 8.07 110.944 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . 0.661 ' HG2' ' HA ' ' A' ' 407' ' ' ALA . 0.0 OUTLIER 65.38 141.53 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.083 -0.508 . . . . 5.51 110.694 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.55 ' HB3' ' CD2' ' A' ' 369' ' ' LEU . 1.4 m-20 -47.52 128.89 10.54 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.177 -0.465 . . . . 6.06 111.293 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.5 46.12 2.1 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.892 2.395 . . . . 6.16 113.575 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.55 ' CD2' ' HB3' ' A' ' 367' ' ' ASP . 2.5 pt? -161.15 -27.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.652 0.263 . . . . 6.94 111.138 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.45 ' O ' ' HG3' ' A' ' 370' ' ' MET . 43.6 tpp -75.3 32.33 0.1 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.056 0.455 . . . . 5.63 111.084 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.446 ' H ' ' C ' ' A' ' 369' ' ' LEU . 73.6 mt-30 -111.27 41.16 1.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.365 0.602 . . . . 5.04 109.932 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.407 ' HE3' ' HE ' ' A' ' 429' ' ' ARG . 50.1 mtmt -78.18 167.08 21.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.249 -0.887 . . . . 5.39 111.935 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.605 HD11 HH11 ' A' ' 429' ' ' ARG . 42.0 mt 68.56 136.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 115.518 -0.765 . . . . 1.48 111.635 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.707 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 57.5 m-20 -150.08 69.0 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.393 -0.821 . . . . 2.17 109.91 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.862 HD11 HG12 ' A' ' 397' ' ' VAL . 60.7 mt -45.48 -35.84 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.542 -0.754 . . . . 0.92 112.431 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 41.9 t -45.84 -35.87 4.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.433 0.531 . . . . 1.71 112.433 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 16.9 pt-20 -79.13 -36.99 39.68 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.11 0.411 . . . . 1.92 112.11 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.691 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 6.8 m120 -145.58 83.49 8.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 112.353 0.501 . . . . 2.14 112.353 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . 0.441 ' HA ' HG23 ' A' ' 375' ' ' ILE . 37.3 Cg_exo -63.95 -41.21 24.12 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.022 2.481 . . . . 0.85 112.875 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.413 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 1.5 m-20 -74.77 -31.97 61.92 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.162 0.431 . . . . 1.21 112.162 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.691 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 87.9 tttt -41.1 129.73 2.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.014 0.435 . . . . 1.66 111.213 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.594 HG21 ' HD3' ' A' ' 394' ' ' ARG . 48.9 mm -83.09 132.69 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.686 -0.688 . . . . 0.41 111.96 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -113.21 143.42 44.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.036 -0.529 . . . . 0.63 109.72 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.524 ' HB3' HG11 ' A' ' 392' ' ' VAL . 27.1 m-85 -93.7 130.51 39.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.673 0.273 . . . . 0.96 111.029 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.668 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.1 mp -117.5 131.03 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.361 -0.382 . . . . 0.49 110.945 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.665 ' N ' HD23 ' A' ' 439' ' ' LEU . 55.4 ttp180 -84.7 124.02 31.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.582 -0.281 . . . . 2.42 110.997 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -73.17 -174.97 1.7 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.799 0.333 . . . . 2.3 110.654 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -67.31 -45.3 76.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 2.82 111.177 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -70.73 -36.1 73.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 1.23 111.8 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.735 ' HA3' HD23 ' A' ' 445' ' ' LEU . . . 141.35 -33.09 2.02 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.436 -0.888 . . . . 1.03 112.764 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.468 ' HB ' ' HA ' ' A' ' 443' ' ' THR . 41.4 p -59.05 112.82 1.82 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.302 0.572 . . . . 0.98 111.611 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.524 HG11 ' HB3' ' A' ' 384' ' ' PHE . 46.6 t -78.98 131.03 35.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.328 -0.851 . . . . 0.55 111.853 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -122.79 138.33 54.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.99 -0.55 . . . . 2.43 110.401 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.594 ' HD3' HG21 ' A' ' 382' ' ' ILE . 64.9 mtt85 -58.73 153.62 16.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.144 0.497 . . . . 2.96 111.988 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -174.37 132.39 2.23 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.501 -0.772 . . . . 0.26 111.828 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 72.1 mt-30 -91.35 129.97 37.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.92 0.36 . . . . 1.28 111.752 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.862 HG12 HD11 ' A' ' 375' ' ' ILE . 16.0 t -84.64 136.08 23.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.821 -0.437 . . . . 0.83 109.821 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.24 -46.58 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.116 0.413 . . . . 1.45 112.116 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.419 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 96.0 mm-40 -125.58 175.71 7.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 2.08 111.82 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 81.0 p -165.47 145.33 6.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.457 -0.792 . . . . 0.56 110.304 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 20.3 ptt-85 -145.64 136.66 24.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.052 0.453 . . . . 1.55 111.528 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.702 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 17.9 p -102.06 37.41 1.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.821 -0.627 . . . . 1.79 111.044 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.881 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.2 m 49.29 -173.33 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.178 -0.465 . . . . 1.95 110.659 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.881 ' H ' HG22 ' A' ' 403' ' ' THR . 59.1 mm-40 -65.08 -40.97 95.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 3.87 111.164 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.459 ' HB2' ' HG3' ' A' ' 409' ' ' PRO . 19.9 m-20 -57.08 -55.16 38.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 3.16 112.053 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.702 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 55.92 41.51 29.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.369 0.604 . . . . 2.18 109.813 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.661 ' HA ' ' HG2' ' A' ' 366' ' ' MET . . . -139.54 10.14 2.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.041 -0.981 . . . . 2.77 110.03 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.643 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -179.9 -50.05 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.005 -0.998 . . . . 2.76 110.16 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 20.4 Cg_endo -59.9 147.57 92.12 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.451 2.1 . . . . 2.49 112.138 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.549 ' HB3' HG22 ' A' ' 402' ' ' THR . 12.1 p-10 -176.85 134.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.424 . . . . 2.14 110.982 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 400' ' ' SER . 51.4 mt-10 -145.93 134.2 21.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 2.1 110.006 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -112.52 128.88 56.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.969 0.414 . . . . 0.72 111.739 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.566 ' O ' HG13 ' A' ' 397' ' ' VAL . 24.5 t80 -67.78 150.37 48.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.93 -0.577 . . . . 0.51 109.769 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.664 HG21 HG12 ' A' ' 385' ' ' ILE . 8.9 p -148.03 137.72 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.175 0.512 . . . . 1.15 112.081 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -115.67 101.14 8.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.62 110.312 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.575 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 2.4 m-85 -63.44 124.41 21.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.437 -0.347 . . . . 0.65 110.62 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.413 ' O ' HD23 ' A' ' 419' ' ' LEU . 91.5 t -74.98 128.36 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 1.34 110.985 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.88 -40.92 1.67 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.895 -0.669 . . . . 0.82 112.905 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 2.8 mm? -59.27 157.53 10.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.229 0.538 . . . . 1.6 111.987 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.592 ' HB2' HD13 ' A' ' 423' ' ' LEU . 4.0 m120 -52.45 147.19 8.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.129 -0.941 . . . . 2.53 111.795 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -61.54 -38.18 86.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.944 -0.571 . . . . 3.98 110.56 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 64.0 mtt-85 -54.51 -39.51 67.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.943 -0.571 . . . . 3.71 109.94 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 420' ' ' ASN . 5.3 mp -63.56 -35.66 81.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.18 -0.918 . . . . 1.49 110.321 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 416' ' ' TYR . 15.2 m-20 -65.88 133.31 50.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.54 -0.755 . . . . 1.2 111.269 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 173.98 -152.92 15.82 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.915 -0.66 . . . . 0.7 112.178 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -96.32 139.81 31.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.854 0.359 . . . . 0.61 110.964 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.463 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 17.8 m -143.15 144.67 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.89 110.991 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -58.89 151.09 34.64 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.832 -0.699 . . . . 1.72 112.425 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.605 HH11 HD11 ' A' ' 373' ' ' ILE . 21.5 tpt180 -51.45 -40.16 58.86 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.769 0.285 . . . . 1.73 111.769 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -51.62 -30.95 23.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.644 0.259 . . . . 1.47 111.426 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.63 ' O ' HD21 ' A' ' 439' ' ' LEU . 99.0 mtt180 -80.16 -38.66 30.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 2.84 111.969 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.805 HD13 HG22 ' A' ' 397' ' ' VAL . 77.5 mt -88.1 132.15 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.648 -0.421 . . . . 0.46 110.749 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.529 ' HB2' HD11 ' A' ' 439' ' ' LEU . 75.7 m -163.42 143.43 8.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.797 -0.638 . . . . 0.53 111.157 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.06 16.46 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 1.35 111.224 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.82 HD21 ' HB2' ' A' ' 437' ' ' ASP . 52.6 t30 -152.12 132.49 13.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.969 0.414 . . . . 2.16 110.651 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' A' ' 441' ' ' GLY . . . -79.21 -34.99 42.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.913 -0.585 . . . . 0.75 112.546 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . 0.82 ' HB2' HD21 ' A' ' 435' ' ' ASN . 1.5 m-20 -48.96 -40.45 30.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.67 0.271 . . . . 1.34 111.499 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.96 -33.69 75.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 1.56 111.084 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 386' ' ' ARG . 7.3 mp -85.34 -86.37 0.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.85 -0.614 . . . . 1.12 112.554 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -167.51 52.92 0.23 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.482 -0.866 . . . . 1.36 113.045 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.604 ' O ' ' HB1' ' A' ' 436' ' ' ALA . . . 71.53 -148.35 43.55 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.831 -0.7 . . . . 1.83 112.748 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.633 HG22 HG22 ' A' ' 443' ' ' THR . 49.2 mm -118.28 108.86 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.427 -0.212 . . . . 1.48 110.427 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.633 HG22 HG22 ' A' ' 442' ' ' ILE . 10.0 t 38.18 39.14 0.25 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.4 0.619 . . . . 3.05 112.074 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 442' ' ' ILE . 81.7 t -149.49 122.23 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.102 -0.954 . . . . 4.18 111.302 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.735 HD23 ' HA3' ' A' ' 390' ' ' GLY . 36.8 tp 175.26 68.2 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.219 0 CA-C-N 115.821 -0.627 . . . . 4.99 110.265 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -52.49 135.58 55.24 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.791 2.328 . . . . 7.4 112.902 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -173.24 135.48 0.7 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.705 -0.68 . . . . 9.06 110.589 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.85 136.32 71.6 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.42 2.08 . . . . 11.06 112.2 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.38 132.04 36.69 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.514 2.143 . . . . 13.5 112.232 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 450' ' ' LEU . 2.1 pt? -62.01 131.16 48.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 15.76 110.856 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . -70.64 131.41 87.95 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.037 -0.529 . . . . 16.74 110.968 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 451' ' ' ALA . 32.0 Cg_exo -58.58 130.75 38.71 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.378 2.052 . . . . 18.53 112.032 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 452' ' ' PRO . 63.7 t0 74.09 -46.24 0.61 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.007 -0.542 . . . . 20.55 111.496 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.251 -0.88 . . . . 21.22 110.264 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.4 -0.28 . . . . 11.64 112.4 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 59.1 m -160.38 41.71 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.819 0.342 . . . . 9.86 110.88 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -67.66 -27.04 66.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 8.07 110.575 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 95.4 mmm 65.99 51.36 1.34 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.38 -0.827 . . . . 5.51 111.33 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.419 ' OD2' ' HE2' ' A' ' 372' ' ' LYS . 57.9 m-20 61.92 154.02 0.11 Allowed Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.119 -0.491 . . . . 6.06 111.8 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . 0.534 ' HG2' ' HG3' ' A' ' 371' ' ' GLN . 77.2 Cg_exo -50.75 -20.46 6.7 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.605 2.203 . . . . 6.16 112.41 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.569 ' O ' HD22 ' A' ' 369' ' ' LEU . 1.1 tm? 178.75 -52.47 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.313 -1.312 . . . . 6.94 109.939 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.532 ' CB ' HD13 ' A' ' 369' ' ' LEU . 4.2 tpt -170.6 33.24 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.776 -0.647 . . . . 5.63 109.62 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.534 ' HG3' ' HG2' ' A' ' 368' ' ' PRO . 8.3 mm100 -70.98 106.13 3.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.611 -0.722 . . . . 5.04 111.012 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.545 ' HD2' ' NE ' ' A' ' 429' ' ' ARG . 67.4 mmtt -160.0 -179.52 7.86 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.235 -0.439 . . . . 5.39 110.988 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.604 HG12 ' CZ ' ' A' ' 429' ' ' ARG . 47.9 mm -59.85 131.43 24.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.008 -0.542 . . . . 1.48 111.892 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.654 ' HB3' ' HG3' ' A' ' 377' ' ' GLU . 1.5 m-20 -90.07 140.95 29.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.833 -0.621 . . . . 2.17 110.44 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.529 HG22 ' N ' ' A' ' 376' ' ' SER . 68.8 mt -111.65 -80.29 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.481 0.549 . . . . 0.92 112.481 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.529 ' N ' HG22 ' A' ' 375' ' ' ILE . 45.4 t -52.42 -22.48 4.76 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.438 0.637 . . . . 1.71 110.818 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.654 ' HG3' ' HB3' ' A' ' 374' ' ' ASP . 21.8 mm-40 -62.48 -39.54 93.76 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.901 -1.045 . . . . 1.92 111.138 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.414 ' C ' HD22 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -155.5 64.13 3.91 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.529 . . . . 2.14 111.109 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -51.31 -40.26 61.74 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.48 2.12 . . . . 0.85 112.273 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -60.02 -36.69 77.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.084 -0.507 . . . . 1.21 110.933 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -54.57 130.09 38.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.064 -0.517 . . . . 1.66 111.358 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.506 HG21 ' HD2' ' A' ' 394' ' ' ARG . 46.6 mm -87.54 136.58 22.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.116 -0.493 . . . . 0.41 110.664 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.414 ' HD1' ' HA ' ' A' ' 396' ' ' GLN . 12.1 m-85 -110.72 144.0 40.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.738 0.304 . . . . 0.63 110.784 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.503 ' C ' HD12 ' A' ' 385' ' ' ILE . 3.3 m-85 -92.62 132.78 36.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.96 110.884 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.719 HG12 HG11 ' A' ' 414' ' ' VAL . 2.3 mp -114.06 123.38 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.29 -0.414 . . . . 0.49 111.023 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.566 ' HD2' ' O ' ' A' ' 387' ' ' ARG . 4.8 tmm_? -92.34 110.27 21.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 2.42 110.273 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.602 ' HG2' ' NH2' ' A' ' 431' ' ' ARG . 70.7 mtp180 -73.81 153.55 39.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.288 -0.414 . . . . 2.3 110.857 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 390' ' ' GLY . 49.5 mt-10 -54.15 -41.31 68.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 2.82 111.685 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -66.7 5.21 0.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.093 0.473 . . . . 1.23 110.633 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.515 ' O ' HD12 ' A' ' 445' ' ' LEU . . . 74.94 35.4 50.23 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.494 -0.775 . . . . 1.03 113.707 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 49.2 p -121.44 110.73 16.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.98 111.19 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 442' ' ' ILE . 51.6 t -73.86 140.69 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.55 111.384 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -150.6 136.59 18.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.936 -0.574 . . . . 2.43 110.43 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.506 ' HD2' HG21 ' A' ' 382' ' ' ILE . 69.9 mtm-85 -56.77 152.88 11.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.058 0.456 . . . . 2.96 112.019 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -173.39 134.97 3.08 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.572 -0.74 . . . . 0.26 112.096 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . 0.414 ' HA ' ' HD1' ' A' ' 383' ' ' TYR . 89.6 mt-30 -95.37 129.56 42.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.726 0.298 . . . . 1.28 111.476 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.724 HG22 HD13 ' A' ' 432' ' ' ILE . 13.2 t -89.09 128.69 41.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.363 -0.381 . . . . 0.83 110.323 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.409 ' HB2' ' HD2' ' A' ' 413' ' ' TYR . 89.6 mt -121.29 -40.03 2.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.096 0.406 . . . . 1.45 112.096 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.56 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 66.1 mt-30 -127.38 175.74 7.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.073 0.463 . . . . 2.08 111.936 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 95.7 p -165.51 148.74 7.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.592 -0.731 . . . . 0.56 110.152 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -163.45 135.69 5.16 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.036 0.446 . . . . 1.55 112.065 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 41.1 p -74.78 139.76 43.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 1.79 109.786 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.84 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.6 m -61.21 -174.84 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.281 -0.266 . . . . 1.95 110.281 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.84 ' H ' HG22 ' A' ' 403' ' ' THR . 7.5 mp0 -50.3 -40.31 48.16 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.744 0.276 . . . . 3.87 111.744 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.558 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 49.3 t30 -56.91 -49.39 75.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 3.16 110.8 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.588 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.28 55.18 8.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 2.18 111.466 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.476 ' HB3' ' ND2' ' A' ' 405' ' ' ASN . . . -158.7 9.77 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 2.77 110.16 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.6 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.38 -48.66 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.039 -0.982 . . . . 2.76 110.209 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 20.2 Cg_exo -65.26 144.69 81.75 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.579 2.186 . . . . 2.49 112.512 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.1 p30 -169.48 129.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 2.14 110.542 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.9 mt-10 -115.87 134.65 54.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.971 -0.559 . . . . 2.1 110.797 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.427 ' HB3' HG13 ' A' ' 397' ' ' VAL . 1.6 m-85 -109.24 123.55 49.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 0.72 110.626 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.56 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 17.1 t80 -56.16 143.09 34.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.502 . . . . 0.51 110.206 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.719 HG11 HG12 ' A' ' 385' ' ' ILE . 28.6 t -136.41 136.91 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.152 0.501 . . . . 1.15 111.823 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -117.25 90.57 3.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.641 -0.709 . . . . 0.62 110.083 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.456 ' HD1' ' H ' ' A' ' 416' ' ' TYR . 4.1 m-85 -59.76 115.63 3.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.65 110.724 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.74 130.99 29.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.0 -0.545 . . . . 1.34 111.008 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.13 -45.71 2.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.894 -0.67 . . . . 0.82 112.574 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 419' ' ' LEU . 7.3 mp -61.43 143.56 55.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.957 0.408 . . . . 1.6 111.121 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.577 HD22 ' HB3' ' A' ' 422' ' ' ARG . 53.1 t30 -56.25 161.49 2.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.862 -0.608 . . . . 2.53 111.327 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -59.96 -29.03 68.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.035 -0.53 . . . . 3.98 110.803 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . 0.577 ' HB3' HD22 ' A' ' 420' ' ' ASN . 12.5 tpt180 -53.43 -39.39 64.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.72 -0.673 . . . . 3.71 111.305 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.613 HD22 ' H ' ' A' ' 423' ' ' LEU . 2.2 mm? -69.75 -35.63 75.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.232 -0.44 . . . . 1.49 110.529 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -60.51 138.41 58.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.85 -0.614 . . . . 1.2 111.089 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -173.3 -137.94 2.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.861 -0.685 . . . . 0.7 112.475 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 37.9 m95 -128.93 132.88 47.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.61 110.916 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.691 HG21 HG13 ' A' ' 432' ' ' ILE . 34.0 m -115.64 150.34 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 0.89 111.011 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -74.3 32.7 0.96 Allowed Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.807 -0.711 . . . . 1.72 113.681 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.604 ' CZ ' HG12 ' A' ' 373' ' ' ILE . 42.2 tpt85 71.55 -45.65 0.62 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.705 0.632 . . . . 1.73 112.705 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.529 ' CE1' ' HG3' ' A' ' 431' ' ' ARG . 8.7 p80 -54.62 -22.79 14.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.823 0.305 . . . . 1.47 111.823 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.602 ' NH2' ' HG2' ' A' ' 387' ' ' ARG . 75.2 mtp180 -79.44 -31.7 42.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.256 0.465 . . . . 2.84 112.256 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.724 HD13 HG22 ' A' ' 397' ' ' VAL . 57.6 mt -87.49 136.85 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.849 0.357 . . . . 0.46 111.333 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 63.7 m -158.7 140.65 13.77 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.98 -0.554 . . . . 0.53 110.938 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -74.75 16.85 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.002 -0.544 . . . . 1.35 112.084 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.78 HD21 ' HB2' ' A' ' 437' ' ' ASP . 53.5 t30 -155.64 132.05 10.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 2.16 111.203 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -73.55 -41.19 63.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.854 -0.612 . . . . 0.75 112.178 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . 0.78 ' HB2' HD21 ' A' ' 435' ' ' ASN . 54.0 m-20 -49.03 -40.5 31.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.503 -0.317 . . . . 1.34 111.391 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -65.37 -44.36 87.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 1.56 110.946 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 386' ' ' ARG . 68.0 mt -62.97 -83.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.227 -0.442 . . . . 1.12 111.179 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -157.98 32.03 0.51 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.489 -0.862 . . . . 1.36 112.825 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 48.98 40.99 28.45 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.924 -0.655 . . . . 1.83 112.515 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.571 ' O ' HG23 ' A' ' 444' ' ' VAL . 45.6 mm 57.27 102.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.178 -0.305 . . . . 1.48 110.178 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.633 HG23 HG23 ' A' ' 444' ' ' VAL . 15.2 t 41.5 -145.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.322 0.389 . . . . 3.05 110.621 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.633 HG23 HG23 ' A' ' 443' ' ' THR . 3.1 t 58.78 63.85 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.369 -0.378 . . . . 4.18 111.88 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 390' ' ' GLY . 83.4 mt -136.89 130.77 17.76 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.753 0.311 . . . . 4.99 111.172 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 145.92 52.78 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.788 2.325 . . . . 7.4 112.621 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -54.3 143.97 43.1 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.017 -0.538 . . . . 9.06 111.171 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.18 136.87 62.92 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.582 2.188 . . . . 11.06 112.377 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.63 135.91 63.58 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.579 2.186 . . . . 13.5 112.276 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 1.3 pp -78.24 33.65 0.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 15.76 111.603 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -63.24 137.58 97.11 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 16.74 111.122 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.62 139.03 73.34 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.555 2.17 . . . . 18.53 112.213 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 34.3 t70 66.2 134.08 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.961 -0.563 . . . . 20.55 111.175 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . 0.433 ' OE1' ' N ' ' A' ' 454' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.293 -0.86 . . . . 21.22 110.883 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.424 ' HA3' ' OG ' ' A' ' 376' ' ' SER . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.464 -0.254 . . . . 11.64 112.464 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 75.7 p -67.23 -124.82 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.518 0.199 . . . . 9.86 110.902 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . 0.55 ' HE2' ' HB2' ' A' ' 372' ' ' LYS . 8.4 p80 -161.19 -152.67 0.27 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 110.332 -0.247 . . . . 8.07 110.332 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -78.1 46.67 0.61 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.881 0.372 . . . . 5.51 111.217 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -62.97 116.26 23.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 6.06 111.469 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . 0.703 ' HD2' ' HG3' ' A' ' 371' ' ' GLN . 74.3 Cg_exo -50.52 -21.29 7.38 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.968 2.446 . . . . 6.16 113.104 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 370' ' ' MET . 2.3 pt? -171.92 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.898 -1.046 . . . . 6.94 110.307 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.534 ' H ' HD23 ' A' ' 369' ' ' LEU . 4.6 tmm? 178.73 38.14 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.51 -0.768 . . . . 5.63 109.503 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.703 ' HG3' ' HD2' ' A' ' 368' ' ' PRO . 22.5 mt-30 -77.95 141.95 38.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.571 . . . . 5.04 111.015 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.55 ' HB2' ' HE2' ' A' ' 365' ' ' HIS . 67.8 mttm 63.14 144.45 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.074 -0.512 . . . . 5.39 111.602 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.56 ' H ' HH22 ' A' ' 429' ' ' ARG . 86.4 mt -50.4 129.39 8.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.932 -0.576 . . . . 1.48 111.836 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.06 129.72 44.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.87 -0.605 . . . . 2.17 110.041 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.451 HD13 ' C ' ' A' ' 398' ' ' LEU . 82.9 mt -68.32 -45.24 82.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.493 -0.321 . . . . 0.92 111.842 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.424 ' OG ' ' HA3' ' A' ' 363' ' ' GLY . 69.0 m -70.15 62.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.692 -0.685 . . . . 1.71 110.848 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -147.52 -33.71 0.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.737 -0.665 . . . . 1.92 110.0 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -173.0 65.7 0.34 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.132 -0.94 . . . . 2.14 110.959 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.6 -38.44 55.04 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.457 2.104 . . . . 0.85 111.859 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.04 -36.99 83.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 1.21 110.593 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -51.64 140.45 18.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.016 -0.538 . . . . 1.66 110.844 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.583 HG21 ' HD2' ' A' ' 394' ' ' ARG . 49.8 mm -86.23 128.89 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.41 111.537 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -105.28 144.76 31.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.63 110.378 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.604 ' CD2' HD11 ' A' ' 442' ' ' ILE . 1.8 m-30 -90.5 133.5 35.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.446 -0.343 . . . . 0.96 110.633 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 385' ' ' ILE . 3.0 mp -128.94 128.98 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.799 0.333 . . . . 0.49 111.145 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 58.1 ttt-85 -92.73 123.24 35.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 2.42 111.193 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -71.05 158.16 36.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.367 -0.379 . . . . 2.3 110.162 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -49.53 -35.59 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 2.82 110.828 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.97 -36.24 69.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 1.23 111.666 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.535 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 135.99 -35.17 2.17 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.378 -0.915 . . . . 1.03 113.126 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.485 ' HA ' HD12 ' A' ' 445' ' ' LEU . 68.7 p -58.67 112.36 1.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 0.98 112.207 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.39 144.92 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.186 -0.916 . . . . 0.55 111.225 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -150.48 139.74 21.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.161 -0.472 . . . . 2.43 110.959 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.583 ' HD2' HG21 ' A' ' 382' ' ' ILE . 66.2 mtm-85 -60.07 151.29 27.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.87 -0.605 . . . . 2.96 112.168 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -169.62 135.13 3.43 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.434 -0.803 . . . . 0.26 111.823 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -91.97 111.57 23.16 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.304 0.483 . . . . 1.28 112.304 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.747 HG22 HD13 ' A' ' 432' ' ' ILE . 24.4 t -76.43 132.87 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.483 -0.326 . . . . 0.83 110.383 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.451 ' C ' HD13 ' A' ' 375' ' ' ILE . 96.0 mt -121.33 -42.92 2.43 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.735 0.643 . . . . 1.45 112.735 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.548 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 97.5 mm-40 -129.18 177.46 7.14 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.212 0.53 . . . . 2.08 112.208 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.0 p -153.35 157.3 39.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.454 -0.794 . . . . 0.56 110.043 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 33.2 ptt180 -154.09 137.09 15.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.08 0.467 . . . . 1.55 112.258 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 409' ' ' PRO . 36.4 p -96.31 136.07 37.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 1.79 110.036 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.839 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.6 m -62.75 -174.52 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.469 -0.332 . . . . 1.95 110.622 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.839 ' H ' HG22 ' A' ' 403' ' ' THR . 64.9 mm-40 -53.13 -40.07 63.95 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.721 0.267 . . . . 3.87 111.721 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.72 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 26.0 t-20 -55.95 -51.01 69.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 3.16 110.994 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 53.49 55.96 7.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.079 0.466 . . . . 2.18 111.89 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.554 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -160.55 10.86 0.1 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.727 -0.669 . . . . 2.77 109.456 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.594 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.64 -48.06 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.611 -1.177 . . . . 2.76 110.213 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.72 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 38.2 Cg_exo -61.04 138.14 76.5 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.736 2.291 . . . . 2.49 112.701 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 13.6 p-10 -173.39 123.31 0.38 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.909 -0.587 . . . . 2.14 111.09 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 400' ' ' SER . 58.3 mp0 -112.51 142.34 45.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.774 -0.648 . . . . 2.1 110.284 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.714 ' HB2' HD12 ' A' ' 432' ' ' ILE . 1.2 m-85 -109.03 124.17 50.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.019 0.438 . . . . 0.72 111.804 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.548 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 18.8 t80 -62.19 150.16 39.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.722 -0.672 . . . . 0.51 109.409 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.442 HG21 HG12 ' A' ' 385' ' ' ILE . 7.3 p -150.92 132.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.286 0.565 . . . . 1.15 112.193 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -110.74 90.98 3.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.268 -0.878 . . . . 0.62 109.596 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.525 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 14.3 m-85 -53.03 135.68 36.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.094 0.473 . . . . 0.65 111.25 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 418' ' ' GLY . 17.6 t -63.67 -124.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.454 -0.794 . . . . 1.34 111.417 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.563 ' N ' HG12 ' A' ' 417' ' ' VAL . . . -39.7 -29.41 0.16 Allowed Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.248 0.459 . . . . 0.82 114.248 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.664 ' HB3' HD23 ' A' ' 423' ' ' LEU . 7.1 mp -58.79 141.31 53.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.244 0.522 . . . . 1.6 110.955 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.431 ' HB3' ' HG2' ' A' ' 422' ' ' ARG . 49.2 t30 -55.42 154.89 5.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.966 -0.561 . . . . 2.53 111.286 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 68.5 mtt-85 -53.35 -29.81 36.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.663 -0.699 . . . . 3.98 112.152 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . 0.582 ' HG3' HD13 ' A' ' 423' ' ' LEU . 16.8 ptm180 -52.65 -40.7 63.08 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.956 0.354 . . . . 3.71 111.956 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.664 HD23 ' HB3' ' A' ' 419' ' ' LEU . 1.1 mm? -71.05 -35.09 71.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.713 0.292 . . . . 1.49 111.028 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.27 130.51 46.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 1.2 111.427 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.67 -145.67 9.19 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.7 112.012 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -100.36 140.22 34.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.61 110.946 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.454 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 28.5 m -140.26 145.72 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.89 110.971 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -59.83 147.55 43.54 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.914 -0.584 . . . . 1.72 113.361 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.56 HH22 ' H ' ' A' ' 373' ' ' ILE . 15.4 tpt180 -50.93 -38.92 53.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.654 0.381 . . . . 1.73 111.72 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.439 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 24.8 p-80 -57.87 -28.83 64.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.092 0.404 . . . . 1.47 112.092 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.8 mtt180 -78.35 -38.62 41.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.993 0.368 . . . . 2.84 111.993 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.747 HD13 HG22 ' A' ' 397' ' ' VAL . 60.1 mt -88.01 133.27 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.898 0.38 . . . . 0.46 110.893 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.745 ' HB2' HD11 ' A' ' 439' ' ' LEU . 58.0 m -165.11 145.71 7.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.736 -0.665 . . . . 0.53 110.806 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . 0.493 ' H ' HD11 ' A' ' 373' ' ' ILE . 52.0 p-10 -71.28 16.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 1.35 111.911 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 433' ' ' SER . 20.7 p30 -165.8 133.93 3.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 2.16 111.095 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . 0.492 ' HB2' ' HD2' ' A' ' 384' ' ' PHE . . . -68.66 -13.27 62.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 0.75 111.949 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.41 -41.08 72.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.686 0.279 . . . . 1.34 111.363 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.47 -6.46 58.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 1.56 111.48 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.5 mp -96.68 -93.28 0.22 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.245 -0.434 . . . . 1.12 111.598 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . 0.521 ' O ' HD11 ' A' ' 445' ' ' LEU . . . -171.56 38.27 0.17 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.776 -0.726 . . . . 1.36 112.485 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.98 138.84 0.05 OUTLIER Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.865 -0.683 . . . . 1.83 112.812 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.604 HD11 ' CD2' ' A' ' 384' ' ' PHE . 43.2 mm -63.84 125.9 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 109.126 -0.694 . . . . 1.48 109.126 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.491 ' O ' ' HG ' ' A' ' 445' ' ' LEU . 13.1 t 41.8 -152.23 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.857 0.723 . . . . 3.05 111.776 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.542 ' O ' HG13 ' A' ' 444' ' ' VAL . 7.4 p 45.04 57.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.627 0.727 . . . . 4.18 112.333 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.521 HD11 ' O ' ' A' ' 440' ' ' GLY . 96.4 mt -134.0 141.55 40.06 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.54 -0.755 . . . . 4.99 110.567 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.66 45.97 1.57 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.726 2.284 . . . . 7.4 112.868 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -61.95 135.64 94.74 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.392 -0.367 . . . . 9.06 110.738 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.13 130.0 25.98 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.352 2.035 . . . . 11.06 111.999 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.04 124.7 12.1 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.361 2.041 . . . . 13.5 112.332 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 57.6 tp -88.29 136.61 32.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 15.76 111.03 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -60.96 137.37 93.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 16.74 110.824 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.33 130.99 34.17 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.425 2.083 . . . . 18.53 112.237 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -176.06 44.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.136 -0.483 . . . . 20.55 110.993 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.247 -0.882 . . . . 21.22 110.896 179.813 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.523 -0.231 . . . . 11.64 112.523 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 69.1 m -164.09 -45.49 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.81 0.338 . . . . 9.86 110.834 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -62.26 139.65 58.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 8.07 110.785 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . 0.568 ' HB3' ' HG2' ' A' ' 371' ' ' GLN . 65.8 mtt -67.27 128.11 35.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.387 -0.37 . . . . 5.51 110.405 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -66.14 136.2 95.3 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.366 -0.379 . . . . 6.06 110.768 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.3 37.26 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.476 2.117 . . . . 6.16 112.389 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.491 ' C ' HD12 ' A' ' 369' ' ' LEU . 2.4 pp -163.42 0.87 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.149 -0.478 . . . . 6.94 111.199 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.415 ' C ' ' H ' ' A' ' 372' ' ' LYS . 55.5 ttp -174.44 66.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.127 -0.488 . . . . 5.63 110.741 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.568 ' HG2' ' HB3' ' A' ' 366' ' ' MET . 65.9 mt-30 -77.83 35.64 0.2 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.979 0.419 . . . . 5.04 111.172 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 372' ' ' LYS . 0.0 OUTLIER 177.3 141.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.623 -0.717 . . . . 5.39 110.263 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.434 HG13 ' HE ' ' A' ' 429' ' ' ARG . 68.1 mt -61.56 130.18 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.814 0.34 . . . . 1.48 110.767 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.534 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 0.9 OUTLIER -88.21 69.86 9.2 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.152 -0.476 . . . . 2.17 110.859 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 377' ' ' GLU . 61.7 mt -45.86 -44.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.92 111.709 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 73.1 m -63.1 73.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 1.71 111.559 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.4 pt-20 -173.97 -31.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 1.92 110.482 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.49 HD22 ' C ' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -152.99 58.16 2.3 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.53 . . . . 2.14 111.606 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 50.3 Cg_exo -53.03 -37.6 79.1 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.283 1.989 . . . . 0.85 111.504 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.1 -34.19 75.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.7 -0.682 . . . . 1.21 110.695 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -53.38 123.22 11.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.191 -0.458 . . . . 1.66 110.784 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 417' ' ' VAL . 45.8 mm -84.91 128.92 38.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 0.41 111.38 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -106.93 143.38 35.11 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.069 -0.345 . . . . 0.63 110.069 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.76 ' HB2' HD11 ' A' ' 439' ' ' LEU . 5.2 m-85 -89.78 139.35 30.66 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.807 -0.357 . . . . 0.96 110.192 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.726 HG12 HG21 ' A' ' 414' ' ' VAL . 2.6 mp -115.25 129.51 71.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.255 -0.429 . . . . 0.49 111.829 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.76 ' CZ ' HG23 ' A' ' 392' ' ' VAL . 5.2 tpm_? -88.25 90.14 8.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.865 -0.607 . . . . 2.42 110.176 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.616 ' HA ' ' NH2' ' A' ' 431' ' ' ARG . 58.1 mtp85 -55.88 153.6 8.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.725 0.297 . . . . 2.3 110.816 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.76 -44.76 77.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.212 -0.449 . . . . 2.82 111.318 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -58.27 -14.86 8.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.263 0.554 . . . . 1.23 109.749 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 91.66 39.77 5.49 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.176 -0.92 . . . . 1.03 112.561 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.46 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 70.8 p -121.91 110.19 15.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.591 0.234 . . . . 0.98 110.917 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.76 HG23 ' CZ ' ' A' ' 386' ' ' ARG . 63.4 t -70.97 132.71 32.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.628 0.252 . . . . 0.55 110.348 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -151.31 135.35 16.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.893 0.378 . . . . 2.43 110.582 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.445 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 71.2 mtt-85 -52.85 151.8 4.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.862 -0.608 . . . . 2.96 112.135 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -170.16 131.51 2.26 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.204 -0.907 . . . . 0.26 111.411 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . 0.413 ' HG2' HD13 ' A' ' 382' ' ' ILE . 80.1 mt-30 -87.14 128.97 35.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.769 0.318 . . . . 1.28 111.734 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.838 HG22 HD13 ' A' ' 432' ' ' ILE . 8.7 t -89.71 132.95 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.462 -0.57 . . . . 0.83 109.462 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 68.2 mt -120.34 -37.32 3.06 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.51 0.559 . . . . 1.45 112.51 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -139.46 175.96 9.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.479 . . . . 2.08 112.13 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.5 p -163.85 149.44 10.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.577 -0.738 . . . . 0.56 110.344 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -158.05 136.85 11.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.869 0.366 . . . . 1.55 111.5 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 63.1 p -77.65 -128.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.356 -0.384 . . . . 1.79 109.969 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.72 HG22 ' H ' ' A' ' 404' ' ' GLU . 0.5 OUTLIER -164.84 -173.41 2.96 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 110.214 -0.291 . . . . 1.95 110.214 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.72 ' H ' HG22 ' A' ' 403' ' ' THR . 94.7 mt-10 -44.9 -45.21 10.22 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.659 0.266 . . . . 3.87 111.588 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.531 HD21 ' HB3' ' A' ' 407' ' ' ALA . 49.6 t30 -66.75 -51.45 55.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.529 -0.305 . . . . 3.16 110.953 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . 52.97 52.92 12.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.131 0.491 . . . . 2.18 111.469 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.531 ' HB3' HD21 ' A' ' 405' ' ' ASN . . . -150.66 10.75 0.65 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.694 -0.684 . . . . 2.77 109.688 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.562 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.48 -47.6 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 114.585 -1.189 . . . . 2.76 110.055 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 31.9 Cg_exo -58.8 143.59 99.0 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.463 2.108 . . . . 2.49 112.447 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.64 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 42.5 p-10 -176.26 136.07 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.796 -0.638 . . . . 2.14 110.804 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.5 mt-10 -130.96 134.18 46.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 2.1 110.342 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 2.4 m-85 -112.32 127.48 56.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.377 . . . . 0.72 111.671 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -64.76 144.78 57.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.437 -0.579 . . . . 0.51 109.437 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.726 HG21 HG12 ' A' ' 385' ' ' ILE . 6.4 p -143.99 129.83 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.43 0.633 . . . . 1.15 112.625 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -111.86 89.22 3.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.929 -1.032 . . . . 0.62 109.123 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.547 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 30.0 m-85 -52.49 115.6 1.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 0.65 110.941 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.634 HG21 HD12 ' A' ' 382' ' ' ILE . 62.1 t -62.47 130.13 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.853 -0.612 . . . . 1.34 110.875 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.81 -42.6 2.5 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.98 -0.628 . . . . 0.82 112.798 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.527 ' HB3' HD22 ' A' ' 423' ' ' LEU . 2.7 mm? -59.6 159.43 8.45 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.92 0.39 . . . . 1.6 111.668 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 69.1 m-20 -53.83 142.86 22.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.79 -0.641 . . . . 2.53 111.383 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -60.73 -36.65 79.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 3.98 111.196 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -56.37 -32.15 64.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.355 -0.384 . . . . 3.71 111.0 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 419' ' ' LEU . 1.1 tp -56.4 -29.78 61.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 1.49 111.351 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.57 140.23 11.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.085 0.469 . . . . 1.2 111.824 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -174.82 -149.83 7.43 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.681 -0.691 . . . . 0.7 112.097 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -127.46 133.08 49.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.61 110.808 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.838 HG21 HG13 ' A' ' 432' ' ' ILE . 5.1 m -109.43 153.17 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.955 -0.566 . . . . 0.89 111.049 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -76.97 29.98 1.57 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.434 -0.888 . . . . 1.72 112.455 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.764 ' H ' HG23 ' A' ' 427' ' ' VAL . 39.2 tpt85 71.88 -37.41 0.39 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.181 0.437 . . . . 1.73 112.181 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -58.83 -27.36 65.04 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.712 0.264 . . . . 1.47 111.712 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.616 ' NH2' ' HA ' ' A' ' 387' ' ' ARG . 81.2 mtp180 -78.56 -38.37 40.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.958 0.355 . . . . 2.84 111.958 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.838 HD13 HG22 ' A' ' 397' ' ' VAL . 73.2 mt -88.44 131.41 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 0.46 110.37 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 49.0 m -154.87 139.6 17.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.006 0.432 . . . . 0.53 111.631 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.41 -25.4 67.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.615 . . . . 1.35 110.349 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.732 HD21 ' HB2' ' A' ' 437' ' ' ASP . 48.4 t30 -108.56 134.13 51.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.837 -0.619 . . . . 2.16 110.286 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -69.26 -42.91 74.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.023 -0.535 . . . . 0.75 112.298 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . 0.732 ' HB2' HD21 ' A' ' 435' ' ' ASN . 54.4 m-20 -57.63 -40.54 79.45 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.584 0.216 . . . . 1.34 111.584 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -56.3 -35.06 67.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 1.56 110.471 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 384' ' ' PHE . 86.4 mt -57.29 -82.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.775 -0.648 . . . . 1.12 111.184 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . 0.529 ' HA3' HH11 ' A' ' 386' ' ' ARG . . . -168.35 -27.98 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.05 -0.595 . . . . 1.36 112.138 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 443' ' ' THR . . . 154.44 143.08 3.59 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.104 -0.57 . . . . 1.83 112.117 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 44.7 mm -62.56 78.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 120.989 0.423 . . . . 1.48 110.884 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.758 HG22 HD11 ' A' ' 445' ' ' LEU . 21.8 m -95.84 55.32 1.6 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.363 0.602 . . . . 3.05 110.359 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.623 HG12 ' HD3' ' A' ' 446' ' ' PRO . 30.1 t -89.75 119.05 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.574 -0.739 . . . . 4.18 111.383 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.758 HD11 HG22 ' A' ' 443' ' ' THR . 0.0 OUTLIER -151.31 57.93 2.58 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.311 -0.404 . . . . 4.99 111.629 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.623 ' HD3' HG12 ' A' ' 444' ' ' VAL . 15.5 Cg_exo -68.23 151.56 76.63 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.924 2.416 . . . . 7.4 112.024 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . -49.59 138.49 16.43 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.319 -0.401 . . . . 9.06 110.878 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 447' ' ' ALA . 39.7 Cg_exo -57.34 116.64 3.36 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.433 2.089 . . . . 11.06 112.606 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 6.0 Cg_endo -86.72 -159.91 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.155 2.57 . . . . 13.5 112.274 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 83.0 mt -85.23 48.95 1.65 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.954 -0.566 . . . . 15.76 110.652 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . 67.13 129.66 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.99 -0.55 . . . . 16.74 111.2 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.77 138.18 37.2 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.637 2.224 . . . . 18.53 112.884 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 64.17 136.38 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.965 -0.561 . . . . 20.55 111.57 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.246 -0.883 . . . . 21.22 111.027 179.771 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.46 -0.256 . . . . 11.64 112.46 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 82.9 p -174.55 130.08 0.34 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 9.86 110.686 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . 0.456 ' HE1' ' HB3' ' A' ' 368' ' ' PRO . 78.8 t60 -71.44 132.85 45.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 8.07 110.815 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 27.8 ttt -174.62 126.02 0.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 5.51 110.523 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 49.88 78.18 0.42 Allowed Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 116.251 -0.431 . . . . 6.06 111.04 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . 0.456 ' HB3' ' HE1' ' A' ' 365' ' ' HIS . 61.5 Cg_endo -73.57 40.15 0.53 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.727 2.285 . . . . 6.16 112.921 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 370' ' ' MET . 2.4 pt? -168.6 -41.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 6.94 110.42 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.576 ' HA ' ' HE3' ' A' ' 370' ' ' MET . 3.9 tpt -90.96 45.84 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.263 0.554 . . . . 5.63 110.217 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -62.59 141.63 58.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.001 -0.545 . . . . 5.04 111.252 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.517 ' HB2' ' NZ ' ' A' ' 372' ' ' LYS . 0.0 OUTLIER -55.6 141.15 38.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.534 -0.757 . . . . 5.39 111.468 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.65 133.07 25.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.255 -0.43 . . . . 1.48 110.76 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.75 128.94 35.64 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 116.265 -0.425 . . . . 2.17 110.727 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.69 HD11 HG12 ' A' ' 397' ' ' VAL . 95.7 mt -91.74 -33.83 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.145 -0.48 . . . . 0.92 110.901 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.4 t -72.05 62.36 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.042 -0.526 . . . . 1.71 111.057 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -168.24 -26.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.695 -0.684 . . . . 1.92 109.874 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.645 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 3.5 m120 -156.63 62.41 2.86 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.347 -0.842 . . . . 2.14 111.517 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 79.0 Cg_exo -52.68 -41.21 70.69 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.998 2.465 . . . . 0.85 112.8 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -70.01 -32.85 71.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.226 -0.443 . . . . 1.21 111.78 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.645 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 64.0 tttm -44.52 127.09 5.8 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.931 0.396 . . . . 1.66 110.967 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.695 HD12 HG21 ' A' ' 417' ' ' VAL . 41.0 mm -86.91 127.07 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.41 111.406 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -107.72 144.0 35.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 0.63 110.004 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.457 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 3.9 m-85 -91.29 138.27 31.72 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.081 -0.247 . . . . 0.96 110.833 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.8 mp -121.37 126.99 75.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.449 -0.341 . . . . 0.49 110.87 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 38.4 ttt85 -91.57 122.53 34.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 2.42 111.032 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -83.23 172.19 12.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.744 0.307 . . . . 2.3 110.695 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -53.05 -71.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 2.82 111.045 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -40.99 -31.64 0.19 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.068 0.461 . . . . 1.23 110.565 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 111.14 39.48 1.38 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.795 -0.639 . . . . 1.03 112.986 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 39.7 p -114.02 111.04 21.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.95 0.405 . . . . 0.98 110.976 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 439' ' ' LEU . 46.1 t -72.53 140.74 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.55 111.39 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -148.14 134.34 19.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.582 . . . . 2.43 110.42 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.584 ' HD2' HG21 ' A' ' 382' ' ' ILE . 83.0 mtm180 -58.43 150.37 22.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.074 0.464 . . . . 2.96 111.94 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -172.73 132.05 2.27 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.638 -0.71 . . . . 0.26 112.254 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -91.72 111.61 23.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.577 0.227 . . . . 1.28 111.607 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.715 HG22 HD13 ' A' ' 432' ' ' ILE . 8.7 t -66.49 134.12 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.927 -0.397 . . . . 0.83 109.927 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 91.6 mt -119.07 -44.49 2.6 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.907 0.336 . . . . 1.45 111.907 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.555 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 84.0 mt-30 -124.5 174.33 7.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.991 0.424 . . . . 2.08 111.645 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 87.7 p -165.88 144.95 6.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.78 -0.645 . . . . 0.56 110.351 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.503 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 41.2 ptt180 -156.97 134.89 10.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.003 0.43 . . . . 1.55 111.448 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 14.1 p -85.99 38.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.942 -0.572 . . . . 1.79 111.041 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.841 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.8 m 51.75 -173.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.545 -0.298 . . . . 1.95 110.272 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.841 ' H ' HG22 ' A' ' 403' ' ' THR . 8.4 mp0 -54.87 -49.52 70.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.721 0.296 . . . . 3.87 110.631 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.661 HD21 ' HB3' ' A' ' 407' ' ' ALA . 41.8 t30 -87.21 115.09 24.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.302 -0.408 . . . . 3.16 110.727 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -94.91 51.84 1.41 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.832 0.349 . . . . 2.18 111.293 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.661 ' HB3' HD21 ' A' ' 405' ' ' ASN . . . -124.98 -11.52 7.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 2.77 111.215 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.635 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -161.84 -50.48 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.868 -0.606 . . . . 2.76 111.107 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 72.1 Cg_exo -50.17 152.06 8.43 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.498 2.132 . . . . 2.49 112.621 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 44.0 p-10 -175.74 137.22 0.34 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.093 -0.503 . . . . 2.14 111.134 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -150.16 135.9 18.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 2.1 110.497 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.746 ' HB2' HD12 ' A' ' 432' ' ' ILE . 2.1 m-85 -115.66 126.48 54.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.45 -0.341 . . . . 0.72 111.358 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 426' ' ' TRP . 12.8 t80 -65.78 142.78 57.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.195 -0.457 . . . . 0.51 110.32 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.637 HG22 HD11 ' A' ' 432' ' ' ILE . 20.1 t -128.33 136.87 58.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 112.546 0.573 . . . . 1.15 112.546 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -120.88 89.87 3.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.62 109.943 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.617 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 50.0 m-85 -56.5 129.25 39.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.65 111.19 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.695 HG21 HD12 ' A' ' 382' ' ' ILE . 2.8 t -82.98 34.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.782 -0.644 . . . . 1.34 111.259 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -178.4 -41.44 0.07 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.455 -0.879 . . . . 0.82 113.103 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.617 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 2.2 mm? -59.77 156.77 13.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.84 0.352 . . . . 1.6 111.081 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -49.72 144.55 6.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.021 -0.536 . . . . 2.53 111.77 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -56.83 -39.4 74.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.88 -0.6 . . . . 3.98 111.092 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 41.4 ptt85 -62.26 -32.15 72.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.895 0.378 . . . . 3.71 110.702 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.67 -32.38 72.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.974 -0.557 . . . . 1.49 111.056 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -48.16 129.1 14.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.301 -0.409 . . . . 1.2 110.448 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.95 165.59 35.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.53 -0.843 . . . . 0.7 112.487 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 8.3 m95 -74.42 128.49 35.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.739 0.304 . . . . 0.61 110.496 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.467 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 4.4 m -119.89 152.68 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.89 110.819 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -56.87 148.59 31.55 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.954 -0.641 . . . . 1.72 112.825 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -50.2 -42.16 50.97 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.567 0.347 . . . . 1.73 111.844 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.444 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 22.2 p-80 -54.81 -28.54 50.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.289 0.477 . . . . 1.47 112.289 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 98.3 mtt180 -78.59 -38.3 40.36 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.601 0.593 . . . . 2.84 112.601 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.746 HD12 ' HB2' ' A' ' 412' ' ' TYR . 68.8 mt -88.6 130.65 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 120.601 -0.44 . . . . 0.46 111.009 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.758 ' HB2' HD11 ' A' ' 439' ' ' LEU . 44.6 m -168.11 140.42 3.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.837 -0.62 . . . . 0.53 110.949 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -66.02 -15.53 63.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.015 -0.539 . . . . 1.35 111.278 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.469 ' O ' HD13 ' A' ' 439' ' ' LEU . 5.8 m120 -108.48 130.9 55.25 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.841 0.353 . . . . 2.16 110.851 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 441' ' ' GLY . . . -74.74 -34.75 62.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.75 112.03 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.03 -40.56 67.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.425 -0.352 . . . . 1.34 111.641 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 435' ' ' ASN . 61.9 m-20 -64.11 -21.21 66.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 1.56 111.369 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.758 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.7 mp -93.94 -88.65 0.23 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.097 -0.501 . . . . 1.12 111.917 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . 0.521 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -164.43 49.92 0.29 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.021 -0.609 . . . . 1.36 112.157 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.475 ' O ' ' HB1' ' A' ' 436' ' ' ALA . . . 69.19 -129.61 23.49 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.59 -0.814 . . . . 1.83 112.375 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.426 HD13 ' O ' ' A' ' 441' ' ' GLY . 43.3 mm -128.54 65.8 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.829 0.347 . . . . 1.48 110.651 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 392' ' ' VAL . 9.9 t 39.64 51.47 2.33 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.756 0.789 . . . . 3.05 111.55 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 444' ' ' VAL . 8.4 p -146.05 60.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.671 -1.15 . . . . 4.18 110.868 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 94.7 mt -50.71 146.31 9.99 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.443 -0.799 . . . . 4.99 111.075 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -47.82 142.62 14.38 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.756 2.304 . . . . 7.4 112.551 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . -157.66 138.56 9.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.531 . . . . 9.06 110.94 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 447' ' ' ALA . 31.9 Cg_exo -58.58 131.73 44.17 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.612 2.208 . . . . 11.06 112.684 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.32 144.8 75.6 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.784 2.323 . . . . 13.5 112.224 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . 0.638 ' O ' HD12 ' A' ' 450' ' ' LEU . 3.6 pp -53.79 147.15 12.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 15.76 111.212 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . 64.93 129.63 0.03 OUTLIER Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 115.872 -0.604 . . . . 16.74 111.301 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.87 133.26 28.75 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.489 2.126 . . . . 18.53 112.507 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -174.53 126.33 0.31 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.07 -0.513 . . . . 20.55 110.573 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.247 -0.882 . . . . 21.22 110.854 179.998 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.111 0 N-CA-C 112.456 -0.258 . . . . 11.64 112.456 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 67.6 m -159.65 44.73 0.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.967 0.413 . . . . 9.86 110.783 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . 0.554 ' HE1' ' HA ' ' A' ' 368' ' ' PRO . 15.0 p80 -169.84 138.62 1.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.984 -0.553 . . . . 8.07 110.542 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . 0.412 ' N ' ' SD ' ' A' ' 366' ' ' MET . 1.6 mpt? -64.59 129.83 41.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 5.51 111.49 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 58.64 126.44 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.696 -0.684 . . . . 6.06 112.229 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . 0.554 ' HA ' ' HE1' ' A' ' 365' ' ' HIS . 72.4 Cg_endo -78.63 40.35 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.596 2.197 . . . . 6.16 112.436 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 369' ' ' LEU . 1.0 OUTLIER -150.84 26.23 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.977 0.417 . . . . 6.94 111.247 -179.468 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.404 ' O ' ' HG3' ' A' ' 370' ' ' MET . 12.2 tpt -172.8 66.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.873 -0.603 . . . . 5.63 110.468 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -58.82 126.31 27.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.804 -0.635 . . . . 5.04 111.093 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.541 ' HE2' ' HA ' ' A' ' 365' ' ' HIS . 54.6 mtmt -59.58 151.39 24.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.863 -0.608 . . . . 5.39 110.924 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.678 HG12 ' CZ ' ' A' ' 429' ' ' ARG . 49.5 mm -46.09 128.7 2.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.139 -0.482 . . . . 1.48 111.939 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -102.59 130.87 49.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.902 -0.59 . . . . 2.17 109.996 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 77.5 mt -81.22 -42.28 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.42 0.526 . . . . 0.92 112.42 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 41.5 t -47.93 -22.75 0.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.137 0.494 . . . . 1.71 111.308 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -54.77 -47.67 73.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.408 -0.815 . . . . 1.92 111.118 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 379' ' ' PRO . 8.2 m120 -167.06 112.9 0.67 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.833 -0.621 . . . . 2.14 110.979 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 378' ' ' ASN . 12.2 Cg_exo -71.5 -41.05 2.56 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.826 2.35 . . . . 0.85 112.699 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.407 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 55.3 m-20 -80.94 -34.24 33.39 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.125 0.417 . . . . 1.21 112.125 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 86.4 tttt -44.82 124.98 4.69 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.765 0.317 . . . . 1.66 111.413 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.96 HD12 HG21 ' A' ' 417' ' ' VAL . 11.4 mm -77.99 131.05 35.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.132 -0.486 . . . . 0.41 111.854 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -111.35 144.15 41.0 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.781 -0.452 . . . . 0.63 109.781 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.425 ' C ' HD12 ' A' ' 385' ' ' ILE . 46.9 m-85 -89.69 134.74 34.0 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.852 -0.339 . . . . 0.96 110.899 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.6 mp -119.47 132.86 68.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.262 -0.426 . . . . 0.49 110.899 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.626 ' N ' HD23 ' A' ' 439' ' ' LEU . 50.3 ttt-85 -93.92 115.78 28.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.672 0.272 . . . . 2.42 110.819 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -76.56 157.04 32.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.524 -0.307 . . . . 2.3 110.554 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -53.9 -44.95 70.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.581 -0.281 . . . . 2.82 111.086 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -54.9 -27.35 42.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.253 0.549 . . . . 1.23 109.597 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 103.13 38.5 2.86 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.34 -0.845 . . . . 1.03 113.183 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 69.1 p -121.07 112.15 18.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.98 111.455 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.33 132.28 33.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.55 110.351 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -146.5 135.89 22.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.021 0.439 . . . . 2.43 111.22 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.541 ' HD3' HG21 ' A' ' 382' ' ' ILE . 74.0 mtt-85 -53.84 153.67 4.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.722 -0.672 . . . . 2.96 111.875 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 415' ' ' HIS . . . -179.59 130.74 1.55 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.763 -0.653 . . . . 0.26 112.192 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 75.5 mt-30 -91.82 134.11 35.04 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.99 0.395 . . . . 1.28 111.885 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.873 HG22 HD13 ' A' ' 432' ' ' ILE . 5.2 t -87.4 133.28 30.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.23 -0.441 . . . . 0.83 110.722 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 85.0 mt -121.16 -46.75 2.29 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.075 0.398 . . . . 1.45 112.075 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.555 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 13.5 mm100 -127.07 176.84 7.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.916 0.389 . . . . 2.08 111.647 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 87.9 p -162.42 139.56 8.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.79 -0.641 . . . . 0.56 110.92 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.677 ' O ' ' HD3' ' A' ' 401' ' ' ARG . 0.1 OUTLIER -148.39 138.64 22.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 1.55 110.906 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.742 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 13.9 m -103.33 42.25 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 1.79 110.096 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.9 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.5 m 51.27 -173.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.736 -0.665 . . . . 1.95 110.648 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.9 ' H ' HG22 ' A' ' 403' ' ' THR . 95.6 mt-10 -63.98 -37.16 86.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 3.87 110.69 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.681 ' HB2' ' HG2' ' A' ' 409' ' ' PRO . 5.1 m120 -56.25 -51.99 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.598 . . . . 3.16 111.442 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.648 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.33 56.43 5.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 2.18 110.863 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -161.9 -3.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 2.77 111.04 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.553 ' H ' ' CD ' ' A' ' 409' ' ' PRO . . . -169.54 -44.54 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.71 -0.677 . . . . 2.76 111.649 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.681 ' HG2' ' HB2' ' A' ' 405' ' ' ASN . 15.7 Cg_exo -69.79 47.85 0.59 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.825 2.35 . . . . 2.49 113.87 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.742 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 47.2 p-10 -68.59 143.84 54.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.908 0.385 . . . . 2.14 110.893 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 50.6 mt-10 -148.72 146.69 28.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.016 -0.538 . . . . 2.1 110.423 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -127.06 125.28 41.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.913 0.387 . . . . 0.72 111.688 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.555 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 20.2 t80 -63.47 149.99 44.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.045 -0.724 . . . . 0.51 109.045 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.542 HG21 HG12 ' A' ' 385' ' ' ILE . 7.8 p -158.83 133.32 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.016 0.747 . . . . 1.15 113.016 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . 0.578 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 76.2 t60 -105.06 106.24 16.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.03 -0.987 . . . . 0.62 109.167 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 2.1 m-85 -62.19 100.63 0.18 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.55 0.691 . . . . 0.65 109.939 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.96 HG21 HD12 ' A' ' 382' ' ' ILE . 44.2 t -48.63 123.74 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.555 -1.202 . . . . 1.34 111.75 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 83.07 -33.37 2.91 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.183 -0.917 . . . . 0.82 113.409 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.657 ' HB3' HD12 ' A' ' 423' ' ' LEU . 8.9 mt -68.23 -173.6 0.42 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.42 0.629 . . . . 1.6 112.456 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.739 ' HB2' ' HG ' ' A' ' 423' ' ' LEU . 5.2 m120 -74.3 145.85 43.62 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 114.961 -1.018 . . . . 2.53 111.053 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.464 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 45.1 mtp85 -65.21 -39.24 92.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.22 -0.446 . . . . 3.98 111.348 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -57.44 -35.71 70.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.742 0.306 . . . . 3.71 111.122 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.739 ' HG ' ' HB2' ' A' ' 420' ' ' ASN . 85.4 mt -56.94 -33.94 67.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 1.49 111.191 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.578 ' OD1' ' HA ' ' A' ' 415' ' ' HIS . 39.8 m-20 -52.94 141.87 20.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.521 . . . . 1.2 111.759 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -171.85 -142.06 3.59 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.644 -0.707 . . . . 0.7 111.954 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -124.29 138.07 54.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.018 0.437 . . . . 0.61 110.715 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.829 HG21 HG13 ' A' ' 432' ' ' ILE . 15.7 m -109.08 158.58 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.925 -0.58 . . . . 0.89 111.844 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -81.61 39.98 2.57 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.882 -0.675 . . . . 1.72 113.009 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.678 ' CZ ' HG12 ' A' ' 373' ' ' ILE . 38.4 tpt85 68.56 -72.4 0.1 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.492 0.553 . . . . 1.73 112.492 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -47.2 -15.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 1.47 113.053 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.564 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 99.5 mtt180 -78.29 -35.55 47.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.723 0.268 . . . . 2.84 111.723 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 397' ' ' VAL . 97.4 mt -88.45 132.23 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.46 111.16 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.683 ' HB2' HD11 ' A' ' 439' ' ' LEU . 75.0 m -166.06 139.29 4.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.855 -0.611 . . . . 0.53 110.779 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -61.86 -23.15 66.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 1.35 111.095 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.446 ' HB2' ' OD2' ' A' ' 438' ' ' ASP . 80.3 m-20 -108.44 131.69 54.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.916 0.389 . . . . 2.16 110.909 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -75.82 -31.96 59.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.75 111.915 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.66 -40.55 62.95 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.453 -0.34 . . . . 1.34 111.462 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . 0.446 ' OD2' ' HB2' ' A' ' 435' ' ' ASN . 57.6 m-20 -61.96 -23.6 66.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 1.56 111.091 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.5 mp -91.61 -84.63 0.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.82 -0.627 . . . . 1.12 112.313 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -158.81 57.02 0.34 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.462 -0.875 . . . . 1.36 112.995 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.68 -129.03 30.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.636 -0.793 . . . . 1.83 112.841 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.55 ' O ' HG22 ' A' ' 443' ' ' THR . 46.2 mm -136.41 144.46 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.395 0.14 . . . . 1.48 110.912 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 442' ' ' ILE . 8.3 t 49.91 179.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.835 0.709 . . . . 3.05 112.585 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 35.3 m -57.31 131.57 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.134 -0.939 . . . . 4.18 112.216 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.527 ' N ' HD23 ' A' ' 445' ' ' LEU . 2.1 pt? -147.99 60.57 5.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.355 -0.839 . . . . 4.99 110.422 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.99 134.1 8.1 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.737 2.291 . . . . 7.4 113.021 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . 63.28 130.16 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.81 -0.632 . . . . 9.06 111.868 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.43 146.23 49.65 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.716 2.277 . . . . 11.06 112.119 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.8 134.97 49.57 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.482 2.121 . . . . 13.5 112.203 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . 0.722 HD23 ' N ' ' A' ' 451' ' ' ALA . 6.6 tt -173.65 143.54 1.02 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.046 -0.524 . . . . 15.76 110.216 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.722 ' N ' HD23 ' A' ' 450' ' ' LEU . . . -46.42 143.75 3.7 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.136 -0.484 . . . . 16.74 111.569 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.758 ' HA ' HE22 ' A' ' 454' ' ' GLN . 72.5 Cg_endo -74.5 43.04 0.85 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.967 2.445 . . . . 18.53 113.071 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.85 -41.53 12.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.673 -0.24 . . . . 20.55 111.27 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . 0.758 HE22 ' HA ' ' A' ' 452' ' ' PRO . 14.7 mp0 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.207 -0.902 . . . . 21.22 110.852 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.434 -0.267 . . . . 11.64 112.434 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 52.2 m 56.6 45.15 22.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.799 0.333 . . . . 9.86 110.943 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -59.12 136.61 58.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 8.07 110.503 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . 0.421 ' N ' ' SD ' ' A' ' 366' ' ' MET . 1.2 mpt? -59.1 121.9 12.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.081 0.467 . . . . 5.51 111.282 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -79.01 139.17 56.92 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.801 -0.636 . . . . 6.06 111.217 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.72 42.46 1.31 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.68 2.253 . . . . 6.16 112.603 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.476 ' C ' HD23 ' A' ' 369' ' ' LEU . 6.8 tt -171.68 -49.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 6.94 109.904 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.437 ' HA ' ' OD1' ' A' ' 374' ' ' ASP . 53.2 ttp -102.74 61.04 0.8 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 5.63 110.314 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.99 103.79 0.07 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.275 -0.421 . . . . 5.04 111.078 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.655 ' HB3' ' OH ' ' A' ' 412' ' ' TYR . 63.1 mttp 44.42 59.14 3.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.779 -0.646 . . . . 5.39 111.804 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 76.4 mt 62.96 131.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.988 -0.551 . . . . 1.48 111.905 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 42.7 m-20 -89.47 77.36 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.833 -0.621 . . . . 2.17 110.923 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.4 mt -48.36 -41.2 10.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 0.92 111.648 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 77.9 p -64.94 76.14 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.545 . . . . 1.71 111.687 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 16.2 pt-20 -174.69 -27.62 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.862 -0.608 . . . . 1.92 110.242 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.598 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 3.5 m120 -156.14 62.3 2.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.691 -0.686 . . . . 2.14 112.235 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.14 -40.97 75.36 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.778 2.319 . . . . 0.85 112.542 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -70.86 -34.41 71.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.041 -0.527 . . . . 1.21 111.722 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 86.2 tttt -43.03 129.73 4.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.981 0.42 . . . . 1.66 111.028 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.508 HG21 ' HD2' ' A' ' 394' ' ' ARG . 46.8 mm -81.64 123.26 37.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.854 -0.612 . . . . 0.41 111.448 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -102.02 143.41 31.9 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.922 -0.399 . . . . 0.63 109.922 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.84 139.2 30.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.587 -0.279 . . . . 0.96 110.798 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.601 ' N ' HD12 ' A' ' 385' ' ' ILE . 1.7 mp -131.94 133.45 60.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.69 0.281 . . . . 0.49 111.168 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.634 ' CZ ' ' HA3' ' A' ' 440' ' ' GLY . 8.1 tpt180 -90.41 121.71 32.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 2.42 110.585 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -74.53 164.22 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 2.3 110.556 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 388' ' ' GLU . 8.7 mp0 -61.3 -45.32 94.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.335 -0.393 . . . . 2.82 110.825 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -61.47 -12.88 16.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.133 0.492 . . . . 1.23 110.058 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.453 ' C ' ' HE ' ' A' ' 386' ' ' ARG . . . 90.78 41.78 5.26 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.409 -0.814 . . . . 1.03 112.53 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.838 HG22 ' HG ' ' A' ' 445' ' ' LEU . 82.8 p -121.35 112.64 18.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.679 0.276 . . . . 0.98 111.352 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 59.4 t -68.43 134.2 30.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 0.55 110.711 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -149.65 137.63 20.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 2.43 110.989 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.508 ' HD2' HG21 ' A' ' 382' ' ' ILE . 77.9 mtm180 -60.79 152.53 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 2.96 111.531 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -171.01 126.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.771 -0.65 . . . . 0.26 112.295 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 57.0 mt-30 -78.8 130.15 35.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.724 0.297 . . . . 1.28 111.514 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 0.7 OUTLIER -98.85 126.87 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.61 -0.515 . . . . 0.83 109.61 178.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.708 HD22 ' N ' ' A' ' 398' ' ' LEU . 0.4 OUTLIER -115.05 -47.21 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.534 0.568 . . . . 1.45 112.534 -177.215 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.426 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 24.2 mt-30 -127.71 176.41 7.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 2.08 111.726 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 84.7 p -165.47 141.93 5.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.784 -0.644 . . . . 0.56 110.967 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.491 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 41.0 ptt180 -142.88 135.23 27.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.346 -0.388 . . . . 1.55 110.772 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.69 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 24.9 p -81.92 40.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 1.79 112.159 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.8 m 50.58 -173.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.506 -0.183 . . . . 1.95 110.506 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.88 ' H ' HG22 ' A' ' 403' ' ' THR . 48.6 mt-10 -56.73 -50.02 73.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.321 . . . . 3.87 110.446 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -83.73 117.85 23.51 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.296 -0.411 . . . . 3.16 110.613 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -101.43 76.68 1.71 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.964 0.411 . . . . 2.18 111.326 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -160.68 10.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 2.77 110.65 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.696 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -178.52 -51.61 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.609 -0.723 . . . . 2.76 110.903 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 49.9 Cg_exo -57.07 154.11 35.16 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.689 2.259 . . . . 2.49 113.028 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.69 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 44.2 p-10 -178.62 130.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.852 -0.613 . . . . 2.14 111.081 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 400' ' ' SER . 58.9 mp0 -136.85 135.28 37.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.85 -0.614 . . . . 2.1 109.933 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.655 ' OH ' ' HB3' ' A' ' 372' ' ' LYS . 0.4 OUTLIER -110.91 130.17 55.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 0.72 111.897 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 14.6 t80 -65.03 141.62 58.7 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.516 -0.92 . . . . 0.51 108.516 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 6.4 p -147.72 110.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.608 0.966 . . . . 1.15 113.608 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -86.44 90.94 8.37 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.531 -0.759 . . . . 0.62 109.344 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 424' ' ' ASP . 35.6 m-85 -52.84 128.71 27.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.055 0.455 . . . . 0.65 111.394 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 86.2 t -73.2 127.81 35.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.748 -0.66 . . . . 1.34 111.166 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 77.34 -44.91 2.25 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.985 -0.626 . . . . 0.82 113.022 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.525 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.7 mp -59.7 148.98 32.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.861 0.362 . . . . 1.6 111.204 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -54.47 137.72 42.01 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.948 -0.569 . . . . 2.53 111.798 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -32.31 50.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.655 -0.702 . . . . 3.98 111.368 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . 0.58 HH11 HD23 ' A' ' 423' ' ' LEU . 0.0 OUTLIER -54.79 -38.85 67.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 3.71 110.52 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.58 HD23 HH11 ' A' ' 422' ' ' ARG . 96.5 mt -65.55 -35.44 80.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.019 0.438 . . . . 1.49 110.54 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.432 ' HA ' ' CD1' ' A' ' 416' ' ' TYR . 16.8 m-20 -54.84 138.32 43.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.654 -0.703 . . . . 1.2 111.602 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -179.46 -141.68 4.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.715 -0.675 . . . . 0.7 111.938 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . 0.491 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 53.4 m95 -106.2 140.28 39.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.61 110.695 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.538 ' CG2' HD11 ' A' ' 432' ' ' ILE . 17.1 m -132.88 141.73 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.89 111.953 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -64.99 150.96 51.66 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.855 -0.611 . . . . 1.72 112.525 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.407 ' HD3' ' CZ ' ' A' ' 412' ' ' TYR . 41.0 tpt85 -51.74 -38.28 54.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.771 0.319 . . . . 1.73 111.269 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.574 ' ND1' ' HG3' ' A' ' 431' ' ' ARG . 6.4 p80 -60.19 -28.96 68.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.44 0.533 . . . . 1.47 112.44 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.574 ' HG3' ' ND1' ' A' ' 430' ' ' HIS . 72.1 mtt-85 -78.23 -35.62 48.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.52 0.2 . . . . 2.84 111.537 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.545 HG12 HG13 ' A' ' 385' ' ' ILE . 66.3 mt -88.67 139.7 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.138 0.494 . . . . 0.46 111.869 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.9 m -163.39 139.17 6.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.5 -0.773 . . . . 0.53 110.327 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -75.83 16.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 1.35 111.359 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 75.9 m-80 -147.88 130.76 16.15 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.879 0.371 . . . . 2.16 110.699 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . 0.621 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -69.87 -37.85 76.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.53 . . . . 0.75 111.898 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -50.39 -40.87 51.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 1.34 111.214 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.14 49.39 1.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 1.56 110.999 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.621 HD12 ' HA ' ' A' ' 436' ' ' ALA . 88.7 mt -145.7 -84.87 0.12 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.521 -0.309 . . . . 1.12 111.539 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . 0.634 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . -167.66 40.5 0.24 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.416 -0.897 . . . . 1.36 113.014 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.46 144.2 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.765 -0.731 . . . . 1.83 112.88 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 48.8 mm -59.19 90.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 110.461 -0.2 . . . . 1.48 110.461 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.479 ' HA ' HD11 ' A' ' 445' ' ' LEU . 8.9 t 39.53 42.39 0.89 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.614 0.721 . . . . 3.05 111.634 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 444' ' ' VAL . 12.8 t -89.82 50.77 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.934 -1.03 . . . . 4.18 111.854 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.838 ' HG ' HG22 ' A' ' 391' ' ' THR . 0.0 OUTLIER -109.34 146.79 34.67 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 4.99 111.165 179.372 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -51.85 148.3 22.96 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.901 2.401 . . . . 7.4 112.707 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -157.64 142.48 12.03 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.022 -0.535 . . . . 9.06 110.912 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.52 129.38 19.8 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.78 2.32 . . . . 11.06 112.91 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.11 151.43 34.64 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.931 2.421 . . . . 13.5 112.578 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . 0.47 ' N ' HD22 ' A' ' 450' ' ' LEU . 3.2 mm? 65.74 148.12 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.093 -0.503 . . . . 15.76 111.513 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -157.77 138.28 9.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.64 . . . . 16.74 110.743 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.78 41.51 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.568 2.179 . . . . 18.53 112.88 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -73.37 -137.62 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.501 -0.318 . . . . 20.55 110.559 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.178 -0.915 . . . . 21.22 110.927 179.716 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 112.479 -0.249 . . . . 11.64 112.479 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.0 t -60.56 -47.02 88.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.796 0.331 . . . . 9.86 110.844 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . 0.441 ' ND1' ' N ' ' A' ' 366' ' ' MET . 26.6 t-80 -70.33 -129.03 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.138 -0.483 . . . . 8.07 109.915 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 371' ' ' GLN . 0.0 OUTLIER -172.17 46.55 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.829 -0.434 . . . . 5.51 109.829 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.446 ' OD2' ' HA ' ' A' ' 372' ' ' LYS . 55.1 m-20 48.36 85.13 0.19 Allowed Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.703 -0.681 . . . . 6.06 111.344 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.57 49.54 2.44 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.627 2.218 . . . . 6.16 112.304 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.575 ' HG ' ' HG2' ' A' ' 370' ' ' MET . 2.0 pt? -162.11 -22.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 6.94 110.47 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.575 ' HG2' ' HG ' ' A' ' 369' ' ' LEU . 19.1 ptp -158.17 13.88 0.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.178 -0.465 . . . . 5.63 111.37 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.641 ' O ' ' HB3' ' A' ' 372' ' ' LYS . 98.4 mm-40 36.11 32.8 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.261 -0.881 . . . . 5.04 112.477 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.641 ' HB3' ' O ' ' A' ' 371' ' ' GLN . 24.1 pttm 139.16 144.9 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.614 1.196 . . . . 5.39 110.488 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.543 HG13 ' HE ' ' A' ' 429' ' ' ARG . 70.4 mt -59.92 128.24 20.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.672 0.273 . . . . 1.48 110.335 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.507 ' OD1' ' HB2' ' A' ' 370' ' ' MET . 1.4 m-20 -89.5 129.36 36.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.877 0.37 . . . . 2.17 111.288 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.476 HD11 HG12 ' A' ' 397' ' ' VAL . 82.5 mt -84.79 -39.43 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.92 110.816 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.4 t -66.55 72.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.751 -0.659 . . . . 1.71 111.022 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.473 ' HG3' ' ND2' ' A' ' 378' ' ' ASN . 12.2 pt-20 -174.45 -28.64 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.536 -0.757 . . . . 1.92 109.644 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.478 HD22 ' C ' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -172.2 57.69 0.24 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.206 -0.906 . . . . 2.14 111.052 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 52.2 Cg_exo -52.86 -39.86 76.82 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.297 1.998 . . . . 0.85 111.893 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.483 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 54.0 m-20 -62.57 -33.84 75.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.93 -0.577 . . . . 1.21 110.877 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 86.1 tttt -49.1 121.29 4.67 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.205 -0.452 . . . . 1.66 110.799 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.878 HG23 HG21 ' A' ' 417' ' ' VAL . 18.6 mm -69.97 129.43 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.41 112.0 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 395' ' ' GLY . 82.0 m-85 -109.75 144.69 37.79 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.283 -0.417 . . . . 0.63 110.234 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.526 ' C ' HD12 ' A' ' 385' ' ' ILE . 2.0 m-85 -85.6 128.5 34.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.731 0.301 . . . . 0.96 110.884 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.765 HG12 HG21 ' A' ' 414' ' ' VAL . 1.8 mp -113.22 128.17 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.238 -0.437 . . . . 0.49 110.66 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.681 ' HD3' ' HB3' ' A' ' 439' ' ' LEU . 25.4 tpt180 -98.27 120.62 39.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.373 -0.376 . . . . 2.42 111.267 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -83.18 157.33 22.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 2.3 110.556 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -55.71 -39.7 71.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 2.82 111.301 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -71.44 5.5 2.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.442 -0.344 . . . . 1.23 111.684 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 74.08 44.14 30.72 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.018 -0.61 . . . . 1.03 113.776 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.429 HG22 HG21 ' A' ' 444' ' ' VAL . 25.3 p -122.38 111.65 17.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.828 0.314 . . . . 0.98 111.625 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.61 HG23 ' NH1' ' A' ' 386' ' ' ARG . 72.4 t -69.36 135.61 27.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.649 -0.25 . . . . 0.55 110.416 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -151.41 133.08 14.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.426 -0.352 . . . . 2.43 111.046 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.77 ' HD2' HG21 ' A' ' 382' ' ' ILE . 88.9 mtm180 -59.07 153.34 18.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 2.96 112.036 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -175.44 132.45 2.16 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.798 -0.637 . . . . 0.26 112.516 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . 0.494 ' HG3' HG22 ' A' ' 417' ' ' VAL . 75.3 mt-30 -96.15 112.03 23.89 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 111.773 0.286 . . . . 1.28 111.773 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.921 HG22 HD13 ' A' ' 432' ' ' ILE . 2.6 t -63.49 136.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.218 -0.29 . . . . 0.83 110.218 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.407 ' HB2' ' HD2' ' A' ' 413' ' ' TYR . 98.8 mt -120.36 -38.92 2.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.16 0.43 . . . . 1.45 112.16 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.475 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 85.7 mt-30 -139.96 176.45 8.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.066 0.46 . . . . 2.08 111.588 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.1 p -163.7 150.94 12.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.692 -0.686 . . . . 0.56 110.24 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.542 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 39.2 ptt180 -156.17 134.58 11.54 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.862 0.363 . . . . 1.55 111.86 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 32.7 p -78.25 136.93 37.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 1.79 110.293 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.832 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.7 m -63.74 -174.49 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.285 -0.416 . . . . 1.95 110.777 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.832 ' H ' HG22 ' A' ' 403' ' ' THR . 49.1 mt-10 -48.76 -43.1 37.47 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.386 0.513 . . . . 3.87 112.386 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.61 ' ND2' ' HB3' ' A' ' 407' ' ' ALA . 50.9 t30 -55.9 -49.67 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.585 0.231 . . . . 3.16 111.457 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.443 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 57.32 59.11 3.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.947 0.403 . . . . 2.18 111.537 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.61 ' HB3' ' ND2' ' A' ' 405' ' ' ASN . . . -154.75 -2.27 0.16 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.602 . . . . 2.77 110.143 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.675 ' N ' ' HD2' ' A' ' 409' ' ' PRO . . . -178.46 -49.35 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 114.848 -1.069 . . . . 2.76 110.181 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 408' ' ' ALA . 11.7 Cg_endo -54.62 141.39 74.84 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.44 2.093 . . . . 2.49 112.298 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 36.6 p-10 -177.09 132.06 0.18 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.799 -0.637 . . . . 2.14 111.077 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.4 mt-10 -108.55 135.45 49.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.595 . . . . 2.1 109.549 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.472 ' OH ' ' HB2' ' A' ' 372' ' ' LYS . 1.0 OUTLIER -108.83 120.61 43.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.894 0.378 . . . . 0.72 111.73 -178.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.475 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 11.9 t80 -60.89 137.47 58.21 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.914 -0.773 . . . . 0.51 108.914 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.765 HG21 HG12 ' A' ' 385' ' ' ILE . 7.3 p -136.87 130.52 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.904 0.705 . . . . 1.15 112.904 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . 0.495 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 81.5 t60 -102.1 89.49 3.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.87 -1.059 . . . . 0.62 109.018 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.622 ' HA ' ' HA2' ' A' ' 395' ' ' GLY . 22.6 m-85 -46.55 123.95 5.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.373 0.606 . . . . 0.65 111.019 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 382' ' ' ILE . 43.5 t -74.7 125.48 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.133 -0.94 . . . . 1.34 111.022 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 79.84 -42.98 2.55 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.585 -0.734 . . . . 0.82 112.279 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.832 HD11 ' HG2' ' A' ' 446' ' ' PRO . 7.1 mp -65.03 151.95 44.69 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.928 0.394 . . . . 1.6 111.44 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.557 HD22 ' HB3' ' A' ' 422' ' ' ARG . 55.9 t30 -57.84 160.14 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 2.53 111.226 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.45 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 68.2 mtt-85 -62.47 -26.56 68.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.257 0.551 . . . . 3.98 110.453 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . 0.557 ' HB3' HD22 ' A' ' 420' ' ' ASN . 68.2 ttt180 -52.31 -36.35 52.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.282 -0.872 . . . . 3.71 111.829 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 423' ' ' LEU . 2.8 mm? -68.91 -34.6 75.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.451 . . . . 1.49 111.584 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 415' ' ' HIS . 1.2 m-20 -45.84 140.52 3.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.15 0.5 . . . . 1.2 112.149 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -178.18 -142.41 4.68 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.584 -0.735 . . . . 0.7 112.176 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . 0.447 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 42.4 m95 -129.7 138.31 51.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.945 0.403 . . . . 0.61 110.815 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.7 HG21 HG13 ' A' ' 432' ' ' ILE . 22.2 m -125.82 149.55 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.89 111.196 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -77.01 29.49 1.59 Allowed Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.904 -0.665 . . . . 1.72 114.475 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.575 ' HB3' ' O ' ' A' ' 428' ' ' GLY . 37.4 tpt85 75.25 -43.96 0.52 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.171 0.804 . . . . 1.73 113.171 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.542 ' H ' ' CD2' ' A' ' 430' ' ' HIS . 2.0 m170 -52.25 -30.47 27.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.736 0.779 . . . . 1.47 110.269 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.572 ' NH1' ' H ' ' A' ' 428' ' ' GLY . 28.8 mtt85 -78.48 -32.31 48.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.311 -1.313 . . . . 2.84 112.595 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.921 HD13 HG22 ' A' ' 397' ' ' VAL . 77.0 mt -88.46 129.72 39.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.799 -0.36 . . . . 0.46 110.375 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.67 ' HB2' HD11 ' A' ' 439' ' ' LEU . 63.3 m -164.92 143.67 6.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.152 -0.476 . . . . 0.53 111.149 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -73.61 16.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 1.35 111.721 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -159.17 135.71 9.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.94 0.4 . . . . 2.16 111.124 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . 0.612 ' HB1' ' H ' ' A' ' 442' ' ' ILE . . . -69.37 -26.41 64.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.79 -0.641 . . . . 0.75 112.21 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -46.67 -40.76 13.75 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.49 -0.323 . . . . 1.34 111.794 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -72.94 -33.01 65.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.004 0.43 . . . . 1.56 111.012 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.681 ' HB3' ' HD3' ' A' ' 386' ' ' ARG . 6.7 mp -77.99 -84.39 0.08 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.706 -0.679 . . . . 1.12 111.866 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 386' ' ' ARG . . . -148.39 28.59 1.35 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.671 -0.776 . . . . 1.36 112.535 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 48.46 55.11 11.27 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.945 -0.645 . . . . 1.83 112.65 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.612 ' H ' ' HB1' ' A' ' 436' ' ' ALA . 31.4 mm 62.83 113.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 110.285 -0.265 . . . . 1.48 110.285 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.751 HG22 HG23 ' A' ' 444' ' ' VAL . 86.8 m -160.94 131.16 5.1 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.866 0.365 . . . . 3.05 111.97 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.751 HG23 HG22 ' A' ' 443' ' ' THR . 33.0 t 48.5 61.69 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 CA-C-N 115.785 -0.643 . . . . 4.18 111.25 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 445' ' ' LEU . 2.4 mm? -89.48 133.64 34.2 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.176 -0.466 . . . . 4.99 111.155 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.832 ' HG2' HD11 ' A' ' 419' ' ' LEU . 32.5 Cg_exo -57.5 141.81 95.2 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.835 2.357 . . . . 7.4 112.531 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -167.99 127.09 1.02 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.041 -0.527 . . . . 9.06 110.792 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 56.8 Cg_endo -70.33 133.28 24.16 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.535 2.157 . . . . 11.06 112.424 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 28.1 Cg_exo -61.65 129.94 29.68 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.416 2.077 . . . . 13.5 111.818 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 99.1 mt 64.06 132.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.26 -0.427 . . . . 15.76 111.04 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . -61.47 124.22 79.95 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 16.74 111.281 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 451' ' ' ALA . 5.8 Cg_exo -78.93 41.93 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.028 2.485 . . . . 18.53 112.273 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -153.25 135.62 15.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 20.55 110.884 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.259 -0.877 . . . . 21.22 110.864 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.427 -0.269 . . . . 11.64 112.427 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 80.2 p -172.71 44.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 9.86 110.698 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 57.31 52.72 8.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 8.07 110.352 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 27.7 ttt -57.19 128.13 35.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.885 -0.598 . . . . 5.51 110.633 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.01 121.16 76.86 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 6.06 111.272 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.3 44.06 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.828 2.352 . . . . 6.16 112.681 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.431 HD23 ' H ' ' A' ' 370' ' ' MET . 2.2 pt? -164.23 -41.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.567 -0.288 . . . . 6.94 111.24 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.431 ' H ' HD23 ' A' ' 369' ' ' LEU . 0.0 OUTLIER -82.54 46.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.078 0.466 . . . . 5.63 110.482 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.418 ' O ' ' HB2' ' A' ' 372' ' ' LYS . 3.4 mm100 -83.18 43.37 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 5.04 111.144 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 371' ' ' GLN . 47.7 mmtm 67.01 139.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.101 0.477 . . . . 5.39 111.561 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.535 ' HB ' HH12 ' A' ' 429' ' ' ARG . 68.8 mt 55.56 90.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.695 -0.684 . . . . 1.48 111.587 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.51 142.7 27.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 2.17 110.354 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.552 HG22 ' HG3' ' A' ' 379' ' ' PRO . 4.6 mp -71.4 -43.31 73.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.742 0.275 . . . . 0.92 111.742 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 49.2 m -49.11 -20.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.982 0.42 . . . . 1.71 111.52 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -58.39 -48.28 81.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.701 -0.681 . . . . 1.92 111.773 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.44 ' N ' ' ND2' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -174.98 73.61 0.3 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.12 -0.491 . . . . 2.14 110.911 -179.105 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . 0.552 ' HG3' HG22 ' A' ' 375' ' ' ILE . 78.2 Cg_exo -51.36 -40.17 62.32 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.521 2.147 . . . . 0.85 112.477 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.536 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 1.5 m-20 -62.39 -37.29 85.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 1.21 111.199 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 79.1 tttt -50.54 127.48 17.89 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.972 0.415 . . . . 1.66 111.006 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.833 HG23 HG21 ' A' ' 417' ' ' VAL . 20.8 mm -73.22 132.6 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.817 -0.629 . . . . 0.41 111.859 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.532 ' HB3' HG23 ' A' ' 432' ' ' ILE . 22.4 m-85 -118.68 144.19 46.37 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.091 -0.504 . . . . 0.63 110.256 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.592 ' CD2' ' HB2' ' A' ' 436' ' ' ALA . 3.0 m-85 -85.58 138.57 32.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.841 0.353 . . . . 0.96 111.183 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.643 HG12 HG21 ' A' ' 414' ' ' VAL . 2.5 mp -116.3 126.36 73.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.129 -0.487 . . . . 0.49 110.852 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.444 ' HB2' ' HB3' ' A' ' 439' ' ' LEU . 36.7 ttt85 -90.57 111.44 22.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 2.42 110.839 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.434 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 76.8 mtp180 -71.89 157.8 37.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.41 -0.359 . . . . 2.3 110.263 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.467 ' HG2' HH22 ' A' ' 431' ' ' ARG . 48.9 mt-10 -49.32 -41.0 37.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 2.82 111.331 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -71.33 -36.13 71.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 1.23 111.572 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 137.19 -28.15 2.82 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.427 -0.892 . . . . 1.03 112.811 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 47.5 p -58.81 112.09 1.52 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.98 111.718 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.725 HG23 ' HA3' ' A' ' 441' ' ' GLY . 73.1 t -84.92 141.14 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.625 -0.716 . . . . 0.55 110.88 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . 0.46 ' CG ' HD21 ' A' ' 419' ' ' LEU . 93.7 m-70 -145.45 139.92 27.21 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.987 0.422 . . . . 2.43 111.243 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.496 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 88.0 mtm180 -55.17 152.24 8.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.793 -0.64 . . . . 2.96 112.064 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -178.74 128.16 1.23 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.481 -0.781 . . . . 0.26 111.861 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . 0.536 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 78.4 mt-30 -84.47 130.74 34.73 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.338 0.496 . . . . 1.28 112.338 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.95 HG22 HD13 ' A' ' 432' ' ' ILE . 9.8 t -81.99 134.56 26.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.547 -0.538 . . . . 0.83 109.547 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 413' ' ' TYR . 90.2 mt -120.78 -43.19 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.475 0.546 . . . . 1.45 112.475 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.53 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 97.6 mm-40 -134.91 175.94 9.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.076 0.465 . . . . 2.08 111.816 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.5 p -165.54 143.43 5.91 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.687 -0.688 . . . . 0.56 110.633 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.463 ' HG2' ' CZ3' ' A' ' 426' ' ' TRP . 40.6 ptt180 -151.08 135.05 16.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.952 0.406 . . . . 1.55 111.346 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 23.3 p -82.91 43.29 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 1.79 111.648 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.853 HG22 ' H ' ' A' ' 404' ' ' GLU . 3.0 m 50.91 -174.08 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.201 -0.454 . . . . 1.95 110.869 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.853 ' H ' HG22 ' A' ' 403' ' ' THR . 93.3 mt-10 -65.38 -42.94 92.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.717 0.294 . . . . 3.87 111.225 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -57.34 -51.31 69.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 3.16 111.18 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.493 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 55.61 63.52 2.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.985 0.421 . . . . 2.18 111.831 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.447 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -160.63 7.76 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.404 0.621 . . . . 2.77 110.039 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.628 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.81 -48.96 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.779 -1.1 . . . . 2.76 109.99 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.628 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 31.4 Cg_exo -59.34 160.92 18.16 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.621 2.214 . . . . 2.49 112.251 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.67 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 2.1 p30 178.43 141.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.128 -0.487 . . . . 2.14 111.049 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 400' ' ' SER . 95.6 mt-10 -142.25 134.74 28.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.97 -0.559 . . . . 2.1 110.285 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 0.6 OUTLIER -109.5 124.27 50.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.72 111.469 -179.208 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.53 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 8.8 t80 -66.41 137.32 56.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.51 109.652 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.643 HG21 HG12 ' A' ' 385' ' ' ILE . 8.0 p -135.61 137.62 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.18 0.514 . . . . 1.15 112.248 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . 0.495 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 73.0 t60 -118.46 108.81 15.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.852 . . . . 0.62 109.585 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.487 ' CD1' HD22 ' A' ' 419' ' ' LEU . 97.9 m-85 -55.99 126.44 25.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.225 0.536 . . . . 0.65 110.727 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.833 HG21 HG23 ' A' ' 382' ' ' ILE . 2.1 t -78.67 28.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.366 -0.834 . . . . 1.34 111.81 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 173.1 -37.45 0.14 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.107 -1.045 . . . . 0.82 113.773 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.487 HD22 ' CD1' ' A' ' 416' ' ' TYR . 7.0 mp -61.79 -166.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.371 0.605 . . . . 1.6 112.432 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.746 ' HB3' ' HD2' ' A' ' 422' ' ' ARG . 5.0 m120 -63.65 146.73 53.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.244 -0.889 . . . . 2.53 111.915 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -72.8 -42.24 64.12 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.165 -0.47 . . . . 3.98 110.94 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . 0.746 ' HD2' ' HB3' ' A' ' 420' ' ' ASN . 0.1 OUTLIER -64.22 -24.77 67.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 3.71 109.713 179.255 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' A' ' 420' ' ' ASN . 1.2 tp -58.04 -33.1 68.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.351 -0.84 . . . . 1.49 111.048 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.495 ' OD1' ' HA ' ' A' ' 415' ' ' HIS . 65.8 m-20 -50.5 137.13 19.72 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.897 -0.592 . . . . 1.2 111.534 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . 0.528 ' O ' HG12 ' A' ' 414' ' ' VAL . . . -179.18 174.09 46.1 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.782 -0.645 . . . . 0.7 112.086 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . 0.463 ' CZ3' ' HG2' ' A' ' 401' ' ' ARG . 15.7 m95 -81.49 140.35 34.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.38 . . . . 0.61 110.851 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.854 HG21 HG13 ' A' ' 432' ' ' ILE . 21.8 m -108.85 160.26 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.508 . . . . 0.89 111.527 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -75.86 24.91 1.53 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.757 -0.735 . . . . 1.72 113.045 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.644 ' H ' HG23 ' A' ' 427' ' ' VAL . 8.2 tpt180 71.93 -45.83 0.63 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.851 0.686 . . . . 1.73 112.851 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -65.61 -14.98 62.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.71 0.291 . . . . 1.47 111.494 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.467 HH22 ' HG2' ' A' ' 388' ' ' GLU . 66.2 mtt-85 -79.38 -36.31 39.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.43 -0.35 . . . . 2.84 111.852 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.95 HD13 HG22 ' A' ' 397' ' ' VAL . 75.2 mt -87.73 132.31 33.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.031 0.444 . . . . 0.46 111.587 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.412 ' HB2' HD21 ' A' ' 439' ' ' LEU . 59.1 m -163.91 139.37 6.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.595 -0.73 . . . . 0.53 110.377 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.27 -22.57 66.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.359 -0.382 . . . . 1.35 111.029 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.68 130.17 55.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.763 0.316 . . . . 2.16 110.8 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . 0.684 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -80.88 -40.51 24.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.75 111.673 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -51.81 -40.79 61.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.391 -0.368 . . . . 1.34 110.744 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -64.08 -38.1 89.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.102 0.477 . . . . 1.56 109.894 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 436' ' ' ALA . 76.8 mt -60.47 -83.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.56 -0.745 . . . . 1.12 110.725 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 139.28 52.19 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.99 -0.624 . . . . 1.36 112.029 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.793 ' HA2' HD21 ' A' ' 445' ' ' LEU . . . -161.83 -70.75 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 119.565 -1.302 . . . . 1.83 114.122 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.583 HD12 ' N ' ' A' ' 442' ' ' ILE . 1.6 mp 61.99 151.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.126 -0.694 . . . . 1.48 109.126 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 57.6 m -46.63 110.57 0.29 Allowed 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.256 -0.577 . . . . 3.05 110.361 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 91.1 t 63.55 117.65 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.631 -0.713 . . . . 4.18 111.28 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.793 HD21 ' HA2' ' A' ' 441' ' ' GLY . 43.8 mt -71.76 139.63 83.33 Favored Pre-proline 0 N--CA 1.463 0.18 0 CA-C-N 116.027 -0.533 . . . . 4.99 111.372 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 445' ' ' LEU . 25.3 Cg_exo -64.02 -148.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.98 2.453 . . . . 7.4 112.53 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -156.52 75.79 4.53 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 9.06 110.962 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 27.8 Cg_endo -62.11 133.25 43.0 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.727 2.285 . . . . 11.06 112.778 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 24.3 Cg_exo -63.33 139.77 73.28 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.71 2.273 . . . . 13.5 112.244 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . 0.473 HD12 ' N ' ' A' ' 450' ' ' LEU . 6.6 mp -65.31 127.69 32.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.412 . . . . 15.76 111.084 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . 61.19 122.0 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 115.9 -0.591 . . . . 16.74 111.756 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.14 125.89 6.73 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.47 2.113 . . . . 18.53 112.392 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 8.9 t70 50.3 51.15 17.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.214 -0.448 . . . . 20.55 110.623 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.309 -0.853 . . . . 21.22 110.918 -179.807 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.432 -0.267 . . . . 11.64 112.432 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 57.0 m -161.51 132.97 5.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.769 0.319 . . . . 9.86 110.767 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -65.82 133.72 51.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 8.07 110.773 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 88.0 mmm -65.72 127.24 31.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 5.51 110.954 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' A' ' 368' ' ' PRO . 9.2 t70 -63.31 130.68 94.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.429 -0.351 . . . . 6.06 110.861 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 367' ' ' ASP . 12.3 Cg_exo -69.74 -44.44 2.1 Favored 'Trans proline' 0 CA--C 1.514 -0.504 0 C-N-CA 122.805 2.337 . . . . 6.16 112.953 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.664 HD23 ' HG2' ' A' ' 370' ' ' MET . 7.1 tt -53.41 -48.58 68.57 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.696 -1.138 . . . . 6.94 110.249 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.664 ' HG2' HD23 ' A' ' 369' ' ' LEU . 63.7 mmm -161.15 119.8 2.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.956 -0.565 . . . . 5.63 110.888 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.724 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.0 OUTLIER -71.76 95.35 1.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 5.04 109.972 179.152 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.539 ' HB2' ' OH ' ' A' ' 412' ' ' TYR . 68.1 mttm 64.29 136.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.912 -0.586 . . . . 5.39 111.354 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.5 mt 61.21 116.83 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.652 -0.704 . . . . 1.48 111.761 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 54.8 m-20 -89.71 77.2 7.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.957 -0.565 . . . . 2.17 110.3 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 80.0 mt -42.51 -36.67 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.305 -0.407 . . . . 0.92 111.964 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.8 t -69.17 68.86 0.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.46 . . . . 1.71 111.486 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.0 pt-20 -173.55 -26.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.009 -0.541 . . . . 1.92 110.062 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 381' ' ' LYS . 0.1 OUTLIER -162.73 57.85 0.73 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.642 -0.708 . . . . 2.14 111.931 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 53.0 Cg_exo -54.21 -35.59 83.29 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.071 1.847 . . . . 0.85 111.179 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -66.04 -33.38 75.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.446 -0.797 . . . . 1.21 110.936 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 63.7 tttp -46.75 131.6 11.57 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.216 -0.447 . . . . 1.66 111.379 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 417' ' ' VAL . 41.5 mm -85.92 126.13 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.41 111.273 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -103.7 144.26 31.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.467 -0.333 . . . . 0.63 110.3 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 2.0 m-85 -85.54 132.51 34.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.96 111.688 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.676 HG12 HG21 ' A' ' 414' ' ' VAL . 2.0 mp -114.05 118.48 58.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.083 -0.508 . . . . 0.49 110.202 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.536 ' HB2' HD22 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -85.85 114.76 23.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.287 -0.415 . . . . 2.42 110.969 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.49 ' O ' ' HD3' ' A' ' 386' ' ' ARG . 25.3 mmm180 -67.02 153.59 43.29 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.442 -0.344 . . . . 2.3 110.146 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -53.17 -39.13 63.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.228 -0.442 . . . . 2.82 110.706 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -64.66 -35.52 81.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 1.23 110.856 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 135.27 -35.56 2.16 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.584 -0.817 . . . . 1.03 113.043 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 80.8 p -58.85 112.54 1.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.043 0.449 . . . . 0.98 112.004 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 56.5 t -74.53 143.15 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.925 -0.58 . . . . 0.55 110.721 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -147.52 133.42 19.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 2.43 111.113 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.444 ' HD2' HG21 ' A' ' 382' ' ' ILE . 88.4 mtm180 -56.21 155.57 6.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.903 -0.589 . . . . 2.96 111.921 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.442 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -172.04 130.67 1.98 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.532 -0.758 . . . . 0.26 112.088 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . 0.434 ' HG2' HD13 ' A' ' 382' ' ' ILE . 86.9 mt-30 -81.74 110.62 17.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.938 0.347 . . . . 1.28 111.938 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 413' ' ' TYR . 1.0 OUTLIER -82.02 132.28 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.83 109.897 178.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 45.1 mt -120.95 -32.51 3.95 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.35 0.5 . . . . 1.45 112.35 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -140.27 176.31 8.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 2.08 111.919 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 90.3 p -165.07 149.93 9.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.739 -0.664 . . . . 0.56 110.723 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 38.2 ptt180 -154.55 138.42 16.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.863 0.364 . . . . 1.55 111.089 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 77.5 p -70.01 -132.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.437 -0.347 . . . . 1.79 110.988 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.794 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -162.43 -172.76 3.29 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.023 -0.362 . . . . 1.95 110.023 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.794 ' H ' HG22 ' A' ' 403' ' ' THR . 48.4 mt-10 -41.65 -45.77 3.5 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.668 0.271 . . . . 3.87 111.47 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.525 HD21 ' HB3' ' A' ' 407' ' ' ALA . 50.0 t30 -67.31 -50.58 59.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.806 0.336 . . . . 3.16 110.633 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.17 56.32 7.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.965 -0.561 . . . . 2.18 111.591 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.525 ' HB3' HD21 ' A' ' 405' ' ' ASN . . . -151.98 9.36 0.51 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.156 0.503 . . . . 2.77 110.421 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.599 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.69 -49.0 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.262 -0.881 . . . . 2.76 110.625 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 32.0 Cg_exo -58.29 147.26 85.58 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.321 2.014 . . . . 2.49 112.179 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.9 p30 -177.95 131.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 2.14 111.438 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 426' ' ' TRP . 50.2 mt-10 -115.25 136.83 52.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.693 -0.685 . . . . 2.1 109.707 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.539 ' OH ' ' HB2' ' A' ' 372' ' ' LYS . 0.6 OUTLIER -109.74 130.08 55.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.909 0.385 . . . . 0.72 111.903 -178.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 31.3 t80 -60.56 146.64 44.38 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.627 -0.879 . . . . 0.51 108.627 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.676 HG21 HG12 ' A' ' 385' ' ' ILE . 7.2 p -151.13 133.65 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 119.662 -0.815 . . . . 1.15 113.181 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -116.2 107.76 15.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.996 -1.002 . . . . 0.62 109.439 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.457 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 63.0 m-85 -61.43 125.37 23.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.028 0.442 . . . . 0.65 111.279 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 382' ' ' ILE . 2.7 t -81.62 32.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.685 -0.688 . . . . 1.34 111.239 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -175.63 -44.2 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.436 -0.888 . . . . 0.82 112.89 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.457 ' HB2' ' CB ' ' A' ' 416' ' ' TYR . 7.2 mp -64.88 -166.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.199 0.523 . . . . 1.6 111.701 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.738 ' HB2' HD13 ' A' ' 423' ' ' LEU . 4.4 m120 -74.1 145.09 44.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.446 -0.797 . . . . 2.53 111.796 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 62.2 mtm-85 -65.33 -38.58 90.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.959 -0.564 . . . . 3.98 110.71 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -55.39 -36.13 66.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.057 0.456 . . . . 3.71 110.967 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.738 HD13 ' HB2' ' A' ' 420' ' ' ASN . 4.5 mp -52.75 -25.87 12.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.468 -0.787 . . . . 1.49 111.787 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.16 135.44 21.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.989 0.423 . . . . 1.2 111.299 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 413' ' ' TYR . . . 177.24 -140.29 4.79 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.953 -0.641 . . . . 0.7 112.302 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . 0.587 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 42.7 m95 -122.27 138.19 54.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.793 0.33 . . . . 0.61 110.709 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.405 ' CG2' HD11 ' A' ' 432' ' ' ILE . 30.8 m -134.05 142.64 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.89 111.765 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.403 ' HA3' ' NH1' ' A' ' 431' ' ' ARG . . . -63.47 144.92 49.65 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.831 -0.7 . . . . 1.72 111.994 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.472 HH12 ' HB3' ' A' ' 372' ' ' LYS . 12.4 tpt180 -55.58 -28.4 54.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.036 0.446 . . . . 1.73 111.49 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.681 ' H ' ' CD2' ' A' ' 430' ' ' HIS . 0.9 OUTLIER -56.58 -31.27 64.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.811 0.815 . . . . 1.47 109.572 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.418 ' HG3' HH11 ' A' ' 431' ' ' ARG . 33.0 mtt85 -83.14 -36.23 24.93 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.117 -1.401 . . . . 2.84 111.418 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.555 HG12 HG13 ' A' ' 385' ' ' ILE . 65.9 mt -88.83 135.31 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.021 0.439 . . . . 0.46 111.766 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 435' ' ' ASN . 55.8 m -161.76 140.12 9.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.843 -0.617 . . . . 0.53 110.619 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -72.67 16.19 0.16 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.243 -0.435 . . . . 1.35 111.612 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 433' ' ' SER . 75.0 m-80 -146.53 131.92 18.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.938 0.399 . . . . 2.16 110.97 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -68.17 -42.32 80.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.983 -0.553 . . . . 0.75 111.441 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -54.66 -40.74 69.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.282 -0.417 . . . . 1.34 111.038 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.59 42.91 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 1.56 110.848 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.536 HD22 ' HB2' ' A' ' 386' ' ' ARG . 97.5 mt -151.82 -83.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 1.12 111.104 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -166.39 44.31 0.27 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.994 -0.622 . . . . 1.36 112.141 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.13 -136.03 45.77 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 1.83 112.298 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.515 HG22 HG22 ' A' ' 443' ' ' THR . 50.1 mm -126.64 105.48 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.586 0.232 . . . . 1.48 110.648 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 442' ' ' ILE . 13.4 t 39.1 35.76 0.15 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.581 0.705 . . . . 3.05 111.758 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 442' ' ' ILE . 96.3 t -153.25 127.57 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.655 -1.157 . . . . 4.18 110.725 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.586 HD12 ' HD2' ' A' ' 446' ' ' PRO . 3.0 tp -97.55 123.47 52.08 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 116.293 -0.412 . . . . 4.99 110.723 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.586 ' HD2' HD12 ' A' ' 445' ' ' LEU . 3.3 Cg_exo -76.64 59.65 6.34 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.113 2.542 . . . . 7.4 112.656 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.495 ' N ' ' HD3' ' A' ' 448' ' ' PRO . . . -164.19 58.07 0.63 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 111.849 0.314 . . . . 9.06 111.849 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 447' ' ' ALA . 28.5 Cg_exo -61.37 134.3 51.07 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.398 2.065 . . . . 11.06 111.859 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.48 43.77 1.49 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.457 2.105 . . . . 13.5 112.782 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 450' ' ' LEU . 6.2 mp 46.32 39.7 6.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.825 -0.625 . . . . 15.76 111.383 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -174.68 133.63 0.51 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.438 -0.346 . . . . 16.74 111.363 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.36 137.45 36.64 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.585 2.19 . . . . 18.53 112.197 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -170.68 55.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.175 0.512 . . . . 20.55 110.381 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.287 -0.863 . . . . 21.22 110.827 -179.82 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.477 -0.249 . . . . 11.64 112.477 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 79.7 p -172.58 46.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.769 0.319 . . . . 9.86 110.791 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . 0.587 ' HE1' ' HA ' ' A' ' 368' ' ' PRO . 31.2 t-80 -60.35 -35.59 76.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.243 0.544 . . . . 8.07 110.392 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 15.3 tpt 60.13 53.72 4.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.217 -0.901 . . . . 5.51 111.698 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' A' ' 368' ' ' PRO . 10.1 t70 63.91 139.46 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.23 -0.441 . . . . 6.06 111.548 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . 0.587 ' HA ' ' HE1' ' A' ' 365' ' ' HIS . 14.7 Cg_exo -70.42 -155.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.178 1.918 . . . . 6.16 110.308 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 369' ' ' LEU . 3.3 pp 37.82 21.39 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.615 0.572 . . . . 6.94 112.301 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.517 ' N ' ' O ' ' A' ' 368' ' ' PRO . 42.6 ttp -169.94 48.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 5.63 110.41 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.81 124.35 18.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 5.04 111.225 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -68.45 139.87 55.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.05 -0.523 . . . . 5.39 110.788 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 63.8 mt -56.23 134.7 20.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.318 -0.401 . . . . 1.48 111.046 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -88.14 110.61 20.81 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.155 -0.475 . . . . 2.17 110.556 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.537 HD11 HG12 ' A' ' 397' ' ' VAL . 93.0 mt -66.82 -43.44 89.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.866 -0.606 . . . . 0.92 111.972 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 75.9 p -69.84 64.84 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.101 0.477 . . . . 1.71 110.842 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -149.46 -27.99 0.27 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.92 109.685 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.44 ' C ' HD22 ' A' ' 378' ' ' ASN . 0.1 OUTLIER -172.28 60.72 0.29 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.282 -0.872 . . . . 2.14 111.239 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -51.32 -37.3 60.04 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.311 2.008 . . . . 0.85 111.676 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -62.96 -34.22 77.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.762 -0.654 . . . . 1.21 110.866 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -53.86 124.68 16.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 1.66 111.199 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.025 HD12 HG21 ' A' ' 417' ' ' VAL . 16.2 mm -79.88 124.4 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.074 -0.512 . . . . 0.41 111.755 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.518 ' HB2' ' O ' ' A' ' 395' ' ' GLY . 4.2 m-85 -104.07 144.21 31.86 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.235 -0.283 . . . . 0.63 110.235 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.42 ' HB3' HG13 ' A' ' 392' ' ' VAL . 15.8 m-30 -94.65 135.91 35.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.012 0.434 . . . . 0.96 110.867 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.8 mp -119.24 126.07 75.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 0.49 110.063 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.813 ' HE ' ' HA3' ' A' ' 440' ' ' GLY . 55.7 ttt-85 -89.19 121.65 31.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 2.42 111.048 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.478 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 59.8 mtp85 -79.63 168.3 19.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 2.3 110.602 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -56.1 -42.87 77.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 2.82 111.233 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -72.3 5.7 2.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 1.23 111.954 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.615 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 73.07 48.81 18.65 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.52 -0.848 . . . . 1.03 113.077 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.478 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 81.9 p -120.69 110.54 16.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.687 0.279 . . . . 0.98 111.561 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 384' ' ' PHE . 58.6 t -70.52 127.56 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.082 -0.34 . . . . 0.55 110.082 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . 0.444 ' HE1' HG13 ' A' ' 444' ' ' VAL . 89.8 m-70 -145.02 135.99 24.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.112 0.482 . . . . 2.43 111.482 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.509 ' HB3' ' HB ' ' A' ' 417' ' ' VAL . 59.6 mtt85 -55.56 155.29 5.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.802 -0.635 . . . . 2.96 112.057 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 383' ' ' TYR . . . 178.02 126.64 1.0 Allowed Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.396 -0.82 . . . . 0.26 111.371 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 85.4 mt-30 -91.74 129.22 37.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.972 0.386 . . . . 1.28 111.739 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.765 HG22 HD13 ' A' ' 432' ' ' ILE . 4.2 t -82.95 126.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.134 -0.691 . . . . 0.83 109.134 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.41 ' C ' HD13 ' A' ' 375' ' ' ILE . 66.8 mt -120.71 -46.85 2.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.251 0.463 . . . . 1.45 112.251 -178.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.595 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 12.0 mm-40 -123.73 176.51 6.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.107 0.48 . . . . 2.08 111.6 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 97.0 p -163.57 146.06 9.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.634 -0.712 . . . . 0.56 110.109 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -162.57 139.03 7.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.879 0.371 . . . . 1.55 111.332 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.725 ' HA ' ' HA ' ' A' ' 410' ' ' ASP . 72.2 p -70.59 -125.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 1.79 110.033 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.778 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.76 -173.41 2.97 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.662 -0.495 . . . . 1.95 109.662 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.778 ' H ' HG22 ' A' ' 403' ' ' THR . 64.2 mm-40 -44.86 -40.39 6.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.802 0.334 . . . . 3.87 110.856 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.638 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 0.7 OUTLIER -68.13 -53.66 23.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.193 -0.458 . . . . 3.16 110.563 179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.414 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 51.29 51.69 16.38 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.192 0.52 . . . . 2.18 111.358 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.495 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -152.83 10.73 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.484 -0.78 . . . . 2.77 109.46 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.578 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -177.82 -48.25 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 114.465 -1.243 . . . . 2.76 110.034 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 36.1 Cg_exo -60.89 149.24 89.47 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.524 2.15 . . . . 2.49 112.383 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.725 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 12.1 p-10 -174.07 137.51 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 2.14 110.348 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 400' ' ' SER . 55.9 mt-10 -134.83 134.68 41.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 2.1 110.902 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 1.2 m-85 -109.76 125.66 52.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.058 0.456 . . . . 0.72 111.175 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.595 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 14.3 t80 -62.22 144.0 56.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.71 -0.677 . . . . 0.51 110.189 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 0.0 OUTLIER -144.56 129.66 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.624 0.602 . . . . 1.15 112.624 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . 0.425 ' O ' ' HA2' ' A' ' 395' ' ' GLY . 38.4 t60 -103.38 97.15 7.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.153 -0.93 . . . . 0.62 109.169 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 36.7 m-85 -53.2 106.41 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.391 0.615 . . . . 0.65 111.22 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 1.025 HG21 HD12 ' A' ' 382' ' ' ILE . 58.3 t -67.16 130.01 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.905 -1.043 . . . . 1.34 111.143 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 81.4 -45.55 3.26 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.747 -0.661 . . . . 0.82 112.608 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 6.9 mp -65.6 166.57 10.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.997 0.427 . . . . 1.6 111.427 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 423' ' ' LEU . 74.5 m-20 -53.86 143.37 21.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.831 -0.622 . . . . 2.53 111.544 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 53.9 mtt85 -61.75 -38.52 88.27 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.854 -0.612 . . . . 3.98 111.286 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -56.25 -32.58 64.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 3.71 111.439 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 420' ' ' ASN . 1.9 mp -58.21 -27.95 64.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.226 -0.443 . . . . 1.49 111.822 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -48.39 139.77 8.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 1.2 111.325 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -171.66 -147.83 5.86 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.76 -0.734 . . . . 0.7 112.466 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -128.65 138.37 52.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.021 0.439 . . . . 0.61 111.18 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.74 HG21 HG13 ' A' ' 432' ' ' ILE . 23.0 m -115.04 155.57 16.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.692 -0.686 . . . . 0.89 111.494 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -78.04 30.94 1.8 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.913 -0.66 . . . . 1.72 114.075 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.559 ' HB2' ' CE1' ' A' ' 412' ' ' TYR . 9.7 tpt180 72.09 -45.63 0.62 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.688 0.625 . . . . 1.73 112.688 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -62.41 -21.53 65.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.706 0.289 . . . . 1.47 111.592 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.454 ' HD2' ' HB ' ' A' ' 427' ' ' VAL . 90.7 mtt180 -79.11 -26.95 42.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.188 0.44 . . . . 2.84 112.188 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.765 HD13 HG22 ' A' ' 397' ' ' VAL . 71.4 mt -88.11 136.8 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.965 0.412 . . . . 0.46 111.243 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 56.4 m -159.69 138.69 10.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.53 110.612 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.29 -26.51 62.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 1.35 111.138 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -112.85 130.62 56.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 2.16 110.729 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 439' ' ' LEU . . . -66.91 -32.52 73.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 0.75 111.176 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -51.54 -40.88 60.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.232 -0.44 . . . . 1.34 110.783 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.85 -38.46 83.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.171 0.51 . . . . 1.56 110.118 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 436' ' ' ALA . 69.3 mt -61.89 -93.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.525 -0.761 . . . . 1.12 111.238 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . 0.813 ' HA3' ' HE ' ' A' ' 386' ' ' ARG . . . -166.29 39.87 0.26 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.116 -0.564 . . . . 1.36 111.931 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 443' ' ' THR . . . 67.62 131.19 0.03 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.018 -0.61 . . . . 1.83 112.162 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.672 HD12 ' H ' ' A' ' 442' ' ' ILE . 5.3 mp -58.48 113.9 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.67 0.271 . . . . 1.48 110.322 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 441' ' ' GLY . 11.5 t -167.6 130.2 1.62 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.309 0.576 . . . . 3.05 112.307 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.727 HG12 ' HD3' ' A' ' 446' ' ' PRO . 67.9 t -100.57 124.47 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 115.405 -0.816 . . . . 4.18 110.135 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 34.0 mt -115.45 69.83 2.97 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.162 -0.472 . . . . 4.99 111.006 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.727 ' HD3' HG12 ' A' ' 444' ' ' VAL . 36.8 Cg_exo -60.28 119.4 6.57 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.473 2.115 . . . . 7.4 112.394 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 448' ' ' PRO . . . 59.45 122.97 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 115.943 -0.571 . . . . 9.06 111.752 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 447' ' ' ALA . 19.9 Cg_exo -65.59 128.62 20.49 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.404 2.07 . . . . 11.06 111.771 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.18 123.0 10.9 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.218 1.945 . . . . 13.5 112.15 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . 0.633 ' H ' HD23 ' A' ' 450' ' ' LEU . 2.3 pt? -72.32 135.62 45.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 15.76 110.923 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' A' ' 453' ' ' ASP . . . 55.46 75.7 0.57 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 16.74 111.115 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.73 16.37 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.333 2.022 . . . . 18.53 112.606 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 451' ' ' ALA . 7.8 t70 -84.91 128.44 34.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.461 . . . . 20.55 110.223 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.195 -0.907 . . . . 21.22 110.438 -179.877 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.488 -0.245 . . . . 11.64 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 32.1 t 56.87 -128.7 1.82 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 110.616 -0.142 . . . . 9.86 110.616 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -168.48 119.25 0.77 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.878 0.37 . . . . 8.07 110.957 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . 0.481 ' HG3' ' HE3' ' A' ' 372' ' ' LYS . 1.5 mpt? -94.93 125.57 39.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 5.51 110.342 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -72.2 110.85 8.84 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.425 -0.352 . . . . 6.06 111.103 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 366' ' ' MET . 91.9 Cg_endo -85.07 34.26 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.545 2.163 . . . . 6.16 112.252 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.675 HD12 ' HG2' ' A' ' 370' ' ' MET . 0.9 OUTLIER -151.76 9.17 0.52 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 112.305 0.483 . . . . 6.94 112.305 -179.121 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.675 ' HG2' HD12 ' A' ' 369' ' ' LEU . 27.5 ptt? -173.57 9.17 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.894 0.378 . . . . 5.63 111.135 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.417 ' H ' ' H ' ' A' ' 370' ' ' MET . 78.5 mt-30 41.97 -163.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.274 -0.875 . . . . 5.04 111.815 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.481 ' HE3' ' HG3' ' A' ' 366' ' ' MET . 42.7 mmtm -73.41 150.35 41.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.166 -0.47 . . . . 5.39 110.698 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.1 mt -52.22 135.61 13.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.437 -0.347 . . . . 1.48 110.711 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.407 ' HB2' ' OE1' ' A' ' 377' ' ' GLU . 59.2 m-20 -88.92 129.45 35.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 2.17 111.228 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 78.7 mt -84.27 -45.18 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.92 111.16 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 48.0 t -64.11 78.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 1.71 110.859 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.551 ' HG3' ' ND2' ' A' ' 378' ' ' ASN . 12.1 pt-20 -173.71 -28.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.528 -0.76 . . . . 1.92 110.074 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.551 ' ND2' ' HG3' ' A' ' 377' ' ' GLU . 0.1 OUTLIER -173.07 61.54 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.536 -0.757 . . . . 2.14 111.509 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.99 -38.67 86.7 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.318 2.012 . . . . 0.85 111.877 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.514 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 28.3 m-20 -65.34 -33.51 76.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.996 -0.547 . . . . 1.21 111.073 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 85.2 tttt -48.02 126.58 10.96 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.942 0.401 . . . . 1.66 111.076 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.779 HG23 HG21 ' A' ' 417' ' ' VAL . 36.5 mm -71.79 120.71 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.89 -0.596 . . . . 0.41 111.724 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -99.57 144.4 28.7 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.587 -0.523 . . . . 0.63 109.587 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.447 ' C ' HD12 ' A' ' 385' ' ' ILE . 45.1 m-85 -88.88 133.08 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.895 -0.322 . . . . 0.96 110.795 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.661 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.1 mp -116.33 144.67 23.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.819 0.342 . . . . 0.49 111.539 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.654 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 39.1 ttt85 -124.48 104.25 8.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 2.42 110.525 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.479 ' HG3' ' CE1' ' A' ' 393' ' ' HIS . 10.0 mtp-105 -65.04 161.6 18.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.831 0.348 . . . . 2.3 110.944 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.609 ' HG3' HH21 ' A' ' 431' ' ' ARG . 50.5 mp0 -48.76 -45.05 39.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.054 0.761 . . . . 2.82 113.054 -177.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.592 ' OD2' HG23 ' A' ' 391' ' ' THR . 8.0 p-10 -60.16 -35.26 74.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.595 0.236 . . . . 1.23 111.59 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.405 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 118.45 44.3 0.52 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.605 -0.807 . . . . 1.03 112.413 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.592 HG23 ' OD2' ' A' ' 389' ' ' ASP . 21.5 p -116.64 112.49 21.34 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.789 0.292 . . . . 0.98 111.789 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.495 HG11 HD13 ' A' ' 442' ' ' ILE . 86.4 t -79.56 134.23 28.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.604 -0.517 . . . . 0.55 109.604 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . 0.487 ' HD1' ' HB ' ' A' ' 385' ' ' ILE . 0.6 OUTLIER -156.47 133.98 10.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.939 0.4 . . . . 2.43 111.03 -178.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.498 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 99.6 mtt180 -60.07 145.18 47.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.931 -0.577 . . . . 2.96 111.75 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -174.21 128.85 1.52 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.532 -0.758 . . . . 0.26 111.976 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . 0.514 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 68.6 mt-30 -78.31 129.68 35.31 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.689 -0.3 . . . . 1.28 111.597 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 413' ' ' TYR . 0.5 OUTLIER -88.28 132.08 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.547 -0.538 . . . . 0.83 109.547 177.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 398' ' ' LEU . 4.9 mp -106.14 -49.44 3.37 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.791 0.663 . . . . 1.45 112.791 -177.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 412' ' ' TYR . 98.1 mm-40 -142.94 178.02 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.004 0.431 . . . . 2.08 111.869 -178.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.7 p -148.83 149.39 31.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.683 -0.69 . . . . 0.56 109.987 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -158.49 139.08 12.69 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.169 0.509 . . . . 1.55 112.356 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 50.6 p -87.6 139.1 30.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.671 -0.695 . . . . 1.79 109.557 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.851 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.9 m -60.53 -174.57 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.58 0.229 . . . . 1.95 110.579 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.851 ' H ' HG22 ' A' ' 403' ' ' THR . 59.1 mm-40 -50.73 -41.74 56.6 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.798 0.295 . . . . 3.87 111.798 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.597 ' ND2' ' HB3' ' A' ' 407' ' ' ALA . 50.8 t30 -59.19 -49.57 77.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.569 -0.287 . . . . 3.16 111.076 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.573 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 52.71 48.25 22.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.154 0.502 . . . . 2.18 111.483 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.597 ' HB3' ' ND2' ' A' ' 405' ' ' ASN . . . -145.75 10.79 1.22 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.603 -0.726 . . . . 2.77 109.478 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.595 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.78 -47.81 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.472 -1.24 . . . . 2.76 110.0 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 36.3 Cg_exo -57.9 143.46 95.86 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.561 2.174 . . . . 2.49 112.513 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -170.48 136.31 1.29 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.69 -0.687 . . . . 2.14 110.326 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 400' ' ' SER . 64.8 mm-40 -140.89 135.12 30.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.193 -0.458 . . . . 2.1 110.886 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.475 ' OH ' ' HB3' ' A' ' 372' ' ' LYS . 1.2 m-85 -109.21 119.19 38.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.145 -0.48 . . . . 0.72 111.213 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.471 ' CE2' HD22 ' A' ' 398' ' ' LEU . 10.5 t80 -57.41 145.99 30.84 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.278 -0.638 . . . . 0.51 109.278 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 396' ' ' GLN . 14.4 p -154.82 129.52 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.201 0.815 . . . . 1.15 113.201 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -101.85 113.09 25.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.344 -0.844 . . . . 0.62 109.084 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.493 ' CD2' HD22 ' A' ' 419' ' ' LEU . 65.1 m-85 -61.42 132.69 54.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.356 0.598 . . . . 0.65 111.125 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.779 HG21 HG23 ' A' ' 382' ' ' ILE . 1.3 t -78.82 27.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.212 -0.904 . . . . 1.34 111.406 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 172.74 -43.04 0.17 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.407 -0.901 . . . . 0.82 113.289 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 423' ' ' LEU . 7.3 mp -59.75 151.88 24.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 1.6 111.604 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -50.36 147.13 4.6 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.494 -0.776 . . . . 2.53 112.203 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.436 ' HA ' ' CG ' ' A' ' 424' ' ' ASP . 87.1 mtm180 -59.24 -28.88 67.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.706 -0.679 . . . . 3.98 110.927 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -53.61 -41.2 66.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.285 0.564 . . . . 3.71 110.059 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 419' ' ' LEU . 6.4 mp -71.56 -33.12 68.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.142 -0.935 . . . . 1.49 110.999 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.436 ' CG ' ' HA ' ' A' ' 421' ' ' ARG . 10.6 m-20 -53.11 131.44 36.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 1.2 110.783 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 176.43 -142.03 5.77 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.702 -0.761 . . . . 0.7 112.51 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 50.6 m95 -105.19 135.83 45.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.61 110.933 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.855 HG23 HD11 ' A' ' 432' ' ' ILE . 3.4 m -128.81 134.56 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.534 . . . . 0.89 111.634 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -57.7 150.06 31.98 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.722 -0.752 . . . . 1.72 111.99 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -47.92 -39.77 19.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.615 0.245 . . . . 1.73 111.331 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.425 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 9.1 p-80 -61.77 -32.26 72.51 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.866 0.321 . . . . 1.47 111.866 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.609 HH21 ' HG3' ' A' ' 388' ' ' GLU . 57.0 mtt85 -82.21 26.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.108 -0.237 . . . . 2.84 111.191 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.855 HD11 HG23 ' A' ' 427' ' ' VAL . 66.0 mt -149.58 135.63 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.46 110.868 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 435' ' ' ASN . 70.5 m -166.25 139.23 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 0.53 110.866 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.65 16.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 1.35 110.507 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 433' ' ' SER . 74.9 m-20 -138.79 128.26 24.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.902 -0.59 . . . . 2.16 110.328 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.1 92.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.75 111.754 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -56.24 -40.36 74.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 1.34 111.333 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.77 42.44 0.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 1.56 111.601 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . . . . . . . . . 85.9 mt -150.2 -88.41 0.07 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.72 -0.218 . . . . 1.12 111.438 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . 0.654 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -171.45 38.12 0.17 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.542 -0.837 . . . . 1.36 112.859 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.83 141.02 0.04 OUTLIER Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.736 -0.745 . . . . 1.83 112.869 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.495 HD13 HG11 ' A' ' 392' ' ' VAL . 42.3 mm -70.06 67.65 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.985 0.421 . . . . 1.48 110.689 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 67.9 m -164.85 136.43 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 3.05 110.991 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.486 ' HA ' HG22 ' A' ' 391' ' ' THR . 23.9 m -79.58 54.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 4.18 111.568 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.706 ' O ' HD12 ' A' ' 445' ' ' LEU . 4.5 pp -65.69 137.47 96.29 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.74 -0.664 . . . . 4.99 111.101 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.69 142.05 17.75 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.702 2.268 . . . . 7.4 112.601 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -171.43 134.59 0.92 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 9.06 111.034 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 18.3 Cg_endo -60.37 133.77 51.25 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.468 2.112 . . . . 11.06 112.01 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 448' ' ' PRO . 24.3 Cg_exo -63.76 127.5 19.78 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.459 2.106 . . . . 13.5 112.331 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 92.4 mt -74.78 137.65 42.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 15.76 110.701 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . -59.08 124.87 76.35 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 16.74 111.229 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 451' ' ' ALA . 21.1 Cg_exo -66.63 -149.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.794 2.329 . . . . 18.53 112.467 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -66.76 -45.74 77.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.367 -0.379 . . . . 20.55 110.775 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.205 -0.902 . . . . 21.22 111.007 -179.877 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.526 -0.23 . . . . 11.64 112.526 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.9 t -174.46 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.876 0.37 . . . . 9.86 110.853 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -58.45 138.17 56.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 8.07 111.207 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . 0.446 ' SD ' ' HB2' ' A' ' 408' ' ' ALA . 64.7 mtt -126.52 122.26 34.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 5.51 110.408 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.505 ' HB3' HD13 ' A' ' 369' ' ' LEU . 30.1 m-20 -73.45 125.82 90.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.159 -0.473 . . . . 6.06 111.559 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -84.27 40.4 0.87 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.698 2.265 . . . . 6.16 112.644 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.679 HD22 ' N ' ' A' ' 370' ' ' MET . 0.0 OUTLIER -160.25 -30.99 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.739 -0.664 . . . . 6.94 109.634 179.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.679 ' N ' HD22 ' A' ' 369' ' ' LEU . 0.0 OUTLIER -94.63 58.08 2.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.583 -0.735 . . . . 5.63 109.031 178.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -71.31 51.51 0.17 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.718 -0.674 . . . . 5.04 112.338 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.496 ' HB3' ' OH ' ' A' ' 412' ' ' TYR . 74.9 mmtt 62.15 147.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.277 0.56 . . . . 5.39 112.461 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.493 HG13 ' HE ' ' A' ' 429' ' ' ARG . 70.6 mt -55.94 131.62 19.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.527 -0.76 . . . . 1.48 111.337 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.68 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 23.6 m-20 -88.87 111.58 22.24 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 116.09 -0.505 . . . . 2.17 110.902 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 86.4 mt -73.17 -39.68 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.709 0.29 . . . . 0.92 111.781 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 40.1 t -46.72 -28.74 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.011 -0.54 . . . . 1.71 112.422 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.68 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 15.5 pt-20 -69.43 -38.47 77.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.508 -0.315 . . . . 1.92 111.772 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.703 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 5.5 m120 -153.06 69.16 6.85 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 112.322 0.49 . . . . 2.14 112.322 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.38 -40.68 77.37 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.684 2.256 . . . . 0.85 112.577 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -70.3 -34.09 72.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.536 . . . . 1.21 111.774 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.703 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 63.0 tttp -46.38 136.36 7.36 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.983 0.421 . . . . 1.66 111.021 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.733 HG21 ' HD3' ' A' ' 394' ' ' ARG . 46.4 mm -84.86 130.47 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.782 -0.644 . . . . 0.41 111.834 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -118.93 143.6 46.92 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.496 -0.557 . . . . 0.63 109.496 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.524 ' CE1' ' HG2' ' A' ' 394' ' ' ARG . 1.3 m-85 -84.83 143.74 28.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.783 0.325 . . . . 0.96 111.351 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.712 HG12 HG11 ' A' ' 414' ' ' VAL . 2.8 mp -119.85 133.83 65.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 116.228 -0.442 . . . . 0.49 111.492 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.551 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 28.3 tpt180 -87.0 106.01 17.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 2.42 110.418 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.488 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 62.5 mtp85 -66.69 160.52 25.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 2.3 111.067 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.7 -71.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.865 -0.607 . . . . 2.82 111.048 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.414 ' OD1' HG23 ' A' ' 391' ' ' THR . 2.4 p30 -41.7 -28.9 0.16 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.052 0.453 . . . . 1.23 110.28 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 110.16 44.3 1.02 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.737 -0.665 . . . . 1.03 113.459 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.488 ' OG1' ' HD3' ' A' ' 387' ' ' ARG . 37.0 p -121.2 110.37 16.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.967 0.413 . . . . 0.98 111.062 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.492 HG23 HH11 ' A' ' 386' ' ' ARG . 90.2 t -71.6 133.13 32.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 0.55 111.352 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -151.93 138.46 18.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.111 -0.495 . . . . 2.43 110.537 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.733 ' HD3' HG21 ' A' ' 382' ' ' ILE . 60.6 mtt85 -51.6 155.65 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.392 0.615 . . . . 2.96 112.601 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -178.61 133.37 2.1 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.103 -0.953 . . . . 0.26 111.84 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -80.95 130.68 35.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.771 0.285 . . . . 1.28 111.771 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.605 ' CG1' ' HB3' ' A' ' 412' ' ' TYR . 14.5 t -91.43 126.61 44.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.81 -0.811 . . . . 0.83 108.81 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.64 HD22 ' N ' ' A' ' 398' ' ' LEU . 0.3 OUTLIER -108.83 -40.08 5.15 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.023 0.749 . . . . 1.45 113.023 -177.029 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -139.95 176.02 9.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.95 0.405 . . . . 2.08 111.901 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 89.2 p -163.56 150.96 12.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.829 -0.623 . . . . 0.56 110.611 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 410' ' ' ASP . 39.9 ptt180 -153.14 134.33 14.15 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.492 -0.322 . . . . 1.55 111.163 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 409' ' ' PRO . 47.7 p -71.93 135.71 46.6 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.96 0.41 . . . . 1.79 110.69 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.827 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.1 m -62.51 -174.1 0.06 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.837 -0.62 . . . . 1.95 110.372 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.827 ' H ' HG22 ' A' ' 403' ' ' THR . 60.3 mm-40 -44.94 -37.04 3.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.86 0.319 . . . . 3.87 111.86 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.579 HD22 ' HD2' ' A' ' 409' ' ' PRO . 45.4 t30 -57.52 -49.76 75.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.747 0.308 . . . . 3.16 110.873 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.612 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.78 66.03 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.183 -0.462 . . . . 2.18 111.603 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.53 ' HB3' ' ND2' ' A' ' 405' ' ' ASN . . . -162.65 -23.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 2.77 110.518 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.67 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . -159.99 -52.33 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.683 -0.69 . . . . 2.76 110.7 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 52.1 Cg_exo -54.96 149.2 43.66 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.196 1.93 . . . . 2.49 111.341 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 401' ' ' ARG . 34.4 p-10 -179.08 143.71 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.091 0.472 . . . . 2.14 111.58 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 400' ' ' SER . 0.5 OUTLIER -106.82 135.25 48.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.756 -0.656 . . . . 2.1 109.859 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.643 ' HB2' HD12 ' A' ' 432' ' ' ILE . 0.4 OUTLIER -109.75 128.11 55.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.345 -0.389 . . . . 0.72 111.958 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.57 ' CD2' HD23 ' A' ' 398' ' ' LEU . 9.4 t80 -64.54 141.56 58.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.51 109.833 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.712 HG11 HG12 ' A' ' 385' ' ' ILE . 48.6 t -132.51 132.99 60.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.153 0.797 . . . . 1.15 113.153 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -116.13 89.9 3.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.036 -0.984 . . . . 0.62 109.304 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.465 ' HD1' ' H ' ' A' ' 416' ' ' TYR . 6.2 m-85 -55.89 127.2 29.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.953 0.406 . . . . 0.65 111.161 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 382' ' ' ILE . 61.9 t -70.38 127.23 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.01 -0.541 . . . . 1.34 111.375 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.53 -41.93 1.69 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.966 -0.635 . . . . 0.82 113.182 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 419' ' ' LEU . 7.7 mp -59.43 156.92 12.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.947 0.403 . . . . 1.6 111.375 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.545 ' OD1' HD13 ' A' ' 423' ' ' LEU . 22.5 p30 -49.58 143.38 7.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.786 -0.643 . . . . 2.53 111.65 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 421' ' ' ARG . 57.0 mtt85 -62.77 -36.16 82.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.636 -0.711 . . . . 3.98 111.898 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -54.09 -30.04 46.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.341 . . . . 3.71 111.029 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.545 HD13 ' OD1' ' A' ' 420' ' ' ASN . 1.1 tp -59.41 -31.69 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 1.49 111.365 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.5 134.83 8.95 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.946 0.403 . . . . 1.2 111.155 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.88 155.08 12.27 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.827 -0.701 . . . . 0.7 112.268 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 413' ' ' TYR . 12.2 m95 -71.05 137.64 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.679 0.276 . . . . 0.61 110.38 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.424 ' HB ' ' HD3' ' A' ' 431' ' ' ARG . 11.4 m -138.0 141.23 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.438 -0.346 . . . . 0.89 110.843 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -50.01 150.7 4.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.668 -0.777 . . . . 1.72 112.442 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.493 ' HE ' HG13 ' A' ' 373' ' ' ILE . 32.6 tpt85 -48.7 -42.03 33.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.479 0.18 . . . . 1.73 111.477 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -55.43 -31.71 62.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.541 -0.3 . . . . 1.47 111.469 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 73.5 mtp180 -81.61 20.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.611 -0.268 . . . . 2.84 111.228 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.643 HD12 ' HB2' ' A' ' 412' ' ' TYR . 83.5 mt -150.33 126.04 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.826 0.346 . . . . 0.46 110.914 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 435' ' ' ASN . 65.5 m -165.67 143.4 5.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.863 -0.608 . . . . 0.53 110.65 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . 0.498 ' OD1' ' HE3' ' A' ' 381' ' ' LYS . 27.5 m-20 -70.62 16.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 1.35 111.293 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 433' ' ' SER . 16.1 p-10 -158.9 128.14 5.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.926 0.393 . . . . 2.16 110.585 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . 0.617 ' HB3' HD13 ' A' ' 442' ' ' ILE . . . -68.09 -25.08 65.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.97 -0.559 . . . . 0.75 111.896 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.34 -41.19 18.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.405 -0.361 . . . . 1.34 111.631 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -82.63 -41.68 19.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.927 0.394 . . . . 1.56 110.948 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 436' ' ' ALA . 49.0 mt -54.63 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 1.12 111.565 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . 0.551 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -157.29 38.66 0.55 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.851 -0.69 . . . . 1.36 112.186 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.12 146.0 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.686 -0.768 . . . . 1.83 112.199 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 436' ' ' ALA . 48.8 mm -48.51 115.65 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.975 -0.38 . . . . 1.48 109.975 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 3.2 m -60.31 117.35 5.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.259 -0.428 . . . . 3.05 110.976 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 444' ' ' VAL . 60.9 t -142.97 63.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.204 0.526 . . . . 4.18 110.733 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.663 ' N ' ' HD3' ' A' ' 446' ' ' PRO . 1.8 pt? -155.01 52.67 0.74 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 4.99 111.344 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.663 ' HD3' ' N ' ' A' ' 445' ' ' LEU . 10.2 Cg_exo -65.61 148.37 87.17 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.958 2.439 . . . . 7.4 111.968 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -55.58 129.67 70.25 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 110.315 -0.254 . . . . 9.06 110.315 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.52 111.06 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.392 2.061 . . . . 11.06 112.663 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -82.47 -162.72 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.711 2.274 . . . . 13.5 112.068 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 93.8 mt -81.93 31.03 0.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.386 -0.37 . . . . 15.76 110.89 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.485 ' HB1' ' OD1' ' A' ' 453' ' ' ASP . . . -84.12 132.67 47.26 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 16.74 111.241 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.46 29.61 0.43 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.417 2.078 . . . . 18.53 112.595 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.485 ' OD1' ' HB1' ' A' ' 451' ' ' ALA . 1.3 m-20 -75.17 136.1 41.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.914 0.388 . . . . 20.55 110.945 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.231 -0.89 . . . . 21.22 110.946 179.904 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.539 -0.224 . . . . 11.64 112.539 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 22.7 t 57.68 -137.62 0.93 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 110.481 -0.192 . . . . 9.86 110.481 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . 0.526 ' HE1' ' HA ' ' A' ' 368' ' ' PRO . 28.8 t-80 56.03 58.39 4.41 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.89 0.376 . . . . 8.07 110.393 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 24.2 ptm -55.6 125.34 20.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.173 -0.467 . . . . 5.51 111.117 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 54.97 113.23 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.823 -0.626 . . . . 6.06 111.713 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . 0.526 ' HA ' ' HE1' ' A' ' 365' ' ' HIS . 60.6 Cg_endo -75.59 34.08 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.464 2.109 . . . . 6.16 112.71 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 27.6 tp -178.88 -48.4 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.268 -0.424 . . . . 6.94 110.684 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.7 31.47 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.134 0.492 . . . . 5.63 109.999 179.378 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -79.55 158.58 27.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.953 -0.567 . . . . 5.04 110.956 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -46.07 146.0 1.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.064 -0.517 . . . . 5.39 111.648 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 69.3 mt -51.12 135.17 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.756 -0.656 . . . . 1.48 111.057 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 30.4 m-20 -88.22 110.47 20.74 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.23 -0.441 . . . . 2.17 110.854 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.447 HD13 ' C ' ' A' ' 398' ' ' LEU . 82.0 mt -76.48 -34.75 25.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.92 111.623 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 80.4 p -70.17 64.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 1.71 111.643 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 12.4 pt-20 -174.66 -27.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.904 -0.589 . . . . 1.92 110.073 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 2.7 m120 -149.49 60.26 4.45 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.77 . . . . 2.14 112.413 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 73.3 Cg_exo -55.69 -40.92 82.46 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.713 2.276 . . . . 0.85 112.341 179.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -69.4 -30.05 67.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 1.21 111.94 -179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 88.1 tttt -44.92 130.03 7.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.001 0.429 . . . . 1.66 111.005 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.536 HG21 ' HD3' ' A' ' 394' ' ' ARG . 38.4 mm -91.99 135.01 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.41 111.5 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.662 ' HB3' HG23 ' A' ' 432' ' ' ILE . 1.6 m-85 -119.95 143.13 48.17 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.961 -0.385 . . . . 0.63 109.961 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.419 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 4.3 m-85 -92.65 136.18 33.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.777 -0.369 . . . . 0.96 110.597 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 385' ' ' ILE . 3.1 mp -125.61 128.37 72.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.868 0.366 . . . . 0.49 110.935 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.656 ' N ' HD23 ' A' ' 439' ' ' LEU . 78.8 ttt180 -81.8 120.65 25.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.994 -0.548 . . . . 2.42 110.801 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.405 ' HB2' ' OD1' ' A' ' 389' ' ' ASP . 59.0 mtm180 -74.63 166.59 23.31 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.759 -0.377 . . . . 2.3 110.623 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' A' ' 388' ' ' GLU . 9.0 mp0 -49.66 -44.67 47.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.29 -0.414 . . . . 2.82 111.398 -179.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 387' ' ' ARG . 41.4 p-10 -65.72 -35.11 79.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.429 -0.351 . . . . 1.23 111.353 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.524 ' HA2' ' HE ' ' A' ' 386' ' ' ARG . . . 130.2 -29.21 3.72 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.76 -0.734 . . . . 1.03 112.293 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 51.3 p -59.48 113.63 2.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.241 0.544 . . . . 0.98 111.843 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 49.1 t -72.62 143.09 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.399 -0.818 . . . . 0.55 111.49 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -146.56 145.09 30.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.707 -0.679 . . . . 2.43 109.35 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.547 ' HB2' ' CG1' ' A' ' 417' ' ' VAL . 55.0 mtt85 -74.07 145.93 44.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.482 0.658 . . . . 2.96 111.604 -178.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -146.42 125.05 2.14 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 114.891 -1.05 . . . . 0.26 110.996 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -81.84 84.07 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.783 0.325 . . . . 1.28 111.132 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.893 HG23 HG22 ' A' ' 414' ' ' VAL . 0.6 OUTLIER -59.0 132.31 23.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.144 -0.48 . . . . 0.83 110.457 179.9 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.447 ' C ' HD13 ' A' ' 375' ' ' ILE . 59.4 mt -120.64 -38.8 2.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.157 -0.474 . . . . 1.45 112.128 -178.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -119.8 170.51 9.16 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.177 0.513 . . . . 2.08 112.076 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 94.1 p -165.69 151.22 9.05 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.437 -0.801 . . . . 0.56 109.9 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -162.3 137.43 7.07 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.388 0.514 . . . . 1.55 112.388 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.516 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 35.9 p -86.34 135.61 33.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.86 -0.609 . . . . 1.79 109.429 177.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.856 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.3 m -60.29 -174.7 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.67 0.272 . . . . 1.95 110.917 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.856 ' H ' HG22 ' A' ' 403' ' ' THR . 4.8 mm-40 -50.66 -42.61 56.75 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.992 0.367 . . . . 3.87 111.992 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.577 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 50.8 t30 -56.65 -48.87 76.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.719 0.295 . . . . 3.16 110.837 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 53.19 52.16 14.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 2.18 111.529 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.484 ' HB3' ' ND2' ' A' ' 405' ' ' ASN . . . -153.53 10.23 0.42 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.44 0.638 . . . . 2.77 109.642 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 409' ' ' PRO . . . 179.81 -48.32 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.688 -1.142 . . . . 2.76 110.122 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 36.3 Cg_exo -60.57 141.64 95.81 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.677 2.252 . . . . 2.49 112.745 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -173.16 127.73 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.652 -0.704 . . . . 2.14 110.784 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 400' ' ' SER . 9.2 mp0 -120.42 134.59 55.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.782 -0.645 . . . . 2.1 109.675 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 412' ' ' TYR . 1.2 m-85 -110.03 123.45 49.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.806 0.336 . . . . 0.72 111.649 -178.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 19.7 t80 -63.86 119.3 9.74 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.317 -0.624 . . . . 0.51 109.317 178.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.893 HG22 HG23 ' A' ' 397' ' ' VAL . 22.6 t -112.36 135.77 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.461 0.912 . . . . 1.15 113.461 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -111.14 89.38 3.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.996 -1.002 . . . . 0.62 108.543 177.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 62.5 m-85 -52.18 103.16 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.281 0.563 . . . . 0.65 110.904 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.547 ' CG1' ' HB2' ' A' ' 394' ' ' ARG . 11.3 p -62.44 136.46 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.147 -0.933 . . . . 1.34 110.932 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 80.43 -47.97 3.54 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.235 -0.746 . . . . 0.82 111.235 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.525 ' HB3' HD22 ' A' ' 423' ' ' LEU . 2.0 mm? -65.68 159.77 24.22 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.74 0.305 . . . . 1.6 110.634 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.553 ' OD1' HD13 ' A' ' 423' ' ' LEU . 21.3 p30 -51.62 141.67 15.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 2.53 111.082 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 31.9 ptt85 -60.55 -33.05 72.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.233 -0.44 . . . . 3.98 111.918 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -56.4 -29.61 61.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 3.71 111.1 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.553 HD13 ' OD1' ' A' ' 420' ' ' ASN . 1.2 tp -58.1 -26.7 62.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 1.49 111.661 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -44.79 135.17 5.21 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.948 0.404 . . . . 1.2 111.174 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -178.82 145.98 7.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.01 -0.614 . . . . 0.7 112.189 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -67.49 121.3 15.51 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.99 -0.374 . . . . 0.61 109.99 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.512 HG22 ' CG2' ' A' ' 414' ' ' VAL . 6.4 m -118.79 149.59 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 0.89 111.537 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -63.27 146.97 50.61 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.625 -0.798 . . . . 1.72 111.674 178.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 37.1 tpt85 -51.34 -29.73 16.21 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.684 0.253 . . . . 1.73 111.684 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.414 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 22.7 p-80 -60.37 -31.94 70.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.955 0.354 . . . . 1.47 111.955 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 385' ' ' ILE . 99.4 mtt180 -79.03 -30.94 44.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.355 -0.384 . . . . 2.84 110.93 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.662 HG23 ' HB3' ' A' ' 383' ' ' TYR . 95.7 mt -89.03 129.93 39.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.46 111.603 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.71 ' HB2' HD11 ' A' ' 439' ' ' LEU . 69.6 m -169.09 140.05 2.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.803 -0.635 . . . . 0.53 110.5 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -75.82 16.21 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.415 -0.357 . . . . 1.35 111.269 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.787 HD21 ' HB2' ' A' ' 437' ' ' ASP . 51.9 t30 -139.45 131.39 27.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.891 0.377 . . . . 2.16 110.652 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -71.72 -37.17 70.65 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.627 0.603 . . . . 0.75 112.627 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . 0.787 ' HB2' HD21 ' A' ' 435' ' ' ASN . 55.5 m-20 -52.51 -40.72 62.75 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.727 0.299 . . . . 1.34 111.597 -178.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 435' ' ' ASN . 61.5 m-20 -64.19 -24.58 67.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.391 -0.368 . . . . 1.56 111.335 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.4 mp -94.81 -85.46 0.31 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.159 -0.473 . . . . 1.12 112.191 -179.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -179.65 51.85 0.09 OUTLIER Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.097 -1.049 . . . . 1.36 113.661 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 68.31 143.97 0.11 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.724 -0.751 . . . . 1.83 113.363 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.488 HG22 HG22 ' A' ' 443' ' ' THR . 46.8 mm -65.59 95.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.485 -0.191 . . . . 1.48 110.485 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.488 HG22 HG22 ' A' ' 442' ' ' ILE . 8.1 t 37.35 53.29 1.3 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.855 0.836 . . . . 3.05 111.385 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . . . . . . . . . 6.4 p -148.12 132.07 9.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.627 -1.17 . . . . 4.18 111.431 -179.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 446' ' ' PRO . 95.8 mt -151.61 131.68 7.07 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.777 -0.647 . . . . 4.99 110.573 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 445' ' ' LEU . 23.9 Cg_exo -64.81 -154.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.694 2.263 . . . . 7.4 112.702 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.92 137.6 69.5 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.894 -0.594 . . . . 9.06 111.583 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.85 140.32 72.85 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.673 2.248 . . . . 11.06 112.068 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.74 131.12 31.95 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.524 2.149 . . . . 13.5 112.288 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 79.4 mt -66.34 129.68 40.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 15.76 110.819 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . -175.55 130.83 0.41 Allowed Pre-proline 0 C--N 1.333 -0.13 0 CA-C-N 116.36 -0.382 . . . . 16.74 111.279 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 451' ' ' ALA . 12.4 Cg_exo -70.23 143.4 48.47 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.878 2.385 . . . . 18.53 112.114 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 38.7 t70 59.81 49.16 8.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.217 -0.447 . . . . 20.55 110.919 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.237 -0.887 . . . . 21.22 110.669 179.966 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.472 -0.251 . . . . 11.64 112.472 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 79.5 p -61.6 -45.33 94.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.783 0.325 . . . . 9.86 110.828 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -159.4 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.196 -0.457 . . . . 8.07 110.48 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . 0.542 ' HG3' ' HA ' ' A' ' 408' ' ' ALA . 94.7 mmm -63.36 147.81 50.12 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.678 0.275 . . . . 5.51 110.675 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -118.56 61.23 4.6 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 112.036 0.384 . . . . 6.06 112.036 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . 0.486 ' HD3' ' C ' ' A' ' 366' ' ' MET . 89.0 Cg_endo -83.94 34.98 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.534 2.156 . . . . 6.16 111.593 179.179 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.706 HD12 ' N ' ' A' ' 370' ' ' MET . 4.2 pp -154.77 -32.15 0.1 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.542 -0.754 . . . . 6.94 110.142 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.706 ' N ' HD12 ' A' ' 369' ' ' LEU . 41.4 ttp -107.55 31.48 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.838 -0.619 . . . . 5.63 110.091 179.213 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -64.04 139.8 58.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.526 . . . . 5.04 111.067 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.451 ' O ' HD13 ' A' ' 373' ' ' ILE . 91.4 mttt -147.78 57.92 1.11 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.879 0.371 . . . . 5.39 111.44 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 372' ' ' LYS . 21.9 mm -137.72 74.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 1.48 110.254 179.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -87.09 110.49 20.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.125 0.488 . . . . 2.17 111.084 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.75 HD11 HG12 ' A' ' 397' ' ' VAL . 72.0 mt -79.89 -39.01 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.678 -0.692 . . . . 0.92 111.248 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 58.1 m -70.71 58.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.597 -0.729 . . . . 1.71 111.983 -179.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -174.47 -30.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 1.92 110.47 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.497 HD22 ' C ' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -156.12 58.41 1.74 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.796 -0.638 . . . . 2.14 111.172 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 378' ' ' ASN . 51.3 Cg_exo -53.72 -39.33 84.0 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.198 1.932 . . . . 0.85 111.461 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.41 ' HA ' ' OE1' ' A' ' 396' ' ' GLN . 1.4 m-20 -64.32 -31.59 72.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.67 -0.696 . . . . 1.21 111.175 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 378' ' ' ASN . 83.7 tttt -45.83 125.45 6.17 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.016 0.436 . . . . 1.66 110.805 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.839 HD12 HG21 ' A' ' 417' ' ' VAL . 21.4 mm -79.71 123.75 36.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.91 -0.586 . . . . 0.41 111.902 -179.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -110.08 143.86 39.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.627 -0.508 . . . . 0.63 109.627 178.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.531 ' HB2' ' CD1' ' A' ' 439' ' ' LEU . 19.6 m-85 -91.47 138.83 31.27 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.822 -0.351 . . . . 0.96 110.617 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.742 HG12 HG21 ' A' ' 414' ' ' VAL . 2.7 mp -124.33 130.35 73.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.313 -0.403 . . . . 0.49 111.439 -179.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 439' ' ' LEU . 57.4 ttt-85 -99.05 122.23 42.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 2.42 110.926 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -82.7 -173.25 4.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.506 -0.316 . . . . 2.3 110.74 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.444 ' N ' ' OE1' ' A' ' 388' ' ' GLU . 0.4 OUTLIER -63.71 -44.62 93.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.835 0.35 . . . . 2.82 110.828 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -71.17 5.57 2.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.115 -0.493 . . . . 1.23 111.249 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 71.35 28.89 69.05 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.021 -0.609 . . . . 1.03 113.074 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 444' ' ' VAL . 42.3 p -93.9 110.33 22.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.668 0.27 . . . . 0.98 111.04 179.274 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.713 HG11 HD13 ' A' ' 442' ' ' ILE . 42.1 t -74.59 131.57 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.852 -0.425 . . . . 0.55 109.852 179.13 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -145.39 135.52 23.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.454 -0.339 . . . . 2.43 111.038 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.515 ' HD3' HG21 ' A' ' 382' ' ' ILE . 58.9 mtt85 -58.9 150.59 23.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.967 0.413 . . . . 2.96 111.576 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -177.05 132.84 2.11 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.755 -0.657 . . . . 0.26 112.097 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' A' ' 380' ' ' ASP . 76.7 mt-30 -90.51 129.72 36.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.64 0.257 . . . . 1.28 111.535 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.855 HG22 HD13 ' A' ' 432' ' ' ILE . 5.8 t -85.4 126.85 40.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 109.613 -0.514 . . . . 0.83 109.613 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 70.5 mt -121.12 -40.14 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.214 0.45 . . . . 1.45 112.214 -178.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.546 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 98.3 mm-40 -128.6 176.45 7.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.987 0.422 . . . . 2.08 112.04 -178.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 87.7 p -161.83 149.4 14.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.684 -0.689 . . . . 0.56 110.594 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -162.49 143.8 10.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.107 0.479 . . . . 1.55 111.33 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.721 HG22 ' HA ' ' A' ' 410' ' ' ASP . 30.2 p -115.13 134.03 55.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.741 -0.663 . . . . 1.79 109.489 178.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.777 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.9 m -58.42 -174.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.889 -0.411 . . . . 1.95 109.889 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.777 ' H ' HG22 ' A' ' 403' ' ' THR . 4.8 mm-40 -39.64 -44.78 1.55 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 3.87 110.207 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -94.09 129.29 40.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.712 -0.676 . . . . 3.16 109.345 178.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -113.89 57.6 0.69 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.164 0.506 . . . . 2.18 111.489 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -138.71 11.35 2.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.623 -0.717 . . . . 2.77 110.028 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.542 ' HA ' ' HG3' ' A' ' 366' ' ' MET . . . -173.8 -46.01 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.077 -0.965 . . . . 2.76 110.951 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 19.8 Cg_exo -68.62 38.85 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 123.162 2.574 . . . . 2.49 113.897 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.721 ' HA ' HG22 ' A' ' 402' ' ' THR . 1.2 m-20 -81.28 131.78 35.31 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.417 -0.586 . . . . 2.14 109.417 178.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 427' ' ' VAL . 50.1 mt-10 -136.79 134.97 37.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.731 0.3 . . . . 2.1 111.265 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 429' ' ' ARG . 1.4 m-85 -119.21 127.62 53.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.482 -0.326 . . . . 0.72 111.113 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.546 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 15.0 t80 -57.82 143.5 42.08 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.483 -0.562 . . . . 0.51 109.483 178.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.742 HG21 HG12 ' A' ' 385' ' ' ILE . 5.7 p -143.8 110.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.688 0.625 . . . . 1.15 112.688 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -90.58 96.49 10.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.483 -0.78 . . . . 0.62 109.254 178.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.527 ' CB ' ' HB2' ' A' ' 419' ' ' LEU . 54.4 m-85 -51.83 125.88 16.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.248 0.547 . . . . 0.65 111.067 -178.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.839 HG21 HD12 ' A' ' 382' ' ' ILE . 2.5 t -79.32 34.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.256 -0.884 . . . . 1.34 111.105 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -179.53 -45.88 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.564 -0.744 . . . . 0.82 112.679 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.851 HD23 HD23 ' A' ' 423' ' ' LEU . 7.0 mp -63.98 155.55 30.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.137 0.494 . . . . 1.6 111.458 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.494 ' HB2' HD13 ' A' ' 423' ' ' LEU . 1.8 m120 -50.43 142.31 10.68 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.45 -0.796 . . . . 2.53 111.693 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.729 ' HD2' ' N ' ' A' ' 422' ' ' ARG . 7.1 ppt_? -58.4 -29.88 66.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.176 -0.466 . . . . 3.98 110.822 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . 0.729 ' N ' ' HD2' ' A' ' 421' ' ' ARG . 38.0 ptt180 -63.98 -37.15 86.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 3.71 110.321 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.851 HD23 HD23 ' A' ' 419' ' ' LEU . 7.0 mp -61.92 -33.35 74.08 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.877 -0.601 . . . . 1.49 110.755 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -50.63 138.19 18.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.681 -0.69 . . . . 1.2 111.141 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -170.99 -141.18 3.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.824 -0.703 . . . . 0.7 112.506 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -122.26 132.58 54.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.859 0.361 . . . . 0.61 110.873 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.624 HG21 HG13 ' A' ' 432' ' ' ILE . 20.3 m -110.81 155.64 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 0.89 111.693 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.489 ' H ' ' NH1' ' A' ' 431' ' ' ARG . . . -71.35 21.32 0.69 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.065 -0.588 . . . . 1.72 113.935 -179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.51 ' HB2' ' CD1' ' A' ' 412' ' ' TYR . 37.7 tpt85 70.64 -46.17 0.62 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.138 0.792 . . . . 1.73 113.138 178.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -59.89 -14.69 16.58 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.67 0.748 . . . . 1.47 109.33 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.489 ' NH1' ' H ' ' A' ' 428' ' ' GLY . 58.0 mtt85 -79.06 -34.89 43.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.571 -1.195 . . . . 2.84 111.221 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.855 HD13 HG22 ' A' ' 397' ' ' VAL . 65.8 mt -87.63 137.34 21.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.857 0.36 . . . . 0.46 110.869 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 69.0 m -159.69 138.8 11.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.53 110.721 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.17 -18.89 60.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 1.35 110.811 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -108.59 132.93 53.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.105 -0.498 . . . . 2.16 111.017 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . 0.457 ' HB1' HG12 ' A' ' 442' ' ' ILE . . . -66.23 -38.73 88.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.75 111.519 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -51.87 -40.73 61.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.308 -0.406 . . . . 1.34 111.257 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -81.69 41.1 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 1.56 110.624 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.556 ' O ' ' HD2' ' A' ' 386' ' ' ARG . 54.7 mt -152.62 -85.88 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.42 . . . . 1.12 111.34 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . 0.585 ' O ' HG22 ' A' ' 443' ' ' THR . . . -165.01 32.91 0.25 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.444 -0.884 . . . . 1.36 112.857 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 54.25 36.94 58.28 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 121.144 -0.55 . . . . 1.83 113.604 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.713 HD13 HG11 ' A' ' 392' ' ' VAL . 48.0 mm 47.05 80.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 111.76 0.281 . . . . 1.48 111.76 178.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 440' ' ' GLY . 15.1 t -172.81 133.37 0.57 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.202 0.525 . . . . 3.05 112.043 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.443 ' HA ' HG22 ' A' ' 391' ' ' THR . 28.8 m -87.66 121.56 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.604 -0.725 . . . . 4.18 111.18 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.463 HD12 ' N ' ' A' ' 445' ' ' LEU . 7.2 mp -76.64 120.29 81.03 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.486 . . . . 4.99 110.973 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.57 146.21 60.66 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.968 2.445 . . . . 7.4 112.592 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . 62.85 71.83 0.64 Allowed Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.03 -0.532 . . . . 9.06 111.841 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.26 133.64 35.96 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.545 2.163 . . . . 11.06 112.182 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -77.15 50.22 3.06 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.634 2.222 . . . . 13.5 112.847 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 59.7 tp -174.49 136.86 0.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.241 -0.436 . . . . 15.76 110.955 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . 64.92 128.36 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 115.958 -0.564 . . . . 16.74 111.404 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 451' ' ' ALA . 24.7 Cg_exo -63.23 135.41 50.35 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.759 2.306 . . . . 18.53 112.262 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -79.29 43.0 0.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 20.55 111.172 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.166 -0.921 . . . . 21.22 110.85 179.797 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.534 -0.226 . . . . 11.64 112.534 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 49.6 m -60.17 -48.21 82.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.347 . . . . 9.86 110.75 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -65.53 132.88 50.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 8.07 110.694 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 51.0 ttm -114.88 133.74 55.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 5.51 111.072 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.465 ' OD1' ' HG2' ' A' ' 371' ' ' GLN . 2.0 p30 -61.65 131.23 92.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.068 -0.515 . . . . 6.06 110.594 179.567 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -87.05 44.25 1.1 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.639 2.226 . . . . 6.16 113.557 -179.113 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 369' ' ' LEU . 2.5 pt? -164.69 -42.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.744 -0.382 . . . . 6.94 111.652 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . . . . . . . . . 36.6 ttp -86.82 46.87 1.41 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.926 0.393 . . . . 5.63 111.148 -179.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.465 ' HG2' ' OD1' ' A' ' 367' ' ' ASP . 3.4 mm100 -134.75 41.3 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.12 0.486 . . . . 5.04 110.516 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -155.43 142.64 19.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.333 -0.849 . . . . 5.39 110.169 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.622 HD11 ' NH1' ' A' ' 429' ' ' ARG . 67.5 mt -141.34 121.24 11.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.873 0.368 . . . . 1.48 111.782 -179.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.573 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 3.6 m-20 -91.68 68.53 5.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.026 -0.534 . . . . 2.17 110.372 178.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.543 HD11 HG12 ' A' ' 397' ' ' VAL . 75.3 mt -51.86 -34.74 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.92 112.073 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 37.6 t -47.8 -24.8 1.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.192 -0.458 . . . . 1.71 112.201 -178.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 11.9 pt-20 -69.22 -37.82 78.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.321 -0.4 . . . . 1.92 111.848 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.453 HD22 ' C ' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -154.17 65.0 4.89 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 111.695 0.257 . . . . 2.14 111.695 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.85 -37.66 85.24 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.396 2.064 . . . . 0.85 111.673 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -64.29 -33.67 76.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.684 -0.689 . . . . 1.21 111.168 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -52.19 127.96 23.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.944 0.402 . . . . 1.66 110.935 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.452 ' CG2' ' HB3' ' A' ' 394' ' ' ARG . 45.1 mm -87.36 131.42 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.971 -0.559 . . . . 0.41 111.604 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -111.24 144.29 40.66 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.255 -0.429 . . . . 0.63 110.026 179.104 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.52 ' C ' HD12 ' A' ' 385' ' ' ILE . 18.2 m-85 -88.92 142.43 27.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.979 -0.288 . . . . 0.96 110.673 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.643 HG12 HG21 ' A' ' 414' ' ' VAL . 3.4 mp -123.96 133.53 69.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.981 0.42 . . . . 0.49 111.92 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.577 ' NH1' ' HA3' ' A' ' 440' ' ' GLY . 42.7 ttt85 -87.14 117.0 25.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 2.42 110.455 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.429 ' HD3' ' OG1' ' A' ' 391' ' ' THR . 58.3 mtp85 -70.12 169.52 13.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.754 0.311 . . . . 2.3 111.142 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -51.72 -45.52 63.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.191 -0.459 . . . . 2.82 111.339 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.53 -36.05 76.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.316 -0.402 . . . . 1.23 111.021 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 120.29 36.14 0.82 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.966 -0.635 . . . . 1.03 112.5 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 443' ' ' THR . 17.5 p -110.71 114.48 27.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.188 0.518 . . . . 0.98 111.289 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 439' ' ' LEU . 91.9 t -66.66 135.02 29.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.456 -0.793 . . . . 0.55 111.842 -178.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -153.77 132.26 12.11 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.411 -0.813 . . . . 2.43 110.38 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.452 ' HB3' ' CG2' ' A' ' 382' ' ' ILE . 73.6 mtt-85 -54.56 154.07 5.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.355 0.598 . . . . 2.96 112.354 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -169.59 135.14 3.44 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.145 -0.934 . . . . 0.26 111.499 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -91.61 111.21 22.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.807 0.303 . . . . 1.28 111.76 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.74 HG22 HD13 ' A' ' 432' ' ' ILE . 4.1 t -74.87 129.09 36.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 109.942 -0.392 . . . . 0.83 109.942 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 77.0 mt -121.2 -41.28 2.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.362 0.504 . . . . 1.45 112.362 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.526 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 72.5 mt-30 -135.47 177.03 8.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.963 0.411 . . . . 2.08 111.577 -178.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 412' ' ' TYR . 80.8 p -151.53 139.39 19.91 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.901 -0.59 . . . . 0.56 110.72 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -154.69 144.08 21.3 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.334 -0.394 . . . . 1.55 111.136 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.542 HG22 ' HA ' ' A' ' 410' ' ' ASP . 41.6 p -94.47 -121.72 0.1 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.713 -0.477 . . . . 1.79 109.713 178.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.755 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.3 m -164.71 -173.38 2.98 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.607 -0.516 . . . . 1.95 109.607 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.755 ' H ' HG22 ' A' ' 403' ' ' THR . 48.9 mt-10 -43.67 -43.42 5.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.758 0.313 . . . . 3.87 111.389 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -70.28 -51.88 27.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 3.16 111.308 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 54.08 53.06 11.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.328 0.585 . . . . 2.18 110.864 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.431 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -162.35 12.38 0.07 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.172 -0.922 . . . . 2.77 109.273 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.697 ' H ' ' HD2' ' A' ' 409' ' ' PRO . . . -161.04 -41.52 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.448 -1.251 . . . . 2.76 111.716 -178.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.697 ' HD2' ' H ' ' A' ' 408' ' ' ALA . 75.5 Cg_exo -52.21 -62.27 0.39 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.234 1.956 . . . . 2.49 113.708 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.542 ' HA ' HG22 ' A' ' 402' ' ' THR . 6.6 p-10 36.02 74.39 0.07 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.228 0.537 . . . . 2.14 111.231 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.41 147.72 30.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 2.1 110.779 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 429' ' ' ARG . 6.0 m-85 -127.21 125.15 40.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.374 . . . . 0.72 111.203 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.526 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 15.5 t80 -57.84 149.89 21.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.923 -0.58 . . . . 0.51 110.414 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.643 HG21 HG12 ' A' ' 385' ' ' ILE . 11.2 p -155.82 138.05 6.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.143 0.497 . . . . 1.15 112.212 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -115.02 101.49 9.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.68 -0.691 . . . . 0.62 110.386 179.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' A' ' 419' ' ' LEU . 8.6 m-85 -62.1 116.1 4.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.193 -0.458 . . . . 0.65 111.298 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.442 ' O ' HD23 ' A' ' 419' ' ' LEU . 63.1 t -67.58 130.42 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 1.34 111.054 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 76.77 -42.8 1.83 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.859 -0.686 . . . . 0.82 112.761 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 416' ' ' TYR . 2.0 mm? -59.33 152.85 20.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.862 0.363 . . . . 1.6 111.209 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.754 HD21 HD13 ' A' ' 423' ' ' LEU . 11.8 p-10 -49.73 136.53 17.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 2.53 111.349 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.423 HH11 ' HG3' ' A' ' 421' ' ' ARG . 60.9 mtt85 -57.35 -40.47 78.13 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.84 0.682 . . . . 3.98 112.84 -178.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . 0.434 ' CG ' HD22 ' A' ' 420' ' ' ASN . 16.9 ptp180 -53.84 -29.15 39.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.777 0.323 . . . . 3.71 110.864 -179.398 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.754 HD13 HD21 ' A' ' 420' ' ' ASN . 1.2 tp -59.26 -34.13 71.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 1.49 110.858 179.056 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -48.21 138.14 9.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.945 -0.57 . . . . 1.2 111.311 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -177.87 -142.91 4.82 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.001 -0.618 . . . . 0.7 112.121 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -128.6 134.59 48.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.376 . . . . 0.61 110.639 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.765 HG21 HG13 ' A' ' 432' ' ' ILE . 29.3 m -109.38 158.76 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.944 -0.571 . . . . 0.89 111.887 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -77.46 35.01 1.56 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.834 -0.621 . . . . 1.72 114.441 -179.135 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.622 ' NH1' HD11 ' A' ' 373' ' ' ILE . 23.6 tpt180 70.69 -70.37 0.15 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.248 0.833 . . . . 1.73 113.248 178.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -45.39 -16.12 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.947 0.403 . . . . 1.47 111.707 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.586 ' HB3' HG23 ' A' ' 385' ' ' ILE . 53.4 mtt85 -77.47 -39.06 47.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.956 -0.565 . . . . 2.84 111.333 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.765 HG13 HG21 ' A' ' 427' ' ' VAL . 86.7 mt -87.04 132.07 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.155 -0.313 . . . . 0.46 110.155 179.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.756 ' HB2' HD11 ' A' ' 439' ' ' LEU . 61.0 m -164.0 142.13 7.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.53 111.136 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -58.72 -26.09 63.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.076 -0.511 . . . . 1.35 110.793 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -121.78 135.15 54.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.161 -0.472 . . . . 2.16 110.851 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . 0.498 ' HA ' HD13 ' A' ' 439' ' ' LEU . . . -70.75 -10.96 60.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.75 111.635 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.07 -40.99 77.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 1.34 111.716 -179.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . 0.54 ' C ' HD12 ' A' ' 439' ' ' LEU . 61.1 m-20 -83.03 18.23 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.826 0.346 . . . . 1.56 111.337 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.756 HD11 ' HB2' ' A' ' 433' ' ' SER . 8.4 mp -118.02 -96.54 0.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.12 111.216 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . 0.577 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -173.9 41.61 0.14 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.323 -0.942 . . . . 1.36 113.431 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 444' ' ' VAL . . . 65.9 149.76 0.09 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.662 -0.78 . . . . 1.83 113.28 179.074 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 442' ' ' ILE . 1.5 mp -61.97 89.42 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 109.128 -0.693 . . . . 1.48 109.128 178.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 443' ' ' THR . 57.9 m 48.71 38.46 11.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.894 -1.048 . . . . 3.05 110.681 -178.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.462 ' O ' ' HA3' ' A' ' 441' ' ' GLY . 70.2 t -155.95 127.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.995 -1.002 . . . . 4.18 110.308 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 445' ' ' LEU . 3.6 mm? -70.88 125.45 92.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.502 -0.317 . . . . 4.99 111.064 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 445' ' ' LEU . 25.3 Cg_exo -62.81 137.84 65.46 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.602 2.201 . . . . 7.4 112.075 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -169.15 60.21 0.4 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 9.06 111.263 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . 0.732 ' HB2' HD13 ' A' ' 450' ' ' LEU . 71.0 Cg_endo -76.08 131.93 13.54 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.525 2.15 . . . . 11.06 112.377 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.469 ' C ' HD12 ' A' ' 450' ' ' LEU . 95.2 Cg_endo -78.08 49.66 3.06 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.682 2.254 . . . . 13.5 112.595 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . 0.732 HD13 ' HB2' ' A' ' 448' ' ' PRO . 5.8 mp -117.2 139.38 50.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 15.76 110.952 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 452' ' ' PRO . . . -168.96 133.32 1.29 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 16.74 110.99 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.442 ' O ' ' HB3' ' A' ' 453' ' ' ASP . 27.9 Cg_exo -61.34 132.5 41.43 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.532 2.155 . . . . 18.53 112.19 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 452' ' ' PRO . 30.2 t70 70.22 -64.66 0.35 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.938 -0.574 . . . . 20.55 111.619 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.3 -0.857 . . . . 21.22 110.767 179.981 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.629 -0.188 . . . . 11.64 112.629 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 52.5 m -72.57 133.82 44.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.767 0.318 . . . . 9.86 111.103 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . 0.494 ' HD2' ' H ' ' A' ' 366' ' ' MET . 0.4 OUTLIER -174.87 -29.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 8.07 111.068 179.604 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . 0.494 ' H ' ' HD2' ' A' ' 365' ' ' HIS . 49.8 tpp -178.33 131.91 0.14 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.68 -0.691 . . . . 5.51 110.442 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.461 ' OD2' ' HG ' ' A' ' 369' ' ' LEU . 37.4 t70 -63.8 121.88 73.55 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.447 -0.342 . . . . 6.06 110.612 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 367' ' ' ASP . 6.3 Cg_exo -74.08 -48.01 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.911 2.407 . . . . 6.16 113.786 -178.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.541 HD12 ' CB ' ' A' ' 370' ' ' MET . 4.3 pp -53.88 -30.82 47.53 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.063 -0.971 . . . . 6.94 110.579 -179.391 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.541 ' CB ' HD12 ' A' ' 369' ' ' LEU . 54.4 ttp -168.24 116.78 0.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.807 -0.633 . . . . 5.63 109.921 179.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.416 ' H ' ' CD ' ' A' ' 371' ' ' GLN . 16.0 mp0 -62.25 108.25 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.828 0.347 . . . . 5.04 110.634 -179.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.432 ' HB3' ' OH ' ' A' ' 412' ' ' TYR . 93.6 mttt 60.65 129.06 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.604 -0.725 . . . . 5.39 111.401 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.72 HG13 ' HE ' ' A' ' 429' ' ' ARG . 85.7 mt -65.5 133.25 30.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.295 -0.411 . . . . 1.48 111.622 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.418 ' HB2' ' CD ' ' A' ' 377' ' ' GLU . 31.6 m-20 -89.56 129.52 36.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 2.17 109.914 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.803 HD11 HG12 ' A' ' 397' ' ' VAL . 95.5 mt -88.26 -41.51 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.409 0.522 . . . . 0.92 112.409 -179.176 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.7 t -46.74 -21.13 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.284 -0.417 . . . . 1.71 111.865 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.418 ' CD ' ' HB2' ' A' ' 374' ' ' ASP . 6.7 mt-10 -61.77 -42.39 98.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.855 -0.611 . . . . 1.92 111.369 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.415 ' N ' ' ND2' ' A' ' 378' ' ' ASN . 0.1 OUTLIER -167.64 69.79 0.91 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 2.14 111.188 -179.21 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.47 -39.66 54.52 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.57 2.18 . . . . 0.85 112.158 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.79 -39.29 84.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 1.21 110.69 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 378' ' ' ASN . 82.0 tttt -54.66 130.83 41.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.144 -0.48 . . . . 1.66 111.048 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.553 HG21 ' HB3' ' A' ' 394' ' ' ARG . 28.7 mm -84.72 135.68 24.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.072 -0.513 . . . . 0.41 111.442 -179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -108.17 143.8 36.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.374 -0.375 . . . . 0.63 110.388 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.428 ' HB3' ' CG1' ' A' ' 392' ' ' VAL . 7.1 m-85 -88.22 133.64 33.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.603 0.24 . . . . 0.96 110.659 179.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 385' ' ' ILE . 1.9 mp -121.77 130.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.75 0.31 . . . . 0.49 110.699 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.492 ' CZ ' ' HA2' ' A' ' 390' ' ' GLY . 60.7 ttt-85 -80.71 117.15 21.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.373 -0.376 . . . . 2.42 110.648 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.751 ' HA ' ' HE ' ' A' ' 387' ' ' ARG . 2.0 mmp_? -68.17 164.81 19.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 2.3 110.571 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 388' ' ' GLU . 0.5 OUTLIER -51.71 -45.02 63.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 2.82 111.615 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.406 ' N ' ' HG2' ' A' ' 388' ' ' GLU . 40.8 p-10 -69.63 -35.72 75.48 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.679 0.252 . . . . 1.23 111.679 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.492 ' HA2' ' CZ ' ' A' ' 386' ' ' ARG . . . 138.8 -32.45 2.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.583 -0.818 . . . . 1.03 112.561 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 72.4 p -59.1 112.24 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.082 0.468 . . . . 0.98 111.657 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 384' ' ' PHE . 57.1 t -72.88 140.92 17.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.738 -0.665 . . . . 0.55 111.274 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -139.7 137.57 35.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 2.43 110.718 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.553 ' HB3' HG21 ' A' ' 382' ' ' ILE . 55.5 mtt85 -62.38 145.04 55.01 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.914 0.388 . . . . 2.96 110.923 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 416' ' ' TYR . . . -164.14 134.4 3.35 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.022 -0.608 . . . . 0.26 112.397 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . 0.541 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 90.0 mt-30 -82.19 132.28 35.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.531 0.205 . . . . 1.28 111.506 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.803 HG12 HD11 ' A' ' 375' ' ' ILE . 11.7 t -99.82 122.19 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.067 -0.716 . . . . 0.83 109.067 178.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.716 HD22 ' N ' ' A' ' 398' ' ' LEU . 0.7 OUTLIER -111.64 -41.91 3.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.703 0.631 . . . . 1.45 112.703 -177.026 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -132.95 176.45 8.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.993 0.425 . . . . 2.08 111.77 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 411' ' ' GLU . 88.2 p -164.27 147.45 9.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.753 -0.658 . . . . 0.56 110.863 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -160.66 134.2 6.8 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.002 0.43 . . . . 1.55 111.41 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.752 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 35.5 p -81.42 137.44 35.66 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.246 -0.434 . . . . 1.79 110.004 178.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.821 HG22 ' H ' ' A' ' 404' ' ' GLU . 2.1 m -62.13 -174.03 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 1.95 110.761 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.821 ' H ' HG22 ' A' ' 403' ' ' THR . 50.6 mt-10 -42.28 -41.84 2.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.977 0.362 . . . . 3.87 111.977 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.732 ' HB3' ' HG2' ' A' ' 409' ' ' PRO . 24.0 t-20 -57.43 -48.48 79.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 3.16 110.673 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.752 ' HA ' ' HB ' ' A' ' 402' ' ' THR . . . 56.63 57.23 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 2.18 111.997 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.521 ' HB3' ' OD1' ' A' ' 405' ' ' ASN . . . -168.95 10.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 2.77 110.629 179.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.474 ' N ' ' CD ' ' A' ' 409' ' ' PRO . . . 179.85 -43.8 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.729 -0.669 . . . . 2.76 111.918 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.732 ' HG2' ' HB3' ' A' ' 405' ' ' ASN . 11.7 Cg_exo -71.73 49.56 1.23 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.77 2.314 . . . . 2.49 114.193 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 1.8 p30 -78.17 126.73 31.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.847 0.356 . . . . 2.14 110.504 178.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 400' ' ' SER . 47.4 mt-10 -114.05 134.63 54.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 2.1 110.482 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.569 ' HB3' HG13 ' A' ' 397' ' ' VAL . 1.6 m-85 -111.91 134.05 53.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.973 0.416 . . . . 0.72 111.941 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 397' ' ' VAL . 17.8 t80 -66.57 138.41 57.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.691 -0.855 . . . . 0.51 108.691 177.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.551 HG11 HG12 ' A' ' 385' ' ' ILE . 21.7 t -140.78 110.08 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 113.202 0.815 . . . . 1.15 113.202 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . 0.484 ' HA ' ' OD1' ' A' ' 424' ' ' ASP . 86.4 t60 -90.1 88.5 7.29 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.661 -0.866 . . . . 0.62 108.661 177.176 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . 0.631 ' HB2' HD11 ' A' ' 419' ' ' LEU . 4.7 m-85 -57.95 116.01 3.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.807 0.813 . . . . 0.65 111.482 -178.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.482 HG21 ' CB ' ' A' ' 394' ' ' ARG . 5.5 m -53.87 129.56 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 CA-C-N 114.027 -1.442 . . . . 1.34 112.818 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 81.88 -52.1 4.55 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 115.415 0.926 . . . . 0.82 115.415 177.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.924 HD13 HD23 ' A' ' 423' ' ' LEU . 0.5 OUTLIER -62.18 162.52 9.48 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.901 0.851 . . . . 1.6 112.561 -177.706 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.617 HD22 ' HB3' ' A' ' 422' ' ' ARG . 56.0 t30 -59.68 143.51 50.5 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.507 -0.77 . . . . 2.53 111.877 -179.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . 0.66 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 99.3 mtt180 -53.39 -20.21 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 3.98 111.716 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . 0.617 ' HB3' HD22 ' A' ' 420' ' ' ASN . 2.6 tpm_? -55.32 -40.34 71.04 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.854 -0.612 . . . . 3.71 112.157 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.924 HD23 HD13 ' A' ' 419' ' ' LEU . 2.1 mm? -70.62 -35.13 72.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.87 0.322 . . . . 1.49 111.87 -179.249 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.66 ' OD2' ' HA ' ' A' ' 421' ' ' ARG . 62.3 m-20 -48.71 132.38 17.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.97 0.415 . . . . 1.2 111.407 -178.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.28 179.99 46.17 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.856 -0.687 . . . . 0.7 112.33 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . 0.57 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 36.2 m95 -76.8 139.21 40.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.605 0.24 . . . . 0.61 110.45 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.417 ' HB ' ' HD2' ' A' ' 431' ' ' ARG . 12.3 m -140.39 146.75 24.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.966 0.412 . . . . 0.89 111.492 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.453 ' HA3' ' CE1' ' A' ' 430' ' ' HIS . . . -59.21 149.16 39.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.873 -0.68 . . . . 1.72 112.407 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.72 ' HE ' HG13 ' A' ' 373' ' ' ILE . 37.9 tpt85 -52.09 -39.62 60.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.727 0.269 . . . . 1.73 111.727 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.453 ' CE1' ' HA3' ' A' ' 428' ' ' GLY . 19.5 p-80 -55.97 -26.7 49.33 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.143 0.423 . . . . 1.47 112.143 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.417 ' HD2' ' HB ' ' A' ' 427' ' ' VAL . 57.3 mtt85 -78.09 -38.58 43.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.845 0.313 . . . . 2.84 111.845 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 412' ' ' TYR . 59.6 mt -88.75 134.78 27.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.88 0.371 . . . . 0.46 111.154 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.746 ' HB2' HD21 ' A' ' 439' ' ' LEU . 71.1 m -160.64 139.74 10.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.53 110.928 -179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -74.37 16.75 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 1.35 111.719 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -138.47 131.31 29.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.986 0.422 . . . . 2.16 111.133 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . . . . . . . . . . . -67.33 -72.77 0.16 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.892 -0.594 . . . . 0.75 111.62 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -40.71 -39.3 1.05 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.927 -0.579 . . . . 1.34 111.715 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.87 47.37 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.301 -0.409 . . . . 1.56 111.298 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 433' ' ' SER . 94.7 mt -149.87 -84.81 0.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.644 -0.253 . . . . 1.12 111.405 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -163.3 40.91 0.33 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.508 -0.853 . . . . 1.36 113.089 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.21 146.83 0.32 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 1.83 113.237 179.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . . . . . . . . . 47.2 mm -57.0 145.92 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.671 0.272 . . . . 1.48 110.99 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 8.1 t -48.1 156.75 0.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 3.05 111.757 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 444' ' ' VAL . 45.9 t 65.93 59.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.382 0.61 . . . . 4.18 111.009 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . . . . . . . . . 91.0 mt -67.82 139.46 93.48 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.613 -0.722 . . . . 4.99 110.658 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.61 127.62 26.12 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.383 2.055 . . . . 7.4 112.305 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -73.6 130.35 83.91 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 9.06 111.453 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . 0.731 ' HG2' ' HB2' ' A' ' 451' ' ' ALA . 31.9 Cg_endo -64.81 141.92 73.85 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.428 2.085 . . . . 11.06 112.034 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.82 133.88 53.64 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.637 2.225 . . . . 13.5 112.637 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . . . . . . . . . 18.4 tp 52.9 42.12 32.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.879 -0.6 . . . . 15.76 110.992 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.731 ' HB2' ' HG2' ' A' ' 448' ' ' PRO . . . -73.51 133.69 80.04 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 16.74 111.232 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 453' ' ' ASP . 41.0 Cg_endo -67.21 129.39 20.35 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.322 2.015 . . . . 18.53 111.901 179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 452' ' ' PRO . 2.5 p30 54.48 135.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.822 0.701 . . . . 20.55 112.191 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.239 -0.886 . . . . 21.22 111.059 -179.883 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.572 -0.211 . . . . 11.64 112.572 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.4 t -60.97 -42.1 97.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.638 0.256 . . . . 9.86 110.889 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 75.6 t60 65.01 133.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.009 -0.541 . . . . 8.07 111.155 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 14.1 tpt -174.66 143.62 0.79 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 5.51 110.287 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.522 ' HB2' ' H ' ' A' ' 371' ' ' GLN . 12.0 p-10 -53.09 112.3 3.45 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.398 -0.365 . . . . 6.06 111.069 -179.613 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . 0.843 ' HD2' ' HG2' ' A' ' 371' ' ' GLN . 87.9 Cg_endo -80.42 42.58 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.891 1.727 . . . . 6.16 113.914 -178.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 370' ' ' MET . 2.0 tm? 166.75 -60.94 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.03 -0.73 . . . . 6.94 109.03 179.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 370' ' ' MET . . . . . 0.704 ' HG3' ' HE3' ' A' ' 372' ' ' LYS . 24.7 ttt 165.9 43.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.022 -1.444 . . . . 5.63 107.883 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.843 ' HG2' ' HD2' ' A' ' 368' ' ' PRO . 1.4 pt20 -75.56 50.03 0.52 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.103 -0.953 . . . . 5.04 112.298 -178.3 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.933 ' HG2' ' HB1' ' A' ' 408' ' ' ALA . 0.0 OUTLIER -139.8 57.98 1.61 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.571 0.7 . . . . 5.39 110.841 178.936 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 77.5 mt 59.15 97.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.136 -0.938 . . . . 1.48 111.977 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 377' ' ' GLU . 21.8 m-20 -88.95 137.7 32.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 2.17 110.673 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.562 HD11 HG12 ' A' ' 397' ' ' VAL . 79.4 mt -96.48 -46.62 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.206 0.527 . . . . 0.92 111.464 -180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 56.8 m -53.9 -18.15 3.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.297 -0.865 . . . . 1.71 111.613 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 374' ' ' ASP . 24.1 pt-20 -74.97 -40.47 60.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.134 -0.485 . . . . 1.92 111.917 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 378' ' ' ASN . . . . . 0.616 ' HB3' ' HB2' ' A' ' 381' ' ' LYS . 6.0 m120 -154.86 74.57 5.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 2.14 112.029 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.44 -40.74 81.91 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.68 2.254 . . . . 0.85 112.172 179.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -67.58 -37.56 82.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.848 -0.614 . . . . 1.21 111.36 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.616 ' HB2' ' HB3' ' A' ' 378' ' ' ASN . 63.9 tttp -50.35 129.44 21.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 1.66 111.261 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 40.2 mm -88.62 132.82 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.037 -0.529 . . . . 0.41 111.189 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.88 143.62 34.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.931 -0.396 . . . . 0.63 109.931 179.018 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -89.72 122.9 33.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.96 110.779 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 385' ' ' ILE . 2.1 mp -106.09 123.09 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 0.49 111.328 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.588 ' HB2' HD22 ' A' ' 439' ' ' LEU . 38.4 ttt85 -84.08 118.53 24.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 2.42 110.534 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -71.45 157.28 38.31 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.887 -0.325 . . . . 2.3 110.566 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.616 ' HA ' HH12 ' A' ' 431' ' ' ARG . 16.3 pt-20 -49.66 -41.2 42.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 2.82 111.74 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -67.01 -36.24 81.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.683 -0.235 . . . . 1.23 111.138 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.492 ' HA3' HD21 ' A' ' 445' ' ' LEU . . . 136.44 -33.68 2.33 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.448 -0.882 . . . . 1.03 112.842 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 57.6 p -59.17 113.87 2.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.317 0.579 . . . . 0.98 112.149 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.17 144.6 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.321 -0.854 . . . . 0.55 111.351 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -151.59 129.75 11.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.006 -0.543 . . . . 2.43 110.684 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.447 ' HG3' HH11 ' A' ' 394' ' ' ARG . 61.3 mtt85 -55.4 153.85 6.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.878 -0.601 . . . . 2.96 112.137 -179.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.454 ' HA3' HD13 ' A' ' 385' ' ' ILE . . . -175.75 135.24 2.91 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.416 -0.811 . . . . 0.26 112.114 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 414' ' ' VAL . 74.7 mt-30 -91.5 138.06 31.87 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.944 -0.151 . . . . 1.28 111.007 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.638 ' CG2' HD13 ' A' ' 432' ' ' ILE . 14.5 t -92.09 102.19 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.211 -0.662 . . . . 0.83 109.211 178.27 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 398' ' ' LEU . 6.2 mp -84.95 -36.81 21.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.594 -0.73 . . . . 1.45 112.473 -177.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 399' ' ' GLN . . . . . 0.546 ' H ' ' HB3' ' A' ' 413' ' ' TYR . 66.0 mt-30 -141.0 175.66 9.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.976 0.417 . . . . 2.08 111.333 -178.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 93.2 p -165.63 144.22 6.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.689 -0.687 . . . . 0.56 110.589 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.591 ' HG3' ' HB3' ' A' ' 410' ' ' ASP . 36.1 ptt180 -118.74 175.4 5.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 1.55 109.989 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 410' ' ' ASP . 26.6 p -127.82 133.38 49.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.128 0.489 . . . . 1.79 111.956 -179.161 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . 0.813 HG22 ' H ' ' A' ' 404' ' ' GLU . 1.4 m -63.19 -170.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.488 -0.778 . . . . 1.95 110.363 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.813 ' H ' HG22 ' A' ' 403' ' ' THR . 49.9 mt-10 -42.44 -35.61 1.08 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.667 0.27 . . . . 3.87 110.566 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -54.17 -46.42 72.32 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.697 -0.483 . . . . 3.16 109.697 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 402' ' ' THR . . . 62.07 64.33 1.0 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.38 -0.827 . . . . 2.18 111.409 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -166.91 -25.1 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.416 0.524 . . . . 2.77 112.416 -179.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 408' ' ' ALA . . . . . 0.933 ' HB1' ' HG2' ' A' ' 372' ' ' LYS . . . -165.46 -47.26 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 114.101 1.148 . . . . 2.76 114.101 -179.045 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 408' ' ' ALA . 55.7 Cg_exo -55.51 -155.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.676 2.25 . . . . 2.49 114.868 -177.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . 0.591 ' HB3' ' HG3' ' A' ' 401' ' ' ARG . 0.1 OUTLIER 80.38 -160.1 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.794 -1.094 . . . . 2.14 113.056 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 426' ' ' TRP . 95.1 mt-10 -106.48 149.02 27.5 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.067 -0.515 . . . . 2.1 111.554 -177.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.535 ' N ' ' HD1' ' A' ' 412' ' ' TYR . 0.4 OUTLIER -112.0 134.93 53.25 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.652 -0.704 . . . . 0.72 112.176 -177.952 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.546 ' HB3' ' H ' ' A' ' 399' ' ' GLN . 14.8 t80 -67.05 145.43 55.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.75 -0.659 . . . . 0.51 110.419 179.318 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.519 HG11 HG12 ' A' ' 385' ' ' ILE . 13.7 t -148.57 129.48 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.127 0.788 . . . . 1.15 113.127 -179.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 415' ' ' HIS . . . . . 0.46 ' HA ' ' OD2' ' A' ' 424' ' ' ASP . 56.0 t60 -105.32 104.03 13.68 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.87 -0.605 . . . . 0.62 109.539 177.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 416' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -66.22 128.84 37.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.933 0.397 . . . . 0.65 111.162 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.24 128.91 36.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.86 -0.609 . . . . 1.34 111.823 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 75.29 -47.17 1.97 Allowed Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.781 -0.645 . . . . 0.82 113.363 179.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.575 ' HB3' HD12 ' A' ' 423' ' ' LEU . 7.6 mp -59.74 161.95 5.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.418 . . . . 1.6 111.62 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 420' ' ' ASN . . . . . 0.469 ' HB3' ' HG2' ' A' ' 422' ' ' ARG . 75.8 m-20 -50.11 139.73 13.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.634 -0.712 . . . . 2.53 111.82 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 421' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -63.59 -31.21 72.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.659 -0.701 . . . . 3.98 111.199 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . 0.469 ' HG2' ' HB3' ' A' ' 420' ' ' ASN . 14.6 ptp180 -52.77 -35.02 55.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 3.71 111.196 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 423' ' ' LEU . . . . . 0.575 HD12 ' HB3' ' A' ' 419' ' ' LEU . 50.8 mt -56.09 -32.13 63.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 1.49 111.357 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' A' ' 415' ' ' HIS . 1.1 m-20 -47.73 134.1 13.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.906 0.384 . . . . 1.2 111.327 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 413' ' ' TYR . . . -179.84 -142.62 5.16 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.749 . . . . 0.7 112.242 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 426' ' ' TRP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 411' ' ' GLU . 37.3 m95 -122.49 138.56 54.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.937 0.399 . . . . 0.61 110.574 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.815 HG21 HG13 ' A' ' 432' ' ' ILE . 10.3 m -109.37 158.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.89 111.652 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 429' ' ' ARG . . . -75.31 27.17 1.23 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.651 -0.785 . . . . 1.72 113.391 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.672 ' H ' HG23 ' A' ' 427' ' ' VAL . 40.8 tpt85 70.9 -47.0 0.65 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.869 0.468 . . . . 1.73 112.144 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.415 ' HE1' ' NE ' ' A' ' 431' ' ' ARG . 10.6 p80 -69.95 -7.09 37.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 1.47 110.801 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.635 ' HB2' ' HB ' ' A' ' 427' ' ' VAL . 39.2 mmt180 -79.2 -37.3 38.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 2.84 110.817 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.815 HG13 HG21 ' A' ' 427' ' ' VAL . 56.4 mt -87.88 135.8 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.46 110.784 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 54.0 m -157.65 139.51 14.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.255 -0.43 . . . . 0.53 111.015 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -79.21 16.31 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 1.35 111.902 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -145.64 132.82 20.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.958 0.408 . . . . 2.16 111.096 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 436' ' ' ALA . . . . . 0.445 ' HB1' HD11 ' A' ' 442' ' ' ILE . . . -70.52 -43.72 69.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.75 111.434 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 437' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -55.09 -40.37 70.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.225 -0.443 . . . . 1.34 111.2 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -79.26 46.38 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 1.56 111.164 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.588 HD22 ' HB2' ' A' ' 386' ' ' ARG . 98.3 mt -151.08 -84.04 0.09 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.502 -0.317 . . . . 1.12 111.133 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . 0.541 ' HA3' ' NH1' ' A' ' 386' ' ' ARG . . . -175.0 52.3 0.13 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.927 -0.654 . . . . 1.36 112.402 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 72.36 -139.51 28.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.839 -0.696 . . . . 1.83 112.407 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 442' ' ' ILE . . . . . 0.621 HG22 HG22 ' A' ' 443' ' ' THR . 33.9 mm -148.52 120.6 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.95 -0.389 . . . . 1.48 109.95 179.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.66 ' O ' HG12 ' A' ' 444' ' ' VAL . 8.9 t 46.47 126.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 124.099 0.875 . . . . 3.05 112.834 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.66 HG12 ' O ' ' A' ' 443' ' ' THR . 1.6 p 55.12 128.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.358 -0.837 . . . . 4.18 112.058 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.492 HD21 ' HA3' ' A' ' 390' ' ' GLY . 92.3 mt -69.21 119.46 70.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.703 -0.68 . . . . 4.99 111.256 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -78.42 137.28 14.7 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.627 2.218 . . . . 7.4 112.201 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -171.51 132.13 0.8 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.507 -0.315 . . . . 9.06 111.471 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 448' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.68 142.17 69.3 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.671 2.247 . . . . 11.06 112.114 179.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.38 116.65 3.48 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.348 2.032 . . . . 13.5 112.132 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 450' ' ' LEU . . . . . 0.648 HD13 ' N ' ' A' ' 451' ' ' ALA . 1.9 tm? -82.64 131.72 35.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 15.76 110.206 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.648 ' N ' HD13 ' A' ' 450' ' ' LEU . . . -172.88 131.51 0.62 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.361 -0.381 . . . . 16.74 111.191 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.22 39.9 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.588 2.192 . . . . 18.53 112.441 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -174.67 52.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.065 0.46 . . . . 20.55 110.474 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.217 -0.897 . . . . 21.22 110.759 -179.922 . . . . . . . . 0 0 . 1 stop_ save_